data_2kom_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kom _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt . . . . . 0 CA--C 1.5 -0.956 0 CA-C-O 120.873 0.368 . . . . 73.1 111.216 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 76.4 mtm180 -103.16 145.12 30.4 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.179 -0.675 . . . . 55.34 109.179 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.6 mm? -124.29 126.26 45.74 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.054 -0.521 . . . . 75.41 110.064 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -91.62 115.58 28.16 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.051 0.929 . . . . 54.34 108.623 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 85.2 mt -124.72 121.71 61.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-N 115.409 -0.814 . . . . 73.02 111.221 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 75.2 mt-30 -104.33 130.22 52.18 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 120.288 -0.565 . . . . 65.21 110.551 172.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.431 ' CD2' ' HB2' ' A' ' 502' ' ' ASP . 94.8 mt -122.72 138.0 54.75 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.85 -1.068 . . . . 72.23 109.655 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -104.14 128.14 51.78 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-O 122.344 1.069 . . . . 72.33 112.63 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -53.12 115.15 1.73 Allowed 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 112.945 -1.934 . . . . 75.13 113.343 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -98.5 -139.22 10.68 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.922 -1.271 . . . . 73.54 109.922 171.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 31.3 m -68.99 -49.35 58.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.607 0.717 . . . . 75.55 109.679 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.67 56.1 0.95 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.101 -1.815 . . . . 74.25 106.101 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -41.61 -63.83 1.55 Allowed Glycine 0 CA--C 1.478 -2.23 0 CA-C-N 113.393 -1.731 . . . . 63.33 115.145 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 49.6 mt -85.43 82.26 8.38 Favored 'General case' 0 C--N 1.272 -2.79 0 C-N-CA 116.273 -2.171 . . . . 73.13 111.257 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -95.84 40.33 2.65 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 113.063 -1.88 . . . . 65.2 111.862 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -137.21 142.19 42.09 Favored 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 108.176 -1.046 . . . . 74.14 108.176 173.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.0 m -132.12 152.66 51.12 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 116.172 -0.467 . . . . 65.01 110.125 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 10.6 pt -109.51 160.8 8.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.612 -0.722 . . . . 72.4 112.544 -173.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' THR . . . . . 0.418 HG22 ' HD3' ' A' ' 491' ' ' LYS . 12.9 t -147.26 159.09 44.06 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.24 -1.022 . . . . 73.03 108.24 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 64.2 p . . . . . 0 C--N 1.299 -1.613 0 N-CA-C 108.041 -1.096 . . . . 75.11 108.041 173.203 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo . . . . . 0 N--CA 1.438 -1.763 0 CA-C-O 121.362 0.484 . . . . 64.41 112.476 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 42.8 mm -97.96 125.04 51.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.936 -1.135 . . . . 70.23 107.936 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -118.61 150.17 40.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 122.344 -0.222 . . . . 74.01 111.054 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 43.3 t -80.9 119.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 106.539 -1.652 . . . . 62.33 106.539 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.418 ' HD3' HG22 ' A' ' 476' ' ' THR . 55.0 tptt -91.3 -53.79 4.2 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.973 -0.558 . . . . 61.42 111.489 -174.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . 0.47 HD21 HD12 ' A' ' 494' ' ' LEU . 6.1 t30 -133.12 144.68 50.1 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.914 -0.714 . . . . 74.44 111.131 -171.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.456 HG12 ' HB1' ' A' ' 507' ' ' ALA . 31.9 mm -121.57 103.88 14.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.007 -0.997 . . . . 71.52 108.688 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.47 HD12 HD21 ' A' ' 492' ' ' ASN . 6.7 mp -63.07 127.73 91.27 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.271 -0.877 . . . . 64.14 109.977 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.28 30.18 0.23 Allowed 'Trans proline' 0 N--CA 1.512 2.56 1 C-N-CA 125.373 4.049 . . . . 64.43 114.035 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -159.7 -8.86 0.06 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 113.862 1.06 . . . . 72.43 113.862 -173.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 501' ' ' GLN . . . -91.62 -159.45 35.47 Favored Glycine 0 C--O 1.212 -1.229 0 C-N-CA 119.387 -1.387 . . . . 65.34 113.457 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 464' ' ' LEU . . . -63.43 -32.45 73.89 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 112.844 0.683 . . . . 73.12 112.844 -174.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.47 78.39 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 116.611 -0.268 . . . . 64.22 110.935 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 5.9 tt -79.98 -30.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 123.637 0.775 . . . . 75.03 111.895 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 497' ' ' GLY . 0.0 OUTLIER -58.7 -45.34 89.75 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.758 0.823 . . . . 72.34 109.317 -177.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.431 ' HB2' ' CD2' ' A' ' 464' ' ' LEU . 23.8 m-20 -97.42 -21.14 17.33 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.441 -0.503 . . . . 65.4 109.68 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 68.67 35.39 80.42 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.487 -0.779 . . . . 73.24 113.97 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -108.31 -26.63 10.43 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.966 0.412 . . . . 70.2 111.962 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 49.8 tp -105.55 153.88 21.15 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.665 -0.414 . . . . 60.13 111.252 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.34 170.27 17.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.84 -1.17 . . . . 74.22 107.84 177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.456 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -92.5 148.83 21.78 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 110.178 -0.304 . . . . 71.42 110.178 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 117.23 -34.99 4.33 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.951 -0.642 . . . . 65.21 111.886 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.5 153.66 43.18 Favored 'General case' 0 C--O 1.25 1.103 0 CA-C-O 121.32 0.581 . . . . 74.23 111.277 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 63.3 ttp180 -90.13 127.08 36.01 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.105 -1.072 . . . . 72.15 108.105 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.446 ' HG ' HD12 ' A' ' 519' ' ' LEU . 23.0 tp -80.74 131.88 35.48 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 107.624 -1.25 . . . . 75.03 107.624 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.0 mm -101.44 -44.96 11.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.177 0.513 . . . . 72.32 110.264 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -152.3 156.01 38.81 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.552 -0.907 . . . . 62.15 108.552 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.471 HG11 HD21 ' A' ' 519' ' ' LEU . 5.2 p -137.65 127.92 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.157 0 N-CA-C 108.515 -0.92 . . . . 71.31 108.515 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 65.91 9.23 5.94 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 126.136 1.774 . . . . 64.44 111.392 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.68 3.56 40.08 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.303 -0.475 . . . . 63.11 113.167 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.95 139.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 122.419 -0.46 . . . . 75.43 110.536 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.72 134.73 37.06 Favored 'General case' 0 CA--C 1.484 -1.591 0 C-N-CA 123.518 0.727 . . . . 55.21 109.584 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.471 HD21 HG11 ' A' ' 514' ' ' VAL . 42.3 mt -90.19 -45.62 8.98 Favored 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 123.654 0.597 . . . . 73.53 112.03 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.67 99.94 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 121.743 0.782 . . . . 71.15 110.05 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 137.93 -21.46 3.17 Favored Glycine 0 N--CA 1.42 -2.417 0 CA-C-N 114.411 -1.268 . . . . 71.33 110.723 -175.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.446 ' HB3' ' HZ3' ' A' ' 522' ' ' LYS . 0.3 OUTLIER -114.24 163.86 14.67 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.67 0.271 . . . . 65.34 111.068 178.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' SER . . . . . 0.469 ' O ' HG21 ' A' ' 527' ' ' VAL . 34.1 m -92.58 164.19 13.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.01 -0.541 . . . . 72.44 111.09 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.523 ' O ' HG12 ' A' ' 528' ' ' VAL . 50.7 mm-40 -50.44 -47.76 56.66 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 113.55 0.944 . . . . 72.11 113.55 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -59.87 -32.29 70.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.057 0.456 . . . . 75.35 111.454 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.24 -38.26 68.95 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.775 -0.648 . . . . 73.33 109.514 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 523' ' ' SER . 16.3 t -76.29 -37.46 31.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.953 -0.567 . . . . 75.11 110.333 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.632 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 12.3 m -65.64 -42.23 92.31 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 C-N-CA 120.722 -0.391 . . . . 73.34 110.601 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.8 p -68.78 -30.37 68.95 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.252 0.549 . . . . 55.43 111.067 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.33 -39.16 89.06 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.27 -0.877 . . . . 71.33 108.769 173.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 48.5 tp -69.91 -48.31 59.07 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.712 -0.677 . . . . 74.41 109.955 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -60.05 -27.68 67.15 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.117 0.567 . . . . 72.23 111.66 -177.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 33.8 t -69.82 -35.23 74.62 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 109.82 -0.437 . . . . 73.24 109.82 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 31.1 m 69.19 -89.67 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.226 1.01 . . . . 73.0 110.546 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 536' ' ' MET . 61.1 tttp 170.87 175.93 0.06 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.035 -2.209 . . . . 75.12 105.035 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' MET . . . . . 0.406 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 27.5 ttt -72.09 -50.72 25.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 119.138 0.881 . . . . 65.04 112.81 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -35.81 39.65 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 118.472 -1.291 . . . . 74.04 108.746 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 115.96 25.14 3.69 Favored Glycine 0 N--CA 1.411 -3.023 0 CA-C-N 115.03 -0.986 . . . . 64.03 113.187 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 3.8 m -107.44 119.87 40.59 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 118.627 -1.229 . . . . 52.35 108.093 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 65.1 t -106.91 131.72 56.1 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 CA-C-N 115.588 -0.733 . . . . 72.5 110.6 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 24.7 m -94.19 113.77 25.76 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.717 -0.674 . . . . 62.4 109.558 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.92 139.59 41.09 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.384 -0.969 . . . . 71.13 108.384 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 44.9 tp -118.79 117.84 29.96 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 105.863 -1.903 . . . . 75.11 105.863 171.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 27.1 m -118.06 158.05 19.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.841 0 C-N-CA 120.24 -0.584 . . . . 73.22 110.898 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -111.89 116.26 30.33 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.402 -0.962 . . . . 74.24 108.402 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.476 -1.88 0 N-CA-C 107.074 -1.454 . . . . 72.32 107.074 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 28.3 mtpp . . . . . 0 CA--C 1.471 -2.06 0 N-CA-C 109.568 -0.53 . . . . 72.33 109.568 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.5 mtm180 -110.97 128.82 55.96 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 115.673 -0.694 . . . . 71.41 109.213 171.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.0 mm? -118.83 129.85 55.45 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 115.021 -0.991 . . . . 74.21 109.317 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -96.55 122.32 39.34 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.119 -0.697 . . . . 73.42 109.119 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 58.8 mt -127.56 142.51 43.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 123.46 0.704 . . . . 74.51 109.942 -174.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 78.7 mt-30 -114.97 127.91 55.96 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.608 0.966 . . . . 72.11 113.608 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.479 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.1 mm? -116.61 134.54 54.71 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 124.588 1.155 . . . . 75.44 109.148 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 39.4 ttmt -108.88 135.71 49.63 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-O 121.513 0.673 . . . . 62.1 111.26 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.411 ' HE2' HG21 ' A' ' 534' ' ' THR . 38.1 mtmt -73.08 100.57 3.06 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.063 -0.972 . . . . 65.41 110.866 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -108.03 -101.23 2.69 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.474 -0.87 . . . . 64.14 112.131 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' THR . . . . . 0.51 HG23 ' H ' ' A' ' 469' ' ' GLU . 8.3 t -66.87 -69.8 0.29 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 112.16 0.43 . . . . 62.33 112.16 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . 0.51 ' H ' HG23 ' A' ' 468' ' ' THR . 25.6 mm-40 -98.29 -18.41 18.38 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.599 0.714 . . . . 74.22 109.14 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 69.27 -149.98 49.45 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 114.651 -1.159 . . . . 74.2 112.98 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 38.4 mt -51.65 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.478 0.918 . . . . 74.32 113.478 -169.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -107.72 56.19 0.49 Allowed Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 114.582 -1.19 . . . . 42.31 111.688 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.37 142.59 29.5 Favored 'General case' 0 C--N 1.281 -2.371 0 C-N-CA 123.369 0.668 . . . . 75.53 110.064 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.9 m -119.59 162.41 18.98 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.396 -0.82 . . . . 62.22 109.807 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 20.6 pt -117.88 158.09 18.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.129 0.49 . . . . 71.32 111.67 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.8 t -148.7 160.09 43.5 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.23 -0.896 . . . . 75.52 108.655 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 31.6 t . . . . . 0 N--CA 1.411 -2.383 0 N-CA-C 107.216 -1.401 . . . . 72.22 107.216 174.777 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 C--O 1.239 0.536 0 CA-C-O 121.192 0.413 . . . . 73.12 112.914 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.522 HD11 HE21 ' A' ' 524' ' ' GLN . 24.8 mm -92.81 128.81 44.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.314 -0.857 . . . . 74.51 108.795 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -127.95 158.71 37.1 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 121.887 -0.508 . . . . 74.44 111.479 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.31 129.55 36.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.206 -1.035 . . . . 75.1 108.206 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -93.27 -61.3 1.59 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.544 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -141.09 148.83 40.78 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.776 -0.647 . . . . 75.41 110.183 -174.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.438 HG13 ' HA ' ' A' ' 506' ' ' LYS . 36.4 mm -118.57 104.32 15.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.411 -1.329 . . . . 64.31 107.411 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 8.3 mp -54.72 152.06 13.77 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.187 -0.915 . . . . 72.12 112.73 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . 0.55 ' O ' HD11 ' A' ' 500' ' ' ILE . 23.0 Cg_endo -77.89 -3.12 13.21 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 124.339 3.359 . . . . 73.24 111.64 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.409 ' N ' ' HG2' ' A' ' 495' ' ' PRO . 95.2 mtt180 -158.64 110.88 2.24 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 124.582 1.153 . . . . 72.05 109.636 -175.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.443 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 160.89 -168.5 36.27 Favored Glycine 1 C--N 1.237 -4.925 0 CA-C-N 112.846 -1.979 . . . . 73.44 111.145 178.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . 0.413 ' C ' HD11 ' A' ' 464' ' ' LEU . . . -57.23 -47.14 82.09 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 124.464 1.106 . . . . 54.13 110.54 -174.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -56.88 -44.11 81.93 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.006 -0.997 . . . . 65.14 111.853 -175.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.55 HD11 ' O ' ' A' ' 495' ' ' PRO . 16.5 tt -80.96 -37.63 16.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.083 0.771 . . . . 65.54 113.083 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.3 mm100 -64.74 -41.83 95.65 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 120.867 0.365 . . . . 73.43 110.771 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.479 ' HB2' HD13 ' A' ' 464' ' ' LEU . 23.7 m-20 -84.95 -32.07 23.26 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.777 -0.823 . . . . 42.42 108.777 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 61.4 45.72 95.84 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.839 0.712 . . . . 65.35 113.864 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -115.07 -28.07 7.11 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.044 0.45 . . . . 62.15 112.18 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 57.0 tp -106.22 146.55 30.15 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.15 -0.685 . . . . 74.1 109.15 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.438 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -138.81 162.05 35.72 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.914 -0.773 . . . . 64.13 108.914 176.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.437 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -83.52 120.69 26.24 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.012 0.434 . . . . 71.34 111.382 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 145.04 -12.28 1.87 Allowed Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.706 -0.679 . . . . 45.12 112.213 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -94.22 172.87 7.94 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 120.975 0.416 . . . . 72.24 112.026 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 544' ' ' VAL . 41.1 ttm180 -102.83 137.99 40.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.637 -0.71 . . . . 72.44 110.269 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.665 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -86.08 119.13 26.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.951 -0.568 . . . . 74.41 110.463 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 47.8 mm -98.65 -47.33 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.849 -0.16 . . . . 73.52 110.588 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.477 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 10.2 pt-20 -149.0 148.61 29.95 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.358 -0.608 . . . . 64.43 109.358 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.531 HG11 HD21 ' A' ' 519' ' ' LEU . 3.6 p -132.56 119.36 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.394 0 CA-C-O 121.975 0.893 . . . . 64.4 109.254 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.72 23.91 11.53 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 126.242 1.817 . . . . 75.31 111.959 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.28 -18.46 33.2 Favored Glycine 0 C--O 1.237 0.289 0 C-N-CA 120.491 -0.861 . . . . 74.45 113.953 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.7 t -96.85 134.49 34.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 109.772 -0.455 . . . . 64.34 109.772 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -84.35 143.1 29.7 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.656 -0.498 . . . . 70.42 109.656 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.665 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 18.4 mt -103.78 -39.67 6.56 Favored 'General case' 0 CA--C 1.482 -1.639 0 CA-C-N 115.432 -0.804 . . . . 73.41 112.257 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 35.4 t -74.61 90.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 121.811 0.815 . . . . 72.41 109.48 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 154.13 -28.61 0.72 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 108.289 -1.925 . . . . 70.22 108.289 -175.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.44 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -105.3 178.78 4.46 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.016 -0.592 . . . . 71.53 109.916 175.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' SER . . . . . 0.538 ' O ' HG21 ' A' ' 527' ' ' VAL . 60.7 p -95.84 164.33 12.78 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.501 0.556 . . . . 72.22 112.501 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.522 HE21 HD11 ' A' ' 488' ' ' ILE . 15.8 mm-40 -49.71 -43.23 47.41 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 124.705 1.202 . . . . 64.23 111.442 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.03 -35.74 82.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.408 0.623 . . . . 61.14 111.961 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.74 -37.25 76.4 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.644 -0.707 . . . . 75.34 109.522 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 523' ' ' SER . 32.3 t -70.2 -41.46 78.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.528 -0.76 . . . . 64.4 109.556 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.669 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 12.5 m -64.57 -44.42 96.8 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 C-N-CA 120.021 -0.672 . . . . 63.44 110.054 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 49.1 m -57.87 -40.29 79.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.485 0.659 . . . . 52.34 110.232 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 50.7 tp -63.11 -47.25 83.62 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 124.545 1.138 . . . . 74.11 109.879 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 35.1 tp -65.2 -44.22 89.07 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.861 -0.609 . . . . 64.25 110.574 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -62.3 -33.51 74.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.155 0.582 . . . . 63.21 110.851 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.6 m -75.53 -41.01 56.16 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.032 -0.531 . . . . 63.21 110.882 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' THR . . . . . 0.478 HG22 ' CG2' ' A' ' 540' ' ' VAL . 32.5 m 66.65 -92.91 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.266 0.627 . . . . 73.25 110.121 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt 170.48 171.86 0.07 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.19 -1.411 . . . . 74.11 107.19 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 26.1 ttt -65.63 -38.6 89.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 111.603 0.223 . . . . 75.23 111.603 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.58 -79.26 0.08 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.461 -0.336 . . . . 75.41 110.473 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 151.56 -21.47 0.93 Allowed Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 118.708 -1.71 . . . . 37.73 114.618 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 463' ' ' GLN . 3.0 m -94.83 125.24 39.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 118.433 1.117 . . . . 74.14 110.251 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 47.1 t -106.81 140.63 24.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.028 -0.987 . . . . 72.42 110.162 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.5 t -99.14 114.69 27.58 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.165 0.507 . . . . 74.22 109.815 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.425 HD21 HD23 ' A' ' 464' ' ' LEU . 3.4 mm? -101.77 122.33 43.74 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 124.538 1.135 . . . . 65.35 109.08 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 36.2 tp -104.98 118.97 37.87 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.376 -1.712 . . . . 72.54 106.376 174.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 36.0 m -115.03 145.55 20.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-O 121.179 0.514 . . . . 72.35 110.957 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 88.8 t80 -112.27 116.06 29.79 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.276 -0.875 . . . . 74.24 110.042 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . 0.53 ' O ' ' HD3' ' A' ' 546' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.29 -1.997 0 N-CA-C 107.478 -1.304 . . . . 55.45 107.478 175.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt . . . . . 0 N--CA 1.435 -1.209 0 CA-C-O 120.974 0.416 . . . . 45.53 110.467 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -106.16 154.51 20.59 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.413 -1.328 . . . . 74.51 107.413 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.8 mm? -125.33 130.89 52.88 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 110.002 -0.37 . . . . 73.32 110.002 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -96.25 116.19 28.62 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.655 -0.868 . . . . 73.03 108.655 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . 0.486 HG23 ' CD2' ' A' ' 464' ' ' LEU . 68.6 mt -123.28 121.16 62.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 115.601 -0.727 . . . . 74.54 110.202 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.2 mt-30 -99.94 128.94 45.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.786 0.662 . . . . 74.44 112.786 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.506 HD11 ' O ' ' A' ' 498' ' ' ALA . 4.3 mm? -115.08 132.82 56.48 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-N 115.361 -0.836 . . . . 63.24 109.841 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.47 ' HE2' ' HB2' ' A' ' 465' ' ' LYS . 25.3 ttmm -101.17 131.9 46.91 Favored 'General case' 0 N--CA 1.394 -3.265 0 CA-C-O 121.936 0.874 . . . . 61.01 110.886 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.12 103.28 0.21 Allowed 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 113.146 -1.843 . . . . 73.13 111.485 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -136.5 137.05 8.78 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.781 -0.928 . . . . 74.32 110.781 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 73.2 m 63.24 -86.72 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.143 0.977 . . . . 62.32 112.642 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.74 -13.93 21.14 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.238 -1.023 . . . . 74.3 108.238 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 70.09 -155.82 53.24 Favored Glycine 0 C--O 1.202 -1.867 0 CA-C-O 117.946 -1.474 . . . . 71.03 109.707 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 6.3 mp -43.83 96.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.707 1.254 . . . . 72.12 113.706 -173.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -106.22 63.58 0.3 Allowed Glycine 0 N--CA 1.411 -3.007 0 CA-C-N 113.546 -1.661 . . . . 71.42 110.448 -174.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -156.66 142.0 17.44 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 107.265 -1.383 . . . . 74.14 107.265 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 12.1 p -115.79 163.61 15.59 Favored 'General case' 0 C--N 1.263 -3.165 0 O-C-N 123.617 0.573 . . . . 73.3 109.868 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 12.6 pt -114.35 154.75 15.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.368 0.604 . . . . 71.03 112.04 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.7 t -137.95 149.33 46.06 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.679 -0.86 . . . . 71.31 108.679 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.461 ' HB3' ' OE1' ' A' ' 524' ' ' GLN . 66.9 p . . . . . 0 C--N 1.308 -1.225 0 N-CA-C 109.193 -0.669 . . . . 64.11 109.193 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . 0.41 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -1.192 0 N-CA-C 109.673 -0.933 . . . . 54.43 109.673 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 519' ' ' LEU . 18.2 mm -91.09 124.46 43.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 115.921 -0.581 . . . . 73.12 109.976 -172.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 88.1 m-85 -125.61 163.0 23.72 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 109.975 -0.38 . . . . 71.14 109.975 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 40.2 t -89.16 119.83 36.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.851 -0.425 . . . . 51.41 109.851 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -70.81 -63.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.47 1.108 . . . . 74.31 110.358 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -151.45 160.19 43.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.931 -0.577 . . . . 74.13 109.911 -174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.497 HG12 ' HB1' ' A' ' 507' ' ' ALA . 44.7 mm -110.28 105.71 19.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.874 -1.158 . . . . 72.35 107.874 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -65.15 128.4 93.75 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.585 -0.734 . . . . 61.23 111.344 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.14 24.68 0.26 Allowed 'Trans proline' 0 N--CA 1.503 2.048 1 C-N-CA 125.334 4.023 . . . . 63.03 114.964 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -160.29 7.02 0.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 113.251 0.834 . . . . 65.23 113.251 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -99.8 -155.21 28.15 Favored Glycine 0 C--N 1.297 -1.631 0 C-N-CA 119.266 -1.445 . . . . 74.23 113.685 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . 0.506 ' O ' HD11 ' A' ' 464' ' ' LEU . . . -66.12 -37.66 86.26 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 123.37 0.668 . . . . 70.4 109.559 -176.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -57.72 -41.76 82.42 Favored 'General case' 0 C--O 1.195 -1.778 0 CA-C-N 115.126 -0.943 . . . . 64.31 112.053 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.3 tt -80.3 -29.36 12.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 120.943 0.401 . . . . 71.54 111.625 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.05 -48.37 80.32 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.228 1.011 . . . . 74.13 108.666 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.486 ' HB2' HD13 ' A' ' 464' ' ' LEU . 12.9 m-20 -93.68 -31.73 14.34 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 120.345 -0.542 . . . . 61.03 110.412 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.29 27.82 72.14 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.879 -0.6 . . . . 44.42 112.967 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.452 ' CG ' HG22 ' A' ' 462' ' ' ILE . 33.0 tpt180 -101.92 -19.35 15.3 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.75 0.31 . . . . 71.41 111.148 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . 0.419 ' HB2' HD22 ' A' ' 464' ' ' LEU . 52.7 tp -106.87 151.19 25.56 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.817 -0.438 . . . . 72.51 109.817 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.455 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -144.21 159.88 41.91 Favored 'General case' 0 N--CA 1.434 -1.258 0 O-C-N 123.176 0.298 . . . . 72.32 110.594 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.497 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -91.4 167.95 11.9 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.323 0.389 . . . . 71.32 111.773 -174.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.87 13.18 65.04 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.446 -0.797 . . . . 54.0 112.153 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -120.01 178.27 4.68 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 107.645 -1.243 . . . . 73.51 107.645 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.01 133.54 47.96 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-N 117.993 0.361 . . . . 74.14 110.646 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 21.4 tp -96.04 117.05 29.91 Favored 'General case' 0 N--CA 1.394 -3.251 0 N-CA-C 108.339 -0.986 . . . . 72.5 108.339 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 512' ' ' ILE . 1.9 mp -99.02 -35.19 4.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.121 0.486 . . . . 73.04 110.211 -177.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -150.34 144.78 25.73 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.716 -0.674 . . . . 72.15 110.551 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.459 HG11 HD21 ' A' ' 519' ' ' LEU . 2.6 p -135.03 123.35 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 N-CA-C 108.328 -0.99 . . . . 71.12 108.328 175.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 70.62 -66.22 0.3 Allowed 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 127.576 2.35 . . . . 71.42 111.231 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -174.02 29.64 0.09 OUTLIER Glycine 0 C--N 1.308 -0.994 0 N-CA-C 111.467 -0.653 . . . . 64.42 111.467 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.6 t -122.18 139.1 50.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 110.155 -0.313 . . . . 74.25 110.155 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -83.18 130.53 35.1 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.575 -0.898 . . . . 45.34 108.575 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.492 ' HB3' HG13 ' A' ' 488' ' ' ILE . 47.5 mt -100.89 -36.0 9.21 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.986 -0.552 . . . . 74.1 112.117 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.48 89.53 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 121.855 0.836 . . . . 74.25 110.205 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 147.95 -32.8 1.29 Allowed Glycine 0 N--CA 1.427 -1.94 0 CA-C-N 114.369 -1.287 . . . . 53.5 110.178 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.502 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -94.6 -177.63 4.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.407 0.521 . . . . 75.24 112.407 179.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' SER . . . . . 0.483 ' O ' HG21 ' A' ' 527' ' ' VAL . 5.0 m -95.24 156.11 16.46 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.909 -0.587 . . . . 75.32 111.244 -175.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.461 ' OE1' ' HB3' ' A' ' 477' ' ' SER . 8.1 mm100 -56.16 -46.36 79.34 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.808 0.843 . . . . 53.14 111.239 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.44 ' O ' HG23 ' A' ' 528' ' ' VAL . 1.1 mp0 -57.85 -31.86 67.09 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.127 0.489 . . . . 71.13 111.951 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -69.64 -37.24 76.69 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.967 -0.56 . . . . 52.02 110.037 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 523' ' ' SER . 17.6 t -75.93 -36.03 31.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.325 -0.852 . . . . 70.41 109.653 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.651 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.3 m -64.98 -40.61 89.65 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.267 0 C-N-CA 120.052 -0.659 . . . . 72.12 111.07 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.9 t -59.46 -44.98 92.86 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.652 0.739 . . . . 70.33 109.277 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 31.8 tp -60.4 -38.72 84.86 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 125.229 1.412 . . . . 72.43 110.398 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 16.6 tp -70.17 -48.63 56.43 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.484 -0.78 . . . . 63.42 109.959 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.651 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.8 OUTLIER -60.27 -44.56 95.21 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.767 0.827 . . . . 74.14 111.382 -176.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 33.7 t -69.23 -31.92 70.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.16 -0.473 . . . . 70.01 111.037 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 84.9 m 66.3 -87.03 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.926 0.49 . . . . 74.33 111.552 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? 165.58 158.26 0.03 OUTLIER 'General case' 0 C--O 1.244 0.774 0 N-CA-C 105.89 -1.893 . . . . 71.33 105.89 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 65.9 mtt -58.84 -50.3 74.49 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.206 0.316 . . . . 73.15 111.416 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -62.49 -65.49 0.68 Allowed 'General case' 0 C--O 1.24 0.576 0 N-CA-C 110.049 -0.352 . . . . 74.13 110.049 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 135.28 -14.3 4.28 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 118.353 -1.88 . . . . 64.4 116.072 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.4 m -94.38 128.11 40.7 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 118.904 1.352 . . . . 74.05 108.534 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 66.7 t -114.79 137.32 48.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 CA-C-N 115.816 -0.629 . . . . 71.54 110.393 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 54.8 m -91.88 113.94 26.35 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.187 0.518 . . . . 72.53 110.467 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.477 HD21 HD23 ' A' ' 464' ' ' LEU . 3.3 mm? -102.36 119.34 38.65 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.556 -0.905 . . . . 65.35 108.556 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 3.1 tm? -110.68 117.06 32.45 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 107.907 -1.146 . . . . 72.52 107.907 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 33.1 m -119.98 162.64 18.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 114.768 -1.105 . . . . 62.4 110.325 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -116.96 114.8 24.32 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 109.495 -0.557 . . . . 73.13 109.495 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 . . . . . 0 N--CA 1.416 -2.142 0 C-N-CA 120.013 -0.675 . . . . 75.4 111.817 -177.391 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt . . . . . 0 CA--C 1.471 -2.07 0 CA-C-O 121.791 0.805 . . . . 70.03 112.874 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 98.3 mtt180 -107.89 131.66 54.28 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-N 113.427 -1.715 . . . . 75.51 106.505 170.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -120.98 133.27 55.27 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 109.486 -0.561 . . . . 64.34 109.486 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -93.09 115.2 27.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.492 0.663 . . . . 73.14 109.278 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . 0.44 HG22 ' HD3' ' A' ' 504' ' ' ARG . 59.7 mt -121.72 122.67 67.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.655 -0.702 . . . . 70.54 109.977 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 27.9 mt-30 -102.42 129.22 48.85 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.99 0.424 . . . . 74.43 111.901 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.423 ' CD2' HG23 ' A' ' 462' ' ' ILE . 3.1 mm? -115.09 135.52 54.11 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.542 0.737 . . . . 43.11 109.879 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.764 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.1 OUTLIER -98.89 137.07 37.99 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.993 -1.114 . . . . 55.31 107.993 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.411 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 36.9 ttmt -59.73 106.1 0.44 Allowed 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.377 -0.829 . . . . 73.01 110.655 174.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -92.67 -138.71 8.69 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.846 -0.901 . . . . 43.31 110.846 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 10.2 t -65.87 -46.55 78.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.859 0.329 . . . . 52.35 110.454 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -121.53 83.42 2.08 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 107.043 -1.466 . . . . 75.41 107.043 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.411 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . -58.63 140.87 46.94 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 120.356 -0.926 . . . . 74.42 113.594 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.507 HD12 HG22 ' A' ' 540' ' ' VAL . 18.2 mt 57.37 89.1 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 125.434 1.494 . . . . 74.41 112.166 -174.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -103.45 56.76 0.58 Allowed Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 114.72 -1.127 . . . . 50.23 111.213 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.578 ' CZ ' HD12 ' A' ' 542' ' ' LEU . 6.4 p90 -144.75 144.78 31.36 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.024 -0.732 . . . . 74.53 109.024 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.2 m -120.88 149.63 42.31 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.97 -1.122 . . . . 64.1 107.97 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 15.4 pt -109.85 155.27 11.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 112.895 0.702 . . . . 73.51 112.895 -175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 7.5 t -129.16 159.83 34.78 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.063 -1.088 . . . . 72.52 108.063 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 33.9 p . . . . . 0 C--N 1.29 -1.998 0 N-CA-C 109.077 -0.712 . . . . 55.31 109.077 178.685 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--O 1.253 1.243 0 N-CA-C 110.027 -0.797 . . . . 60.21 110.027 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 48.3 mm -102.62 136.16 36.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.983 -0.553 . . . . 72.41 110.298 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 95.6 m-85 -134.82 162.48 32.25 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.326 -0.62 . . . . 75.53 109.326 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 23.2 t -82.23 122.89 37.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 109.141 -0.689 . . . . 61.25 109.141 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -89.87 -55.27 3.69 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.817 -0.628 . . . . 75.2 110.674 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -146.48 151.02 36.72 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.191 -0.67 . . . . 64.12 109.191 -175.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.517 HG12 ' HB1' ' A' ' 507' ' ' ALA . 35.3 mm -111.2 110.98 34.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.002 -1.11 . . . . 63.34 108.002 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 496' ' ' ARG . 3.1 mm? -62.24 123.52 78.65 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 115.775 -0.648 . . . . 64.45 109.298 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.02 22.19 0.15 Allowed 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.945 3.763 . . . . 75.33 114.836 -171.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 494' ' ' LEU . 32.8 ptt180 -160.07 -2.98 0.07 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.819 0.674 . . . . 75.11 112.819 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.59 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -84.55 -167.97 43.61 Favored Glycine 0 C--O 1.216 -0.971 0 C-N-CA 119.788 -1.196 . . . . 44.41 112.515 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -57.11 -34.77 68.69 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.014 0.907 . . . . 53.13 111.759 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.79 86.14 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.61 -0.723 . . . . 74.04 112.261 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 500' ' ' ILE . 8.8 tt -79.03 -31.3 14.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 O-C-N 123.233 0.333 . . . . 63.4 111.388 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 71.1 mm-40 -62.39 -43.28 99.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.763 -0.458 . . . . 73.14 109.763 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.4 ' HB2' HD13 ' A' ' 464' ' ' LEU . 11.0 t70 -82.77 -41.64 18.93 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.865 -1.531 . . . . 73.32 106.865 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.56 -7.52 76.1 Favored Glycine 0 N--CA 1.426 -1.973 0 CA-C-N 115.372 -0.831 . . . . 75.23 115.118 174.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.44 ' HD3' HG22 ' A' ' 462' ' ' ILE . 73.4 ttt180 -85.83 -19.16 31.06 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 120.974 0.416 . . . . 71.13 111.727 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 62.1 tp -101.19 130.48 47.29 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.091 -0.337 . . . . 73.32 110.091 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.5 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -134.83 171.77 13.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.657 0.265 . . . . 74.02 111.448 176.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.517 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -96.82 130.8 44.03 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.35 -0.386 . . . . 73.33 111.107 -176.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 144.13 -23.27 2.08 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.659 -0.701 . . . . 61.44 111.465 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -93.29 172.23 8.42 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-O 120.942 0.401 . . . . 74.33 111.099 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.415 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 35.0 ttt180 -93.75 138.75 31.61 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.679 -0.692 . . . . 74.34 110.308 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -89.77 127.96 36.05 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 105.892 -1.892 . . . . 73.15 105.892 177.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.474 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.0 mm -96.16 -50.78 11.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.861 -0.524 . . . . 74.32 109.97 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -157.54 145.76 19.14 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.694 -0.685 . . . . 75.44 109.267 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.04 130.37 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.308 0 CA-C-O 121.359 0.599 . . . . 74.45 109.69 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 62.05 20.08 11.32 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 126.208 1.803 . . . . 73.3 111.389 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 95.47 2.09 61.94 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.78 -0.724 . . . . 63.31 113.473 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.99 138.21 38.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.639 -0.504 . . . . 74.24 109.639 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -84.35 148.22 26.75 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 123.571 0.544 . . . . 75.02 110.036 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 28.1 mt -90.48 -50.98 5.64 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.773 -0.649 . . . . 55.51 112.003 -173.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.12 86.32 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 122.623 1.202 . . . . 75.51 111.305 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 166.2 -24.34 0.14 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 108.278 -1.929 . . . . 44.14 108.278 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.523 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -117.58 172.49 7.31 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.793 -0.817 . . . . 74.31 108.793 175.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 42.4 m -91.88 165.15 13.39 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 110.256 -0.275 . . . . 72.42 110.256 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -53.96 -44.97 71.18 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.572 0.749 . . . . 73.0 111.847 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 528' ' ' VAL . 39.4 mt-10 -61.58 -31.55 71.61 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 112.463 0.542 . . . . 75.53 112.463 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.75 -34.01 69.15 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.291 -0.633 . . . . 71.34 109.291 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 47.6 t -70.45 -38.22 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.559 -0.746 . . . . 75.42 109.372 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.707 ' O ' ' HG3' ' A' ' 532' ' ' ARG . 19.9 m -69.57 -36.64 71.9 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.893 0 C-N-CA 119.099 -1.04 . . . . 73.42 110.676 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.8 t -59.28 -44.11 92.49 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 109.226 -0.657 . . . . 65.53 109.226 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 34.4 tp -58.82 -41.9 87.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.843 1.257 . . . . 75.22 109.594 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.487 ' O ' HD11 ' A' ' 471' ' ' LEU . 3.2 tt -64.98 -48.05 75.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.323 -0.853 . . . . 63.53 111.944 174.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' A' ' 528' ' ' VAL . 23.0 mtm180 -61.41 -31.11 71.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.49 -0.323 . . . . 62.5 110.837 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 535' ' ' LYS . 48.5 t -65.56 -44.43 86.79 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.253 -0.431 . . . . 53.41 110.006 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 24.6 m 63.85 -2.88 0.49 Allowed 'General case' 0 CA--C 1.578 2.026 0 C-N-CA 123.797 0.839 . . . . 72.11 112.812 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . 0.624 ' HE3' ' OE1' ' A' ' 537' ' ' GLU . 61.6 tttp 70.13 146.4 0.06 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.215 1.006 . . . . 62.23 111.912 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 46.7 ttm -63.3 -32.37 73.77 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 116.569 2.062 . . . . 51.2 116.569 -167.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . 0.624 ' OE1' ' HE3' ' A' ' 535' ' ' LYS . 0.0 OUTLIER -78.24 -28.24 47.76 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 118.021 -1.472 . . . . 70.33 108.782 178.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 99.86 30.98 6.18 Favored Glycine 0 N--CA 1.415 -2.733 0 CA-C-N 114.771 -1.104 . . . . 54.02 113.613 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 4.0 m -128.58 132.22 48.2 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.034 -1.099 . . . . 61.54 108.034 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.507 HG22 HD12 ' A' ' 471' ' ' LEU . 61.5 t -120.07 134.34 63.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 116.178 -0.465 . . . . 73.13 111.239 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.7 m -91.76 114.4 26.93 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.199 -0.91 . . . . 72.13 110.047 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.578 HD12 ' CZ ' ' A' ' 473' ' ' PHE . 3.2 mm? -104.04 121.24 42.77 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.744 -1.206 . . . . 73.21 107.744 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 41.8 tp -104.51 117.92 35.32 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.252 -1.759 . . . . 74.02 106.252 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 35.3 m -115.31 148.47 18.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 C-N-CA 120.503 -0.479 . . . . 54.23 110.827 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -111.97 122.32 47.44 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.829 -0.623 . . . . 74.22 109.655 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 . . . . . 0 N--CA 1.409 -2.519 0 CA-C-N 114.59 -1.186 . . . . 63.31 109.436 179.767 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt . . . . . 0 N--CA 1.42 -1.974 0 N-CA-C 108.28 -1.007 . . . . 65.44 108.28 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -100.67 145.57 28.27 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 110.005 -0.368 . . . . 73.41 110.005 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.0 mm? -124.12 131.91 53.59 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.124 -0.695 . . . . 72.43 109.124 -174.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -104.89 115.27 30.0 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.655 0.74 . . . . 70.11 109.093 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 50.0 mt -122.51 142.6 38.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 115.318 -0.855 . . . . 73.15 110.506 -171.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 43.5 mt-30 -114.99 128.24 56.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.901 0.381 . . . . 74.2 111.279 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 539' ' ' THR . 6.3 mp -119.04 152.47 36.38 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.108 0.963 . . . . 71.45 111.885 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -115.81 129.04 56.28 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.323 -0.992 . . . . 75.11 108.323 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.54 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 23.8 ttmm -60.81 88.01 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.419 0.628 . . . . 72.23 112.044 176.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -90.45 -128.47 3.81 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.63 -0.714 . . . . 73.3 112.277 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' THR . . . . . 0.707 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 17.1 m -48.99 -72.73 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.322 1.049 . . . . 74.12 111.507 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . 0.459 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 46.1 mm-40 -82.36 -38.54 24.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.245 -1.391 . . . . 72.14 107.245 171.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.54 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . 65.78 109.09 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.179 -1.373 . . . . 70.31 112.096 -174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.596 ' H ' ' CB ' ' A' ' 498' ' ' ALA . 33.9 mt 69.16 85.51 0.14 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 125.64 1.576 . . . . 71.3 108.076 -168.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . 0.452 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . -103.18 56.76 0.59 Allowed Glycine 0 CA--C 1.471 -2.698 0 CA-C-N 114.393 -1.276 . . . . 45.3 112.151 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 2.9 p90 -147.72 142.94 27.21 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.01 0.433 . . . . 73.11 110.253 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 19.9 m -114.69 145.2 42.32 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 107.237 -1.394 . . . . 72.33 107.237 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.86 153.94 14.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 112.812 0.671 . . . . 63.34 112.812 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' THR . . . . . 0.526 ' HB ' ' HE3' ' A' ' 491' ' ' LYS . 8.2 t -143.33 149.43 37.76 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.119 -0.946 . . . . 65.44 109.563 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.424 -1.732 0 N-CA-C 108.092 -1.077 . . . . 72.22 108.092 174.964 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . 0.493 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 43.5 Cg_exo . . . . . 0 C--O 1.245 0.872 0 CA-C-O 121.379 0.491 . . . . 74.33 113.285 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.421 HG13 ' HB3' ' A' ' 519' ' ' LEU . 38.9 mm -87.98 120.82 37.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.963 -1.017 . . . . 71.12 108.883 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.493 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 66.3 m-85 -120.51 150.47 40.79 Favored 'General case' 0 CA--C 1.483 -1.613 0 CA-C-O 120.804 0.335 . . . . 74.01 111.897 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.43 119.42 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 107.185 -1.413 . . . . 72.14 107.185 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.526 ' HE3' ' HB ' ' A' ' 476' ' ' THR . 41.0 ttmt -87.87 -53.82 4.56 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.312 0.577 . . . . 61.42 111.078 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 61.5 t30 -142.04 149.68 40.27 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.287 -0.87 . . . . 71.0 110.446 -171.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.507 HG12 ' HB1' ' A' ' 507' ' ' ALA . 32.2 mm -115.87 106.54 20.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 124.149 0.906 . . . . 74.13 109.26 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.442 ' C ' ' H ' ' A' ' 496' ' ' ARG . 3.5 mm? -53.09 131.11 50.47 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.551 -0.749 . . . . 74.55 111.069 176.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -70.01 15.15 0.25 Allowed 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 124.557 3.505 . . . . 74.31 114.095 -173.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.707 ' O ' ' HB ' ' A' ' 468' ' ' THR . 12.1 ptt180 -164.35 12.68 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.109 0.957 . . . . 74.41 111.097 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.459 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . -84.83 -174.84 50.52 Favored Glycine 0 C--N 1.286 -2.209 0 C-N-CA 120.013 -1.089 . . . . 60.23 111.565 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . 0.596 ' CB ' ' H ' ' A' ' 471' ' ' LEU . . . -62.21 -28.12 69.46 Favored 'General case' 0 C--O 1.198 -1.633 0 CA-C-N 117.999 0.9 . . . . 72.34 110.934 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.62 87.81 Favored 'General case' 0 C--O 1.204 -1.302 0 CA-C-N 116.069 -0.514 . . . . 53.03 111.697 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 500' ' ' ILE . 11.4 tt -79.84 -36.99 17.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.877 0.37 . . . . 73.14 111.546 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 9.1 mm-40 -66.85 -39.94 87.76 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.69 -0.686 . . . . 62.11 110.219 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -92.45 -22.66 19.49 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.594 -0.73 . . . . 71.33 111.455 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.87 -57.36 5.01 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 116.647 1.419 . . . . 43.44 116.647 171.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -46.13 -30.8 2.06 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.519 1.674 . . . . 73.51 115.519 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 59.4 tp -98.02 132.05 43.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 117.824 0.284 . . . . 71.22 111.173 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.432 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -143.91 164.89 29.26 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 121.046 -0.261 . . . . 72.24 110.963 174.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.507 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -83.7 98.8 9.85 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.266 0.555 . . . . 71.35 111.963 -174.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 174.1 29.38 0.03 OUTLIER Glycine 0 C--N 1.304 -1.228 0 N-CA-C 111.107 -0.797 . . . . 51.24 111.107 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -148.18 177.79 9.1 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 120.748 0.309 . . . . 74.42 110.979 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -106.82 129.25 54.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.527 -0.76 . . . . 72.41 109.43 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 28.2 tp -83.46 120.77 26.32 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 107.957 -1.127 . . . . 74.21 107.957 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.462 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 49.1 mm -97.93 -45.84 12.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 120.911 0.386 . . . . 71.22 111.129 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.465 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 10.2 pt-20 -154.02 146.02 23.6 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.123 -0.49 . . . . 72.33 110.145 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 541' ' ' SER . 2.6 p -130.65 129.13 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.458 0 N-CA-C 107.401 -1.333 . . . . 71.14 107.401 176.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 10.6 m120 68.01 4.8 4.22 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.82 0.848 . . . . 74.33 112.667 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 104.56 -6.96 45.68 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 121.065 -0.588 . . . . 53.55 112.075 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.3 t -87.14 125.75 40.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.776 -0.453 . . . . 72.2 109.776 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -79.75 134.25 36.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.982 -0.554 . . . . 73.15 110.512 -176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 17.3 mt -98.63 -22.87 15.71 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.864 -0.607 . . . . 60.22 110.658 -174.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.31 9.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 125.413 1.485 . . . . 63.42 113.84 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -144.05 18.45 2.14 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 110.875 -0.89 . . . . 44.54 110.875 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.516 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -144.5 174.6 10.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.466 0.543 . . . . 75.22 112.466 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' SER . . . . . 0.422 ' O ' HG21 ' A' ' 527' ' ' VAL . 32.4 m -93.34 159.8 15.1 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.757 -0.656 . . . . 75.34 112.731 -175.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.5 ' O ' HG12 ' A' ' 528' ' ' VAL . 36.9 mm-40 -50.19 -47.68 54.47 Favored 'General case' 0 C--O 1.209 -1.046 0 C-N-CA 124.472 1.109 . . . . 73.11 113.626 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 525' ' ' GLU . 4.1 mp0 -59.1 -34.28 71.82 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.235 0.54 . . . . 75.22 111.185 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.85 -39.2 83.82 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.673 -0.694 . . . . 65.42 109.73 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 523' ' ' SER . 15.2 t -75.48 -36.78 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 115.571 -0.74 . . . . 74.44 109.762 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.649 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 7.5 m -66.11 -42.55 91.58 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.049 0 C-N-CA 120.214 -0.595 . . . . 50.21 110.127 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 29.7 m -59.57 -44.05 93.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.454 0.645 . . . . 74.12 109.84 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 25.2 tp -58.32 -46.55 85.94 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 124.916 1.287 . . . . 74.2 109.658 176.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 471' ' ' LEU . 30.2 tp -62.9 -48.39 79.16 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.522 -0.763 . . . . 72.44 110.533 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.649 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 29.7 mmm180 -60.97 -38.27 85.33 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.87 -0.604 . . . . 61.14 110.908 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 22.4 m -70.94 -40.49 72.0 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 115.986 -0.552 . . . . 74.04 110.226 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' THR . . . . . 0.462 HG21 ' HE2' ' A' ' 466' ' ' LYS . 61.9 m 69.72 -84.47 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.882 0.873 . . . . 71.5 111.577 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt 174.45 167.96 0.24 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.948 -1.501 . . . . 71.33 106.948 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 88.2 mtp -59.49 -51.22 70.8 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.398 0.888 . . . . 64.32 113.398 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.81 -64.65 1.13 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.503 -0.879 . . . . 55.13 109.307 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 150.19 18.07 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 118.721 -1.704 . . . . 43.54 115.691 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.1 m -100.22 130.36 46.34 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 119.036 1.418 . . . . 70.12 108.373 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 51.9 t -124.0 135.52 63.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 112.154 0.427 . . . . 65.33 112.154 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 42.9 m -94.18 115.24 27.5 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.073 -0.967 . . . . 74.32 110.289 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.57 121.21 44.18 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.091 -1.078 . . . . 72.32 108.091 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 2.8 tm? -110.0 116.48 31.66 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 105.854 -1.906 . . . . 73.42 105.854 174.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 34.8 m -118.25 157.79 19.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 115.057 -0.974 . . . . 71.12 111.206 -174.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -123.6 116.36 22.99 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.915 -0.584 . . . . 64.24 109.988 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 . . . . . 0 C--N 1.294 -1.835 0 N-CA-C 108.332 -0.988 . . . . 71.31 108.332 175.657 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 29.1 mtpp . . . . . 0 N--CA 1.423 -1.799 0 CA-C-O 121.3 0.571 . . . . 73.13 111.963 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 94.3 mtt180 -118.6 126.09 51.21 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.069 -1.826 . . . . 75.25 106.069 170.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.9 mp -124.74 136.76 54.15 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 116.468 -0.333 . . . . 72.11 110.934 -175.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -99.6 115.14 28.7 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 123.988 0.805 . . . . 64.12 108.956 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 55.4 mt -121.85 142.69 37.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.685 -0.857 . . . . 71.31 108.685 -176.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.408 ' HB3' HG22 ' A' ' 539' ' ' THR . 76.5 mt-30 -117.3 127.06 53.7 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.424 0.527 . . . . 64.52 112.424 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.57 133.19 56.27 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 124.46 1.104 . . . . 73.44 109.586 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 465' ' ' LYS . 37.4 ttpt -108.15 136.35 47.97 Favored 'General case' 0 N--CA 1.401 -2.897 0 N-CA-C 108.815 -0.809 . . . . 62.45 108.815 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.405 ' CD ' HG21 ' A' ' 534' ' ' THR . 48.8 mtmt -54.7 99.3 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 124.066 0.854 . . . . 71.41 111.506 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -131.19 136.82 9.04 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.696 -0.962 . . . . 51.43 110.696 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 64.5 m 63.1 -88.13 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.235 1.014 . . . . 73.05 111.446 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -98.01 -5.73 33.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.556 0.693 . . . . 64.15 109.364 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 69.17 -154.61 53.32 Favored Glycine 0 CA--C 1.486 -1.767 0 CA-C-O 118.109 -1.384 . . . . 73.42 110.842 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.439 HD12 HG22 ' A' ' 540' ' ' VAL . 48.1 mt -43.76 101.52 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.425 1.112 . . . . 60.42 112.348 -173.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -111.98 56.26 0.47 Allowed Glycine 0 CA--C 1.477 -2.282 0 CA-C-N 114.739 -1.119 . . . . 62.24 112.329 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.586 ' CZ ' HD12 ' A' ' 542' ' ' LEU . 5.3 p90 -144.45 142.12 30.07 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.055 -1.091 . . . . 75.03 108.055 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 28.9 p -116.57 162.36 17.74 Favored 'General case' 0 C--N 1.272 -2.797 0 N-CA-C 108.44 -0.948 . . . . 74.12 108.44 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.28 159.39 35.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.316 0.579 . . . . 74.3 111.505 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.8 t -148.12 153.73 39.24 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.358 -1.719 . . . . 62.42 106.358 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 C--N 1.293 -1.851 0 N-CA-C 108.595 -0.891 . . . . 74.52 108.595 178.632 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 C--O 1.249 1.072 0 N-CA-C 110.957 -0.44 . . . . 52.13 110.957 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 43.1 mm -93.74 130.64 42.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.644 -0.707 . . . . 71.14 109.235 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -127.51 153.46 46.31 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.255 0.222 . . . . 75.13 110.474 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 28.2 t -73.36 122.72 26.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.572 -0.899 . . . . 73.51 108.572 177.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -80.68 -62.26 1.72 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.437 -0.579 . . . . 72.14 109.437 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -143.05 163.71 32.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.368 -0.975 . . . . 71.41 108.368 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.428 HG13 ' HA ' ' A' ' 506' ' ' LYS . 26.4 mm -123.42 110.16 25.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 124.805 1.242 . . . . 61.3 108.445 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.02 125.4 73.97 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.217 -0.901 . . . . 72.34 110.633 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.28 21.33 0.23 Allowed 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 124.895 3.73 . . . . 71.42 114.6 -172.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -165.35 7.25 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.241 0.543 . . . . 75.02 112.424 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.445 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -89.48 -161.79 37.82 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 120.18 -1.009 . . . . 37.27 112.782 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -61.61 -39.84 92.69 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 123.817 0.847 . . . . 61.14 109.968 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.65 -41.4 81.39 Favored 'General case' 0 C--O 1.201 -1.461 0 CA-C-N 114.625 -1.171 . . . . 70.02 112.696 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.1 tt -79.48 -31.02 13.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 111.628 0.233 . . . . 72.12 111.628 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 30.9 mm-40 -59.71 -43.15 94.23 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.167 0.508 . . . . 61.14 109.65 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.42 -50.93 7.34 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.787 -0.642 . . . . 70.25 110.385 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 101.2 -36.09 4.44 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.044 -1.55 . . . . 37.27 116.235 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -65.87 -32.83 74.56 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.564 0.682 . . . . 64.53 112.232 -173.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 61.7 tp -84.44 102.7 12.99 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.921 -0.581 . . . . 73.45 110.508 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.428 ' HA ' HG13 ' A' ' 493' ' ' ILE . 10.3 ptmm? -113.69 177.0 4.79 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.181 -0.463 . . . . 74.14 111.52 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.44 ' HA ' ' CG1' ' A' ' 490' ' ' VAL . . . -87.43 147.52 25.39 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.997 -0.547 . . . . 62.43 110.371 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 110.11 -27.19 12.12 Favored Glycine 0 C--N 1.311 -0.852 0 C-N-CA 120.702 -0.761 . . . . 61.21 112.775 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -79.98 163.22 24.42 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 120.62 0.248 . . . . 62.4 110.945 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.496 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 31.6 ttm180 -96.8 142.5 28.73 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-O 120.796 0.331 . . . . 71.21 111.48 -178.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.687 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -90.54 126.96 36.1 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.902 0.881 . . . . 72.14 111.288 175.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.465 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 33.4 mt -103.33 -45.68 10.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.156 -0.683 . . . . 73.33 109.156 173.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.501 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 0.5 OUTLIER -150.96 155.15 38.5 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 109.716 -0.476 . . . . 73.33 109.716 176.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 541' ' ' SER . 7.1 p -143.3 130.58 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 O-C-N 123.827 0.705 . . . . 61.03 109.232 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . 0.458 HD22 ' HG2' ' A' ' 535' ' ' LYS . 1.4 t-20 64.78 15.42 9.8 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 125.918 1.687 . . . . 73.31 112.521 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 100.37 7.67 51.33 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.499 -0.858 . . . . 37.27 113.578 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 57.9 t -121.1 142.93 35.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 117.2 0.5 . . . . 63.45 110.415 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -73.96 144.5 45.21 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.472 0.709 . . . . 72.35 110.138 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.687 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 15.2 mt -108.43 -42.79 4.48 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.677 -0.409 . . . . 73.44 112.0 -175.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.34 -26.95 37.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 116.054 -0.521 . . . . 72.04 111.373 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -78.55 -18.52 75.56 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.747 -0.739 . . . . 63.55 112.416 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.451 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -110.62 -175.55 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.328 -0.513 . . . . 73.32 111.802 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' SER . . . . . 0.42 ' O ' HG21 ' A' ' 527' ' ' VAL . 11.3 m -87.32 158.75 18.98 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.901 -0.591 . . . . 71.43 111.183 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -59.71 -47.71 84.55 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.854 1.262 . . . . 71.31 109.843 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.476 ' O ' HG23 ' A' ' 528' ' ' VAL . 47.1 mt-10 -68.5 -30.36 69.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.694 0.998 . . . . 74.12 113.694 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.43 ' CB ' ' HD3' ' A' ' 522' ' ' LYS . 49.4 mt-10 -59.98 -37.59 80.08 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.515 -0.55 . . . . 60.23 109.515 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.429 HG13 HD23 ' A' ' 519' ' ' LEU . 43.4 t -65.64 -36.92 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.74 -0.663 . . . . 73.13 110.276 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.663 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 25.0 m -70.53 -39.09 75.74 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 C-N-CA 118.977 -1.089 . . . . 74.33 110.403 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 37.4 t -61.29 -37.41 83.09 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.017 -0.538 . . . . 42.23 109.873 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 33.7 tp -64.14 -42.52 96.75 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.876 1.27 . . . . 60.32 109.951 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 tt -64.7 -44.15 91.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.337 -0.847 . . . . 73.15 111.928 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 31.3 mmm180 -64.63 -27.08 68.69 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.054 -0.521 . . . . 75.11 112.055 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 23.2 p -82.53 -45.84 14.15 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 113.447 0.906 . . . . 72.32 113.447 -176.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' THR . . . . . 0.405 HG21 ' CD ' ' A' ' 466' ' ' LYS . 88.4 m 59.4 133.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.296 0.57 . . . . 72.02 112.466 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . 0.458 ' HG2' HD22 ' A' ' 515' ' ' ASN . 18.2 ptpt -64.96 152.56 42.96 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.053 -1.029 . . . . 62.43 109.68 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 50.9 ttm -54.76 -32.23 59.65 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 123.473 0.709 . . . . 71.31 112.784 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.56 -15.89 53.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.649 0.611 . . . . 74.2 112.649 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 85.93 -20.35 20.69 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.666 -0.778 . . . . 43.25 113.923 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 463' ' ' GLN . 3.9 m -104.09 129.07 51.76 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.48 0.657 . . . . 64.31 109.756 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.439 HG22 HD12 ' A' ' 471' ' ' LEU . 77.1 t -111.68 141.77 26.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.935 -1.029 . . . . 65.13 110.83 -176.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 34.3 t -91.15 132.95 35.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.743 -0.662 . . . . 71.53 109.444 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.586 HD12 ' CZ ' ' A' ' 473' ' ' PHE . 3.7 mm? -120.77 118.57 30.36 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.692 -1.225 . . . . 74.41 107.692 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.495 ' CB ' ' HG3' ' A' ' 513' ' ' GLU . 51.1 tp -104.63 117.66 34.67 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 105.213 -2.143 . . . . 71.44 105.213 172.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 28.6 m -115.98 151.78 17.73 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.135 0 C-N-CA 120.233 -0.587 . . . . 73.34 111.143 -176.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 85.6 t80 -110.92 116.14 30.7 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.68 -1.97 . . . . 74.12 105.68 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 . . . . . 0 C--N 1.287 -2.136 0 N-CA-C 108.865 -0.791 . . . . 72.4 108.865 -174.219 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt . . . . . 0 CA--C 1.487 -1.469 0 N-CA-C 113.786 1.032 . . . . 74.35 113.786 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 89.2 mtm180 -105.81 138.66 41.63 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 113.743 -1.571 . . . . 71.23 107.395 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 6.0 mp -123.4 128.24 49.58 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 120.989 0.424 . . . . 72.1 110.705 -177.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -96.27 116.26 28.73 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.042 -0.981 . . . . 72.53 109.787 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 53.6 mt -123.67 144.21 34.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 114.783 -1.099 . . . . 60.32 110.414 -172.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.3 mt-30 -119.98 129.99 54.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.594 0.59 . . . . 53.24 112.594 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' A' ' 502' ' ' ASP . 3.8 mm? -116.85 153.03 33.23 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 124.962 1.305 . . . . 74.24 110.189 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.464 ' HB3' ' HE3' ' A' ' 465' ' ' LYS . 17.6 ttpp -113.16 129.34 56.54 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 108.159 -1.052 . . . . 64.24 108.159 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -60.24 102.91 0.19 Allowed 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.547 -0.751 . . . . 73.23 109.664 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -146.16 150.45 22.69 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.369 -0.692 . . . . 44.32 111.369 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 50.1 m 65.21 -78.56 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.241 1.017 . . . . 64.04 111.131 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -119.48 -6.68 10.24 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.035 -0.728 . . . . 61.12 109.035 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 69.24 -151.08 50.79 Favored Glycine 0 C--O 1.206 -1.598 0 CA-C-O 118.673 -1.07 . . . . 70.13 110.784 -175.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 7.8 mp -46.83 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.217 1.192 . . . . 51.55 114.217 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -104.06 43.66 1.63 Allowed Glycine 0 N--CA 1.428 -1.847 0 CA-C-N 113.951 -1.477 . . . . 62.53 112.044 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -129.17 142.16 50.95 Favored 'General case' 0 N--CA 1.409 -2.518 0 N-CA-C 108.596 -0.89 . . . . 64.42 108.596 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 45.0 t -115.0 148.53 38.71 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.401 -1.333 . . . . 72.31 107.401 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 14.9 pt -116.62 156.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.474 0.654 . . . . 72.32 112.611 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.4 t -138.21 159.85 40.98 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.934 -1.506 . . . . 72.21 106.934 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 14.9 p . . . . . 0 C--N 1.285 -2.236 0 N-CA-C 109.666 -0.494 . . . . 73.12 109.666 -178.49 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo . . . . . 0 C--O 1.247 0.972 0 CA-C-O 121.712 0.63 . . . . 74.43 112.847 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.403 HG13 HG23 ' A' ' 527' ' ' VAL . 47.8 mm -97.74 135.6 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 115.01 -0.995 . . . . 65.14 108.728 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 97.7 m-85 -127.22 155.98 42.59 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 116.68 -0.236 . . . . 73.14 110.66 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.415 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 32.6 t -82.72 119.0 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 N-CA-C 107.665 -1.235 . . . . 55.32 107.665 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.436 ' HG2' ' OD1' ' A' ' 492' ' ' ASN . 61.2 tttm -85.14 -54.81 4.39 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.561 -0.745 . . . . 73.31 109.461 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . 0.436 ' OD1' ' HG2' ' A' ' 491' ' ' LYS . 18.4 m120 -136.98 157.08 47.55 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 115.447 -0.797 . . . . 63.4 112.55 -176.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.503 HG12 ' HB1' ' A' ' 507' ' ' ALA . 26.6 mm -120.53 115.59 47.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.314 -1.736 . . . . 62.34 106.314 172.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.92 163.11 17.5 Favored Pre-proline 0 C--N 1.304 -1.399 0 C-N-CA 123.839 0.855 . . . . 72.41 112.146 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -74.75 -5.22 16.55 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 123.645 2.896 . . . . 71.35 111.219 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.429 ' HA ' HG22 ' A' ' 500' ' ' ILE . 97.9 mtt180 -157.97 174.3 15.45 Favored 'General case' 0 N--CA 1.41 -2.437 0 C-N-CA 125.113 1.365 . . . . 73.03 107.843 -172.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 106.74 -175.93 21.11 Favored Glycine 1 C--N 1.251 -4.176 0 CA-C-N 114.659 -1.155 . . . . 53.51 112.262 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.51 81.39 Favored 'General case' 0 N--CA 1.422 -1.828 0 C-N-CA 123.783 0.833 . . . . 61.41 110.872 -175.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.31 -41.89 80.77 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 114.655 -1.157 . . . . 74.24 112.788 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 496' ' ' ARG . 13.6 tt -81.08 -43.66 20.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.955 0.724 . . . . 62.53 112.955 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -59.02 -37.79 77.75 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 112.436 0.532 . . . . 74.24 112.436 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.459 ' HB2' HD13 ' A' ' 464' ' ' LEU . 3.6 m-20 -89.48 -33.36 16.81 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.211 -0.596 . . . . 73.41 109.778 173.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 62.16 50.79 61.84 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.759 -0.655 . . . . 53.05 113.74 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -117.08 -18.7 9.99 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.714 -0.795 . . . . 71.03 111.415 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . 0.413 HD21 ' N ' ' A' ' 506' ' ' LYS . 6.8 tt -119.84 138.96 53.07 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.988 -0.745 . . . . 73.45 108.988 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.413 ' N ' HD21 ' A' ' 505' ' ' LEU . 0.0 OUTLIER -132.05 160.91 34.53 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.41 0.892 . . . . 63.4 113.41 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.503 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -79.13 166.7 21.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.511 0.724 . . . . 65.43 111.912 -174.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 73.43 20.33 79.84 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.857 -0.897 . . . . 54.0 110.857 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . 0.502 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 4.4 t70 -117.94 172.58 7.3 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.685 -1.228 . . . . 70.12 107.685 -176.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.428 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 30.3 ttm180 -107.3 135.25 49.12 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.311 -0.556 . . . . 75.04 110.951 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 27.4 mt -95.46 126.4 40.73 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 120.493 -0.483 . . . . 72.14 110.798 174.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.47 -45.39 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 116.019 -0.537 . . . . 75.12 111.203 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -156.63 155.08 31.19 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.329 -0.619 . . . . 73.45 109.329 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.442 HG11 HD21 ' A' ' 519' ' ' LEU . 6.4 p -132.6 125.03 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.726 0.774 . . . . 65.12 108.975 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 66.09 7.46 4.78 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 126.737 2.015 . . . . 74.23 112.65 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.53 -10.46 16.6 Favored Glycine 0 CA--C 1.508 -0.371 0 C-N-CA 120.484 -0.865 . . . . 75.4 112.734 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . 0.414 ' HB ' HD22 ' A' ' 530' ' ' LEU . 79.6 t -96.05 127.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.633 -0.506 . . . . 60.31 109.633 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.08 142.07 43.73 Favored 'General case' 0 CA--C 1.491 -1.324 0 O-C-N 123.868 0.73 . . . . 72.15 111.409 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.442 HD21 HG11 ' A' ' 514' ' ' VAL . 18.2 mt -100.08 -39.79 7.93 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 115.533 -0.758 . . . . 71.04 110.5 -176.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 38.6 t -73.92 98.75 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 108.587 -0.894 . . . . 75.02 108.587 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 136.52 -15.89 3.85 Favored Glycine 0 N--CA 1.424 -2.101 0 CA-C-N 114.313 -1.312 . . . . 73.21 110.173 -174.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.503 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -117.29 176.57 5.09 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-O 120.904 0.383 . . . . 71.34 111.681 176.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 37.3 m -91.11 161.09 15.24 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.889 -0.596 . . . . 73.25 111.235 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -55.42 -47.93 75.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.991 0.916 . . . . 71.31 111.694 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -62.42 -31.71 72.45 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 123.885 0.874 . . . . 71.14 112.429 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.85 -41.41 95.73 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.132 -0.692 . . . . 61.43 109.132 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.403 HG23 HG13 ' A' ' 488' ' ' ILE . 35.0 t -71.37 -39.44 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.993 -1.003 . . . . 72.11 110.389 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.663 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.9 m -65.18 -42.07 93.25 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.303 0 C-N-CA 119.347 -0.941 . . . . 71.13 110.164 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 36.8 m -62.09 -41.81 98.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.343 0.592 . . . . 72.42 110.199 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.414 HD22 ' HB ' ' A' ' 517' ' ' VAL . 54.7 tp -61.43 -46.26 90.84 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 124.125 0.97 . . . . 73.55 109.694 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.2 tt -63.39 -44.96 93.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.452 0.701 . . . . 74.23 112.408 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 28.0 mmm180 -63.06 -32.82 74.27 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.349 0.595 . . . . 72.2 109.943 -177.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 43.2 t -72.31 -44.39 62.77 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-N 115.076 -0.965 . . . . 75.13 109.779 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 86.3 m 69.6 -70.57 0.14 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.886 0.874 . . . . 65.53 110.839 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . 0.467 ' HA ' ' HE3' ' A' ' 535' ' ' LYS . 1.3 tpmt? 168.6 166.49 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 104.245 -2.502 . . . . 73.35 104.245 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 86.8 mtp -87.69 -28.59 21.71 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.025 -0.67 . . . . 64.34 109.257 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.66 -77.06 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.271 -0.877 . . . . 71.5 111.624 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 156.46 -29.31 0.56 Allowed Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 119.502 -1.332 . . . . 64.23 112.934 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 4.3 m -94.19 141.3 28.71 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.208 -1.405 . . . . 71.21 107.208 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 5.0 p -124.61 136.49 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 N-CA-C 109.223 -0.658 . . . . 74.11 109.223 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.4 m -92.25 132.87 36.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.937 -0.394 . . . . 72.12 109.937 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.442 HD21 HD23 ' A' ' 464' ' ' LEU . 1.3 mm? -124.18 138.56 54.4 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.096 -1.446 . . . . 74.14 107.096 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 39.2 tp -119.03 122.35 41.95 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 106.765 -1.569 . . . . 63.2 106.765 173.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.502 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 31.9 m -114.74 161.56 13.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 109.371 -0.604 . . . . 73.22 109.371 -177.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.408 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 84.4 t80 -132.96 129.2 37.94 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.405 0.621 . . . . 74.23 111.307 -177.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 . . . . . 0 C--N 1.292 -1.927 0 N-CA-C 108.194 -1.039 . . . . 75.44 108.194 177.293 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.517 ' HA ' ' HE3' ' A' ' 458' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.422 -1.844 0 CA-C-O 120.909 0.385 . . . . 64.43 110.111 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 79.7 mtm180 -100.55 142.38 32.11 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.998 -1.112 . . . . 75.52 107.998 172.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -132.48 132.43 42.7 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 109.264 -0.643 . . . . 65.41 109.264 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -95.55 115.71 27.81 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.753 -1.573 . . . . 72.24 106.753 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.36 142.84 38.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.689 -0.856 . . . . 64.33 108.689 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.439 ' HB3' HG22 ' A' ' 539' ' ' THR . 75.7 mt-30 -120.32 127.22 52.15 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.446 -0.502 . . . . 71.51 111.666 176.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.523 HD13 ' HB2' ' A' ' 502' ' ' ASP . 3.9 mm? -114.7 132.29 56.46 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.377 -0.972 . . . . 74.54 108.377 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 39.6 ttmt -105.19 136.13 45.27 Favored 'General case' 0 N--CA 1.401 -2.892 0 CA-C-O 121.832 0.825 . . . . 72.21 110.768 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -72.8 102.44 3.39 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 113.937 -1.483 . . . . 71.55 109.471 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -137.9 -84.28 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.422 -1.071 . . . . 43.23 110.422 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' THR . . . . . 0.444 ' O ' ' HA2' ' A' ' 497' ' ' GLY . 26.9 m -91.25 123.95 35.08 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.661 -1.607 . . . . 73.32 106.661 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . 0.602 ' HB3' ' CA ' ' A' ' 497' ' ' GLY . 10.9 tp10 39.17 52.85 2.14 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 125.157 1.383 . . . . 61.4 108.214 -174.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -53.14 127.88 36.79 Favored Glycine 0 N--CA 1.416 -2.681 0 CA-C-N 113.393 -1.731 . . . . 63.14 114.144 -171.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.531 ' H ' ' HB2' ' A' ' 498' ' ' ALA . 43.4 mt 65.95 74.34 0.36 Allowed 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 126.351 1.86 . . . . 74.13 110.475 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -92.51 57.15 2.69 Favored Glycine 0 N--CA 1.422 -2.24 0 CA-C-N 113.862 -1.517 . . . . 43.13 111.619 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.567 ' CE2' HD12 ' A' ' 542' ' ' LEU . 33.1 p90 -150.03 142.94 24.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.026 0.441 . . . . 73.31 111.558 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 46.4 p -128.7 164.75 22.27 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.826 -1.079 . . . . 74.43 108.742 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 22.7 pt -121.75 153.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 113.409 0.892 . . . . 73.22 113.409 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.8 t -137.18 141.33 42.17 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.178 -0.919 . . . . 63.01 109.567 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--N 1.306 -1.306 0 N-CA-C 107.58 -1.267 . . . . 61.15 107.58 177.435 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . 0.469 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 5.2 Cg_exo . . . . . 0 N--CA 1.441 -1.569 0 CA-C-O 121.189 0.412 . . . . 70.2 111.301 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 47.9 mm -86.42 120.61 36.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.943 -0.571 . . . . 72.43 109.954 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.469 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 90.6 m-85 -121.22 150.11 41.83 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 122.288 -0.257 . . . . 74.44 110.352 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 41.1 t -72.05 119.82 19.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.931 -0.766 . . . . 75.42 108.931 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -84.65 -57.47 3.12 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.357 -0.838 . . . . 72.34 110.897 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -136.81 151.94 49.73 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.899 -0.591 . . . . 73.32 109.781 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' A' ' 506' ' ' LYS . 27.8 mm -123.08 106.94 18.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.881 -1.155 . . . . 74.24 107.881 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.421 ' C ' ' H ' ' A' ' 496' ' ' ARG . 3.3 mm? -63.72 113.99 11.84 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 108.982 -0.748 . . . . 75.04 108.982 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.21 29.52 0.39 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 124.903 3.736 . . . . 73.43 112.55 -172.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 494' ' ' LEU . 10.7 ptp180 -154.5 1.98 0.21 Allowed 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 115.568 -0.742 . . . . 71.11 112.133 -175.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.602 ' CA ' ' HB3' ' A' ' 469' ' ' GLU . . . -113.94 -146.63 9.44 Favored Glycine 0 C--O 1.218 -0.849 0 C-N-CA 119.124 -1.512 . . . . 75.4 115.296 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . 0.531 ' HB2' ' H ' ' A' ' 471' ' ' LEU . . . -59.79 -40.49 88.47 Favored 'General case' 0 C--N 1.364 1.225 0 CA-C-N 118.24 1.02 . . . . 63.51 110.563 -173.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.61 -37.82 73.89 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 115.091 -0.959 . . . . 62.44 112.864 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 500' ' ' ILE . 11.6 tt -80.14 -35.58 15.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.01 0.374 . . . . 65.12 112.01 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -58.79 -47.28 85.27 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.017 0.437 . . . . 73.35 110.28 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.523 ' HB2' HD13 ' A' ' 464' ' ' LEU . 21.1 m-20 -89.86 -30.19 18.07 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.443 -0.503 . . . . 72.34 110.275 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 76.27 -23.63 1.83 Allowed Glycine 0 CA--C 1.529 0.933 0 N-CA-C 118.075 1.99 . . . . 52.0 118.075 170.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -67.33 -17.46 64.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.834 1.049 . . . . 75.34 113.834 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 42.8 tp -101.76 132.3 47.57 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 122.134 -0.354 . . . . 71.44 111.672 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.424 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.261 0.0 OUTLIER -135.79 146.44 47.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 113.379 0.881 . . . . 62.35 113.379 176.657 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.401 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -65.07 123.39 19.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.306 -0.861 . . . . 54.1 110.609 -177.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 131.67 -18.87 4.82 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 111.064 -0.814 . . . . 50.41 111.064 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -81.05 156.78 25.69 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 109.212 -0.662 . . . . 72.43 109.212 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -95.57 136.49 35.89 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.775 -0.454 . . . . 64.44 109.775 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.409 ' HB3' HD12 ' A' ' 519' ' ' LEU . 24.8 mt -85.7 136.01 33.53 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 119.707 -0.797 . . . . 73.53 110.708 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.36 -45.64 10.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.318 -0.623 . . . . 72.31 109.318 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.35 157.13 36.65 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.06 -0.718 . . . . 72.33 109.06 176.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.52 HG11 HD21 ' A' ' 519' ' ' LEU . 7.6 p -144.46 136.22 21.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-N 116.021 -0.536 . . . . 63.55 109.931 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . 0.418 HD21 HG13 ' A' ' 540' ' ' VAL . 5.3 t-20 65.96 12.32 8.34 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 125.505 1.522 . . . . 71.52 111.734 176.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 92.7 14.05 55.85 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 120.857 -0.687 . . . . 37.8 111.959 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 37.3 t -121.1 146.45 26.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.921 -0.77 . . . . 75.21 108.921 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . 0.571 ' O ' ' HE2' ' A' ' 522' ' ' LYS . 5.3 p-10 -88.51 152.66 21.72 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 109.232 -0.655 . . . . 75.34 109.232 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.52 HD21 HG11 ' A' ' 514' ' ' VAL . 18.7 mt -100.53 -52.54 3.32 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.369 -0.532 . . . . 75.31 111.731 -172.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.25 110.01 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.938 0.875 . . . . 70.24 110.503 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 135.42 -33.94 2.36 Favored Glycine 0 N--CA 1.418 -2.534 0 N-CA-C 109.285 -1.526 . . . . 70.5 109.285 -174.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.571 ' HE2' ' O ' ' A' ' 518' ' ' ASP . 0.1 OUTLIER -107.93 161.54 14.84 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 109.79 -0.448 . . . . 62.32 109.79 178.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 29.4 m -87.22 162.4 17.48 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.659 -0.246 . . . . 72.32 111.498 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.436 ' O ' HG12 ' A' ' 528' ' ' VAL . 53.8 mt-30 -51.74 -46.92 64.22 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.372 0.669 . . . . 74.33 112.32 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.01 -32.39 70.83 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.209 0.448 . . . . 72.02 112.209 -178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.13 -39.87 68.51 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.42 -0.585 . . . . 53.13 109.42 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.411 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 49.0 t -67.04 -41.75 87.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 74.43 109.584 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.668 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 8.6 m -66.7 -40.94 87.29 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.152 0 C-N-CA 119.209 -0.996 . . . . 74.42 110.012 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.8 m -60.41 -44.1 96.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.296 -0.411 . . . . 61.25 111.382 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.487 HD12 HG13 ' A' ' 514' ' ' VAL . 3.5 pp -67.46 -30.29 69.97 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.299 0.571 . . . . 62.23 110.232 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.426 ' CD1' HD13 ' A' ' 471' ' ' LEU . 65.2 tp -69.85 -48.22 59.71 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.679 -0.691 . . . . 73.23 109.576 175.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 27.6 mmm180 -61.11 -39.11 88.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.642 -0.708 . . . . 72.54 111.85 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 30.6 t -65.25 -38.7 91.17 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.384 -0.598 . . . . 42.32 109.384 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 17.6 m 69.92 166.57 0.28 Allowed 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.474 0.71 . . . . 73.35 111.432 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -81.41 150.98 28.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.653 -1.61 . . . . 75.44 106.653 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 91.9 mmm -63.86 -31.95 73.31 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.772 1.027 . . . . 73.22 113.772 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.27 -32.33 73.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 122.007 0.908 . . . . 72.04 108.675 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 105.68 -14.01 46.21 Favored Glycine 0 N--CA 1.422 -2.28 0 CA-C-N 114.778 -1.101 . . . . 72.24 111.453 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 463' ' ' GLN . 1.8 m -96.7 129.08 44.17 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.336 -0.616 . . . . 63.34 109.336 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.418 HG13 HD21 ' A' ' 515' ' ' ASN . 86.9 t -106.76 133.5 51.15 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 115.532 -0.758 . . . . 73.2 109.915 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 21.8 t -91.48 129.59 37.44 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 109.075 -0.713 . . . . 73.51 109.075 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.567 HD12 ' CE2' ' A' ' 473' ' ' PHE . 3.8 mm? -117.56 130.33 56.34 Favored 'General case' 0 C--N 1.283 -2.309 0 C-N-CA 124.607 1.163 . . . . 74.52 108.846 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 54.6 tp -112.8 117.91 33.49 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.733 -1.951 . . . . 63.12 105.733 169.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 25.9 m -115.73 150.98 17.54 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.788 0 C-N-CA 120.133 -0.627 . . . . 74.12 110.075 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -111.77 115.8 29.66 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 106.509 -1.663 . . . . 63.22 106.509 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 N--CA 1.399 -3.023 0 CA-C-N 115.213 -0.903 . . . . 74.22 109.093 -178.87 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 N--CA 1.409 -2.488 0 N-CA-C 109.182 -0.673 . . . . 71.5 109.182 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 97.5 mtt180 -99.36 132.46 44.67 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.246 -1.761 . . . . 74.11 106.246 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 15.6 tp -126.44 132.72 51.42 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.286 -0.566 . . . . 64.52 110.153 -171.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -98.63 114.61 27.15 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-O 121.97 0.89 . . . . 72.54 108.952 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.05 133.54 60.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 CA-C-N 115.074 -0.966 . . . . 64.44 109.754 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 48.4 mt-30 -106.76 128.97 54.68 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.999 -0.68 . . . . 74.33 112.177 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.489 HD23 HD21 ' A' ' 542' ' ' LEU . 4.5 mm? -112.9 150.0 32.39 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.811 -1.086 . . . . 71.33 108.697 175.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -107.54 136.37 47.43 Favored 'General case' 0 N--CA 1.389 -3.485 0 O-C-N 124.017 0.823 . . . . 61.3 109.931 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -70.82 85.12 0.67 Allowed 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 115.117 -0.947 . . . . 74.33 108.765 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -84.84 -129.98 2.07 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.45 -0.795 . . . . 62.13 112.253 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 8.7 t -66.91 -57.7 6.43 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.495 0.554 . . . . 72.22 112.495 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.82 -6.82 35.12 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.811 -0.556 . . . . 74.14 110.751 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 58.72 -153.18 29.76 Favored Glycine 0 C--O 1.207 -1.545 0 CA-C-O 118.669 -1.073 . . . . 70.12 112.184 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.499 HD12 HG22 ' A' ' 540' ' ' VAL . 61.1 mt -47.25 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.996 0.903 . . . . 74.53 112.903 -171.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.36 62.12 0.35 Allowed Glycine 0 CA--C 1.475 -2.433 0 CA-C-N 114.399 -1.273 . . . . 75.23 111.003 -176.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -155.58 142.59 19.12 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.932 -0.766 . . . . 72.22 108.932 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.3 m -117.84 158.35 24.98 Favored 'General case' 0 C--N 1.281 -2.4 0 O-C-N 124.112 0.883 . . . . 75.43 109.226 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 17.0 pt -116.73 157.31 17.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.275 0.56 . . . . 72.23 111.469 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.7 t -140.2 155.99 46.69 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 107.898 -1.149 . . . . 72.24 107.898 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 62.7 p . . . . . 0 C--N 1.306 -1.298 0 N-CA-C 108.924 -0.769 . . . . 70.31 108.924 -179.83 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 C--O 1.243 0.767 0 CA-C-O 121.392 0.497 . . . . 65.42 112.465 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 46.0 mm -93.57 136.42 25.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.778 -0.823 . . . . 62.24 108.778 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -131.18 159.33 38.03 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 121.986 0.114 . . . . 73.32 110.776 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.33 121.34 26.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.017 -0.734 . . . . 72.15 109.017 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -83.16 -57.15 3.4 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.303 0.573 . . . . 72.34 110.113 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -147.0 153.73 40.4 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.701 -0.681 . . . . 71.42 109.935 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.505 HG12 ' HB1' ' A' ' 507' ' ' ALA . 33.7 mm -114.06 106.48 20.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.081 -1.081 . . . . 63.54 108.081 175.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.2 mp -61.47 122.37 70.23 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 109.085 -0.709 . . . . 61.12 109.085 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . 0.448 ' C ' HG22 ' A' ' 500' ' ' ILE . 87.7 Cg_endo -69.86 28.42 0.18 Allowed 'Trans proline' 0 N--CA 1.521 3.127 1 C-N-CA 125.733 4.289 . . . . 75.23 115.038 -170.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.503 ' N ' HG22 ' A' ' 500' ' ' ILE . 13.6 ptm180 -163.51 -0.81 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 113.179 0.807 . . . . 73.25 113.179 -175.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -97.33 -166.16 32.45 Favored Glycine 0 C--N 1.306 -1.103 0 C-N-CA 119.613 -1.279 . . . . 72.44 112.421 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . 0.477 ' C ' HD11 ' A' ' 464' ' ' LEU . . . -49.55 -48.6 48.3 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 125.451 1.5 . . . . 74.12 112.758 -172.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.16 80.66 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 115.492 -0.777 . . . . 62.35 112.108 -173.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 496' ' ' ARG . 0.0 OUTLIER -81.33 -35.99 14.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 123.488 0.715 . . . . 74.34 112.908 179.283 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.8 mm100 -67.79 -37.73 82.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.014 0.435 . . . . 75.21 110.929 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.431 ' HB2' HD13 ' A' ' 464' ' ' LEU . 10.0 m-20 -87.77 -30.41 20.3 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.531 -0.914 . . . . 61.34 108.531 174.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 68.75 49.26 44.03 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.311 -0.859 . . . . 62.23 113.537 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -118.04 -38.51 3.21 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.361 -0.935 . . . . 64.43 111.497 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 58.6 tp -109.01 148.47 30.72 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.529 -0.305 . . . . 71.25 110.39 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.461 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -137.46 170.75 15.55 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 123.306 0.378 . . . . 72.33 110.021 177.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.505 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -88.2 85.18 6.89 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.956 0.725 . . . . 71.24 112.956 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 176.4 19.44 0.02 OUTLIER Glycine 0 C--N 1.293 -1.806 0 CA-C-N 114.658 -1.156 . . . . 54.11 110.254 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -116.82 153.25 32.81 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-O 121.02 0.438 . . . . 75.24 110.983 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.428 HH21 HG23 ' A' ' 520' ' ' VAL . 38.4 ttt180 -94.27 134.65 36.52 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.485 -0.779 . . . . 73.24 110.201 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.681 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.2 mm? -83.21 129.59 35.02 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.016 -0.993 . . . . 74.01 110.16 174.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.455 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 36.2 mm -107.52 -43.64 6.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.152 0.501 . . . . 73.34 109.971 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 517' ' ' VAL . 28.9 tt0 -158.49 155.02 27.73 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.554 -0.748 . . . . 74.32 110.02 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 541' ' ' SER . 3.5 p -143.49 125.52 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 109.484 -0.562 . . . . 74.35 109.484 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . 0.498 HD22 HG13 ' A' ' 540' ' ' VAL . 61.0 m-80 62.48 12.79 5.64 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 125.367 1.467 . . . . 62.11 114.029 -176.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 101.69 15.55 26.62 Favored Glycine 0 C--N 1.31 -0.91 0 C-N-CA 120.201 -0.999 . . . . 63.43 112.875 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' A' ' 513' ' ' GLU . 61.1 t -116.48 128.75 73.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.614 -0.884 . . . . 72.41 108.614 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.22 144.14 29.13 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.172 -0.677 . . . . 71.21 109.172 -173.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.681 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 33.6 mt -97.86 -49.54 4.76 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.762 0.652 . . . . 71.33 112.762 -171.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . 0.428 HG23 HH21 ' A' ' 510' ' ' ARG . 95.7 t -70.81 96.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 122.274 1.035 . . . . 64.35 111.087 -175.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 145.62 -23.44 1.83 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 109.143 -1.583 . . . . 71.34 109.143 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.464 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -110.57 178.02 4.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 120.666 0.27 . . . . 61.03 111.172 177.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 6.5 m -89.8 159.54 16.97 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.613 -0.721 . . . . 73.13 109.48 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -60.58 -43.97 96.74 Favored 'General case' 0 C--O 1.222 -0.347 0 O-C-N 123.089 0.243 . . . . 73.13 111.341 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.492 ' O ' HG23 ' A' ' 528' ' ' VAL . 1.6 mp0 -56.86 -35.83 69.34 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.037 -0.529 . . . . 73.13 111.337 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -62.52 -38.69 90.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.818 -0.628 . . . . 74.32 109.703 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.12 -36.72 31.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.452 -0.795 . . . . 60.1 110.144 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 14.8 m -65.29 -41.4 91.33 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 C-N-CA 119.718 -0.793 . . . . 71.33 110.424 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 46.0 t -60.93 -40.07 91.87 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.494 0.664 . . . . 72.22 110.02 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 36.8 tp -64.33 -36.47 84.24 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 124.371 1.068 . . . . 71.42 109.814 177.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.9 -45.31 64.54 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.682 -0.69 . . . . 73.33 109.333 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -59.69 -39.86 85.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.164 0.986 . . . . 71.44 110.891 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 29.1 t -64.77 -41.52 95.82 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.393 -0.821 . . . . 71.31 109.923 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 87.4 m 63.73 -91.05 0.03 OUTLIER 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.477 0.711 . . . . 64.21 111.072 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt 166.98 145.89 0.02 OUTLIER 'General case' 0 C--O 1.25 1.1 0 N-CA-C 105.757 -1.942 . . . . 71.33 105.757 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.5 mtt -66.37 -40.81 89.97 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.982 -0.287 . . . . 75.31 111.537 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.4 -79.84 0.06 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 119.248 -0.406 . . . . 73.12 111.944 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 178.66 -25.98 0.05 OUTLIER Glycine 0 C--O 1.218 -0.89 0 C-N-CA 116.634 -2.698 . . . . 55.04 116.562 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 1.3 p -94.78 120.37 34.89 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 114.926 1.454 . . . . 74.55 114.926 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.499 HG22 HD12 ' A' ' 471' ' ' LEU . 98.7 t -107.95 131.98 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 114.239 -1.346 . . . . 72.55 108.646 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 24.2 p -95.39 114.58 26.36 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.256 0.551 . . . . 70.3 111.193 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.489 HD21 HD23 ' A' ' 464' ' ' LEU . 2.9 mm? -103.76 122.94 46.12 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.161 -1.052 . . . . 53.14 108.161 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 44.3 tp -103.92 117.92 35.46 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 106.445 -1.687 . . . . 63.42 106.445 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 29.0 m -116.79 161.22 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 120.63 -0.428 . . . . 74.44 110.789 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.452 ' HB2' HD11 ' A' ' 512' ' ' ILE . 91.9 t80 -111.33 117.48 33.25 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.367 0.604 . . . . 73.42 109.59 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 . . . . . 0 C--N 1.287 -2.148 0 N-CA-C 107.354 -1.35 . . . . 60.44 107.354 177.562 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm . . . . . 0 CA--C 1.489 -1.394 0 CA-C-O 120.928 0.394 . . . . 73.11 111.968 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 93.5 mtt180 -104.66 135.4 46.13 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.331 -0.988 . . . . 72.53 108.331 175.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 6.4 mp -131.76 142.01 49.65 Favored 'General case' 0 CA--C 1.48 -1.742 0 CA-C-O 120.735 0.303 . . . . 74.42 110.953 -172.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -98.01 115.98 29.3 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.263 -0.88 . . . . 73.01 108.693 174.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 71.0 mt -123.77 123.17 66.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.13 -0.941 . . . . 71.21 110.12 -175.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.491 ' HB3' ' CG2' ' A' ' 539' ' ' THR . 25.6 mt-30 -100.41 137.29 39.03 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.836 -0.746 . . . . 74.43 112.558 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.491 ' CD1' ' HA ' ' A' ' 499' ' ' ALA . 4.3 mm? -116.66 136.26 53.11 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 115.112 -0.949 . . . . 74.51 110.228 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.8 120.48 42.38 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 106.861 -1.533 . . . . 72.13 106.861 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -45.73 100.9 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.753 1.221 . . . . 74.12 111.465 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -92.96 -121.59 3.07 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.5 -0.773 . . . . 72.31 112.953 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' THR . . . . . 0.706 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 36.3 m -59.87 -56.97 15.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.943 0.497 . . . . 75.2 111.737 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -112.32 -6.69 14.03 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.672 0.749 . . . . 63.13 111.58 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 77.79 -156.51 44.34 Favored Glycine 0 C--O 1.199 -2.088 0 CA-C-O 118.377 -1.235 . . . . 55.51 110.949 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.427 HD12 HG22 ' A' ' 540' ' ' VAL . 41.6 mt -50.41 102.36 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.71 1.255 . . . . 71.44 112.9 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -122.35 53.64 0.72 Allowed Glycine 0 N--CA 1.422 -2.281 0 CA-C-N 114.488 -1.233 . . . . 62.22 111.257 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.609 ' CZ ' HD12 ' A' ' 542' ' ' LEU . 6.1 p90 -126.51 145.16 50.62 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.746 -1.576 . . . . 75.42 106.746 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 38.9 m -114.97 138.33 50.97 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 109.033 -0.728 . . . . 64.33 109.033 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 14.2 pt -109.72 152.58 11.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-O 121.421 0.629 . . . . 75.12 111.786 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.1 t -136.34 159.61 41.23 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.27 -1.382 . . . . 74.42 107.27 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.642 ' HB3' ' OE1' ' A' ' 524' ' ' GLN . 33.3 p . . . . . 0 C--N 1.282 -2.357 0 N-CA-C 109.021 -0.733 . . . . 65.35 109.021 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo . . . . . 0 C--O 1.245 0.856 0 N-CA-C 113.449 0.519 . . . . 71.43 113.449 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 24.2 mm -95.58 133.51 36.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.156 -0.929 . . . . 74.25 109.014 -176.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 97.2 m-85 -131.05 151.76 51.08 Favored 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 122.079 -0.388 . . . . 75.2 110.642 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 56.2 t -84.52 119.02 32.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.709 -0.849 . . . . 54.21 108.709 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -83.1 -55.86 4.12 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.629 0.772 . . . . 74.21 110.167 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -141.65 152.89 44.34 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.487 -0.778 . . . . 63.33 110.49 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.449 HG12 ' HB1' ' A' ' 507' ' ' ALA . 30.0 mm -117.11 105.09 17.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.735 -1.58 . . . . 74.34 106.735 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.09 146.36 88.19 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 116.114 -0.494 . . . . 75.15 111.463 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . 0.438 ' C ' HG22 ' A' ' 500' ' ' ILE . 84.9 Cg_endo -74.82 12.28 1.21 Allowed 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 124.579 3.519 . . . . 73.11 116.189 -172.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.706 ' O ' ' HB ' ' A' ' 468' ' ' THR . 13.0 ptp180 -155.37 3.48 0.19 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 115.361 1.615 . . . . 74.22 115.361 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.504 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -83.92 -161.14 31.78 Favored Glycine 0 C--N 1.286 -2.195 0 C-N-CA 119.265 -1.445 . . . . 75.42 112.625 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -69.1 -39.35 79.04 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 123.414 0.686 . . . . 73.02 110.001 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . 0.491 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -56.86 -42.76 80.31 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 114.441 -1.254 . . . . 73.53 111.827 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 496' ' ' ARG . 0.0 OUTLIER -80.03 -37.15 17.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 112.571 0.582 . . . . 75.41 112.571 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.5 mm100 -61.13 -40.85 95.36 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.814 0.34 . . . . 72.42 110.641 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.446 ' HB2' HD13 ' A' ' 464' ' ' LEU . 6.4 m-20 -84.11 -43.3 15.17 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.21 -0.45 . . . . 72.41 109.969 174.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 70.44 13.97 71.46 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 121.346 -0.454 . . . . 63.21 113.62 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -88.16 -14.06 39.63 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.433 0.635 . . . . 70.02 109.686 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . 0.403 ' HB2' HD22 ' A' ' 464' ' ' LEU . 49.2 tp -114.83 138.39 50.83 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.88 -1.156 . . . . 74.44 107.88 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.446 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -140.98 169.34 17.81 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.811 0.671 . . . . 62.4 112.811 178.483 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.449 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -82.55 161.9 22.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.013 -0.539 . . . . 70.43 111.938 -173.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 74.96 42.21 30.63 Favored Glycine 0 CA--C 1.506 -0.485 0 N-CA-C 110.802 -0.919 . . . . 74.05 110.802 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -146.68 149.11 32.81 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.959 -1.497 . . . . 73.34 106.959 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 41.6 ttm180 -87.7 138.22 31.66 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 118.095 0.407 . . . . 73.23 111.385 -174.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.445 ' HG ' HD12 ' A' ' 519' ' ' LEU . 25.9 tp -100.23 127.38 46.52 Favored 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 108.442 -0.948 . . . . 73.23 108.442 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.502 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 34.5 mm -100.97 -47.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.096 0.474 . . . . 74.54 110.966 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -157.13 149.35 22.9 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 109.022 -0.733 . . . . 62.44 109.022 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 541' ' ' SER . 7.1 p -137.57 134.43 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 CA-C-O 121.254 0.55 . . . . 73.14 109.727 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . 0.435 HD22 ' HB2' ' A' ' 535' ' ' LYS . 4.1 t-20 58.81 23.21 11.0 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 127.003 2.121 . . . . 70.14 112.944 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 89.72 15.4 58.21 Favored Glycine 0 CA--C 1.502 -0.752 0 C-N-CA 121.036 -0.602 . . . . 63.24 112.538 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.5 t -115.38 131.41 67.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 O-C-N 122.709 -0.289 . . . . 71.14 110.308 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.73 130.48 35.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.343 0.657 . . . . 70.02 110.364 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 10.7 mt -95.87 -30.5 13.62 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.587 0.708 . . . . 72.32 110.205 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 55.3 t -58.83 -34.74 53.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.133 -1.394 . . . . 64.44 112.049 -171.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -99.38 20.68 48.81 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.929 -0.653 . . . . 51.21 113.831 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.548 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -138.46 -179.83 6.03 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 117.797 0.798 . . . . 70.02 111.954 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 32.6 m -92.16 163.21 14.02 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.649 0.261 . . . . 63.51 111.471 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.642 ' OE1' ' HB3' ' A' ' 477' ' ' SER . 43.6 tp60 -59.7 -44.93 93.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.329 1.052 . . . . 75.13 110.694 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 528' ' ' VAL . 47.8 mt-10 -62.32 -31.95 72.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.695 0.628 . . . . 72.14 112.695 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.415 ' CD ' ' HB2' ' A' ' 522' ' ' LYS . 50.1 mt-10 -63.81 -36.83 85.2 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.651 -0.5 . . . . 64.41 109.651 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 17.3 t -73.68 -36.51 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 115.588 -0.733 . . . . 74.44 109.478 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 13.9 m -69.45 -39.39 78.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.417 0 C-N-CA 119.592 -0.843 . . . . 65.14 111.177 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.9 t -62.33 -43.3 99.14 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.196 0.522 . . . . 70.43 109.661 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.85 -41.84 78.66 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.811 1.244 . . . . 74.41 109.383 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.428 HD12 ' O ' ' A' ' 473' ' ' PHE . 3.2 tt -69.0 -45.13 71.32 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.921 -1.036 . . . . 73.12 112.58 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.507 ' HA ' ' HE ' ' A' ' 532' ' ' ARG . 1.1 mmp_? -62.15 -43.72 98.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.554 -0.294 . . . . 73.14 110.48 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.1 m -68.54 -32.36 72.25 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.226 -0.443 . . . . 71.04 111.434 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 51.4 m 68.49 -94.88 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.02 0.528 . . . . 55.55 111.348 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . 0.435 ' HB2' HD22 ' A' ' 515' ' ' ASN . 86.1 tttt 169.26 141.17 0.02 OUTLIER 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.435 -1.32 . . . . 74.04 107.435 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 86.8 mtp -68.75 -31.87 71.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.646 0.26 . . . . 71.43 111.598 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -59.61 -38.33 80.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.315 0.578 . . . . 71.21 110.288 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 112.02 -29.74 8.22 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.159 -1.02 . . . . 74.22 114.129 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.491 ' CG2' ' HB3' ' A' ' 463' ' ' GLN . 6.4 m -103.93 136.3 43.84 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.973 -0.691 . . . . 70.24 109.238 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.427 HG22 HD12 ' A' ' 471' ' ' LEU . 61.3 t -118.92 138.24 50.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.915 -0.584 . . . . 45.53 110.039 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 69.2 m -91.93 115.0 27.7 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-O 121.077 0.465 . . . . 63.54 111.478 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.609 HD12 ' CZ ' ' A' ' 473' ' ' PHE . 3.3 mm? -102.09 119.73 39.27 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.8 -1.185 . . . . 75.22 107.8 176.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 2.8 tm? -108.23 117.07 33.2 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 104.832 -2.284 . . . . 65.32 104.832 173.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 33.5 m -115.9 161.33 14.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 115.379 -0.828 . . . . 74.1 111.624 -173.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.406 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 66.4 t80 -120.87 116.55 25.38 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.514 -0.921 . . . . 73.22 108.514 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 . . . . . 0 N--CA 1.396 -3.146 0 CA-C-N 115.054 -0.975 . . . . 74.01 108.77 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 29.5 mtpp . . . . . 0 CA--C 1.482 -1.661 0 CA-C-O 121.224 0.535 . . . . 71.11 111.962 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 95.0 mtt180 -116.17 126.22 53.38 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.821 -1.178 . . . . 65.14 107.821 167.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.2 mp -123.93 142.08 51.46 Favored 'General case' 0 CA--C 1.465 -2.29 0 CA-C-N 116.536 -0.302 . . . . 53.14 110.49 -172.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -98.19 114.95 27.35 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 115.104 -0.953 . . . . 70.23 108.929 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . 0.436 HG22 ' CG ' ' A' ' 504' ' ' ARG . 54.9 mt -118.86 129.58 74.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-N 114.893 -1.049 . . . . 72.12 109.463 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.2 mt-30 -115.86 127.94 55.41 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 113.046 0.758 . . . . 72.34 113.046 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 502' ' ' ASP . 3.9 mm? -115.64 137.86 51.65 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 115.009 -0.996 . . . . 60.13 109.769 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 465' ' ' LYS . 34.5 ttpt -107.48 135.96 48.08 Favored 'General case' 0 N--CA 1.4 -2.939 0 N-CA-C 108.867 -0.79 . . . . 75.53 108.867 -177.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.405 ' HB2' HG21 ' A' ' 534' ' ' THR . 39.4 ttmt -61.76 98.59 0.1 Allowed 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.639 0.733 . . . . 73.42 111.601 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -130.86 139.55 11.04 Favored Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 108.375 -1.89 . . . . 61.51 108.375 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 469' ' ' GLU 0.365 7.3 t 52.75 -81.55 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.104 1.361 . . . . 72.23 113.819 -175.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . 0.407 ' OE1' ' HG3' ' A' ' 496' ' ' ARG . 37.9 mt-10 -106.79 -7.68 17.09 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.732 0.697 . . . . 65.52 110.858 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 67.8 -157.04 52.42 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.255 -0.884 . . . . 72.43 111.826 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.452 HD22 ' CD1' ' A' ' 531' ' ' LEU . 5.3 mp -44.4 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.32 1.23 . . . . 74.02 114.32 -170.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -97.54 65.11 0.89 Allowed Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.018 -1.446 . . . . 52.4 111.291 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.44 ' CE2' HD12 ' A' ' 531' ' ' LEU . 27.1 p90 -155.44 147.84 23.88 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.193 -0.504 . . . . 75.15 110.184 176.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -126.27 162.77 24.69 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.474 -0.785 . . . . 73.44 109.446 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.2 pt -119.68 155.46 22.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 120.95 0.405 . . . . 72.22 111.703 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.9 t -135.68 129.53 32.87 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.877 -0.601 . . . . 74.02 110.239 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 24.0 t . . . . . 0 N--CA 1.423 -1.796 0 N-CA-C 108.621 -0.881 . . . . 75.21 108.621 173.92 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.436 -1.895 0 N-CA-C 109.998 -0.808 . . . . 75.22 109.998 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 41.9 mm -96.24 139.65 18.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 109.325 -0.62 . . . . 74.13 109.325 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.17 153.4 48.59 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 122.311 -0.243 . . . . 73.15 110.575 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 26.3 t -73.74 121.32 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.86 -1.163 . . . . 73.44 107.86 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -90.38 -52.44 4.92 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.563 0.697 . . . . 73.4 110.976 -176.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -146.32 150.89 36.6 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.414 -0.812 . . . . 53.15 110.3 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.482 HG12 ' HB1' ' A' ' 507' ' ' ALA . 34.6 mm -119.96 104.83 16.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 107.444 -1.317 . . . . 62.44 107.444 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -62.9 122.62 75.87 Favored Pre-proline 0 C--N 1.307 -1.253 0 CA-C-N 115.585 -0.734 . . . . 71.31 109.83 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.36 22.79 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 124.768 3.645 . . . . 74.23 114.3 -171.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.407 ' HG3' ' OE1' ' A' ' 469' ' ' GLU . 8.3 ptp180 -157.43 6.99 0.15 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 113.437 0.903 . . . . 72.43 113.437 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -101.14 -149.96 23.54 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 119.814 -1.184 . . . . 74.14 112.449 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -64.09 -40.29 95.9 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.156 0.582 . . . . 70.0 111.207 -176.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.8 71.01 Favored 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 115.545 -0.752 . . . . 73.31 112.635 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.8 tt -80.72 -42.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.445 0.535 . . . . 62.31 112.445 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 501' ' ' GLN . 14.7 mm-40 -61.46 -37.73 84.66 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.057 0.392 . . . . 73.31 112.057 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.472 ' HB2' HD12 ' A' ' 464' ' ' LEU . 17.5 m-20 -94.93 -28.98 14.9 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 109.442 -0.577 . . . . 72.24 109.442 175.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 57.7 28.7 60.45 Favored Glycine 0 CA--C 1.496 -1.1 0 CA-C-N 115.467 -0.788 . . . . 74.13 114.36 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.436 ' CG ' HG22 ' A' ' 462' ' ' ILE . 26.7 tpt180 -99.4 -13.94 19.36 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.248 -0.581 . . . . 73.24 110.772 -174.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 49.7 tp -123.41 148.1 46.46 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.541 0.21 . . . . 74.43 110.449 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 506' ' ' LYS . 0.0 OUTLIER -141.98 165.41 27.53 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.764 -0.828 . . . . 71.24 108.764 177.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.482 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -85.39 130.62 34.55 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.48 -0.563 . . . . 62.4 109.48 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 140.85 -20.28 2.71 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.211 -0.756 . . . . 60.43 111.211 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -89.17 165.76 14.26 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-O 121.132 0.491 . . . . 74.52 111.419 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.564 ' NH1' HD12 ' A' ' 512' ' ' ILE . 2.2 tmt_? -107.79 141.03 39.98 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 116.042 -0.526 . . . . 71.21 110.026 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.641 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.6 mm? -86.79 129.09 35.01 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.861 -0.609 . . . . 70.04 112.29 -175.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.564 HD12 ' NH1' ' A' ' 510' ' ' ARG . 32.8 mm -106.69 -59.17 3.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.405 -0.361 . . . . 74.14 110.141 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -158.81 149.27 19.8 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.393 0.433 . . . . 75.14 110.38 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 6.0 p -123.03 129.91 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 109.115 -0.698 . . . . 61.45 109.115 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 60.91 2.77 0.57 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.539 1.135 . . . . 71.54 113.746 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 113.57 -4.28 24.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 121.051 -0.595 . . . . 73.22 112.511 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.5 t -93.22 134.73 30.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.385 -0.598 . . . . 72.02 109.385 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -77.63 145.72 36.56 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 123.601 0.563 . . . . 62.51 110.145 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.641 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 18.8 mt -101.48 -38.14 8.12 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.901 -0.778 . . . . 73.45 108.901 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.22 104.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 115.185 -0.916 . . . . 74.31 108.561 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 136.33 -21.19 3.48 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 108.934 -1.666 . . . . 73.24 108.934 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.513 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -118.97 172.83 7.27 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.514 -0.343 . . . . 74.21 110.511 177.247 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 23.8 m -89.24 161.77 16.24 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.326 -0.397 . . . . 75.13 111.226 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -57.83 -46.63 84.46 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 123.005 0.522 . . . . 71.12 111.563 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.453 ' O ' HG23 ' A' ' 528' ' ' VAL . 48.5 mt-10 -58.18 -32.89 68.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.178 -0.465 . . . . 70.34 112.118 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.13 -41.62 90.22 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.325 -0.62 . . . . 73.42 109.325 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 44.2 t -70.28 -37.34 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 115.495 -0.775 . . . . 75.34 110.199 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.653 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.1 m -66.29 -41.26 88.73 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.439 0 C-N-CA 119.731 -0.788 . . . . 54.13 110.514 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.6 t -63.19 -42.95 99.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.205 0.526 . . . . 71.31 109.718 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 29.1 tp -59.96 -34.93 73.94 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.838 1.255 . . . . 73.11 110.099 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.452 ' CD1' HD22 ' A' ' 471' ' ' LEU . 26.5 tp -77.64 -47.98 17.95 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.856 -0.611 . . . . 54.24 110.312 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.653 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 4.8 mmp_? -57.79 -41.06 81.31 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.005 0.522 . . . . 75.23 110.887 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 46.0 m -60.34 -30.2 69.38 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.878 -0.601 . . . . 64.12 111.562 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' THR . . . . . 0.405 HG21 ' HB2' ' A' ' 466' ' ' LYS . 40.8 m 67.26 -91.14 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.399 0.68 . . . . 71.23 111.76 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 88.6 tttt 164.93 144.35 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 104.535 -2.394 . . . . 74.24 104.535 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 85.0 mtp -66.91 -25.49 66.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.769 0.713 . . . . 63.34 111.444 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.87 -65.65 0.65 Allowed 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.053 -1.091 . . . . 75.1 108.053 172.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 143.39 -31.56 1.92 Allowed Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 119.084 -1.532 . . . . 64.12 114.662 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 1.8 m -94.57 142.19 27.73 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.344 -0.943 . . . . 75.42 109.214 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 58.2 t -122.43 142.16 39.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 123.575 0.75 . . . . 75.33 109.062 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.7 m -105.76 113.4 26.94 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.44 0.638 . . . . 74.44 110.674 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.422 HD21 HD23 ' A' ' 464' ' ' LEU . 2.6 mm? -102.36 119.03 38.13 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.899 -1.148 . . . . 74.14 107.899 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 2.9 tm? -104.77 115.95 31.19 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 105.216 -2.142 . . . . 75.22 105.216 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 32.7 m -117.41 161.01 16.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.024 -0.989 . . . . 73.44 111.328 -174.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 86.9 t80 -112.06 117.96 34.1 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 108.399 -0.963 . . . . 73.11 108.399 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 . . . . . 0 N--CA 1.411 -2.382 0 N-CA-C 107.968 -1.123 . . . . 74.14 107.968 176.726 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt . . . . . 0 N--CA 1.437 -1.101 0 CA-C-O 120.822 0.344 . . . . 61.15 110.819 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 71.3 mtm180 -100.43 148.78 24.36 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.633 -0.712 . . . . 73.34 109.306 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -130.95 134.22 46.54 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.283 -0.636 . . . . 73.41 109.283 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -92.88 115.47 28.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.909 -1.145 . . . . 74.34 107.909 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 60.6 mt -119.94 137.64 53.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 115.746 -0.661 . . . . 73.03 109.844 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.0 mt-30 -120.83 127.52 52.0 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.744 0.646 . . . . 73.04 112.744 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.48 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.2 mm? -113.8 142.13 46.45 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 114.895 -1.048 . . . . 63.55 111.002 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -101.34 127.33 48.01 Favored 'General case' 0 N--CA 1.398 -3.029 0 N-CA-C 107.584 -1.265 . . . . 72.2 107.584 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.11 95.6 0.13 Allowed 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.903 -0.59 . . . . 61.52 109.594 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -136.95 153.51 21.79 Favored Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 115.511 -0.768 . . . . 37.19 111.856 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 22.0 m 59.28 -91.74 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.945 1.298 . . . . 74.22 111.497 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -101.84 -3.98 27.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.291 0.567 . . . . 75.11 109.918 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.29 -161.22 54.21 Favored Glycine 0 C--O 1.205 -1.706 0 CA-C-O 118.922 -0.932 . . . . 70.44 111.595 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.436 HD12 HG22 ' A' ' 540' ' ' VAL . 66.4 mt -48.36 99.94 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.832 0.825 . . . . 74.24 112.712 -171.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -111.28 61.0 0.31 Allowed Glycine 0 CA--C 1.479 -2.184 0 CA-C-N 114.567 -1.197 . . . . 44.23 111.641 -174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -150.13 142.26 24.06 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 109.138 -0.69 . . . . 71.52 109.138 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.5 p -115.53 155.19 28.0 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.943 -0.571 . . . . 73.34 110.58 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.6 pt -116.33 150.34 18.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.059 0.457 . . . . 64.23 111.757 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' THR . . . . . 0.403 ' CB ' ' HE3' ' A' ' 491' ' ' LYS . 9.0 t -136.22 147.07 47.43 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.476 -0.784 . . . . 72.54 109.987 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 57.9 p . . . . . 0 N--CA 1.439 -0.984 0 N-CA-C 108.862 -0.792 . . . . 74.34 108.862 176.935 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . 0.411 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 9.6 Cg_endo . . . . . 0 N--CA 1.433 -2.061 0 N-CA-C 109.974 -0.818 . . . . 71.31 109.974 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.19 132.14 41.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.34 -0.615 . . . . 54.31 109.34 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 90.8 m-85 -129.02 152.76 48.28 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 110.31 -0.255 . . . . 71.3 110.31 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.39 119.51 30.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.469 -0.937 . . . . 75.04 108.469 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.403 ' HE3' ' CB ' ' A' ' 476' ' ' THR . 4.7 tppp? -82.15 -59.62 2.5 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.791 -0.64 . . . . 74.14 110.722 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -140.16 155.49 46.93 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 120.316 -0.554 . . . . 61.35 110.675 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.498 HG12 ' HB1' ' A' ' 507' ' ' ALA . 33.8 mm -119.2 104.8 16.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.306 -1.368 . . . . 62.3 107.306 177.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.23 130.53 89.5 Favored Pre-proline 0 C--N 1.307 -1.282 0 CA-C-N 116.022 -0.535 . . . . 63.54 111.084 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.81 18.03 0.2 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 125.027 3.818 . . . . 73.12 115.45 -171.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -161.13 6.81 0.07 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 113.916 1.08 . . . . 72.11 113.916 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -91.63 -155.86 32.17 Favored Glycine 0 C--N 1.294 -1.754 0 C-N-CA 119.464 -1.35 . . . . 73.12 113.085 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . 0.444 ' C ' HD11 ' A' ' 464' ' ' LEU . . . -63.39 -41.6 98.78 Favored 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 123.942 0.897 . . . . 72.03 109.876 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . 0.47 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -56.65 -43.81 80.69 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 114.856 -1.065 . . . . 75.43 112.074 -173.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 500' ' ' ILE . 12.1 tt -80.49 -29.34 12.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 112.19 0.441 . . . . 65.42 112.19 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -48.26 81.3 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.226 -1.028 . . . . 71.01 108.226 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.48 ' HB2' HD13 ' A' ' 464' ' ' LEU . 10.2 m-20 -87.08 -34.23 19.22 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 109.789 -0.449 . . . . 62.4 109.789 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 62.45 39.59 98.0 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.504 -0.771 . . . . 65.32 112.538 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -111.36 -4.89 14.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.33 0.586 . . . . 71.21 109.917 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 57.7 tp -125.73 142.74 51.36 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.857 -0.611 . . . . 71.51 110.546 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.456 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.28 0.0 OUTLIER -138.51 164.55 29.14 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.17 -0.468 . . . . 70.13 111.854 175.451 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.498 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -83.46 156.43 22.89 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.655 0.613 . . . . 75.21 112.655 -171.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.5 8.0 55.17 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.99 -0.624 . . . . 73.25 113.682 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -113.33 164.96 12.91 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 117.388 0.594 . . . . 63.42 110.191 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -89.95 129.32 36.3 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 123.095 0.247 . . . . 74.31 110.624 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.455 HD12 HD12 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.93 124.33 33.02 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 106.069 -1.826 . . . . 75.31 106.069 177.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 50.7 mm -96.3 -51.11 11.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 120.562 0.22 . . . . 53.54 111.258 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -157.99 148.85 20.9 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 116.102 -0.499 . . . . 74.24 109.66 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 541' ' ' SER . 3.7 p -130.05 125.51 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.523 0 CA-C-N 116.025 -0.534 . . . . 71.32 109.566 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 59.51 26.9 15.94 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 114.864 -1.062 . . . . 75.41 112.067 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.54 -4.8 73.41 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.748 -0.66 . . . . 63.33 113.367 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.44 124.84 47.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.393 -0.595 . . . . 71.13 109.393 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -84.01 141.69 31.01 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.727 0.642 . . . . 74.35 109.382 -173.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 19.0 mt -99.72 -42.96 6.63 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.161 0.8 . . . . 73.21 113.161 -171.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.14 89.08 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-O 122.23 1.014 . . . . 74.24 110.629 -174.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 151.03 -13.87 0.85 Allowed Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 113.994 -1.457 . . . . 73.24 109.693 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.482 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -117.82 177.78 4.65 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 122.85 -0.206 . . . . 74.44 110.89 175.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 48.9 m -88.61 156.68 18.9 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.514 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.417 ' O ' HG12 ' A' ' 528' ' ' VAL . 34.2 tt0 -58.76 -44.38 90.59 Favored 'General case' 0 C--O 1.21 -0.996 0 C-N-CA 122.487 0.315 . . . . 71.14 110.514 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 528' ' ' VAL . 28.3 mm-40 -57.72 -31.46 66.44 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 112.661 0.615 . . . . 61.55 112.661 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -66.58 -39.8 88.62 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.188 -0.671 . . . . 71.22 109.188 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 33.8 t -75.48 -36.39 35.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.135 -0.938 . . . . 73.24 110.285 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.693 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 10.7 m -63.67 -44.81 98.58 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 C-N-CA 120.351 -0.54 . . . . 65.3 109.933 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.7 m -64.51 -36.98 85.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.4 0.619 . . . . 74.5 110.267 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 32.6 tp -61.03 -43.6 98.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.736 1.214 . . . . 63.32 109.428 175.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 35.2 tp -67.3 -48.03 68.83 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.75 -0.659 . . . . 74.24 109.845 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.693 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 32.2 mmm180 -57.41 -30.11 64.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.731 0.813 . . . . 64.42 111.192 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 61.2 m -73.6 -43.64 59.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.925 -0.579 . . . . 62.12 111.532 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 40.4 m 68.26 142.2 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.664 0.786 . . . . 74.14 111.311 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . 0.445 ' H ' HG21 ' A' ' 540' ' ' VAL . 60.4 tptt -59.9 132.17 53.12 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.636 -0.711 . . . . 74.42 109.641 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -63.35 -20.11 65.22 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.513 0.725 . . . . 64.23 111.938 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 38.4 tt0 -73.89 -15.17 61.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.492 0.663 . . . . 70.31 110.253 177.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 94.69 -20.29 49.37 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.085 -0.579 . . . . 71.11 112.333 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 2.7 m -114.19 128.79 56.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.748 -1.204 . . . . 72.23 107.748 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 57.4 t -105.23 134.19 47.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 C-N-CA 122.816 0.446 . . . . 61.14 110.5 -176.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 29.9 m -98.48 115.14 27.9 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.744 -0.662 . . . . 54.2 110.832 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.429 HD21 HD23 ' A' ' 464' ' ' LEU . 2.7 mm? -110.95 124.68 52.6 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.4 -0.963 . . . . 60.1 108.4 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 53.0 tp -104.23 118.34 36.41 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.534 -1.654 . . . . 75.23 106.534 174.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.4 m -116.06 145.59 21.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 120.293 -0.563 . . . . 74.24 111.27 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -112.02 116.42 30.53 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.066 -1.086 . . . . 74.1 108.066 175.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . 0.453 ' O ' ' HD3' ' A' ' 546' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.406 -2.651 0 N-CA-C 108.2 -1.037 . . . . 73.44 108.2 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.633 ' HE2' ' H ' ' A' ' 458' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.448 0 N-CA-C 109.538 -0.542 . . . . 62.54 109.538 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 97.6 mtt180 -99.13 142.28 30.82 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.881 -0.785 . . . . 74.21 108.881 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.1 mm? -123.72 133.71 53.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.189 -0.671 . . . . 73.11 109.189 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -100.07 116.62 32.51 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.454 -0.943 . . . . 64.35 108.454 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 57.0 mt -123.3 125.02 71.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.61 -0.723 . . . . 73.54 110.959 -173.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.8 mt-30 -91.52 126.78 36.72 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.993 0.738 . . . . 61.42 112.993 178.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.1 mm? -115.79 144.34 44.12 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.4 1.08 . . . . 72.05 110.332 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -103.03 136.67 42.41 Favored 'General case' 0 N--CA 1.404 -2.75 0 N-CA-C 107.833 -1.173 . . . . 73.51 107.833 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.442 ' HE2' HG21 ' A' ' 534' ' ' THR . 23.5 ttmm -54.44 99.58 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.766 0.794 . . . . 72.14 111.328 175.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -85.3 -147.57 9.49 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 114.943 -1.026 . . . . 73.32 111.454 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 16.7 m -55.41 -45.41 76.72 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.978 0.511 . . . . 61.21 110.946 -177.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.59 9.81 17.98 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 120.691 0.281 . . . . 62.32 111.137 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 58.01 -141.96 44.71 Favored Glycine 0 C--O 1.185 -2.967 0 CA-C-O 117.17 -1.905 . . . . 63.23 109.804 -170.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 531' ' ' LEU . 2.5 mm? -44.08 108.61 0.12 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.54 1.67 . . . . 70.51 112.459 -173.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -100.19 47.78 1.25 Allowed Glycine 0 N--CA 1.421 -2.311 0 CA-C-N 114.55 -1.204 . . . . 53.42 112.433 -173.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -140.92 144.8 35.39 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 109.356 -0.609 . . . . 72.32 109.356 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 18.8 m -114.6 139.38 49.66 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.889 -1.523 . . . . 52.32 106.889 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 489' ' ' TYR . 14.8 pt -111.46 151.24 13.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-O 120.976 0.417 . . . . 62.51 112.072 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -144.73 151.17 38.49 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.888 -0.596 . . . . 73.23 109.618 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.437 -1.096 0 N-CA-C 109.138 -0.69 . . . . 54.41 109.138 175.932 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . 0.563 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 3.2 Cg_exo . . . . . 0 N--CA 1.427 -2.422 0 N-CA-C 110.166 -0.744 . . . . 64.12 110.166 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.48 HG13 ' HB3' ' A' ' 519' ' ' LEU . 34.2 mm -90.52 119.94 38.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.286 -1.005 . . . . 64.42 108.286 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 78.8 m-85 -121.63 152.95 38.75 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 122.281 -0.262 . . . . 74.52 111.492 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 47.2 t -78.56 119.06 26.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.973 -0.751 . . . . 74.22 108.973 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -84.52 -53.84 5.15 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.78 -0.646 . . . . 75.55 109.425 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -143.13 154.04 43.5 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.327 -0.852 . . . . 64.42 109.044 -175.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.432 HG12 ' HB1' ' A' ' 507' ' ' ALA . 26.2 mm -110.44 110.2 31.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.842 -1.17 . . . . 74.02 107.842 174.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 496' ' ' ARG . 6.0 mp -52.82 128.04 44.92 Favored Pre-proline 0 C--N 1.321 -0.665 0 O-C-N 123.941 0.776 . . . . 73.51 110.372 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.49 20.48 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 124.668 3.578 . . . . 71.32 114.908 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.454 ' O ' ' HB ' ' A' ' 468' ' ' THR . 14.2 ptp180 -168.82 5.9 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.323 0.583 . . . . 65.23 112.459 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -83.86 -167.87 42.81 Favored Glycine 0 C--N 1.298 -1.561 0 C-N-CA 119.893 -1.146 . . . . 65.43 112.663 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 464' ' ' LEU . . . -55.86 -47.4 77.39 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 124.932 1.293 . . . . 75.31 111.151 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.23 -40.6 77.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.743 -1.117 . . . . 72.53 112.559 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 8.5 tt -79.94 -40.43 20.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 112.57 0.582 . . . . 63.14 112.57 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 8.2 mm-40 -67.43 -37.87 83.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 72.34 110.841 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.483 ' HB2' HD13 ' A' ' 464' ' ' LEU . 7.8 m-20 -91.56 -21.95 20.59 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 116.116 -0.493 . . . . 63.55 109.87 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 63.92 55.78 22.46 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 120.742 -0.742 . . . . 54.54 114.803 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -123.85 -73.53 0.64 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.873 -0.731 . . . . 73.54 110.796 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . 0.42 HD11 HG13 ' A' ' 544' ' ' VAL . 67.4 tp -73.68 137.7 44.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.778 0.323 . . . . 64.13 111.807 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.402 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.267 0.0 OUTLIER -126.32 174.26 8.7 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.717 -0.674 . . . . 74.13 112.403 177.061 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.432 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -83.18 138.8 33.49 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 113.435 0.902 . . . . 62.13 113.435 -171.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 105.39 13.88 23.43 Favored Glycine 0 C--N 1.321 -0.253 0 CA-C-N 115.583 -0.735 . . . . 71.5 112.577 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.63 162.44 13.96 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 122.678 0.391 . . . . 74.3 110.398 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -101.45 134.36 44.66 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 120.81 -0.356 . . . . 74.04 110.649 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.588 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 3.6 mm? -86.97 132.99 33.63 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.553 -0.749 . . . . 62.01 110.171 174.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.7 mm -111.72 -39.07 3.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.06 -0.718 . . . . 74.42 109.06 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -154.72 148.43 25.42 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.517 -0.765 . . . . 61.12 109.156 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.491 HG11 HD21 ' A' ' 519' ' ' LEU . 6.8 p -136.51 125.47 37.07 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.077 0 N-CA-C 107.397 -1.334 . . . . 63.3 107.397 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 72.33 -52.27 0.7 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 125.982 1.713 . . . . 73.23 111.963 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 163.29 30.61 0.02 OUTLIER Glycine 0 C--N 1.287 -2.146 0 N-CA-C 109.519 -1.432 . . . . 72.21 109.519 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.1 t -122.5 134.43 65.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.305 -0.447 . . . . 64.2 109.902 -175.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.0 148.77 36.06 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.704 -0.48 . . . . 72.42 109.704 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.588 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 60.5 mt -111.51 -45.81 3.34 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 113.338 0.866 . . . . 73.32 113.338 -171.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.68 -1.31 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 113.146 0.795 . . . . 70.44 113.146 -172.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -112.41 12.18 25.95 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 111.616 -0.594 . . . . 63.13 111.616 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.567 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.2 OUTLIER -146.53 -177.59 5.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 117.172 0.486 . . . . 62.33 111.505 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' SER . . . . . 0.456 ' O ' HG21 ' A' ' 527' ' ' VAL . 76.3 p -96.17 163.3 13.16 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.214 0.53 . . . . 74.22 111.998 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.519 ' O ' HG12 ' A' ' 528' ' ' VAL . 37.9 mm-40 -55.24 -41.91 72.74 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.987 -1.006 . . . . 75.25 111.962 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.08 -31.81 73.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.105 0.479 . . . . 73.34 112.178 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.88 -36.03 67.28 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.737 -0.665 . . . . 75.01 110.529 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.544 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 17.5 t -75.39 -41.5 42.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.393 -0.595 . . . . 73.31 109.393 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.697 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.3 m -62.18 -43.46 97.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 120.356 -0.538 . . . . 74.22 110.942 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.9 t -64.5 -37.06 86.22 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.451 -0.341 . . . . 75.43 111.325 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 527' ' ' VAL . 1.2 pp -68.07 -37.54 81.39 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.011 -1.107 . . . . 73.53 108.011 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 471' ' ' LEU . 3.6 tt -62.98 -46.49 87.47 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.894 -1.048 . . . . 63.33 111.175 176.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 27.1 mmm180 -61.68 -33.63 74.32 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.127 -0.488 . . . . 73.13 110.409 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.0 m -82.96 -30.71 28.09 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.073 0.464 . . . . 74.12 110.685 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' THR . . . . . 0.442 HG21 ' HE2' ' A' ' 466' ' ' LYS . 30.5 m 71.98 -83.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.606 1.162 . . . . 65.31 112.115 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . 0.49 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 17.3 tppt? 167.27 157.64 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 106.405 -1.702 . . . . 75.53 106.405 -176.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.94 6.45 18.55 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.77 0.795 . . . . 72.03 110.212 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . 0.49 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 13.3 tp10 -96.88 -54.3 3.24 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.039 -1.096 . . . . 75.31 108.039 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 116.39 -20.21 12.54 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.322 -0.942 . . . . 72.51 112.587 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 3.4 m -104.7 136.23 44.6 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.987 -0.745 . . . . 72.3 108.987 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 87.2 t -123.43 136.69 59.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 123.139 0.575 . . . . 73.33 110.743 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.8 t -92.15 114.61 27.2 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.364 -0.606 . . . . 72.13 109.364 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 43.6 mt -99.51 119.72 38.48 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.498 -0.927 . . . . 61.44 108.498 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 45.5 tp -104.61 116.93 32.91 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.747 -1.575 . . . . 73.14 106.747 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 31.1 m -122.67 157.96 27.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.924 -0.58 . . . . 64.33 111.886 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -114.4 116.69 29.31 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.863 -0.608 . . . . 73.41 109.703 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 . . . . . 0 C--N 1.302 -1.466 0 CA-C-N 115.699 -0.682 . . . . 71.01 109.463 179.428 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 26.7 mtpp . . . . . 0 CA--C 1.478 -1.791 0 CA-C-O 121.363 0.601 . . . . 74.54 111.185 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 62.2 mtm180 -112.04 129.6 56.15 Favored 'General case' 0 N--CA 1.406 -2.663 0 N-CA-C 107.579 -1.267 . . . . 73.45 107.579 170.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -116.21 131.73 56.86 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.636 -0.875 . . . . 71.23 108.636 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -95.86 115.34 27.29 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.787 -0.82 . . . . 73.24 108.787 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . 0.431 HG23 ' CD2' ' A' ' 464' ' ' LEU . 60.8 mt -119.38 123.91 72.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 115.357 -0.838 . . . . 74.43 109.853 -175.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 47.6 mt-30 -102.37 130.55 49.15 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 121.824 -0.547 . . . . 53.31 112.282 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 539' ' ' THR . 4.3 mm? -115.06 139.48 49.84 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.848 -0.614 . . . . 73.2 111.958 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -91.04 132.67 35.87 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 123.849 0.859 . . . . 72.21 110.481 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -72.87 105.21 4.3 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 114.593 -1.185 . . . . 65.15 109.402 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -144.53 137.33 7.2 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.82 -0.627 . . . . 63.22 111.741 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 35.5 m 64.54 -79.11 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.468 1.107 . . . . 73.55 112.048 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -102.28 -11.34 18.79 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.127 -0.694 . . . . 74.21 109.127 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 66.8 -144.51 45.37 Favored Glycine 0 CA--C 1.473 -2.582 0 CA-C-O 117.528 -1.707 . . . . 55.42 108.924 -172.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.443 HD11 ' O ' ' A' ' 531' ' ' LEU . 43.4 mt -52.25 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.316 1.558 . . . . 75.2 112.275 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -102.43 59.64 0.55 Allowed Glycine 0 CA--C 1.464 -3.122 0 CA-C-N 114.256 -1.338 . . . . 54.11 111.237 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.402 ' CZ ' HD12 ' A' ' 542' ' ' LEU . 18.7 p90 -148.01 142.52 26.45 Favored 'General case' 0 C--N 1.258 -3.387 0 N-CA-C 108.117 -1.068 . . . . 72.21 108.117 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 20.0 m -115.0 143.81 44.6 Favored 'General case' 0 C--N 1.271 -2.843 0 N-CA-C 108.157 -1.053 . . . . 71.31 108.157 -176.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 10.2 pt -109.81 156.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-O 121.209 0.528 . . . . 54.4 111.502 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.1 t -136.63 141.21 43.21 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.908 -0.775 . . . . 75.4 108.908 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 59.3 p . . . . . 0 C--N 1.293 -1.881 0 N-CA-C 106.749 -1.575 . . . . 60.41 106.749 174.401 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo . . . . . 0 C--O 1.255 1.347 0 N-CA-C 109.464 -1.014 . . . . 74.14 109.464 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.529 HD11 ' OE1' ' A' ' 524' ' ' GLN . 41.1 mm -101.32 145.02 12.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.559 -1.275 . . . . 75.54 107.559 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -130.26 149.67 51.85 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 122.214 -0.304 . . . . 70.33 110.357 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 47.3 t -81.52 119.55 31.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.187 -1.042 . . . . 52.4 108.187 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -90.44 -52.51 4.88 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.237 0.615 . . . . 63.53 111.272 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -130.18 150.25 51.52 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.076 -0.649 . . . . 75.22 111.327 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.523 HG12 ' HB1' ' A' ' 507' ' ' ALA . 28.7 mm -121.22 104.97 15.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.624 -1.25 . . . . 51.1 107.624 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.49 133.97 95.85 Favored Pre-proline 0 C--N 1.311 -1.101 0 CA-C-N 115.437 -0.801 . . . . 64.31 111.283 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.82 14.09 0.55 Allowed 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 124.624 3.549 . . . . 74.31 114.952 -172.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -156.63 6.09 0.17 Allowed 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 120.016 -0.673 . . . . 71.42 112.606 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.604 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -91.23 -163.01 38.43 Favored Glycine 0 C--N 1.291 -1.936 0 C-N-CA 120.096 -1.049 . . . . 64.41 111.984 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . 0.448 ' C ' HD11 ' A' ' 464' ' ' LEU . . . -55.92 -40.9 73.76 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 125.016 1.326 . . . . 71.21 110.374 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.0 76.21 Favored 'General case' 0 C--O 1.194 -1.861 0 CA-C-N 114.5 -1.227 . . . . 74.23 112.515 -174.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 500' ' ' ILE . 11.5 tt -80.47 -29.57 12.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 112.216 0.45 . . . . 62.41 112.216 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.604 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 73.5 mm-40 -58.53 -45.75 88.22 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.333 -0.617 . . . . 62.24 109.333 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.431 ' HB2' HD13 ' A' ' 464' ' ' LEU . 3.3 m-20 -93.49 -38.28 11.49 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.486 -0.779 . . . . 71.03 110.561 175.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 71.8 17.11 76.54 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.847 -0.692 . . . . 73.21 113.304 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.408 ' CG ' HG22 ' A' ' 462' ' ' ILE . 27.5 tpt180 -91.32 -18.93 23.53 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.172 0.51 . . . . 75.33 110.822 -175.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 46.9 tp -108.52 150.49 27.38 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 110.159 -0.311 . . . . 75.0 110.159 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 506' ' ' LYS . 0.0 OUTLIER -143.98 170.25 16.28 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.38 -0.6 . . . . 74.3 109.38 178.048 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.523 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -89.33 150.2 22.68 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.982 0.42 . . . . 64.43 110.765 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 113.36 -30.56 7.21 Favored Glycine 0 C--N 1.303 -1.303 0 N-CA-C 111.088 -0.805 . . . . 70.15 111.088 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -68.37 146.99 52.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.112 0.482 . . . . 72.01 111.375 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 25.0 ttm180 -85.52 128.68 34.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.165 -0.679 . . . . 53.04 109.165 177.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.436 ' HG ' HD12 ' A' ' 519' ' ' LEU . 22.4 tp -90.03 127.72 36.12 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 108.494 -0.928 . . . . 73.12 108.494 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.2 mm -98.15 -41.54 10.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.079 0.466 . . . . 74.02 110.247 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -158.65 159.12 35.01 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.602 -0.726 . . . . 61.21 109.778 176.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.29 130.52 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 109.149 -0.685 . . . . 74.13 109.149 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 70.05 -48.1 0.62 Allowed 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 127.919 2.488 . . . . 71.13 111.867 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 169.49 8.3 0.03 OUTLIER Glycine 0 C--N 1.293 -1.81 0 CA-C-N 116.101 -0.5 . . . . 45.15 112.159 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 29.2 t -115.08 138.8 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.89 -0.781 . . . . 73.53 108.89 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -83.48 155.83 23.18 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 123.755 0.659 . . . . 75.42 110.28 -174.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 21.7 mt -104.79 -42.24 5.43 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.621 -0.718 . . . . 72.34 111.648 -174.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.7 t -72.37 91.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 115.571 -0.74 . . . . 63.45 109.747 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 144.63 -7.23 1.72 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 110.07 -1.212 . . . . 72.42 110.07 -174.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.417 ' HD3' ' CB ' ' A' ' 526' ' ' GLU . 17.5 ptpt -130.65 -178.46 4.8 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 110.021 -0.363 . . . . 74.13 110.021 175.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' SER . . . . . 0.404 ' O ' HG21 ' A' ' 527' ' ' VAL . 46.2 t -95.56 162.61 13.56 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.113 0.482 . . . . 63.11 111.014 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.529 ' OE1' HD11 ' A' ' 488' ' ' ILE . 7.3 tp60 -58.37 -38.88 78.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.946 -1.024 . . . . 75.32 110.328 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.99 -31.62 72.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.489 -0.778 . . . . 74.25 111.428 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.417 ' CB ' ' HD3' ' A' ' 522' ' ' LYS . 15.1 mm-40 -71.31 -39.89 71.14 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.893 -0.78 . . . . 75.22 108.893 177.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 523' ' ' SER . 18.4 t -69.34 -40.5 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.365 -0.834 . . . . 63.42 110.012 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.0 m -62.46 -42.56 96.16 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.111 0 C-N-CA 120.16 -0.616 . . . . 74.21 110.383 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.2 t -62.68 -43.31 99.12 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 116.203 -0.453 . . . . 65.21 110.133 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 46.8 tp -58.27 -45.99 86.86 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.522 1.129 . . . . 65.43 109.566 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.443 ' O ' HD11 ' A' ' 471' ' ' LEU . 2.4 tt -62.94 -45.45 92.43 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.391 -0.822 . . . . 72.42 112.362 175.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.7 OUTLIER -58.17 -39.58 79.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.243 0.544 . . . . 71.42 110.416 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.2 t -63.9 -43.57 95.61 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.211 -0.904 . . . . 74.22 110.672 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 63.0 m 67.51 -88.41 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.249 0.62 . . . . 63.01 110.811 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 40.5 tttm 172.74 153.74 0.08 Allowed 'General case' 0 C--O 1.251 1.164 0 N-CA-C 106.685 -1.598 . . . . 64.44 106.685 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 16.0 tpt -75.03 -35.71 61.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.418 -0.513 . . . . 72.42 109.946 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.11 -48.67 56.63 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.977 -0.556 . . . . 75.25 110.56 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 133.12 -28.54 3.31 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 118.564 -1.779 . . . . 61.12 115.984 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 4.5 m -94.93 135.18 36.75 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 118.625 -1.23 . . . . 74.32 109.805 -177.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 63.5 t -118.35 137.29 52.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.851 -0.613 . . . . 72.41 110.267 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 68.9 m -91.86 113.29 25.52 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.426 0.632 . . . . 72.11 111.039 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.418 HD21 HD23 ' A' ' 464' ' ' LEU . 3.6 mm? -101.36 122.41 43.68 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.657 -0.868 . . . . 73.53 108.657 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 36.9 tp -105.09 118.17 35.85 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.035 -1.469 . . . . 74.13 107.035 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 30.0 m -115.99 154.84 17.45 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 CA-C-O 121.042 0.449 . . . . 74.03 110.786 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.454 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 69.3 t80 -111.77 118.35 35.35 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.522 -0.918 . . . . 74.54 108.522 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 . . . . . 0 C--N 1.298 -1.649 0 N-CA-C 107.504 -1.295 . . . . 63.03 107.504 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt . . . . . 0 N--CA 1.428 -1.571 0 N-CA-C 109.596 -0.52 . . . . 74.3 109.596 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.421 ' HB3' HD12 ' A' ' 543' ' ' LEU . 41.7 mtm180 -111.18 150.89 28.88 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.89 -0.595 . . . . 73.45 109.745 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.9 mm? -131.62 137.33 48.34 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.339 -0.615 . . . . 55.45 109.339 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -103.3 123.56 47.0 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.273 -0.64 . . . . 72.52 109.273 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 76.0 mt -119.26 120.8 64.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.197 -0.668 . . . . 75.31 109.197 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.0 mt-30 -100.75 127.27 47.24 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.39 0.614 . . . . 74.53 111.723 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 539' ' ' THR . 5.9 tp -114.96 140.33 49.11 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-N 114.655 -1.157 . . . . 72.12 108.281 -173.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 465' ' ' LYS . 1.3 tpmt? -101.98 121.98 43.19 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.303 -0.999 . . . . 64.31 108.303 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -63.49 92.02 0.06 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.786 -0.643 . . . . 73.13 110.103 175.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -116.47 142.87 17.81 Favored Glycine 0 N--CA 1.428 -1.845 0 CA-C-N 115.667 -0.697 . . . . 50.54 111.766 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 469' ' ' GLU 0.354 10.0 t 52.03 -82.86 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.11 1.764 . . . . 72.21 114.885 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . 0.48 ' H ' HG23 ' A' ' 468' ' ' THR . 32.9 tt0 -97.04 -15.02 21.23 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.847 0.832 . . . . 71.43 109.081 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.42 -155.85 51.67 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 114.981 -1.009 . . . . 75.33 113.419 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.446 HD21 HG22 ' A' ' 540' ' ' VAL . 5.8 mp -48.12 104.5 0.06 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 113.517 0.932 . . . . 63.21 113.517 -170.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -118.56 54.58 0.62 Allowed Glycine 0 N--CA 1.422 -2.261 0 CA-C-N 114.567 -1.197 . . . . 72.15 111.174 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.523 ' CZ ' HD12 ' A' ' 542' ' ' LEU . 16.2 p90 -136.64 142.24 43.24 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 109.292 -0.633 . . . . 75.55 109.292 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 37.1 p -115.26 153.41 30.94 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.948 -0.569 . . . . 74.02 109.963 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.41 151.3 21.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 121.076 0.465 . . . . 65.3 110.698 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.1 t -144.23 157.4 44.31 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.881 -0.599 . . . . 64.24 109.691 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 61.4 p . . . . . 0 N--CA 1.425 -1.721 0 N-CA-C 107.713 -1.217 . . . . 73.41 107.713 175.886 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.478 0.612 0 N-CA-C 114.601 0.962 . . . . 44.04 114.601 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 34.6 mm -87.55 130.28 37.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.163 -0.926 . . . . 74.02 108.956 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -128.6 151.15 49.8 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 110.422 -0.214 . . . . 74.02 110.422 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 48.8 t -80.06 119.48 29.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.126 -1.064 . . . . 63.5 108.126 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -73.92 -60.74 2.12 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.102 -0.499 . . . . 74.25 110.536 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -145.51 158.04 43.9 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.369 0.604 . . . . 72.51 110.43 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.508 HG13 ' HA ' ' A' ' 506' ' ' LYS . 30.2 mm -116.49 104.92 17.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 106.597 -1.631 . . . . 73.53 106.597 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.33 137.42 94.48 Favored Pre-proline 0 C--N 1.304 -1.37 0 CA-C-N 115.242 -0.89 . . . . 72.43 111.035 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -73.34 17.16 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 124.789 3.659 . . . . 70.11 117.0 -167.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -159.87 3.94 0.08 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 115.132 1.53 . . . . 74.14 115.132 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -98.69 -154.81 29.01 Favored Glycine 0 C--N 1.297 -1.623 0 C-N-CA 119.672 -1.251 . . . . 74.04 113.834 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.72 86.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.096 0.958 . . . . 44.04 111.616 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . 0.415 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -58.11 -38.85 77.25 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.246 -0.888 . . . . 65.23 112.77 -176.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.5 tt -80.81 -32.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 112.286 0.476 . . . . 70.04 112.286 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 83.4 mm-40 -58.76 -41.92 87.72 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.998 0.428 . . . . 63.44 110.914 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -89.35 -39.76 13.22 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.017 -0.538 . . . . 73.51 110.204 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 77.87 -19.18 4.39 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 115.639 1.016 . . . . 74.3 115.639 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -64.84 -23.38 67.22 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.234 0.54 . . . . 74.43 111.214 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.3 tp -92.72 135.64 33.93 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.143 -0.688 . . . . 64.24 109.143 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.508 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -138.4 170.44 16.02 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.199 -0.297 . . . . 74.31 110.199 176.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.465 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -86.9 160.03 18.85 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.211 -0.449 . . . . 61.15 110.646 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 103.7 -29.21 12.66 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 121.054 -0.593 . . . . 74.41 113.014 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.56 162.31 24.36 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-O 121.28 0.562 . . . . 74.31 111.929 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -90.13 126.98 35.99 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.023 -0.99 . . . . 64.03 109.23 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.486 HD12 HD12 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -88.28 123.7 33.14 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.012 -1.477 . . . . 72.54 107.012 178.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.54 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 35.5 mm -98.46 -47.63 12.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 120.956 0.408 . . . . 62.44 111.248 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -158.16 145.52 18.09 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.703 -0.68 . . . . 60.03 110.201 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 541' ' ' SER . 4.5 p -124.72 127.84 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 CA-C-O 121.276 0.56 . . . . 74.13 109.692 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 17.4 m120 59.46 15.6 4.6 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.873 1.269 . . . . 73.12 113.142 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.7 -7.77 33.99 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.682 -0.77 . . . . 63.33 113.854 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 67.3 t -97.77 127.09 50.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 117.563 0.681 . . . . 71.54 110.554 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.24 136.5 40.95 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 123.837 0.855 . . . . 73.14 111.423 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 13.4 mt -101.64 -23.81 14.2 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.649 0.738 . . . . 64.43 109.935 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.46 -24.56 35.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.498 -1.228 . . . . 74.45 111.47 -171.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -106.9 21.34 32.06 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.988 -0.625 . . . . 54.11 112.742 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.496 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -142.4 178.67 7.43 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.669 0.618 . . . . 75.1 112.669 178.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' SER . . . . . 0.434 ' O ' HG21 ' A' ' 527' ' ' VAL . 33.7 m -95.73 161.25 14.1 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.169 -0.469 . . . . 75.33 111.856 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -51.33 -46.72 62.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.997 1.319 . . . . 74.12 113.679 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.35 -35.05 74.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.199 0.444 . . . . 74.23 112.199 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -67.22 -40.32 86.4 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.135 -0.691 . . . . 53.15 109.135 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 523' ' ' SER . 30.0 t -70.38 -39.5 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 115.422 -0.808 . . . . 74.21 110.293 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.63 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.6 m -66.37 -39.95 85.43 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 C-N-CA 119.67 -0.812 . . . . 72.01 110.401 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.9 t -62.14 -38.86 90.57 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.489 0.661 . . . . 74.32 109.899 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.13 -39.64 94.47 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 123.861 0.865 . . . . 73.41 109.244 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 2.8 tt -66.61 -45.1 80.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.443 0.697 . . . . 75.33 111.241 173.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.63 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 29.3 mmm180 -62.58 -32.98 74.06 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.062 -0.517 . . . . 64.3 110.949 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.0 m -68.32 -30.5 69.5 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 116.111 -0.495 . . . . 72.32 110.572 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 535' ' ' LYS . 90.7 m 66.81 -86.93 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.301 -0.863 . . . . 74.35 111.462 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 534' ' ' THR . 25.6 tptp 162.92 154.37 0.02 OUTLIER 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.158 -2.164 . . . . 74.05 105.158 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 85.9 mtp -70.41 -20.99 62.88 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.44 0.564 . . . . 61.24 111.655 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.71 -13.98 43.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.355 0.598 . . . . 74.15 109.783 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 75.12 6.08 78.29 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.398 -0.819 . . . . 65.42 112.746 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 6.2 m -104.34 125.1 50.29 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.721 -1.215 . . . . 61.43 107.721 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.446 HG22 HD21 ' A' ' 471' ' ' LEU . 60.2 t -108.65 127.06 65.43 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 CA-C-N 115.673 -0.694 . . . . 72.15 109.329 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 14.9 m -102.12 111.95 24.42 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 119.907 -0.717 . . . . 75.41 109.114 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.523 HD12 ' CZ ' ' A' ' 473' ' ' PHE . 2.5 mm? -99.43 119.27 37.71 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.8 -1.185 . . . . 71.31 107.8 177.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.48 HD11 ' HB ' ' A' ' 512' ' ' ILE . 2.6 tm? -104.6 117.96 35.41 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 105.963 -1.866 . . . . 74.41 105.963 177.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.69 160.51 14.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.287 -0.869 . . . . 43.32 110.196 -174.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.526 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 25.5 t80 -122.53 130.49 53.1 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.418 -1.327 . . . . 73.44 107.418 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 . . . . . 0 N--CA 1.422 -1.846 0 CA-C-O 121.266 0.555 . . . . 74.34 109.718 177.267 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt . . . . . 0 N--CA 1.422 -1.838 0 CA-C-O 120.742 0.306 . . . . 72.11 110.356 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.505 ' C ' HD12 ' A' ' 460' ' ' LEU . 70.4 mtm180 -100.85 138.69 37.57 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 107.628 -1.249 . . . . 75.11 107.628 172.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 459' ' ' ARG . 6.1 mp -130.29 134.07 46.95 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 123.236 0.335 . . . . 72.4 110.221 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -94.38 115.71 27.96 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.66 -0.7 . . . . 71.53 109.189 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . 0.46 HG22 ' CG ' ' A' ' 504' ' ' ARG . 66.0 mt -120.92 141.92 39.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.659 -0.701 . . . . 74.5 110.356 -174.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 76.2 mt-30 -123.93 130.34 52.44 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.517 0.562 . . . . 75.54 112.517 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.2 mm? -115.6 133.48 55.99 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 124.122 0.969 . . . . 61.35 109.466 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 465' ' ' LYS . 22.5 ttpp -102.82 134.96 45.36 Favored 'General case' 0 N--CA 1.397 -3.096 0 CA-C-O 121.437 0.637 . . . . 75.43 109.839 -177.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -58.88 126.7 28.78 Favored 'General case' 0 C--N 1.268 -2.952 0 CA-C-N 114.699 -1.137 . . . . 62.33 109.561 175.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . 0.498 ' H ' ' HA2' ' A' ' 470' ' ' GLY . . . -140.22 -138.18 3.57 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 115.722 -0.672 . . . . 74.31 111.494 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 469' ' ' GLU . 10.0 t -50.08 -70.72 0.08 Allowed 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 123.7 0.8 . . . . 72.31 113.057 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . 0.481 ' H ' HG23 ' A' ' 468' ' ' THR . 0.6 OUTLIER -92.65 -2.62 55.94 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.451 -0.781 . . . . 73.54 110.351 175.038 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.498 ' HA2' ' H ' ' A' ' 467' ' ' GLY . . . 54.52 -149.23 19.65 Favored Glycine 0 C--O 1.2 -1.988 0 CA-C-N 114.603 -1.18 . . . . 39.01 113.264 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.421 HD12 HG22 ' A' ' 540' ' ' VAL . 66.2 mt -53.54 99.39 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 117.955 0.877 . . . . 54.25 111.324 -173.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -118.19 54.5 0.61 Allowed Glycine 0 N--CA 1.416 -2.673 0 CA-C-N 114.467 -1.242 . . . . 43.32 111.15 -174.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -137.56 141.28 41.36 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 114.984 -0.608 . . . . 74.53 109.441 173.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 36.7 m -118.41 148.92 42.05 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.489 -0.778 . . . . 63.54 109.508 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.3 pt -111.05 153.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.179 0.514 . . . . 74.12 111.822 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 491' ' ' LYS . 9.7 t -134.05 159.9 39.39 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.455 -1.313 . . . . 75.32 107.455 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 31.0 p . . . . . 0 C--N 1.285 -2.21 0 N-CA-C 109.845 -0.428 . . . . 73.01 109.845 178.857 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . 0.462 ' HA ' HG11 ' A' ' 520' ' ' VAL . 14.9 Cg_endo . . . . . 0 N--CA 1.439 -1.677 0 CA-C-O 121.408 0.503 . . . . 62.53 112.311 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.495 ' O ' ' HG3' ' A' ' 510' ' ' ARG . 49.9 mm -97.19 136.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.515 -0.766 . . . . 73.13 109.5 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.593 ' CE1' ' HD3' ' A' ' 510' ' ' ARG . 95.1 m-85 -129.46 153.99 47.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 122.223 0.209 . . . . 71.45 111.003 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 44.6 t -80.15 119.47 29.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 107.733 -1.21 . . . . 72.44 107.733 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.402 ' HD2' ' HB ' ' A' ' 476' ' ' THR . 76.0 tttt -95.14 -46.6 6.71 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.52 0.676 . . . . 62.12 110.387 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -137.13 142.33 42.26 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.466 -0.788 . . . . 65.25 109.871 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.425 HG13 ' HA ' ' A' ' 506' ' ' LYS . 28.3 mm -123.93 101.9 10.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 N-CA-C 106.312 -1.736 . . . . 73.3 106.312 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 496' ' ' ARG . 3.4 mm? -65.89 126.85 92.54 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 115.934 -0.575 . . . . 72.31 110.972 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.07 34.38 0.33 Allowed 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 125.011 3.807 . . . . 70.22 112.73 -175.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.415 ' H ' ' C ' ' A' ' 494' ' ' LEU . 3.3 ptp180 -164.42 -4.63 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.867 0.691 . . . . 72.22 112.867 -176.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 500' ' ' ILE . . . -92.8 -158.7 34.53 Favored Glycine 0 C--N 1.302 -1.336 0 C-N-CA 119.115 -1.517 . . . . 75.02 112.596 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.71 85.77 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 124.119 0.968 . . . . 70.34 109.591 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -57.49 -37.79 73.53 Favored 'General case' 0 C--O 1.204 -1.31 0 CA-C-N 114.506 -1.224 . . . . 73.23 112.913 -176.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.432 HG21 ' O ' ' A' ' 497' ' ' GLY . 10.8 tt -81.47 -35.8 14.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.764 0.316 . . . . 73.4 111.83 176.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -58.64 -46.08 87.89 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.984 -0.553 . . . . 75.34 110.185 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.483 ' HB2' HD13 ' A' ' 464' ' ' LEU . 16.4 m-20 -89.47 -36.1 15.6 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.43 -0.581 . . . . 74.35 109.43 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.77 24.88 70.14 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.894 -0.594 . . . . 72.53 113.551 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.46 ' CG ' HG22 ' A' ' 462' ' ' ILE . 8.9 tpt180 -96.26 -11.84 25.4 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.434 -0.507 . . . . 72.41 110.625 -176.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 47.6 tp -120.29 154.19 35.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.687 -0.233 . . . . 74.3 110.654 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.425 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.1 OUTLIER -144.84 159.02 43.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.284 0.634 . . . . 72.42 111.517 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.402 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -83.46 155.55 23.35 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 120.798 0.332 . . . . 75.53 111.103 -176.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.82 18.06 57.0 Favored Glycine 0 C--N 1.312 -0.784 0 N-CA-C 110.713 -0.955 . . . . 63.43 110.713 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . 0.636 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 16.3 t0 -108.74 165.54 11.47 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.99 -1.485 . . . . 72.22 106.99 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.593 ' HD3' ' CE1' ' A' ' 489' ' ' TYR . 44.9 ttp180 -107.64 122.29 46.4 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 118.572 0.624 . . . . 74.41 111.537 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.451 ' O ' HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.32 120.63 27.88 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 107.307 -1.368 . . . . 75.53 107.307 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.473 ' HB ' HD11 ' A' ' 543' ' ' LEU . 47.9 mm -98.39 -43.86 11.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 120.594 0.235 . . . . 74.41 111.579 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.405 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 9.3 pt-20 -156.99 148.05 21.89 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.833 -0.432 . . . . 72.04 109.833 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 541' ' ' SER . 5.7 p -129.57 128.44 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 109.77 -0.456 . . . . 75.42 109.77 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 58.61 21.24 8.49 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.137 0.975 . . . . 74.22 112.811 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.45 -5.97 60.89 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.192 -0.528 . . . . 70.45 113.25 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.88 132.37 39.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.608 -0.515 . . . . 63.15 109.608 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -77.3 144.37 38.15 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 123.862 0.726 . . . . 73.14 109.596 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.451 HD11 ' O ' ' A' ' 511' ' ' LEU . 22.7 mt -101.36 -52.51 3.23 Favored 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 120.51 -0.476 . . . . 61.21 111.116 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 487' ' ' PRO . 27.8 m -69.46 97.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.696 0 CA-C-O 122.605 1.193 . . . . 54.22 111.011 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.29 -31.74 1.15 Allowed Glycine 0 N--CA 1.419 -2.498 0 CA-C-N 113.477 -1.692 . . . . 73.53 108.989 -173.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.553 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -108.73 174.52 5.83 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.249 -0.476 . . . . 75.44 110.771 177.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 54.2 m -91.0 159.15 16.3 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.156 0.428 . . . . 75.55 112.156 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -56.95 -46.47 82.1 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.119 0.567 . . . . 72.13 111.752 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -58.86 -31.95 69.01 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.966 -0.561 . . . . 73.01 111.852 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.96 -41.73 90.87 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.709 -0.478 . . . . 73.25 109.709 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.71 -38.12 71.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.355 -0.839 . . . . 61.13 110.75 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.704 ' O ' ' HG3' ' A' ' 532' ' ' ARG . 19.7 m -65.26 -42.12 93.17 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.136 0 C-N-CA 119.443 -0.903 . . . . 64.45 110.135 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.0 m -62.31 -35.85 80.32 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.734 0.778 . . . . 65.42 109.813 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 22.8 tp -67.47 -36.28 80.84 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 124.941 1.296 . . . . 63.42 110.382 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 54.2 tp -76.36 -48.58 19.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.188 -0.46 . . . . 72.12 111.084 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.704 ' HG3' ' O ' ' A' ' 528' ' ' VAL . 20.4 mtm180 -54.7 -36.04 64.26 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.898 0.479 . . . . 65.22 111.013 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 34.1 t -66.45 -41.3 89.3 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.535 -0.757 . . . . 64.02 111.889 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 15.5 m 64.51 174.12 0.19 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 108.336 -0.987 . . . . 73.42 108.336 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . 0.723 ' HE2' ' O ' ' A' ' 539' ' ' THR . 37.0 mtmt -91.83 168.72 11.25 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 120.651 -1.28 . . . . 71.03 108.023 175.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 83.6 mtp -74.83 -23.01 58.38 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.058 0.456 . . . . 75.4 109.851 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.63 -64.19 0.95 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.724 -1.584 . . . . 73.03 106.724 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 138.08 -19.77 3.25 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 119.971 -1.109 . . . . 75.04 114.393 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.723 ' O ' ' HE2' ' A' ' 535' ' ' LYS . 4.8 m -94.23 136.22 34.76 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.364 -0.976 . . . . 75.44 108.364 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 91.7 t -111.59 136.31 48.09 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 C-N-CA 123.103 0.561 . . . . 74.22 110.583 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 36.2 t -98.73 119.54 37.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.142 0.496 . . . . 73.42 110.983 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.454 HD21 HD23 ' A' ' 464' ' ' LEU . 2.6 mm? -113.56 123.16 49.31 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.019 -1.104 . . . . 72.23 108.019 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.473 HD11 ' HB ' ' A' ' 512' ' ' ILE . 3.0 tm? -104.84 120.07 40.52 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 105.979 -1.859 . . . . 64.0 105.979 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.636 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 33.6 m -115.03 161.6 13.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.601 -0.727 . . . . 64.12 111.124 -173.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -129.72 116.41 18.74 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.829 -0.623 . . . . 75.05 110.468 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . 0.479 ' HD3' ' OD2' ' A' ' 509' ' ' ASP . 36.0 mtm-85 . . . . . 0 CA--C 1.498 -1.051 0 CA-C-N 116.139 -0.482 . . . . 72.15 111.238 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 120.886 0.374 . . . . 74.35 110.937 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 92.5 mtt180 -104.69 139.64 39.22 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.023 -0.535 . . . . 74.5 110.404 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -127.82 135.4 50.01 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.147 0.579 . . . . 72.22 110.08 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -96.46 124.8 40.57 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.199 0.523 . . . . 74.32 109.788 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 66.4 mt -125.19 139.06 52.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 123.787 0.835 . . . . 72.33 109.467 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.9 mt-30 -120.78 126.97 51.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.663 0.986 . . . . 70.32 113.663 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.508 HD21 ' HA ' ' A' ' 499' ' ' ALA . 7.3 mp -118.15 150.29 39.62 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 124.833 1.253 . . . . 75.42 111.328 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -115.3 131.95 56.77 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.096 -1.075 . . . . 74.23 108.096 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.485 ' HE2' HG21 ' A' ' 534' ' ' THR . 24.0 ttmm -52.62 96.9 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 124.536 1.134 . . . . 71.11 112.086 177.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.14 -136.75 9.34 Favored Glycine 0 CA--C 1.519 0.32 0 CA-C-N 116.194 -0.457 . . . . 74.14 113.002 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 87.9 m -46.29 -65.42 0.56 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.641 1.176 . . . . 74.34 113.081 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.4 -2.18 52.43 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.226 -1.027 . . . . 75.2 108.226 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 60.56 -143.29 48.01 Favored Glycine 0 CA--C 1.473 -2.54 0 N-CA-C 108.885 -1.686 . . . . 38.47 108.885 -168.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.42 HD11 ' O ' ' A' ' 531' ' ' LEU . 50.2 mt -53.0 99.27 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.824 1.312 . . . . 53.12 111.809 -174.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -104.73 56.78 0.54 Allowed Glycine 0 CA--C 1.466 -2.971 0 CA-C-N 114.292 -1.322 . . . . 75.21 111.956 -172.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -149.87 142.13 24.16 Favored 'General case' 0 C--N 1.267 -3.017 0 N-CA-C 108.392 -0.966 . . . . 75.52 108.392 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 40.0 m -115.8 160.7 19.78 Favored 'General case' 0 C--N 1.271 -2.81 0 N-CA-C 107.977 -1.12 . . . . 75.2 107.977 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 20.7 pt -117.45 151.09 19.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.2 0.524 . . . . 70.1 111.472 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.1 t -138.21 159.1 42.93 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.551 -1.277 . . . . 75.22 107.551 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 53.9 p . . . . . 0 C--N 1.291 -1.961 0 N-CA-C 109.536 -0.542 . . . . 71.12 109.536 178.868 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 C--O 1.237 0.457 0 CA-C-O 121.128 0.387 . . . . 71.24 111.506 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 42.9 mm -95.4 129.51 45.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.528 -0.76 . . . . 72.31 109.603 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -128.24 153.66 46.7 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.559 -0.534 . . . . 74.02 109.559 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.78 118.97 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 107.671 -1.233 . . . . 74.5 107.671 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -81.29 -56.96 3.72 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.293 -0.867 . . . . 73.44 110.377 -175.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -147.3 157.77 43.71 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.824 -0.626 . . . . 61.34 109.427 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.45 HG12 ' HB1' ' A' ' 507' ' ' ALA . 29.8 mm -121.49 105.81 17.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.491 -1.299 . . . . 71.45 107.491 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.9 mp -55.93 133.92 73.51 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.49 -0.777 . . . . 60.43 111.987 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -66.55 6.92 0.45 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 124.896 3.731 . . . . 75.44 115.051 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.496 ' O ' ' HB ' ' A' ' 468' ' ' THR . 31.5 ptt180 -162.74 10.95 0.06 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.919 0.866 . . . . 61.12 111.752 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -85.84 -174.29 49.74 Favored Glycine 0 C--N 1.294 -1.758 0 CA-C-N 115.42 -0.809 . . . . 61.42 112.512 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -51.52 -38.27 53.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.453 1.101 . . . . 74.34 110.538 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . 0.508 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -61.68 -42.95 99.63 Favored 'General case' 0 C--O 1.197 -1.71 0 CA-C-N 114.185 -1.371 . . . . 72.15 113.248 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.0 tt -80.05 -29.44 12.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 120.925 0.393 . . . . 65.43 111.166 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 28.9 mm-40 -62.04 -46.31 89.72 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.89 -0.595 . . . . 74.34 109.633 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -84.65 -42.04 15.73 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 120.579 -0.448 . . . . 65.34 109.82 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 81.24 -14.66 27.0 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 116.753 1.461 . . . . 74.24 116.753 174.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -74.21 -16.69 60.96 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 117.77 0.785 . . . . 74.51 111.38 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.62 147.5 26.35 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.675 -0.491 . . . . 75.32 109.675 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.59 171.25 15.38 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.706 -0.479 . . . . 72.24 109.706 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.45 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -89.34 149.72 22.9 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 123.238 0.336 . . . . 72.01 110.529 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 107.0 5.27 35.49 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.55 -0.833 . . . . 38.47 113.504 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -113.74 156.18 24.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.942 0.371 . . . . 75.03 111.159 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -85.56 130.86 34.47 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.261 -0.427 . . . . 70.02 110.417 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.465 HD12 HD12 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.67 128.95 35.03 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.832 -1.544 . . . . 71.32 106.832 -179.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.479 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.5 mm -100.04 -49.59 11.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.05 0.452 . . . . 73.55 111.252 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.24 150.51 21.96 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.898 -0.592 . . . . 73.41 109.858 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 541' ' ' SER . 4.2 p -125.05 123.82 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 CA-C-O 121.38 0.61 . . . . 72.44 109.98 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 19.4 m120 56.09 18.16 3.04 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.23 1.412 . . . . 61.54 114.475 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.76 -7.83 29.76 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.257 -0.973 . . . . 54.31 112.999 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.51 123.12 45.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 108.561 -0.903 . . . . 72.05 108.561 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -90.91 133.38 35.3 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.225 -1.028 . . . . 72.32 108.225 -172.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 23.2 mt -86.33 -46.31 10.4 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 112.427 0.529 . . . . 70.14 112.427 -170.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.38 100.59 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.854 0.835 . . . . 74.15 110.503 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 141.59 -33.55 1.96 Allowed Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 109.629 -1.388 . . . . 52.41 109.629 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.473 ' HB3' ' HZ3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -105.94 166.52 10.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.614 -0.293 . . . . 71.01 110.722 178.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 58.3 m -88.65 162.55 16.26 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.719 0.295 . . . . 74.11 111.763 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -54.92 -46.47 74.92 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 123.897 0.879 . . . . 73.43 112.205 -175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.522 ' O ' HG23 ' A' ' 528' ' ' VAL . 40.9 mm-40 -60.39 -31.05 69.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.888 0.699 . . . . 74.52 112.888 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.63 -37.48 86.69 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.491 0.662 . . . . 63.4 109.258 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 39.0 t -75.69 -34.94 29.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.69 -0.686 . . . . 73.33 110.04 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 13.5 m -66.5 -41.32 88.34 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 C-N-CA 119.953 -0.699 . . . . 63.34 110.687 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 40.5 t -59.67 -44.1 93.74 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.782 0.801 . . . . 70.2 109.327 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 25.3 tp -58.35 -41.97 85.85 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 125.487 1.515 . . . . 55.01 110.163 176.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.42 ' O ' HD11 ' A' ' 471' ' ' LEU . 35.4 tp -69.27 -48.07 62.78 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.724 0.81 . . . . 74.24 110.383 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 4.2 mmp_? -55.1 -45.39 75.46 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.761 0.825 . . . . 63.13 112.355 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 32.1 m -71.53 -37.12 71.18 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 111.553 0.205 . . . . 74.14 111.553 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' THR . . . . . 0.485 HG21 ' HE2' ' A' ' 466' ' ' LYS . 26.3 m 70.42 152.45 0.11 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.057 0.943 . . . . 73.44 111.009 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.99 125.68 25.66 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.98 -1.489 . . . . 75.31 106.98 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.7 mtt -71.8 -6.3 40.49 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.269 0.841 . . . . 61.03 113.269 -173.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.55 -27.69 61.47 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.12 -1.067 . . . . 73.41 108.12 171.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 109.97 -25.16 17.22 Favored Glycine 0 N--CA 1.427 -1.965 0 CA-C-N 115.207 -0.906 . . . . 62.1 112.43 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.5 m -101.59 127.0 48.5 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 109.369 -0.604 . . . . 62.11 109.369 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 76.6 t -106.46 128.23 61.18 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.681 0 CA-C-N 115.744 -0.662 . . . . 72.34 110.363 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 20.2 m -100.9 114.02 27.51 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.575 -0.739 . . . . 62.54 109.519 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -104.77 128.23 52.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.802 -0.814 . . . . 72.52 108.802 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 37.3 tp -104.85 118.28 36.16 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 105.935 -1.876 . . . . 71.31 105.935 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 27.6 m -115.48 160.17 14.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 CA-C-O 120.966 0.412 . . . . 75.44 110.042 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -111.96 115.39 28.87 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-N 115.546 -0.752 . . . . 74.05 109.08 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.428 -1.567 0 N-CA-C 106.047 -1.834 . . . . 64.32 106.047 177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.519 ' HA ' ' HE3' ' A' ' 458' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.432 -1.357 0 N-CA-C 109.319 -0.623 . . . . 74.25 109.319 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -102.03 149.4 24.29 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.166 -0.679 . . . . 75.54 109.166 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.4 mm? -133.98 150.53 51.27 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.358 -0.608 . . . . 71.55 109.358 -173.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.51 117.27 28.55 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.904 0.859 . . . . 75.11 110.935 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 54.7 mt -121.78 139.2 49.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 106.853 -1.536 . . . . 72.01 106.853 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 42.4 tt0 -125.66 126.58 44.92 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.895 -1.122 . . . . 72.11 108.512 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 6.4 mp -114.66 153.05 30.9 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.081 -0.647 . . . . 75.2 112.433 -177.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.72 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.2 OUTLIER -100.56 128.37 46.64 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.558 -0.904 . . . . 71.2 108.558 -177.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.51 ' HE3' HG21 ' A' ' 534' ' ' THR . 39.9 ttmt -60.1 113.28 2.26 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.952 -0.567 . . . . 53.24 110.182 172.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -104.58 -131.71 7.22 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 120.796 -0.716 . . . . 64.03 111.799 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 26.4 m -62.53 -64.97 0.76 Allowed 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.198 0.599 . . . . 75.5 111.947 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . 0.486 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 11.8 mm-40 -85.24 -32.45 22.59 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.82 -0.752 . . . . 63.22 109.545 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.458 ' N ' ' HA2' ' A' ' 497' ' ' GLY . . . 70.77 141.63 0.21 Allowed Glycine 0 C--O 1.21 -1.352 0 CA-C-N 114.878 -1.055 . . . . 54.53 112.894 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 471' ' ' LEU 0.25 4.9 mp 39.56 84.38 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.551 1.54 . . . . 72.45 114.118 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -94.04 54.14 2.2 Favored Glycine 0 CA--C 1.493 -1.297 0 CA-C-N 115.078 -0.965 . . . . 63.33 112.433 -173.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.52 ' CZ ' HD12 ' A' ' 542' ' ' LEU . 3.7 p90 -146.67 142.05 27.48 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.177 0.513 . . . . 63.31 110.763 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 29.6 m -120.57 143.9 48.38 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.089 -1.448 . . . . 72.44 107.089 177.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 23.9 pt -109.59 158.85 9.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 121.441 0.638 . . . . 74.24 111.929 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.6 t -132.5 159.23 39.99 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.703 -1.591 . . . . 75.42 106.703 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 55.4 p . . . . . 0 C--N 1.269 -2.911 0 N-CA-C 108.953 -0.758 . . . . 73.23 108.953 179.747 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 C--O 1.249 1.068 0 CA-C-O 120.867 0.278 . . . . 74.5 111.702 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.462 ' O ' ' HG3' ' A' ' 510' ' ' ARG . 44.3 mm -109.56 136.59 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.966 -0.561 . . . . 74.23 109.976 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.493 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 91.9 m-85 -137.99 157.79 45.65 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.138 0.575 . . . . 70.22 110.468 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 13.0 t -74.68 121.41 26.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.108 -1.071 . . . . 70.14 108.108 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -85.44 -58.9 2.48 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.728 -0.471 . . . . 74.15 109.728 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -146.61 147.83 31.47 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.042 -1.096 . . . . 63.22 108.042 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.502 HG13 ' HA ' ' A' ' 506' ' ' LYS . 26.1 mm -109.4 109.46 28.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.635 -0.876 . . . . 64.11 108.635 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 86.5 mt -53.69 154.69 6.52 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 114.838 -1.073 . . . . 74.33 111.168 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.17 -1.67 11.26 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 123.902 3.068 . . . . 72.13 111.657 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.453 ' HA ' HG22 ' A' ' 500' ' ' ILE . 99.5 mtt180 -150.39 -157.65 0.84 Allowed 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 115.12 -0.946 . . . . 65.32 108.559 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.486 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 82.98 -162.9 41.21 Favored Glycine 0 C--N 1.277 -2.735 0 N-CA-C 111.398 -0.681 . . . . 71.35 111.398 -176.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . 0.496 ' O ' HD21 ' A' ' 464' ' ' LEU . . . -70.49 -27.78 64.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.885 0.342 . . . . 74.51 110.843 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . 0.539 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -58.9 -41.37 87.05 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-N 115.182 -0.917 . . . . 71.22 112.057 -173.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 496' ' ' ARG . 16.9 tt -79.48 -29.29 13.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.984 -0.553 . . . . 52.31 111.547 -179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 12.6 mm100 -62.37 -45.91 91.03 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.263 -0.643 . . . . 73.42 109.263 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.405 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 8.8 t70 -93.74 -34.88 13.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.291 -0.868 . . . . 51.43 110.048 -177.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 83.8 -27.65 4.27 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.622 1.409 . . . . 44.3 116.622 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -67.93 -13.59 62.29 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.191 1.182 . . . . 75.44 114.191 -174.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 46.7 tp -97.89 124.78 42.47 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 120.595 -0.442 . . . . 64.54 111.158 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.502 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.1 OUTLIER -135.27 164.07 28.55 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 111.809 0.3 . . . . 75.5 111.809 178.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.468 ' HA ' ' CG1' ' A' ' 490' ' ' VAL . . . -82.64 160.36 22.47 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 113.835 1.05 . . . . 64.34 113.835 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 78.93 46.77 8.14 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.234 -0.894 . . . . 37.36 112.247 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . 0.49 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 7.5 t70 -144.08 178.63 7.74 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.579 -1.637 . . . . 62.54 106.579 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.493 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 48.6 ttp85 -109.28 136.83 48.09 Favored 'General case' 0 C--O 1.212 -0.875 0 C-N-CA 119.176 -1.01 . . . . 71.24 113.217 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.72 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -88.02 121.31 30.28 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.196 -0.911 . . . . 70.02 110.781 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 512' ' ' ILE . 1.9 mp -106.83 -48.47 8.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 109.447 -0.575 . . . . 55.31 109.447 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.42 143.0 31.43 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.302 -0.863 . . . . 62.2 109.543 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 541' ' ' SER . 7.5 p -145.03 122.41 4.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 CA-C-N 114.632 -1.167 . . . . 75.25 109.506 175.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . 0.596 ' ND2' HG13 ' A' ' 540' ' ' VAL . 49.0 m-80 66.65 21.94 10.54 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.113 0.965 . . . . 63.4 112.176 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 83.41 25.96 45.26 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 121.147 -0.549 . . . . 73.03 112.158 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.0 t -121.8 138.04 53.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 109.752 -0.462 . . . . 75.32 109.752 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.99 128.31 34.57 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.038 -0.727 . . . . 74.42 109.038 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.72 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 24.6 mt -96.55 -44.05 7.33 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 113.057 0.762 . . . . 74.43 113.057 -170.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 56.4 t -72.47 92.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.752 0.787 . . . . 74.05 110.448 -174.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.29 -25.77 1.24 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 109.889 -1.284 . . . . 63.23 109.889 -175.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.51 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.2 OUTLIER -107.09 179.09 4.36 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.793 -0.203 . . . . 63.14 110.671 177.079 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 52.5 m -94.2 157.97 15.81 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-O 121.065 0.46 . . . . 73.31 111.75 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -52.8 -47.18 67.78 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.42 1.088 . . . . 73.21 112.156 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.402 ' HA ' HG23 ' A' ' 528' ' ' VAL . 42.9 mt-10 -60.87 -34.29 74.39 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.564 0.579 . . . . 37.36 112.564 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.99 -42.18 97.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.48 0.657 . . . . 73.32 109.536 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.512 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 44.5 t -71.06 -40.36 75.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.715 -1.129 . . . . 75.42 110.374 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.476 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 12.7 m -68.62 -38.91 79.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 C-N-CA 119.041 -1.064 . . . . 63.3 110.371 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 25.8 t -62.04 -43.14 99.48 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.874 -0.603 . . . . 74.25 110.54 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 527' ' ' VAL . 3.5 pp -67.19 -32.29 73.26 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.24 0.543 . . . . 75.43 109.656 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.416 ' O ' HD23 ' A' ' 471' ' ' LEU . 2.6 tt -65.15 -47.97 75.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.918 -1.037 . . . . 71.21 111.073 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.57 ' HA ' ' HE ' ' A' ' 532' ' ' ARG . 0.2 OUTLIER -63.28 -37.04 85.68 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.906 -0.588 . . . . 72.21 110.447 -177.632 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.4 m -73.61 -40.95 63.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.492 -0.322 . . . . 73.31 110.502 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' THR . . . . . 0.51 HG21 ' HE3' ' A' ' 466' ' ' LYS . 24.0 m 68.92 158.32 0.16 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.095 0.958 . . . . 64.44 111.261 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . 0.411 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 16.5 tppt? -67.67 127.25 32.07 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.075 -1.454 . . . . 70.33 107.075 172.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.6 ptp -61.38 -18.0 56.71 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.279 0.562 . . . . 73.04 111.493 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 39.6 tt0 -69.4 -24.17 63.82 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.888 0.875 . . . . 72.5 110.413 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 103.05 -29.09 13.19 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 116.053 -0.521 . . . . 54.43 112.684 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 0.6 OUTLIER -94.83 124.08 38.66 Favored 'General case' 0 N--CA 1.424 -1.733 0 C-N-CA 123.117 0.567 . . . . 72.3 112.372 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.596 HG13 ' ND2' ' A' ' 515' ' ' ASN . 72.1 t -104.3 129.74 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 108.565 -0.902 . . . . 74.3 108.565 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' SER . . . . . 0.702 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 47.2 t -91.1 134.0 34.88 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.506 -0.924 . . . . 72.0 108.506 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.52 HD12 ' CZ ' ' A' ' 473' ' ' PHE . 3.4 mm? -122.93 118.21 27.32 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.952 -1.129 . . . . 73.23 107.952 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 4.2 tt -110.31 117.65 34.21 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 104.35 -2.463 . . . . 73.31 104.35 173.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.49 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 30.6 m -121.25 160.39 22.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-N 115.888 -0.596 . . . . 72.13 111.336 -175.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.408 ' CB ' HD13 ' A' ' 512' ' ' ILE . 76.4 t80 -125.56 119.38 28.0 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 120.966 0.412 . . . . 71.31 110.601 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 . . . . . 0 N--CA 1.401 -2.878 0 N-CA-C 108.191 -1.04 . . . . 71.22 108.191 174.928 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt . . . . . 0 N--CA 1.426 -1.646 0 CA-C-O 121.172 0.51 . . . . 74.02 110.181 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 62.8 mtm180 -101.37 137.14 40.09 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 106.252 -1.758 . . . . 75.43 106.252 172.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 16.4 tp -129.18 129.05 44.58 Favored 'General case' 0 C--N 1.265 -3.099 0 CA-C-N 116.019 -0.537 . . . . 75.0 109.822 -172.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -98.53 115.65 29.05 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 108.859 -0.793 . . . . 75.31 108.859 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . 0.471 HG22 ' HD3' ' A' ' 504' ' ' ARG . 67.4 mt -116.43 142.56 29.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.384 -0.969 . . . . 74.41 108.384 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 78.5 mt-30 -122.36 128.63 51.23 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 118.564 0.62 . . . . 73.32 112.152 176.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.586 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 9.3 mp -115.75 146.69 41.69 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 123.834 0.854 . . . . 71.2 111.634 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.771 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.2 OUTLIER -100.35 125.67 46.61 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 108.16 -1.052 . . . . 74.2 108.16 -178.219 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.88 114.97 2.32 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.249 -0.887 . . . . 63.12 110.358 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -87.08 -140.68 6.4 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.158 -1.177 . . . . 52.52 110.158 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' THR . . . . . 0.462 HG21 ' OE2' ' A' ' 469' ' ' GLU . 9.9 t -81.8 -31.61 31.7 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.834 -0.747 . . . . 64.24 111.359 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . 0.516 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 12.0 mp0 -91.77 -42.8 9.91 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 107.79 -1.189 . . . . 72.44 107.79 173.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 84.57 -148.09 23.57 Favored Glycine 0 C--O 1.202 -1.866 0 CA-C-O 118.365 -1.242 . . . . 50.32 111.312 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.442 HD21 ' H ' ' A' ' 471' ' ' LEU . 1.7 mm? -45.95 108.07 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.478 1.139 . . . . 70.0 113.294 -169.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.87 45.62 1.28 Allowed Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.744 -1.117 . . . . 74.05 111.679 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.43 ' CZ ' HD12 ' A' ' 542' ' ' LEU . 23.1 p90 -134.69 143.11 47.04 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.036 -0.727 . . . . 71.43 109.036 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 39.5 m -115.46 157.47 23.93 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.469 -1.308 . . . . 75.21 107.469 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 15.2 pt -126.03 160.08 33.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.364 0.602 . . . . 70.21 112.366 -176.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' THR . . . . . 0.407 ' HB ' ' CE ' ' A' ' 491' ' ' LYS . 10.1 t -152.26 158.26 42.57 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.218 -1.03 . . . . 70.41 108.218 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 35.3 p . . . . . 0 N--CA 1.422 -1.832 0 N-CA-C 106.446 -1.687 . . . . 71.41 106.446 174.451 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo . . . . . 0 C--O 1.246 0.895 0 CA-C-O 121.169 0.404 . . . . 55.54 112.039 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 39.2 mm -85.64 128.63 39.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 108.145 -1.057 . . . . 61.34 108.145 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -124.61 155.66 38.75 Favored 'General case' 0 CA--C 1.487 -1.455 0 O-C-N 122.117 -0.365 . . . . 73.42 110.962 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 49.4 t -74.04 125.91 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 108.592 -0.892 . . . . 72.12 108.592 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.407 ' CE ' ' HB ' ' A' ' 476' ' ' THR . 41.4 ttmt -82.54 -53.24 6.12 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.89 -0.781 . . . . 63.02 108.89 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -149.41 151.79 34.63 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.145 -0.934 . . . . 73.42 109.332 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.447 HG13 ' HA ' ' A' ' 506' ' ' LYS . 27.4 mm -114.39 106.83 21.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.175 -1.417 . . . . 72.44 107.175 175.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 8.3 mp -50.55 157.79 1.2 Allowed Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 124.903 1.281 . . . . 75.23 113.124 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -72.21 -6.46 19.13 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 123.961 3.107 . . . . 41.33 111.979 -175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.459 ' HA ' HG22 ' A' ' 500' ' ' ILE . 77.2 mtt180 -151.19 -161.05 1.25 Allowed 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.199 -0.91 . . . . 70.13 109.149 -174.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.546 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 81.48 -167.27 48.57 Favored Glycine 0 C--N 1.282 -2.461 0 CA-C-N 115.254 -0.885 . . . . 62.24 113.722 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . 0.451 ' O ' HD22 ' A' ' 464' ' ' LEU . . . -65.76 -35.83 81.83 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 124.318 1.047 . . . . 71.31 110.377 -174.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . 0.586 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -59.63 -39.62 84.91 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 115.089 -0.959 . . . . 53.41 112.331 -174.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.459 HG22 ' HA ' ' A' ' 496' ' ' ARG . 15.0 tt -80.09 -30.1 12.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 121.111 -0.235 . . . . 75.42 111.371 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.546 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 31.6 mm-40 -60.89 -45.57 94.06 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.879 -0.6 . . . . 74.5 110.307 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.458 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 7.5 t70 -92.67 -35.75 13.33 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.779 -0.823 . . . . 52.15 108.779 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 56.54 25.39 50.01 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 115.551 0.98 . . . . 72.21 115.551 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.471 ' HD3' HG22 ' A' ' 462' ' ' ILE . 63.9 ttt180 -99.95 -6.69 26.21 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.92 0.867 . . . . 73.23 109.331 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 44.4 tp -109.5 138.91 45.17 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.738 -1.208 . . . . 73.02 107.738 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.522 ' HD2' ' OD2' ' A' ' 509' ' ' ASP . 0.0 OUTLIER -138.27 177.5 7.84 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.597 -0.841 . . . . 75.11 109.149 175.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -82.99 29.12 0.48 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.513 0.673 . . . . 72.21 112.037 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . -126.23 13.7 7.03 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.021 -0.832 . . . . 72.14 111.021 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . 0.522 ' OD2' ' HD2' ' A' ' 506' ' ' LYS . 42.6 m-20 -102.6 148.21 25.83 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 120.773 0.32 . . . . 74.45 110.694 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 544' ' ' VAL . 19.0 ttm180 -101.16 129.76 47.13 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 116.27 -0.423 . . . . 72.44 109.938 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.617 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.6 mm? -83.41 117.01 22.76 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 112.451 0.537 . . . . 61.24 112.451 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.9 mm -104.98 -39.63 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.69 0.757 . . . . 65.33 109.516 174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -148.57 145.8 27.99 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 114.929 -1.032 . . . . 73.32 108.867 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.476 ' CG1' HD12 ' A' ' 530' ' ' LEU . 2.4 p -139.15 129.17 31.51 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.446 0 CA-C-N 115.051 -0.977 . . . . 72.34 108.375 174.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . 0.475 HD22 ' HB2' ' A' ' 535' ' ' LYS . 6.3 t-20 68.65 -58.92 0.47 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 127.712 2.405 . . . . 71.44 111.673 -176.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 178.08 27.26 0.04 OUTLIER Glycine 0 C--N 1.296 -1.642 0 N-CA-C 110.081 -1.208 . . . . 54.12 110.081 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.88 136.76 57.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 109.829 -0.434 . . . . 63.31 109.829 -174.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.75 125.56 31.4 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.937 -0.764 . . . . 62.34 108.937 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.617 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 32.5 mt -94.52 -35.2 12.38 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.01 -0.541 . . . . 74.3 112.061 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 41.5 t -75.98 87.95 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 122.072 0.939 . . . . 74.43 110.374 -173.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.66 -26.51 1.19 Allowed Glycine 0 N--CA 1.425 -2.042 0 CA-C-N 114.132 -1.395 . . . . 36.63 110.142 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.483 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -104.31 176.95 4.99 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.808 0.337 . . . . 71.44 111.78 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 22.2 m -90.23 160.54 16.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.293 0.568 . . . . 51.33 112.394 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -53.0 -47.48 68.22 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.67 1.188 . . . . 74.31 113.834 177.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.65 -32.24 73.25 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 120.781 -0.368 . . . . 71.52 111.844 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.71 -38.81 92.5 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.075 0.464 . . . . 71.35 110.406 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.595 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 21.6 t -73.74 -41.42 54.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.738 -0.665 . . . . 74.04 109.61 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.591 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 11.4 m -65.65 -40.29 87.51 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 C-N-CA 119.462 -0.895 . . . . 75.24 110.456 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 27.6 m -63.06 -38.3 90.65 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.791 -0.641 . . . . 73.34 111.705 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 527' ' ' VAL . 2.1 pp -69.56 -33.06 72.2 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.613 -0.884 . . . . 63.14 108.613 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.2 tt -65.22 -48.18 74.26 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 115.329 -0.85 . . . . 64.1 110.071 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 30.5 mmm180 -61.2 -31.43 71.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.377 -0.828 . . . . 65.05 110.184 -177.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.0 t -76.39 -43.74 39.21 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.426 -0.806 . . . . 61.33 110.391 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 535' ' ' LYS . 12.6 m 64.49 177.41 0.18 Allowed 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 109.064 -0.717 . . . . 75.11 109.064 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . 0.475 ' HB2' HD22 ' A' ' 515' ' ' ASN . 38.1 ttpt -102.33 139.5 37.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.833 -0.803 . . . . 51.33 108.833 175.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 88.1 mtp -65.36 -20.68 66.5 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.234 0.827 . . . . 72.33 113.234 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.54 -39.07 79.17 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.431 -0.951 . . . . 71.14 108.431 172.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 115.96 -24.35 10.17 Favored Glycine 0 N--CA 1.431 -1.64 0 CA-C-N 114.878 -1.056 . . . . 75.55 112.443 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.462 ' O ' ' HE2' ' A' ' 535' ' ' LYS . 0.6 OUTLIER -96.17 140.69 30.51 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.707 -0.397 . . . . 74.12 109.944 -177.307 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 53.6 t -119.15 133.32 66.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 122.849 0.46 . . . . 64.2 111.544 174.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.1 m -91.6 138.33 31.65 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.531 -0.759 . . . . 74.21 110.097 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.43 HD12 ' CZ ' ' A' ' 473' ' ' PHE . 2.7 mm? -124.14 120.35 32.06 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 106.82 -1.548 . . . . 65.14 106.82 176.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 54.2 tp -104.88 117.07 33.12 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.027 -1.472 . . . . 64.3 107.027 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 510' ' ' ARG . 33.0 m -117.82 140.14 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.121 0 C-N-CA 119.907 -0.717 . . . . 74.01 111.701 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.403 ' HB3' ' HD2' ' A' ' 510' ' ' ARG . 62.2 t80 -111.3 116.79 31.6 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.138 -0.69 . . . . 73.34 109.138 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . 0.459 ' HD3' ' OD1' ' A' ' 509' ' ' ASP . 23.9 mtm180 . . . . . 0 C--N 1.289 -2.05 0 N-CA-C 108.292 -1.003 . . . . 73.22 108.292 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 51.1 mtpt . . . . . 0 N--CA 1.426 -1.626 0 N-CA-C 113.159 0.8 . . . . 74.15 113.159 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 98.8 mtt180 -107.69 126.79 53.03 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 113.883 -1.508 . . . . 75.35 107.227 169.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.2 mm? -115.9 132.57 56.61 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 109.116 -0.698 . . . . 74.23 109.116 -176.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -98.14 120.18 38.1 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.393 -0.965 . . . . 73.01 108.393 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . 0.438 ' HA ' ' NH1' ' A' ' 504' ' ' ARG . 45.7 mt -122.16 142.64 37.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.898 -1.149 . . . . 61.01 107.898 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 93.1 mt-30 -123.03 125.97 46.23 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.606 0.717 . . . . 73.12 112.701 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.507 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 7.9 mp -121.56 141.55 50.96 Favored 'General case' 0 CA--C 1.478 -1.802 0 CA-C-N 115.225 -0.898 . . . . 72.41 112.308 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -112.71 136.06 52.74 Favored 'General case' 0 N--CA 1.398 -3.031 0 CA-C-N 115.456 -0.793 . . . . 75.11 110.005 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.459 ' HB2' HG21 ' A' ' 534' ' ' THR . 39.4 ttmt -65.93 113.74 4.62 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.724 -1.125 . . . . 73.42 111.865 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -93.1 -104.2 1.63 Allowed Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.142 -1.183 . . . . 62.01 110.142 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 41.5 m -90.73 -57.0 2.97 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 122.554 -0.38 . . . . 74.34 111.113 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -94.43 -33.51 13.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.933 -1.506 . . . . 62.33 106.933 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 79.51 -145.27 27.62 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 114.407 -1.27 . . . . 44.53 110.995 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.409 HD21 HG12 ' A' ' 540' ' ' VAL . 6.6 mp -43.43 97.64 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.205 1.187 . . . . 73.41 114.205 -172.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -103.79 50.08 0.9 Allowed Glycine 0 N--CA 1.433 -1.555 0 CA-C-N 114.432 -1.258 . . . . 63.0 112.417 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -133.39 146.67 51.45 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.537 -0.912 . . . . 71.33 108.537 175.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 47.1 m -116.03 156.97 25.39 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 108.465 -0.939 . . . . 71.32 108.465 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 12.2 pt -124.18 154.66 31.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.26 0.552 . . . . 72.32 111.799 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.8 t -142.07 159.03 43.04 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.05 -1.092 . . . . 70.22 108.05 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 64.4 p . . . . . 0 N--CA 1.421 -1.922 0 N-CA-C 107.65 -1.241 . . . . 73.22 107.65 174.444 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.438 -1.743 0 N-CA-C 109.498 -1.001 . . . . 38.5 109.498 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.455 HG13 ' HB3' ' A' ' 519' ' ' LEU . 32.4 mm -89.95 131.37 37.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 116.135 -0.484 . . . . 74.24 109.971 -174.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 90.1 m-85 -129.97 161.63 30.48 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.091 0.556 . . . . 74.14 109.828 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 23.4 t -74.58 127.03 36.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.612 -0.884 . . . . 73.02 108.612 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -87.39 -51.18 6.08 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.741 -0.837 . . . . 73.33 108.741 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -159.0 157.84 32.04 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.282 -0.872 . . . . 73.34 109.307 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.458 HG12 ' HB1' ' A' ' 507' ' ' ALA . 32.5 mm -121.07 109.33 24.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 106.523 -1.658 . . . . 73.21 106.523 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.12 158.95 6.47 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-N 115.575 -0.739 . . . . 74.31 111.761 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . 0.416 ' HG2' ' HG2' ' A' ' 496' ' ' ARG . 26.5 Cg_endo -79.18 7.36 4.44 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 123.475 2.783 . . . . 72.43 111.453 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.502 ' HA ' HG22 ' A' ' 500' ' ' ILE . 17.3 ptp180 -159.41 -158.3 0.65 Allowed 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 115.728 -0.669 . . . . 75.15 110.371 -174.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 72.61 -157.46 52.66 Favored Glycine 0 C--N 1.287 -2.143 0 CA-C-N 114.954 -1.021 . . . . 74.55 111.013 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -69.85 -35.47 74.74 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 122.742 0.417 . . . . 74.21 111.242 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . 0.507 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -58.07 -37.4 74.39 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 113.428 0.899 . . . . 70.14 113.428 -172.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.502 HG22 ' HA ' ' A' ' 496' ' ' ARG . 15.7 tt -79.71 -36.17 17.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 112.134 0.42 . . . . 65.41 112.134 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -63.75 -33.66 76.16 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.303 0.573 . . . . 74.24 110.789 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.406 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 16.5 t70 -89.75 -48.06 7.51 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.88 -0.6 . . . . 70.5 109.951 173.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 72.79 -3.49 27.04 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 117.559 1.784 . . . . 51.13 117.559 175.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.438 ' NH1' ' HA ' ' A' ' 462' ' ' ILE . 70.5 mtp180 -80.46 -15.06 57.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.882 1.341 . . . . 73.23 110.109 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 39.3 tp -96.49 134.47 39.64 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.282 -0.872 . . . . 61.24 108.949 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' A' ' 506' ' ' LYS . 0.0 OUTLIER -142.76 175.41 9.83 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.765 -0.457 . . . . 65.01 109.765 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.458 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -102.4 82.74 2.21 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 120.351 -0.54 . . . . 42.33 110.676 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . -175.01 35.48 0.1 Allowed Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.306 -1.118 . . . . 61.24 110.306 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -153.76 177.19 11.26 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 122.96 0.504 . . . . 74.41 111.541 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.563 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 0.2 OUTLIER -115.19 142.31 46.83 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.358 0.503 . . . . 72.42 112.358 -174.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.595 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.6 mm? -85.3 128.06 34.56 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.889 -0.596 . . . . 73.03 112.599 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 36.6 mm -102.53 -58.77 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.062 0 CA-C-N 116.189 -0.46 . . . . 63.22 109.775 176.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.499 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.5 pt-20 -156.29 144.55 19.82 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 121.438 0.637 . . . . 51.55 111.056 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 541' ' ' SER . 2.6 p -130.61 135.2 60.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 N-CA-C 107.829 -1.174 . . . . 72.41 107.829 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 17.4 m120 66.47 9.91 6.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.52 0.728 . . . . 75.23 111.727 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 84.07 13.11 75.24 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 111.455 -0.658 . . . . 51.03 111.455 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.83 135.67 39.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.792 -0.818 . . . . 74.53 108.792 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.64 132.15 36.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.68 -0.489 . . . . 75.42 109.68 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.595 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 15.9 mt -97.76 -45.29 6.4 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 112.425 0.528 . . . . 71.45 112.425 -170.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' VAL . . . . . 0.448 HG23 HH21 ' A' ' 510' ' ' ARG . 59.8 t -78.41 99.9 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-O 121.787 0.803 . . . . 64.24 109.126 -175.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 143.68 -26.19 2.1 Favored Glycine 0 N--CA 1.414 -2.815 0 N-CA-C 109.249 -1.541 . . . . 74.11 109.249 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.407 ' HB3' ' HZ3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -102.01 179.71 4.25 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 110.163 -0.31 . . . . 73.33 110.163 175.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 46.5 t -87.3 155.02 20.24 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.268 0.556 . . . . 74.33 110.68 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.501 ' O ' HG12 ' A' ' 528' ' ' VAL . 28.8 mm-40 -54.55 -39.99 68.27 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.719 1.207 . . . . 74.02 111.41 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.81 -32.11 73.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.191 -0.459 . . . . 71.31 111.572 -176.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.18 -44.58 83.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.05 -0.523 . . . . 73.03 109.835 176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 19.0 t -67.68 -43.56 86.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.665 -0.698 . . . . 61.34 109.634 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.505 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 10.2 m -64.91 -38.73 83.52 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.044 0 C-N-CA 119.774 -0.77 . . . . 73.51 110.265 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.1 t -63.05 -45.43 92.24 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.857 -0.61 . . . . 62.43 110.763 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 531' ' ' LEU . 2.6 pp -66.27 -35.52 80.61 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.441 0.639 . . . . 71.04 109.434 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.462 ' N ' HD11 ' A' ' 530' ' ' LEU . 2.5 tt -62.11 -47.97 82.22 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.054 -0.976 . . . . 70.33 111.607 175.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 1.4 mmp_? -63.95 -37.08 86.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.105 -0.498 . . . . 73.03 109.705 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.2 m -67.4 -39.86 85.57 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.575 -0.739 . . . . 71.04 109.238 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' THR . . . . . 0.459 HG21 ' HB2' ' A' ' 466' ' ' LYS . 95.3 m 72.78 -85.7 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.804 0.842 . . . . 71.24 111.599 177.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 537' ' ' GLU . 39.9 ttmt 170.8 133.67 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.71 1.204 . . . . 71.34 107.864 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.2 mtt -65.97 -29.26 69.62 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.666 0.269 . . . . 62.41 111.141 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . 0.433 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 38.8 tt0 -74.07 -37.05 64.34 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.361 -0.381 . . . . 73.24 110.995 177.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 135.79 -45.48 1.09 Allowed Glycine 0 CA--C 1.539 1.584 0 N-CA-C 117.322 1.689 . . . . 75.31 117.322 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' A' ' 463' ' ' GLN . 5.5 m -101.95 140.19 36.58 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.442 1.121 . . . . 71.4 112.366 -172.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 69.2 t -113.52 140.28 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 124.037 0.935 . . . . 74.22 110.808 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 46.6 t -95.65 124.78 39.83 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.23 -0.656 . . . . 63.31 109.23 176.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -115.37 119.21 35.5 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.298 -1.371 . . . . 72.11 107.298 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 33.9 tp -108.54 117.37 34.0 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.074 -1.454 . . . . 71.53 107.074 174.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 35.6 m -116.17 150.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.803 -0.635 . . . . 71.32 110.837 -177.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 69.6 t80 -112.14 116.52 30.62 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.207 -1.035 . . . . 72.51 108.207 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 . . . . . 0 C--N 1.286 -2.165 0 CA-C-N 115.817 -0.628 . . . . 73.21 110.474 -178.99 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.904 0 N-CA-C 110.572 -1.011 . . . . 63.05 110.572 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 39.3 m -85.62 96.65 9.74 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.1 0.476 . . . . 73.32 110.925 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -123.37 105.85 10.17 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.028 -1.101 . . . . 74.52 108.028 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -142.95 112.07 6.59 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.445 -0.798 . . . . 62.23 109.62 -173.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 9.0 t -139.79 -35.88 0.52 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.216 -0.447 . . . . 61.12 110.548 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 65.0 mttp 64.22 89.74 0.09 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.53 1.132 . . . . 53.55 113.613 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -109.52 143.42 39.2 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.77 -1.196 . . . . 72.41 107.77 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.53 87.44 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.973 0.892 . . . . 74.21 109.615 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 159.2 138.66 2.51 Favored Glycine 0 C--N 1.294 -1.802 0 N-CA-C 108.494 -1.842 . . . . 72.51 108.494 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -136.43 159.21 42.47 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 117.505 0.652 . . . . 73.1 111.216 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 76.4 mtm180 -103.16 145.12 30.4 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.179 -0.675 . . . . 55.34 109.179 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.6 mm? -124.29 126.26 45.74 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.054 -0.521 . . . . 75.41 110.064 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -91.62 115.58 28.16 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.051 0.929 . . . . 54.34 108.623 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 85.2 mt -124.72 121.71 61.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-N 115.409 -0.814 . . . . 73.02 111.221 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 75.2 mt-30 -104.33 130.22 52.18 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 120.288 -0.565 . . . . 65.21 110.551 172.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.431 ' CD2' ' HB2' ' A' ' 502' ' ' ASP . 94.8 mt -122.72 138.0 54.75 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.85 -1.068 . . . . 72.23 109.655 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -104.14 128.14 51.78 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-O 122.344 1.069 . . . . 72.33 112.63 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -53.12 115.15 1.73 Allowed 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 112.945 -1.934 . . . . 75.13 113.343 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -98.5 -139.22 10.68 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.922 -1.271 . . . . 73.54 109.922 171.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 31.3 m -68.99 -49.35 58.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.607 0.717 . . . . 75.55 109.679 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.67 56.1 0.95 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.101 -1.815 . . . . 74.25 106.101 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -41.61 -63.83 1.55 Allowed Glycine 0 CA--C 1.478 -2.23 0 CA-C-N 113.393 -1.731 . . . . 63.33 115.145 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 49.6 mt -85.43 82.26 8.38 Favored 'General case' 0 C--N 1.272 -2.79 0 C-N-CA 116.273 -2.171 . . . . 73.13 111.257 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -95.84 40.33 2.65 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 113.063 -1.88 . . . . 65.2 111.862 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -137.21 142.19 42.09 Favored 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 108.176 -1.046 . . . . 74.14 108.176 173.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.0 m -132.12 152.66 51.12 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 116.172 -0.467 . . . . 65.01 110.125 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 10.6 pt -109.51 160.8 8.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.612 -0.722 . . . . 72.4 112.544 -173.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' THR . . . . . 0.418 HG22 ' HD3' ' A' ' 491' ' ' LYS . 12.9 t -147.26 159.09 44.06 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.24 -1.022 . . . . 73.03 108.24 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 64.2 p -138.02 131.17 30.29 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.041 -1.096 . . . . 75.11 108.041 173.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -118.37 -83.76 0.65 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.218 -0.593 . . . . 73.41 111.88 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -138.28 154.32 49.04 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.25 -0.58 . . . . 75.11 109.86 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 486' ' ' ALA . 9.9 p -108.69 131.96 57.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 116.439 -0.346 . . . . 73.02 110.326 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.5 t -117.62 131.82 56.6 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.492 -1.299 . . . . 72.22 107.492 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 65.7 mt 66.8 90.61 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-O 121.702 0.763 . . . . 73.35 109.724 -175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 127.52 -145.2 15.71 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 115.558 -0.746 . . . . 72.22 111.382 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 170.62 104.07 0.17 Allowed Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 111.391 -0.684 . . . . 52.31 111.391 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 27.0 t 173.39 -18.55 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.171 0.588 . . . . 74.23 110.027 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . 0.47 ' HA ' ' HB ' ' A' ' 480' ' ' VAL . . . 71.12 115.52 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.837 0.855 . . . . 75.32 110.626 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.448 ' HD3' ' HB ' ' A' ' 480' ' ' VAL . 9.2 Cg_endo -85.52 153.09 10.43 Favored 'Trans proline' 0 N--CA 1.438 -1.763 0 C-N-CA 122.167 1.911 . . . . 64.41 112.476 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 42.8 mm -97.96 125.04 51.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.936 -1.135 . . . . 70.23 107.936 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -118.61 150.17 40.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 122.344 -0.222 . . . . 74.01 111.054 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 43.3 t -80.9 119.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 106.539 -1.652 . . . . 62.33 106.539 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.418 ' HD3' HG22 ' A' ' 476' ' ' THR . 55.0 tptt -91.3 -53.79 4.2 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.973 -0.558 . . . . 61.42 111.489 -174.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . 0.47 HD21 HD12 ' A' ' 494' ' ' LEU . 6.1 t30 -133.12 144.68 50.1 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.914 -0.714 . . . . 74.44 111.131 -171.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.456 HG12 ' HB1' ' A' ' 507' ' ' ALA . 31.9 mm -121.57 103.88 14.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.007 -0.997 . . . . 71.52 108.688 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.47 HD12 HD21 ' A' ' 492' ' ' ASN . 6.7 mp -63.07 127.73 91.27 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.271 -0.877 . . . . 64.14 109.977 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.28 30.18 0.23 Allowed 'Trans proline' 0 N--CA 1.512 2.56 1 C-N-CA 125.373 4.049 . . . . 64.43 114.035 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -159.7 -8.86 0.06 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 113.862 1.06 . . . . 72.43 113.862 -173.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 501' ' ' GLN . . . -91.62 -159.45 35.47 Favored Glycine 0 C--O 1.212 -1.229 0 C-N-CA 119.387 -1.387 . . . . 65.34 113.457 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 464' ' ' LEU . . . -63.43 -32.45 73.89 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 112.844 0.683 . . . . 73.12 112.844 -174.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.47 78.39 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 116.611 -0.268 . . . . 64.22 110.935 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 5.9 tt -79.98 -30.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 123.637 0.775 . . . . 75.03 111.895 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 497' ' ' GLY . 0.0 OUTLIER -58.7 -45.34 89.75 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.758 0.823 . . . . 72.34 109.317 -177.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.431 ' HB2' ' CD2' ' A' ' 464' ' ' LEU . 23.8 m-20 -97.42 -21.14 17.33 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.441 -0.503 . . . . 65.4 109.68 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 68.67 35.39 80.42 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.487 -0.779 . . . . 73.24 113.97 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -108.31 -26.63 10.43 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.966 0.412 . . . . 70.2 111.962 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 49.8 tp -105.55 153.88 21.15 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.665 -0.414 . . . . 60.13 111.252 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.34 170.27 17.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.84 -1.17 . . . . 74.22 107.84 177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.456 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -92.5 148.83 21.78 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 110.178 -0.304 . . . . 71.42 110.178 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 117.23 -34.99 4.33 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.951 -0.642 . . . . 65.21 111.886 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.5 153.66 43.18 Favored 'General case' 0 C--O 1.25 1.103 0 CA-C-O 121.32 0.581 . . . . 74.23 111.277 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 63.3 ttp180 -90.13 127.08 36.01 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.105 -1.072 . . . . 72.15 108.105 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.446 ' HG ' HD12 ' A' ' 519' ' ' LEU . 23.0 tp -80.74 131.88 35.48 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 107.624 -1.25 . . . . 75.03 107.624 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.0 mm -101.44 -44.96 11.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.177 0.513 . . . . 72.32 110.264 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -152.3 156.01 38.81 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.552 -0.907 . . . . 62.15 108.552 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.471 HG11 HD21 ' A' ' 519' ' ' LEU . 5.2 p -137.65 127.92 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.157 0 N-CA-C 108.515 -0.92 . . . . 71.31 108.515 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 65.91 9.23 5.94 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 126.136 1.774 . . . . 64.44 111.392 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.68 3.56 40.08 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.303 -0.475 . . . . 63.11 113.167 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.95 139.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 122.419 -0.46 . . . . 75.43 110.536 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.72 134.73 37.06 Favored 'General case' 0 CA--C 1.484 -1.591 0 C-N-CA 123.518 0.727 . . . . 55.21 109.584 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.471 HD21 HG11 ' A' ' 514' ' ' VAL . 42.3 mt -90.19 -45.62 8.98 Favored 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 123.654 0.597 . . . . 73.53 112.03 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.67 99.94 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 121.743 0.782 . . . . 71.15 110.05 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 137.93 -21.46 3.17 Favored Glycine 0 N--CA 1.42 -2.417 0 CA-C-N 114.411 -1.268 . . . . 71.33 110.723 -175.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.446 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.3 OUTLIER -114.24 163.86 14.67 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.67 0.271 . . . . 65.34 111.068 178.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' SER . . . . . 0.469 ' O ' HG21 ' A' ' 527' ' ' VAL . 34.1 m -92.58 164.19 13.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.01 -0.541 . . . . 72.44 111.09 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.523 ' O ' HG12 ' A' ' 528' ' ' VAL . 50.7 mm-40 -50.44 -47.76 56.66 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 113.55 0.944 . . . . 72.11 113.55 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -59.87 -32.29 70.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.057 0.456 . . . . 75.35 111.454 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.24 -38.26 68.95 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.775 -0.648 . . . . 73.33 109.514 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 523' ' ' SER . 16.3 t -76.29 -37.46 31.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.953 -0.567 . . . . 75.11 110.333 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.632 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 12.3 m -65.64 -42.23 92.31 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 C-N-CA 120.722 -0.391 . . . . 73.34 110.601 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.8 p -68.78 -30.37 68.95 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.252 0.549 . . . . 55.43 111.067 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.33 -39.16 89.06 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.27 -0.877 . . . . 71.33 108.769 173.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 48.5 tp -69.91 -48.31 59.07 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.712 -0.677 . . . . 74.41 109.955 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -60.05 -27.68 67.15 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.117 0.567 . . . . 72.23 111.66 -177.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 33.8 t -69.82 -35.23 74.62 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 109.82 -0.437 . . . . 73.24 109.82 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 31.1 m 69.19 -89.67 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.226 1.01 . . . . 73.0 110.546 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 536' ' ' MET . 61.1 tttp 170.87 175.93 0.06 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.035 -2.209 . . . . 75.12 105.035 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' MET . . . . . 0.406 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 27.5 ttt -72.09 -50.72 25.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 119.138 0.881 . . . . 65.04 112.81 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -35.81 39.65 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 118.472 -1.291 . . . . 74.04 108.746 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 115.96 25.14 3.69 Favored Glycine 0 N--CA 1.411 -3.023 0 CA-C-N 115.03 -0.986 . . . . 64.03 113.187 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 3.8 m -107.44 119.87 40.59 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 118.627 -1.229 . . . . 52.35 108.093 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 65.1 t -106.91 131.72 56.1 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 CA-C-N 115.588 -0.733 . . . . 72.5 110.6 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 24.7 m -94.19 113.77 25.76 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.717 -0.674 . . . . 62.4 109.558 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.92 139.59 41.09 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.384 -0.969 . . . . 71.13 108.384 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 44.9 tp -118.79 117.84 29.96 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 105.863 -1.903 . . . . 75.11 105.863 171.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 27.1 m -118.06 158.05 19.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.841 0 C-N-CA 120.24 -0.584 . . . . 73.22 110.898 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -111.89 116.26 30.33 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.402 -0.962 . . . . 74.24 108.402 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.52 118.42 25.03 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 107.074 -1.454 . . . . 72.32 107.074 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -130.81 141.59 50.35 Favored 'General case' 0 C--N 1.267 -2.996 0 CA-C-N 114.948 -1.024 . . . . 75.44 110.238 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -119.08 76.44 1.11 Allowed 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.297 -1.001 . . . . 71.24 108.297 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 C--N 1.309 -1.19 0 CA-C-N 114.568 -1.196 . . . . 74.53 109.198 -176.464 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.888 0 N-CA-C 110.466 -1.054 . . . . 71.32 110.466 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 40.8 m -95.95 -0.02 51.27 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 117.258 0.529 . . . . 54.53 111.915 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 65.84 148.56 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.783 1.233 . . . . 73.32 113.785 175.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -85.67 -64.98 1.06 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.731 -0.84 . . . . 71.34 108.731 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 44.9 p -105.57 135.52 46.83 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.96 -0.564 . . . . 63.13 109.611 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.521 ' HB2' ' HZ3' ' A' ' 454' ' ' LYS . 4.3 ttmp? 63.57 86.87 0.11 Allowed 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.356 1.062 . . . . 73.13 109.883 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -79.08 115.35 18.69 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.529 -0.76 . . . . 74.14 109.14 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 63.7 mt -86.64 93.39 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 CA-C-N 115.464 -0.789 . . . . 75.05 110.81 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 546' ' ' ARG . . . 101.47 148.7 21.87 Favored Glycine 0 N--CA 1.416 -2.643 0 C-N-CA 120.339 -0.934 . . . . 73.44 114.395 173.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 28.3 mtpp -129.78 148.57 51.67 Favored 'General case' 0 CA--C 1.471 -2.06 0 CA-C-N 114.771 -0.715 . . . . 72.33 109.568 174.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.5 mtm180 -110.97 128.82 55.96 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 115.673 -0.694 . . . . 71.41 109.213 171.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.0 mm? -118.83 129.85 55.45 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 115.021 -0.991 . . . . 74.21 109.317 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -96.55 122.32 39.34 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.119 -0.697 . . . . 73.42 109.119 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 58.8 mt -127.56 142.51 43.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 123.46 0.704 . . . . 74.51 109.942 -174.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 78.7 mt-30 -114.97 127.91 55.96 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.608 0.966 . . . . 72.11 113.608 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.479 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.1 mm? -116.61 134.54 54.71 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 124.588 1.155 . . . . 75.44 109.148 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 39.4 ttmt -108.88 135.71 49.63 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-O 121.513 0.673 . . . . 62.1 111.26 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.411 ' HE2' HG21 ' A' ' 534' ' ' THR . 38.1 mtmt -73.08 100.57 3.06 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.063 -0.972 . . . . 65.41 110.866 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -108.03 -101.23 2.69 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.474 -0.87 . . . . 64.14 112.131 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' THR . . . . . 0.51 HG23 ' H ' ' A' ' 469' ' ' GLU . 8.3 t -66.87 -69.8 0.29 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 112.16 0.43 . . . . 62.33 112.16 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . 0.51 ' H ' HG23 ' A' ' 468' ' ' THR . 25.6 mm-40 -98.29 -18.41 18.38 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.599 0.714 . . . . 74.22 109.14 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 69.27 -149.98 49.45 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 114.651 -1.159 . . . . 74.2 112.98 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 38.4 mt -51.65 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.478 0.918 . . . . 74.32 113.478 -169.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -107.72 56.19 0.49 Allowed Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 114.582 -1.19 . . . . 42.31 111.688 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.37 142.59 29.5 Favored 'General case' 0 C--N 1.281 -2.371 0 C-N-CA 123.369 0.668 . . . . 75.53 110.064 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.9 m -119.59 162.41 18.98 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.396 -0.82 . . . . 62.22 109.807 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 20.6 pt -117.88 158.09 18.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.129 0.49 . . . . 71.32 111.67 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.8 t -148.7 160.09 43.5 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.23 -0.896 . . . . 75.52 108.655 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 31.6 t -141.11 150.1 42.42 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 107.216 -1.401 . . . . 72.22 107.216 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -95.32 -68.24 0.81 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.392 -0.966 . . . . 74.1 108.392 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 16.0 t70 170.31 151.22 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 105.152 -2.166 . . . . 74.34 105.152 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 486' ' ' ALA . 12.5 p -88.45 -16.09 8.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 120.029 -0.669 . . . . 53.52 110.905 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 32.5 m 53.09 70.17 0.62 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.819 1.248 . . . . 63.23 111.355 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 12.1 tt 172.68 -23.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 114.654 -1.157 . . . . 62.12 108.937 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 94.48 99.24 1.65 Allowed Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.076 -1.21 . . . . 54.23 110.076 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -172.0 -144.93 4.7 Favored Glycine 0 N--CA 1.425 -2.059 0 C-N-CA 119.949 -1.12 . . . . 64.01 113.033 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 15.7 m -76.38 -35.45 58.65 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 123.482 0.713 . . . . 61.03 112.306 -174.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . 0.465 ' HA ' ' HB ' ' A' ' 480' ' ' VAL . . . 77.03 110.77 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 124.638 1.175 . . . . 63.33 111.283 -177.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.31 135.85 66.7 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 123.233 2.622 . . . . 73.12 112.914 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.522 HD11 HE21 ' A' ' 524' ' ' GLN . 24.8 mm -92.81 128.81 44.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.314 -0.857 . . . . 74.51 108.795 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -127.95 158.71 37.1 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 121.887 -0.508 . . . . 74.44 111.479 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.31 129.55 36.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.206 -1.035 . . . . 75.1 108.206 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -93.27 -61.3 1.59 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.544 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -141.09 148.83 40.78 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.776 -0.647 . . . . 75.41 110.183 -174.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.438 HG13 ' HA ' ' A' ' 506' ' ' LYS . 36.4 mm -118.57 104.32 15.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.411 -1.329 . . . . 64.31 107.411 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 8.3 mp -54.72 152.06 13.77 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.187 -0.915 . . . . 72.12 112.73 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . 0.55 ' O ' HD11 ' A' ' 500' ' ' ILE . 23.0 Cg_endo -77.89 -3.12 13.21 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 124.339 3.359 . . . . 73.24 111.64 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.409 ' N ' ' HG2' ' A' ' 495' ' ' PRO . 95.2 mtt180 -158.64 110.88 2.24 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 124.582 1.153 . . . . 72.05 109.636 -175.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.443 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 160.89 -168.5 36.27 Favored Glycine 1 C--N 1.237 -4.925 0 CA-C-N 112.846 -1.979 . . . . 73.44 111.145 178.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . 0.413 ' C ' HD11 ' A' ' 464' ' ' LEU . . . -57.23 -47.14 82.09 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 124.464 1.106 . . . . 54.13 110.54 -174.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -56.88 -44.11 81.93 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.006 -0.997 . . . . 65.14 111.853 -175.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.55 HD11 ' O ' ' A' ' 495' ' ' PRO . 16.5 tt -80.96 -37.63 16.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.083 0.771 . . . . 65.54 113.083 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.3 mm100 -64.74 -41.83 95.65 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 120.867 0.365 . . . . 73.43 110.771 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.479 ' HB2' HD13 ' A' ' 464' ' ' LEU . 23.7 m-20 -84.95 -32.07 23.26 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.777 -0.823 . . . . 42.42 108.777 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 61.4 45.72 95.84 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.839 0.712 . . . . 65.35 113.864 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -115.07 -28.07 7.11 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.044 0.45 . . . . 62.15 112.18 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 57.0 tp -106.22 146.55 30.15 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.15 -0.685 . . . . 74.1 109.15 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.438 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -138.81 162.05 35.72 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.914 -0.773 . . . . 64.13 108.914 176.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.437 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -83.52 120.69 26.24 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.012 0.434 . . . . 71.34 111.382 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 145.04 -12.28 1.87 Allowed Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.706 -0.679 . . . . 45.12 112.213 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -94.22 172.87 7.94 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 120.975 0.416 . . . . 72.24 112.026 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 544' ' ' VAL . 41.1 ttm180 -102.83 137.99 40.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.637 -0.71 . . . . 72.44 110.269 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.665 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -86.08 119.13 26.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.951 -0.568 . . . . 74.41 110.463 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 47.8 mm -98.65 -47.33 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.849 -0.16 . . . . 73.52 110.588 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.477 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 10.2 pt-20 -149.0 148.61 29.95 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.358 -0.608 . . . . 64.43 109.358 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.531 HG11 HD21 ' A' ' 519' ' ' LEU . 3.6 p -132.56 119.36 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.394 0 CA-C-O 121.975 0.893 . . . . 64.4 109.254 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.72 23.91 11.53 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 126.242 1.817 . . . . 75.31 111.959 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.28 -18.46 33.2 Favored Glycine 0 C--O 1.237 0.289 0 C-N-CA 120.491 -0.861 . . . . 74.45 113.953 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.7 t -96.85 134.49 34.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 109.772 -0.455 . . . . 64.34 109.772 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -84.35 143.1 29.7 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.656 -0.498 . . . . 70.42 109.656 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.665 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 18.4 mt -103.78 -39.67 6.56 Favored 'General case' 0 CA--C 1.482 -1.639 0 CA-C-N 115.432 -0.804 . . . . 73.41 112.257 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 35.4 t -74.61 90.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 121.811 0.815 . . . . 72.41 109.48 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 154.13 -28.61 0.72 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 108.289 -1.925 . . . . 70.22 108.289 -175.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.44 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -105.3 178.78 4.46 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.016 -0.592 . . . . 71.53 109.916 175.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' SER . . . . . 0.538 ' O ' HG21 ' A' ' 527' ' ' VAL . 60.7 p -95.84 164.33 12.78 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.501 0.556 . . . . 72.22 112.501 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.522 HE21 HD11 ' A' ' 488' ' ' ILE . 15.8 mm-40 -49.71 -43.23 47.41 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 124.705 1.202 . . . . 64.23 111.442 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.03 -35.74 82.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.408 0.623 . . . . 61.14 111.961 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.74 -37.25 76.4 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.644 -0.707 . . . . 75.34 109.522 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 523' ' ' SER . 32.3 t -70.2 -41.46 78.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.528 -0.76 . . . . 64.4 109.556 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.669 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 12.5 m -64.57 -44.42 96.8 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 C-N-CA 120.021 -0.672 . . . . 63.44 110.054 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 49.1 m -57.87 -40.29 79.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.485 0.659 . . . . 52.34 110.232 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 50.7 tp -63.11 -47.25 83.62 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 124.545 1.138 . . . . 74.11 109.879 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 35.1 tp -65.2 -44.22 89.07 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.861 -0.609 . . . . 64.25 110.574 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -62.3 -33.51 74.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.155 0.582 . . . . 63.21 110.851 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.6 m -75.53 -41.01 56.16 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.032 -0.531 . . . . 63.21 110.882 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' THR . . . . . 0.478 HG22 ' CG2' ' A' ' 540' ' ' VAL . 32.5 m 66.65 -92.91 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.266 0.627 . . . . 73.25 110.121 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt 170.48 171.86 0.07 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.19 -1.411 . . . . 74.11 107.19 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 26.1 ttt -65.63 -38.6 89.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 111.603 0.223 . . . . 75.23 111.603 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.58 -79.26 0.08 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.461 -0.336 . . . . 75.41 110.473 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 151.56 -21.47 0.93 Allowed Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 118.708 -1.71 . . . . 37.73 114.618 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 463' ' ' GLN . 3.0 m -94.83 125.24 39.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 118.433 1.117 . . . . 74.14 110.251 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 47.1 t -106.81 140.63 24.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.028 -0.987 . . . . 72.42 110.162 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.5 t -99.14 114.69 27.58 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.165 0.507 . . . . 74.22 109.815 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.425 HD21 HD23 ' A' ' 464' ' ' LEU . 3.4 mm? -101.77 122.33 43.74 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 124.538 1.135 . . . . 65.35 109.08 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 36.2 tp -104.98 118.97 37.87 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.376 -1.712 . . . . 72.54 106.376 174.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 36.0 m -115.03 145.55 20.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-O 121.179 0.514 . . . . 72.35 110.957 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 88.8 t80 -112.27 116.06 29.79 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.276 -0.875 . . . . 74.24 110.042 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . 0.573 ' O ' ' HA2' ' A' ' 457' ' ' GLY . 0.0 OUTLIER -101.57 118.19 36.45 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.478 -1.304 . . . . 55.45 107.478 175.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -89.36 121.27 31.45 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.231 -0.441 . . . . 63.15 111.317 -172.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 69.7 -177.49 0.21 Allowed 'General case' 0 N--CA 1.473 0.725 0 O-C-N 124.544 1.153 . . . . 72.13 110.4 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 C--N 1.305 -1.358 0 CA-C-O 118.856 -0.592 . . . . 65.44 109.783 179.072 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.762 0 N-CA-C 110.817 -0.913 . . . . 63.01 110.817 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 31.9 t -146.37 162.66 37.7 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.631 -0.877 . . . . 63.25 108.631 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -64.52 -51.18 64.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.308 0.575 . . . . 74.34 109.718 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -122.11 112.55 18.35 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.106 -1.442 . . . . 73.55 107.106 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 34.2 p -93.04 -73.18 0.57 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 112.086 0.402 . . . . 70.34 112.086 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -127.86 107.62 10.01 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.032 0.444 . . . . 75.42 110.487 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -89.14 126.06 35.3 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.004 -0.544 . . . . 74.1 111.162 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 11.7 tt -102.44 -41.62 8.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 120.963 0.411 . . . . 61.15 110.413 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -175.99 138.34 4.1 Favored Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 108.366 -1.894 . . . . 74.45 108.366 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -137.21 165.26 26.53 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 120.269 -0.573 . . . . 45.53 110.467 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -106.16 154.51 20.59 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.413 -1.328 . . . . 74.51 107.413 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.8 mm? -125.33 130.89 52.88 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 110.002 -0.37 . . . . 73.32 110.002 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -96.25 116.19 28.62 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.655 -0.868 . . . . 73.03 108.655 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . 0.486 HG23 ' CD2' ' A' ' 464' ' ' LEU . 68.6 mt -123.28 121.16 62.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 115.601 -0.727 . . . . 74.54 110.202 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.2 mt-30 -99.94 128.94 45.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.786 0.662 . . . . 74.44 112.786 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.506 HD11 ' O ' ' A' ' 498' ' ' ALA . 4.3 mm? -115.08 132.82 56.48 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-N 115.361 -0.836 . . . . 63.24 109.841 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.47 ' HE2' ' HB2' ' A' ' 465' ' ' LYS . 25.3 ttmm -101.17 131.9 46.91 Favored 'General case' 0 N--CA 1.394 -3.265 0 CA-C-O 121.936 0.874 . . . . 61.01 110.886 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.12 103.28 0.21 Allowed 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 113.146 -1.843 . . . . 73.13 111.485 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -136.5 137.05 8.78 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.781 -0.928 . . . . 74.32 110.781 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 73.2 m 63.24 -86.72 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.143 0.977 . . . . 62.32 112.642 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.74 -13.93 21.14 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.238 -1.023 . . . . 74.3 108.238 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 70.09 -155.82 53.24 Favored Glycine 0 C--O 1.202 -1.867 0 CA-C-O 117.946 -1.474 . . . . 71.03 109.707 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 6.3 mp -43.83 96.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.707 1.254 . . . . 72.12 113.706 -173.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -106.22 63.58 0.3 Allowed Glycine 0 N--CA 1.411 -3.007 0 CA-C-N 113.546 -1.661 . . . . 71.42 110.448 -174.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -156.66 142.0 17.44 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 107.265 -1.383 . . . . 74.14 107.265 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 12.1 p -115.79 163.61 15.59 Favored 'General case' 0 C--N 1.263 -3.165 0 O-C-N 123.617 0.573 . . . . 73.3 109.868 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 12.6 pt -114.35 154.75 15.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.368 0.604 . . . . 71.03 112.04 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.7 t -137.95 149.33 46.06 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.679 -0.86 . . . . 71.31 108.679 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.461 ' HB3' ' OE1' ' A' ' 524' ' ' GLN . 66.9 p -117.32 133.15 56.31 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.193 -0.669 . . . . 64.11 109.193 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -95.14 -74.26 0.56 Allowed 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.242 -0.983 . . . . 70.24 112.433 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -150.32 128.96 12.31 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.272 -0.422 . . . . 65.53 109.932 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.76 88.39 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-O 122.263 1.03 . . . . 73.43 113.056 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 481' ' ' THR . 89.0 m -108.44 13.1 25.73 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 123.38 1.562 . . . . 72.24 108.624 174.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 45.8 pt -116.06 171.5 5.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 114.17 -1.377 . . . . 73.33 108.766 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -87.18 66.58 3.49 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.667 -0.777 . . . . 38.5 111.872 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -158.8 -154.59 7.26 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 110.304 -1.118 . . . . 70.31 110.304 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 42.7 m -79.16 -40.26 31.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 117.231 0.516 . . . . 64.41 110.164 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -179.94 160.54 0.86 Allowed Pre-proline 0 C--N 1.332 -0.163 0 N-CA-C 107.484 -1.302 . . . . 61.03 107.484 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.41 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 1.0 OUTLIER -86.27 135.85 4.63 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 122.362 2.041 . . . . 54.43 109.673 174.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 519' ' ' LEU . 18.2 mm -91.09 124.46 43.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 115.921 -0.581 . . . . 73.12 109.976 -172.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 88.1 m-85 -125.61 163.0 23.72 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 109.975 -0.38 . . . . 71.14 109.975 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 40.2 t -89.16 119.83 36.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.851 -0.425 . . . . 51.41 109.851 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -70.81 -63.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.47 1.108 . . . . 74.31 110.358 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -151.45 160.19 43.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.931 -0.577 . . . . 74.13 109.911 -174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.497 HG12 ' HB1' ' A' ' 507' ' ' ALA . 44.7 mm -110.28 105.71 19.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.874 -1.158 . . . . 72.35 107.874 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -65.15 128.4 93.75 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.585 -0.734 . . . . 61.23 111.344 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.14 24.68 0.26 Allowed 'Trans proline' 0 N--CA 1.503 2.048 1 C-N-CA 125.334 4.023 . . . . 63.03 114.964 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -160.29 7.02 0.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 113.251 0.834 . . . . 65.23 113.251 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -99.8 -155.21 28.15 Favored Glycine 0 C--N 1.297 -1.631 0 C-N-CA 119.266 -1.445 . . . . 74.23 113.685 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . 0.506 ' O ' HD11 ' A' ' 464' ' ' LEU . . . -66.12 -37.66 86.26 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 123.37 0.668 . . . . 70.4 109.559 -176.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -57.72 -41.76 82.42 Favored 'General case' 0 C--O 1.195 -1.778 0 CA-C-N 115.126 -0.943 . . . . 64.31 112.053 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.3 tt -80.3 -29.36 12.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 120.943 0.401 . . . . 71.54 111.625 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.05 -48.37 80.32 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.228 1.011 . . . . 74.13 108.666 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.486 ' HB2' HD13 ' A' ' 464' ' ' LEU . 12.9 m-20 -93.68 -31.73 14.34 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 120.345 -0.542 . . . . 61.03 110.412 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.29 27.82 72.14 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.879 -0.6 . . . . 44.42 112.967 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.452 ' CG ' HG22 ' A' ' 462' ' ' ILE . 33.0 tpt180 -101.92 -19.35 15.3 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.75 0.31 . . . . 71.41 111.148 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . 0.419 ' HB2' HD22 ' A' ' 464' ' ' LEU . 52.7 tp -106.87 151.19 25.56 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.817 -0.438 . . . . 72.51 109.817 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.455 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -144.21 159.88 41.91 Favored 'General case' 0 N--CA 1.434 -1.258 0 O-C-N 123.176 0.298 . . . . 72.32 110.594 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.497 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -91.4 167.95 11.9 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.323 0.389 . . . . 71.32 111.773 -174.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.87 13.18 65.04 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.446 -0.797 . . . . 54.0 112.153 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -120.01 178.27 4.68 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 107.645 -1.243 . . . . 73.51 107.645 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.01 133.54 47.96 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-N 117.993 0.361 . . . . 74.14 110.646 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 21.4 tp -96.04 117.05 29.91 Favored 'General case' 0 N--CA 1.394 -3.251 0 N-CA-C 108.339 -0.986 . . . . 72.5 108.339 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 512' ' ' ILE . 1.9 mp -99.02 -35.19 4.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.121 0.486 . . . . 73.04 110.211 -177.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -150.34 144.78 25.73 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.716 -0.674 . . . . 72.15 110.551 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.459 HG11 HD21 ' A' ' 519' ' ' LEU . 2.6 p -135.03 123.35 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 N-CA-C 108.328 -0.99 . . . . 71.12 108.328 175.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 70.62 -66.22 0.3 Allowed 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 127.576 2.35 . . . . 71.42 111.231 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -174.02 29.64 0.09 OUTLIER Glycine 0 C--N 1.308 -0.994 0 N-CA-C 111.467 -0.653 . . . . 64.42 111.467 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.6 t -122.18 139.1 50.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 110.155 -0.313 . . . . 74.25 110.155 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -83.18 130.53 35.1 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.575 -0.898 . . . . 45.34 108.575 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.492 ' HB3' HG13 ' A' ' 488' ' ' ILE . 47.5 mt -100.89 -36.0 9.21 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.986 -0.552 . . . . 74.1 112.117 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.48 89.53 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 121.855 0.836 . . . . 74.25 110.205 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 147.95 -32.8 1.29 Allowed Glycine 0 N--CA 1.427 -1.94 0 CA-C-N 114.369 -1.287 . . . . 53.5 110.178 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.502 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -94.6 -177.63 4.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.407 0.521 . . . . 75.24 112.407 179.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' SER . . . . . 0.483 ' O ' HG21 ' A' ' 527' ' ' VAL . 5.0 m -95.24 156.11 16.46 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.909 -0.587 . . . . 75.32 111.244 -175.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.461 ' OE1' ' HB3' ' A' ' 477' ' ' SER . 8.1 mm100 -56.16 -46.36 79.34 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.808 0.843 . . . . 53.14 111.239 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.44 ' O ' HG23 ' A' ' 528' ' ' VAL . 1.1 mp0 -57.85 -31.86 67.09 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.127 0.489 . . . . 71.13 111.951 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -69.64 -37.24 76.69 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.967 -0.56 . . . . 52.02 110.037 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 523' ' ' SER . 17.6 t -75.93 -36.03 31.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.325 -0.852 . . . . 70.41 109.653 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.651 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.3 m -64.98 -40.61 89.65 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.267 0 C-N-CA 120.052 -0.659 . . . . 72.12 111.07 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.9 t -59.46 -44.98 92.86 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.652 0.739 . . . . 70.33 109.277 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 31.8 tp -60.4 -38.72 84.86 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 125.229 1.412 . . . . 72.43 110.398 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 16.6 tp -70.17 -48.63 56.43 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.484 -0.78 . . . . 63.42 109.959 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.651 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.8 OUTLIER -60.27 -44.56 95.21 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.767 0.827 . . . . 74.14 111.382 -176.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 33.7 t -69.23 -31.92 70.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.16 -0.473 . . . . 70.01 111.037 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 84.9 m 66.3 -87.03 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.926 0.49 . . . . 74.33 111.552 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? 165.58 158.26 0.03 OUTLIER 'General case' 0 C--O 1.244 0.774 0 N-CA-C 105.89 -1.893 . . . . 71.33 105.89 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 65.9 mtt -58.84 -50.3 74.49 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.206 0.316 . . . . 73.15 111.416 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -62.49 -65.49 0.68 Allowed 'General case' 0 C--O 1.24 0.576 0 N-CA-C 110.049 -0.352 . . . . 74.13 110.049 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 135.28 -14.3 4.28 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 118.353 -1.88 . . . . 64.4 116.072 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.4 m -94.38 128.11 40.7 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 118.904 1.352 . . . . 74.05 108.534 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 66.7 t -114.79 137.32 48.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 CA-C-N 115.816 -0.629 . . . . 71.54 110.393 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 54.8 m -91.88 113.94 26.35 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.187 0.518 . . . . 72.53 110.467 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.477 HD21 HD23 ' A' ' 464' ' ' LEU . 3.3 mm? -102.36 119.34 38.65 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.556 -0.905 . . . . 65.35 108.556 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 3.1 tm? -110.68 117.06 32.45 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 107.907 -1.146 . . . . 72.52 107.907 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 33.1 m -119.98 162.64 18.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 114.768 -1.105 . . . . 62.4 110.325 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -116.96 114.8 24.32 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 109.495 -0.557 . . . . 73.13 109.495 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -102.24 118.6 37.24 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 120.013 -0.675 . . . . 75.4 111.817 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -79.71 137.49 37.06 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.902 -1.518 . . . . 71.35 106.902 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -91.92 138.88 31.18 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 120.248 -0.581 . . . . 72.43 109.84 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 C--N 1.312 -1.035 0 CA-C-O 118.533 -0.746 . . . . 72.44 110.718 -178.94 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.807 0 N-CA-C 110.973 -0.851 . . . . 72.22 110.973 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 67.4 m -145.12 91.8 2.18 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.352 0.596 . . . . 71.32 111.048 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -107.12 128.01 54.0 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 115.558 -0.746 . . . . 75.31 109.375 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -114.24 91.27 3.57 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.317 -0.623 . . . . 53.42 109.317 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 50.0 m -121.37 114.03 20.73 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.399 -0.963 . . . . 75.33 108.399 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -68.39 105.77 2.28 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.358 0.599 . . . . 73.15 109.673 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -99.13 114.41 27.14 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 109.211 -0.663 . . . . 54.45 109.211 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.14 1.37 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.828 -1.545 . . . . 75.42 106.828 174.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 147.11 174.23 18.99 Favored Glycine 1 N--CA 1.386 -4.68 0 N-CA-C 106.796 -2.522 . . . . 71.21 106.796 -173.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -130.78 163.39 27.45 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-O 121.791 0.805 . . . . 70.03 112.874 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 98.3 mtt180 -107.89 131.66 54.28 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-N 113.427 -1.715 . . . . 75.51 106.505 170.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -120.98 133.27 55.27 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 109.486 -0.561 . . . . 64.34 109.486 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -93.09 115.2 27.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.492 0.663 . . . . 73.14 109.278 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . 0.44 HG22 ' HD3' ' A' ' 504' ' ' ARG . 59.7 mt -121.72 122.67 67.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.655 -0.702 . . . . 70.54 109.977 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 27.9 mt-30 -102.42 129.22 48.85 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.99 0.424 . . . . 74.43 111.901 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.423 ' CD2' HG23 ' A' ' 462' ' ' ILE . 3.1 mm? -115.09 135.52 54.11 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.542 0.737 . . . . 43.11 109.879 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.764 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.1 OUTLIER -98.89 137.07 37.99 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.993 -1.114 . . . . 55.31 107.993 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.411 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 36.9 ttmt -59.73 106.1 0.44 Allowed 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.377 -0.829 . . . . 73.01 110.655 174.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -92.67 -138.71 8.69 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.846 -0.901 . . . . 43.31 110.846 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 10.2 t -65.87 -46.55 78.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.859 0.329 . . . . 52.35 110.454 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -121.53 83.42 2.08 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 107.043 -1.466 . . . . 75.41 107.043 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.411 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . -58.63 140.87 46.94 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 120.356 -0.926 . . . . 74.42 113.594 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.507 HD12 HG22 ' A' ' 540' ' ' VAL . 18.2 mt 57.37 89.1 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 125.434 1.494 . . . . 74.41 112.166 -174.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -103.45 56.76 0.58 Allowed Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 114.72 -1.127 . . . . 50.23 111.213 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.578 ' CZ ' HD12 ' A' ' 542' ' ' LEU . 6.4 p90 -144.75 144.78 31.36 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.024 -0.732 . . . . 74.53 109.024 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.2 m -120.88 149.63 42.31 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.97 -1.122 . . . . 64.1 107.97 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 15.4 pt -109.85 155.27 11.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 112.895 0.702 . . . . 73.51 112.895 -175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 7.5 t -129.16 159.83 34.78 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.063 -1.088 . . . . 72.52 108.063 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 33.9 p -131.09 136.68 48.62 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 109.077 -0.712 . . . . 55.31 109.077 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . 0.405 ' HG2' ' CD2' ' A' ' 489' ' ' TYR . 34.5 mmt180 -91.8 -2.91 56.7 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.659 -0.416 . . . . 72.45 110.307 -177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 21.2 t70 70.44 148.9 0.08 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.592 1.157 . . . . 62.41 110.509 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 10.8 p -86.56 4.06 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.745 0.784 . . . . 75.33 110.499 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . 0.267 73.8 p 63.4 85.64 0.13 Allowed 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 125.457 1.503 . . . . 53.12 112.026 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 65.1 mt 71.28 86.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 114.243 -1.344 . . . . 71.02 109.687 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 161.61 -156.36 27.83 Favored Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 114.77 -1.105 . . . . 64.1 110.434 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -136.49 -177.45 15.02 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.643 -0.789 . . . . 60.44 112.281 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 45.0 m 74.79 -61.06 0.5 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.13 1.372 . . . . 75.34 111.989 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 69.36 147.12 0.11 Allowed Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 124.367 1.067 . . . . 75.41 113.399 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.7 135.33 23.62 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 121.911 1.741 . . . . 60.21 110.027 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 48.3 mm -102.62 136.16 36.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.983 -0.553 . . . . 72.41 110.298 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 95.6 m-85 -134.82 162.48 32.25 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.326 -0.62 . . . . 75.53 109.326 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 23.2 t -82.23 122.89 37.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 109.141 -0.689 . . . . 61.25 109.141 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -89.87 -55.27 3.69 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.817 -0.628 . . . . 75.2 110.674 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -146.48 151.02 36.72 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.191 -0.67 . . . . 64.12 109.191 -175.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.517 HG12 ' HB1' ' A' ' 507' ' ' ALA . 35.3 mm -111.2 110.98 34.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.002 -1.11 . . . . 63.34 108.002 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 496' ' ' ARG . 3.1 mm? -62.24 123.52 78.65 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 115.775 -0.648 . . . . 64.45 109.298 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.02 22.19 0.15 Allowed 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.945 3.763 . . . . 75.33 114.836 -171.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 494' ' ' LEU . 32.8 ptt180 -160.07 -2.98 0.07 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.819 0.674 . . . . 75.11 112.819 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.59 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -84.55 -167.97 43.61 Favored Glycine 0 C--O 1.216 -0.971 0 C-N-CA 119.788 -1.196 . . . . 44.41 112.515 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -57.11 -34.77 68.69 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.014 0.907 . . . . 53.13 111.759 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.79 86.14 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.61 -0.723 . . . . 74.04 112.261 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 500' ' ' ILE . 8.8 tt -79.03 -31.3 14.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 O-C-N 123.233 0.333 . . . . 63.4 111.388 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 71.1 mm-40 -62.39 -43.28 99.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.763 -0.458 . . . . 73.14 109.763 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.4 ' HB2' HD13 ' A' ' 464' ' ' LEU . 11.0 t70 -82.77 -41.64 18.93 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.865 -1.531 . . . . 73.32 106.865 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.56 -7.52 76.1 Favored Glycine 0 N--CA 1.426 -1.973 0 CA-C-N 115.372 -0.831 . . . . 75.23 115.118 174.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.44 ' HD3' HG22 ' A' ' 462' ' ' ILE . 73.4 ttt180 -85.83 -19.16 31.06 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 120.974 0.416 . . . . 71.13 111.727 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 62.1 tp -101.19 130.48 47.29 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.091 -0.337 . . . . 73.32 110.091 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.5 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -134.83 171.77 13.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.657 0.265 . . . . 74.02 111.448 176.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.517 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -96.82 130.8 44.03 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.35 -0.386 . . . . 73.33 111.107 -176.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 144.13 -23.27 2.08 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.659 -0.701 . . . . 61.44 111.465 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -93.29 172.23 8.42 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-O 120.942 0.401 . . . . 74.33 111.099 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.415 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 35.0 ttt180 -93.75 138.75 31.61 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.679 -0.692 . . . . 74.34 110.308 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -89.77 127.96 36.05 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 105.892 -1.892 . . . . 73.15 105.892 177.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.474 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.0 mm -96.16 -50.78 11.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.861 -0.524 . . . . 74.32 109.97 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -157.54 145.76 19.14 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.694 -0.685 . . . . 75.44 109.267 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.04 130.37 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.308 0 CA-C-O 121.359 0.599 . . . . 74.45 109.69 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 62.05 20.08 11.32 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 126.208 1.803 . . . . 73.3 111.389 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 95.47 2.09 61.94 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.78 -0.724 . . . . 63.31 113.473 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.99 138.21 38.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.639 -0.504 . . . . 74.24 109.639 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -84.35 148.22 26.75 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 123.571 0.544 . . . . 75.02 110.036 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 28.1 mt -90.48 -50.98 5.64 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.773 -0.649 . . . . 55.51 112.003 -173.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.12 86.32 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 122.623 1.202 . . . . 75.51 111.305 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 166.2 -24.34 0.14 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 108.278 -1.929 . . . . 44.14 108.278 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.523 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -117.58 172.49 7.31 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.793 -0.817 . . . . 74.31 108.793 175.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 42.4 m -91.88 165.15 13.39 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 110.256 -0.275 . . . . 72.42 110.256 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -53.96 -44.97 71.18 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.572 0.749 . . . . 73.0 111.847 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 528' ' ' VAL . 39.4 mt-10 -61.58 -31.55 71.61 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 112.463 0.542 . . . . 75.53 112.463 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.75 -34.01 69.15 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.291 -0.633 . . . . 71.34 109.291 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 47.6 t -70.45 -38.22 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.559 -0.746 . . . . 75.42 109.372 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.707 ' O ' ' HG3' ' A' ' 532' ' ' ARG . 19.9 m -69.57 -36.64 71.9 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.893 0 C-N-CA 119.099 -1.04 . . . . 73.42 110.676 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.8 t -59.28 -44.11 92.49 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 109.226 -0.657 . . . . 65.53 109.226 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 34.4 tp -58.82 -41.9 87.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.843 1.257 . . . . 75.22 109.594 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.487 ' O ' HD11 ' A' ' 471' ' ' LEU . 3.2 tt -64.98 -48.05 75.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.323 -0.853 . . . . 63.53 111.944 174.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' A' ' 528' ' ' VAL . 23.0 mtm180 -61.41 -31.11 71.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.49 -0.323 . . . . 62.5 110.837 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 535' ' ' LYS . 48.5 t -65.56 -44.43 86.79 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.253 -0.431 . . . . 53.41 110.006 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 24.6 m 63.85 -2.88 0.49 Allowed 'General case' 0 CA--C 1.578 2.026 0 C-N-CA 123.797 0.839 . . . . 72.11 112.812 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . 0.624 ' HE3' ' OE1' ' A' ' 537' ' ' GLU . 61.6 tttp 70.13 146.4 0.06 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.215 1.006 . . . . 62.23 111.912 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 46.7 ttm -63.3 -32.37 73.77 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 116.569 2.062 . . . . 51.2 116.569 -167.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . 0.624 ' OE1' ' HE3' ' A' ' 535' ' ' LYS . 0.0 OUTLIER -78.24 -28.24 47.76 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 118.021 -1.472 . . . . 70.33 108.782 178.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 99.86 30.98 6.18 Favored Glycine 0 N--CA 1.415 -2.733 0 CA-C-N 114.771 -1.104 . . . . 54.02 113.613 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 4.0 m -128.58 132.22 48.2 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.034 -1.099 . . . . 61.54 108.034 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.507 HG22 HD12 ' A' ' 471' ' ' LEU . 61.5 t -120.07 134.34 63.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 116.178 -0.465 . . . . 73.13 111.239 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.7 m -91.76 114.4 26.93 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.199 -0.91 . . . . 72.13 110.047 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.578 HD12 ' CZ ' ' A' ' 473' ' ' PHE . 3.2 mm? -104.04 121.24 42.77 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.744 -1.206 . . . . 73.21 107.744 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 41.8 tp -104.51 117.92 35.32 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.252 -1.759 . . . . 74.02 106.252 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 35.3 m -115.31 148.47 18.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 C-N-CA 120.503 -0.479 . . . . 54.23 110.827 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -111.97 122.32 47.44 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.829 -0.623 . . . . 74.22 109.655 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -122.13 124.76 44.65 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 114.59 -1.186 . . . . 63.31 109.436 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -79.21 133.71 36.69 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.594 -0.73 . . . . 75.32 109.596 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -134.34 127.67 32.16 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.177 -0.465 . . . . 72.31 109.875 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 C--N 1.304 -1.408 0 N-CA-C 108.891 -0.781 . . . . 52.35 108.891 179.733 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.935 0 N-CA-C 110.833 -0.907 . . . . 60.34 110.833 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 47.5 m -127.78 124.03 36.68 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.513 -0.551 . . . . 61.02 109.513 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -76.06 -31.17 58.67 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.106 -1.072 . . . . 72.13 108.106 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -109.78 100.94 9.86 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.414 -1.266 . . . . 71.31 108.409 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 27.9 m -97.09 114.62 26.3 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.527 -0.916 . . . . 71.35 108.527 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -131.74 88.27 2.55 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 113.956 1.095 . . . . 64.34 113.956 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -123.1 157.86 31.92 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 104.254 -2.498 . . . . 74.01 104.254 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 548' ' ' GLU . 26.3 pt -84.13 74.93 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 118.031 -1.468 . . . . 64.03 110.343 175.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 143.05 139.27 3.54 Favored Glycine 0 N--CA 1.419 -2.491 0 CA-C-N 113.726 -1.579 . . . . 51.32 109.693 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -122.82 160.63 25.63 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.28 -1.007 . . . . 65.44 108.28 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -100.67 145.57 28.27 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 110.005 -0.368 . . . . 73.41 110.005 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.0 mm? -124.12 131.91 53.59 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.124 -0.695 . . . . 72.43 109.124 -174.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -104.89 115.27 30.0 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.655 0.74 . . . . 70.11 109.093 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 50.0 mt -122.51 142.6 38.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 115.318 -0.855 . . . . 73.15 110.506 -171.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 43.5 mt-30 -114.99 128.24 56.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.901 0.381 . . . . 74.2 111.279 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 539' ' ' THR . 6.3 mp -119.04 152.47 36.38 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.108 0.963 . . . . 71.45 111.885 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -115.81 129.04 56.28 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.323 -0.992 . . . . 75.11 108.323 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.54 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 23.8 ttmm -60.81 88.01 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.419 0.628 . . . . 72.23 112.044 176.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -90.45 -128.47 3.81 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.63 -0.714 . . . . 73.3 112.277 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' THR . . . . . 0.707 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 17.1 m -48.99 -72.73 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.322 1.049 . . . . 74.12 111.507 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . 0.459 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 46.1 mm-40 -82.36 -38.54 24.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.245 -1.391 . . . . 72.14 107.245 171.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.54 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . 65.78 109.09 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.179 -1.373 . . . . 70.31 112.096 -174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.596 ' H ' ' CB ' ' A' ' 498' ' ' ALA . 33.9 mt 69.16 85.51 0.14 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 125.64 1.576 . . . . 71.3 108.076 -168.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . 0.452 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . -103.18 56.76 0.59 Allowed Glycine 0 CA--C 1.471 -2.698 0 CA-C-N 114.393 -1.276 . . . . 45.3 112.151 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 2.9 p90 -147.72 142.94 27.21 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.01 0.433 . . . . 73.11 110.253 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 19.9 m -114.69 145.2 42.32 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 107.237 -1.394 . . . . 72.33 107.237 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.86 153.94 14.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 112.812 0.671 . . . . 63.34 112.812 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' THR . . . . . 0.526 ' HB ' ' HE3' ' A' ' 491' ' ' LYS . 8.2 t -143.33 149.43 37.76 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.119 -0.946 . . . . 65.44 109.563 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 21.4 p -106.31 132.07 52.79 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 108.092 -1.077 . . . . 72.22 108.092 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -122.53 -176.02 3.28 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 121.015 0.436 . . . . 71.14 111.764 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -46.47 109.14 0.17 Allowed 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 125.999 1.719 . . . . 43.03 112.359 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 482' ' ' ILE . 34.7 m -50.59 138.34 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.555 -1.202 . . . . 63.4 112.723 177.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.9 t -121.41 16.05 11.31 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.388 -1.708 . . . . 65.1 106.388 174.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.431 ' O ' ' HB ' ' A' ' 480' ' ' VAL . 10.4 tt -150.77 155.68 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 N-CA-C 105.95 -1.87 . . . . 73.24 105.95 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -67.87 109.6 2.99 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.634 -0.793 . . . . 44.4 111.24 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 78.53 -151.23 35.87 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 110.657 -0.977 . . . . 74.33 110.657 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 42.6 t 72.0 -61.02 0.51 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.099 0.96 . . . . 73.43 112.386 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . 0.404 ' HA ' HG11 ' A' ' 480' ' ' VAL . . . 59.73 90.74 0.09 OUTLIER Pre-proline 0 C--O 1.243 0.727 0 N-CA-C 108.663 -0.866 . . . . 36.18 108.663 -172.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.493 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 43.5 Cg_exo -54.93 135.4 68.18 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.942 2.428 . . . . 74.33 113.285 -174.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.421 HG13 ' HB3' ' A' ' 519' ' ' LEU . 38.9 mm -87.98 120.82 37.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.963 -1.017 . . . . 71.12 108.883 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.493 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 66.3 m-85 -120.51 150.47 40.79 Favored 'General case' 0 CA--C 1.483 -1.613 0 CA-C-O 120.804 0.335 . . . . 74.01 111.897 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.43 119.42 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 107.185 -1.413 . . . . 72.14 107.185 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.526 ' HE3' ' HB ' ' A' ' 476' ' ' THR . 41.0 ttmt -87.87 -53.82 4.56 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.312 0.577 . . . . 61.42 111.078 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 61.5 t30 -142.04 149.68 40.27 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.287 -0.87 . . . . 71.0 110.446 -171.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.507 HG12 ' HB1' ' A' ' 507' ' ' ALA . 32.2 mm -115.87 106.54 20.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 124.149 0.906 . . . . 74.13 109.26 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.442 ' C ' ' H ' ' A' ' 496' ' ' ARG . 3.5 mm? -53.09 131.11 50.47 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.551 -0.749 . . . . 74.55 111.069 176.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -70.01 15.15 0.25 Allowed 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 124.557 3.505 . . . . 74.31 114.095 -173.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.707 ' O ' ' HB ' ' A' ' 468' ' ' THR . 12.1 ptt180 -164.35 12.68 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.109 0.957 . . . . 74.41 111.097 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.459 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . -84.83 -174.84 50.52 Favored Glycine 0 C--N 1.286 -2.209 0 C-N-CA 120.013 -1.089 . . . . 60.23 111.565 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . 0.596 ' CB ' ' H ' ' A' ' 471' ' ' LEU . . . -62.21 -28.12 69.46 Favored 'General case' 0 C--O 1.198 -1.633 0 CA-C-N 117.999 0.9 . . . . 72.34 110.934 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.62 87.81 Favored 'General case' 0 C--O 1.204 -1.302 0 CA-C-N 116.069 -0.514 . . . . 53.03 111.697 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 500' ' ' ILE . 11.4 tt -79.84 -36.99 17.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.877 0.37 . . . . 73.14 111.546 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 9.1 mm-40 -66.85 -39.94 87.76 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.69 -0.686 . . . . 62.11 110.219 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -92.45 -22.66 19.49 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.594 -0.73 . . . . 71.33 111.455 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.87 -57.36 5.01 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 116.647 1.419 . . . . 43.44 116.647 171.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -46.13 -30.8 2.06 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.519 1.674 . . . . 73.51 115.519 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 59.4 tp -98.02 132.05 43.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 117.824 0.284 . . . . 71.22 111.173 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.432 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -143.91 164.89 29.26 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 121.046 -0.261 . . . . 72.24 110.963 174.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.507 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -83.7 98.8 9.85 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.266 0.555 . . . . 71.35 111.963 -174.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 174.1 29.38 0.03 OUTLIER Glycine 0 C--N 1.304 -1.228 0 N-CA-C 111.107 -0.797 . . . . 51.24 111.107 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -148.18 177.79 9.1 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 120.748 0.309 . . . . 74.42 110.979 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -106.82 129.25 54.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.527 -0.76 . . . . 72.41 109.43 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 28.2 tp -83.46 120.77 26.32 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 107.957 -1.127 . . . . 74.21 107.957 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.462 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 49.1 mm -97.93 -45.84 12.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 120.911 0.386 . . . . 71.22 111.129 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.465 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 10.2 pt-20 -154.02 146.02 23.6 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.123 -0.49 . . . . 72.33 110.145 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 541' ' ' SER . 2.6 p -130.65 129.13 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.458 0 N-CA-C 107.401 -1.333 . . . . 71.14 107.401 176.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 10.6 m120 68.01 4.8 4.22 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.82 0.848 . . . . 74.33 112.667 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 104.56 -6.96 45.68 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 121.065 -0.588 . . . . 53.55 112.075 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.3 t -87.14 125.75 40.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.776 -0.453 . . . . 72.2 109.776 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -79.75 134.25 36.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.982 -0.554 . . . . 73.15 110.512 -176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 17.3 mt -98.63 -22.87 15.71 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.864 -0.607 . . . . 60.22 110.658 -174.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.31 9.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 125.413 1.485 . . . . 63.42 113.84 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -144.05 18.45 2.14 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 110.875 -0.89 . . . . 44.54 110.875 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.516 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -144.5 174.6 10.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.466 0.543 . . . . 75.22 112.466 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' SER . . . . . 0.422 ' O ' HG21 ' A' ' 527' ' ' VAL . 32.4 m -93.34 159.8 15.1 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.757 -0.656 . . . . 75.34 112.731 -175.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.5 ' O ' HG12 ' A' ' 528' ' ' VAL . 36.9 mm-40 -50.19 -47.68 54.47 Favored 'General case' 0 C--O 1.209 -1.046 0 C-N-CA 124.472 1.109 . . . . 73.11 113.626 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 525' ' ' GLU . 4.1 mp0 -59.1 -34.28 71.82 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.235 0.54 . . . . 75.22 111.185 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.85 -39.2 83.82 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.673 -0.694 . . . . 65.42 109.73 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 523' ' ' SER . 15.2 t -75.48 -36.78 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 115.571 -0.74 . . . . 74.44 109.762 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.649 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 7.5 m -66.11 -42.55 91.58 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.049 0 C-N-CA 120.214 -0.595 . . . . 50.21 110.127 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 29.7 m -59.57 -44.05 93.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.454 0.645 . . . . 74.12 109.84 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 25.2 tp -58.32 -46.55 85.94 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 124.916 1.287 . . . . 74.2 109.658 176.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 471' ' ' LEU . 30.2 tp -62.9 -48.39 79.16 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.522 -0.763 . . . . 72.44 110.533 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.649 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 29.7 mmm180 -60.97 -38.27 85.33 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.87 -0.604 . . . . 61.14 110.908 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 22.4 m -70.94 -40.49 72.0 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 115.986 -0.552 . . . . 74.04 110.226 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' THR . . . . . 0.462 HG21 ' HE2' ' A' ' 466' ' ' LYS . 61.9 m 69.72 -84.47 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.882 0.873 . . . . 71.5 111.577 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt 174.45 167.96 0.24 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.948 -1.501 . . . . 71.33 106.948 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 88.2 mtp -59.49 -51.22 70.8 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.398 0.888 . . . . 64.32 113.398 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.81 -64.65 1.13 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.503 -0.879 . . . . 55.13 109.307 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 150.19 18.07 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 118.721 -1.704 . . . . 43.54 115.691 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.1 m -100.22 130.36 46.34 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 119.036 1.418 . . . . 70.12 108.373 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 51.9 t -124.0 135.52 63.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 112.154 0.427 . . . . 65.33 112.154 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 42.9 m -94.18 115.24 27.5 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.073 -0.967 . . . . 74.32 110.289 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.57 121.21 44.18 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.091 -1.078 . . . . 72.32 108.091 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 2.8 tm? -110.0 116.48 31.66 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 105.854 -1.906 . . . . 73.42 105.854 174.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 34.8 m -118.25 157.79 19.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 115.057 -0.974 . . . . 71.12 111.206 -174.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -123.6 116.36 22.99 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.915 -0.584 . . . . 64.24 109.988 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -109.23 125.65 52.47 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.332 -0.988 . . . . 71.31 108.332 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -85.39 128.71 34.81 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.255 0.55 . . . . 70.13 110.374 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . 0.423 ' O ' ' HB ' ' A' ' 456' ' ' ILE . 46.1 mt-10 -100.78 88.61 3.62 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.765 -0.828 . . . . 62.04 108.765 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--N 1.303 -1.445 0 CA-C-N 115.1 -0.955 . . . . 63.53 108.733 -175.628 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.754 0 N-CA-C 111.261 -0.736 . . . . 37.27 111.261 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 23.6 p -105.85 -68.66 0.86 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.155 0.502 . . . . 73.11 110.189 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -130.49 84.02 2.17 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.662 0.744 . . . . 73.33 110.423 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -88.87 -55.49 3.67 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.174 -1.375 . . . . 73.23 111.44 -175.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 38.8 p -94.47 117.34 29.97 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 112.66 0.615 . . . . 73.41 112.66 -174.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 454' ' ' LYS . 3.9 mptp? -95.34 99.65 11.55 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.856 -0.794 . . . . 73.04 108.856 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -85.73 168.4 14.39 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.912 -0.403 . . . . 63.12 109.912 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 57.9 mt -74.64 98.88 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 108.343 -0.984 . . . . 72.12 108.343 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 143.1 116.13 1.13 Allowed Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 108.68 -1.768 . . . . 65.23 108.68 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 29.1 mtpp -89.17 156.81 18.56 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.3 0.571 . . . . 73.13 111.963 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 94.3 mtt180 -118.6 126.09 51.21 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.069 -1.826 . . . . 75.25 106.069 170.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.9 mp -124.74 136.76 54.15 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 116.468 -0.333 . . . . 72.11 110.934 -175.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -99.6 115.14 28.7 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 123.988 0.805 . . . . 64.12 108.956 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 55.4 mt -121.85 142.69 37.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.685 -0.857 . . . . 71.31 108.685 -176.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.408 ' HB3' HG22 ' A' ' 539' ' ' THR . 76.5 mt-30 -117.3 127.06 53.7 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.424 0.527 . . . . 64.52 112.424 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.57 133.19 56.27 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 124.46 1.104 . . . . 73.44 109.586 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 465' ' ' LYS . 37.4 ttpt -108.15 136.35 47.97 Favored 'General case' 0 N--CA 1.401 -2.897 0 N-CA-C 108.815 -0.809 . . . . 62.45 108.815 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.405 ' CD ' HG21 ' A' ' 534' ' ' THR . 48.8 mtmt -54.7 99.3 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 124.066 0.854 . . . . 71.41 111.506 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -131.19 136.82 9.04 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.696 -0.962 . . . . 51.43 110.696 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 64.5 m 63.1 -88.13 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.235 1.014 . . . . 73.05 111.446 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -98.01 -5.73 33.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.556 0.693 . . . . 64.15 109.364 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 69.17 -154.61 53.32 Favored Glycine 0 CA--C 1.486 -1.767 0 CA-C-O 118.109 -1.384 . . . . 73.42 110.842 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.439 HD12 HG22 ' A' ' 540' ' ' VAL . 48.1 mt -43.76 101.52 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.425 1.112 . . . . 60.42 112.348 -173.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -111.98 56.26 0.47 Allowed Glycine 0 CA--C 1.477 -2.282 0 CA-C-N 114.739 -1.119 . . . . 62.24 112.329 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.586 ' CZ ' HD12 ' A' ' 542' ' ' LEU . 5.3 p90 -144.45 142.12 30.07 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.055 -1.091 . . . . 75.03 108.055 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 28.9 p -116.57 162.36 17.74 Favored 'General case' 0 C--N 1.272 -2.797 0 N-CA-C 108.44 -0.948 . . . . 74.12 108.44 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.28 159.39 35.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.316 0.579 . . . . 74.3 111.505 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.8 t -148.12 153.73 39.24 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.358 -1.719 . . . . 62.42 106.358 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 34.8 p -106.22 140.14 39.63 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.595 -0.891 . . . . 74.52 108.595 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.55 -93.15 0.49 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 114.61 1.337 . . . . 72.54 114.61 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -87.56 76.43 8.94 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.397 -0.921 . . . . 70.34 113.142 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.43 137.97 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 114.569 -1.196 . . . . 74.42 110.271 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 23.7 p -97.18 153.96 17.67 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.85 -0.796 . . . . 73.51 108.85 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 24.2 pt -63.74 110.16 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.353 0.597 . . . . 72.44 110.103 176.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 157.63 -41.48 0.53 Allowed Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 110.779 -0.929 . . . . 37.27 110.779 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 135.4 -17.63 4.0 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.018 -1.087 . . . . 53.03 111.378 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 45.7 m -82.49 85.81 6.88 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 122.144 0.973 . . . . 74.05 112.828 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -84.69 116.3 64.61 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 113.932 -1.485 . . . . 73.22 108.782 171.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.97 135.43 44.11 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 122.127 1.885 . . . . 52.13 110.957 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 43.1 mm -93.74 130.64 42.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.644 -0.707 . . . . 71.14 109.235 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -127.51 153.46 46.31 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.255 0.222 . . . . 75.13 110.474 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 28.2 t -73.36 122.72 26.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.572 -0.899 . . . . 73.51 108.572 177.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -80.68 -62.26 1.72 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.437 -0.579 . . . . 72.14 109.437 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -143.05 163.71 32.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.368 -0.975 . . . . 71.41 108.368 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.428 HG13 ' HA ' ' A' ' 506' ' ' LYS . 26.4 mm -123.42 110.16 25.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 124.805 1.242 . . . . 61.3 108.445 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.02 125.4 73.97 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.217 -0.901 . . . . 72.34 110.633 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.28 21.33 0.23 Allowed 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 124.895 3.73 . . . . 71.42 114.6 -172.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -165.35 7.25 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.241 0.543 . . . . 75.02 112.424 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.445 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -89.48 -161.79 37.82 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 120.18 -1.009 . . . . 37.27 112.782 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -61.61 -39.84 92.69 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 123.817 0.847 . . . . 61.14 109.968 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.65 -41.4 81.39 Favored 'General case' 0 C--O 1.201 -1.461 0 CA-C-N 114.625 -1.171 . . . . 70.02 112.696 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.1 tt -79.48 -31.02 13.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 111.628 0.233 . . . . 72.12 111.628 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 30.9 mm-40 -59.71 -43.15 94.23 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.167 0.508 . . . . 61.14 109.65 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.42 -50.93 7.34 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.787 -0.642 . . . . 70.25 110.385 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 101.2 -36.09 4.44 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.044 -1.55 . . . . 37.27 116.235 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -65.87 -32.83 74.56 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.564 0.682 . . . . 64.53 112.232 -173.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 61.7 tp -84.44 102.7 12.99 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.921 -0.581 . . . . 73.45 110.508 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.428 ' HA ' HG13 ' A' ' 493' ' ' ILE . 10.3 ptmm? -113.69 177.0 4.79 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.181 -0.463 . . . . 74.14 111.52 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.44 ' HA ' ' CG1' ' A' ' 490' ' ' VAL . . . -87.43 147.52 25.39 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.997 -0.547 . . . . 62.43 110.371 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 110.11 -27.19 12.12 Favored Glycine 0 C--N 1.311 -0.852 0 C-N-CA 120.702 -0.761 . . . . 61.21 112.775 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -79.98 163.22 24.42 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 120.62 0.248 . . . . 62.4 110.945 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.496 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 31.6 ttm180 -96.8 142.5 28.73 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-O 120.796 0.331 . . . . 71.21 111.48 -178.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.687 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -90.54 126.96 36.1 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.902 0.881 . . . . 72.14 111.288 175.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.465 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 33.4 mt -103.33 -45.68 10.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.156 -0.683 . . . . 73.33 109.156 173.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.501 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 0.5 OUTLIER -150.96 155.15 38.5 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 109.716 -0.476 . . . . 73.33 109.716 176.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 541' ' ' SER . 7.1 p -143.3 130.58 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 O-C-N 123.827 0.705 . . . . 61.03 109.232 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . 0.458 HD22 ' HG2' ' A' ' 535' ' ' LYS . 1.4 t-20 64.78 15.42 9.8 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 125.918 1.687 . . . . 73.31 112.521 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 100.37 7.67 51.33 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.499 -0.858 . . . . 37.27 113.578 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 57.9 t -121.1 142.93 35.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 117.2 0.5 . . . . 63.45 110.415 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -73.96 144.5 45.21 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.472 0.709 . . . . 72.35 110.138 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.687 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 15.2 mt -108.43 -42.79 4.48 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.677 -0.409 . . . . 73.44 112.0 -175.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.34 -26.95 37.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 116.054 -0.521 . . . . 72.04 111.373 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -78.55 -18.52 75.56 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.747 -0.739 . . . . 63.55 112.416 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.451 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -110.62 -175.55 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.328 -0.513 . . . . 73.32 111.802 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' SER . . . . . 0.42 ' O ' HG21 ' A' ' 527' ' ' VAL . 11.3 m -87.32 158.75 18.98 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.901 -0.591 . . . . 71.43 111.183 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -59.71 -47.71 84.55 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.854 1.262 . . . . 71.31 109.843 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.476 ' O ' HG23 ' A' ' 528' ' ' VAL . 47.1 mt-10 -68.5 -30.36 69.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.694 0.998 . . . . 74.12 113.694 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.43 ' CB ' ' HD3' ' A' ' 522' ' ' LYS . 49.4 mt-10 -59.98 -37.59 80.08 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.515 -0.55 . . . . 60.23 109.515 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.429 HG13 HD23 ' A' ' 519' ' ' LEU . 43.4 t -65.64 -36.92 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.74 -0.663 . . . . 73.13 110.276 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.663 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 25.0 m -70.53 -39.09 75.74 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 C-N-CA 118.977 -1.089 . . . . 74.33 110.403 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 37.4 t -61.29 -37.41 83.09 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.017 -0.538 . . . . 42.23 109.873 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 33.7 tp -64.14 -42.52 96.75 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.876 1.27 . . . . 60.32 109.951 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 tt -64.7 -44.15 91.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.337 -0.847 . . . . 73.15 111.928 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 31.3 mmm180 -64.63 -27.08 68.69 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.054 -0.521 . . . . 75.11 112.055 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 23.2 p -82.53 -45.84 14.15 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 113.447 0.906 . . . . 72.32 113.447 -176.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' THR . . . . . 0.405 HG21 ' CD ' ' A' ' 466' ' ' LYS . 88.4 m 59.4 133.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.296 0.57 . . . . 72.02 112.466 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . 0.458 ' HG2' HD22 ' A' ' 515' ' ' ASN . 18.2 ptpt -64.96 152.56 42.96 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.053 -1.029 . . . . 62.43 109.68 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 50.9 ttm -54.76 -32.23 59.65 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 123.473 0.709 . . . . 71.31 112.784 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.56 -15.89 53.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.649 0.611 . . . . 74.2 112.649 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 85.93 -20.35 20.69 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.666 -0.778 . . . . 43.25 113.923 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 463' ' ' GLN . 3.9 m -104.09 129.07 51.76 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.48 0.657 . . . . 64.31 109.756 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.439 HG22 HD12 ' A' ' 471' ' ' LEU . 77.1 t -111.68 141.77 26.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.935 -1.029 . . . . 65.13 110.83 -176.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 34.3 t -91.15 132.95 35.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.743 -0.662 . . . . 71.53 109.444 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.586 HD12 ' CZ ' ' A' ' 473' ' ' PHE . 3.7 mm? -120.77 118.57 30.36 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.692 -1.225 . . . . 74.41 107.692 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.495 ' CB ' ' HG3' ' A' ' 513' ' ' GLU . 51.1 tp -104.63 117.66 34.67 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 105.213 -2.143 . . . . 71.44 105.213 172.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 28.6 m -115.98 151.78 17.73 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.135 0 C-N-CA 120.233 -0.587 . . . . 73.34 111.143 -176.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 85.6 t80 -110.92 116.14 30.7 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.68 -1.97 . . . . 74.12 105.68 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -115.87 118.42 32.93 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.865 -0.791 . . . . 72.4 108.865 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.69 122.89 33.85 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 105.82 -1.919 . . . . 71.41 105.82 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -80.08 121.09 25.1 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.569 -0.287 . . . . 72.14 110.747 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 . . . . . 0 C--O 1.245 0.841 0 C-N-CA 123.886 0.874 . . . . 52.0 110.559 -179.113 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.765 0 N-CA-C 111.24 -0.744 . . . . 55.11 111.24 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 29.9 p -93.02 125.69 37.74 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.155 0.502 . . . . 71.22 111.941 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -100.35 -3.42 31.22 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.148 -0.478 . . . . 73.34 110.386 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -78.63 155.42 29.57 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.004 0.431 . . . . 72.41 110.527 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 88.1 m -147.17 100.61 3.31 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.573 -0.528 . . . . 75.33 109.573 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -79.31 98.57 6.74 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 108.99 -0.744 . . . . 65.32 108.99 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -98.84 130.36 45.25 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.639 -1.164 . . . . 72.34 109.978 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . 0.515 ' O ' HD12 ' A' ' 456' ' ' ILE . 2.6 pp -83.53 126.01 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-O 121.279 0.562 . . . . 75.43 109.675 173.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 98.12 65.63 0.88 Allowed Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 108.368 -1.893 . . . . 64.41 108.368 -173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -87.66 137.14 32.59 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 113.786 1.032 . . . . 74.35 113.786 -175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 89.2 mtm180 -105.81 138.66 41.63 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 113.743 -1.571 . . . . 71.23 107.395 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 6.0 mp -123.4 128.24 49.58 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 120.989 0.424 . . . . 72.1 110.705 -177.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -96.27 116.26 28.73 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.042 -0.981 . . . . 72.53 109.787 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 53.6 mt -123.67 144.21 34.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 114.783 -1.099 . . . . 60.32 110.414 -172.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.3 mt-30 -119.98 129.99 54.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.594 0.59 . . . . 53.24 112.594 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' A' ' 502' ' ' ASP . 3.8 mm? -116.85 153.03 33.23 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 124.962 1.305 . . . . 74.24 110.189 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.464 ' HB3' ' HE3' ' A' ' 465' ' ' LYS . 17.6 ttpp -113.16 129.34 56.54 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 108.159 -1.052 . . . . 64.24 108.159 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -60.24 102.91 0.19 Allowed 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.547 -0.751 . . . . 73.23 109.664 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -146.16 150.45 22.69 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.369 -0.692 . . . . 44.32 111.369 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 50.1 m 65.21 -78.56 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.241 1.017 . . . . 64.04 111.131 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -119.48 -6.68 10.24 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.035 -0.728 . . . . 61.12 109.035 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 69.24 -151.08 50.79 Favored Glycine 0 C--O 1.206 -1.598 0 CA-C-O 118.673 -1.07 . . . . 70.13 110.784 -175.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 7.8 mp -46.83 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.217 1.192 . . . . 51.55 114.217 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -104.06 43.66 1.63 Allowed Glycine 0 N--CA 1.428 -1.847 0 CA-C-N 113.951 -1.477 . . . . 62.53 112.044 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -129.17 142.16 50.95 Favored 'General case' 0 N--CA 1.409 -2.518 0 N-CA-C 108.596 -0.89 . . . . 64.42 108.596 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 45.0 t -115.0 148.53 38.71 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.401 -1.333 . . . . 72.31 107.401 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 14.9 pt -116.62 156.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.474 0.654 . . . . 72.32 112.611 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.4 t -138.21 159.85 40.98 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.934 -1.506 . . . . 72.21 106.934 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 14.9 p -120.96 131.28 54.23 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.666 -0.494 . . . . 73.12 109.666 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -117.55 117.47 29.51 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.537 -0.912 . . . . 72.5 108.537 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . 0.445 ' HA ' ' CB ' ' A' ' 486' ' ' ALA . 33.7 t70 -61.05 121.7 13.11 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 123.939 0.774 . . . . 74.21 110.09 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.441 HG13 ' H ' ' A' ' 486' ' ' ALA . 14.7 p -85.36 128.94 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 121.017 0.437 . . . . 74.13 111.797 -174.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.8 m -76.64 -42.99 40.0 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.776 0.798 . . . . 72.05 109.531 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 19.5 pt -89.19 83.05 2.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-N 114.338 -1.301 . . . . 63.15 111.217 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 128.76 -157.34 21.47 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 109.998 -1.241 . . . . 74.31 109.998 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -163.78 94.86 0.12 Allowed Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.088 -0.805 . . . . 38.91 111.088 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 43.8 t -172.29 -44.17 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.817 -0.438 . . . . 62.11 109.817 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 479' ' ' ASP . . . 72.79 94.09 0.05 OUTLIER Pre-proline 0 C--O 1.247 0.927 0 C-N-CA 124.345 1.058 . . . . 75.11 110.427 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -66.71 160.0 48.49 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 123.058 2.505 . . . . 74.43 112.847 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.403 HG13 HG23 ' A' ' 527' ' ' VAL . 47.8 mm -97.74 135.6 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 115.01 -0.995 . . . . 65.14 108.728 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 97.7 m-85 -127.22 155.98 42.59 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 116.68 -0.236 . . . . 73.14 110.66 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.415 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 32.6 t -82.72 119.0 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 N-CA-C 107.665 -1.235 . . . . 55.32 107.665 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.436 ' HG2' ' OD1' ' A' ' 492' ' ' ASN . 61.2 tttm -85.14 -54.81 4.39 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.561 -0.745 . . . . 73.31 109.461 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . 0.436 ' OD1' ' HG2' ' A' ' 491' ' ' LYS . 18.4 m120 -136.98 157.08 47.55 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 115.447 -0.797 . . . . 63.4 112.55 -176.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.503 HG12 ' HB1' ' A' ' 507' ' ' ALA . 26.6 mm -120.53 115.59 47.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.314 -1.736 . . . . 62.34 106.314 172.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.92 163.11 17.5 Favored Pre-proline 0 C--N 1.304 -1.399 0 C-N-CA 123.839 0.855 . . . . 72.41 112.146 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -74.75 -5.22 16.55 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 123.645 2.896 . . . . 71.35 111.219 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.429 ' HA ' HG22 ' A' ' 500' ' ' ILE . 97.9 mtt180 -157.97 174.3 15.45 Favored 'General case' 0 N--CA 1.41 -2.437 0 C-N-CA 125.113 1.365 . . . . 73.03 107.843 -172.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 106.74 -175.93 21.11 Favored Glycine 1 C--N 1.251 -4.176 0 CA-C-N 114.659 -1.155 . . . . 53.51 112.262 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.51 81.39 Favored 'General case' 0 N--CA 1.422 -1.828 0 C-N-CA 123.783 0.833 . . . . 61.41 110.872 -175.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.31 -41.89 80.77 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 114.655 -1.157 . . . . 74.24 112.788 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 496' ' ' ARG . 13.6 tt -81.08 -43.66 20.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.955 0.724 . . . . 62.53 112.955 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -59.02 -37.79 77.75 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 112.436 0.532 . . . . 74.24 112.436 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.459 ' HB2' HD13 ' A' ' 464' ' ' LEU . 3.6 m-20 -89.48 -33.36 16.81 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.211 -0.596 . . . . 73.41 109.778 173.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 62.16 50.79 61.84 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.759 -0.655 . . . . 53.05 113.74 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -117.08 -18.7 9.99 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.714 -0.795 . . . . 71.03 111.415 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . 0.413 HD21 ' N ' ' A' ' 506' ' ' LYS . 6.8 tt -119.84 138.96 53.07 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.988 -0.745 . . . . 73.45 108.988 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.413 ' N ' HD21 ' A' ' 505' ' ' LEU . 0.0 OUTLIER -132.05 160.91 34.53 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.41 0.892 . . . . 63.4 113.41 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.503 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -79.13 166.7 21.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.511 0.724 . . . . 65.43 111.912 -174.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 73.43 20.33 79.84 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.857 -0.897 . . . . 54.0 110.857 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.502 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 4.4 t70 -117.94 172.58 7.3 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.685 -1.228 . . . . 70.12 107.685 -176.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.428 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 30.3 ttm180 -107.3 135.25 49.12 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.311 -0.556 . . . . 75.04 110.951 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 27.4 mt -95.46 126.4 40.73 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 120.493 -0.483 . . . . 72.14 110.798 174.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.47 -45.39 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 116.019 -0.537 . . . . 75.12 111.203 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -156.63 155.08 31.19 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.329 -0.619 . . . . 73.45 109.329 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.442 HG11 HD21 ' A' ' 519' ' ' LEU . 6.4 p -132.6 125.03 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.726 0.774 . . . . 65.12 108.975 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 66.09 7.46 4.78 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 126.737 2.015 . . . . 74.23 112.65 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.53 -10.46 16.6 Favored Glycine 0 CA--C 1.508 -0.371 0 C-N-CA 120.484 -0.865 . . . . 75.4 112.734 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . 0.414 ' HB ' HD22 ' A' ' 530' ' ' LEU . 79.6 t -96.05 127.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.633 -0.506 . . . . 60.31 109.633 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.08 142.07 43.73 Favored 'General case' 0 CA--C 1.491 -1.324 0 O-C-N 123.868 0.73 . . . . 72.15 111.409 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.442 HD21 HG11 ' A' ' 514' ' ' VAL . 18.2 mt -100.08 -39.79 7.93 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 115.533 -0.758 . . . . 71.04 110.5 -176.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 38.6 t -73.92 98.75 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 108.587 -0.894 . . . . 75.02 108.587 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 136.52 -15.89 3.85 Favored Glycine 0 N--CA 1.424 -2.101 0 CA-C-N 114.313 -1.312 . . . . 73.21 110.173 -174.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.503 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -117.29 176.57 5.09 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-O 120.904 0.383 . . . . 71.34 111.681 176.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 37.3 m -91.11 161.09 15.24 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.889 -0.596 . . . . 73.25 111.235 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -55.42 -47.93 75.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.991 0.916 . . . . 71.31 111.694 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -62.42 -31.71 72.45 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 123.885 0.874 . . . . 71.14 112.429 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.85 -41.41 95.73 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.132 -0.692 . . . . 61.43 109.132 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.403 HG23 HG13 ' A' ' 488' ' ' ILE . 35.0 t -71.37 -39.44 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.993 -1.003 . . . . 72.11 110.389 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.663 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.9 m -65.18 -42.07 93.25 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.303 0 C-N-CA 119.347 -0.941 . . . . 71.13 110.164 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 36.8 m -62.09 -41.81 98.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.343 0.592 . . . . 72.42 110.199 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.414 HD22 ' HB ' ' A' ' 517' ' ' VAL . 54.7 tp -61.43 -46.26 90.84 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 124.125 0.97 . . . . 73.55 109.694 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.2 tt -63.39 -44.96 93.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.452 0.701 . . . . 74.23 112.408 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 28.0 mmm180 -63.06 -32.82 74.27 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.349 0.595 . . . . 72.2 109.943 -177.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 43.2 t -72.31 -44.39 62.77 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-N 115.076 -0.965 . . . . 75.13 109.779 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 86.3 m 69.6 -70.57 0.14 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.886 0.874 . . . . 65.53 110.839 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . 0.467 ' HA ' ' HE3' ' A' ' 535' ' ' LYS . 1.3 tpmt? 168.6 166.49 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 104.245 -2.502 . . . . 73.35 104.245 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 86.8 mtp -87.69 -28.59 21.71 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.025 -0.67 . . . . 64.34 109.257 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.66 -77.06 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.271 -0.877 . . . . 71.5 111.624 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 156.46 -29.31 0.56 Allowed Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 119.502 -1.332 . . . . 64.23 112.934 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 4.3 m -94.19 141.3 28.71 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.208 -1.405 . . . . 71.21 107.208 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 5.0 p -124.61 136.49 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 N-CA-C 109.223 -0.658 . . . . 74.11 109.223 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.4 m -92.25 132.87 36.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.937 -0.394 . . . . 72.12 109.937 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.442 HD21 HD23 ' A' ' 464' ' ' LEU . 1.3 mm? -124.18 138.56 54.4 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.096 -1.446 . . . . 74.14 107.096 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 39.2 tp -119.03 122.35 41.95 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 106.765 -1.569 . . . . 63.2 106.765 173.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.502 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 31.9 m -114.74 161.56 13.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 109.371 -0.604 . . . . 73.22 109.371 -177.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.408 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 84.4 t80 -132.96 129.2 37.94 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.405 0.621 . . . . 74.23 111.307 -177.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -122.13 140.87 52.03 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.194 -1.039 . . . . 75.44 108.194 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -77.35 135.97 38.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.969 -1.493 . . . . 74.31 106.969 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 65.48 -160.56 0.27 Allowed 'General case' 0 C--O 1.24 0.588 0 O-C-N 124.165 0.915 . . . . 62.41 109.379 -172.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--N 1.305 -1.368 0 C-N-CA 120.052 -0.659 . . . . 75.02 110.268 -177.959 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.078 0 N-CA-C 110.165 -1.174 . . . . 53.05 110.165 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 43.5 m -87.12 84.22 7.31 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 117.674 0.737 . . . . 74.14 112.798 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -142.35 87.38 2.01 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 108.533 -0.914 . . . . 72.23 108.533 173.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -148.56 133.89 18.48 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.679 -0.691 . . . . 72.13 110.022 -177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 25.7 m -114.68 95.39 5.22 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.956 -1.127 . . . . 64.14 107.956 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -79.38 103.86 9.59 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.443 -0.947 . . . . 71.35 108.443 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -136.79 144.97 44.0 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.699 -1.137 . . . . 75.31 108.24 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.81 112.07 23.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.519 -0.919 . . . . 71.42 108.519 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 121.32 96.48 1.46 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 108.175 -1.97 . . . . 73.14 108.175 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.517 ' HA ' ' HE3' ' A' ' 458' ' ' LYS . 0.4 OUTLIER -92.75 132.7 36.72 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 120.909 0.385 . . . . 64.43 110.111 -172.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 79.7 mtm180 -100.55 142.38 32.11 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.998 -1.112 . . . . 75.52 107.998 172.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -132.48 132.43 42.7 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 109.264 -0.643 . . . . 65.41 109.264 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -95.55 115.71 27.81 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.753 -1.573 . . . . 72.24 106.753 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.36 142.84 38.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.689 -0.856 . . . . 64.33 108.689 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.439 ' HB3' HG22 ' A' ' 539' ' ' THR . 75.7 mt-30 -120.32 127.22 52.15 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.446 -0.502 . . . . 71.51 111.666 176.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.523 HD13 ' HB2' ' A' ' 502' ' ' ASP . 3.9 mm? -114.7 132.29 56.46 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.377 -0.972 . . . . 74.54 108.377 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 39.6 ttmt -105.19 136.13 45.27 Favored 'General case' 0 N--CA 1.401 -2.892 0 CA-C-O 121.832 0.825 . . . . 72.21 110.768 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -72.8 102.44 3.39 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 113.937 -1.483 . . . . 71.55 109.471 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -137.9 -84.28 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.422 -1.071 . . . . 43.23 110.422 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' THR . . . . . 0.444 ' O ' ' HA2' ' A' ' 497' ' ' GLY . 26.9 m -91.25 123.95 35.08 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.661 -1.607 . . . . 73.32 106.661 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . 0.602 ' HB3' ' CA ' ' A' ' 497' ' ' GLY . 10.9 tp10 39.17 52.85 2.14 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 125.157 1.383 . . . . 61.4 108.214 -174.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -53.14 127.88 36.79 Favored Glycine 0 N--CA 1.416 -2.681 0 CA-C-N 113.393 -1.731 . . . . 63.14 114.144 -171.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.531 ' H ' ' HB2' ' A' ' 498' ' ' ALA . 43.4 mt 65.95 74.34 0.36 Allowed 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 126.351 1.86 . . . . 74.13 110.475 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -92.51 57.15 2.69 Favored Glycine 0 N--CA 1.422 -2.24 0 CA-C-N 113.862 -1.517 . . . . 43.13 111.619 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.567 ' CE2' HD12 ' A' ' 542' ' ' LEU . 33.1 p90 -150.03 142.94 24.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.026 0.441 . . . . 73.31 111.558 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 46.4 p -128.7 164.75 22.27 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.826 -1.079 . . . . 74.43 108.742 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 22.7 pt -121.75 153.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 113.409 0.892 . . . . 73.22 113.409 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.8 t -137.18 141.33 42.17 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.178 -0.919 . . . . 63.01 109.567 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.4 m -142.33 131.82 23.78 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.58 -1.267 . . . . 61.15 107.58 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -122.57 -63.74 1.25 Allowed 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.967 -0.693 . . . . 75.05 110.636 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -138.37 152.67 48.64 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 116.301 -0.409 . . . . 74.41 110.175 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 5.2 p -53.72 117.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.784 0.802 . . . . 71.32 110.842 172.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 16.5 p -130.34 -78.18 0.54 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.607 -0.724 . . . . 73.3 111.268 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 62.8 mt -93.07 -43.33 13.57 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 114.873 -1.058 . . . . 74.34 109.857 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -96.08 -150.05 26.44 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.676 -0.773 . . . . 75.1 112.897 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -73.9 -160.01 6.43 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-O 119.972 -0.349 . . . . 75.44 112.837 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 52.6 m -45.46 -40.22 8.06 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.817 0.847 . . . . 72.1 113.265 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -142.22 97.64 6.23 Favored Pre-proline 0 N--CA 1.431 -1.384 0 N-CA-C 108.457 -0.942 . . . . 50.44 108.457 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.469 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 5.2 Cg_exo -78.09 138.91 16.65 Favored 'Trans proline' 0 N--CA 1.441 -1.569 0 C-N-CA 122.089 1.859 . . . . 70.2 111.301 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 47.9 mm -86.42 120.61 36.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.943 -0.571 . . . . 72.43 109.954 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.469 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 90.6 m-85 -121.22 150.11 41.83 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 122.288 -0.257 . . . . 74.44 110.352 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 41.1 t -72.05 119.82 19.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.931 -0.766 . . . . 75.42 108.931 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -84.65 -57.47 3.12 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.357 -0.838 . . . . 72.34 110.897 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -136.81 151.94 49.73 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.899 -0.591 . . . . 73.32 109.781 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' A' ' 506' ' ' LYS . 27.8 mm -123.08 106.94 18.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.881 -1.155 . . . . 74.24 107.881 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.421 ' C ' ' H ' ' A' ' 496' ' ' ARG . 3.3 mm? -63.72 113.99 11.84 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 108.982 -0.748 . . . . 75.04 108.982 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.21 29.52 0.39 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 124.903 3.736 . . . . 73.43 112.55 -172.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 494' ' ' LEU . 10.7 ptp180 -154.5 1.98 0.21 Allowed 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 115.568 -0.742 . . . . 71.11 112.133 -175.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.602 ' CA ' ' HB3' ' A' ' 469' ' ' GLU . . . -113.94 -146.63 9.44 Favored Glycine 0 C--O 1.218 -0.849 0 C-N-CA 119.124 -1.512 . . . . 75.4 115.296 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . 0.531 ' HB2' ' H ' ' A' ' 471' ' ' LEU . . . -59.79 -40.49 88.47 Favored 'General case' 0 C--N 1.364 1.225 0 CA-C-N 118.24 1.02 . . . . 63.51 110.563 -173.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.61 -37.82 73.89 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 115.091 -0.959 . . . . 62.44 112.864 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 500' ' ' ILE . 11.6 tt -80.14 -35.58 15.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.01 0.374 . . . . 65.12 112.01 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -58.79 -47.28 85.27 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.017 0.437 . . . . 73.35 110.28 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.523 ' HB2' HD13 ' A' ' 464' ' ' LEU . 21.1 m-20 -89.86 -30.19 18.07 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.443 -0.503 . . . . 72.34 110.275 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 76.27 -23.63 1.83 Allowed Glycine 0 CA--C 1.529 0.933 0 N-CA-C 118.075 1.99 . . . . 52.0 118.075 170.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -67.33 -17.46 64.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.834 1.049 . . . . 75.34 113.834 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 42.8 tp -101.76 132.3 47.57 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 122.134 -0.354 . . . . 71.44 111.672 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.424 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.261 0.0 OUTLIER -135.79 146.44 47.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 113.379 0.881 . . . . 62.35 113.379 176.657 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.401 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -65.07 123.39 19.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.306 -0.861 . . . . 54.1 110.609 -177.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 131.67 -18.87 4.82 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 111.064 -0.814 . . . . 50.41 111.064 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -81.05 156.78 25.69 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 109.212 -0.662 . . . . 72.43 109.212 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -95.57 136.49 35.89 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.775 -0.454 . . . . 64.44 109.775 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.409 ' HB3' HD12 ' A' ' 519' ' ' LEU . 24.8 mt -85.7 136.01 33.53 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 119.707 -0.797 . . . . 73.53 110.708 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.36 -45.64 10.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.318 -0.623 . . . . 72.31 109.318 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.35 157.13 36.65 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.06 -0.718 . . . . 72.33 109.06 176.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.52 HG11 HD21 ' A' ' 519' ' ' LEU . 7.6 p -144.46 136.22 21.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-N 116.021 -0.536 . . . . 63.55 109.931 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . 0.418 HD21 HG13 ' A' ' 540' ' ' VAL . 5.3 t-20 65.96 12.32 8.34 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 125.505 1.522 . . . . 71.52 111.734 176.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 92.7 14.05 55.85 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 120.857 -0.687 . . . . 37.8 111.959 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 37.3 t -121.1 146.45 26.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.921 -0.77 . . . . 75.21 108.921 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . 0.571 ' O ' ' HE2' ' A' ' 522' ' ' LYS . 5.3 p-10 -88.51 152.66 21.72 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 109.232 -0.655 . . . . 75.34 109.232 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.52 HD21 HG11 ' A' ' 514' ' ' VAL . 18.7 mt -100.53 -52.54 3.32 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.369 -0.532 . . . . 75.31 111.731 -172.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.25 110.01 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.938 0.875 . . . . 70.24 110.503 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 135.42 -33.94 2.36 Favored Glycine 0 N--CA 1.418 -2.534 0 N-CA-C 109.285 -1.526 . . . . 70.5 109.285 -174.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.571 ' HE2' ' O ' ' A' ' 518' ' ' ASP . 0.1 OUTLIER -107.93 161.54 14.84 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 109.79 -0.448 . . . . 62.32 109.79 178.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 29.4 m -87.22 162.4 17.48 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.659 -0.246 . . . . 72.32 111.498 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.436 ' O ' HG12 ' A' ' 528' ' ' VAL . 53.8 mt-30 -51.74 -46.92 64.22 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.372 0.669 . . . . 74.33 112.32 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.01 -32.39 70.83 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.209 0.448 . . . . 72.02 112.209 -178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.13 -39.87 68.51 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.42 -0.585 . . . . 53.13 109.42 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.411 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 49.0 t -67.04 -41.75 87.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 74.43 109.584 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.668 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 8.6 m -66.7 -40.94 87.29 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.152 0 C-N-CA 119.209 -0.996 . . . . 74.42 110.012 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.8 m -60.41 -44.1 96.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.296 -0.411 . . . . 61.25 111.382 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.487 HD12 HG13 ' A' ' 514' ' ' VAL . 3.5 pp -67.46 -30.29 69.97 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.299 0.571 . . . . 62.23 110.232 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.426 ' CD1' HD13 ' A' ' 471' ' ' LEU . 65.2 tp -69.85 -48.22 59.71 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.679 -0.691 . . . . 73.23 109.576 175.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 27.6 mmm180 -61.11 -39.11 88.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.642 -0.708 . . . . 72.54 111.85 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 30.6 t -65.25 -38.7 91.17 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.384 -0.598 . . . . 42.32 109.384 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 17.6 m 69.92 166.57 0.28 Allowed 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.474 0.71 . . . . 73.35 111.432 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -81.41 150.98 28.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.653 -1.61 . . . . 75.44 106.653 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 91.9 mmm -63.86 -31.95 73.31 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.772 1.027 . . . . 73.22 113.772 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.27 -32.33 73.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 122.007 0.908 . . . . 72.04 108.675 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 105.68 -14.01 46.21 Favored Glycine 0 N--CA 1.422 -2.28 0 CA-C-N 114.778 -1.101 . . . . 72.24 111.453 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 463' ' ' GLN . 1.8 m -96.7 129.08 44.17 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.336 -0.616 . . . . 63.34 109.336 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.418 HG13 HD21 ' A' ' 515' ' ' ASN . 86.9 t -106.76 133.5 51.15 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 115.532 -0.758 . . . . 73.2 109.915 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 21.8 t -91.48 129.59 37.44 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 109.075 -0.713 . . . . 73.51 109.075 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.567 HD12 ' CE2' ' A' ' 473' ' ' PHE . 3.8 mm? -117.56 130.33 56.34 Favored 'General case' 0 C--N 1.283 -2.309 0 C-N-CA 124.607 1.163 . . . . 74.52 108.846 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 54.6 tp -112.8 117.91 33.49 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.733 -1.951 . . . . 63.12 105.733 169.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 25.9 m -115.73 150.98 17.54 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.788 0 C-N-CA 120.133 -0.627 . . . . 74.12 110.075 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -111.77 115.8 29.66 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 106.509 -1.663 . . . . 63.22 106.509 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -109.29 122.81 48.15 Favored 'General case' 0 N--CA 1.399 -3.023 0 CA-C-N 115.213 -0.903 . . . . 74.22 109.093 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -79.35 138.4 37.68 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.358 -0.837 . . . . 70.51 110.02 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -111.96 105.7 14.19 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.836 -0.802 . . . . 71.24 108.836 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 . . . . . 0 CA--C 1.494 -1.203 0 N-CA-C 108.564 -0.902 . . . . 75.13 108.564 179.267 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.82 0 N-CA-C 110.469 -1.052 . . . . 63.14 110.469 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 51.1 m 67.82 113.68 0.04 OUTLIER 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.881 1.273 . . . . 73.21 112.622 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -79.67 88.12 5.18 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.786 0.803 . . . . 70.2 110.674 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -142.24 111.49 6.49 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.665 -1.606 . . . . 63.45 106.665 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 40.5 p -92.42 174.12 7.45 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 116.18 -0.464 . . . . 53.11 111.718 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -80.17 87.71 5.49 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.216 0.532 . . . . 71.33 109.96 175.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -80.29 115.57 19.9 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.425 -1.694 . . . . 70.3 106.425 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 38.2 pt -67.4 -31.45 52.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 113.24 0.83 . . . . 71.24 113.24 -172.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -166.97 -175.21 36.88 Favored Glycine 1 N--CA 1.386 -4.674 0 C-N-CA 119.462 -1.351 . . . . 71.5 111.68 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -125.67 134.59 51.79 Favored 'General case' 0 C--N 1.261 -3.255 0 CA-C-N 114.265 -0.967 . . . . 71.5 109.182 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 97.5 mtt180 -99.36 132.46 44.67 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.246 -1.761 . . . . 74.11 106.246 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 15.6 tp -126.44 132.72 51.42 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.286 -0.566 . . . . 64.52 110.153 -171.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -98.63 114.61 27.15 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-O 121.97 0.89 . . . . 72.54 108.952 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.05 133.54 60.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 CA-C-N 115.074 -0.966 . . . . 64.44 109.754 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 48.4 mt-30 -106.76 128.97 54.68 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.999 -0.68 . . . . 74.33 112.177 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.489 HD23 HD21 ' A' ' 542' ' ' LEU . 4.5 mm? -112.9 150.0 32.39 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.811 -1.086 . . . . 71.33 108.697 175.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -107.54 136.37 47.43 Favored 'General case' 0 N--CA 1.389 -3.485 0 O-C-N 124.017 0.823 . . . . 61.3 109.931 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -70.82 85.12 0.67 Allowed 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 115.117 -0.947 . . . . 74.33 108.765 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -84.84 -129.98 2.07 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.45 -0.795 . . . . 62.13 112.253 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 8.7 t -66.91 -57.7 6.43 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.495 0.554 . . . . 72.22 112.495 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.82 -6.82 35.12 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.811 -0.556 . . . . 74.14 110.751 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 58.72 -153.18 29.76 Favored Glycine 0 C--O 1.207 -1.545 0 CA-C-O 118.669 -1.073 . . . . 70.12 112.184 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.499 HD12 HG22 ' A' ' 540' ' ' VAL . 61.1 mt -47.25 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.996 0.903 . . . . 74.53 112.903 -171.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.36 62.12 0.35 Allowed Glycine 0 CA--C 1.475 -2.433 0 CA-C-N 114.399 -1.273 . . . . 75.23 111.003 -176.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -155.58 142.59 19.12 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.932 -0.766 . . . . 72.22 108.932 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.3 m -117.84 158.35 24.98 Favored 'General case' 0 C--N 1.281 -2.4 0 O-C-N 124.112 0.883 . . . . 75.43 109.226 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 17.0 pt -116.73 157.31 17.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.275 0.56 . . . . 72.23 111.469 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.7 t -140.2 155.99 46.69 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 107.898 -1.149 . . . . 72.24 107.898 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 62.7 p -136.41 149.9 48.51 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.924 -0.769 . . . . 70.31 108.924 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -134.94 166.37 23.17 Favored 'General case' 0 N--CA 1.405 -2.687 0 N-CA-C 109.77 -0.455 . . . . 74.22 109.77 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -60.93 137.59 58.21 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 124.373 1.046 . . . . 65.51 108.941 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.34 129.04 50.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-O 121.053 0.454 . . . . 75.44 111.75 -174.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 481' ' ' THR . 29.1 m -129.12 10.0 5.79 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 122.843 1.306 . . . . 65.23 109.005 174.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.2 mp -81.73 -31.7 11.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.659 -1.155 . . . . 61.41 109.865 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 114.76 57.66 0.37 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.835 -0.906 . . . . 55.41 110.835 -176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -160.29 -155.05 7.59 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 111.296 -0.722 . . . . 43.35 111.296 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 38.1 t -124.45 83.37 2.14 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.097 0.448 . . . . 71.13 110.88 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 45.05 99.47 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.378 0 C-N-CA 125.806 1.642 . . . . 62.51 114.946 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.61 138.55 26.87 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.32 2.013 . . . . 65.42 112.465 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 46.0 mm -93.57 136.42 25.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.778 -0.823 . . . . 62.24 108.778 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -131.18 159.33 38.03 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 121.986 0.114 . . . . 73.32 110.776 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.33 121.34 26.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.017 -0.734 . . . . 72.15 109.017 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -83.16 -57.15 3.4 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.303 0.573 . . . . 72.34 110.113 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -147.0 153.73 40.4 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.701 -0.681 . . . . 71.42 109.935 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.505 HG12 ' HB1' ' A' ' 507' ' ' ALA . 33.7 mm -114.06 106.48 20.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.081 -1.081 . . . . 63.54 108.081 175.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.2 mp -61.47 122.37 70.23 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 109.085 -0.709 . . . . 61.12 109.085 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . 0.448 ' C ' HG22 ' A' ' 500' ' ' ILE . 87.7 Cg_endo -69.86 28.42 0.18 Allowed 'Trans proline' 0 N--CA 1.521 3.127 1 C-N-CA 125.733 4.289 . . . . 75.23 115.038 -170.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.503 ' N ' HG22 ' A' ' 500' ' ' ILE . 13.6 ptm180 -163.51 -0.81 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 113.179 0.807 . . . . 73.25 113.179 -175.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -97.33 -166.16 32.45 Favored Glycine 0 C--N 1.306 -1.103 0 C-N-CA 119.613 -1.279 . . . . 72.44 112.421 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . 0.477 ' C ' HD11 ' A' ' 464' ' ' LEU . . . -49.55 -48.6 48.3 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 125.451 1.5 . . . . 74.12 112.758 -172.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.16 80.66 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 115.492 -0.777 . . . . 62.35 112.108 -173.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 496' ' ' ARG . 0.0 OUTLIER -81.33 -35.99 14.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 123.488 0.715 . . . . 74.34 112.908 179.283 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.8 mm100 -67.79 -37.73 82.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.014 0.435 . . . . 75.21 110.929 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.431 ' HB2' HD13 ' A' ' 464' ' ' LEU . 10.0 m-20 -87.77 -30.41 20.3 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.531 -0.914 . . . . 61.34 108.531 174.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 68.75 49.26 44.03 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.311 -0.859 . . . . 62.23 113.537 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -118.04 -38.51 3.21 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.361 -0.935 . . . . 64.43 111.497 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 58.6 tp -109.01 148.47 30.72 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.529 -0.305 . . . . 71.25 110.39 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.461 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -137.46 170.75 15.55 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 123.306 0.378 . . . . 72.33 110.021 177.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.505 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -88.2 85.18 6.89 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.956 0.725 . . . . 71.24 112.956 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 176.4 19.44 0.02 OUTLIER Glycine 0 C--N 1.293 -1.806 0 CA-C-N 114.658 -1.156 . . . . 54.11 110.254 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -116.82 153.25 32.81 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-O 121.02 0.438 . . . . 75.24 110.983 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.428 HH21 HG23 ' A' ' 520' ' ' VAL . 38.4 ttt180 -94.27 134.65 36.52 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.485 -0.779 . . . . 73.24 110.201 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.681 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.2 mm? -83.21 129.59 35.02 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.016 -0.993 . . . . 74.01 110.16 174.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.455 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 36.2 mm -107.52 -43.64 6.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.152 0.501 . . . . 73.34 109.971 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 517' ' ' VAL . 28.9 tt0 -158.49 155.02 27.73 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.554 -0.748 . . . . 74.32 110.02 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 541' ' ' SER . 3.5 p -143.49 125.52 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 109.484 -0.562 . . . . 74.35 109.484 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . 0.498 HD22 HG13 ' A' ' 540' ' ' VAL . 61.0 m-80 62.48 12.79 5.64 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 125.367 1.467 . . . . 62.11 114.029 -176.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 101.69 15.55 26.62 Favored Glycine 0 C--N 1.31 -0.91 0 C-N-CA 120.201 -0.999 . . . . 63.43 112.875 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' A' ' 513' ' ' GLU . 61.1 t -116.48 128.75 73.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.614 -0.884 . . . . 72.41 108.614 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.22 144.14 29.13 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.172 -0.677 . . . . 71.21 109.172 -173.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.681 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 33.6 mt -97.86 -49.54 4.76 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.762 0.652 . . . . 71.33 112.762 -171.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . 0.428 HG23 HH21 ' A' ' 510' ' ' ARG . 95.7 t -70.81 96.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 122.274 1.035 . . . . 64.35 111.087 -175.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 145.62 -23.44 1.83 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 109.143 -1.583 . . . . 71.34 109.143 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.464 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -110.57 178.02 4.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 120.666 0.27 . . . . 61.03 111.172 177.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 6.5 m -89.8 159.54 16.97 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.613 -0.721 . . . . 73.13 109.48 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -60.58 -43.97 96.74 Favored 'General case' 0 C--O 1.222 -0.347 0 O-C-N 123.089 0.243 . . . . 73.13 111.341 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.492 ' O ' HG23 ' A' ' 528' ' ' VAL . 1.6 mp0 -56.86 -35.83 69.34 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.037 -0.529 . . . . 73.13 111.337 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -62.52 -38.69 90.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.818 -0.628 . . . . 74.32 109.703 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.12 -36.72 31.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.452 -0.795 . . . . 60.1 110.144 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 14.8 m -65.29 -41.4 91.33 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 C-N-CA 119.718 -0.793 . . . . 71.33 110.424 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 46.0 t -60.93 -40.07 91.87 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.494 0.664 . . . . 72.22 110.02 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 36.8 tp -64.33 -36.47 84.24 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 124.371 1.068 . . . . 71.42 109.814 177.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.9 -45.31 64.54 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.682 -0.69 . . . . 73.33 109.333 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -59.69 -39.86 85.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.164 0.986 . . . . 71.44 110.891 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 29.1 t -64.77 -41.52 95.82 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.393 -0.821 . . . . 71.31 109.923 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 87.4 m 63.73 -91.05 0.03 OUTLIER 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.477 0.711 . . . . 64.21 111.072 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt 166.98 145.89 0.02 OUTLIER 'General case' 0 C--O 1.25 1.1 0 N-CA-C 105.757 -1.942 . . . . 71.33 105.757 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.5 mtt -66.37 -40.81 89.97 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.982 -0.287 . . . . 75.31 111.537 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.4 -79.84 0.06 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 119.248 -0.406 . . . . 73.12 111.944 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 178.66 -25.98 0.05 OUTLIER Glycine 0 C--O 1.218 -0.89 0 C-N-CA 116.634 -2.698 . . . . 55.04 116.562 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 1.3 p -94.78 120.37 34.89 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 114.926 1.454 . . . . 74.55 114.926 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.499 HG22 HD12 ' A' ' 471' ' ' LEU . 98.7 t -107.95 131.98 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 114.239 -1.346 . . . . 72.55 108.646 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 24.2 p -95.39 114.58 26.36 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.256 0.551 . . . . 70.3 111.193 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.489 HD21 HD23 ' A' ' 464' ' ' LEU . 2.9 mm? -103.76 122.94 46.12 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.161 -1.052 . . . . 53.14 108.161 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 44.3 tp -103.92 117.92 35.46 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 106.445 -1.687 . . . . 63.42 106.445 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 29.0 m -116.79 161.22 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 120.63 -0.428 . . . . 74.44 110.789 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.452 ' HB2' HD11 ' A' ' 512' ' ' ILE . 91.9 t80 -111.33 117.48 33.25 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.367 0.604 . . . . 73.42 109.59 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -105.71 138.22 42.26 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.354 -1.35 . . . . 60.44 107.354 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -95.09 120.09 34.72 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.349 -0.982 . . . . 63.12 108.349 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -101.35 88.97 3.6 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.821 -0.807 . . . . 74.21 108.821 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 11.4 t70 . . . . . 0 C--N 1.303 -1.413 0 CA-C-N 114.958 -1.019 . . . . 63.13 109.268 -176.366 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.428 0 N-CA-C 111.979 -0.448 . . . . 74.03 111.979 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 67.5 m -156.36 165.76 35.41 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.707 -0.849 . . . . 71.34 108.707 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -85.24 136.25 33.59 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.671 -1.233 . . . . 73.35 107.671 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -64.3 110.26 2.18 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.171 0.434 . . . . 72.32 112.171 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 28.8 m -73.21 -40.36 64.78 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.537 -1.283 . . . . 70.01 107.537 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -98.55 98.74 9.88 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.735 -1.121 . . . . 61.41 109.915 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -139.3 137.32 35.74 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.999 -1.111 . . . . 73.21 107.999 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 11.0 tt -114.38 116.12 51.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 120.544 -0.462 . . . . 73.53 110.898 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 74.81 172.84 30.26 Favored Glycine 0 N--CA 1.398 -3.868 0 CA-C-O 122.261 0.923 . . . . 52.42 113.318 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -122.08 133.86 54.77 Favored 'General case' 0 C--N 1.264 -3.129 0 CA-C-N 114.022 -1.089 . . . . 73.11 111.968 176.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 93.5 mtt180 -104.66 135.4 46.13 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.331 -0.988 . . . . 72.53 108.331 175.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 6.4 mp -131.76 142.01 49.65 Favored 'General case' 0 CA--C 1.48 -1.742 0 CA-C-O 120.735 0.303 . . . . 74.42 110.953 -172.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -98.01 115.98 29.3 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.263 -0.88 . . . . 73.01 108.693 174.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 71.0 mt -123.77 123.17 66.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.13 -0.941 . . . . 71.21 110.12 -175.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.491 ' HB3' ' CG2' ' A' ' 539' ' ' THR . 25.6 mt-30 -100.41 137.29 39.03 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.836 -0.746 . . . . 74.43 112.558 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.491 ' CD1' ' HA ' ' A' ' 499' ' ' ALA . 4.3 mm? -116.66 136.26 53.11 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 115.112 -0.949 . . . . 74.51 110.228 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.8 120.48 42.38 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 106.861 -1.533 . . . . 72.13 106.861 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -45.73 100.9 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.753 1.221 . . . . 74.12 111.465 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -92.96 -121.59 3.07 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.5 -0.773 . . . . 72.31 112.953 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' THR . . . . . 0.706 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 36.3 m -59.87 -56.97 15.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.943 0.497 . . . . 75.2 111.737 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -112.32 -6.69 14.03 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.672 0.749 . . . . 63.13 111.58 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 77.79 -156.51 44.34 Favored Glycine 0 C--O 1.199 -2.088 0 CA-C-O 118.377 -1.235 . . . . 55.51 110.949 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.427 HD12 HG22 ' A' ' 540' ' ' VAL . 41.6 mt -50.41 102.36 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.71 1.255 . . . . 71.44 112.9 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -122.35 53.64 0.72 Allowed Glycine 0 N--CA 1.422 -2.281 0 CA-C-N 114.488 -1.233 . . . . 62.22 111.257 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.609 ' CZ ' HD12 ' A' ' 542' ' ' LEU . 6.1 p90 -126.51 145.16 50.62 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.746 -1.576 . . . . 75.42 106.746 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 38.9 m -114.97 138.33 50.97 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 109.033 -0.728 . . . . 64.33 109.033 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 14.2 pt -109.72 152.58 11.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-O 121.421 0.629 . . . . 75.12 111.786 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.1 t -136.34 159.61 41.23 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.27 -1.382 . . . . 74.42 107.27 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.642 ' HB3' ' OE1' ' A' ' 524' ' ' GLN . 33.3 p -118.82 142.47 47.69 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 109.021 -0.733 . . . . 65.35 109.021 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -109.36 115.63 30.32 Favored 'General case' 0 N--CA 1.418 -2.028 0 C-N-CA 119.673 -0.811 . . . . 72.23 108.964 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -41.18 126.28 2.63 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 125.448 1.499 . . . . 62.4 113.135 -174.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 9.4 p -80.29 -20.2 11.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.238 -0.892 . . . . 71.3 110.716 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 29.4 m 62.51 78.18 0.3 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.452 -0.795 . . . . 71.03 110.245 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 51.4 mm 64.98 94.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 114.378 -1.283 . . . . 72.52 110.567 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -170.29 -103.3 0.16 Allowed Glycine 0 CA--C 1.492 -1.352 0 C-N-CA 120.666 -0.778 . . . . 72.43 112.147 -177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -170.59 112.06 0.44 Allowed Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 120.606 -0.807 . . . . 74.04 112.097 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 53.2 m 72.31 -44.74 0.6 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.482 1.66 . . . . 72.11 115.482 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 78.59 143.14 0.09 OUTLIER Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 124.638 1.175 . . . . 62.25 110.366 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.22 144.72 92.46 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 122.796 2.331 . . . . 71.43 113.449 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 24.2 mm -95.58 133.51 36.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.156 -0.929 . . . . 74.25 109.014 -176.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 97.2 m-85 -131.05 151.76 51.08 Favored 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 122.079 -0.388 . . . . 75.2 110.642 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 56.2 t -84.52 119.02 32.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.709 -0.849 . . . . 54.21 108.709 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -83.1 -55.86 4.12 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.629 0.772 . . . . 74.21 110.167 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -141.65 152.89 44.34 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.487 -0.778 . . . . 63.33 110.49 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.449 HG12 ' HB1' ' A' ' 507' ' ' ALA . 30.0 mm -117.11 105.09 17.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.735 -1.58 . . . . 74.34 106.735 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.09 146.36 88.19 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 116.114 -0.494 . . . . 75.15 111.463 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . 0.438 ' C ' HG22 ' A' ' 500' ' ' ILE . 84.9 Cg_endo -74.82 12.28 1.21 Allowed 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 124.579 3.519 . . . . 73.11 116.189 -172.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.706 ' O ' ' HB ' ' A' ' 468' ' ' THR . 13.0 ptp180 -155.37 3.48 0.19 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 115.361 1.615 . . . . 74.22 115.361 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.504 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -83.92 -161.14 31.78 Favored Glycine 0 C--N 1.286 -2.195 0 C-N-CA 119.265 -1.445 . . . . 75.42 112.625 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -69.1 -39.35 79.04 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 123.414 0.686 . . . . 73.02 110.001 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . 0.491 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -56.86 -42.76 80.31 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 114.441 -1.254 . . . . 73.53 111.827 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 496' ' ' ARG . 0.0 OUTLIER -80.03 -37.15 17.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 112.571 0.582 . . . . 75.41 112.571 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.5 mm100 -61.13 -40.85 95.36 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.814 0.34 . . . . 72.42 110.641 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.446 ' HB2' HD13 ' A' ' 464' ' ' LEU . 6.4 m-20 -84.11 -43.3 15.17 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.21 -0.45 . . . . 72.41 109.969 174.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 70.44 13.97 71.46 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 121.346 -0.454 . . . . 63.21 113.62 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -88.16 -14.06 39.63 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.433 0.635 . . . . 70.02 109.686 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . 0.403 ' HB2' HD22 ' A' ' 464' ' ' LEU . 49.2 tp -114.83 138.39 50.83 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.88 -1.156 . . . . 74.44 107.88 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.446 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -140.98 169.34 17.81 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.811 0.671 . . . . 62.4 112.811 178.483 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.449 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -82.55 161.9 22.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.013 -0.539 . . . . 70.43 111.938 -173.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 74.96 42.21 30.63 Favored Glycine 0 CA--C 1.506 -0.485 0 N-CA-C 110.802 -0.919 . . . . 74.05 110.802 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -146.68 149.11 32.81 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.959 -1.497 . . . . 73.34 106.959 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 41.6 ttm180 -87.7 138.22 31.66 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 118.095 0.407 . . . . 73.23 111.385 -174.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.445 ' HG ' HD12 ' A' ' 519' ' ' LEU . 25.9 tp -100.23 127.38 46.52 Favored 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 108.442 -0.948 . . . . 73.23 108.442 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.502 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 34.5 mm -100.97 -47.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.096 0.474 . . . . 74.54 110.966 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -157.13 149.35 22.9 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 109.022 -0.733 . . . . 62.44 109.022 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 541' ' ' SER . 7.1 p -137.57 134.43 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 CA-C-O 121.254 0.55 . . . . 73.14 109.727 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . 0.435 HD22 ' HB2' ' A' ' 535' ' ' LYS . 4.1 t-20 58.81 23.21 11.0 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 127.003 2.121 . . . . 70.14 112.944 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 89.72 15.4 58.21 Favored Glycine 0 CA--C 1.502 -0.752 0 C-N-CA 121.036 -0.602 . . . . 63.24 112.538 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.5 t -115.38 131.41 67.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 O-C-N 122.709 -0.289 . . . . 71.14 110.308 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.73 130.48 35.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.343 0.657 . . . . 70.02 110.364 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 10.7 mt -95.87 -30.5 13.62 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.587 0.708 . . . . 72.32 110.205 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 55.3 t -58.83 -34.74 53.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.133 -1.394 . . . . 64.44 112.049 -171.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -99.38 20.68 48.81 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.929 -0.653 . . . . 51.21 113.831 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.548 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -138.46 -179.83 6.03 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 117.797 0.798 . . . . 70.02 111.954 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 32.6 m -92.16 163.21 14.02 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.649 0.261 . . . . 63.51 111.471 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.642 ' OE1' ' HB3' ' A' ' 477' ' ' SER . 43.6 tp60 -59.7 -44.93 93.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.329 1.052 . . . . 75.13 110.694 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 528' ' ' VAL . 47.8 mt-10 -62.32 -31.95 72.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.695 0.628 . . . . 72.14 112.695 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.415 ' CD ' ' HB2' ' A' ' 522' ' ' LYS . 50.1 mt-10 -63.81 -36.83 85.2 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.651 -0.5 . . . . 64.41 109.651 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 17.3 t -73.68 -36.51 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 115.588 -0.733 . . . . 74.44 109.478 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 13.9 m -69.45 -39.39 78.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.417 0 C-N-CA 119.592 -0.843 . . . . 65.14 111.177 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.9 t -62.33 -43.3 99.14 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.196 0.522 . . . . 70.43 109.661 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.85 -41.84 78.66 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.811 1.244 . . . . 74.41 109.383 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.428 HD12 ' O ' ' A' ' 473' ' ' PHE . 3.2 tt -69.0 -45.13 71.32 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.921 -1.036 . . . . 73.12 112.58 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.507 ' HA ' ' HE ' ' A' ' 532' ' ' ARG . 1.1 mmp_? -62.15 -43.72 98.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.554 -0.294 . . . . 73.14 110.48 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.1 m -68.54 -32.36 72.25 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.226 -0.443 . . . . 71.04 111.434 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 51.4 m 68.49 -94.88 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.02 0.528 . . . . 55.55 111.348 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . 0.435 ' HB2' HD22 ' A' ' 515' ' ' ASN . 86.1 tttt 169.26 141.17 0.02 OUTLIER 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.435 -1.32 . . . . 74.04 107.435 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 86.8 mtp -68.75 -31.87 71.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.646 0.26 . . . . 71.43 111.598 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -59.61 -38.33 80.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.315 0.578 . . . . 71.21 110.288 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 112.02 -29.74 8.22 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.159 -1.02 . . . . 74.22 114.129 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.491 ' CG2' ' HB3' ' A' ' 463' ' ' GLN . 6.4 m -103.93 136.3 43.84 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.973 -0.691 . . . . 70.24 109.238 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.427 HG22 HD12 ' A' ' 471' ' ' LEU . 61.3 t -118.92 138.24 50.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.915 -0.584 . . . . 45.53 110.039 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 69.2 m -91.93 115.0 27.7 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-O 121.077 0.465 . . . . 63.54 111.478 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.609 HD12 ' CZ ' ' A' ' 473' ' ' PHE . 3.3 mm? -102.09 119.73 39.27 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.8 -1.185 . . . . 75.22 107.8 176.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 2.8 tm? -108.23 117.07 33.2 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 104.832 -2.284 . . . . 65.32 104.832 173.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 33.5 m -115.9 161.33 14.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 115.379 -0.828 . . . . 74.1 111.624 -173.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.406 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 66.4 t80 -120.87 116.55 25.38 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.514 -0.921 . . . . 73.22 108.514 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -102.39 130.49 49.17 Favored 'General case' 0 N--CA 1.396 -3.146 0 CA-C-N 115.054 -0.975 . . . . 74.01 108.77 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.6 142.43 35.65 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 114.598 1.333 . . . . 62.41 114.598 -172.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -153.08 93.11 1.69 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.84 -1.073 . . . . 73.53 108.628 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 19.6 t70 . . . . . 0 C--N 1.301 -1.532 0 N-CA-C 107.841 -1.17 . . . . 71.33 107.841 -179.68 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.492 0 N-CA-C 111.037 -0.825 . . . . 74.33 111.037 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 46.6 m 64.84 -176.93 0.17 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.658 0.783 . . . . 73.44 111.912 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 72.73 -51.32 0.71 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.145 1.165 . . . . 75.41 114.145 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -88.22 91.18 8.68 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.019 0.914 . . . . 74.45 108.891 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 37.2 m -75.11 -39.85 60.35 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.172 -0.922 . . . . 74.33 108.833 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.59 ' HZ2' ' HB3' ' A' ' 454' ' ' LYS . 9.1 mtpm? -94.82 161.65 14.08 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 122.005 0.907 . . . . 65.35 112.093 178.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -140.21 169.52 17.53 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 104.707 -2.331 . . . . 53.15 104.707 176.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.65 85.17 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 105.276 -2.12 . . . . 71.43 105.276 168.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 126.7 161.66 10.97 Favored Glycine 0 N--CA 1.41 -3.063 0 N-CA-C 107.538 -2.225 . . . . 73.43 107.538 -172.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 29.5 mtpp -124.77 151.79 44.68 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 117.721 0.76 . . . . 71.11 111.962 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 95.0 mtt180 -116.17 126.22 53.38 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.821 -1.178 . . . . 65.14 107.821 167.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.2 mp -123.93 142.08 51.46 Favored 'General case' 0 CA--C 1.465 -2.29 0 CA-C-N 116.536 -0.302 . . . . 53.14 110.49 -172.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -98.19 114.95 27.35 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 115.104 -0.953 . . . . 70.23 108.929 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . 0.436 HG22 ' CG ' ' A' ' 504' ' ' ARG . 54.9 mt -118.86 129.58 74.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-N 114.893 -1.049 . . . . 72.12 109.463 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.2 mt-30 -115.86 127.94 55.41 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 113.046 0.758 . . . . 72.34 113.046 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 502' ' ' ASP . 3.9 mm? -115.64 137.86 51.65 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 115.009 -0.996 . . . . 60.13 109.769 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 465' ' ' LYS . 34.5 ttpt -107.48 135.96 48.08 Favored 'General case' 0 N--CA 1.4 -2.939 0 N-CA-C 108.867 -0.79 . . . . 75.53 108.867 -177.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.405 ' HB2' HG21 ' A' ' 534' ' ' THR . 39.4 ttmt -61.76 98.59 0.1 Allowed 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.639 0.733 . . . . 73.42 111.601 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -130.86 139.55 11.04 Favored Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 108.375 -1.89 . . . . 61.51 108.375 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 469' ' ' GLU 0.365 7.3 t 52.75 -81.55 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.104 1.361 . . . . 72.23 113.819 -175.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . 0.407 ' OE1' ' HG3' ' A' ' 496' ' ' ARG . 37.9 mt-10 -106.79 -7.68 17.09 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.732 0.697 . . . . 65.52 110.858 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 67.8 -157.04 52.42 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.255 -0.884 . . . . 72.43 111.826 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.452 HD22 ' CD1' ' A' ' 531' ' ' LEU . 5.3 mp -44.4 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.32 1.23 . . . . 74.02 114.32 -170.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -97.54 65.11 0.89 Allowed Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.018 -1.446 . . . . 52.4 111.291 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.44 ' CE2' HD12 ' A' ' 531' ' ' LEU . 27.1 p90 -155.44 147.84 23.88 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.193 -0.504 . . . . 75.15 110.184 176.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -126.27 162.77 24.69 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.474 -0.785 . . . . 73.44 109.446 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.2 pt -119.68 155.46 22.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 120.95 0.405 . . . . 72.22 111.703 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.9 t -135.68 129.53 32.87 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.877 -0.601 . . . . 74.02 110.239 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 24.0 t -143.67 130.75 20.63 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.621 -0.881 . . . . 75.21 108.621 173.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -126.29 38.41 4.14 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 107.297 -1.371 . . . . 72.21 107.297 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . 0.585 ' HA ' ' CB ' ' A' ' 486' ' ' ALA . 9.2 t70 69.26 -163.03 0.18 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 112.522 -2.126 . . . . 73.44 108.171 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.491 ' CG1' ' HD3' ' A' ' 487' ' ' PRO . 33.6 m -91.4 16.67 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.959 -1.126 . . . . 65.12 107.959 177.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 23.7 m 77.83 73.56 0.06 Allowed 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 125.539 1.536 . . . . 74.21 108.575 -173.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 54.0 mt 65.41 90.64 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 113.482 -1.69 . . . . 51.0 111.296 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -167.05 -52.65 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.888 -0.672 . . . . 72.3 112.429 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.8 -27.66 6.42 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.301 -0.476 . . . . 72.14 112.644 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 9.9 p -86.72 40.26 0.89 Allowed 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.131 0.972 . . . . 64.12 111.731 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . 0.585 ' CB ' ' HA ' ' A' ' 479' ' ' ASP . . . -43.12 117.93 2.38 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 125.267 1.427 . . . . 61.15 114.444 -175.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.491 ' HD3' ' CG1' ' A' ' 480' ' ' VAL . 55.6 Cg_endo -89.13 143.33 4.75 Favored 'Trans proline' 0 N--CA 1.436 -1.895 0 C-N-CA 122.515 2.143 . . . . 75.22 109.998 174.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 41.9 mm -96.24 139.65 18.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 109.325 -0.62 . . . . 74.13 109.325 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.17 153.4 48.59 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 122.311 -0.243 . . . . 73.15 110.575 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 26.3 t -73.74 121.32 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.86 -1.163 . . . . 73.44 107.86 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -90.38 -52.44 4.92 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.563 0.697 . . . . 73.4 110.976 -176.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -146.32 150.89 36.6 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.414 -0.812 . . . . 53.15 110.3 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.482 HG12 ' HB1' ' A' ' 507' ' ' ALA . 34.6 mm -119.96 104.83 16.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 107.444 -1.317 . . . . 62.44 107.444 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -62.9 122.62 75.87 Favored Pre-proline 0 C--N 1.307 -1.253 0 CA-C-N 115.585 -0.734 . . . . 71.31 109.83 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.36 22.79 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 124.768 3.645 . . . . 74.23 114.3 -171.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.407 ' HG3' ' OE1' ' A' ' 469' ' ' GLU . 8.3 ptp180 -157.43 6.99 0.15 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 113.437 0.903 . . . . 72.43 113.437 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -101.14 -149.96 23.54 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 119.814 -1.184 . . . . 74.14 112.449 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -64.09 -40.29 95.9 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.156 0.582 . . . . 70.0 111.207 -176.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.8 71.01 Favored 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 115.545 -0.752 . . . . 73.31 112.635 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.8 tt -80.72 -42.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.445 0.535 . . . . 62.31 112.445 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 501' ' ' GLN . 14.7 mm-40 -61.46 -37.73 84.66 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.057 0.392 . . . . 73.31 112.057 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.472 ' HB2' HD12 ' A' ' 464' ' ' LEU . 17.5 m-20 -94.93 -28.98 14.9 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 109.442 -0.577 . . . . 72.24 109.442 175.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 57.7 28.7 60.45 Favored Glycine 0 CA--C 1.496 -1.1 0 CA-C-N 115.467 -0.788 . . . . 74.13 114.36 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.436 ' CG ' HG22 ' A' ' 462' ' ' ILE . 26.7 tpt180 -99.4 -13.94 19.36 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.248 -0.581 . . . . 73.24 110.772 -174.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 49.7 tp -123.41 148.1 46.46 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.541 0.21 . . . . 74.43 110.449 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 506' ' ' LYS . 0.0 OUTLIER -141.98 165.41 27.53 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.764 -0.828 . . . . 71.24 108.764 177.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.482 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -85.39 130.62 34.55 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.48 -0.563 . . . . 62.4 109.48 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 140.85 -20.28 2.71 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.211 -0.756 . . . . 60.43 111.211 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -89.17 165.76 14.26 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-O 121.132 0.491 . . . . 74.52 111.419 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.564 ' NH1' HD12 ' A' ' 512' ' ' ILE . 2.2 tmt_? -107.79 141.03 39.98 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 116.042 -0.526 . . . . 71.21 110.026 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.641 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.6 mm? -86.79 129.09 35.01 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.861 -0.609 . . . . 70.04 112.29 -175.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.564 HD12 ' NH1' ' A' ' 510' ' ' ARG . 32.8 mm -106.69 -59.17 3.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.405 -0.361 . . . . 74.14 110.141 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -158.81 149.27 19.8 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.393 0.433 . . . . 75.14 110.38 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 6.0 p -123.03 129.91 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 109.115 -0.698 . . . . 61.45 109.115 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 60.91 2.77 0.57 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.539 1.135 . . . . 71.54 113.746 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 113.57 -4.28 24.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 121.051 -0.595 . . . . 73.22 112.511 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.5 t -93.22 134.73 30.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.385 -0.598 . . . . 72.02 109.385 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -77.63 145.72 36.56 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 123.601 0.563 . . . . 62.51 110.145 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.641 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 18.8 mt -101.48 -38.14 8.12 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.901 -0.778 . . . . 73.45 108.901 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.22 104.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 115.185 -0.916 . . . . 74.31 108.561 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 136.33 -21.19 3.48 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 108.934 -1.666 . . . . 73.24 108.934 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.513 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -118.97 172.83 7.27 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.514 -0.343 . . . . 74.21 110.511 177.247 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 23.8 m -89.24 161.77 16.24 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.326 -0.397 . . . . 75.13 111.226 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -57.83 -46.63 84.46 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 123.005 0.522 . . . . 71.12 111.563 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.453 ' O ' HG23 ' A' ' 528' ' ' VAL . 48.5 mt-10 -58.18 -32.89 68.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.178 -0.465 . . . . 70.34 112.118 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.13 -41.62 90.22 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.325 -0.62 . . . . 73.42 109.325 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 44.2 t -70.28 -37.34 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 115.495 -0.775 . . . . 75.34 110.199 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.653 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.1 m -66.29 -41.26 88.73 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.439 0 C-N-CA 119.731 -0.788 . . . . 54.13 110.514 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.6 t -63.19 -42.95 99.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.205 0.526 . . . . 71.31 109.718 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 29.1 tp -59.96 -34.93 73.94 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.838 1.255 . . . . 73.11 110.099 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.452 ' CD1' HD22 ' A' ' 471' ' ' LEU . 26.5 tp -77.64 -47.98 17.95 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.856 -0.611 . . . . 54.24 110.312 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.653 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 4.8 mmp_? -57.79 -41.06 81.31 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.005 0.522 . . . . 75.23 110.887 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 46.0 m -60.34 -30.2 69.38 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.878 -0.601 . . . . 64.12 111.562 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' THR . . . . . 0.405 HG21 ' HB2' ' A' ' 466' ' ' LYS . 40.8 m 67.26 -91.14 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.399 0.68 . . . . 71.23 111.76 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 88.6 tttt 164.93 144.35 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 104.535 -2.394 . . . . 74.24 104.535 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 85.0 mtp -66.91 -25.49 66.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.769 0.713 . . . . 63.34 111.444 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.87 -65.65 0.65 Allowed 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.053 -1.091 . . . . 75.1 108.053 172.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 143.39 -31.56 1.92 Allowed Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 119.084 -1.532 . . . . 64.12 114.662 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 1.8 m -94.57 142.19 27.73 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.344 -0.943 . . . . 75.42 109.214 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 58.2 t -122.43 142.16 39.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 123.575 0.75 . . . . 75.33 109.062 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.7 m -105.76 113.4 26.94 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.44 0.638 . . . . 74.44 110.674 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.422 HD21 HD23 ' A' ' 464' ' ' LEU . 2.6 mm? -102.36 119.03 38.13 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.899 -1.148 . . . . 74.14 107.899 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 2.9 tm? -104.77 115.95 31.19 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 105.216 -2.142 . . . . 75.22 105.216 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 32.7 m -117.41 161.01 16.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.024 -0.989 . . . . 73.44 111.328 -174.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 86.9 t80 -112.06 117.96 34.1 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 108.399 -0.963 . . . . 73.11 108.399 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -105.82 131.9 52.59 Favored 'General case' 0 N--CA 1.411 -2.382 0 N-CA-C 107.968 -1.123 . . . . 74.14 107.968 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -78.94 134.97 36.82 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 116.117 -0.492 . . . . 65.1 110.218 -175.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -107.57 101.97 11.26 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.502 0.668 . . . . 73.4 109.678 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 C--N 1.292 -1.934 0 N-CA-C 107.687 -1.227 . . . . 74.33 107.687 179.852 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.997 0 N-CA-C 110.308 -1.117 . . . . 55.14 110.308 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 23.1 p -89.72 88.79 7.51 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.381 0.61 . . . . 73.52 111.414 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -87.19 101.6 13.66 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.547 -0.908 . . . . 74.4 108.547 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -128.06 100.28 5.81 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.244 -0.435 . . . . 72.12 110.69 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 23.6 p -98.54 142.93 29.52 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.84 -0.618 . . . . 65.15 109.951 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -82.54 -34.11 27.95 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.157 0.503 . . . . 72.14 110.281 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -105.25 149.56 25.88 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.504 -0.924 . . . . 74.12 108.504 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 10.6 tt -100.63 85.3 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 122.094 0.95 . . . . 72.14 112.032 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 546' ' ' ARG . . . -112.87 92.12 0.61 Allowed Glycine 0 CA--C 1.485 -1.829 0 N-CA-C 108.607 -1.797 . . . . 54.41 108.607 174.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -136.86 169.64 17.43 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.822 0.344 . . . . 61.15 110.819 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 71.3 mtm180 -100.43 148.78 24.36 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.633 -0.712 . . . . 73.34 109.306 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -130.95 134.22 46.54 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.283 -0.636 . . . . 73.41 109.283 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -92.88 115.47 28.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.909 -1.145 . . . . 74.34 107.909 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 60.6 mt -119.94 137.64 53.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 115.746 -0.661 . . . . 73.03 109.844 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.0 mt-30 -120.83 127.52 52.0 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.744 0.646 . . . . 73.04 112.744 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.48 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.2 mm? -113.8 142.13 46.45 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 114.895 -1.048 . . . . 63.55 111.002 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -101.34 127.33 48.01 Favored 'General case' 0 N--CA 1.398 -3.029 0 N-CA-C 107.584 -1.265 . . . . 72.2 107.584 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.11 95.6 0.13 Allowed 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.903 -0.59 . . . . 61.52 109.594 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -136.95 153.51 21.79 Favored Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 115.511 -0.768 . . . . 37.19 111.856 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 22.0 m 59.28 -91.74 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.945 1.298 . . . . 74.22 111.497 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -101.84 -3.98 27.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.291 0.567 . . . . 75.11 109.918 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.29 -161.22 54.21 Favored Glycine 0 C--O 1.205 -1.706 0 CA-C-O 118.922 -0.932 . . . . 70.44 111.595 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.436 HD12 HG22 ' A' ' 540' ' ' VAL . 66.4 mt -48.36 99.94 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.832 0.825 . . . . 74.24 112.712 -171.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -111.28 61.0 0.31 Allowed Glycine 0 CA--C 1.479 -2.184 0 CA-C-N 114.567 -1.197 . . . . 44.23 111.641 -174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -150.13 142.26 24.06 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 109.138 -0.69 . . . . 71.52 109.138 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.5 p -115.53 155.19 28.0 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.943 -0.571 . . . . 73.34 110.58 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.6 pt -116.33 150.34 18.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.059 0.457 . . . . 64.23 111.757 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' THR . . . . . 0.403 ' CB ' ' HE3' ' A' ' 491' ' ' LYS . 9.0 t -136.22 147.07 47.43 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.476 -0.784 . . . . 72.54 109.987 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 57.9 p -142.41 131.74 23.53 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.862 -0.792 . . . . 74.34 108.862 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -107.86 -68.87 0.88 Allowed 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.618 -0.433 . . . . 64.32 112.069 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -152.28 144.11 23.66 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.215 -1.032 . . . . 70.44 108.215 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.49 HG21 ' H ' ' A' ' 484' ' ' GLY . 13.7 p -72.25 125.24 30.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.549 0.69 . . . . 74.43 112.174 -176.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 30.0 m -109.61 78.7 1.15 Allowed 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 108.492 -0.929 . . . . 71.4 108.492 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 62.1 mt 58.75 98.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.482 1.113 . . . . 73.5 112.289 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 173.94 -59.09 0.13 Allowed Glycine 0 C--N 1.318 -0.456 0 C-N-CA 120.222 -0.99 . . . . 43.24 113.05 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . 0.49 ' H ' HG21 ' A' ' 480' ' ' VAL . . . -176.68 -121.5 0.67 Allowed Glycine 0 C--N 1.312 -0.75 0 C-N-CA 120.856 -0.688 . . . . 37.19 111.615 -177.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' SER . . . . . 0.408 ' O ' ' HB ' ' A' ' 480' ' ' VAL . 50.1 m -73.78 -59.08 2.88 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.939 0.4 . . . . 73.45 111.336 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -161.96 153.81 15.97 Favored Pre-proline 0 N--CA 1.438 -1.039 0 N-CA-C 108.293 -1.003 . . . . 62.03 108.293 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 480' ' ' VAL . 9.6 Cg_endo -93.61 134.68 1.0 Allowed 'Trans proline' 0 N--CA 1.433 -2.061 0 C-N-CA 122.369 2.046 . . . . 71.31 109.974 176.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.19 132.14 41.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.34 -0.615 . . . . 54.31 109.34 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 90.8 m-85 -129.02 152.76 48.28 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 110.31 -0.255 . . . . 71.3 110.31 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.39 119.51 30.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.469 -0.937 . . . . 75.04 108.469 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.403 ' HE3' ' CB ' ' A' ' 476' ' ' THR . 4.7 tppp? -82.15 -59.62 2.5 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.791 -0.64 . . . . 74.14 110.722 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -140.16 155.49 46.93 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 120.316 -0.554 . . . . 61.35 110.675 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.498 HG12 ' HB1' ' A' ' 507' ' ' ALA . 33.8 mm -119.2 104.8 16.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.306 -1.368 . . . . 62.3 107.306 177.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.23 130.53 89.5 Favored Pre-proline 0 C--N 1.307 -1.282 0 CA-C-N 116.022 -0.535 . . . . 63.54 111.084 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.81 18.03 0.2 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 125.027 3.818 . . . . 73.12 115.45 -171.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -161.13 6.81 0.07 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 113.916 1.08 . . . . 72.11 113.916 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -91.63 -155.86 32.17 Favored Glycine 0 C--N 1.294 -1.754 0 C-N-CA 119.464 -1.35 . . . . 73.12 113.085 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . 0.444 ' C ' HD11 ' A' ' 464' ' ' LEU . . . -63.39 -41.6 98.78 Favored 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 123.942 0.897 . . . . 72.03 109.876 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . 0.47 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -56.65 -43.81 80.69 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 114.856 -1.065 . . . . 75.43 112.074 -173.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 500' ' ' ILE . 12.1 tt -80.49 -29.34 12.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 112.19 0.441 . . . . 65.42 112.19 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -48.26 81.3 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.226 -1.028 . . . . 71.01 108.226 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.48 ' HB2' HD13 ' A' ' 464' ' ' LEU . 10.2 m-20 -87.08 -34.23 19.22 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 109.789 -0.449 . . . . 62.4 109.789 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 62.45 39.59 98.0 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.504 -0.771 . . . . 65.32 112.538 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -111.36 -4.89 14.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.33 0.586 . . . . 71.21 109.917 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 57.7 tp -125.73 142.74 51.36 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.857 -0.611 . . . . 71.51 110.546 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.456 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.28 0.0 OUTLIER -138.51 164.55 29.14 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.17 -0.468 . . . . 70.13 111.854 175.451 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.498 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -83.46 156.43 22.89 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.655 0.613 . . . . 75.21 112.655 -171.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.5 8.0 55.17 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.99 -0.624 . . . . 73.25 113.682 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -113.33 164.96 12.91 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 117.388 0.594 . . . . 63.42 110.191 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -89.95 129.32 36.3 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 123.095 0.247 . . . . 74.31 110.624 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.455 HD12 HD12 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.93 124.33 33.02 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 106.069 -1.826 . . . . 75.31 106.069 177.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 50.7 mm -96.3 -51.11 11.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 120.562 0.22 . . . . 53.54 111.258 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -157.99 148.85 20.9 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 116.102 -0.499 . . . . 74.24 109.66 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 541' ' ' SER . 3.7 p -130.05 125.51 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.523 0 CA-C-N 116.025 -0.534 . . . . 71.32 109.566 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 59.51 26.9 15.94 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 114.864 -1.062 . . . . 75.41 112.067 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.54 -4.8 73.41 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.748 -0.66 . . . . 63.33 113.367 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.44 124.84 47.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.393 -0.595 . . . . 71.13 109.393 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -84.01 141.69 31.01 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.727 0.642 . . . . 74.35 109.382 -173.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 19.0 mt -99.72 -42.96 6.63 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.161 0.8 . . . . 73.21 113.161 -171.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.14 89.08 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-O 122.23 1.014 . . . . 74.24 110.629 -174.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 151.03 -13.87 0.85 Allowed Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 113.994 -1.457 . . . . 73.24 109.693 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.482 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -117.82 177.78 4.65 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 122.85 -0.206 . . . . 74.44 110.89 175.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 48.9 m -88.61 156.68 18.9 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.514 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.417 ' O ' HG12 ' A' ' 528' ' ' VAL . 34.2 tt0 -58.76 -44.38 90.59 Favored 'General case' 0 C--O 1.21 -0.996 0 C-N-CA 122.487 0.315 . . . . 71.14 110.514 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 528' ' ' VAL . 28.3 mm-40 -57.72 -31.46 66.44 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 112.661 0.615 . . . . 61.55 112.661 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -66.58 -39.8 88.62 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.188 -0.671 . . . . 71.22 109.188 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 33.8 t -75.48 -36.39 35.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.135 -0.938 . . . . 73.24 110.285 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.693 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 10.7 m -63.67 -44.81 98.58 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 C-N-CA 120.351 -0.54 . . . . 65.3 109.933 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.7 m -64.51 -36.98 85.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.4 0.619 . . . . 74.5 110.267 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 32.6 tp -61.03 -43.6 98.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.736 1.214 . . . . 63.32 109.428 175.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 35.2 tp -67.3 -48.03 68.83 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.75 -0.659 . . . . 74.24 109.845 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.693 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 32.2 mmm180 -57.41 -30.11 64.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.731 0.813 . . . . 64.42 111.192 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 61.2 m -73.6 -43.64 59.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.925 -0.579 . . . . 62.12 111.532 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 40.4 m 68.26 142.2 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.664 0.786 . . . . 74.14 111.311 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . 0.445 ' H ' HG21 ' A' ' 540' ' ' VAL . 60.4 tptt -59.9 132.17 53.12 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.636 -0.711 . . . . 74.42 109.641 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -63.35 -20.11 65.22 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.513 0.725 . . . . 64.23 111.938 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 38.4 tt0 -73.89 -15.17 61.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.492 0.663 . . . . 70.31 110.253 177.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 94.69 -20.29 49.37 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.085 -0.579 . . . . 71.11 112.333 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 2.7 m -114.19 128.79 56.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.748 -1.204 . . . . 72.23 107.748 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 57.4 t -105.23 134.19 47.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 C-N-CA 122.816 0.446 . . . . 61.14 110.5 -176.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 29.9 m -98.48 115.14 27.9 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.744 -0.662 . . . . 54.2 110.832 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.429 HD21 HD23 ' A' ' 464' ' ' LEU . 2.7 mm? -110.95 124.68 52.6 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.4 -0.963 . . . . 60.1 108.4 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 53.0 tp -104.23 118.34 36.41 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.534 -1.654 . . . . 75.23 106.534 174.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.4 m -116.06 145.59 21.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 120.293 -0.563 . . . . 74.24 111.27 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -112.02 116.42 30.53 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.066 -1.086 . . . . 74.1 108.066 175.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . 0.496 ' O ' ' HA2' ' A' ' 457' ' ' GLY . 0.0 OUTLIER -103.7 120.89 41.85 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 108.2 -1.037 . . . . 73.44 108.2 178.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -98.37 143.53 28.73 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.993 -0.549 . . . . 74.14 109.843 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . 0.427 ' HB2' ' NH1' ' A' ' 546' ' ' ARG . 31.4 tt0 -116.88 110.18 18.01 Favored 'General case' 0 N--CA 1.418 -2.034 0 C-N-CA 120.468 -0.493 . . . . 64.2 110.065 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--O 1.25 1.104 0 CA-C-N 114.682 -1.144 . . . . 74.44 111.149 -177.817 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.544 0 N-CA-C 111.497 -0.641 . . . . 44.14 111.497 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 40.7 t -73.05 -42.21 63.36 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.765 -0.828 . . . . 74.13 108.765 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -144.65 154.27 42.62 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 107.373 -1.343 . . . . 74.34 107.373 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -79.0 113.21 16.94 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 120.43 -0.508 . . . . 65.13 109.928 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 27.4 m -75.84 99.32 4.42 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.783 -0.821 . . . . 71.34 108.783 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -110.21 98.96 8.1 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 116.17 -0.468 . . . . 74.44 111.418 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -137.05 115.1 11.52 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.703 -0.851 . . . . 72.23 108.703 176.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 38.0 pt -90.77 1.81 7.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 122.483 1.135 . . . . 72.3 108.639 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 158.76 145.17 4.16 Favored Glycine 1 N--CA 1.395 -4.039 0 N-CA-C 108.355 -1.898 . . . . 65.53 108.355 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.633 ' HE2' ' H ' ' A' ' 458' ' ' LYS . 0.0 OUTLIER -137.83 170.64 15.7 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 109.538 -0.542 . . . . 62.54 109.538 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 97.6 mtt180 -99.13 142.28 30.82 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.881 -0.785 . . . . 74.21 108.881 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.1 mm? -123.72 133.71 53.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.189 -0.671 . . . . 73.11 109.189 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -100.07 116.62 32.51 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.454 -0.943 . . . . 64.35 108.454 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 57.0 mt -123.3 125.02 71.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.61 -0.723 . . . . 73.54 110.959 -173.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.8 mt-30 -91.52 126.78 36.72 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.993 0.738 . . . . 61.42 112.993 178.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.1 mm? -115.79 144.34 44.12 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.4 1.08 . . . . 72.05 110.332 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -103.03 136.67 42.41 Favored 'General case' 0 N--CA 1.404 -2.75 0 N-CA-C 107.833 -1.173 . . . . 73.51 107.833 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.442 ' HE2' HG21 ' A' ' 534' ' ' THR . 23.5 ttmm -54.44 99.58 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.766 0.794 . . . . 72.14 111.328 175.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -85.3 -147.57 9.49 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 114.943 -1.026 . . . . 73.32 111.454 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 16.7 m -55.41 -45.41 76.72 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.978 0.511 . . . . 61.21 110.946 -177.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.59 9.81 17.98 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 120.691 0.281 . . . . 62.32 111.137 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 58.01 -141.96 44.71 Favored Glycine 0 C--O 1.185 -2.967 0 CA-C-O 117.17 -1.905 . . . . 63.23 109.804 -170.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 531' ' ' LEU . 2.5 mm? -44.08 108.61 0.12 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.54 1.67 . . . . 70.51 112.459 -173.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -100.19 47.78 1.25 Allowed Glycine 0 N--CA 1.421 -2.311 0 CA-C-N 114.55 -1.204 . . . . 53.42 112.433 -173.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -140.92 144.8 35.39 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 109.356 -0.609 . . . . 72.32 109.356 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 18.8 m -114.6 139.38 49.66 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.889 -1.523 . . . . 52.32 106.889 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 489' ' ' TYR . 14.8 pt -111.46 151.24 13.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-O 120.976 0.417 . . . . 62.51 112.072 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -144.73 151.17 38.49 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.888 -0.596 . . . . 73.23 109.618 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 78.3 p -142.67 129.88 20.94 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.138 -0.69 . . . . 54.41 109.138 175.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -153.28 14.97 0.52 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.008 0.908 . . . . 61.12 109.065 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -106.46 11.29 30.9 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.709 -1.132 . . . . 72.34 108.78 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.413 ' HB ' ' CB ' ' A' ' 486' ' ' ALA . 7.6 p -79.48 84.7 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-O 122.032 0.92 . . . . 70.41 111.431 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.4 t -145.8 4.91 1.0 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.481 -0.781 . . . . 74.02 110.435 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.444 HD11 ' N ' ' A' ' 482' ' ' ILE . 2.7 mp -103.93 10.32 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 N-CA-C 106.803 -1.554 . . . . 74.23 106.803 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 140.73 -120.62 1.77 Allowed Glycine 0 N--CA 1.427 -1.951 0 CA-C-N 114.607 -1.178 . . . . 63.05 110.246 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -121.72 9.25 9.91 Favored Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 108.142 -1.983 . . . . 74.05 108.142 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 13.6 p -79.73 65.01 4.76 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.487 -0.856 . . . . 75.3 110.721 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . 0.413 ' CB ' ' HB ' ' A' ' 480' ' ' VAL . . . -69.81 112.11 11.24 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-N 114.644 -1.162 . . . . 74.41 109.22 174.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.563 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 3.2 Cg_exo -77.41 135.25 14.69 Favored 'Trans proline' 0 N--CA 1.427 -2.422 0 C-N-CA 121.144 1.229 . . . . 64.12 110.166 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.48 HG13 ' HB3' ' A' ' 519' ' ' LEU . 34.2 mm -90.52 119.94 38.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.286 -1.005 . . . . 64.42 108.286 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 78.8 m-85 -121.63 152.95 38.75 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 122.281 -0.262 . . . . 74.52 111.492 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 47.2 t -78.56 119.06 26.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.973 -0.751 . . . . 74.22 108.973 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -84.52 -53.84 5.15 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.78 -0.646 . . . . 75.55 109.425 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -143.13 154.04 43.5 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.327 -0.852 . . . . 64.42 109.044 -175.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.432 HG12 ' HB1' ' A' ' 507' ' ' ALA . 26.2 mm -110.44 110.2 31.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.842 -1.17 . . . . 74.02 107.842 174.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 496' ' ' ARG . 6.0 mp -52.82 128.04 44.92 Favored Pre-proline 0 C--N 1.321 -0.665 0 O-C-N 123.941 0.776 . . . . 73.51 110.372 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.49 20.48 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 124.668 3.578 . . . . 71.32 114.908 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.454 ' O ' ' HB ' ' A' ' 468' ' ' THR . 14.2 ptp180 -168.82 5.9 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.323 0.583 . . . . 65.23 112.459 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -83.86 -167.87 42.81 Favored Glycine 0 C--N 1.298 -1.561 0 C-N-CA 119.893 -1.146 . . . . 65.43 112.663 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 464' ' ' LEU . . . -55.86 -47.4 77.39 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 124.932 1.293 . . . . 75.31 111.151 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.23 -40.6 77.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.743 -1.117 . . . . 72.53 112.559 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 8.5 tt -79.94 -40.43 20.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 112.57 0.582 . . . . 63.14 112.57 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 8.2 mm-40 -67.43 -37.87 83.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 72.34 110.841 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.483 ' HB2' HD13 ' A' ' 464' ' ' LEU . 7.8 m-20 -91.56 -21.95 20.59 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 116.116 -0.493 . . . . 63.55 109.87 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 63.92 55.78 22.46 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 120.742 -0.742 . . . . 54.54 114.803 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -123.85 -73.53 0.64 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.873 -0.731 . . . . 73.54 110.796 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . 0.42 HD11 HG13 ' A' ' 544' ' ' VAL . 67.4 tp -73.68 137.7 44.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.778 0.323 . . . . 64.13 111.807 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.402 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.267 0.0 OUTLIER -126.32 174.26 8.7 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.717 -0.674 . . . . 74.13 112.403 177.061 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.432 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -83.18 138.8 33.49 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 113.435 0.902 . . . . 62.13 113.435 -171.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 105.39 13.88 23.43 Favored Glycine 0 C--N 1.321 -0.253 0 CA-C-N 115.583 -0.735 . . . . 71.5 112.577 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.63 162.44 13.96 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 122.678 0.391 . . . . 74.3 110.398 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -101.45 134.36 44.66 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 120.81 -0.356 . . . . 74.04 110.649 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.588 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 3.6 mm? -86.97 132.99 33.63 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.553 -0.749 . . . . 62.01 110.171 174.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.7 mm -111.72 -39.07 3.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.06 -0.718 . . . . 74.42 109.06 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -154.72 148.43 25.42 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.517 -0.765 . . . . 61.12 109.156 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.491 HG11 HD21 ' A' ' 519' ' ' LEU . 6.8 p -136.51 125.47 37.07 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.077 0 N-CA-C 107.397 -1.334 . . . . 63.3 107.397 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 72.33 -52.27 0.7 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 125.982 1.713 . . . . 73.23 111.963 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 163.29 30.61 0.02 OUTLIER Glycine 0 C--N 1.287 -2.146 0 N-CA-C 109.519 -1.432 . . . . 72.21 109.519 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.1 t -122.5 134.43 65.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.305 -0.447 . . . . 64.2 109.902 -175.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.0 148.77 36.06 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.704 -0.48 . . . . 72.42 109.704 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.588 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 60.5 mt -111.51 -45.81 3.34 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 113.338 0.866 . . . . 73.32 113.338 -171.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.68 -1.31 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 113.146 0.795 . . . . 70.44 113.146 -172.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -112.41 12.18 25.95 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 111.616 -0.594 . . . . 63.13 111.616 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.567 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.2 OUTLIER -146.53 -177.59 5.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 117.172 0.486 . . . . 62.33 111.505 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' SER . . . . . 0.456 ' O ' HG21 ' A' ' 527' ' ' VAL . 76.3 p -96.17 163.3 13.16 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.214 0.53 . . . . 74.22 111.998 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.519 ' O ' HG12 ' A' ' 528' ' ' VAL . 37.9 mm-40 -55.24 -41.91 72.74 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.987 -1.006 . . . . 75.25 111.962 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.08 -31.81 73.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.105 0.479 . . . . 73.34 112.178 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.88 -36.03 67.28 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.737 -0.665 . . . . 75.01 110.529 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.544 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 17.5 t -75.39 -41.5 42.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.393 -0.595 . . . . 73.31 109.393 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.697 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.3 m -62.18 -43.46 97.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 120.356 -0.538 . . . . 74.22 110.942 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.9 t -64.5 -37.06 86.22 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.451 -0.341 . . . . 75.43 111.325 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 527' ' ' VAL . 1.2 pp -68.07 -37.54 81.39 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.011 -1.107 . . . . 73.53 108.011 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 471' ' ' LEU . 3.6 tt -62.98 -46.49 87.47 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.894 -1.048 . . . . 63.33 111.175 176.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 27.1 mmm180 -61.68 -33.63 74.32 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.127 -0.488 . . . . 73.13 110.409 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.0 m -82.96 -30.71 28.09 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.073 0.464 . . . . 74.12 110.685 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' THR . . . . . 0.442 HG21 ' HE2' ' A' ' 466' ' ' LYS . 30.5 m 71.98 -83.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.606 1.162 . . . . 65.31 112.115 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . 0.49 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 17.3 tppt? 167.27 157.64 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 106.405 -1.702 . . . . 75.53 106.405 -176.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.94 6.45 18.55 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.77 0.795 . . . . 72.03 110.212 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . 0.49 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 13.3 tp10 -96.88 -54.3 3.24 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.039 -1.096 . . . . 75.31 108.039 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 116.39 -20.21 12.54 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.322 -0.942 . . . . 72.51 112.587 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 3.4 m -104.7 136.23 44.6 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.987 -0.745 . . . . 72.3 108.987 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 87.2 t -123.43 136.69 59.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 123.139 0.575 . . . . 73.33 110.743 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.8 t -92.15 114.61 27.2 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.364 -0.606 . . . . 72.13 109.364 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 43.6 mt -99.51 119.72 38.48 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.498 -0.927 . . . . 61.44 108.498 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 45.5 tp -104.61 116.93 32.91 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.747 -1.575 . . . . 73.14 106.747 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 31.1 m -122.67 157.96 27.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.924 -0.58 . . . . 64.33 111.886 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -114.4 116.69 29.31 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.863 -0.608 . . . . 73.41 109.703 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -119.84 135.58 54.82 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.699 -0.682 . . . . 71.01 109.463 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -93.37 133.22 36.86 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.599 0.562 . . . . 73.12 111.583 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -102.21 133.02 47.75 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.475 -0.935 . . . . 74.15 108.475 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 C--N 1.292 -1.928 0 N-CA-C 108.992 -0.744 . . . . 73.3 108.992 -177.917 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.439 0 N-CA-C 110.88 -0.888 . . . . 38.63 110.88 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 51.5 m 64.36 86.49 0.12 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.778 0.831 . . . . 75.54 112.519 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -84.06 -52.95 5.89 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.94 -1.133 . . . . 72.23 107.94 175.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 16.2 m120 63.76 22.13 12.95 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.736 -1.12 . . . . 51.41 110.931 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 18.7 p -66.57 -39.02 88.27 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.893 -0.594 . . . . 70.53 110.323 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.92 95.77 10.24 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 109.118 -0.697 . . . . 74.25 109.118 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -132.22 158.2 42.37 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.247 -0.433 . . . . 73.33 110.127 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 11.8 tt -77.56 81.03 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 122.343 1.068 . . . . 74.45 110.767 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . 99.62 131.5 7.36 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 114.364 -1.289 . . . . 42.31 111.976 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 26.7 mtpp -103.5 157.51 16.99 Favored 'General case' 0 CA--C 1.478 -1.791 0 CA-C-O 121.363 0.601 . . . . 74.54 111.185 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 62.2 mtm180 -112.04 129.6 56.15 Favored 'General case' 0 N--CA 1.406 -2.663 0 N-CA-C 107.579 -1.267 . . . . 73.45 107.579 170.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -116.21 131.73 56.86 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.636 -0.875 . . . . 71.23 108.636 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -95.86 115.34 27.29 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.787 -0.82 . . . . 73.24 108.787 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . 0.431 HG23 ' CD2' ' A' ' 464' ' ' LEU . 60.8 mt -119.38 123.91 72.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 115.357 -0.838 . . . . 74.43 109.853 -175.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 47.6 mt-30 -102.37 130.55 49.15 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 121.824 -0.547 . . . . 53.31 112.282 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 539' ' ' THR . 4.3 mm? -115.06 139.48 49.84 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.848 -0.614 . . . . 73.2 111.958 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -91.04 132.67 35.87 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 123.849 0.859 . . . . 72.21 110.481 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -72.87 105.21 4.3 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 114.593 -1.185 . . . . 65.15 109.402 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -144.53 137.33 7.2 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.82 -0.627 . . . . 63.22 111.741 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 35.5 m 64.54 -79.11 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.468 1.107 . . . . 73.55 112.048 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -102.28 -11.34 18.79 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.127 -0.694 . . . . 74.21 109.127 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 66.8 -144.51 45.37 Favored Glycine 0 CA--C 1.473 -2.582 0 CA-C-O 117.528 -1.707 . . . . 55.42 108.924 -172.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.443 HD11 ' O ' ' A' ' 531' ' ' LEU . 43.4 mt -52.25 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.316 1.558 . . . . 75.2 112.275 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -102.43 59.64 0.55 Allowed Glycine 0 CA--C 1.464 -3.122 0 CA-C-N 114.256 -1.338 . . . . 54.11 111.237 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.402 ' CZ ' HD12 ' A' ' 542' ' ' LEU . 18.7 p90 -148.01 142.52 26.45 Favored 'General case' 0 C--N 1.258 -3.387 0 N-CA-C 108.117 -1.068 . . . . 72.21 108.117 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 20.0 m -115.0 143.81 44.6 Favored 'General case' 0 C--N 1.271 -2.843 0 N-CA-C 108.157 -1.053 . . . . 71.31 108.157 -176.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 10.2 pt -109.81 156.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-O 121.209 0.528 . . . . 54.4 111.502 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.1 t -136.63 141.21 43.21 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.908 -0.775 . . . . 75.4 108.908 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 59.3 p -114.44 130.7 56.73 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.749 -1.575 . . . . 60.41 106.749 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -155.91 -18.4 0.1 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 113.939 1.088 . . . . 74.25 113.939 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . 0.433 ' HB3' ' HD2' ' A' ' 487' ' ' PRO . 29.8 t70 -81.5 -5.04 57.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.279 1.038 . . . . 74.41 109.846 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 4.4 p -74.91 108.1 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-N 114.7 -1.137 . . . . 74.41 109.631 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.8 t -111.41 3.05 17.88 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.716 -0.674 . . . . 70.51 111.054 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 12.5 tt -153.42 -46.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 116.228 -0.442 . . . . 74.4 110.909 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 137.78 159.31 8.13 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 111.03 -0.828 . . . . 74.41 111.03 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 85.22 -61.74 4.6 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.676 -0.97 . . . . 74.42 110.676 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 26.6 m -87.18 84.02 7.32 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 108.442 -0.947 . . . . 74.11 108.442 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -122.57 98.8 43.02 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.835 -0.62 . . . . 75.21 111.372 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 479' ' ' ASP . 9.6 Cg_exo -74.92 134.93 18.56 Favored 'Trans proline' 0 C--O 1.255 1.347 0 C-N-CA 121.815 1.676 . . . . 74.14 109.464 172.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.529 HD11 ' OE1' ' A' ' 524' ' ' GLN . 41.1 mm -101.32 145.02 12.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.559 -1.275 . . . . 75.54 107.559 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -130.26 149.67 51.85 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 122.214 -0.304 . . . . 70.33 110.357 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 47.3 t -81.52 119.55 31.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.187 -1.042 . . . . 52.4 108.187 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -90.44 -52.51 4.88 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.237 0.615 . . . . 63.53 111.272 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -130.18 150.25 51.52 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.076 -0.649 . . . . 75.22 111.327 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.523 HG12 ' HB1' ' A' ' 507' ' ' ALA . 28.7 mm -121.22 104.97 15.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.624 -1.25 . . . . 51.1 107.624 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.49 133.97 95.85 Favored Pre-proline 0 C--N 1.311 -1.101 0 CA-C-N 115.437 -0.801 . . . . 64.31 111.283 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.82 14.09 0.55 Allowed 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 124.624 3.549 . . . . 74.31 114.952 -172.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -156.63 6.09 0.17 Allowed 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 120.016 -0.673 . . . . 71.42 112.606 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.604 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -91.23 -163.01 38.43 Favored Glycine 0 C--N 1.291 -1.936 0 C-N-CA 120.096 -1.049 . . . . 64.41 111.984 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . 0.448 ' C ' HD11 ' A' ' 464' ' ' LEU . . . -55.92 -40.9 73.76 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 125.016 1.326 . . . . 71.21 110.374 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.0 76.21 Favored 'General case' 0 C--O 1.194 -1.861 0 CA-C-N 114.5 -1.227 . . . . 74.23 112.515 -174.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 500' ' ' ILE . 11.5 tt -80.47 -29.57 12.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 112.216 0.45 . . . . 62.41 112.216 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.604 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 73.5 mm-40 -58.53 -45.75 88.22 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.333 -0.617 . . . . 62.24 109.333 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.431 ' HB2' HD13 ' A' ' 464' ' ' LEU . 3.3 m-20 -93.49 -38.28 11.49 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.486 -0.779 . . . . 71.03 110.561 175.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 71.8 17.11 76.54 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.847 -0.692 . . . . 73.21 113.304 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.408 ' CG ' HG22 ' A' ' 462' ' ' ILE . 27.5 tpt180 -91.32 -18.93 23.53 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.172 0.51 . . . . 75.33 110.822 -175.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 46.9 tp -108.52 150.49 27.38 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 110.159 -0.311 . . . . 75.0 110.159 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 506' ' ' LYS . 0.0 OUTLIER -143.98 170.25 16.28 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.38 -0.6 . . . . 74.3 109.38 178.048 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.523 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -89.33 150.2 22.68 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.982 0.42 . . . . 64.43 110.765 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 113.36 -30.56 7.21 Favored Glycine 0 C--N 1.303 -1.303 0 N-CA-C 111.088 -0.805 . . . . 70.15 111.088 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -68.37 146.99 52.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.112 0.482 . . . . 72.01 111.375 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 25.0 ttm180 -85.52 128.68 34.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.165 -0.679 . . . . 53.04 109.165 177.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.436 ' HG ' HD12 ' A' ' 519' ' ' LEU . 22.4 tp -90.03 127.72 36.12 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 108.494 -0.928 . . . . 73.12 108.494 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.2 mm -98.15 -41.54 10.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.079 0.466 . . . . 74.02 110.247 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -158.65 159.12 35.01 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.602 -0.726 . . . . 61.21 109.778 176.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.29 130.52 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 109.149 -0.685 . . . . 74.13 109.149 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 70.05 -48.1 0.62 Allowed 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 127.919 2.488 . . . . 71.13 111.867 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 169.49 8.3 0.03 OUTLIER Glycine 0 C--N 1.293 -1.81 0 CA-C-N 116.101 -0.5 . . . . 45.15 112.159 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 29.2 t -115.08 138.8 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.89 -0.781 . . . . 73.53 108.89 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -83.48 155.83 23.18 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 123.755 0.659 . . . . 75.42 110.28 -174.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 21.7 mt -104.79 -42.24 5.43 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.621 -0.718 . . . . 72.34 111.648 -174.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.7 t -72.37 91.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 115.571 -0.74 . . . . 63.45 109.747 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 144.63 -7.23 1.72 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 110.07 -1.212 . . . . 72.42 110.07 -174.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.417 ' HD3' ' CB ' ' A' ' 526' ' ' GLU . 17.5 ptpt -130.65 -178.46 4.8 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 110.021 -0.363 . . . . 74.13 110.021 175.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' SER . . . . . 0.404 ' O ' HG21 ' A' ' 527' ' ' VAL . 46.2 t -95.56 162.61 13.56 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.113 0.482 . . . . 63.11 111.014 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.529 ' OE1' HD11 ' A' ' 488' ' ' ILE . 7.3 tp60 -58.37 -38.88 78.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.946 -1.024 . . . . 75.32 110.328 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.99 -31.62 72.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.489 -0.778 . . . . 74.25 111.428 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.417 ' CB ' ' HD3' ' A' ' 522' ' ' LYS . 15.1 mm-40 -71.31 -39.89 71.14 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.893 -0.78 . . . . 75.22 108.893 177.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 523' ' ' SER . 18.4 t -69.34 -40.5 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.365 -0.834 . . . . 63.42 110.012 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.0 m -62.46 -42.56 96.16 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.111 0 C-N-CA 120.16 -0.616 . . . . 74.21 110.383 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.2 t -62.68 -43.31 99.12 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 116.203 -0.453 . . . . 65.21 110.133 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 46.8 tp -58.27 -45.99 86.86 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.522 1.129 . . . . 65.43 109.566 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.443 ' O ' HD11 ' A' ' 471' ' ' LEU . 2.4 tt -62.94 -45.45 92.43 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.391 -0.822 . . . . 72.42 112.362 175.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.7 OUTLIER -58.17 -39.58 79.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.243 0.544 . . . . 71.42 110.416 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.2 t -63.9 -43.57 95.61 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.211 -0.904 . . . . 74.22 110.672 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 63.0 m 67.51 -88.41 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.249 0.62 . . . . 63.01 110.811 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 40.5 tttm 172.74 153.74 0.08 Allowed 'General case' 0 C--O 1.251 1.164 0 N-CA-C 106.685 -1.598 . . . . 64.44 106.685 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 16.0 tpt -75.03 -35.71 61.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.418 -0.513 . . . . 72.42 109.946 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.11 -48.67 56.63 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.977 -0.556 . . . . 75.25 110.56 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 133.12 -28.54 3.31 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 118.564 -1.779 . . . . 61.12 115.984 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 4.5 m -94.93 135.18 36.75 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 118.625 -1.23 . . . . 74.32 109.805 -177.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 63.5 t -118.35 137.29 52.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.851 -0.613 . . . . 72.41 110.267 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 68.9 m -91.86 113.29 25.52 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.426 0.632 . . . . 72.11 111.039 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.418 HD21 HD23 ' A' ' 464' ' ' LEU . 3.6 mm? -101.36 122.41 43.68 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.657 -0.868 . . . . 73.53 108.657 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 36.9 tp -105.09 118.17 35.85 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.035 -1.469 . . . . 74.13 107.035 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 30.0 m -115.99 154.84 17.45 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 CA-C-O 121.042 0.449 . . . . 74.03 110.786 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 69.3 t80 -111.77 118.35 35.35 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.522 -0.918 . . . . 74.54 108.522 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -131.15 139.38 49.78 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.504 -1.295 . . . . 63.03 107.504 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -129.4 120.42 25.51 Favored 'General case' 0 C--N 1.269 -2.902 0 C-N-CA 120.298 -0.561 . . . . 64.21 109.823 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.67 99.03 4.91 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.256 -1.387 . . . . 62.24 107.256 173.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 108.958 -0.756 . . . . 71.44 108.958 -176.113 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.482 0 N-CA-C 111.566 -0.613 . . . . 38.18 111.566 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 35.2 p -76.21 146.46 39.07 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 122.229 0.212 . . . . 73.51 110.448 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -79.87 -67.39 0.77 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.938 -0.393 . . . . 74.23 109.938 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -148.96 103.37 3.35 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.791 -0.448 . . . . 64.21 109.791 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 29.3 p -119.74 155.98 31.44 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.328 -0.396 . . . . 73.52 111.898 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt 62.34 34.87 15.43 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.181 0.992 . . . . 72.13 111.81 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -75.48 144.49 42.03 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.463 -0.569 . . . . 61.34 109.463 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 29.6 pt -80.73 -17.2 12.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 112.208 0.447 . . . . 64.11 112.208 -174.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -133.57 109.26 0.8 Allowed Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 120.26 -0.971 . . . . 51.25 112.144 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -113.62 153.23 29.21 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 109.596 -0.52 . . . . 74.3 109.596 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.421 ' HB3' HD12 ' A' ' 543' ' ' LEU . 41.7 mtm180 -111.18 150.89 28.88 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.89 -0.595 . . . . 73.45 109.745 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.9 mm? -131.62 137.33 48.34 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.339 -0.615 . . . . 55.45 109.339 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -103.3 123.56 47.0 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.273 -0.64 . . . . 72.52 109.273 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 76.0 mt -119.26 120.8 64.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.197 -0.668 . . . . 75.31 109.197 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.0 mt-30 -100.75 127.27 47.24 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.39 0.614 . . . . 74.53 111.723 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 539' ' ' THR . 5.9 tp -114.96 140.33 49.11 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-N 114.655 -1.157 . . . . 72.12 108.281 -173.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 465' ' ' LYS . 1.3 tpmt? -101.98 121.98 43.19 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.303 -0.999 . . . . 64.31 108.303 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -63.49 92.02 0.06 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.786 -0.643 . . . . 73.13 110.103 175.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -116.47 142.87 17.81 Favored Glycine 0 N--CA 1.428 -1.845 0 CA-C-N 115.667 -0.697 . . . . 50.54 111.766 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 469' ' ' GLU 0.354 10.0 t 52.03 -82.86 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.11 1.764 . . . . 72.21 114.885 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . 0.48 ' H ' HG23 ' A' ' 468' ' ' THR . 32.9 tt0 -97.04 -15.02 21.23 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.847 0.832 . . . . 71.43 109.081 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.42 -155.85 51.67 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 114.981 -1.009 . . . . 75.33 113.419 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.446 HD21 HG22 ' A' ' 540' ' ' VAL . 5.8 mp -48.12 104.5 0.06 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 113.517 0.932 . . . . 63.21 113.517 -170.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -118.56 54.58 0.62 Allowed Glycine 0 N--CA 1.422 -2.261 0 CA-C-N 114.567 -1.197 . . . . 72.15 111.174 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.523 ' CZ ' HD12 ' A' ' 542' ' ' LEU . 16.2 p90 -136.64 142.24 43.24 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 109.292 -0.633 . . . . 75.55 109.292 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 37.1 p -115.26 153.41 30.94 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.948 -0.569 . . . . 74.02 109.963 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.41 151.3 21.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 121.076 0.465 . . . . 65.3 110.698 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.1 t -144.23 157.4 44.31 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.881 -0.599 . . . . 64.24 109.691 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 61.4 p -141.47 131.87 25.19 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.713 -1.217 . . . . 73.41 107.713 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -118.8 -60.2 1.79 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.94 0.4 . . . . 64.03 110.955 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -157.4 162.62 39.01 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.574 -0.898 . . . . 72.54 108.574 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.562 ' HA ' ' HD2' ' A' ' 487' ' ' PRO . 46.1 t -76.2 96.75 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-O 121.815 0.817 . . . . 70.3 109.889 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.6 p -85.32 -11.19 55.24 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.263 -1.335 . . . . 74.43 112.015 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.408 HG23 ' H ' ' A' ' 483' ' ' GLY . 6.4 tp -150.75 -59.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.547 -0.751 . . . . 75.13 112.075 -176.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . 0.408 ' H ' HG23 ' A' ' 482' ' ' ILE . . . 177.46 148.62 7.38 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.398 -1.081 . . . . 74.02 110.398 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.34 174.85 15.37 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.792 -0.923 . . . . 70.22 110.792 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 14.8 m -83.25 77.1 9.83 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.355 -0.98 . . . . 71.31 108.355 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 59.33 80.16 0.28 Allowed Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 114.414 -1.266 . . . . 75.31 109.691 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.562 ' HD2' ' HA ' ' A' ' 480' ' ' VAL . 6.1 Cg_exo -36.43 134.96 0.3 Allowed 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 124.43 3.42 . . . . 44.04 114.601 -177.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 34.6 mm -87.55 130.28 37.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.163 -0.926 . . . . 74.02 108.956 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -128.6 151.15 49.8 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 110.422 -0.214 . . . . 74.02 110.422 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 48.8 t -80.06 119.48 29.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.126 -1.064 . . . . 63.5 108.126 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -73.92 -60.74 2.12 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.102 -0.499 . . . . 74.25 110.536 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -145.51 158.04 43.9 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.369 0.604 . . . . 72.51 110.43 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.508 HG13 ' HA ' ' A' ' 506' ' ' LYS . 30.2 mm -116.49 104.92 17.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 106.597 -1.631 . . . . 73.53 106.597 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.33 137.42 94.48 Favored Pre-proline 0 C--N 1.304 -1.37 0 CA-C-N 115.242 -0.89 . . . . 72.43 111.035 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -73.34 17.16 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 124.789 3.659 . . . . 70.11 117.0 -167.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -159.87 3.94 0.08 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 115.132 1.53 . . . . 74.14 115.132 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -98.69 -154.81 29.01 Favored Glycine 0 C--N 1.297 -1.623 0 C-N-CA 119.672 -1.251 . . . . 74.04 113.834 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.72 86.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.096 0.958 . . . . 44.04 111.616 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . 0.415 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -58.11 -38.85 77.25 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.246 -0.888 . . . . 65.23 112.77 -176.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.5 tt -80.81 -32.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 112.286 0.476 . . . . 70.04 112.286 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 83.4 mm-40 -58.76 -41.92 87.72 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.998 0.428 . . . . 63.44 110.914 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -89.35 -39.76 13.22 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.017 -0.538 . . . . 73.51 110.204 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 77.87 -19.18 4.39 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 115.639 1.016 . . . . 74.3 115.639 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -64.84 -23.38 67.22 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.234 0.54 . . . . 74.43 111.214 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.3 tp -92.72 135.64 33.93 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.143 -0.688 . . . . 64.24 109.143 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.508 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -138.4 170.44 16.02 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.199 -0.297 . . . . 74.31 110.199 176.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.465 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -86.9 160.03 18.85 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.211 -0.449 . . . . 61.15 110.646 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 103.7 -29.21 12.66 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 121.054 -0.593 . . . . 74.41 113.014 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.56 162.31 24.36 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-O 121.28 0.562 . . . . 74.31 111.929 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.403 ' CZ ' HG22 ' A' ' 482' ' ' ILE . 20.0 ttm180 -90.13 126.98 35.99 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.023 -0.99 . . . . 64.03 109.23 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.486 HD12 HD12 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -88.28 123.7 33.14 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.012 -1.477 . . . . 72.54 107.012 178.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.54 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 35.5 mm -98.46 -47.63 12.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 120.956 0.408 . . . . 62.44 111.248 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -158.16 145.52 18.09 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.703 -0.68 . . . . 60.03 110.201 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 541' ' ' SER . 4.5 p -124.72 127.84 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 CA-C-O 121.276 0.56 . . . . 74.13 109.692 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 17.4 m120 59.46 15.6 4.6 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.873 1.269 . . . . 73.12 113.142 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.7 -7.77 33.99 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.682 -0.77 . . . . 63.33 113.854 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 67.3 t -97.77 127.09 50.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 117.563 0.681 . . . . 71.54 110.554 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.24 136.5 40.95 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 123.837 0.855 . . . . 73.14 111.423 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 13.4 mt -101.64 -23.81 14.2 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.649 0.738 . . . . 64.43 109.935 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.46 -24.56 35.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.498 -1.228 . . . . 74.45 111.47 -171.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -106.9 21.34 32.06 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.988 -0.625 . . . . 54.11 112.742 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.496 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -142.4 178.67 7.43 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.669 0.618 . . . . 75.1 112.669 178.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' SER . . . . . 0.434 ' O ' HG21 ' A' ' 527' ' ' VAL . 33.7 m -95.73 161.25 14.1 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.169 -0.469 . . . . 75.33 111.856 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -51.33 -46.72 62.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.997 1.319 . . . . 74.12 113.679 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.35 -35.05 74.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.199 0.444 . . . . 74.23 112.199 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -67.22 -40.32 86.4 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.135 -0.691 . . . . 53.15 109.135 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 523' ' ' SER . 30.0 t -70.38 -39.5 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 115.422 -0.808 . . . . 74.21 110.293 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.63 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.6 m -66.37 -39.95 85.43 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 C-N-CA 119.67 -0.812 . . . . 72.01 110.401 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.9 t -62.14 -38.86 90.57 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.489 0.661 . . . . 74.32 109.899 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.13 -39.64 94.47 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 123.861 0.865 . . . . 73.41 109.244 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 2.8 tt -66.61 -45.1 80.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.443 0.697 . . . . 75.33 111.241 173.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.63 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 29.3 mmm180 -62.58 -32.98 74.06 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.062 -0.517 . . . . 64.3 110.949 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.0 m -68.32 -30.5 69.5 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 116.111 -0.495 . . . . 72.32 110.572 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 535' ' ' LYS . 90.7 m 66.81 -86.93 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.301 -0.863 . . . . 74.35 111.462 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 534' ' ' THR . 25.6 tptp 162.92 154.37 0.02 OUTLIER 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.158 -2.164 . . . . 74.05 105.158 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 85.9 mtp -70.41 -20.99 62.88 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.44 0.564 . . . . 61.24 111.655 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.71 -13.98 43.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.355 0.598 . . . . 74.15 109.783 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 75.12 6.08 78.29 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.398 -0.819 . . . . 65.42 112.746 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 6.2 m -104.34 125.1 50.29 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.721 -1.215 . . . . 61.43 107.721 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.446 HG22 HD21 ' A' ' 471' ' ' LEU . 60.2 t -108.65 127.06 65.43 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 CA-C-N 115.673 -0.694 . . . . 72.15 109.329 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 14.9 m -102.12 111.95 24.42 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 119.907 -0.717 . . . . 75.41 109.114 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.523 HD12 ' CZ ' ' A' ' 473' ' ' PHE . 2.5 mm? -99.43 119.27 37.71 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.8 -1.185 . . . . 71.31 107.8 177.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.48 HD11 ' HB ' ' A' ' 512' ' ' ILE . 2.6 tm? -104.6 117.96 35.41 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 105.963 -1.866 . . . . 74.41 105.963 177.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.69 160.51 14.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.287 -0.869 . . . . 43.32 110.196 -174.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.526 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 25.5 t80 -122.53 130.49 53.1 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.418 -1.327 . . . . 73.44 107.418 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -129.87 118.27 21.46 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.266 0.555 . . . . 74.34 109.718 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -101.59 142.89 32.26 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.017 -0.992 . . . . 70.13 112.858 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -71.77 139.29 48.97 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 107.938 -1.134 . . . . 73.32 107.938 175.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 27.7 t70 . . . . . 0 C--N 1.304 -1.398 0 N-CA-C 109.273 -0.639 . . . . 71.43 109.273 -177.379 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.083 0 N-CA-C 110.314 -1.114 . . . . 61.31 110.314 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 39.6 m -125.51 85.99 2.48 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 121.034 0.445 . . . . 75.54 110.559 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -140.08 77.66 1.62 Allowed 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.398 -0.819 . . . . 74.31 110.544 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 454' ' ' LYS . 18.1 m120 -137.92 104.18 5.19 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.112 -1.07 . . . . 74.15 108.112 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 86.9 m 75.47 -18.42 0.45 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.505 0.722 . . . . 73.43 111.762 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 452' ' ' ASN . 32.7 mmtp 71.56 155.25 0.15 Allowed 'General case' 0 C--O 1.245 0.854 0 C-N-CA 124.567 1.147 . . . . 74.51 112.045 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -102.86 115.71 31.14 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 105.804 -1.924 . . . . 72.52 105.804 169.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 456' ' ' ILE . 2.1 mp -78.15 105.34 7.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.403 -0.591 . . . . 75.43 109.403 -174.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 126.37 135.6 4.26 Favored Glycine 0 N--CA 1.419 -2.49 0 CA-C-N 115.74 -0.664 . . . . 71.55 112.47 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -100.79 133.83 44.67 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 123.552 0.741 . . . . 72.11 110.356 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.505 ' C ' HD12 ' A' ' 460' ' ' LEU . 70.4 mtm180 -100.85 138.69 37.57 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 107.628 -1.249 . . . . 75.11 107.628 172.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 459' ' ' ARG . 6.1 mp -130.29 134.07 46.95 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 123.236 0.335 . . . . 72.4 110.221 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -94.38 115.71 27.96 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.66 -0.7 . . . . 71.53 109.189 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . 0.46 HG22 ' CG ' ' A' ' 504' ' ' ARG . 66.0 mt -120.92 141.92 39.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.659 -0.701 . . . . 74.5 110.356 -174.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 76.2 mt-30 -123.93 130.34 52.44 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.517 0.562 . . . . 75.54 112.517 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.2 mm? -115.6 133.48 55.99 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 124.122 0.969 . . . . 61.35 109.466 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 465' ' ' LYS . 22.5 ttpp -102.82 134.96 45.36 Favored 'General case' 0 N--CA 1.397 -3.096 0 CA-C-O 121.437 0.637 . . . . 75.43 109.839 -177.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -58.88 126.7 28.78 Favored 'General case' 0 C--N 1.268 -2.952 0 CA-C-N 114.699 -1.137 . . . . 62.33 109.561 175.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . 0.498 ' H ' ' HA2' ' A' ' 470' ' ' GLY . . . -140.22 -138.18 3.57 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 115.722 -0.672 . . . . 74.31 111.494 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 469' ' ' GLU . 10.0 t -50.08 -70.72 0.08 Allowed 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 123.7 0.8 . . . . 72.31 113.057 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . 0.481 ' H ' HG23 ' A' ' 468' ' ' THR . 0.6 OUTLIER -92.65 -2.62 55.94 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.451 -0.781 . . . . 73.54 110.351 175.038 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.498 ' HA2' ' H ' ' A' ' 467' ' ' GLY . . . 54.52 -149.23 19.65 Favored Glycine 0 C--O 1.2 -1.988 0 CA-C-N 114.603 -1.18 . . . . 39.01 113.264 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.421 HD12 HG22 ' A' ' 540' ' ' VAL . 66.2 mt -53.54 99.39 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 117.955 0.877 . . . . 54.25 111.324 -173.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -118.19 54.5 0.61 Allowed Glycine 0 N--CA 1.416 -2.673 0 CA-C-N 114.467 -1.242 . . . . 43.32 111.15 -174.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -137.56 141.28 41.36 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 114.984 -0.608 . . . . 74.53 109.441 173.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 36.7 m -118.41 148.92 42.05 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.489 -0.778 . . . . 63.54 109.508 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.3 pt -111.05 153.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.179 0.514 . . . . 74.12 111.822 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 491' ' ' LYS . 9.7 t -134.05 159.9 39.39 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.455 -1.313 . . . . 75.32 107.455 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 31.0 p -130.29 154.62 47.44 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.845 -0.428 . . . . 73.01 109.845 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . 0.42 ' O ' ' HD2' ' A' ' 487' ' ' PRO . 26.5 mtm180 -132.56 167.18 20.48 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 106.071 -1.826 . . . . 75.51 106.071 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -72.63 136.72 45.75 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.104 -1.073 . . . . 72.45 108.104 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.79 129.88 30.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 114.433 1.272 . . . . 64.42 114.433 -171.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 26.8 m -124.06 86.29 2.55 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 106.444 -1.687 . . . . 75.33 106.444 171.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 mp 68.28 103.07 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 124.135 0.974 . . . . 72.12 111.218 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 167.19 -30.34 0.18 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 119.962 -1.113 . . . . 74.34 113.732 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 132.59 -144.7 16.59 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.605 -0.998 . . . . 75.11 110.605 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 30.2 m -89.59 87.5 7.06 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.949 -0.7 . . . . 73.41 111.663 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . . . 67.57 120.55 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 124.872 1.269 . . . . 73.21 113.577 176.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.462 ' HA ' HG11 ' A' ' 520' ' ' VAL . 14.9 Cg_endo -88.68 135.86 3.05 Favored 'Trans proline' 0 N--CA 1.439 -1.677 0 C-N-CA 122.199 1.933 . . . . 62.53 112.311 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.495 ' O ' ' HG3' ' A' ' 510' ' ' ARG . 49.9 mm -97.19 136.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.515 -0.766 . . . . 73.13 109.5 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.593 ' CE1' ' HD3' ' A' ' 510' ' ' ARG . 95.1 m-85 -129.46 153.99 47.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 122.223 0.209 . . . . 71.45 111.003 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 44.6 t -80.15 119.47 29.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 107.733 -1.21 . . . . 72.44 107.733 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.402 ' HD2' ' HB ' ' A' ' 476' ' ' THR . 76.0 tttt -95.14 -46.6 6.71 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.52 0.676 . . . . 62.12 110.387 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -137.13 142.33 42.26 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.466 -0.788 . . . . 65.25 109.871 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.425 HG13 ' HA ' ' A' ' 506' ' ' LYS . 28.3 mm -123.93 101.9 10.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 N-CA-C 106.312 -1.736 . . . . 73.3 106.312 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 496' ' ' ARG . 3.4 mm? -65.89 126.85 92.54 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 115.934 -0.575 . . . . 72.31 110.972 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.07 34.38 0.33 Allowed 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 125.011 3.807 . . . . 70.22 112.73 -175.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.415 ' H ' ' C ' ' A' ' 494' ' ' LEU . 3.3 ptp180 -164.42 -4.63 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.867 0.691 . . . . 72.22 112.867 -176.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 500' ' ' ILE . . . -92.8 -158.7 34.53 Favored Glycine 0 C--N 1.302 -1.336 0 C-N-CA 119.115 -1.517 . . . . 75.02 112.596 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.71 85.77 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 124.119 0.968 . . . . 70.34 109.591 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -57.49 -37.79 73.53 Favored 'General case' 0 C--O 1.204 -1.31 0 CA-C-N 114.506 -1.224 . . . . 73.23 112.913 -176.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.432 HG21 ' O ' ' A' ' 497' ' ' GLY . 10.8 tt -81.47 -35.8 14.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.764 0.316 . . . . 73.4 111.83 176.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -58.64 -46.08 87.89 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.984 -0.553 . . . . 75.34 110.185 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.483 ' HB2' HD13 ' A' ' 464' ' ' LEU . 16.4 m-20 -89.47 -36.1 15.6 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.43 -0.581 . . . . 74.35 109.43 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.77 24.88 70.14 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.894 -0.594 . . . . 72.53 113.551 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.46 ' CG ' HG22 ' A' ' 462' ' ' ILE . 8.9 tpt180 -96.26 -11.84 25.4 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.434 -0.507 . . . . 72.41 110.625 -176.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 47.6 tp -120.29 154.19 35.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.687 -0.233 . . . . 74.3 110.654 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.425 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.1 OUTLIER -144.84 159.02 43.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.284 0.634 . . . . 72.42 111.517 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.402 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -83.46 155.55 23.35 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 120.798 0.332 . . . . 75.53 111.103 -176.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.82 18.06 57.0 Favored Glycine 0 C--N 1.312 -0.784 0 N-CA-C 110.713 -0.955 . . . . 63.43 110.713 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.636 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 16.3 t0 -108.74 165.54 11.47 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.99 -1.485 . . . . 72.22 106.99 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.593 ' HD3' ' CE1' ' A' ' 489' ' ' TYR . 44.9 ttp180 -107.64 122.29 46.4 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 118.572 0.624 . . . . 74.41 111.537 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.451 ' O ' HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.32 120.63 27.88 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 107.307 -1.368 . . . . 75.53 107.307 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.473 ' HB ' HD11 ' A' ' 543' ' ' LEU . 47.9 mm -98.39 -43.86 11.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 120.594 0.235 . . . . 74.41 111.579 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.405 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 9.3 pt-20 -156.99 148.05 21.89 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.833 -0.432 . . . . 72.04 109.833 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 541' ' ' SER . 5.7 p -129.57 128.44 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 109.77 -0.456 . . . . 75.42 109.77 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 58.61 21.24 8.49 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.137 0.975 . . . . 74.22 112.811 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.45 -5.97 60.89 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.192 -0.528 . . . . 70.45 113.25 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.88 132.37 39.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.608 -0.515 . . . . 63.15 109.608 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -77.3 144.37 38.15 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 123.862 0.726 . . . . 73.14 109.596 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.451 HD11 ' O ' ' A' ' 511' ' ' LEU . 22.7 mt -101.36 -52.51 3.23 Favored 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 120.51 -0.476 . . . . 61.21 111.116 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 487' ' ' PRO . 27.8 m -69.46 97.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.696 0 CA-C-O 122.605 1.193 . . . . 54.22 111.011 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.29 -31.74 1.15 Allowed Glycine 0 N--CA 1.419 -2.498 0 CA-C-N 113.477 -1.692 . . . . 73.53 108.989 -173.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.553 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -108.73 174.52 5.83 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.249 -0.476 . . . . 75.44 110.771 177.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 54.2 m -91.0 159.15 16.3 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.156 0.428 . . . . 75.55 112.156 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -56.95 -46.47 82.1 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.119 0.567 . . . . 72.13 111.752 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -58.86 -31.95 69.01 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.966 -0.561 . . . . 73.01 111.852 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.96 -41.73 90.87 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.709 -0.478 . . . . 73.25 109.709 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.71 -38.12 71.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.355 -0.839 . . . . 61.13 110.75 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.704 ' O ' ' HG3' ' A' ' 532' ' ' ARG . 19.7 m -65.26 -42.12 93.17 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.136 0 C-N-CA 119.443 -0.903 . . . . 64.45 110.135 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.0 m -62.31 -35.85 80.32 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.734 0.778 . . . . 65.42 109.813 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 22.8 tp -67.47 -36.28 80.84 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 124.941 1.296 . . . . 63.42 110.382 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 54.2 tp -76.36 -48.58 19.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.188 -0.46 . . . . 72.12 111.084 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.704 ' HG3' ' O ' ' A' ' 528' ' ' VAL . 20.4 mtm180 -54.7 -36.04 64.26 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.898 0.479 . . . . 65.22 111.013 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 34.1 t -66.45 -41.3 89.3 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.535 -0.757 . . . . 64.02 111.889 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 15.5 m 64.51 174.12 0.19 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 108.336 -0.987 . . . . 73.42 108.336 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . 0.723 ' HE2' ' O ' ' A' ' 539' ' ' THR . 37.0 mtmt -91.83 168.72 11.25 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 120.651 -1.28 . . . . 71.03 108.023 175.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 83.6 mtp -74.83 -23.01 58.38 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.058 0.456 . . . . 75.4 109.851 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.63 -64.19 0.95 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.724 -1.584 . . . . 73.03 106.724 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 138.08 -19.77 3.25 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 119.971 -1.109 . . . . 75.04 114.393 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.723 ' O ' ' HE2' ' A' ' 535' ' ' LYS . 4.8 m -94.23 136.22 34.76 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.364 -0.976 . . . . 75.44 108.364 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 91.7 t -111.59 136.31 48.09 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 C-N-CA 123.103 0.561 . . . . 74.22 110.583 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 36.2 t -98.73 119.54 37.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.142 0.496 . . . . 73.42 110.983 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.454 HD21 HD23 ' A' ' 464' ' ' LEU . 2.6 mm? -113.56 123.16 49.31 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.019 -1.104 . . . . 72.23 108.019 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.473 HD11 ' HB ' ' A' ' 512' ' ' ILE . 3.0 tm? -104.84 120.07 40.52 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 105.979 -1.859 . . . . 64.0 105.979 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.636 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 33.6 m -115.03 161.6 13.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.601 -0.727 . . . . 64.12 111.124 -173.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -129.72 116.41 18.74 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.829 -0.623 . . . . 75.05 110.468 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . 0.479 ' HD3' ' OD2' ' A' ' 509' ' ' ASP . 36.0 mtm-85 -129.2 137.45 51.14 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 116.139 -0.482 . . . . 72.15 111.238 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -132.56 143.44 49.72 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.868 -0.605 . . . . 72.25 109.857 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.43 92.45 4.61 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.265 -0.643 . . . . 73.4 109.265 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 C--O 1.251 1.182 0 CA-C-N 114.634 -1.166 . . . . 74.05 108.746 -176.21 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.086 0 N-CA-C 110.564 -1.014 . . . . 72.35 110.564 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 23.2 p -135.52 129.84 33.69 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.286 0.565 . . . . 73.13 111.495 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -101.04 -36.23 9.07 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.628 -0.714 . . . . 72.03 110.738 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -75.55 -19.42 59.32 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.737 -0.665 . . . . 74.22 112.427 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 21.9 p -72.34 -70.82 0.32 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.265 0.555 . . . . 73.31 112.437 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -125.53 139.92 53.19 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.868 -0.606 . . . . 75.13 109.82 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -115.67 122.77 46.56 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.063 -0.718 . . . . 75.24 109.063 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 15.6 tt -142.42 25.44 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-O 123.528 1.632 . . . . 63.53 106.775 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 154.2 144.3 3.88 Favored Glycine 0 N--CA 1.426 -2.008 0 CA-C-N 112.839 -1.982 . . . . 73.24 109.552 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -137.27 168.57 19.37 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 117.812 0.806 . . . . 74.35 110.937 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 92.5 mtt180 -104.69 139.64 39.22 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.023 -0.535 . . . . 74.5 110.404 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -127.82 135.4 50.01 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.147 0.579 . . . . 72.22 110.08 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -96.46 124.8 40.57 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.199 0.523 . . . . 74.32 109.788 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 66.4 mt -125.19 139.06 52.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 123.787 0.835 . . . . 72.33 109.467 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.9 mt-30 -120.78 126.97 51.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.663 0.986 . . . . 70.32 113.663 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.508 HD21 ' HA ' ' A' ' 499' ' ' ALA . 7.3 mp -118.15 150.29 39.62 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 124.833 1.253 . . . . 75.42 111.328 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -115.3 131.95 56.77 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.096 -1.075 . . . . 74.23 108.096 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.485 ' HE2' HG21 ' A' ' 534' ' ' THR . 24.0 ttmm -52.62 96.9 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 124.536 1.134 . . . . 71.11 112.086 177.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.14 -136.75 9.34 Favored Glycine 0 CA--C 1.519 0.32 0 CA-C-N 116.194 -0.457 . . . . 74.14 113.002 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 87.9 m -46.29 -65.42 0.56 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.641 1.176 . . . . 74.34 113.081 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.4 -2.18 52.43 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.226 -1.027 . . . . 75.2 108.226 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 60.56 -143.29 48.01 Favored Glycine 0 CA--C 1.473 -2.54 0 N-CA-C 108.885 -1.686 . . . . 38.47 108.885 -168.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.42 HD11 ' O ' ' A' ' 531' ' ' LEU . 50.2 mt -53.0 99.27 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.824 1.312 . . . . 53.12 111.809 -174.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -104.73 56.78 0.54 Allowed Glycine 0 CA--C 1.466 -2.971 0 CA-C-N 114.292 -1.322 . . . . 75.21 111.956 -172.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -149.87 142.13 24.16 Favored 'General case' 0 C--N 1.267 -3.017 0 N-CA-C 108.392 -0.966 . . . . 75.52 108.392 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 40.0 m -115.8 160.7 19.78 Favored 'General case' 0 C--N 1.271 -2.81 0 N-CA-C 107.977 -1.12 . . . . 75.2 107.977 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 20.7 pt -117.45 151.09 19.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.2 0.524 . . . . 70.1 111.472 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.1 t -138.21 159.1 42.93 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.551 -1.277 . . . . 75.22 107.551 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 53.9 p -141.13 137.48 32.79 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.536 -0.542 . . . . 71.12 109.536 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 479' ' ' ASP . 4.2 tmm_? -71.43 -70.59 0.31 Allowed 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 106.772 -1.566 . . . . 71.2 106.772 176.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 478' ' ' ARG . 5.3 t70 165.72 -176.45 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 106.096 -1.816 . . . . 73.31 106.096 171.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 482' ' ' ILE . 8.7 p -140.69 -17.7 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 109.697 -0.483 . . . . 61.13 109.697 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . 0.26 75.6 p 65.09 -17.1 0.09 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.385 1.874 . . . . 61.32 115.247 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.457 ' H ' ' C ' ' A' ' 480' ' ' VAL . 32.8 pt -126.29 131.21 71.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 115.846 -0.615 . . . . 73.22 110.309 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 88.67 -81.35 1.55 Allowed Glycine 0 C--N 1.306 -1.117 0 C-N-CA 120.532 -0.842 . . . . 71.42 111.938 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 134.25 12.1 1.48 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.196 -1.002 . . . . 62.12 113.925 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 40.0 t -75.26 -61.51 1.88 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.32 0.56 . . . . 73.31 109.688 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 72.55 126.28 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.736 0 C-N-CA 124.694 1.198 . . . . 71.21 110.852 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.69 134.14 58.72 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.973 1.782 . . . . 71.24 111.506 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 42.9 mm -95.4 129.51 45.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.528 -0.76 . . . . 72.31 109.603 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -128.24 153.66 46.7 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.559 -0.534 . . . . 74.02 109.559 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.78 118.97 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 107.671 -1.233 . . . . 74.5 107.671 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -81.29 -56.96 3.72 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.293 -0.867 . . . . 73.44 110.377 -175.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -147.3 157.77 43.71 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.824 -0.626 . . . . 61.34 109.427 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.45 HG12 ' HB1' ' A' ' 507' ' ' ALA . 29.8 mm -121.49 105.81 17.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.491 -1.299 . . . . 71.45 107.491 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.9 mp -55.93 133.92 73.51 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.49 -0.777 . . . . 60.43 111.987 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -66.55 6.92 0.45 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 124.896 3.731 . . . . 75.44 115.051 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.496 ' O ' ' HB ' ' A' ' 468' ' ' THR . 31.5 ptt180 -162.74 10.95 0.06 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.919 0.866 . . . . 61.12 111.752 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -85.84 -174.29 49.74 Favored Glycine 0 C--N 1.294 -1.758 0 CA-C-N 115.42 -0.809 . . . . 61.42 112.512 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -51.52 -38.27 53.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.453 1.101 . . . . 74.34 110.538 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . 0.508 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -61.68 -42.95 99.63 Favored 'General case' 0 C--O 1.197 -1.71 0 CA-C-N 114.185 -1.371 . . . . 72.15 113.248 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.0 tt -80.05 -29.44 12.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 120.925 0.393 . . . . 65.43 111.166 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 28.9 mm-40 -62.04 -46.31 89.72 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.89 -0.595 . . . . 74.34 109.633 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -84.65 -42.04 15.73 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 120.579 -0.448 . . . . 65.34 109.82 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 81.24 -14.66 27.0 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 116.753 1.461 . . . . 74.24 116.753 174.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -74.21 -16.69 60.96 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 117.77 0.785 . . . . 74.51 111.38 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.62 147.5 26.35 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.675 -0.491 . . . . 75.32 109.675 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.59 171.25 15.38 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.706 -0.479 . . . . 72.24 109.706 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.45 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -89.34 149.72 22.9 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 123.238 0.336 . . . . 72.01 110.529 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 107.0 5.27 35.49 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.55 -0.833 . . . . 38.47 113.504 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -113.74 156.18 24.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.942 0.371 . . . . 75.03 111.159 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -85.56 130.86 34.47 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.261 -0.427 . . . . 70.02 110.417 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.465 HD12 HD12 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.67 128.95 35.03 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.832 -1.544 . . . . 71.32 106.832 -179.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.479 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.5 mm -100.04 -49.59 11.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.05 0.452 . . . . 73.55 111.252 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.24 150.51 21.96 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.898 -0.592 . . . . 73.41 109.858 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 541' ' ' SER . 4.2 p -125.05 123.82 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 CA-C-O 121.38 0.61 . . . . 72.44 109.98 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 19.4 m120 56.09 18.16 3.04 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.23 1.412 . . . . 61.54 114.475 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.76 -7.83 29.76 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.257 -0.973 . . . . 54.31 112.999 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.51 123.12 45.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 108.561 -0.903 . . . . 72.05 108.561 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -90.91 133.38 35.3 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.225 -1.028 . . . . 72.32 108.225 -172.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 23.2 mt -86.33 -46.31 10.4 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 112.427 0.529 . . . . 70.14 112.427 -170.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.38 100.59 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.854 0.835 . . . . 74.15 110.503 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 141.59 -33.55 1.96 Allowed Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 109.629 -1.388 . . . . 52.41 109.629 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.473 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -105.94 166.52 10.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.614 -0.293 . . . . 71.01 110.722 178.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 58.3 m -88.65 162.55 16.26 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.719 0.295 . . . . 74.11 111.763 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -54.92 -46.47 74.92 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 123.897 0.879 . . . . 73.43 112.205 -175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.522 ' O ' HG23 ' A' ' 528' ' ' VAL . 40.9 mm-40 -60.39 -31.05 69.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.888 0.699 . . . . 74.52 112.888 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.63 -37.48 86.69 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.491 0.662 . . . . 63.4 109.258 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 39.0 t -75.69 -34.94 29.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.69 -0.686 . . . . 73.33 110.04 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 13.5 m -66.5 -41.32 88.34 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 C-N-CA 119.953 -0.699 . . . . 63.34 110.687 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 40.5 t -59.67 -44.1 93.74 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.782 0.801 . . . . 70.2 109.327 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 25.3 tp -58.35 -41.97 85.85 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 125.487 1.515 . . . . 55.01 110.163 176.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.42 ' O ' HD11 ' A' ' 471' ' ' LEU . 35.4 tp -69.27 -48.07 62.78 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.724 0.81 . . . . 74.24 110.383 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 4.2 mmp_? -55.1 -45.39 75.46 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.761 0.825 . . . . 63.13 112.355 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 32.1 m -71.53 -37.12 71.18 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 111.553 0.205 . . . . 74.14 111.553 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' THR . . . . . 0.485 HG21 ' HE2' ' A' ' 466' ' ' LYS . 26.3 m 70.42 152.45 0.11 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.057 0.943 . . . . 73.44 111.009 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.99 125.68 25.66 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.98 -1.489 . . . . 75.31 106.98 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.7 mtt -71.8 -6.3 40.49 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.269 0.841 . . . . 61.03 113.269 -173.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.55 -27.69 61.47 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.12 -1.067 . . . . 73.41 108.12 171.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 109.97 -25.16 17.22 Favored Glycine 0 N--CA 1.427 -1.965 0 CA-C-N 115.207 -0.906 . . . . 62.1 112.43 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.5 m -101.59 127.0 48.5 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 109.369 -0.604 . . . . 62.11 109.369 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 76.6 t -106.46 128.23 61.18 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.681 0 CA-C-N 115.744 -0.662 . . . . 72.34 110.363 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 20.2 m -100.9 114.02 27.51 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.575 -0.739 . . . . 62.54 109.519 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -104.77 128.23 52.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.802 -0.814 . . . . 72.52 108.802 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 37.3 tp -104.85 118.28 36.16 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 105.935 -1.876 . . . . 71.31 105.935 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 27.6 m -115.48 160.17 14.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 CA-C-O 120.966 0.412 . . . . 75.44 110.042 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -111.96 115.39 28.87 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-N 115.546 -0.752 . . . . 74.05 109.08 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.51 118.16 26.8 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 106.047 -1.834 . . . . 64.32 106.047 177.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -99.88 122.78 43.33 Favored 'General case' 0 C--N 1.26 -3.284 0 CA-C-N 115.306 -0.861 . . . . 75.33 109.863 -174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -93.54 86.92 5.36 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 122.052 0.929 . . . . 74.41 109.284 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--N 1.292 -1.903 0 CA-C-N 114.638 -1.164 . . . . 73.41 109.881 -178.148 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.958 0 N-CA-C 110.971 -0.852 . . . . 74.54 110.971 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 37.3 p -160.39 110.13 1.77 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.21 -0.663 . . . . 72.53 109.21 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -146.76 133.08 19.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.769 -0.456 . . . . 72.2 109.769 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -90.19 98.62 11.88 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.364 -0.606 . . . . 55.42 109.364 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 72.2 p -67.3 129.5 40.11 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.533 -0.758 . . . . 72.43 110.99 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -86.38 118.53 25.87 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.022 -0.733 . . . . 75.42 109.022 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -107.39 168.62 9.11 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.519 -0.919 . . . . 54.55 108.519 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 11.3 tt -121.84 90.19 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 122.284 1.04 . . . . 63.43 111.131 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 547' ' ' GLN . . . 139.06 142.55 4.29 Favored Glycine 0 N--CA 1.42 -2.417 0 CA-C-N 114.892 -1.049 . . . . 62.44 111.635 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.519 ' HA ' ' HE3' ' A' ' 458' ' ' LYS . 0.5 OUTLIER -126.24 133.0 51.6 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.319 -0.623 . . . . 74.25 109.319 -179.014 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -102.03 149.4 24.29 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.166 -0.679 . . . . 75.54 109.166 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.4 mm? -133.98 150.53 51.27 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.358 -0.608 . . . . 71.55 109.358 -173.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.51 117.27 28.55 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.904 0.859 . . . . 75.11 110.935 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 54.7 mt -121.78 139.2 49.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 106.853 -1.536 . . . . 72.01 106.853 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 42.4 tt0 -125.66 126.58 44.92 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.895 -1.122 . . . . 72.11 108.512 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 6.4 mp -114.66 153.05 30.9 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.081 -0.647 . . . . 75.2 112.433 -177.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.72 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.2 OUTLIER -100.56 128.37 46.64 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.558 -0.904 . . . . 71.2 108.558 -177.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.51 ' HE3' HG21 ' A' ' 534' ' ' THR . 39.9 ttmt -60.1 113.28 2.26 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.952 -0.567 . . . . 53.24 110.182 172.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -104.58 -131.71 7.22 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 120.796 -0.716 . . . . 64.03 111.799 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 26.4 m -62.53 -64.97 0.76 Allowed 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.198 0.599 . . . . 75.5 111.947 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . 0.486 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 11.8 mm-40 -85.24 -32.45 22.59 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.82 -0.752 . . . . 63.22 109.545 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.458 ' N ' ' HA2' ' A' ' 497' ' ' GLY . . . 70.77 141.63 0.21 Allowed Glycine 0 C--O 1.21 -1.352 0 CA-C-N 114.878 -1.055 . . . . 54.53 112.894 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 471' ' ' LEU 0.25 4.9 mp 39.56 84.38 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.551 1.54 . . . . 72.45 114.118 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -94.04 54.14 2.2 Favored Glycine 0 CA--C 1.493 -1.297 0 CA-C-N 115.078 -0.965 . . . . 63.33 112.433 -173.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.52 ' CZ ' HD12 ' A' ' 542' ' ' LEU . 3.7 p90 -146.67 142.05 27.48 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.177 0.513 . . . . 63.31 110.763 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 29.6 m -120.57 143.9 48.38 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.089 -1.448 . . . . 72.44 107.089 177.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 23.9 pt -109.59 158.85 9.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 121.441 0.638 . . . . 74.24 111.929 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.6 t -132.5 159.23 39.99 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.703 -1.591 . . . . 75.42 106.703 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 55.4 p -129.32 144.74 51.35 Favored 'General case' 0 C--N 1.269 -2.911 0 N-CA-C 108.953 -0.758 . . . . 73.23 108.953 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -83.37 -6.06 59.34 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.069 -1.086 . . . . 74.34 108.069 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 17.6 t70 69.08 156.26 0.13 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 112.894 -1.957 . . . . 74.14 111.932 172.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.431 HG23 ' H ' ' A' ' 482' ' ' ILE . 8.0 p -83.64 136.07 23.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 115.709 -0.678 . . . . 61.13 109.741 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.6 t -88.03 -8.09 56.09 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.892 -0.723 . . . . 73.14 111.715 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.431 ' H ' HG23 ' A' ' 480' ' ' VAL . 63.1 mt -116.15 -75.01 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 115.85 -0.614 . . . . 64.51 109.492 175.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 166.43 118.46 0.44 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.069 -0.813 . . . . 64.13 111.069 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . 0.42 ' H ' HG11 ' A' ' 480' ' ' VAL . . . 127.9 -88.89 0.33 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.324 -0.941 . . . . 60.44 112.705 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 32.6 t -79.88 89.27 5.27 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.476 0.655 . . . . 45.33 112.077 -174.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -92.57 128.94 42.34 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 115.487 -0.778 . . . . 45.54 110.136 175.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.85 134.97 20.7 Favored 'Trans proline' 0 C--O 1.249 1.068 0 C-N-CA 121.976 1.784 . . . . 74.5 111.702 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.462 ' O ' ' HG3' ' A' ' 510' ' ' ARG . 44.3 mm -109.56 136.59 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.966 -0.561 . . . . 74.23 109.976 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.493 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 91.9 m-85 -137.99 157.79 45.65 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.138 0.575 . . . . 70.22 110.468 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 13.0 t -74.68 121.41 26.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.108 -1.071 . . . . 70.14 108.108 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -85.44 -58.9 2.48 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.728 -0.471 . . . . 74.15 109.728 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -146.61 147.83 31.47 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.042 -1.096 . . . . 63.22 108.042 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.502 HG13 ' HA ' ' A' ' 506' ' ' LYS . 26.1 mm -109.4 109.46 28.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.635 -0.876 . . . . 64.11 108.635 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 86.5 mt -53.69 154.69 6.52 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 114.838 -1.073 . . . . 74.33 111.168 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.17 -1.67 11.26 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 123.902 3.068 . . . . 72.13 111.657 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.453 ' HA ' HG22 ' A' ' 500' ' ' ILE . 99.5 mtt180 -150.39 -157.65 0.84 Allowed 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 115.12 -0.946 . . . . 65.32 108.559 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.486 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 82.98 -162.9 41.21 Favored Glycine 0 C--N 1.277 -2.735 0 N-CA-C 111.398 -0.681 . . . . 71.35 111.398 -176.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . 0.496 ' O ' HD21 ' A' ' 464' ' ' LEU . . . -70.49 -27.78 64.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.885 0.342 . . . . 74.51 110.843 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . 0.539 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -58.9 -41.37 87.05 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-N 115.182 -0.917 . . . . 71.22 112.057 -173.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 496' ' ' ARG . 16.9 tt -79.48 -29.29 13.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.984 -0.553 . . . . 52.31 111.547 -179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 12.6 mm100 -62.37 -45.91 91.03 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.263 -0.643 . . . . 73.42 109.263 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.405 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 8.8 t70 -93.74 -34.88 13.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.291 -0.868 . . . . 51.43 110.048 -177.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 83.8 -27.65 4.27 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.622 1.409 . . . . 44.3 116.622 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -67.93 -13.59 62.29 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.191 1.182 . . . . 75.44 114.191 -174.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 46.7 tp -97.89 124.78 42.47 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 120.595 -0.442 . . . . 64.54 111.158 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.502 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.1 OUTLIER -135.27 164.07 28.55 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 111.809 0.3 . . . . 75.5 111.809 178.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.468 ' HA ' ' CG1' ' A' ' 490' ' ' VAL . . . -82.64 160.36 22.47 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 113.835 1.05 . . . . 64.34 113.835 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 78.93 46.77 8.14 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.234 -0.894 . . . . 37.36 112.247 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.49 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 7.5 t70 -144.08 178.63 7.74 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.579 -1.637 . . . . 62.54 106.579 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.493 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 48.6 ttp85 -109.28 136.83 48.09 Favored 'General case' 0 C--O 1.212 -0.875 0 C-N-CA 119.176 -1.01 . . . . 71.24 113.217 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.72 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -88.02 121.31 30.28 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.196 -0.911 . . . . 70.02 110.781 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 512' ' ' ILE . 1.9 mp -106.83 -48.47 8.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 109.447 -0.575 . . . . 55.31 109.447 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.42 143.0 31.43 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.302 -0.863 . . . . 62.2 109.543 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 541' ' ' SER . 7.5 p -145.03 122.41 4.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 CA-C-N 114.632 -1.167 . . . . 75.25 109.506 175.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . 0.596 ' ND2' HG13 ' A' ' 540' ' ' VAL . 49.0 m-80 66.65 21.94 10.54 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.113 0.965 . . . . 63.4 112.176 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 83.41 25.96 45.26 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 121.147 -0.549 . . . . 73.03 112.158 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.0 t -121.8 138.04 53.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 109.752 -0.462 . . . . 75.32 109.752 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.99 128.31 34.57 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.038 -0.727 . . . . 74.42 109.038 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.72 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 24.6 mt -96.55 -44.05 7.33 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 113.057 0.762 . . . . 74.43 113.057 -170.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 56.4 t -72.47 92.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.752 0.787 . . . . 74.05 110.448 -174.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.29 -25.77 1.24 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 109.889 -1.284 . . . . 63.23 109.889 -175.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.51 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.2 OUTLIER -107.09 179.09 4.36 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.793 -0.203 . . . . 63.14 110.671 177.079 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 52.5 m -94.2 157.97 15.81 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-O 121.065 0.46 . . . . 73.31 111.75 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -52.8 -47.18 67.78 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.42 1.088 . . . . 73.21 112.156 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.402 ' HA ' HG23 ' A' ' 528' ' ' VAL . 42.9 mt-10 -60.87 -34.29 74.39 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.564 0.579 . . . . 37.36 112.564 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.99 -42.18 97.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.48 0.657 . . . . 73.32 109.536 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.512 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 44.5 t -71.06 -40.36 75.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.715 -1.129 . . . . 75.42 110.374 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.476 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 12.7 m -68.62 -38.91 79.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 C-N-CA 119.041 -1.064 . . . . 63.3 110.371 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 25.8 t -62.04 -43.14 99.48 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.874 -0.603 . . . . 74.25 110.54 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 527' ' ' VAL . 3.5 pp -67.19 -32.29 73.26 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.24 0.543 . . . . 75.43 109.656 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.416 ' O ' HD23 ' A' ' 471' ' ' LEU . 2.6 tt -65.15 -47.97 75.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.918 -1.037 . . . . 71.21 111.073 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.57 ' HA ' ' HE ' ' A' ' 532' ' ' ARG . 0.2 OUTLIER -63.28 -37.04 85.68 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.906 -0.588 . . . . 72.21 110.447 -177.632 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.4 m -73.61 -40.95 63.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.492 -0.322 . . . . 73.31 110.502 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' THR . . . . . 0.51 HG21 ' HE3' ' A' ' 466' ' ' LYS . 24.0 m 68.92 158.32 0.16 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.095 0.958 . . . . 64.44 111.261 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . 0.411 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 16.5 tppt? -67.67 127.25 32.07 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.075 -1.454 . . . . 70.33 107.075 172.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.6 ptp -61.38 -18.0 56.71 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.279 0.562 . . . . 73.04 111.493 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 39.6 tt0 -69.4 -24.17 63.82 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.888 0.875 . . . . 72.5 110.413 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 103.05 -29.09 13.19 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 116.053 -0.521 . . . . 54.43 112.684 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 0.6 OUTLIER -94.83 124.08 38.66 Favored 'General case' 0 N--CA 1.424 -1.733 0 C-N-CA 123.117 0.567 . . . . 72.3 112.372 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.596 HG13 ' ND2' ' A' ' 515' ' ' ASN . 72.1 t -104.3 129.74 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 108.565 -0.902 . . . . 74.3 108.565 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' SER . . . . . 0.702 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 47.2 t -91.1 134.0 34.88 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.506 -0.924 . . . . 72.0 108.506 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.52 HD12 ' CZ ' ' A' ' 473' ' ' PHE . 3.4 mm? -122.93 118.21 27.32 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.952 -1.129 . . . . 73.23 107.952 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 4.2 tt -110.31 117.65 34.21 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 104.35 -2.463 . . . . 73.31 104.35 173.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.49 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 30.6 m -121.25 160.39 22.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-N 115.888 -0.596 . . . . 72.13 111.336 -175.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.408 ' CB ' HD13 ' A' ' 512' ' ' ILE . 76.4 t80 -125.56 119.38 28.0 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 120.966 0.412 . . . . 71.31 110.601 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -119.62 123.3 43.54 Favored 'General case' 0 N--CA 1.401 -2.878 0 N-CA-C 108.191 -1.04 . . . . 71.22 108.191 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . 0.505 ' HA ' ' HA2' ' A' ' 457' ' ' GLY . 53.6 tt0 -79.78 119.98 23.43 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.426 -0.806 . . . . 70.34 109.861 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -76.03 102.1 5.52 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 106.575 -1.639 . . . . 64.23 106.575 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--N 1.289 -2.023 0 N-CA-C 107.181 -1.414 . . . . 37.36 107.181 -174.224 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.176 0 N-CA-C 111.961 -0.456 . . . . 65.32 111.961 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 34.1 p -87.0 124.1 32.82 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 112.2 0.444 . . . . 63.3 112.2 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -127.34 115.19 18.6 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 122.852 0.461 . . . . 73.45 110.362 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -122.37 103.23 8.6 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.315 -0.624 . . . . 73.23 109.315 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 9.9 t -87.49 98.95 11.67 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.982 0.896 . . . . 72.23 110.338 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -88.57 104.59 16.98 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.053 -0.721 . . . . 62.23 109.053 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -84.39 125.89 32.73 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.062 -0.718 . . . . 73.12 109.062 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 2.0 mp -77.74 106.33 7.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.714 -1.217 . . . . 65.23 107.714 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 547' ' ' GLN . . . 108.57 107.76 3.17 Favored Glycine 0 N--CA 1.421 -2.358 0 N-CA-C 109.636 -1.386 . . . . 63.52 109.636 -173.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -91.72 133.31 35.71 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 120.146 -0.622 . . . . 74.02 110.181 -178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 62.8 mtm180 -101.37 137.14 40.09 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 106.252 -1.758 . . . . 75.43 106.252 172.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 16.4 tp -129.18 129.05 44.58 Favored 'General case' 0 C--N 1.265 -3.099 0 CA-C-N 116.019 -0.537 . . . . 75.0 109.822 -172.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -98.53 115.65 29.05 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 108.859 -0.793 . . . . 75.31 108.859 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . 0.471 HG22 ' HD3' ' A' ' 504' ' ' ARG . 67.4 mt -116.43 142.56 29.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.384 -0.969 . . . . 74.41 108.384 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 78.5 mt-30 -122.36 128.63 51.23 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 118.564 0.62 . . . . 73.32 112.152 176.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.586 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 9.3 mp -115.75 146.69 41.69 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 123.834 0.854 . . . . 71.2 111.634 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.771 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.2 OUTLIER -100.35 125.67 46.61 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 108.16 -1.052 . . . . 74.2 108.16 -178.219 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.88 114.97 2.32 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.249 -0.887 . . . . 63.12 110.358 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -87.08 -140.68 6.4 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.158 -1.177 . . . . 52.52 110.158 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' THR . . . . . 0.462 HG21 ' OE2' ' A' ' 469' ' ' GLU . 9.9 t -81.8 -31.61 31.7 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.834 -0.747 . . . . 64.24 111.359 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . 0.516 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 12.0 mp0 -91.77 -42.8 9.91 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 107.79 -1.189 . . . . 72.44 107.79 173.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 84.57 -148.09 23.57 Favored Glycine 0 C--O 1.202 -1.866 0 CA-C-O 118.365 -1.242 . . . . 50.32 111.312 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.442 HD21 ' H ' ' A' ' 471' ' ' LEU . 1.7 mm? -45.95 108.07 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.478 1.139 . . . . 70.0 113.294 -169.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.87 45.62 1.28 Allowed Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.744 -1.117 . . . . 74.05 111.679 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.43 ' CZ ' HD12 ' A' ' 542' ' ' LEU . 23.1 p90 -134.69 143.11 47.04 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.036 -0.727 . . . . 71.43 109.036 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 39.5 m -115.46 157.47 23.93 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.469 -1.308 . . . . 75.21 107.469 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 15.2 pt -126.03 160.08 33.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.364 0.602 . . . . 70.21 112.366 -176.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' THR . . . . . 0.407 ' HB ' ' CE ' ' A' ' 491' ' ' LYS . 10.1 t -152.26 158.26 42.57 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.218 -1.03 . . . . 70.41 108.218 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 35.3 p -106.98 129.24 54.81 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 106.446 -1.687 . . . . 71.41 106.446 174.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -146.76 88.93 1.78 Allowed 'General case' 0 N--CA 1.41 -2.474 0 C-N-CA 119.713 -0.795 . . . . 71.41 111.941 -174.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 66.0 140.51 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.209 1.404 . . . . 73.54 114.656 177.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 485' ' ' SER . 7.6 p -85.82 107.53 16.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.552 -0.749 . . . . 70.4 112.13 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 32.7 m -124.37 96.55 4.95 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.064 -1.458 . . . . 63.42 107.064 173.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 1.9 mp 65.55 96.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.526 0.679 . . . . 64.33 109.358 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 160.34 -155.92 27.13 Favored Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 111.25 -0.74 . . . . 64.41 111.25 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -100.93 -92.66 2.14 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.372 -0.918 . . . . 61.3 112.55 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' SER . . . . . 0.474 ' O ' ' HB ' ' A' ' 480' ' ' VAL . 19.8 m -89.39 -52.25 5.13 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.129 0.49 . . . . 71.14 110.282 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -168.34 114.98 0.59 Allowed Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.195 -0.669 . . . . 74.53 109.195 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.47 149.79 89.72 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.433 2.089 . . . . 55.54 112.039 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 39.2 mm -85.64 128.63 39.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 108.145 -1.057 . . . . 61.34 108.145 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -124.61 155.66 38.75 Favored 'General case' 0 CA--C 1.487 -1.455 0 O-C-N 122.117 -0.365 . . . . 73.42 110.962 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 49.4 t -74.04 125.91 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 108.592 -0.892 . . . . 72.12 108.592 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.407 ' CE ' ' HB ' ' A' ' 476' ' ' THR . 41.4 ttmt -82.54 -53.24 6.12 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.89 -0.781 . . . . 63.02 108.89 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -149.41 151.79 34.63 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.145 -0.934 . . . . 73.42 109.332 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.447 HG13 ' HA ' ' A' ' 506' ' ' LYS . 27.4 mm -114.39 106.83 21.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.175 -1.417 . . . . 72.44 107.175 175.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 8.3 mp -50.55 157.79 1.2 Allowed Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 124.903 1.281 . . . . 75.23 113.124 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -72.21 -6.46 19.13 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 123.961 3.107 . . . . 41.33 111.979 -175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.459 ' HA ' HG22 ' A' ' 500' ' ' ILE . 77.2 mtt180 -151.19 -161.05 1.25 Allowed 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.199 -0.91 . . . . 70.13 109.149 -174.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.546 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 81.48 -167.27 48.57 Favored Glycine 0 C--N 1.282 -2.461 0 CA-C-N 115.254 -0.885 . . . . 62.24 113.722 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . 0.451 ' O ' HD22 ' A' ' 464' ' ' LEU . . . -65.76 -35.83 81.83 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 124.318 1.047 . . . . 71.31 110.377 -174.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . 0.586 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -59.63 -39.62 84.91 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 115.089 -0.959 . . . . 53.41 112.331 -174.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.459 HG22 ' HA ' ' A' ' 496' ' ' ARG . 15.0 tt -80.09 -30.1 12.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 121.111 -0.235 . . . . 75.42 111.371 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.546 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 31.6 mm-40 -60.89 -45.57 94.06 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.879 -0.6 . . . . 74.5 110.307 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.458 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 7.5 t70 -92.67 -35.75 13.33 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.779 -0.823 . . . . 52.15 108.779 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 56.54 25.39 50.01 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 115.551 0.98 . . . . 72.21 115.551 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.471 ' HD3' HG22 ' A' ' 462' ' ' ILE . 63.9 ttt180 -99.95 -6.69 26.21 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.92 0.867 . . . . 73.23 109.331 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 44.4 tp -109.5 138.91 45.17 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.738 -1.208 . . . . 73.02 107.738 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.522 ' HD2' ' OD2' ' A' ' 509' ' ' ASP . 0.0 OUTLIER -138.27 177.5 7.84 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.597 -0.841 . . . . 75.11 109.149 175.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -82.99 29.12 0.48 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.513 0.673 . . . . 72.21 112.037 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . -126.23 13.7 7.03 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.021 -0.832 . . . . 72.14 111.021 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.522 ' OD2' ' HD2' ' A' ' 506' ' ' LYS . 42.6 m-20 -102.6 148.21 25.83 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 120.773 0.32 . . . . 74.45 110.694 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 544' ' ' VAL . 19.0 ttm180 -101.16 129.76 47.13 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 116.27 -0.423 . . . . 72.44 109.938 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.617 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.6 mm? -83.41 117.01 22.76 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 112.451 0.537 . . . . 61.24 112.451 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.9 mm -104.98 -39.63 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.69 0.757 . . . . 65.33 109.516 174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -148.57 145.8 27.99 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 114.929 -1.032 . . . . 73.32 108.867 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.476 ' CG1' HD12 ' A' ' 530' ' ' LEU . 2.4 p -139.15 129.17 31.51 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.446 0 CA-C-N 115.051 -0.977 . . . . 72.34 108.375 174.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . 0.475 HD22 ' HB2' ' A' ' 535' ' ' LYS . 6.3 t-20 68.65 -58.92 0.47 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 127.712 2.405 . . . . 71.44 111.673 -176.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 178.08 27.26 0.04 OUTLIER Glycine 0 C--N 1.296 -1.642 0 N-CA-C 110.081 -1.208 . . . . 54.12 110.081 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.88 136.76 57.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 109.829 -0.434 . . . . 63.31 109.829 -174.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.75 125.56 31.4 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.937 -0.764 . . . . 62.34 108.937 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.617 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 32.5 mt -94.52 -35.2 12.38 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.01 -0.541 . . . . 74.3 112.061 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 41.5 t -75.98 87.95 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 122.072 0.939 . . . . 74.43 110.374 -173.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.66 -26.51 1.19 Allowed Glycine 0 N--CA 1.425 -2.042 0 CA-C-N 114.132 -1.395 . . . . 36.63 110.142 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.483 ' HZ3' ' HB3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -104.31 176.95 4.99 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.808 0.337 . . . . 71.44 111.78 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 22.2 m -90.23 160.54 16.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.293 0.568 . . . . 51.33 112.394 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -53.0 -47.48 68.22 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.67 1.188 . . . . 74.31 113.834 177.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.65 -32.24 73.25 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 120.781 -0.368 . . . . 71.52 111.844 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.71 -38.81 92.5 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.075 0.464 . . . . 71.35 110.406 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.595 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 21.6 t -73.74 -41.42 54.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.738 -0.665 . . . . 74.04 109.61 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.591 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 11.4 m -65.65 -40.29 87.51 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 C-N-CA 119.462 -0.895 . . . . 75.24 110.456 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 27.6 m -63.06 -38.3 90.65 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.791 -0.641 . . . . 73.34 111.705 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 527' ' ' VAL . 2.1 pp -69.56 -33.06 72.2 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.613 -0.884 . . . . 63.14 108.613 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.2 tt -65.22 -48.18 74.26 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 115.329 -0.85 . . . . 64.1 110.071 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 30.5 mmm180 -61.2 -31.43 71.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.377 -0.828 . . . . 65.05 110.184 -177.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.0 t -76.39 -43.74 39.21 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.426 -0.806 . . . . 61.33 110.391 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 535' ' ' LYS . 12.6 m 64.49 177.41 0.18 Allowed 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 109.064 -0.717 . . . . 75.11 109.064 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . 0.475 ' HB2' HD22 ' A' ' 515' ' ' ASN . 38.1 ttpt -102.33 139.5 37.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.833 -0.803 . . . . 51.33 108.833 175.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 88.1 mtp -65.36 -20.68 66.5 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.234 0.827 . . . . 72.33 113.234 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.54 -39.07 79.17 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.431 -0.951 . . . . 71.14 108.431 172.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 115.96 -24.35 10.17 Favored Glycine 0 N--CA 1.431 -1.64 0 CA-C-N 114.878 -1.056 . . . . 75.55 112.443 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.462 ' O ' ' HE2' ' A' ' 535' ' ' LYS . 0.6 OUTLIER -96.17 140.69 30.51 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.707 -0.397 . . . . 74.12 109.944 -177.307 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 53.6 t -119.15 133.32 66.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 122.849 0.46 . . . . 64.2 111.544 174.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.1 m -91.6 138.33 31.65 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.531 -0.759 . . . . 74.21 110.097 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.43 HD12 ' CZ ' ' A' ' 473' ' ' PHE . 2.7 mm? -124.14 120.35 32.06 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 106.82 -1.548 . . . . 65.14 106.82 176.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 54.2 tp -104.88 117.07 33.12 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.027 -1.472 . . . . 64.3 107.027 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 510' ' ' ARG . 33.0 m -117.82 140.14 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.121 0 C-N-CA 119.907 -0.717 . . . . 74.01 111.701 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.403 ' HB3' ' HD2' ' A' ' 510' ' ' ARG . 62.2 t80 -111.3 116.79 31.6 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.138 -0.69 . . . . 73.34 109.138 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . 0.459 ' HD3' ' OD1' ' A' ' 509' ' ' ASP . 23.9 mtm180 -127.89 122.1 31.68 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.292 -1.003 . . . . 73.22 108.292 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . 0.472 ' HA ' ' HA2' ' A' ' 457' ' ' GLY . 9.9 tt0 -97.19 119.17 35.2 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.722 -1.214 . . . . 74.2 107.722 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . 0.47 ' HG2' ' H ' ' A' ' 549' ' ' ASP . 32.5 tt0 60.38 179.38 0.1 Allowed 'General case' 0 CA--C 1.564 1.509 0 O-C-N 124.408 1.067 . . . . 73.12 109.051 -174.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . 0.47 ' H ' ' HG2' ' A' ' 548' ' ' GLU . 31.2 t70 . . . . . 0 C--N 1.292 -1.932 0 O-C-N 121.29 -0.881 . . . . 54.42 108.797 175.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.293 0 N-CA-C 110.255 -1.138 . . . . 53.14 110.255 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 25.5 p -80.88 100.56 8.93 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 121.153 0.501 . . . . 73.43 110.949 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -162.42 109.53 1.3 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.788 -0.642 . . . . 73.32 110.315 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -102.18 136.6 41.74 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.501 -1.296 . . . . 73.14 107.501 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 40.2 p -80.18 95.02 6.15 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.994 0.902 . . . . 61.42 110.03 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -110.17 9.04 23.96 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.806 -1.088 . . . . 75.51 109.643 -173.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -120.77 165.52 15.02 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.53 -0.759 . . . . 73.31 110.372 -176.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 49.4 mm 54.01 97.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.242 1.417 . . . . 64.5 112.905 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 60.62 91.23 0.02 OUTLIER Glycine 0 CA--C 1.519 0.344 0 CA-C-N 116.182 -0.463 . . . . 44.35 112.537 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 51.1 mtpt -96.13 151.96 18.99 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 113.159 0.8 . . . . 74.15 113.159 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 98.8 mtt180 -107.69 126.79 53.03 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 113.883 -1.508 . . . . 75.35 107.227 169.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.2 mm? -115.9 132.57 56.61 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 109.116 -0.698 . . . . 74.23 109.116 -176.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -98.14 120.18 38.1 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.393 -0.965 . . . . 73.01 108.393 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . 0.438 ' HA ' ' NH1' ' A' ' 504' ' ' ARG . 45.7 mt -122.16 142.64 37.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.898 -1.149 . . . . 61.01 107.898 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 93.1 mt-30 -123.03 125.97 46.23 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.606 0.717 . . . . 73.12 112.701 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.507 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 7.9 mp -121.56 141.55 50.96 Favored 'General case' 0 CA--C 1.478 -1.802 0 CA-C-N 115.225 -0.898 . . . . 72.41 112.308 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -112.71 136.06 52.74 Favored 'General case' 0 N--CA 1.398 -3.031 0 CA-C-N 115.456 -0.793 . . . . 75.11 110.005 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.459 ' HB2' HG21 ' A' ' 534' ' ' THR . 39.4 ttmt -65.93 113.74 4.62 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.724 -1.125 . . . . 73.42 111.865 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -93.1 -104.2 1.63 Allowed Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.142 -1.183 . . . . 62.01 110.142 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 41.5 m -90.73 -57.0 2.97 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 122.554 -0.38 . . . . 74.34 111.113 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -94.43 -33.51 13.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.933 -1.506 . . . . 62.33 106.933 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 79.51 -145.27 27.62 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 114.407 -1.27 . . . . 44.53 110.995 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.409 HD21 HG12 ' A' ' 540' ' ' VAL . 6.6 mp -43.43 97.64 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.205 1.187 . . . . 73.41 114.205 -172.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -103.79 50.08 0.9 Allowed Glycine 0 N--CA 1.433 -1.555 0 CA-C-N 114.432 -1.258 . . . . 63.0 112.417 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -133.39 146.67 51.45 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.537 -0.912 . . . . 71.33 108.537 175.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 47.1 m -116.03 156.97 25.39 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 108.465 -0.939 . . . . 71.32 108.465 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 12.2 pt -124.18 154.66 31.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.26 0.552 . . . . 72.32 111.799 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.8 t -142.07 159.03 43.04 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.05 -1.092 . . . . 70.22 108.05 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 64.4 p -107.97 134.42 50.91 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 107.65 -1.241 . . . . 73.22 107.65 174.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -88.11 -69.12 0.72 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.912 0.386 . . . . 70.41 110.398 -176.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -173.88 139.36 0.67 Allowed 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 106.412 -1.699 . . . . 74.23 106.412 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.448 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . 8.5 p -68.58 83.89 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 122.653 1.215 . . . . 71.43 112.855 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 38.2 p -93.32 -33.07 14.06 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.445 -1.252 . . . . 70.05 109.72 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 8.6 tp -141.42 140.57 31.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 CA-C-N 113.63 -1.623 . . . . 72.14 108.268 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 88.65 -164.16 32.77 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.716 -0.754 . . . . 45.45 111.273 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -119.12 146.3 18.28 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.805 -0.712 . . . . 75.13 111.703 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 57.1 m 70.31 -70.58 0.15 Allowed 'General case' 0 C--O 1.246 0.916 0 C-N-CA 124.461 1.104 . . . . 74.42 113.229 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -163.29 129.62 2.34 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 110.393 -0.225 . . . . 62.01 110.393 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 480' ' ' VAL . 2.4 Cg_endo -82.44 136.09 8.52 Favored 'Trans proline' 0 N--CA 1.438 -1.743 0 C-N-CA 122.151 1.901 . . . . 38.5 109.498 173.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.455 HG13 ' HB3' ' A' ' 519' ' ' LEU . 32.4 mm -89.95 131.37 37.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 116.135 -0.484 . . . . 74.24 109.971 -174.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 90.1 m-85 -129.97 161.63 30.48 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.091 0.556 . . . . 74.14 109.828 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 23.4 t -74.58 127.03 36.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.612 -0.884 . . . . 73.02 108.612 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -87.39 -51.18 6.08 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.741 -0.837 . . . . 73.33 108.741 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -159.0 157.84 32.04 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.282 -0.872 . . . . 73.34 109.307 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.458 HG12 ' HB1' ' A' ' 507' ' ' ALA . 32.5 mm -121.07 109.33 24.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 106.523 -1.658 . . . . 73.21 106.523 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.12 158.95 6.47 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-N 115.575 -0.739 . . . . 74.31 111.761 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . 0.416 ' HG2' ' HG2' ' A' ' 496' ' ' ARG . 26.5 Cg_endo -79.18 7.36 4.44 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 123.475 2.783 . . . . 72.43 111.453 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.502 ' HA ' HG22 ' A' ' 500' ' ' ILE . 17.3 ptp180 -159.41 -158.3 0.65 Allowed 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 115.728 -0.669 . . . . 75.15 110.371 -174.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 72.61 -157.46 52.66 Favored Glycine 0 C--N 1.287 -2.143 0 CA-C-N 114.954 -1.021 . . . . 74.55 111.013 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -69.85 -35.47 74.74 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 122.742 0.417 . . . . 74.21 111.242 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . 0.507 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -58.07 -37.4 74.39 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 113.428 0.899 . . . . 70.14 113.428 -172.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.502 HG22 ' HA ' ' A' ' 496' ' ' ARG . 15.7 tt -79.71 -36.17 17.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 112.134 0.42 . . . . 65.41 112.134 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -63.75 -33.66 76.16 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.303 0.573 . . . . 74.24 110.789 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.406 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 16.5 t70 -89.75 -48.06 7.51 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.88 -0.6 . . . . 70.5 109.951 173.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 72.79 -3.49 27.04 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 117.559 1.784 . . . . 51.13 117.559 175.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.438 ' NH1' ' HA ' ' A' ' 462' ' ' ILE . 70.5 mtp180 -80.46 -15.06 57.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.882 1.341 . . . . 73.23 110.109 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 39.3 tp -96.49 134.47 39.64 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.282 -0.872 . . . . 61.24 108.949 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' A' ' 506' ' ' LYS . 0.0 OUTLIER -142.76 175.41 9.83 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.765 -0.457 . . . . 65.01 109.765 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.458 ' HB1' HG12 ' A' ' 493' ' ' ILE . . . -102.4 82.74 2.21 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 120.351 -0.54 . . . . 42.33 110.676 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . -175.01 35.48 0.1 Allowed Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.306 -1.118 . . . . 61.24 110.306 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -153.76 177.19 11.26 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 122.96 0.504 . . . . 74.41 111.541 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.563 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 0.2 OUTLIER -115.19 142.31 46.83 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.358 0.503 . . . . 72.42 112.358 -174.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.595 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.6 mm? -85.3 128.06 34.56 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.889 -0.596 . . . . 73.03 112.599 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 36.6 mm -102.53 -58.77 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.062 0 CA-C-N 116.189 -0.46 . . . . 63.22 109.775 176.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.499 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.5 pt-20 -156.29 144.55 19.82 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 121.438 0.637 . . . . 51.55 111.056 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 541' ' ' SER . 2.6 p -130.61 135.2 60.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 N-CA-C 107.829 -1.174 . . . . 72.41 107.829 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 17.4 m120 66.47 9.91 6.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.52 0.728 . . . . 75.23 111.727 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 84.07 13.11 75.24 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 111.455 -0.658 . . . . 51.03 111.455 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.83 135.67 39.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.792 -0.818 . . . . 74.53 108.792 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.64 132.15 36.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.68 -0.489 . . . . 75.42 109.68 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.595 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 15.9 mt -97.76 -45.29 6.4 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 112.425 0.528 . . . . 71.45 112.425 -170.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' VAL . . . . . 0.448 HG23 HH21 ' A' ' 510' ' ' ARG . 59.8 t -78.41 99.9 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-O 121.787 0.803 . . . . 64.24 109.126 -175.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 143.68 -26.19 2.1 Favored Glycine 0 N--CA 1.414 -2.815 0 N-CA-C 109.249 -1.541 . . . . 74.11 109.249 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.407 ' HB3' ' HZ3' ' A' ' 522' ' ' LYS . 0.1 OUTLIER -102.01 179.71 4.25 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 110.163 -0.31 . . . . 73.33 110.163 175.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 46.5 t -87.3 155.02 20.24 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.268 0.556 . . . . 74.33 110.68 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.501 ' O ' HG12 ' A' ' 528' ' ' VAL . 28.8 mm-40 -54.55 -39.99 68.27 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.719 1.207 . . . . 74.02 111.41 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.81 -32.11 73.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.191 -0.459 . . . . 71.31 111.572 -176.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.18 -44.58 83.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.05 -0.523 . . . . 73.03 109.835 176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 19.0 t -67.68 -43.56 86.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.665 -0.698 . . . . 61.34 109.634 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.505 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 10.2 m -64.91 -38.73 83.52 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.044 0 C-N-CA 119.774 -0.77 . . . . 73.51 110.265 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.1 t -63.05 -45.43 92.24 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.857 -0.61 . . . . 62.43 110.763 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 531' ' ' LEU . 2.6 pp -66.27 -35.52 80.61 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.441 0.639 . . . . 71.04 109.434 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.462 ' N ' HD11 ' A' ' 530' ' ' LEU . 2.5 tt -62.11 -47.97 82.22 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.054 -0.976 . . . . 70.33 111.607 175.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 1.4 mmp_? -63.95 -37.08 86.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.105 -0.498 . . . . 73.03 109.705 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.2 m -67.4 -39.86 85.57 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.575 -0.739 . . . . 71.04 109.238 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' THR . . . . . 0.459 HG21 ' HB2' ' A' ' 466' ' ' LYS . 95.3 m 72.78 -85.7 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.804 0.842 . . . . 71.24 111.599 177.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 537' ' ' GLU . 39.9 ttmt 170.8 133.67 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.71 1.204 . . . . 71.34 107.864 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.2 mtt -65.97 -29.26 69.62 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.666 0.269 . . . . 62.41 111.141 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . 0.433 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 38.8 tt0 -74.07 -37.05 64.34 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.361 -0.381 . . . . 73.24 110.995 177.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 135.79 -45.48 1.09 Allowed Glycine 0 CA--C 1.539 1.584 0 N-CA-C 117.322 1.689 . . . . 75.31 117.322 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' A' ' 463' ' ' GLN . 5.5 m -101.95 140.19 36.58 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.442 1.121 . . . . 71.4 112.366 -172.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 69.2 t -113.52 140.28 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 124.037 0.935 . . . . 74.22 110.808 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 46.6 t -95.65 124.78 39.83 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.23 -0.656 . . . . 63.31 109.23 176.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -115.37 119.21 35.5 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.298 -1.371 . . . . 72.11 107.298 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 33.9 tp -108.54 117.37 34.0 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.074 -1.454 . . . . 71.53 107.074 174.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 35.6 m -116.17 150.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.803 -0.635 . . . . 71.32 110.837 -177.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 69.6 t80 -112.14 116.52 30.62 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.207 -1.035 . . . . 72.51 108.207 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -116.57 130.74 56.92 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.817 -0.628 . . . . 73.21 110.474 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -82.9 128.07 34.1 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.01 -1.107 . . . . 73.55 108.01 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 64.61 -173.84 0.17 Allowed 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.126 0.97 . . . . 75.14 111.506 -175.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--N 1.302 -1.463 0 N-CA-C 109.018 -0.734 . . . . 74.52 109.018 -178.42 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.405 ' HE2' ' CD1' ' A' ' 460' ' ' LEU . 21.7 ptmt . . . . . 0 CA--C 1.5 -0.956 0 CA-C-O 120.873 0.368 . . . . 73.1 111.216 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 76.4 mtm180 -103.16 145.12 30.4 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.179 -0.675 . . . . 55.34 109.179 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.6 mm? -124.29 126.26 45.74 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.054 -0.521 . . . . 75.41 110.064 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.62 115.58 28.16 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.051 0.929 . . . . 54.34 108.623 173.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 85.2 mt -124.72 121.71 61.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-N 115.409 -0.814 . . . . 73.02 111.221 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 75.2 mt-30 -104.33 130.22 52.18 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 120.288 -0.565 . . . . 65.21 110.551 172.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.584 ' HB3' ' HB1' ' A' ' 498' ' ' ALA . 94.8 mt -122.72 138.0 54.75 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.85 -1.068 . . . . 72.23 109.655 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 465' ' ' LYS . 20.2 ptmt -104.14 128.14 51.78 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-O 122.344 1.069 . . . . 72.33 112.63 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -53.12 115.15 1.73 Allowed 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 112.945 -1.934 . . . . 75.13 113.343 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' GLY . . . . . 0.438 ' H ' ' HA2' ' A' ' 470' ' ' GLY . . . -98.5 -139.22 10.68 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.922 -1.271 . . . . 73.54 109.922 171.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 31.3 m -68.99 -49.35 58.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.607 0.717 . . . . 75.55 109.679 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.67 56.1 0.95 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.101 -1.815 . . . . 74.25 106.101 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.438 ' HA2' ' H ' ' A' ' 467' ' ' GLY . . . -41.61 -63.83 1.55 Allowed Glycine 0 CA--C 1.478 -2.23 0 CA-C-N 113.393 -1.731 . . . . 63.33 115.145 -171.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.454 HD13 HD12 ' A' ' 531' ' ' LEU . 49.6 mt -85.43 82.26 8.38 Favored 'General case' 0 C--N 1.272 -2.79 0 C-N-CA 116.273 -2.171 . . . . 73.13 111.257 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -95.84 40.33 2.65 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 113.063 -1.88 . . . . 65.2 111.862 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 31.6 p90 -137.21 142.19 42.09 Favored 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 108.176 -1.046 . . . . 74.14 108.176 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.0 m -132.12 152.66 51.12 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 116.172 -0.467 . . . . 65.01 110.125 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 10.6 pt -109.51 160.8 8.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.612 -0.722 . . . . 72.4 112.544 -173.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.488 HG21 ' HD3' ' A' ' 491' ' ' LYS . 12.9 t -147.26 159.09 44.06 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.24 -1.022 . . . . 73.03 108.24 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.416 ' HB3' HE21 ' A' ' 524' ' ' GLN . 64.2 p . . . . . 0 C--N 1.299 -1.613 0 N-CA-C 108.041 -1.096 . . . . 75.11 108.041 173.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo . . . . . 0 N--CA 1.438 -1.763 0 CA-C-O 121.362 0.484 . . . . 64.41 112.476 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.422 HG23 HE22 ' A' ' 524' ' ' GLN . 42.8 mm -97.96 125.04 51.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.936 -1.135 . . . . 63.54 107.936 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -118.61 150.17 40.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 122.344 -0.222 . . . . 74.01 111.054 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 43.3 t -80.9 119.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 106.539 -1.652 . . . . 62.33 106.539 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.488 ' HD3' HG21 ' A' ' 476' ' ' THR . 55.0 tptt -91.3 -53.79 4.2 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.973 -0.558 . . . . 61.42 111.489 -174.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 492' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 14.1 t-20 -133.12 144.68 50.1 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.914 -0.714 . . . . 74.44 111.131 -171.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.538 HG12 ' HB2' ' A' ' 507' ' ' ALA . 31.9 mm -121.57 103.88 14.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.007 -0.997 . . . . 71.52 108.688 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.07 127.73 91.27 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.271 -0.877 . . . . 52.11 109.977 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.28 30.18 0.23 Allowed 'Trans proline' 0 N--CA 1.512 2.56 1 C-N-CA 125.373 4.049 . . . . 64.43 114.035 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.403 ' N ' HG21 ' A' ' 500' ' ' ILE . 13.3 ptp180 -159.7 -8.86 0.06 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 113.862 1.06 . . . . 72.43 113.862 -173.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 501' ' ' GLN . . . -91.62 -159.45 35.47 Favored Glycine 0 C--O 1.212 -1.229 0 C-N-CA 119.387 -1.387 . . . . 65.34 113.457 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 464' ' ' LEU . . . -63.43 -32.45 73.89 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 112.844 0.683 . . . . 73.12 112.844 -174.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.47 78.39 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 116.611 -0.268 . . . . 64.22 110.935 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.403 HG21 ' N ' ' A' ' 496' ' ' ARG . 5.9 tt -79.98 -30.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 123.637 0.775 . . . . 75.03 111.895 176.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.523 ' HB2' ' O ' ' A' ' 497' ' ' GLY . 0.0 OUTLIER -58.7 -45.34 89.75 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.758 0.823 . . . . 72.34 109.317 -177.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.448 ' HB2' ' CD2' ' A' ' 464' ' ' LEU . 23.8 m-20 -97.42 -21.14 17.33 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.441 -0.503 . . . . 65.4 109.68 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 68.67 35.39 80.42 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.487 -0.779 . . . . 73.24 113.97 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -108.31 -26.63 10.43 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.966 0.412 . . . . 70.2 111.962 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.403 ' CD1' HG11 ' A' ' 544' ' ' VAL . 49.8 tp -105.55 153.88 21.15 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.665 -0.414 . . . . 60.13 111.252 -174.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.34 170.27 17.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.84 -1.17 . . . . 74.22 107.84 177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.538 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -92.5 148.83 21.78 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 110.178 -0.304 . . . . 62.43 110.178 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 117.23 -34.99 4.33 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.951 -0.642 . . . . 65.21 111.886 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.5 153.66 43.18 Favored 'General case' 0 C--O 1.25 1.103 0 CA-C-O 121.32 0.581 . . . . 74.23 111.277 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 63.3 ttp180 -90.13 127.08 36.01 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.105 -1.072 . . . . 64.0 108.105 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.491 ' HG ' HD11 ' A' ' 519' ' ' LEU . 23.0 tp -80.74 131.88 35.48 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 107.624 -1.25 . . . . 75.03 107.624 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.0 mm -101.44 -44.96 11.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.177 0.513 . . . . 72.32 110.264 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.53 ' HG2' ' HB3' ' A' ' 543' ' ' LEU . 10.5 pt-20 -152.3 156.01 38.81 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.552 -0.907 . . . . 62.15 108.552 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.55 HG12 HD21 ' A' ' 519' ' ' LEU . 5.2 p -137.65 127.92 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.157 0 N-CA-C 108.515 -0.92 . . . . 71.31 108.515 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.2 t30 65.91 9.23 5.94 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 126.136 1.774 . . . . 64.44 111.392 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.68 3.56 40.08 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.303 -0.475 . . . . 63.11 113.167 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.95 139.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 122.419 -0.46 . . . . 75.43 110.536 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.72 134.73 37.06 Favored 'General case' 0 CA--C 1.484 -1.591 0 C-N-CA 123.518 0.727 . . . . 51.2 109.584 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.55 HD21 HG12 ' A' ' 514' ' ' VAL . 42.3 mt -90.19 -45.62 8.98 Favored 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 123.654 0.597 . . . . 73.53 112.03 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.67 99.94 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 121.743 0.782 . . . . 71.15 110.05 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 137.93 -21.46 3.17 Favored Glycine 0 N--CA 1.42 -2.417 0 CA-C-N 114.411 -1.268 . . . . 71.33 110.723 -175.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.24 163.86 14.67 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.67 0.271 . . . . 65.34 111.068 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 523' ' ' SER . . . . . 0.478 ' O ' HG23 ' A' ' 527' ' ' VAL . 34.1 m -92.58 164.19 13.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.01 -0.541 . . . . 63.01 111.09 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.537 ' O ' HG13 ' A' ' 528' ' ' VAL . 50.7 mm-40 -50.44 -47.76 56.66 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 113.55 0.944 . . . . 72.11 113.55 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.427 ' HA ' HG22 ' A' ' 528' ' ' VAL . 5.5 mp0 -59.87 -32.29 70.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.057 0.456 . . . . 75.35 111.454 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.24 -38.26 68.95 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.775 -0.648 . . . . 73.33 109.514 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 523' ' ' SER . 16.3 t -76.29 -37.46 31.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.953 -0.567 . . . . 75.11 110.333 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.65 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 12.3 m -65.64 -42.23 92.31 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 C-N-CA 120.722 -0.391 . . . . 53.14 110.601 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.8 p -68.78 -30.37 68.95 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.252 0.549 . . . . 55.43 111.067 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.33 -39.16 89.06 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.27 -0.877 . . . . 71.33 108.769 173.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.454 HD12 HD13 ' A' ' 471' ' ' LEU . 48.5 tp -69.91 -48.31 59.07 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.712 -0.677 . . . . 74.41 109.955 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.65 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -60.05 -27.68 67.15 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.117 0.567 . . . . 72.23 111.66 -177.555 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 33.8 t -69.82 -35.23 74.62 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 109.82 -0.437 . . . . 73.24 109.82 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 534' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 535' ' ' LYS . 31.1 m 69.19 -89.67 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.226 1.01 . . . . 70.53 110.546 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' A' ' 536' ' ' MET . 61.1 tttp 170.87 175.93 0.06 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.035 -2.209 . . . . 75.12 105.035 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 536' ' ' MET . . . . . 0.417 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 27.5 ttt -72.09 -50.72 25.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 119.138 0.881 . . . . 65.04 112.81 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -35.81 39.65 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 118.472 -1.291 . . . . 74.04 108.746 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 115.96 25.14 3.69 Favored Glycine 0 N--CA 1.411 -3.023 0 CA-C-N 115.03 -0.986 . . . . 64.03 113.187 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 3.8 m -107.44 119.87 40.59 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 118.627 -1.229 . . . . 41.52 108.093 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 65.1 t -106.91 131.72 56.1 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 CA-C-N 115.588 -0.733 . . . . 72.41 110.6 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 24.7 m -94.19 113.77 25.76 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.717 -0.674 . . . . 62.4 109.558 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.465 HD13 HG23 ' A' ' 514' ' ' VAL . 2.5 mm? -106.92 139.59 41.09 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.384 -0.969 . . . . 71.13 108.384 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.53 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 44.9 tp -118.79 117.84 29.96 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 105.863 -1.903 . . . . 75.11 105.863 171.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 27.1 m -118.06 158.05 19.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.841 0 C-N-CA 120.24 -0.584 . . . . 73.22 110.898 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -111.89 116.26 30.33 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.402 -0.962 . . . . 74.24 108.402 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.476 -1.88 0 N-CA-C 107.074 -1.454 . . . . 72.32 107.074 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 28.3 mtpp . . . . . 0 CA--C 1.471 -2.06 0 N-CA-C 109.568 -0.53 . . . . 72.33 109.568 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.5 mtm180 -110.97 128.82 55.96 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 115.673 -0.694 . . . . 71.41 109.213 171.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.435 HD11 ' HE3' ' A' ' 458' ' ' LYS . 2.0 mm? -118.83 129.85 55.45 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 115.021 -0.991 . . . . 74.21 109.317 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -96.55 122.32 39.34 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.119 -0.697 . . . . 73.42 109.119 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 58.8 mt -127.56 142.51 43.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 123.46 0.704 . . . . 74.51 109.942 -174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 78.7 mt-30 -114.97 127.91 55.96 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.608 0.966 . . . . 62.42 113.608 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.537 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.1 mm? -116.61 134.54 54.71 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 124.588 1.155 . . . . 75.44 109.148 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 39.4 ttmt -108.88 135.71 49.63 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-O 121.513 0.673 . . . . 62.1 111.26 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.516 ' HA ' ' HA2' ' A' ' 470' ' ' GLY . 38.1 mtmt -73.08 100.57 3.06 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.063 -0.972 . . . . 62.4 110.866 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -108.03 -101.23 2.69 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.474 -0.87 . . . . 64.14 112.131 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' THR . . . . . 0.545 HG23 ' H ' ' A' ' 469' ' ' GLU . 8.3 t -66.87 -69.8 0.29 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 112.16 0.43 . . . . 55.31 112.16 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.545 ' H ' HG23 ' A' ' 468' ' ' THR . 25.6 mm-40 -98.29 -18.41 18.38 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.599 0.714 . . . . 70.53 109.14 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 69.27 -149.98 49.45 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 114.651 -1.159 . . . . 74.2 112.98 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.458 HD11 HG21 ' A' ' 540' ' ' VAL . 38.4 mt -51.65 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.478 0.918 . . . . 74.32 113.478 -169.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -107.72 56.19 0.49 Allowed Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 114.582 -1.19 . . . . 42.31 111.688 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.37 142.59 29.5 Favored 'General case' 0 C--N 1.281 -2.371 0 C-N-CA 123.369 0.668 . . . . 75.53 110.064 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.9 m -119.59 162.41 18.98 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.396 -0.82 . . . . 62.22 109.807 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 20.6 pt -117.88 158.09 18.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.129 0.49 . . . . 71.32 111.67 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.8 t -148.7 160.09 43.5 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.23 -0.896 . . . . 75.52 108.655 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 31.6 t . . . . . 0 N--CA 1.411 -2.383 0 N-CA-C 107.216 -1.401 . . . . 65.41 107.216 174.777 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 C--O 1.239 0.536 0 CA-C-O 121.192 0.413 . . . . 73.12 112.914 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 24.8 mm -92.81 128.81 44.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.314 -0.857 . . . . 74.51 108.795 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -127.95 158.71 37.1 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 121.887 -0.508 . . . . 74.44 111.479 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.43 HG22 HD21 ' A' ' 511' ' ' LEU . 21.7 t -74.31 129.55 36.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.206 -1.035 . . . . 75.1 108.206 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -93.27 -61.3 1.59 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.544 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -141.09 148.83 40.78 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.776 -0.647 . . . . 75.41 110.183 -174.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.474 HG12 ' HB2' ' A' ' 507' ' ' ALA . 36.4 mm -118.57 104.32 15.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.411 -1.329 . . . . 64.31 107.411 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 8.3 mp -54.72 152.06 13.77 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.187 -0.915 . . . . 70.11 112.73 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.493 ' O ' HD13 ' A' ' 500' ' ' ILE . 23.0 Cg_endo -77.89 -3.12 13.21 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 124.339 3.359 . . . . 73.24 111.64 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -158.64 110.88 2.24 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 124.582 1.153 . . . . 72.05 109.636 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 160.89 -168.5 36.27 Favored Glycine 1 C--N 1.237 -4.925 0 CA-C-N 112.846 -1.979 . . . . 73.44 111.145 178.537 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.418 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -57.23 -47.14 82.09 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 124.464 1.106 . . . . 54.13 110.54 -174.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -56.88 -44.11 81.93 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.006 -0.997 . . . . 65.14 111.853 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.493 HD13 ' O ' ' A' ' 495' ' ' PRO . 16.5 tt -80.96 -37.63 16.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.083 0.771 . . . . 65.54 113.083 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.3 mm100 -64.74 -41.83 95.65 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 120.867 0.365 . . . . 73.43 110.771 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.537 ' HB2' HD13 ' A' ' 464' ' ' LEU . 23.7 m-20 -84.95 -32.07 23.26 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.777 -0.823 . . . . 42.42 108.777 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 61.4 45.72 95.84 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.839 0.712 . . . . 65.35 113.864 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -115.07 -28.07 7.11 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.044 0.45 . . . . 62.15 112.18 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 57.0 tp -106.22 146.55 30.15 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.15 -0.685 . . . . 63.04 109.15 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.437 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -138.81 162.05 35.72 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.914 -0.773 . . . . 64.13 108.914 176.784 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.474 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.52 120.69 26.24 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.012 0.434 . . . . 71.34 111.382 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 508' ' ' GLY . . . . . 0.41 ' H ' ' HB ' ' A' ' 490' ' ' VAL . . . 145.04 -12.28 1.87 Allowed Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.706 -0.679 . . . . 45.12 112.213 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -94.22 172.87 7.94 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 120.975 0.416 . . . . 72.24 112.026 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 544' ' ' VAL . 41.1 ttm180 -102.83 137.99 40.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.637 -0.71 . . . . 72.44 110.269 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.688 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -86.08 119.13 26.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.951 -0.568 . . . . 74.41 110.463 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 47.8 mm -98.65 -47.33 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.849 -0.16 . . . . 73.52 110.588 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.524 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 10.2 pt-20 -149.0 148.61 29.95 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.358 -0.608 . . . . 64.43 109.358 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.677 HG12 HD21 ' A' ' 519' ' ' LEU . 3.6 p -132.56 119.36 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.394 0 CA-C-O 121.975 0.893 . . . . 64.4 109.254 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.72 23.91 11.53 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 126.242 1.817 . . . . 75.31 111.959 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.28 -18.46 33.2 Favored Glycine 0 C--O 1.237 0.289 0 C-N-CA 120.491 -0.861 . . . . 74.45 113.953 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.7 t -96.85 134.49 34.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 109.772 -0.455 . . . . 64.34 109.772 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -84.35 143.1 29.7 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.656 -0.498 . . . . 63.13 109.656 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.688 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 18.4 mt -103.78 -39.67 6.56 Favored 'General case' 0 CA--C 1.482 -1.639 0 CA-C-N 115.432 -0.804 . . . . 73.41 112.257 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 35.4 t -74.61 90.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 121.811 0.815 . . . . 72.41 109.48 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 154.13 -28.61 0.72 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 108.289 -1.925 . . . . 70.22 108.289 -175.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.411 ' HB2' ' CD ' ' A' ' 526' ' ' GLU . 0.1 OUTLIER -105.3 178.78 4.46 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.016 -0.592 . . . . 71.53 109.916 175.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 523' ' ' SER . . . . . 0.562 ' O ' HG23 ' A' ' 527' ' ' VAL . 60.7 p -95.84 164.33 12.78 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.501 0.556 . . . . 72.22 112.501 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.486 ' O ' HG13 ' A' ' 528' ' ' VAL . 8.0 mm100 -49.71 -43.23 47.41 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 124.705 1.202 . . . . 64.23 111.442 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.423 ' HA ' HG22 ' A' ' 528' ' ' VAL . 42.7 mt-10 -65.03 -35.74 82.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.408 0.623 . . . . 61.14 111.961 -174.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.411 ' CD ' ' HB2' ' A' ' 522' ' ' LYS . 43.9 mt-10 -69.74 -37.25 76.4 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.644 -0.707 . . . . 75.34 109.522 177.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 523' ' ' SER . 32.3 t -70.2 -41.46 78.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.528 -0.76 . . . . 64.4 109.556 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.687 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 12.5 m -64.57 -44.42 96.8 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 C-N-CA 120.021 -0.672 . . . . 63.44 110.054 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 49.1 m -57.87 -40.29 79.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.485 0.659 . . . . 52.34 110.232 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 50.7 tp -63.11 -47.25 83.62 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 124.545 1.138 . . . . 74.11 109.879 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.437 HD12 HD13 ' A' ' 471' ' ' LEU . 35.1 tp -65.2 -44.22 89.07 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.861 -0.609 . . . . 64.25 110.574 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.687 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -62.3 -33.51 74.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.155 0.582 . . . . 63.21 110.851 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.6 m -75.53 -41.01 56.16 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.032 -0.531 . . . . 62.44 110.882 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 534' ' ' THR . . . . . 0.482 HG23 ' CG2' ' A' ' 540' ' ' VAL . 32.5 m 66.65 -92.91 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.266 0.627 . . . . 73.25 110.121 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt 170.48 171.86 0.07 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.19 -1.411 . . . . 74.11 107.19 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 26.1 ttt -65.63 -38.6 89.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 111.603 0.223 . . . . 75.23 111.603 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.58 -79.26 0.08 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.461 -0.336 . . . . 75.41 110.473 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 151.56 -21.47 0.93 Allowed Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 118.708 -1.71 . . . . 25.42 114.618 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.489 HG22 ' HB3' ' A' ' 463' ' ' GLN . 3.0 m -94.83 125.24 39.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 118.433 1.117 . . . . 74.14 110.251 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 47.1 t -106.81 140.63 24.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.028 -0.987 . . . . 72.42 110.162 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.5 t -99.14 114.69 27.58 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.165 0.507 . . . . 74.22 109.815 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.533 HD23 HD23 ' A' ' 464' ' ' LEU . 3.4 mm? -101.77 122.33 43.74 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 124.538 1.135 . . . . 65.35 109.08 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 36.2 tp -104.98 118.97 37.87 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.376 -1.712 . . . . 72.54 106.376 174.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 36.0 m -115.03 145.55 20.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-O 121.179 0.514 . . . . 72.35 110.957 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 88.8 t80 -112.27 116.06 29.79 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.276 -0.875 . . . . 74.22 110.042 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 546' ' ' ARG . . . . . 0.536 ' O ' ' HD3' ' A' ' 546' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.29 -1.997 0 N-CA-C 107.478 -1.304 . . . . 55.45 107.478 175.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.405 ' HE2' HD13 ' A' ' 460' ' ' LEU . 22.0 ptmt . . . . . 0 N--CA 1.435 -1.209 0 CA-C-O 120.974 0.416 . . . . 45.53 110.467 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -106.16 154.51 20.59 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.413 -1.328 . . . . 64.43 107.413 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.8 mm? -125.33 130.89 52.88 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 110.002 -0.37 . . . . 73.32 110.002 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -96.25 116.19 28.62 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.655 -0.868 . . . . 73.03 108.655 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' ILE . . . . . 0.505 HG23 ' CG ' ' A' ' 504' ' ' ARG . 68.6 mt -123.28 121.16 62.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 115.601 -0.727 . . . . 72.12 110.202 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.2 mt-30 -99.94 128.94 45.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.786 0.662 . . . . 74.44 112.786 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.586 HD23 HD23 ' A' ' 542' ' ' LEU . 4.3 mm? -115.08 132.82 56.48 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-N 115.361 -0.836 . . . . 63.24 109.841 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.445 ' HE2' ' HB2' ' A' ' 465' ' ' LYS . 25.3 ttmm -101.17 131.9 46.91 Favored 'General case' 0 N--CA 1.394 -3.265 0 CA-C-O 121.936 0.874 . . . . 61.01 110.886 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.12 103.28 0.21 Allowed 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 113.146 -1.843 . . . . 73.13 111.485 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -136.5 137.05 8.78 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.781 -0.928 . . . . 74.32 110.781 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 73.2 m 63.24 -86.72 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.143 0.977 . . . . 62.32 112.642 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.481 ' HB3' ' HA2' ' A' ' 497' ' ' GLY . 8.6 tp10 -97.74 -13.93 21.14 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.238 -1.023 . . . . 74.3 108.238 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 70.09 -155.82 53.24 Favored Glycine 0 C--O 1.202 -1.867 0 CA-C-O 117.946 -1.474 . . . . 71.03 109.707 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.501 HD23 HD12 ' A' ' 531' ' ' LEU . 6.3 mp -43.83 96.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.707 1.254 . . . . 72.02 113.706 -173.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -106.22 63.58 0.3 Allowed Glycine 0 N--CA 1.411 -3.007 0 CA-C-N 113.546 -1.661 . . . . 71.42 110.448 -174.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 27.7 p90 -156.66 142.0 17.44 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 107.265 -1.383 . . . . 71.43 107.265 175.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 12.1 p -115.79 163.61 15.59 Favored 'General case' 0 C--N 1.263 -3.165 0 O-C-N 123.617 0.573 . . . . 73.3 109.868 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 12.6 pt -114.35 154.75 15.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.368 0.604 . . . . 71.03 112.04 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.7 t -137.95 149.33 46.06 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.679 -0.86 . . . . 71.31 108.679 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.46 ' HB3' ' OE1' ' A' ' 524' ' ' GLN . 66.9 p . . . . . 0 C--N 1.308 -1.225 0 N-CA-C 109.193 -0.669 . . . . 64.11 109.193 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.415 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -1.192 0 N-CA-C 109.673 -0.933 . . . . 54.43 109.673 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.56 HG13 ' HB3' ' A' ' 519' ' ' LEU . 18.2 mm -91.09 124.46 43.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 115.921 -0.581 . . . . 62.41 109.976 -172.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.415 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 88.1 m-85 -125.61 163.0 23.72 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 109.975 -0.38 . . . . 64.32 109.975 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 40.2 t -89.16 119.83 36.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.851 -0.425 . . . . 51.41 109.851 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -70.81 -63.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.47 1.108 . . . . 74.31 110.358 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 492' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 64.0 t30 -151.45 160.19 43.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.931 -0.577 . . . . 74.13 109.911 -174.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 507' ' ' ALA . 44.7 mm -110.28 105.71 19.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.874 -1.158 . . . . 72.35 107.874 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -65.15 128.4 93.75 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.585 -0.734 . . . . 61.23 111.344 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.14 24.68 0.26 Allowed 'Trans proline' 0 N--CA 1.503 2.048 1 C-N-CA 125.334 4.023 . . . . 61.02 114.964 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -160.29 7.02 0.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 113.251 0.834 . . . . 65.23 113.251 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 469' ' ' GLU . . . -99.8 -155.21 28.15 Favored Glycine 0 C--N 1.297 -1.631 0 C-N-CA 119.266 -1.445 . . . . 74.23 113.685 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.519 ' O ' HD12 ' A' ' 464' ' ' LEU . . . -66.12 -37.66 86.26 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 123.37 0.668 . . . . 52.41 109.559 -176.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -57.72 -41.76 82.42 Favored 'General case' 0 C--O 1.195 -1.778 0 CA-C-N 115.126 -0.943 . . . . 64.31 112.053 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.3 tt -80.3 -29.36 12.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 120.943 0.401 . . . . 71.54 111.625 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.05 -48.37 80.32 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.228 1.011 . . . . 74.13 108.666 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.531 ' HB2' HD13 ' A' ' 464' ' ' LEU . 12.9 m-20 -93.68 -31.73 14.34 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 120.345 -0.542 . . . . 61.03 110.412 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.29 27.82 72.14 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.879 -0.6 . . . . 44.42 112.967 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.505 ' CG ' HG23 ' A' ' 462' ' ' ILE . 33.0 tpt180 -101.92 -19.35 15.3 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.75 0.31 . . . . 71.41 111.148 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.516 ' HB2' HD21 ' A' ' 464' ' ' LEU . 52.7 tp -106.87 151.19 25.56 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.817 -0.438 . . . . 72.51 109.817 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.479 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -144.21 159.88 41.91 Favored 'General case' 0 N--CA 1.434 -1.258 0 O-C-N 123.176 0.298 . . . . 72.32 110.594 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.541 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -91.4 167.95 11.9 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.323 0.389 . . . . 71.32 111.773 -174.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.87 13.18 65.04 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.446 -0.797 . . . . 54.0 112.153 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -120.01 178.27 4.68 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 107.645 -1.243 . . . . 73.51 107.645 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.01 133.54 47.96 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-N 117.993 0.361 . . . . 74.14 110.646 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 511' ' ' LEU . 21.4 tp -96.04 117.05 29.91 Favored 'General case' 0 N--CA 1.394 -3.251 0 N-CA-C 108.339 -0.986 . . . . 72.24 108.339 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.444 ' HB ' HD12 ' A' ' 543' ' ' LEU . 1.9 mp -99.02 -35.19 4.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.121 0.486 . . . . 73.04 110.211 -177.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 543' ' ' LEU . 31.2 tt0 -150.34 144.78 25.73 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.716 -0.674 . . . . 64.35 110.551 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.524 HG12 HD21 ' A' ' 519' ' ' LEU . 2.6 p -135.03 123.35 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 N-CA-C 108.328 -0.99 . . . . 63.02 108.328 175.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 70.62 -66.22 0.3 Allowed 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 127.576 2.35 . . . . 71.42 111.231 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -174.02 29.64 0.09 OUTLIER Glycine 0 C--N 1.308 -0.994 0 N-CA-C 111.467 -0.653 . . . . 64.42 111.467 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.6 t -122.18 139.1 50.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 110.155 -0.313 . . . . 74.25 110.155 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -83.18 130.53 35.1 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.575 -0.898 . . . . 45.34 108.575 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.56 ' HB3' HG13 ' A' ' 488' ' ' ILE . 47.5 mt -100.89 -36.0 9.21 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.986 -0.552 . . . . 74.1 112.117 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.48 89.53 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 121.855 0.836 . . . . 60.23 110.205 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 147.95 -32.8 1.29 Allowed Glycine 0 N--CA 1.427 -1.94 0 CA-C-N 114.369 -1.287 . . . . 53.5 110.178 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.6 -177.63 4.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.407 0.521 . . . . 75.24 112.407 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 523' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 527' ' ' VAL . 5.0 m -95.24 156.11 16.46 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.909 -0.587 . . . . 75.32 111.244 -175.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.46 ' OE1' ' HB3' ' A' ' 477' ' ' SER . 8.1 mm100 -56.16 -46.36 79.34 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.808 0.843 . . . . 53.14 111.239 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.43 ' HA ' HG22 ' A' ' 528' ' ' VAL . 1.1 mp0 -57.85 -31.86 67.09 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.127 0.489 . . . . 71.13 111.951 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -69.64 -37.24 76.69 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.967 -0.56 . . . . 52.02 110.037 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 523' ' ' SER . 17.6 t -75.93 -36.03 31.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.325 -0.852 . . . . 70.41 109.653 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.671 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.3 m -64.98 -40.61 89.65 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.267 0 C-N-CA 120.052 -0.659 . . . . 72.12 111.07 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.9 t -59.46 -44.98 92.86 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.652 0.739 . . . . 44.13 109.277 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 31.8 tp -60.4 -38.72 84.86 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 125.229 1.412 . . . . 72.43 110.398 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.501 HD12 HD23 ' A' ' 471' ' ' LEU . 16.6 tp -70.17 -48.63 56.43 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.484 -0.78 . . . . 63.42 109.959 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.8 OUTLIER -60.27 -44.56 95.21 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.767 0.827 . . . . 74.14 111.382 -176.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 33.7 t -69.23 -31.92 70.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.16 -0.473 . . . . 70.01 111.037 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 84.9 m 66.3 -87.03 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.926 0.49 . . . . 54.2 111.552 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? 165.58 158.26 0.03 OUTLIER 'General case' 0 C--O 1.244 0.774 0 N-CA-C 105.89 -1.893 . . . . 44.52 105.89 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 65.9 mtt -58.84 -50.3 74.49 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.206 0.316 . . . . 73.15 111.416 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -62.49 -65.49 0.68 Allowed 'General case' 0 C--O 1.24 0.576 0 N-CA-C 110.049 -0.352 . . . . 74.13 110.049 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 135.28 -14.3 4.28 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 118.353 -1.88 . . . . 64.4 116.072 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.4 m -94.38 128.11 40.7 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 118.904 1.352 . . . . 63.45 108.534 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 66.7 t -114.79 137.32 48.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 CA-C-N 115.816 -0.629 . . . . 71.54 110.393 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 54.8 m -91.88 113.94 26.35 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.187 0.518 . . . . 72.53 110.467 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.586 HD23 HD23 ' A' ' 464' ' ' LEU . 3.3 mm? -102.36 119.34 38.65 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.556 -0.905 . . . . 65.35 108.556 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 3.1 tm? -110.68 117.06 32.45 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 107.907 -1.146 . . . . 72.52 107.907 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 33.1 m -119.98 162.64 18.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 114.768 -1.105 . . . . 62.4 110.325 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -116.96 114.8 24.32 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 109.495 -0.557 . . . . 73.13 109.495 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 . . . . . 0 N--CA 1.416 -2.142 0 C-N-CA 120.013 -0.675 . . . . 75.4 111.817 -177.391 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 458' ' ' LYS . 43.9 mtpt . . . . . 0 CA--C 1.471 -2.07 0 CA-C-O 121.791 0.805 . . . . 70.03 112.874 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 98.3 mtt180 -107.89 131.66 54.28 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-N 113.427 -1.715 . . . . 75.51 106.505 170.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -120.98 133.27 55.27 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 109.486 -0.561 . . . . 63.54 109.486 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -93.09 115.2 27.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.492 0.663 . . . . 73.14 109.278 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' ILE . . . . . 0.458 HG23 ' HD3' ' A' ' 504' ' ' ARG . 59.7 mt -121.72 122.67 67.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.655 -0.702 . . . . 70.0 109.977 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 73.4 mt-30 -102.42 129.22 48.85 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.99 0.424 . . . . 74.43 111.901 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.463 HD23 HD23 ' A' ' 542' ' ' LEU . 3.1 mm? -115.09 135.52 54.11 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.542 0.737 . . . . 43.11 109.879 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.764 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.1 OUTLIER -98.89 137.07 37.99 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.993 -1.114 . . . . 55.31 107.993 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.443 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 36.9 ttmt -59.73 106.1 0.44 Allowed 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.377 -0.829 . . . . 71.31 110.655 174.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -92.67 -138.71 8.69 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.846 -0.901 . . . . 43.31 110.846 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 10.2 t -65.87 -46.55 78.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.859 0.329 . . . . 42.44 110.454 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -121.53 83.42 2.08 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 107.043 -1.466 . . . . 75.41 107.043 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.443 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . -58.63 140.87 46.94 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 120.356 -0.926 . . . . 74.42 113.594 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.564 HD11 HG21 ' A' ' 540' ' ' VAL . 18.2 mt 57.37 89.1 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 125.434 1.494 . . . . 65.22 112.166 -174.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -103.45 56.76 0.58 Allowed Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 114.72 -1.127 . . . . 50.23 111.213 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.605 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 6.4 p90 -144.75 144.78 31.36 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.024 -0.732 . . . . 74.53 109.024 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.2 m -120.88 149.63 42.31 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.97 -1.122 . . . . 52.34 107.97 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 15.4 pt -109.85 155.27 11.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 112.895 0.702 . . . . 73.51 112.895 -175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 7.5 t -129.16 159.83 34.78 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.063 -1.088 . . . . 72.43 108.063 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 33.9 p . . . . . 0 C--N 1.29 -1.998 0 N-CA-C 109.077 -0.712 . . . . 55.31 109.077 178.685 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--O 1.253 1.243 0 N-CA-C 110.027 -0.797 . . . . 60.21 110.027 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.43 ' HB ' HD13 ' A' ' 519' ' ' LEU . 48.3 mm -102.62 136.16 36.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.983 -0.553 . . . . 72.41 110.298 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -134.82 162.48 32.25 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.326 -0.62 . . . . 75.53 109.326 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 23.2 t -82.23 122.89 37.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 109.141 -0.689 . . . . 61.25 109.141 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -89.87 -55.27 3.69 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.817 -0.628 . . . . 75.2 110.674 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -146.48 151.02 36.72 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.191 -0.67 . . . . 64.12 109.191 -175.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.634 HG12 ' HB2' ' A' ' 507' ' ' ALA . 35.3 mm -111.2 110.98 34.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.002 -1.11 . . . . 50.3 108.002 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.24 123.52 78.65 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 115.775 -0.648 . . . . 64.45 109.298 176.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.02 22.19 0.15 Allowed 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.945 3.763 . . . . 75.33 114.836 -171.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -160.07 -2.98 0.07 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.819 0.674 . . . . 75.11 112.819 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.602 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -84.55 -167.97 43.61 Favored Glycine 0 C--O 1.216 -0.971 0 C-N-CA 119.788 -1.196 . . . . 44.41 112.515 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.461 ' CB ' ' H ' ' A' ' 471' ' ' LEU . . . -57.11 -34.77 68.69 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.014 0.907 . . . . 53.13 111.759 -175.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.79 86.14 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.61 -0.723 . . . . 74.04 112.261 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 8.8 tt -79.03 -31.3 14.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 O-C-N 123.233 0.333 . . . . 63.4 111.388 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 71.1 mm-40 -62.39 -43.28 99.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.763 -0.458 . . . . 73.14 109.763 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.406 ' HB2' HD13 ' A' ' 464' ' ' LEU . 11.0 t70 -82.77 -41.64 18.93 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.865 -1.531 . . . . 64.2 106.865 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.56 -7.52 76.1 Favored Glycine 0 N--CA 1.426 -1.973 0 CA-C-N 115.372 -0.831 . . . . 75.23 115.118 174.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.458 ' HD3' HG23 ' A' ' 462' ' ' ILE . 73.4 ttt180 -85.83 -19.16 31.06 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 120.974 0.416 . . . . 63.02 111.727 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 62.1 tp -101.19 130.48 47.29 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.091 -0.337 . . . . 73.32 110.091 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.527 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -134.83 171.77 13.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.657 0.265 . . . . 74.02 111.448 176.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.634 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -96.82 130.8 44.03 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.35 -0.386 . . . . 73.33 111.107 -176.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 144.13 -23.27 2.08 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.659 -0.701 . . . . 61.44 111.465 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -93.29 172.23 8.42 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-O 120.942 0.401 . . . . 74.33 111.099 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -93.75 138.75 31.61 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.679 -0.692 . . . . 74.34 110.308 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.525 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -89.77 127.96 36.05 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 105.892 -1.892 . . . . 73.15 105.892 177.59 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.0 mm -96.16 -50.78 11.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.861 -0.524 . . . . 74.32 109.97 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -157.54 145.76 19.14 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.694 -0.685 . . . . 75.44 109.267 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.433 HG23 HD13 ' A' ' 542' ' ' LEU . 4.8 p -126.04 130.37 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.308 0 CA-C-O 121.359 0.599 . . . . 74.45 109.69 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 62.05 20.08 11.32 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 126.208 1.803 . . . . 71.44 111.389 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 95.47 2.09 61.94 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.78 -0.724 . . . . 63.31 113.473 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.99 138.21 38.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.639 -0.504 . . . . 74.24 109.639 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -84.35 148.22 26.75 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 123.571 0.544 . . . . 75.02 110.036 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.525 HD11 HD12 ' A' ' 511' ' ' LEU . 28.1 mt -90.48 -50.98 5.64 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.773 -0.649 . . . . 55.51 112.003 -173.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.12 86.32 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 122.623 1.202 . . . . 75.51 111.305 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 166.2 -24.34 0.14 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 108.278 -1.929 . . . . 44.14 108.278 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.58 172.49 7.31 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.793 -0.817 . . . . 74.31 108.793 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 42.4 m -91.88 165.15 13.39 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 110.256 -0.275 . . . . 72.42 110.256 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -53.96 -44.97 71.18 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.572 0.749 . . . . 73.0 111.847 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.609 ' HA ' HG22 ' A' ' 528' ' ' VAL . 39.4 mt-10 -61.58 -31.55 71.61 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 112.463 0.542 . . . . 75.53 112.463 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.75 -34.01 69.15 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.291 -0.633 . . . . 54.31 109.291 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 47.6 t -70.45 -38.22 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.559 -0.746 . . . . 75.42 109.372 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.715 ' O ' ' HG3' ' A' ' 532' ' ' ARG . 19.9 m -69.57 -36.64 71.9 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.893 0 C-N-CA 119.099 -1.04 . . . . 73.42 110.676 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.8 t -59.28 -44.11 92.49 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 109.226 -0.657 . . . . 53.34 109.226 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 34.4 tp -58.82 -41.9 87.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.843 1.257 . . . . 75.22 109.594 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 471' ' ' LEU . 3.2 tt -64.98 -48.05 75.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.323 -0.853 . . . . 63.53 111.944 174.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.715 ' HG3' ' O ' ' A' ' 528' ' ' VAL . 23.0 mtm180 -61.41 -31.11 71.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.49 -0.323 . . . . 62.5 110.837 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.5 t -65.56 -44.43 86.79 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.253 -0.431 . . . . 53.41 110.006 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 24.6 m 63.85 -2.88 0.49 Allowed 'General case' 0 CA--C 1.578 2.026 0 C-N-CA 123.797 0.839 . . . . 62.41 112.812 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.586 ' HE3' ' OE1' ' A' ' 537' ' ' GLU . 61.6 tttp 70.13 146.4 0.06 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.215 1.006 . . . . 62.23 111.912 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 46.7 ttm -63.3 -32.37 73.77 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 116.569 2.062 . . . . 51.2 116.569 -167.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 537' ' ' GLU . . . . . 0.586 ' OE1' ' HE3' ' A' ' 535' ' ' LYS . 0.0 OUTLIER -78.24 -28.24 47.76 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 118.021 -1.472 . . . . 63.2 108.782 178.117 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 99.86 30.98 6.18 Favored Glycine 0 N--CA 1.415 -2.733 0 CA-C-N 114.771 -1.104 . . . . 54.02 113.613 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 4.0 m -128.58 132.22 48.2 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.034 -1.099 . . . . 45.14 108.034 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.564 HG21 HD11 ' A' ' 471' ' ' LEU . 61.5 t -120.07 134.34 63.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 116.178 -0.465 . . . . 61.14 111.239 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.7 m -91.76 114.4 26.93 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.199 -0.91 . . . . 71.12 110.047 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.605 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.2 mm? -104.04 121.24 42.77 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.744 -1.206 . . . . 71.32 107.744 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 41.8 tp -104.51 117.92 35.32 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.252 -1.759 . . . . 52.31 106.252 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 35.3 m -115.31 148.47 18.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 C-N-CA 120.503 -0.479 . . . . 54.23 110.827 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -111.97 122.32 47.44 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.829 -0.623 . . . . 74.22 109.655 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 . . . . . 0 N--CA 1.409 -2.519 0 CA-C-N 114.59 -1.186 . . . . 63.31 109.436 179.767 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt . . . . . 0 N--CA 1.42 -1.974 0 N-CA-C 108.28 -1.007 . . . . 65.44 108.28 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 43.8 mtm180 -100.67 145.57 28.27 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 110.005 -0.368 . . . . 73.41 110.005 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.0 mm? -124.12 131.91 53.59 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.124 -0.695 . . . . 72.43 109.124 -174.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -104.89 115.27 30.0 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.655 0.74 . . . . 70.11 109.093 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 50.0 mt -122.51 142.6 38.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 115.318 -0.855 . . . . 73.15 110.506 -171.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 43.5 mt-30 -114.99 128.24 56.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.901 0.381 . . . . 74.2 111.279 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 539' ' ' THR . 6.3 mp -119.04 152.47 36.38 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.108 0.963 . . . . 71.45 111.885 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -115.81 129.04 56.28 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.323 -0.992 . . . . 75.11 108.323 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.633 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 23.8 ttmm -60.81 88.01 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.419 0.628 . . . . 72.23 112.044 176.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -90.45 -128.47 3.81 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.63 -0.714 . . . . 73.3 112.277 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' THR . . . . . 0.723 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 17.1 m -48.99 -72.73 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.322 1.049 . . . . 64.22 111.507 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.601 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 46.1 mm-40 -82.36 -38.54 24.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.245 -1.391 . . . . 72.14 107.245 171.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.633 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . 65.78 109.09 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.179 -1.373 . . . . 70.31 112.096 -174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.664 ' H ' ' CB ' ' A' ' 498' ' ' ALA . 33.9 mt 69.16 85.51 0.14 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 125.64 1.576 . . . . 71.3 108.076 -168.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . -103.18 56.76 0.59 Allowed Glycine 0 CA--C 1.471 -2.698 0 CA-C-N 114.393 -1.276 . . . . 45.3 112.151 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 2.9 p90 -147.72 142.94 27.21 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.01 0.433 . . . . 73.11 110.253 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 19.9 m -114.69 145.2 42.32 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 107.237 -1.394 . . . . 72.33 107.237 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.86 153.94 14.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 112.812 0.671 . . . . 52.21 112.812 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.655 ' HB ' ' HE3' ' A' ' 491' ' ' LYS . 8.2 t -143.33 149.43 37.76 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.119 -0.946 . . . . 43.33 109.563 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.424 -1.732 0 N-CA-C 108.092 -1.077 . . . . 72.22 108.092 174.964 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.51 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 43.5 Cg_exo . . . . . 0 C--O 1.245 0.872 0 CA-C-O 121.379 0.491 . . . . 74.33 113.285 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.494 HG13 ' HB3' ' A' ' 519' ' ' LEU . 38.9 mm -87.98 120.82 37.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.963 -1.017 . . . . 71.12 108.883 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 66.3 m-85 -120.51 150.47 40.79 Favored 'General case' 0 CA--C 1.483 -1.613 0 CA-C-O 120.804 0.335 . . . . 74.01 111.897 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.43 119.42 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 107.185 -1.413 . . . . 70.52 107.185 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.655 ' HE3' ' HB ' ' A' ' 476' ' ' THR . 41.0 ttmt -87.87 -53.82 4.56 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.312 0.577 . . . . 61.42 111.078 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 492' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 61.5 t30 -142.04 149.68 40.27 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.287 -0.87 . . . . 71.0 110.446 -171.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 507' ' ' ALA . 32.2 mm -115.87 106.54 20.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 124.149 0.906 . . . . 74.13 109.26 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -53.09 131.11 50.47 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.551 -0.749 . . . . 74.55 111.069 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -70.01 15.15 0.25 Allowed 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 124.557 3.505 . . . . 74.31 114.095 -173.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.723 ' O ' ' HB ' ' A' ' 468' ' ' THR . 12.1 ptt180 -164.35 12.68 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.109 0.957 . . . . 74.41 111.097 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.601 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . -84.83 -174.84 50.52 Favored Glycine 0 C--N 1.286 -2.209 0 C-N-CA 120.013 -1.089 . . . . 60.23 111.565 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.664 ' CB ' ' H ' ' A' ' 471' ' ' LEU . . . -62.21 -28.12 69.46 Favored 'General case' 0 C--O 1.198 -1.633 0 CA-C-N 117.999 0.9 . . . . 72.34 110.934 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.424 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -58.93 -41.62 87.81 Favored 'General case' 0 C--O 1.204 -1.302 0 CA-C-N 116.069 -0.514 . . . . 53.03 111.697 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.4 tt -79.84 -36.99 17.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.877 0.37 . . . . 73.14 111.546 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 9.1 mm-40 -66.85 -39.94 87.76 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.69 -0.686 . . . . 62.11 110.219 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.471 ' HB2' ' HG ' ' A' ' 464' ' ' LEU . 10.8 m-20 -92.45 -22.66 19.49 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.594 -0.73 . . . . 71.33 111.455 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.87 -57.36 5.01 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 116.647 1.419 . . . . 43.44 116.647 171.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -46.13 -30.8 2.06 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.519 1.674 . . . . 73.51 115.519 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 59.4 tp -98.02 132.05 43.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 117.824 0.284 . . . . 71.22 111.173 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.454 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -143.91 164.89 29.26 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 121.046 -0.261 . . . . 72.24 110.963 174.589 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.524 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.7 98.8 9.85 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.266 0.555 . . . . 71.35 111.963 -174.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 174.1 29.38 0.03 OUTLIER Glycine 0 C--N 1.304 -1.228 0 N-CA-C 111.107 -0.797 . . . . 51.24 111.107 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -148.18 177.79 9.1 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 120.748 0.309 . . . . 74.42 110.979 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -106.82 129.25 54.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.527 -0.76 . . . . 72.41 109.43 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' A' ' 519' ' ' LEU . 28.2 tp -83.46 120.77 26.32 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 107.957 -1.127 . . . . 74.21 107.957 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 543' ' ' LEU . 49.1 mm -97.93 -45.84 12.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 120.911 0.386 . . . . 71.22 111.129 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.491 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 10.2 pt-20 -154.02 146.02 23.6 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.123 -0.49 . . . . 72.33 110.145 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.458 HG13 HD21 ' A' ' 530' ' ' LEU . 2.6 p -130.65 129.13 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.458 0 N-CA-C 107.401 -1.333 . . . . 71.02 107.401 176.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 68.01 4.8 4.22 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.82 0.848 . . . . 74.33 112.667 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 104.56 -6.96 45.68 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 121.065 -0.588 . . . . 53.55 112.075 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.3 t -87.14 125.75 40.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.776 -0.453 . . . . 35.42 109.776 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -79.75 134.25 36.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.982 -0.554 . . . . 73.15 110.512 -176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.494 ' HB3' HG13 ' A' ' 488' ' ' ILE . 17.3 mt -98.63 -22.87 15.71 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.864 -0.607 . . . . 44.54 110.658 -174.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.31 9.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 125.413 1.485 . . . . 63.42 113.84 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -144.05 18.45 2.14 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 110.875 -0.89 . . . . 44.54 110.875 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 174.6 10.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.466 0.543 . . . . 72.31 112.466 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 523' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 527' ' ' VAL . 32.4 m -93.34 159.8 15.1 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.757 -0.656 . . . . 75.34 112.731 -175.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.507 ' O ' HG13 ' A' ' 528' ' ' VAL . 36.9 mm-40 -50.19 -47.68 54.47 Favored 'General case' 0 C--O 1.209 -1.046 0 C-N-CA 124.472 1.109 . . . . 73.11 113.626 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' A' ' 525' ' ' GLU . 4.1 mp0 -59.1 -34.28 71.82 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.235 0.54 . . . . 75.22 111.185 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.85 -39.2 83.82 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.673 -0.694 . . . . 65.42 109.73 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 523' ' ' SER . 15.2 t -75.48 -36.78 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 115.571 -0.74 . . . . 74.44 109.762 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.664 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 7.5 m -66.11 -42.55 91.58 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.049 0 C-N-CA 120.214 -0.595 . . . . 50.21 110.127 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 29.7 m -59.57 -44.05 93.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.454 0.645 . . . . 74.12 109.84 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.458 HD21 HG13 ' A' ' 514' ' ' VAL . 25.2 tp -58.32 -46.55 85.94 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 124.916 1.287 . . . . 74.2 109.658 176.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.569 HD12 HD13 ' A' ' 471' ' ' LEU . 30.2 tp -62.9 -48.39 79.16 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.522 -0.763 . . . . 64.31 110.533 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 29.7 mmm180 -60.97 -38.27 85.33 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.87 -0.604 . . . . 61.14 110.908 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 22.4 m -70.94 -40.49 72.0 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 115.986 -0.552 . . . . 73.01 110.226 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 534' ' ' THR . . . . . 0.514 HG21 ' HE2' ' A' ' 466' ' ' LYS . 61.9 m 69.72 -84.47 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.882 0.873 . . . . 70.12 111.577 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt 174.45 167.96 0.24 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.948 -1.501 . . . . 71.33 106.948 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 88.2 mtp -59.49 -51.22 70.8 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.398 0.888 . . . . 64.32 113.398 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.81 -64.65 1.13 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.503 -0.879 . . . . 55.13 109.307 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 150.19 18.07 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 118.721 -1.704 . . . . 43.54 115.691 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.1 m -100.22 130.36 46.34 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 119.036 1.418 . . . . 63.53 108.373 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 51.9 t -124.0 135.52 63.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 112.154 0.427 . . . . 63.12 112.154 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 42.9 m -94.18 115.24 27.5 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.073 -0.967 . . . . 74.32 110.289 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.57 121.21 44.18 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.091 -1.078 . . . . 72.32 108.091 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 2.8 tm? -110.0 116.48 31.66 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 105.854 -1.906 . . . . 73.42 105.854 174.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.8 m -118.25 157.79 19.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 115.057 -0.974 . . . . 71.12 111.206 -174.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -123.6 116.36 22.99 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.915 -0.584 . . . . 62.1 109.988 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 . . . . . 0 C--N 1.294 -1.835 0 N-CA-C 108.332 -0.988 . . . . 71.02 108.332 175.657 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 29.1 mtpp . . . . . 0 N--CA 1.423 -1.799 0 CA-C-O 121.3 0.571 . . . . 73.13 111.963 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 94.3 mtt180 -118.6 126.09 51.21 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.069 -1.826 . . . . 75.25 106.069 170.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.9 mp -124.74 136.76 54.15 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 116.468 -0.333 . . . . 71.13 110.934 -175.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -99.6 115.14 28.7 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 123.988 0.805 . . . . 64.12 108.956 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 55.4 mt -121.85 142.69 37.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.685 -0.857 . . . . 53.55 108.685 -176.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.47 ' HB3' HG22 ' A' ' 539' ' ' THR . 76.5 mt-30 -117.3 127.06 53.7 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.424 0.527 . . . . 64.52 112.424 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.454 HD23 HD23 ' A' ' 542' ' ' LEU . 3.9 mm? -115.57 133.19 56.27 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 124.46 1.104 . . . . 73.44 109.586 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 37.4 ttpt -108.15 136.35 47.97 Favored 'General case' 0 N--CA 1.401 -2.897 0 N-CA-C 108.815 -0.809 . . . . 62.45 108.815 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.451 ' HA ' ' HA2' ' A' ' 470' ' ' GLY . 48.8 mtmt -54.7 99.3 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 124.066 0.854 . . . . 71.41 111.506 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -131.19 136.82 9.04 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.696 -0.962 . . . . 51.43 110.696 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 64.5 m 63.1 -88.13 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.235 1.014 . . . . 73.05 111.446 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.428 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 31.0 mm-40 -98.01 -5.73 33.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.556 0.693 . . . . 64.15 109.364 177.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 69.17 -154.61 53.32 Favored Glycine 0 CA--C 1.486 -1.767 0 CA-C-O 118.109 -1.384 . . . . 73.42 110.842 -177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 540' ' ' VAL . 48.1 mt -43.76 101.52 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.425 1.112 . . . . 60.42 112.348 -173.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -111.98 56.26 0.47 Allowed Glycine 0 CA--C 1.477 -2.282 0 CA-C-N 114.739 -1.119 . . . . 62.24 112.329 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.597 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 5.3 p90 -144.45 142.12 30.07 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.055 -1.091 . . . . 75.03 108.055 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 28.9 p -116.57 162.36 17.74 Favored 'General case' 0 C--N 1.272 -2.797 0 N-CA-C 108.44 -0.948 . . . . 54.4 108.44 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.28 159.39 35.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.316 0.579 . . . . 74.3 111.505 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.8 t -148.12 153.73 39.24 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.358 -1.719 . . . . 62.42 106.358 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 C--N 1.293 -1.851 0 N-CA-C 108.595 -0.891 . . . . 70.24 108.595 178.632 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 C--O 1.249 1.072 0 N-CA-C 110.957 -0.44 . . . . 52.13 110.957 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 43.1 mm -93.74 130.64 42.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.644 -0.707 . . . . 71.14 109.235 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -127.51 153.46 46.31 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.255 0.222 . . . . 63.32 110.474 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 28.2 t -73.36 122.72 26.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.572 -0.899 . . . . 61.24 108.572 177.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -80.68 -62.26 1.72 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.437 -0.579 . . . . 72.14 109.437 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -143.05 163.71 32.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.368 -0.975 . . . . 71.41 108.368 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 506' ' ' LYS . 26.4 mm -123.42 110.16 25.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 124.805 1.242 . . . . 61.3 108.445 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.02 125.4 73.97 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.217 -0.901 . . . . 72.34 110.633 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.28 21.33 0.23 Allowed 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 124.895 3.73 . . . . 71.42 114.6 -172.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -165.35 7.25 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.241 0.543 . . . . 75.02 112.424 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -89.48 -161.79 37.82 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 120.18 -1.009 . . . . 31.44 112.782 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -61.61 -39.84 92.69 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 123.817 0.847 . . . . 61.14 109.968 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.65 -41.4 81.39 Favored 'General case' 0 C--O 1.201 -1.461 0 CA-C-N 114.625 -1.171 . . . . 70.02 112.696 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.1 tt -79.48 -31.02 13.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 111.628 0.233 . . . . 72.12 111.628 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 30.9 mm-40 -59.71 -43.15 94.23 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.167 0.508 . . . . 61.14 109.65 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.42 -50.93 7.34 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.787 -0.642 . . . . 70.25 110.385 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 101.2 -36.09 4.44 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.044 -1.55 . . . . 32.02 116.235 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -65.87 -32.83 74.56 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.564 0.682 . . . . 64.53 112.232 -173.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 61.7 tp -84.44 102.7 12.99 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.921 -0.581 . . . . 73.23 110.508 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.488 ' HA ' HG13 ' A' ' 493' ' ' ILE . 10.3 ptmm? -113.69 177.0 4.79 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.181 -0.463 . . . . 74.14 111.52 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.447 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -87.43 147.52 25.39 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.997 -0.547 . . . . 62.43 110.371 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 110.11 -27.19 12.12 Favored Glycine 0 C--N 1.311 -0.852 0 C-N-CA 120.702 -0.761 . . . . 61.21 112.775 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -79.98 163.22 24.42 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 120.62 0.248 . . . . 62.4 110.945 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 31.6 ttm180 -96.8 142.5 28.73 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-O 120.796 0.331 . . . . 71.21 111.48 -178.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.703 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -90.54 126.96 36.1 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.902 0.881 . . . . 72.14 111.288 175.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 33.4 mt -103.33 -45.68 10.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.156 -0.683 . . . . 73.33 109.156 173.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.551 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 0.5 OUTLIER -150.96 155.15 38.5 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 109.716 -0.476 . . . . 73.33 109.716 176.326 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.672 HG12 HD21 ' A' ' 519' ' ' LEU . 7.1 p -143.3 130.58 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 O-C-N 123.827 0.705 . . . . 55.24 109.232 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 49.9 t30 64.78 15.42 9.8 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 125.918 1.687 . . . . 73.31 112.521 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 100.37 7.67 51.33 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.499 -0.858 . . . . 34.53 113.578 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 57.9 t -121.1 142.93 35.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 117.2 0.5 . . . . 63.45 110.415 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -73.96 144.5 45.21 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.472 0.709 . . . . 72.35 110.138 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.703 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 15.2 mt -108.43 -42.79 4.48 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.677 -0.409 . . . . 73.44 112.0 -175.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.34 -26.95 37.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 116.054 -0.521 . . . . 71.11 111.373 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -78.55 -18.52 75.56 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.747 -0.739 . . . . 63.55 112.416 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.441 ' HD3' ' CB ' ' A' ' 526' ' ' GLU . 0.1 OUTLIER -110.62 -175.55 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.328 -0.513 . . . . 73.32 111.802 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 523' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 527' ' ' VAL . 11.3 m -87.32 158.75 18.98 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.901 -0.591 . . . . 71.43 111.183 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.71 -47.71 84.55 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.854 1.262 . . . . 44.31 109.843 -175.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 528' ' ' VAL . 47.1 mt-10 -68.5 -30.36 69.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.694 0.998 . . . . 74.12 113.694 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.441 ' CB ' ' HD3' ' A' ' 522' ' ' LYS . 49.4 mt-10 -59.98 -37.59 80.08 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.515 -0.55 . . . . 60.23 109.515 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.471 HG13 HD22 ' A' ' 519' ' ' LEU . 43.4 t -65.64 -36.92 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.74 -0.663 . . . . 73.13 110.276 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.673 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 25.0 m -70.53 -39.09 75.74 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 C-N-CA 118.977 -1.089 . . . . 74.33 110.403 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 37.4 t -61.29 -37.41 83.09 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.017 -0.538 . . . . 42.23 109.873 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 33.7 tp -64.14 -42.52 96.75 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.876 1.27 . . . . 54.43 109.951 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 tt -64.7 -44.15 91.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.337 -0.847 . . . . 73.15 111.928 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 31.3 mmm180 -64.63 -27.08 68.69 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.054 -0.521 . . . . 71.32 112.055 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 23.2 p -82.53 -45.84 14.15 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 113.447 0.906 . . . . 70.12 113.447 -176.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' THR . . . . . 0.416 HG21 ' CD ' ' A' ' 466' ' ' LYS . 88.4 m 59.4 133.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.296 0.57 . . . . 44.22 112.466 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -64.96 152.56 42.96 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.053 -1.029 . . . . 62.43 109.68 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 50.9 ttm -54.76 -32.23 59.65 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 123.473 0.709 . . . . 71.31 112.784 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.56 -15.89 53.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.649 0.611 . . . . 74.2 112.649 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 85.93 -20.35 20.69 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.666 -0.778 . . . . 43.25 113.923 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 463' ' ' GLN . 3.9 m -104.09 129.07 51.76 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.48 0.657 . . . . 62.33 109.756 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.477 HG21 HD11 ' A' ' 471' ' ' LEU . 77.1 t -111.68 141.77 26.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.935 -1.029 . . . . 65.13 110.83 -176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 34.3 t -91.15 132.95 35.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.743 -0.662 . . . . 54.0 109.444 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.597 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.7 mm? -120.77 118.57 30.36 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.692 -1.225 . . . . 74.41 107.692 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.514 ' CB ' ' HG3' ' A' ' 513' ' ' GLU . 51.1 tp -104.63 117.66 34.67 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 105.213 -2.143 . . . . 71.44 105.213 172.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 28.6 m -115.98 151.78 17.73 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.135 0 C-N-CA 120.233 -0.587 . . . . 73.34 111.143 -176.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.536 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 85.6 t80 -110.92 116.14 30.7 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.68 -1.97 . . . . 74.12 105.68 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 . . . . . 0 C--N 1.287 -2.136 0 N-CA-C 108.865 -0.791 . . . . 72.4 108.865 -174.219 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt . . . . . 0 CA--C 1.487 -1.469 0 N-CA-C 113.786 1.032 . . . . 74.35 113.786 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 89.2 mtm180 -105.81 138.66 41.63 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 113.743 -1.571 . . . . 71.23 107.395 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.43 ' O ' HD12 ' A' ' 543' ' ' LEU . 6.0 mp -123.4 128.24 49.58 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 120.989 0.424 . . . . 72.1 110.705 -177.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -96.27 116.26 28.73 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.042 -0.981 . . . . 72.53 109.787 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 53.6 mt -123.67 144.21 34.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 114.783 -1.099 . . . . 60.32 110.414 -172.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.3 mt-30 -119.98 129.99 54.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.594 0.59 . . . . 53.24 112.594 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.599 HD23 HD23 ' A' ' 542' ' ' LEU . 3.8 mm? -116.85 153.03 33.23 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 124.962 1.305 . . . . 74.24 110.189 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -113.16 129.34 56.54 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 108.159 -1.052 . . . . 64.24 108.159 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -60.24 102.91 0.19 Allowed 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.547 -0.751 . . . . 73.23 109.664 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -146.16 150.45 22.69 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.369 -0.692 . . . . 44.32 111.369 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 50.1 m 65.21 -78.56 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.241 1.017 . . . . 60.42 111.131 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -119.48 -6.68 10.24 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.035 -0.728 . . . . 61.12 109.035 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 69.24 -151.08 50.79 Favored Glycine 0 C--O 1.206 -1.598 0 CA-C-O 118.673 -1.07 . . . . 70.13 110.784 -175.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 7.8 mp -46.83 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.217 1.192 . . . . 50.21 114.217 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -104.06 43.66 1.63 Allowed Glycine 0 N--CA 1.428 -1.847 0 CA-C-N 113.951 -1.477 . . . . 62.53 112.044 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -129.17 142.16 50.95 Favored 'General case' 0 N--CA 1.409 -2.518 0 N-CA-C 108.596 -0.89 . . . . 64.42 108.596 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 45.0 t -115.0 148.53 38.71 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.401 -1.333 . . . . 72.31 107.401 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.434 HG21 HD12 ' A' ' 511' ' ' LEU . 14.9 pt -116.62 156.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.474 0.654 . . . . 72.32 112.611 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.4 t -138.21 159.85 40.98 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.934 -1.506 . . . . 72.21 106.934 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 14.9 p . . . . . 0 C--N 1.285 -2.236 0 N-CA-C 109.666 -0.494 . . . . 73.12 109.666 -178.49 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo . . . . . 0 C--O 1.247 0.972 0 CA-C-O 121.712 0.63 . . . . 74.43 112.847 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.427 HG13 HG21 ' A' ' 527' ' ' VAL . 47.8 mm -97.74 135.6 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 115.01 -0.995 . . . . 65.14 108.728 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 97.7 m-85 -127.22 155.98 42.59 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 116.68 -0.236 . . . . 73.14 110.66 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.418 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 32.6 t -82.72 119.0 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 N-CA-C 107.665 -1.235 . . . . 55.32 107.665 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.434 ' HG2' ' OD1' ' A' ' 492' ' ' ASN . 61.2 tttm -85.14 -54.81 4.39 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.561 -0.745 . . . . 73.31 109.461 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 492' ' ' ASN . . . . . 0.434 ' OD1' ' HG2' ' A' ' 491' ' ' LYS . 18.4 m120 -136.98 157.08 47.55 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 115.447 -0.797 . . . . 63.4 112.55 -176.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 507' ' ' ALA . 26.6 mm -120.53 115.59 47.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.314 -1.736 . . . . 61.21 106.314 172.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 495' ' ' PRO . 9.3 mp -62.92 163.11 17.5 Favored Pre-proline 0 C--N 1.304 -1.399 0 C-N-CA 123.839 0.855 . . . . 72.41 112.146 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 494' ' ' LEU . 43.6 Cg_endo -74.75 -5.22 16.55 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 123.645 2.896 . . . . 71.35 111.219 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.443 ' HA ' HG21 ' A' ' 500' ' ' ILE . 97.9 mtt180 -157.97 174.3 15.45 Favored 'General case' 0 N--CA 1.41 -2.437 0 C-N-CA 125.113 1.365 . . . . 73.03 107.843 -172.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 106.74 -175.93 21.11 Favored Glycine 1 C--N 1.251 -4.176 0 CA-C-N 114.659 -1.155 . . . . 53.51 112.262 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.51 81.39 Favored 'General case' 0 N--CA 1.422 -1.828 0 C-N-CA 123.783 0.833 . . . . 61.41 110.872 -175.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.31 -41.89 80.77 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 114.655 -1.157 . . . . 70.31 112.788 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.443 HG21 ' HA ' ' A' ' 496' ' ' ARG . 13.6 tt -81.08 -43.66 20.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.955 0.724 . . . . 62.53 112.955 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -59.02 -37.79 77.75 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 112.436 0.532 . . . . 74.24 112.436 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.568 ' HB2' HD13 ' A' ' 464' ' ' LEU . 3.6 m-20 -89.48 -33.36 16.81 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.211 -0.596 . . . . 73.41 109.778 173.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 62.16 50.79 61.84 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.759 -0.655 . . . . 53.05 113.74 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -117.08 -18.7 9.99 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.714 -0.795 . . . . 71.03 111.415 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.467 HD12 ' HG ' ' A' ' 542' ' ' LEU . 6.8 tt -119.84 138.96 53.07 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.988 -0.745 . . . . 73.45 108.988 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.427 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -132.05 160.91 34.53 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.41 0.892 . . . . 63.4 113.41 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.525 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -79.13 166.7 21.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.511 0.724 . . . . 65.43 111.912 -174.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 73.43 20.33 79.84 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.857 -0.897 . . . . 54.0 110.857 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 509' ' ' ASP . . . . . 0.519 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 4.4 t70 -117.94 172.58 7.3 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.685 -1.228 . . . . 70.12 107.685 -176.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 30.3 ttm180 -107.3 135.25 49.12 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.311 -0.556 . . . . 73.22 110.951 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.434 HD12 HG21 ' A' ' 475' ' ' ILE . 27.4 mt -95.46 126.4 40.73 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 120.493 -0.483 . . . . 72.14 110.798 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.47 -45.39 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 116.019 -0.537 . . . . 75.12 111.203 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.436 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.0 pt-20 -156.63 155.08 31.19 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.329 -0.619 . . . . 73.45 109.329 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.47 HG12 HD21 ' A' ' 519' ' ' LEU . 6.4 p -132.6 125.03 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.726 0.774 . . . . 65.12 108.975 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 66.09 7.46 4.78 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 126.737 2.015 . . . . 74.23 112.65 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.53 -10.46 16.6 Favored Glycine 0 CA--C 1.508 -0.371 0 C-N-CA 120.484 -0.865 . . . . 75.4 112.734 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.484 ' HB ' HD21 ' A' ' 530' ' ' LEU . 79.6 t -96.05 127.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.633 -0.506 . . . . 60.31 109.633 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.08 142.07 43.73 Favored 'General case' 0 CA--C 1.491 -1.324 0 O-C-N 123.868 0.73 . . . . 72.15 111.409 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.47 HD21 HG12 ' A' ' 514' ' ' VAL . 18.2 mt -100.08 -39.79 7.93 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 115.533 -0.758 . . . . 71.04 110.5 -176.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 38.6 t -73.92 98.75 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 108.587 -0.894 . . . . 75.02 108.587 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 136.52 -15.89 3.85 Favored Glycine 0 N--CA 1.424 -2.101 0 CA-C-N 114.313 -1.312 . . . . 73.21 110.173 -174.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.29 176.57 5.09 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-O 120.904 0.383 . . . . 71.34 111.681 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 37.3 m -91.11 161.09 15.24 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.889 -0.596 . . . . 71.1 111.235 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -55.42 -47.93 75.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.991 0.916 . . . . 71.31 111.694 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.481 ' HA ' HG22 ' A' ' 528' ' ' VAL . 36.3 mt-10 -62.42 -31.71 72.45 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 123.885 0.874 . . . . 71.14 112.429 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.85 -41.41 95.73 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.132 -0.692 . . . . 61.43 109.132 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.465 HG13 HD22 ' A' ' 519' ' ' LEU . 35.0 t -71.37 -39.44 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.993 -1.003 . . . . 72.11 110.389 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.663 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.9 m -65.18 -42.07 93.25 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.303 0 C-N-CA 119.347 -0.941 . . . . 71.13 110.164 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 36.8 m -62.09 -41.81 98.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.343 0.592 . . . . 72.42 110.199 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.484 HD21 ' HB ' ' A' ' 517' ' ' VAL . 54.7 tp -61.43 -46.26 90.84 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 124.125 0.97 . . . . 73.55 109.694 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.2 tt -63.39 -44.96 93.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.452 0.701 . . . . 74.23 112.408 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 28.0 mmm180 -63.06 -32.82 74.27 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.349 0.595 . . . . 72.2 109.943 -177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 43.2 t -72.31 -44.39 62.77 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-N 115.076 -0.965 . . . . 74.31 109.779 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 86.3 m 69.6 -70.57 0.14 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.886 0.874 . . . . 65.53 110.839 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.594 ' HA ' ' HE3' ' A' ' 535' ' ' LYS . 1.3 tpmt? 168.6 166.49 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 104.245 -2.502 . . . . 73.35 104.245 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 86.8 mtp -87.69 -28.59 21.71 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.025 -0.67 . . . . 64.34 109.257 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.66 -77.06 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.271 -0.877 . . . . 71.5 111.624 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 156.46 -29.31 0.56 Allowed Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 119.502 -1.332 . . . . 64.23 112.934 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 4.3 m -94.19 141.3 28.71 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.208 -1.405 . . . . 71.21 107.208 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 5.0 p -124.61 136.49 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 N-CA-C 109.223 -0.658 . . . . 74.11 109.223 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.4 m -92.25 132.87 36.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.937 -0.394 . . . . 71.01 109.937 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.599 HD23 HD23 ' A' ' 464' ' ' LEU . 1.3 mm? -124.18 138.56 54.4 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.096 -1.446 . . . . 74.14 107.096 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 39.2 tp -119.03 122.35 41.95 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 106.765 -1.569 . . . . 63.2 106.765 173.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.519 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 31.9 m -114.74 161.56 13.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 109.371 -0.604 . . . . 73.22 109.371 -177.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.443 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 84.4 t80 -132.96 129.2 37.94 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.405 0.621 . . . . 74.23 111.307 -177.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 . . . . . 0 C--N 1.292 -1.927 0 N-CA-C 108.194 -1.039 . . . . 75.44 108.194 177.293 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.576 ' HA ' ' HE3' ' A' ' 458' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.422 -1.844 0 CA-C-O 120.909 0.385 . . . . 64.12 110.111 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 79.7 mtm180 -100.55 142.38 32.11 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.998 -1.112 . . . . 75.52 107.998 172.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -132.48 132.43 42.7 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 109.264 -0.643 . . . . 65.41 109.264 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -95.55 115.71 27.81 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.753 -1.573 . . . . 54.22 106.753 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.36 142.84 38.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.689 -0.856 . . . . 53.33 108.689 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.515 ' HB3' HG22 ' A' ' 539' ' ' THR . 75.7 mt-30 -120.32 127.22 52.15 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.446 -0.502 . . . . 71.51 111.666 176.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.657 HD13 ' HB2' ' A' ' 502' ' ' ASP . 3.9 mm? -114.7 132.29 56.46 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.377 -0.972 . . . . 74.54 108.377 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 39.6 ttmt -105.19 136.13 45.27 Favored 'General case' 0 N--CA 1.401 -2.892 0 CA-C-O 121.832 0.825 . . . . 72.21 110.768 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.449 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 37.5 ttpt -72.8 102.44 3.39 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 113.937 -1.483 . . . . 71.55 109.471 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -137.9 -84.28 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.422 -1.071 . . . . 43.23 110.422 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' THR . . . . . 0.52 ' O ' ' HA2' ' A' ' 497' ' ' GLY . 26.9 m -91.25 123.95 35.08 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.661 -1.607 . . . . 73.32 106.661 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.638 ' HB3' ' CA ' ' A' ' 497' ' ' GLY . 10.9 tp10 39.17 52.85 2.14 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 125.157 1.383 . . . . 61.4 108.214 -174.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.449 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . -53.14 127.88 36.79 Favored Glycine 0 N--CA 1.416 -2.681 0 CA-C-N 113.393 -1.731 . . . . 63.14 114.144 -171.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.646 ' H ' ' HB2' ' A' ' 498' ' ' ALA . 43.4 mt 65.95 74.34 0.36 Allowed 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 126.351 1.86 . . . . 74.13 110.475 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -92.51 57.15 2.69 Favored Glycine 0 N--CA 1.422 -2.24 0 CA-C-N 113.862 -1.517 . . . . 43.13 111.619 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.597 ' CE2' HD11 ' A' ' 542' ' ' LEU . 33.1 p90 -150.03 142.94 24.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.026 0.441 . . . . 52.3 111.558 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 46.4 p -128.7 164.75 22.27 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.826 -1.079 . . . . 54.25 108.742 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 511' ' ' LEU . 22.7 pt -121.75 153.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 113.409 0.892 . . . . 71.22 113.409 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.8 t -137.18 141.33 42.17 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.178 -0.919 . . . . 63.01 109.567 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--N 1.306 -1.306 0 N-CA-C 107.58 -1.267 . . . . 61.15 107.58 177.435 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.477 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 5.2 Cg_exo . . . . . 0 N--CA 1.441 -1.569 0 CA-C-O 121.189 0.412 . . . . 70.2 111.301 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 47.9 mm -86.42 120.61 36.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.943 -0.571 . . . . 72.43 109.954 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 90.6 m-85 -121.22 150.11 41.83 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 122.288 -0.257 . . . . 74.44 110.352 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 41.1 t -72.05 119.82 19.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.931 -0.766 . . . . 75.21 108.931 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -84.65 -57.47 3.12 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.357 -0.838 . . . . 72.34 110.897 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -136.81 151.94 49.73 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.899 -0.591 . . . . 71.51 109.781 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.441 HG13 ' HA ' ' A' ' 506' ' ' LYS . 27.8 mm -123.08 106.94 18.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.881 -1.155 . . . . 74.24 107.881 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.72 113.99 11.84 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 108.982 -0.748 . . . . 75.04 108.982 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.21 29.52 0.39 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 124.903 3.736 . . . . 61.4 112.55 -172.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -154.5 1.98 0.21 Allowed 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 115.568 -0.742 . . . . 71.11 112.133 -175.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.638 ' CA ' ' HB3' ' A' ' 469' ' ' GLU . . . -113.94 -146.63 9.44 Favored Glycine 0 C--O 1.218 -0.849 0 C-N-CA 119.124 -1.512 . . . . 75.4 115.296 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.646 ' HB2' ' H ' ' A' ' 471' ' ' LEU . . . -59.79 -40.49 88.47 Favored 'General case' 0 C--N 1.364 1.225 0 CA-C-N 118.24 1.02 . . . . 63.51 110.563 -173.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.61 -37.82 73.89 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 115.091 -0.959 . . . . 62.44 112.864 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.6 tt -80.14 -35.58 15.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.01 0.374 . . . . 65.12 112.01 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -58.79 -47.28 85.27 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.017 0.437 . . . . 73.35 110.28 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.657 ' HB2' HD13 ' A' ' 464' ' ' LEU . 21.1 m-20 -89.86 -30.19 18.07 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.443 -0.503 . . . . 72.34 110.275 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 76.27 -23.63 1.83 Allowed Glycine 0 CA--C 1.529 0.933 0 N-CA-C 118.075 1.99 . . . . 52.0 118.075 170.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -67.33 -17.46 64.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.834 1.049 . . . . 74.53 113.834 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 42.8 tp -101.76 132.3 47.57 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 122.134 -0.354 . . . . 65.11 111.672 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.441 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.261 0.0 OUTLIER -135.79 146.44 47.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 113.379 0.881 . . . . 62.35 113.379 176.657 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.422 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -65.07 123.39 19.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.306 -0.861 . . . . 53.4 110.609 -177.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 131.67 -18.87 4.82 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 111.064 -0.814 . . . . 50.41 111.064 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -81.05 156.78 25.69 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 109.212 -0.662 . . . . 72.43 109.212 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -95.57 136.49 35.89 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.775 -0.454 . . . . 64.44 109.775 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 519' ' ' LEU . 24.8 mt -85.7 136.01 33.53 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 119.707 -0.797 . . . . 73.53 110.708 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.36 -45.64 10.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.318 -0.623 . . . . 72.31 109.318 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.428 ' HG3' ' HB3' ' A' ' 543' ' ' LEU . 0.0 OUTLIER -155.35 157.13 36.65 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.06 -0.718 . . . . 72.33 109.06 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.642 HG12 HD21 ' A' ' 519' ' ' LEU . 7.6 p -144.46 136.22 21.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-N 116.021 -0.536 . . . . 63.55 109.931 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.3 t30 65.96 12.32 8.34 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 125.505 1.522 . . . . 71.52 111.734 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 92.7 14.05 55.85 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 120.857 -0.687 . . . . 35.42 111.959 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 37.3 t -121.1 146.45 26.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.921 -0.77 . . . . 62.23 108.921 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 518' ' ' ASP . . . . . 0.572 ' O ' ' HE2' ' A' ' 522' ' ' LYS . 5.3 p-10 -88.51 152.66 21.72 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 109.232 -0.655 . . . . 63.44 109.232 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.642 HD21 HG12 ' A' ' 514' ' ' VAL . 18.7 mt -100.53 -52.54 3.32 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.369 -0.532 . . . . 75.31 111.731 -172.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.25 110.01 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.938 0.875 . . . . 70.24 110.503 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 135.42 -33.94 2.36 Favored Glycine 0 N--CA 1.418 -2.534 0 N-CA-C 109.285 -1.526 . . . . 70.5 109.285 -174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.572 ' HE2' ' O ' ' A' ' 518' ' ' ASP . 0.1 OUTLIER -107.93 161.54 14.84 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 109.79 -0.448 . . . . 62.32 109.79 178.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 29.4 m -87.22 162.4 17.48 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.659 -0.246 . . . . 72.32 111.498 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.445 ' O ' HG13 ' A' ' 528' ' ' VAL . 53.8 mt-30 -51.74 -46.92 64.22 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.372 0.669 . . . . 74.33 112.32 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.417 ' HA ' HG22 ' A' ' 528' ' ' VAL . 40.4 mt-10 -60.01 -32.39 70.83 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.209 0.448 . . . . 64.12 112.209 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.13 -39.87 68.51 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.42 -0.585 . . . . 53.13 109.42 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 49.0 t -67.04 -41.75 87.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 74.43 109.584 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.665 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 8.6 m -66.7 -40.94 87.29 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.152 0 C-N-CA 119.209 -0.996 . . . . 74.31 110.012 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.8 m -60.41 -44.1 96.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.296 -0.411 . . . . 61.25 111.382 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.612 HD11 HG13 ' A' ' 514' ' ' VAL . 3.5 pp -67.46 -30.29 69.97 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.299 0.571 . . . . 62.23 110.232 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.44 ' CD1' HD13 ' A' ' 471' ' ' LEU . 65.2 tp -69.85 -48.22 59.71 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.679 -0.691 . . . . 73.23 109.576 175.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 27.6 mmm180 -61.11 -39.11 88.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.642 -0.708 . . . . 72.54 111.85 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 30.6 t -65.25 -38.7 91.17 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.384 -0.598 . . . . 42.32 109.384 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 17.6 m 69.92 166.57 0.28 Allowed 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.474 0.71 . . . . 60.52 111.432 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -81.41 150.98 28.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.653 -1.61 . . . . 75.44 106.653 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 91.9 mmm -63.86 -31.95 73.31 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.772 1.027 . . . . 73.2 113.772 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.27 -32.33 73.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 122.007 0.908 . . . . 72.04 108.675 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 105.68 -14.01 46.21 Favored Glycine 0 N--CA 1.422 -2.28 0 CA-C-N 114.778 -1.101 . . . . 72.24 111.453 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.515 HG22 ' HB3' ' A' ' 463' ' ' GLN . 1.8 m -96.7 129.08 44.17 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.336 -0.616 . . . . 63.34 109.336 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 86.9 t -106.76 133.5 51.15 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 115.532 -0.758 . . . . 73.2 109.915 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 21.8 t -91.48 129.59 37.44 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 109.075 -0.713 . . . . 52.25 109.075 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.597 HD11 ' CE2' ' A' ' 473' ' ' PHE . 3.8 mm? -117.56 130.33 56.34 Favored 'General case' 0 C--N 1.283 -2.309 0 C-N-CA 124.607 1.163 . . . . 74.52 108.846 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 513' ' ' GLU . 54.6 tp -112.8 117.91 33.49 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.733 -1.951 . . . . 63.12 105.733 169.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 25.9 m -115.73 150.98 17.54 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.788 0 C-N-CA 120.133 -0.627 . . . . 74.12 110.075 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -111.77 115.8 29.66 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 106.509 -1.663 . . . . 63.22 106.509 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 N--CA 1.399 -3.023 0 CA-C-N 115.213 -0.903 . . . . 74.22 109.093 -178.87 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 N--CA 1.409 -2.488 0 N-CA-C 109.182 -0.673 . . . . 71.5 109.182 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 97.5 mtt180 -99.36 132.46 44.67 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.246 -1.761 . . . . 53.13 106.246 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 15.6 tp -126.44 132.72 51.42 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.286 -0.566 . . . . 64.52 110.153 -171.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -98.63 114.61 27.15 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-O 121.97 0.89 . . . . 72.23 108.952 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.05 133.54 60.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 CA-C-N 115.074 -0.966 . . . . 64.44 109.754 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 48.4 mt-30 -106.76 128.97 54.68 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.999 -0.68 . . . . 74.33 112.177 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.582 HD23 HD23 ' A' ' 542' ' ' LEU . 4.5 mm? -112.9 150.0 32.39 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.811 -1.086 . . . . 71.33 108.697 175.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 465' ' ' LYS . 35.5 ttpt -107.54 136.37 47.43 Favored 'General case' 0 N--CA 1.389 -3.485 0 O-C-N 124.017 0.823 . . . . 61.3 109.931 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -70.82 85.12 0.67 Allowed 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 115.117 -0.947 . . . . 74.33 108.765 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -84.84 -129.98 2.07 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.45 -0.795 . . . . 62.13 112.253 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 8.7 t -66.91 -57.7 6.43 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.495 0.554 . . . . 65.44 112.495 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.82 -6.82 35.12 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.811 -0.556 . . . . 74.14 110.751 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 58.72 -153.18 29.76 Favored Glycine 0 C--O 1.207 -1.545 0 CA-C-O 118.669 -1.073 . . . . 70.12 112.184 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.576 HD11 HG21 ' A' ' 540' ' ' VAL . 61.1 mt -47.25 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.996 0.903 . . . . 74.53 112.903 -171.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.36 62.12 0.35 Allowed Glycine 0 CA--C 1.475 -2.433 0 CA-C-N 114.399 -1.273 . . . . 75.23 111.003 -176.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -155.58 142.59 19.12 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.932 -0.766 . . . . 63.41 108.932 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.3 m -117.84 158.35 24.98 Favored 'General case' 0 C--N 1.281 -2.4 0 O-C-N 124.112 0.883 . . . . 75.43 109.226 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 17.0 pt -116.73 157.31 17.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.275 0.56 . . . . 72.23 111.469 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.7 t -140.2 155.99 46.69 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 107.898 -1.149 . . . . 72.24 107.898 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 62.7 p . . . . . 0 C--N 1.306 -1.298 0 N-CA-C 108.924 -0.769 . . . . 70.31 108.924 -179.83 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 C--O 1.243 0.767 0 CA-C-O 121.392 0.497 . . . . 65.42 112.465 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 46.0 mm -93.57 136.42 25.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.778 -0.823 . . . . 43.35 108.778 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -131.18 159.33 38.03 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 121.986 0.114 . . . . 73.32 110.776 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.33 121.34 26.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.017 -0.734 . . . . 72.15 109.017 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -83.16 -57.15 3.4 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.303 0.573 . . . . 72.34 110.113 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -147.0 153.73 40.4 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.701 -0.681 . . . . 71.42 109.935 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.539 HG12 ' HB2' ' A' ' 507' ' ' ALA . 33.7 mm -114.06 106.48 20.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.081 -1.081 . . . . 63.54 108.081 175.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.2 mp -61.47 122.37 70.23 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 109.085 -0.709 . . . . 51.2 109.085 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.449 ' C ' HG21 ' A' ' 500' ' ' ILE . 87.7 Cg_endo -69.86 28.42 0.18 Allowed 'Trans proline' 0 N--CA 1.521 3.127 1 C-N-CA 125.733 4.289 . . . . 75.23 115.038 -170.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.505 ' N ' HG21 ' A' ' 500' ' ' ILE . 13.6 ptm180 -163.51 -0.81 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 113.179 0.807 . . . . 72.32 113.179 -175.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -97.33 -166.16 32.45 Favored Glycine 0 C--N 1.306 -1.103 0 C-N-CA 119.613 -1.279 . . . . 72.44 112.421 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.458 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -49.55 -48.6 48.3 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 125.451 1.5 . . . . 74.12 112.758 -172.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.473 ' HA ' HD11 ' A' ' 464' ' ' LEU . . . -56.74 -47.16 80.66 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 115.492 -0.777 . . . . 62.35 112.108 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.505 HG21 ' N ' ' A' ' 496' ' ' ARG . 0.0 OUTLIER -81.33 -35.99 14.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 123.488 0.715 . . . . 72.55 112.908 179.283 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.8 mm100 -67.79 -37.73 82.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.014 0.435 . . . . 73.31 110.929 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.473 ' HB2' HD13 ' A' ' 464' ' ' LEU . 10.0 m-20 -87.77 -30.41 20.3 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.531 -0.914 . . . . 61.34 108.531 174.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 68.75 49.26 44.03 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.311 -0.859 . . . . 62.23 113.537 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -118.04 -38.51 3.21 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.361 -0.935 . . . . 64.43 111.497 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 58.6 tp -109.01 148.47 30.72 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.529 -0.305 . . . . 71.25 110.39 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.492 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -137.46 170.75 15.55 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 123.306 0.378 . . . . 72.33 110.021 177.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.539 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -88.2 85.18 6.89 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.956 0.725 . . . . 71.24 112.956 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 176.4 19.44 0.02 OUTLIER Glycine 0 C--N 1.293 -1.806 0 CA-C-N 114.658 -1.156 . . . . 54.11 110.254 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -116.82 153.25 32.81 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-O 121.02 0.438 . . . . 75.12 110.983 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.453 HH21 HG21 ' A' ' 520' ' ' VAL . 38.4 ttt180 -94.27 134.65 36.52 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.485 -0.779 . . . . 73.24 110.201 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.693 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.2 mm? -83.21 129.59 35.02 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.016 -0.993 . . . . 74.01 110.16 174.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 545' ' ' PHE . 36.2 mm -107.52 -43.64 6.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.152 0.501 . . . . 64.41 109.971 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 517' ' ' VAL . 28.9 tt0 -158.49 155.02 27.73 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.554 -0.748 . . . . 74.32 110.02 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 541' ' ' SER . 3.5 p -143.49 125.52 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 109.484 -0.562 . . . . 74.35 109.484 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 515' ' ' ASN . . . . . 0.419 ' HA ' ' OG ' ' A' ' 541' ' ' SER . 27.5 m120 62.48 12.79 5.64 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 125.367 1.467 . . . . 62.11 114.029 -176.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 101.69 15.55 26.62 Favored Glycine 0 C--N 1.31 -0.91 0 C-N-CA 120.201 -0.999 . . . . 63.43 112.875 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 513' ' ' GLU . 61.1 t -116.48 128.75 73.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.614 -0.884 . . . . 72.41 108.614 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.22 144.14 29.13 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.172 -0.677 . . . . 71.21 109.172 -173.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.693 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 33.6 mt -97.86 -49.54 4.76 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.762 0.652 . . . . 71.33 112.762 -171.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 520' ' ' VAL . . . . . 0.453 HG21 HH21 ' A' ' 510' ' ' ARG . 95.7 t -70.81 96.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 122.274 1.035 . . . . 64.35 111.087 -175.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 145.62 -23.44 1.83 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 109.143 -1.583 . . . . 71.34 109.143 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.57 178.02 4.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 120.666 0.27 . . . . 61.03 111.172 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 6.5 m -89.8 159.54 16.97 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.613 -0.721 . . . . 73.13 109.48 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -60.58 -43.97 96.74 Favored 'General case' 0 C--O 1.222 -0.347 0 O-C-N 123.089 0.243 . . . . 73.13 111.341 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.52 ' HA ' HG22 ' A' ' 528' ' ' VAL . 1.6 mp0 -56.86 -35.83 69.34 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.037 -0.529 . . . . 73.13 111.337 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -62.52 -38.69 90.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.818 -0.628 . . . . 74.32 109.703 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.12 -36.72 31.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.452 -0.795 . . . . 60.1 110.144 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.57 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 14.8 m -65.29 -41.4 91.33 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 C-N-CA 119.718 -0.793 . . . . 71.33 110.424 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 46.0 t -60.93 -40.07 91.87 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.494 0.664 . . . . 72.22 110.02 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.443 ' CD2' HG13 ' A' ' 514' ' ' VAL . 36.8 tp -64.33 -36.47 84.24 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 124.371 1.068 . . . . 71.42 109.814 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 471' ' ' LEU . 25.6 tp -70.9 -45.31 64.54 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.682 -0.69 . . . . 73.33 109.333 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -59.69 -39.86 85.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.164 0.986 . . . . 71.44 110.891 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 29.1 t -64.77 -41.52 95.82 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.393 -0.821 . . . . 71.31 109.923 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 87.4 m 63.73 -91.05 0.03 OUTLIER 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.477 0.711 . . . . 33.51 111.072 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt 166.98 145.89 0.02 OUTLIER 'General case' 0 C--O 1.25 1.1 0 N-CA-C 105.757 -1.942 . . . . 71.33 105.757 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.5 mtt -66.37 -40.81 89.97 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.982 -0.287 . . . . 73.24 111.537 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.4 -79.84 0.06 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 119.248 -0.406 . . . . 73.12 111.944 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 178.66 -25.98 0.05 OUTLIER Glycine 0 C--O 1.218 -0.89 0 C-N-CA 116.634 -2.698 . . . . 55.04 116.562 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 1.3 p -94.78 120.37 34.89 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 114.926 1.454 . . . . 74.55 114.926 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 471' ' ' LEU . 98.7 t -107.95 131.98 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 114.239 -1.346 . . . . 72.55 108.646 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 24.2 p -95.39 114.58 26.36 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.256 0.551 . . . . 64.15 111.193 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.582 HD23 HD23 ' A' ' 464' ' ' LEU . 2.9 mm? -103.76 122.94 46.12 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.161 -1.052 . . . . 53.14 108.161 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 44.3 tp -103.92 117.92 35.46 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 106.445 -1.687 . . . . 63.42 106.445 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 29.0 m -116.79 161.22 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 120.63 -0.428 . . . . 71.22 110.789 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.528 ' HB2' HD11 ' A' ' 512' ' ' ILE . 91.9 t80 -111.33 117.48 33.25 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.367 0.604 . . . . 73.42 109.59 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 . . . . . 0 C--N 1.287 -2.148 0 N-CA-C 107.354 -1.35 . . . . 60.44 107.354 177.562 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm . . . . . 0 CA--C 1.489 -1.394 0 CA-C-O 120.928 0.394 . . . . 73.11 111.968 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 93.5 mtt180 -104.66 135.4 46.13 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.331 -0.988 . . . . 72.53 108.331 175.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 6.4 mp -131.76 142.01 49.65 Favored 'General case' 0 CA--C 1.48 -1.742 0 CA-C-O 120.735 0.303 . . . . 74.42 110.953 -172.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -98.01 115.98 29.3 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.263 -0.88 . . . . 73.01 108.693 174.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' ILE . . . . . 0.413 HG23 ' HG2' ' A' ' 504' ' ' ARG . 71.0 mt -123.77 123.17 66.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.13 -0.941 . . . . 63.12 110.12 -175.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.502 ' HB3' ' CG2' ' A' ' 539' ' ' THR . 87.6 mt-30 -100.41 137.29 39.03 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.836 -0.746 . . . . 74.43 112.558 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 505' ' ' LEU . 4.3 mm? -116.66 136.26 53.11 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 115.112 -0.949 . . . . 74.51 110.228 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.8 120.48 42.38 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 106.861 -1.533 . . . . 72.13 106.861 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -45.73 100.9 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.753 1.221 . . . . 74.12 111.465 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -92.96 -121.59 3.07 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.5 -0.773 . . . . 72.31 112.953 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 468' ' ' THR . . . . . 0.717 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 36.3 m -59.87 -56.97 15.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.943 0.497 . . . . 64.34 111.737 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -112.32 -6.69 14.03 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.672 0.749 . . . . 63.13 111.58 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 77.79 -156.51 44.34 Favored Glycine 0 C--O 1.199 -2.088 0 CA-C-O 118.377 -1.235 . . . . 55.51 110.949 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.473 HD11 HG21 ' A' ' 540' ' ' VAL . 41.6 mt -50.41 102.36 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.71 1.255 . . . . 71.44 112.9 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -122.35 53.64 0.72 Allowed Glycine 0 N--CA 1.422 -2.281 0 CA-C-N 114.488 -1.233 . . . . 62.22 111.257 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.633 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 6.1 p90 -126.51 145.16 50.62 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.746 -1.576 . . . . 74.5 106.746 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 38.9 m -114.97 138.33 50.97 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 109.033 -0.728 . . . . 62.13 109.033 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 14.2 pt -109.72 152.58 11.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-O 121.421 0.629 . . . . 75.12 111.786 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.418 HG21 ' HE3' ' A' ' 491' ' ' LYS . 9.1 t -136.34 159.61 41.23 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.27 -1.382 . . . . 74.42 107.27 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.647 ' HB3' ' OE1' ' A' ' 524' ' ' GLN . 33.3 p . . . . . 0 C--N 1.282 -2.357 0 N-CA-C 109.021 -0.733 . . . . 54.15 109.021 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo . . . . . 0 C--O 1.245 0.856 0 N-CA-C 113.449 0.519 . . . . 71.43 113.449 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.411 HG13 ' HB3' ' A' ' 519' ' ' LEU . 24.2 mm -95.58 133.51 36.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.156 -0.929 . . . . 74.25 109.014 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.05 151.76 51.08 Favored 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 122.079 -0.388 . . . . 75.2 110.642 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 56.2 t -84.52 119.02 32.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.709 -0.849 . . . . 54.21 108.709 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.418 ' HE3' HG21 ' A' ' 476' ' ' THR . 5.2 tppp? -83.1 -55.86 4.12 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.629 0.772 . . . . 74.21 110.167 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -141.65 152.89 44.34 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.487 -0.778 . . . . 63.33 110.49 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.495 HG12 ' HB2' ' A' ' 507' ' ' ALA . 30.0 mm -117.11 105.09 17.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.735 -1.58 . . . . 74.34 106.735 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.09 146.36 88.19 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 116.114 -0.494 . . . . 60.45 111.463 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.447 ' C ' HG21 ' A' ' 500' ' ' ILE . 84.9 Cg_endo -74.82 12.28 1.21 Allowed 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 124.579 3.519 . . . . 62.43 116.189 -172.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.717 ' O ' ' HB ' ' A' ' 468' ' ' THR . 13.0 ptp180 -155.37 3.48 0.19 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 115.361 1.615 . . . . 74.22 115.361 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.519 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -83.92 -161.14 31.78 Favored Glycine 0 C--N 1.286 -2.195 0 C-N-CA 119.265 -1.445 . . . . 75.42 112.625 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -69.1 -39.35 79.04 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 123.414 0.686 . . . . 73.02 110.001 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -56.86 -42.76 80.31 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 114.441 -1.254 . . . . 73.53 111.827 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.56 HG21 ' N ' ' A' ' 496' ' ' ARG . 0.0 OUTLIER -80.03 -37.15 17.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 112.571 0.582 . . . . 73.15 112.571 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.5 mm100 -61.13 -40.85 95.36 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.814 0.34 . . . . 72.42 110.641 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.511 ' HB2' HD13 ' A' ' 464' ' ' LEU . 6.4 m-20 -84.11 -43.3 15.17 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.21 -0.45 . . . . 50.14 109.969 174.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 70.44 13.97 71.46 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 121.346 -0.454 . . . . 63.21 113.62 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.413 ' HG2' HG23 ' A' ' 462' ' ' ILE . 77.6 ttt180 -88.16 -14.06 39.63 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.433 0.635 . . . . 70.02 109.686 -178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.542 ' HB2' HD21 ' A' ' 464' ' ' LEU . 49.2 tp -114.83 138.39 50.83 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.88 -1.156 . . . . 64.31 107.88 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.466 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -140.98 169.34 17.81 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.811 0.671 . . . . 61.42 112.811 178.483 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.495 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -82.55 161.9 22.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.013 -0.539 . . . . 62.4 111.938 -173.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 74.96 42.21 30.63 Favored Glycine 0 CA--C 1.506 -0.485 0 N-CA-C 110.802 -0.919 . . . . 74.05 110.802 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -146.68 149.11 32.81 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.959 -1.497 . . . . 73.34 106.959 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.453 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 41.6 ttm180 -87.7 138.22 31.66 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 118.095 0.407 . . . . 73.23 111.385 -174.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.494 ' HG ' HD11 ' A' ' 519' ' ' LEU . 25.9 tp -100.23 127.38 46.52 Favored 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 108.442 -0.948 . . . . 73.23 108.442 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.542 ' HB ' HD12 ' A' ' 543' ' ' LEU . 34.5 mm -100.97 -47.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.096 0.474 . . . . 74.54 110.966 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 543' ' ' LEU . 10.5 pt-20 -157.13 149.35 22.9 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 109.022 -0.733 . . . . 62.44 109.022 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 541' ' ' SER . 7.1 p -137.57 134.43 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 CA-C-O 121.254 0.55 . . . . 73.14 109.727 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 515' ' ' ASN . . . . . 0.449 HD22 ' HD2' ' A' ' 535' ' ' LYS . 0.1 OUTLIER 58.81 23.21 11.0 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 127.003 2.121 . . . . 53.14 112.944 -179.292 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 89.72 15.4 58.21 Favored Glycine 0 CA--C 1.502 -0.752 0 C-N-CA 121.036 -0.602 . . . . 63.24 112.538 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.5 t -115.38 131.41 67.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 O-C-N 122.709 -0.289 . . . . 71.14 110.308 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.73 130.48 35.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.343 0.657 . . . . 70.02 110.364 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.494 HD11 ' HG ' ' A' ' 511' ' ' LEU . 10.7 mt -95.87 -30.5 13.62 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.587 0.708 . . . . 72.32 110.205 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 55.3 t -58.83 -34.74 53.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.133 -1.394 . . . . 64.44 112.049 -171.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -99.38 20.68 48.81 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.929 -0.653 . . . . 51.21 113.831 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.422 ' HB2' ' CD ' ' A' ' 526' ' ' GLU . 0.1 OUTLIER -138.46 -179.83 6.03 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 117.797 0.798 . . . . 70.02 111.954 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 32.6 m -92.16 163.21 14.02 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.649 0.261 . . . . 63.51 111.471 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.647 ' OE1' ' HB3' ' A' ' 477' ' ' SER . 43.6 tp60 -59.7 -44.93 93.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.329 1.052 . . . . 75.13 110.694 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.491 ' HA ' HG22 ' A' ' 528' ' ' VAL . 47.8 mt-10 -62.32 -31.95 72.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.695 0.628 . . . . 64.12 112.695 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.422 ' CD ' ' HB2' ' A' ' 522' ' ' LYS . 50.1 mt-10 -63.81 -36.83 85.2 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.651 -0.5 . . . . 64.41 109.651 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.464 HG13 HD22 ' A' ' 519' ' ' LEU . 17.3 t -73.68 -36.51 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 115.588 -0.733 . . . . 74.44 109.478 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 13.9 m -69.45 -39.39 78.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.417 0 C-N-CA 119.592 -0.843 . . . . 63.15 111.177 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.9 t -62.33 -43.3 99.14 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.196 0.522 . . . . 64.05 109.661 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.85 -41.84 78.66 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.811 1.244 . . . . 61.31 109.383 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 473' ' ' PHE . 3.2 tt -69.0 -45.13 71.32 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.921 -1.036 . . . . 73.12 112.58 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.537 ' HA ' ' HE ' ' A' ' 532' ' ' ARG . 1.1 mmp_? -62.15 -43.72 98.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.554 -0.294 . . . . 73.14 110.48 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.1 m -68.54 -32.36 72.25 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.226 -0.443 . . . . 71.04 111.434 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 51.4 m 68.49 -94.88 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.02 0.528 . . . . 55.55 111.348 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.449 ' HD2' HD22 ' A' ' 515' ' ' ASN . 86.1 tttt 169.26 141.17 0.02 OUTLIER 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.435 -1.32 . . . . 74.04 107.435 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 86.8 mtp -68.75 -31.87 71.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.646 0.26 . . . . 71.43 111.598 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -59.61 -38.33 80.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.315 0.578 . . . . 71.21 110.288 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 112.02 -29.74 8.22 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.159 -1.02 . . . . 74.22 114.129 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 463' ' ' GLN . 6.4 m -103.93 136.3 43.84 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.973 -0.691 . . . . 61.44 109.238 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 471' ' ' LEU . 61.3 t -118.92 138.24 50.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.915 -0.584 . . . . 41.44 110.039 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 69.2 m -91.93 115.0 27.7 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-O 121.077 0.465 . . . . 63.54 111.478 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.633 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.3 mm? -102.09 119.73 39.27 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.8 -1.185 . . . . 75.22 107.8 176.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.542 HD12 ' HB ' ' A' ' 512' ' ' ILE . 2.8 tm? -108.23 117.07 33.2 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 104.832 -2.284 . . . . 52.14 104.832 173.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 33.5 m -115.9 161.33 14.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 115.379 -0.828 . . . . 74.1 111.624 -173.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.453 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 66.4 t80 -120.87 116.55 25.38 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.514 -0.921 . . . . 73.22 108.514 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 . . . . . 0 N--CA 1.396 -3.146 0 CA-C-N 115.054 -0.975 . . . . 74.01 108.77 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 29.5 mtpp . . . . . 0 CA--C 1.482 -1.661 0 CA-C-O 121.224 0.535 . . . . 71.11 111.962 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 95.0 mtt180 -116.17 126.22 53.38 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.821 -1.178 . . . . 62.44 107.821 167.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.2 mp -123.93 142.08 51.46 Favored 'General case' 0 CA--C 1.465 -2.29 0 CA-C-N 116.536 -0.302 . . . . 52.42 110.49 -172.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -98.19 114.95 27.35 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 115.104 -0.953 . . . . 70.23 108.929 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' ILE . . . . . 0.457 HG23 ' CG ' ' A' ' 504' ' ' ARG . 54.9 mt -118.86 129.58 74.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-N 114.893 -1.049 . . . . 72.12 109.463 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.2 mt-30 -115.86 127.94 55.41 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 113.046 0.758 . . . . 72.34 113.046 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.562 HD23 HD23 ' A' ' 542' ' ' LEU . 3.9 mm? -115.64 137.86 51.65 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 115.009 -0.996 . . . . 60.13 109.769 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.46 ' HE2' ' HB3' ' A' ' 465' ' ' LYS . 34.5 ttpt -107.48 135.96 48.08 Favored 'General case' 0 N--CA 1.4 -2.939 0 N-CA-C 108.867 -0.79 . . . . 75.42 108.867 -177.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.451 ' HB2' HG21 ' A' ' 534' ' ' THR . 39.4 ttmt -61.76 98.59 0.1 Allowed 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.639 0.733 . . . . 55.34 111.601 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -130.86 139.55 11.04 Favored Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 108.375 -1.89 . . . . 61.51 108.375 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 468' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 469' ' ' GLU 0.365 7.3 t 52.75 -81.55 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.104 1.361 . . . . 62.22 113.819 -175.217 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.43 ' OE1' ' HG3' ' A' ' 496' ' ' ARG . 37.9 mt-10 -106.79 -7.68 17.09 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.732 0.697 . . . . 63.33 110.858 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 67.8 -157.04 52.42 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.255 -0.884 . . . . 72.43 111.826 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 498' ' ' ALA . 5.3 mp -44.4 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.32 1.23 . . . . 63.12 114.32 -170.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -97.54 65.11 0.89 Allowed Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.018 -1.446 . . . . 52.4 111.291 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.446 ' HB3' HD13 ' A' ' 493' ' ' ILE . 27.1 p90 -155.44 147.84 23.88 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.193 -0.504 . . . . 75.15 110.184 176.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -126.27 162.77 24.69 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.474 -0.785 . . . . 35.13 109.446 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.2 pt -119.68 155.46 22.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 120.95 0.405 . . . . 51.41 111.703 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.9 t -135.68 129.53 32.87 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.877 -0.601 . . . . 74.02 110.239 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 24.0 t . . . . . 0 N--CA 1.423 -1.796 0 N-CA-C 108.621 -0.881 . . . . 75.21 108.621 173.92 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.436 -1.895 0 N-CA-C 109.998 -0.808 . . . . 75.22 109.998 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 511' ' ' LEU . 41.9 mm -96.24 139.65 18.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 109.325 -0.62 . . . . 74.13 109.325 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.17 153.4 48.59 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 122.311 -0.243 . . . . 73.15 110.575 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.408 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 26.3 t -73.74 121.32 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.86 -1.163 . . . . 73.44 107.86 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -90.38 -52.44 4.92 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.563 0.697 . . . . 73.4 110.976 -176.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -146.32 150.89 36.6 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.414 -0.812 . . . . 53.15 110.3 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.522 HG12 ' HB2' ' A' ' 507' ' ' ALA . 34.6 mm -119.96 104.83 16.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 107.444 -1.317 . . . . 62.44 107.444 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -62.9 122.62 75.87 Favored Pre-proline 0 C--N 1.307 -1.253 0 CA-C-N 115.585 -0.734 . . . . 71.31 109.83 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.36 22.79 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 124.768 3.645 . . . . 74.23 114.3 -171.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.43 ' HG3' ' OE1' ' A' ' 469' ' ' GLU . 8.3 ptp180 -157.43 6.99 0.15 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 113.437 0.903 . . . . 72.43 113.437 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -101.14 -149.96 23.54 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 119.814 -1.184 . . . . 74.14 112.449 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 471' ' ' LEU . . . -64.09 -40.29 95.9 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.156 0.582 . . . . 70.0 111.207 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.415 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . -57.08 -36.8 71.01 Favored 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 115.545 -0.752 . . . . 73.31 112.635 -174.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.8 tt -80.72 -42.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.445 0.535 . . . . 62.31 112.445 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 501' ' ' GLN . 14.7 mm-40 -61.46 -37.73 84.66 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.057 0.392 . . . . 73.31 112.057 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.521 ' HB2' HD13 ' A' ' 464' ' ' LEU . 17.5 m-20 -94.93 -28.98 14.9 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 109.442 -0.577 . . . . 72.24 109.442 175.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 499' ' ' ALA . . . 57.7 28.7 60.45 Favored Glycine 0 CA--C 1.496 -1.1 0 CA-C-N 115.467 -0.788 . . . . 74.13 114.36 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.457 ' CG ' HG23 ' A' ' 462' ' ' ILE . 26.7 tpt180 -99.4 -13.94 19.36 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.248 -0.581 . . . . 73.13 110.772 -174.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 49.7 tp -123.41 148.1 46.46 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.541 0.21 . . . . 74.43 110.449 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 506' ' ' LYS . 0.0 OUTLIER -141.98 165.41 27.53 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.764 -0.828 . . . . 71.24 108.764 177.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.522 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -85.39 130.62 34.55 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.48 -0.563 . . . . 62.4 109.48 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 140.85 -20.28 2.71 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.211 -0.756 . . . . 60.43 111.211 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -89.17 165.76 14.26 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-O 121.132 0.491 . . . . 74.52 111.419 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.571 ' NH1' HD13 ' A' ' 512' ' ' ILE . 2.2 tmt_? -107.79 141.03 39.98 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 116.042 -0.526 . . . . 64.02 110.026 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.648 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.6 mm? -86.79 129.09 35.01 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.861 -0.609 . . . . 70.04 112.29 -175.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.571 HD13 ' NH1' ' A' ' 510' ' ' ARG . 32.8 mm -106.69 -59.17 3.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.405 -0.361 . . . . 74.14 110.141 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -158.81 149.27 19.8 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.393 0.433 . . . . 75.14 110.38 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 6.0 p -123.03 129.91 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 109.115 -0.698 . . . . 61.45 109.115 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 60.91 2.77 0.57 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.539 1.135 . . . . 71.54 113.746 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 113.57 -4.28 24.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 121.051 -0.595 . . . . 73.22 112.511 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.5 t -93.22 134.73 30.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.385 -0.598 . . . . 72.02 109.385 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -77.63 145.72 36.56 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 123.601 0.563 . . . . 62.51 110.145 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.648 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 18.8 mt -101.48 -38.14 8.12 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.901 -0.778 . . . . 73.45 108.901 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.22 104.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 115.185 -0.916 . . . . 74.31 108.561 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 136.33 -21.19 3.48 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 108.934 -1.666 . . . . 73.24 108.934 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.97 172.83 7.27 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.514 -0.343 . . . . 74.21 110.511 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 23.8 m -89.24 161.77 16.24 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.326 -0.397 . . . . 75.13 111.226 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -57.83 -46.63 84.46 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 123.005 0.522 . . . . 71.12 111.563 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.535 ' HA ' HG22 ' A' ' 528' ' ' VAL . 48.5 mt-10 -58.18 -32.89 68.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.178 -0.465 . . . . 70.34 112.118 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.13 -41.62 90.22 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.325 -0.62 . . . . 73.42 109.325 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 44.2 t -70.28 -37.34 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 115.495 -0.775 . . . . 44.43 110.199 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.662 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.1 m -66.29 -41.26 88.73 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.439 0 C-N-CA 119.731 -0.788 . . . . 54.13 110.514 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.6 t -63.19 -42.95 99.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.205 0.526 . . . . 71.31 109.718 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 29.1 tp -59.96 -34.93 73.94 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.838 1.255 . . . . 73.11 110.099 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.45 ' CD1' HD23 ' A' ' 471' ' ' LEU . 26.5 tp -77.64 -47.98 17.95 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.856 -0.611 . . . . 54.24 110.312 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 4.8 mmp_? -57.79 -41.06 81.31 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.005 0.522 . . . . 74.34 110.887 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 46.0 m -60.34 -30.2 69.38 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.878 -0.601 . . . . 64.12 111.562 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 534' ' ' THR . . . . . 0.451 HG21 ' HB2' ' A' ' 466' ' ' LYS . 40.8 m 67.26 -91.14 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.399 0.68 . . . . 71.23 111.76 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 537' ' ' GLU . 88.6 tttt 164.93 144.35 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 104.535 -2.394 . . . . 74.24 104.535 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 85.0 mtp -66.91 -25.49 66.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.769 0.713 . . . . 63.34 111.444 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 537' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 0.9 OUTLIER -64.87 -65.65 0.65 Allowed 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.053 -1.091 . . . . 75.1 108.053 172.565 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 143.39 -31.56 1.92 Allowed Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 119.084 -1.532 . . . . 64.12 114.662 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 465' ' ' LYS . 1.8 m -94.57 142.19 27.73 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.344 -0.943 . . . . 64.13 109.214 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 58.2 t -122.43 142.16 39.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 123.575 0.75 . . . . 75.33 109.062 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.7 m -105.76 113.4 26.94 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.44 0.638 . . . . 74.44 110.674 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.562 HD23 HD23 ' A' ' 464' ' ' LEU . 2.6 mm? -102.36 119.03 38.13 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.899 -1.148 . . . . 74.14 107.899 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 2.9 tm? -104.77 115.95 31.19 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 105.216 -2.142 . . . . 75.22 105.216 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 32.7 m -117.41 161.01 16.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.024 -0.989 . . . . 73.44 111.328 -174.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 86.9 t80 -112.06 117.96 34.1 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 108.399 -0.963 . . . . 55.23 108.399 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 . . . . . 0 N--CA 1.411 -2.382 0 N-CA-C 107.968 -1.123 . . . . 74.14 107.968 176.726 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt . . . . . 0 N--CA 1.437 -1.101 0 CA-C-O 120.822 0.344 . . . . 61.15 110.819 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 71.3 mtm180 -100.43 148.78 24.36 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.633 -0.712 . . . . 73.34 109.306 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -130.95 134.22 46.54 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.283 -0.636 . . . . 65.33 109.283 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -92.88 115.47 28.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.909 -1.145 . . . . 74.34 107.909 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' ILE . . . . . 0.415 HG23 ' CG ' ' A' ' 504' ' ' ARG . 60.6 mt -119.94 137.64 53.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 115.746 -0.661 . . . . 70.12 109.844 -174.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.0 mt-30 -120.83 127.52 52.0 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.744 0.646 . . . . 73.04 112.744 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.584 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.2 mm? -113.8 142.13 46.45 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 114.895 -1.048 . . . . 63.55 111.002 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -101.34 127.33 48.01 Favored 'General case' 0 N--CA 1.398 -3.029 0 N-CA-C 107.584 -1.265 . . . . 72.2 107.584 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.11 95.6 0.13 Allowed 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.903 -0.59 . . . . 61.52 109.594 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -136.95 153.51 21.79 Favored Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 115.511 -0.768 . . . . 32.45 111.856 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 22.0 m 59.28 -91.74 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.945 1.298 . . . . 74.22 111.497 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -101.84 -3.98 27.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.291 0.567 . . . . 75.11 109.918 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.29 -161.22 54.21 Favored Glycine 0 C--O 1.205 -1.706 0 CA-C-O 118.922 -0.932 . . . . 70.44 111.595 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.507 HD11 HG21 ' A' ' 540' ' ' VAL . 66.4 mt -48.36 99.94 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.832 0.825 . . . . 72.25 112.712 -171.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -111.28 61.0 0.31 Allowed Glycine 0 CA--C 1.479 -2.184 0 CA-C-N 114.567 -1.197 . . . . 44.23 111.641 -174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -150.13 142.26 24.06 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 109.138 -0.69 . . . . 65.33 109.138 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.5 p -115.53 155.19 28.0 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.943 -0.571 . . . . 60.43 110.58 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.6 pt -116.33 150.34 18.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.059 0.457 . . . . 64.23 111.757 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.415 ' CB ' ' HE3' ' A' ' 491' ' ' LYS . 9.0 t -136.22 147.07 47.43 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.476 -0.784 . . . . 72.54 109.987 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 57.9 p . . . . . 0 N--CA 1.439 -0.984 0 N-CA-C 108.862 -0.792 . . . . 63.03 108.862 176.935 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.42 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 9.6 Cg_endo . . . . . 0 N--CA 1.433 -2.061 0 N-CA-C 109.974 -0.818 . . . . 71.31 109.974 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.19 132.14 41.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.34 -0.615 . . . . 54.31 109.34 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 90.8 m-85 -129.02 152.76 48.28 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 110.31 -0.255 . . . . 55.22 110.31 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.39 119.51 30.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.469 -0.937 . . . . 75.04 108.469 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.415 ' HE3' ' CB ' ' A' ' 476' ' ' THR . 4.7 tppp? -82.15 -59.62 2.5 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.791 -0.64 . . . . 74.14 110.722 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -140.16 155.49 46.93 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 120.316 -0.554 . . . . 61.35 110.675 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.534 HG12 ' HB2' ' A' ' 507' ' ' ALA . 33.8 mm -119.2 104.8 16.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.306 -1.368 . . . . 62.3 107.306 177.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.23 130.53 89.5 Favored Pre-proline 0 C--N 1.307 -1.282 0 CA-C-N 116.022 -0.535 . . . . 55.41 111.084 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.81 18.03 0.2 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 125.027 3.818 . . . . 73.12 115.45 -171.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -161.13 6.81 0.07 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 113.916 1.08 . . . . 72.11 113.916 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -91.63 -155.86 32.17 Favored Glycine 0 C--N 1.294 -1.754 0 C-N-CA 119.464 -1.35 . . . . 73.12 113.085 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.416 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -63.39 -41.6 98.78 Favored 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 123.942 0.897 . . . . 72.03 109.876 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.542 ' HA ' HD11 ' A' ' 464' ' ' LEU . . . -56.65 -43.81 80.69 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 114.856 -1.065 . . . . 75.43 112.074 -173.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.1 tt -80.49 -29.34 12.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 112.19 0.441 . . . . 65.42 112.19 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -48.26 81.3 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.226 -1.028 . . . . 71.01 108.226 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.584 ' HB2' HD13 ' A' ' 464' ' ' LEU . 10.2 m-20 -87.08 -34.23 19.22 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 109.789 -0.449 . . . . 62.4 109.789 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 62.45 39.59 98.0 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.504 -0.771 . . . . 65.32 112.538 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.415 ' CG ' HG23 ' A' ' 462' ' ' ILE . 30.0 tpt180 -111.36 -4.89 14.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.33 0.586 . . . . 71.21 109.917 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 57.7 tp -125.73 142.74 51.36 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.857 -0.611 . . . . 71.51 110.546 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.492 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.28 0.0 OUTLIER -138.51 164.55 29.14 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.17 -0.468 . . . . 70.13 111.854 175.451 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.534 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.46 156.43 22.89 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.655 0.613 . . . . 75.21 112.655 -171.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.5 8.0 55.17 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.99 -0.624 . . . . 73.25 113.682 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -113.33 164.96 12.91 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 117.388 0.594 . . . . 63.42 110.191 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.408 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 43.1 ttm180 -89.95 129.32 36.3 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 123.095 0.247 . . . . 74.31 110.624 -177.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.93 124.33 33.02 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 106.069 -1.826 . . . . 75.31 106.069 177.346 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 50.7 mm -96.3 -51.11 11.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 120.562 0.22 . . . . 53.54 111.258 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -157.99 148.85 20.9 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 116.102 -0.499 . . . . 74.24 109.66 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 541' ' ' SER . 3.7 p -130.05 125.51 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.523 0 CA-C-N 116.025 -0.534 . . . . 71.32 109.566 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 59.51 26.9 15.94 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 114.864 -1.062 . . . . 75.41 112.067 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.54 -4.8 73.41 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.748 -0.66 . . . . 63.33 113.367 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.44 124.84 47.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.393 -0.595 . . . . 71.13 109.393 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -84.01 141.69 31.01 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.727 0.642 . . . . 74.35 109.382 -173.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.535 HD11 HD12 ' A' ' 511' ' ' LEU . 19.0 mt -99.72 -42.96 6.63 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.161 0.8 . . . . 73.21 113.161 -171.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.14 89.08 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-O 122.23 1.014 . . . . 74.24 110.629 -174.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 151.03 -13.87 0.85 Allowed Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 113.994 -1.457 . . . . 73.24 109.693 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.82 177.78 4.65 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 122.85 -0.206 . . . . 74.44 110.89 175.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 48.9 m -88.61 156.68 18.9 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.514 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.419 ' O ' HG13 ' A' ' 528' ' ' VAL . 24.2 tt0 -58.76 -44.38 90.59 Favored 'General case' 0 C--O 1.21 -0.996 0 C-N-CA 122.487 0.315 . . . . 71.14 110.514 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.519 ' HA ' HG22 ' A' ' 528' ' ' VAL . 28.3 mm-40 -57.72 -31.46 66.44 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 112.661 0.615 . . . . 61.55 112.661 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -66.58 -39.8 88.62 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.188 -0.671 . . . . 71.22 109.188 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 33.8 t -75.48 -36.39 35.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.135 -0.938 . . . . 73.24 110.285 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.704 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 10.7 m -63.67 -44.81 98.58 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 C-N-CA 120.351 -0.54 . . . . 65.3 109.933 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.7 m -64.51 -36.98 85.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.4 0.619 . . . . 74.5 110.267 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 32.6 tp -61.03 -43.6 98.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.736 1.214 . . . . 63.32 109.428 175.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.45 HD12 HD13 ' A' ' 471' ' ' LEU . 35.2 tp -67.3 -48.03 68.83 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.75 -0.659 . . . . 74.24 109.845 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.704 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 32.2 mmm180 -57.41 -30.11 64.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.731 0.813 . . . . 64.42 111.192 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 61.2 m -73.6 -43.64 59.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.925 -0.579 . . . . 61.21 111.532 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 40.4 m 68.26 142.2 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.664 0.786 . . . . 74.14 111.311 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.523 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 60.4 tptt -59.9 132.17 53.12 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.636 -0.711 . . . . 74.42 109.641 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -63.35 -20.11 65.22 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.513 0.725 . . . . 64.23 111.938 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 537' ' ' GLU . . . . . 0.523 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 38.4 tt0 -73.89 -15.17 61.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.492 0.663 . . . . 70.31 110.253 177.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 94.69 -20.29 49.37 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.085 -0.579 . . . . 71.11 112.333 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 463' ' ' GLN . 2.7 m -114.19 128.79 56.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.748 -1.204 . . . . 72.23 107.748 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.521 HG22 ' H ' ' A' ' 535' ' ' LYS . 57.4 t -105.23 134.19 47.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 C-N-CA 122.816 0.446 . . . . 61.14 110.5 -176.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 29.9 m -98.48 115.14 27.9 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.744 -0.662 . . . . 54.2 110.832 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.484 HD23 HD23 ' A' ' 464' ' ' LEU . 2.7 mm? -110.95 124.68 52.6 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.4 -0.963 . . . . 60.1 108.4 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 53.0 tp -104.23 118.34 36.41 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.534 -1.654 . . . . 64.32 106.534 174.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.4 m -116.06 145.59 21.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 120.293 -0.563 . . . . 74.24 111.27 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -112.02 116.42 30.53 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.066 -1.086 . . . . 65.02 108.066 175.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 546' ' ' ARG . . . . . 0.455 ' O ' ' HD3' ' A' ' 546' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.406 -2.651 0 N-CA-C 108.2 -1.037 . . . . 73.44 108.2 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.576 ' N ' ' HE2' ' A' ' 458' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.448 0 N-CA-C 109.538 -0.542 . . . . 62.54 109.538 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 97.6 mtt180 -99.13 142.28 30.82 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.881 -0.785 . . . . 74.21 108.881 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.1 mm? -123.72 133.71 53.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.189 -0.671 . . . . 73.11 109.189 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -100.07 116.62 32.51 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.454 -0.943 . . . . 64.35 108.454 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' ILE . . . . . 0.434 HG21 ' HB3' ' A' ' 504' ' ' ARG . 57.0 mt -123.3 125.02 71.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.61 -0.723 . . . . 73.54 110.959 -173.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.8 mt-30 -91.52 126.78 36.72 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.993 0.738 . . . . 61.42 112.993 178.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.1 mm? -115.79 144.34 44.12 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.4 1.08 . . . . 71.33 110.332 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -103.03 136.67 42.41 Favored 'General case' 0 N--CA 1.404 -2.75 0 N-CA-C 107.833 -1.173 . . . . 73.51 107.833 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.491 ' HA ' ' HA2' ' A' ' 470' ' ' GLY . 23.5 ttmm -54.44 99.58 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.766 0.794 . . . . 72.14 111.328 175.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -85.3 -147.57 9.49 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 114.943 -1.026 . . . . 73.32 111.454 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 16.7 m -55.41 -45.41 76.72 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.978 0.511 . . . . 61.21 110.946 -177.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.59 9.81 17.98 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 120.691 0.281 . . . . 62.32 111.137 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 58.01 -141.96 44.71 Favored Glycine 0 C--O 1.185 -2.967 0 CA-C-O 117.17 -1.905 . . . . 63.23 109.804 -170.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.538 ' H ' HD22 ' A' ' 471' ' ' LEU . 2.5 mm? -44.08 108.61 0.12 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.54 1.67 . . . . 70.51 112.459 -173.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -100.19 47.78 1.25 Allowed Glycine 0 N--CA 1.421 -2.311 0 CA-C-N 114.55 -1.204 . . . . 53.42 112.433 -173.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -140.92 144.8 35.39 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 109.356 -0.609 . . . . 71.32 109.356 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 18.8 m -114.6 139.38 49.66 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.889 -1.523 . . . . 52.32 106.889 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 489' ' ' TYR . 14.8 pt -111.46 151.24 13.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-O 120.976 0.417 . . . . 62.51 112.072 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -144.73 151.17 38.49 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.888 -0.596 . . . . 73.23 109.618 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.437 -1.096 0 N-CA-C 109.138 -0.69 . . . . 54.41 109.138 175.932 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.579 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 3.2 Cg_exo . . . . . 0 N--CA 1.427 -2.422 0 N-CA-C 110.166 -0.744 . . . . 64.12 110.166 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.568 HG13 ' HB3' ' A' ' 519' ' ' LEU . 34.2 mm -90.52 119.94 38.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.286 -1.005 . . . . 64.42 108.286 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 78.8 m-85 -121.63 152.95 38.75 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 122.281 -0.262 . . . . 74.52 111.492 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 47.2 t -78.56 119.06 26.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.973 -0.751 . . . . 74.11 108.973 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -84.52 -53.84 5.15 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.78 -0.646 . . . . 75.55 109.425 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -143.13 154.04 43.5 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.327 -0.852 . . . . 64.42 109.044 -175.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.502 HG12 ' HB2' ' A' ' 507' ' ' ALA . 26.2 mm -110.44 110.2 31.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.842 -1.17 . . . . 71.12 107.842 174.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.0 mp -52.82 128.04 44.92 Favored Pre-proline 0 C--N 1.321 -0.665 0 O-C-N 123.941 0.776 . . . . 73.51 110.372 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.49 20.48 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 124.668 3.578 . . . . 71.32 114.908 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.44 ' O ' ' HB ' ' A' ' 468' ' ' THR . 14.2 ptp180 -168.82 5.9 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.323 0.583 . . . . 65.23 112.459 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -83.86 -167.87 42.81 Favored Glycine 0 C--N 1.298 -1.561 0 C-N-CA 119.893 -1.146 . . . . 65.43 112.663 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 464' ' ' LEU . . . -55.86 -47.4 77.39 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 124.932 1.293 . . . . 75.31 111.151 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.23 -40.6 77.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.743 -1.117 . . . . 72.53 112.559 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 8.5 tt -79.94 -40.43 20.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 112.57 0.582 . . . . 63.14 112.57 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 8.2 mm-40 -67.43 -37.87 83.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 72.34 110.841 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.567 ' HB2' HD13 ' A' ' 464' ' ' LEU . 7.8 m-20 -91.56 -21.95 20.59 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 116.116 -0.493 . . . . 63.55 109.87 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 63.92 55.78 22.46 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 120.742 -0.742 . . . . 54.54 114.803 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.434 ' HB3' HG21 ' A' ' 462' ' ' ILE . 14.3 mmm180 -123.85 -73.53 0.64 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.873 -0.731 . . . . 73.54 110.796 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.537 HD13 HG11 ' A' ' 544' ' ' VAL . 67.4 tp -73.68 137.7 44.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.778 0.323 . . . . 64.13 111.807 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.464 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.267 0.0 OUTLIER -126.32 174.26 8.7 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.717 -0.674 . . . . 74.13 112.403 177.061 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.502 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.18 138.8 33.49 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 113.435 0.902 . . . . 62.13 113.435 -171.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 105.39 13.88 23.43 Favored Glycine 0 C--N 1.321 -0.253 0 CA-C-N 115.583 -0.735 . . . . 71.5 112.577 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.63 162.44 13.96 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 122.678 0.391 . . . . 74.3 110.398 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -101.45 134.36 44.66 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 120.81 -0.356 . . . . 74.04 110.649 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.597 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 3.6 mm? -86.97 132.99 33.63 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.553 -0.749 . . . . 62.01 110.171 174.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.426 HG21 ' HD3' ' A' ' 459' ' ' ARG . 49.7 mm -111.72 -39.07 3.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.06 -0.718 . . . . 74.42 109.06 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 543' ' ' LEU . 32.7 tt0 -154.72 148.43 25.42 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.517 -0.765 . . . . 61.12 109.156 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.597 HG13 HD11 ' A' ' 530' ' ' LEU . 6.8 p -136.51 125.47 37.07 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.077 0 N-CA-C 107.397 -1.334 . . . . 63.3 107.397 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 72.33 -52.27 0.7 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 125.982 1.713 . . . . 73.23 111.963 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 163.29 30.61 0.02 OUTLIER Glycine 0 C--N 1.287 -2.146 0 N-CA-C 109.519 -1.432 . . . . 72.21 109.519 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.1 t -122.5 134.43 65.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.305 -0.447 . . . . 64.2 109.902 -175.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.0 148.77 36.06 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.704 -0.48 . . . . 72.42 109.704 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.597 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 60.5 mt -111.51 -45.81 3.34 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 113.338 0.866 . . . . 73.32 113.338 -171.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.68 -1.31 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 113.146 0.795 . . . . 70.44 113.146 -172.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -112.41 12.18 25.95 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 111.616 -0.594 . . . . 63.13 111.616 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.413 ' NZ ' ' HB3' ' A' ' 522' ' ' LYS . 0.2 OUTLIER -146.53 -177.59 5.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 117.172 0.486 . . . . 53.52 111.505 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 523' ' ' SER . . . . . 0.466 ' O ' HG23 ' A' ' 527' ' ' VAL . 76.3 p -96.17 163.3 13.16 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.214 0.53 . . . . 74.22 111.998 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.522 ' O ' HG13 ' A' ' 528' ' ' VAL . 37.9 mm-40 -55.24 -41.91 72.74 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.987 -1.006 . . . . 75.25 111.962 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.44 ' HA ' HG22 ' A' ' 528' ' ' VAL . 43.2 mt-10 -63.08 -31.81 73.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.105 0.479 . . . . 73.34 112.178 -175.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.88 -36.03 67.28 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.737 -0.665 . . . . 75.01 110.529 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.567 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 17.5 t -75.39 -41.5 42.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.393 -0.595 . . . . 73.31 109.393 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.709 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.3 m -62.18 -43.46 97.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 120.356 -0.538 . . . . 64.25 110.942 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.9 t -64.5 -37.06 86.22 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.451 -0.341 . . . . 73.31 111.325 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.597 HD11 HG13 ' A' ' 514' ' ' VAL . 1.2 pp -68.07 -37.54 81.39 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.011 -1.107 . . . . 73.53 108.011 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 471' ' ' LEU . 3.6 tt -62.98 -46.49 87.47 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.894 -1.048 . . . . 55.44 111.175 176.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.709 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 27.1 mmm180 -61.68 -33.63 74.32 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.127 -0.488 . . . . 73.13 110.409 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.0 m -82.96 -30.71 28.09 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.073 0.464 . . . . 74.12 110.685 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 534' ' ' THR . . . . . 0.476 HG21 ' HE2' ' A' ' 466' ' ' LYS . 30.5 m 71.98 -83.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.606 1.162 . . . . 64.15 112.115 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.543 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 17.3 tppt? 167.27 157.64 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 106.405 -1.702 . . . . 75.53 106.405 -176.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.94 6.45 18.55 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.77 0.795 . . . . 72.03 110.212 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 537' ' ' GLU . . . . . 0.543 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 13.3 tp10 -96.88 -54.3 3.24 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.039 -1.096 . . . . 75.2 108.039 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 116.39 -20.21 12.54 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.322 -0.942 . . . . 72.51 112.587 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 3.4 m -104.7 136.23 44.6 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.987 -0.745 . . . . 72.3 108.987 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 87.2 t -123.43 136.69 59.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 123.139 0.575 . . . . 73.33 110.743 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.8 t -92.15 114.61 27.2 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.364 -0.606 . . . . 60.24 109.364 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.467 HD13 HD22 ' A' ' 505' ' ' LEU . 43.6 mt -99.51 119.72 38.48 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.498 -0.927 . . . . 61.44 108.498 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.595 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 45.5 tp -104.61 116.93 32.91 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.747 -1.575 . . . . 73.14 106.747 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 31.1 m -122.67 157.96 27.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.924 -0.58 . . . . 64.33 111.886 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -114.4 116.69 29.31 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.863 -0.608 . . . . 73.41 109.703 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 . . . . . 0 C--N 1.302 -1.466 0 CA-C-N 115.699 -0.682 . . . . 71.01 109.463 179.428 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 26.7 mtpp . . . . . 0 CA--C 1.478 -1.791 0 CA-C-O 121.363 0.601 . . . . 74.54 111.185 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 62.2 mtm180 -112.04 129.6 56.15 Favored 'General case' 0 N--CA 1.406 -2.663 0 N-CA-C 107.579 -1.267 . . . . 65.13 107.579 170.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -116.21 131.73 56.86 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.636 -0.875 . . . . 71.23 108.636 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -95.86 115.34 27.29 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.787 -0.82 . . . . 73.24 108.787 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' ILE . . . . . 0.437 HG22 ' CD2' ' A' ' 464' ' ' LEU . 60.8 mt -119.38 123.91 72.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 115.357 -0.838 . . . . 74.43 109.853 -175.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 47.6 mt-30 -102.37 130.55 49.15 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 121.824 -0.547 . . . . 53.31 112.282 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 542' ' ' LEU . 4.3 mm? -115.06 139.48 49.84 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.848 -0.614 . . . . 73.2 111.958 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -91.04 132.67 35.87 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 123.849 0.859 . . . . 72.21 110.481 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -72.87 105.21 4.3 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 114.593 -1.185 . . . . 63.35 109.402 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -144.53 137.33 7.2 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.82 -0.627 . . . . 63.22 111.741 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 35.5 m 64.54 -79.11 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.468 1.107 . . . . 73.55 112.048 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.412 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 5.7 mm-40 -102.28 -11.34 18.79 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.127 -0.694 . . . . 74.21 109.127 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 66.8 -144.51 45.37 Favored Glycine 0 CA--C 1.473 -2.582 0 CA-C-O 117.528 -1.707 . . . . 55.42 108.924 -172.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 531' ' ' LEU . 43.4 mt -52.25 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.316 1.558 . . . . 45.05 112.275 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . -102.43 59.64 0.55 Allowed Glycine 0 CA--C 1.464 -3.122 0 CA-C-N 114.256 -1.338 . . . . 54.11 111.237 -173.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.467 ' HB3' HD13 ' A' ' 493' ' ' ILE . 18.7 p90 -148.01 142.52 26.45 Favored 'General case' 0 C--N 1.258 -3.387 0 N-CA-C 108.117 -1.068 . . . . 72.21 108.117 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 20.0 m -115.0 143.81 44.6 Favored 'General case' 0 C--N 1.271 -2.843 0 N-CA-C 108.157 -1.053 . . . . 71.31 108.157 -176.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 10.2 pt -109.81 156.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-O 121.209 0.528 . . . . 54.4 111.502 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.486 HG21 ' HE2' ' A' ' 491' ' ' LYS . 9.1 t -136.63 141.21 43.21 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.908 -0.775 . . . . 72.14 108.908 176.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 59.3 p . . . . . 0 C--N 1.293 -1.881 0 N-CA-C 106.749 -1.575 . . . . 43.03 106.749 174.401 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo . . . . . 0 C--O 1.255 1.347 0 N-CA-C 109.464 -1.014 . . . . 74.14 109.464 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.534 HD12 ' OE1' ' A' ' 524' ' ' GLN . 41.1 mm -101.32 145.02 12.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.559 -1.275 . . . . 75.54 107.559 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -130.26 149.67 51.85 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 122.214 -0.304 . . . . 64.12 110.357 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 47.3 t -81.52 119.55 31.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.187 -1.042 . . . . 52.4 108.187 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.486 ' HE2' HG21 ' A' ' 476' ' ' THR . 17.8 tppt? -90.44 -52.51 4.88 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.237 0.615 . . . . 63.53 111.272 -177.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 492' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 64.4 t30 -130.18 150.25 51.52 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.076 -0.649 . . . . 75.22 111.327 -173.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 507' ' ' ALA . 28.7 mm -121.22 104.97 15.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.624 -1.25 . . . . 51.1 107.624 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.49 133.97 95.85 Favored Pre-proline 0 C--N 1.311 -1.101 0 CA-C-N 115.437 -0.801 . . . . 64.31 111.283 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.82 14.09 0.55 Allowed 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 124.624 3.549 . . . . 74.31 114.952 -172.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.441 ' HA ' HG21 ' A' ' 500' ' ' ILE . 18.8 ptt180 -156.63 6.09 0.17 Allowed 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 120.016 -0.673 . . . . 71.42 112.606 -176.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.612 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -91.23 -163.01 38.43 Favored Glycine 0 C--N 1.291 -1.936 0 C-N-CA 120.096 -1.049 . . . . 64.41 111.984 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.452 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -55.92 -40.9 73.76 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 125.016 1.326 . . . . 70.35 110.374 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.0 76.21 Favored 'General case' 0 C--O 1.194 -1.861 0 CA-C-N 114.5 -1.227 . . . . 74.23 112.515 -174.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.441 HG21 ' HA ' ' A' ' 496' ' ' ARG . 11.5 tt -80.47 -29.57 12.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 112.216 0.45 . . . . 61.24 112.216 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 73.5 mm-40 -58.53 -45.75 88.22 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.333 -0.617 . . . . 62.24 109.333 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.504 ' HB2' HD13 ' A' ' 464' ' ' LEU . 3.3 m-20 -93.49 -38.28 11.49 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.486 -0.779 . . . . 71.03 110.561 175.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 71.8 17.11 76.54 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.847 -0.692 . . . . 73.21 113.304 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.429 ' CG ' HG23 ' A' ' 462' ' ' ILE . 27.5 tpt180 -91.32 -18.93 23.53 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.172 0.51 . . . . 75.33 110.822 -175.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 46.9 tp -108.52 150.49 27.38 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 110.159 -0.311 . . . . 74.11 110.159 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.41 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -143.98 170.25 16.28 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.38 -0.6 . . . . 74.3 109.38 178.048 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.564 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -89.33 150.2 22.68 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.982 0.42 . . . . 64.43 110.765 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 113.36 -30.56 7.21 Favored Glycine 0 C--N 1.303 -1.303 0 N-CA-C 111.088 -0.805 . . . . 70.15 111.088 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -68.37 146.99 52.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.112 0.482 . . . . 72.01 111.375 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 25.0 ttm180 -85.52 128.68 34.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.165 -0.679 . . . . 53.04 109.165 177.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.471 ' HG ' HD11 ' A' ' 519' ' ' LEU . 22.4 tp -90.03 127.72 36.12 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 108.494 -0.928 . . . . 73.12 108.494 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.454 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.2 mm -98.15 -41.54 10.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.079 0.466 . . . . 74.02 110.247 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -158.65 159.12 35.01 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.602 -0.726 . . . . 61.21 109.778 176.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.29 130.52 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 109.149 -0.685 . . . . 74.13 109.149 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.3 t30 70.05 -48.1 0.62 Allowed 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 127.919 2.488 . . . . 71.13 111.867 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 169.49 8.3 0.03 OUTLIER Glycine 0 C--N 1.293 -1.81 0 CA-C-N 116.101 -0.5 . . . . 45.15 112.159 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 29.2 t -115.08 138.8 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.89 -0.781 . . . . 73.53 108.89 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -83.48 155.83 23.18 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 123.755 0.659 . . . . 75.42 110.28 -174.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.471 HD11 ' HG ' ' A' ' 511' ' ' LEU . 21.7 mt -104.79 -42.24 5.43 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.621 -0.718 . . . . 72.34 111.648 -174.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.7 t -72.37 91.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 115.571 -0.74 . . . . 55.14 109.747 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 144.63 -7.23 1.72 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 110.07 -1.212 . . . . 72.42 110.07 -174.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.442 ' HD3' ' HB2' ' A' ' 526' ' ' GLU . 17.5 ptpt -130.65 -178.46 4.8 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 110.021 -0.363 . . . . 74.13 110.021 175.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 523' ' ' SER . . . . . 0.431 ' O ' HG23 ' A' ' 527' ' ' VAL . 46.2 t -95.56 162.61 13.56 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.113 0.482 . . . . 63.11 111.014 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.534 ' OE1' HD12 ' A' ' 488' ' ' ILE . 7.3 tp60 -58.37 -38.88 78.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.946 -1.024 . . . . 75.32 110.328 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.99 -31.62 72.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.489 -0.778 . . . . 74.25 111.428 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.442 ' HB2' ' HD3' ' A' ' 522' ' ' LYS . 15.1 mm-40 -71.31 -39.89 71.14 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.893 -0.78 . . . . 75.22 108.893 177.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 523' ' ' SER . 18.4 t -69.34 -40.5 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.365 -0.834 . . . . 52.23 110.012 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.609 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.0 m -62.46 -42.56 96.16 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.111 0 C-N-CA 120.16 -0.616 . . . . 74.21 110.383 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.2 t -62.68 -43.31 99.12 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 116.203 -0.453 . . . . 65.21 110.133 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 46.8 tp -58.27 -45.99 86.86 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.522 1.129 . . . . 65.43 109.566 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 471' ' ' LEU . 2.4 tt -62.94 -45.45 92.43 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.391 -0.822 . . . . 72.42 112.362 175.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.7 OUTLIER -58.17 -39.58 79.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.243 0.544 . . . . 71.42 110.416 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.2 t -63.9 -43.57 95.61 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.211 -0.904 . . . . 55.31 110.672 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 63.0 m 67.51 -88.41 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.249 0.62 . . . . 60.42 110.811 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 40.5 tttm 172.74 153.74 0.08 Allowed 'General case' 0 C--O 1.251 1.164 0 N-CA-C 106.685 -1.598 . . . . 64.23 106.685 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 16.0 tpt -75.03 -35.71 61.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.418 -0.513 . . . . 72.42 109.946 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.11 -48.67 56.63 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.977 -0.556 . . . . 71.44 110.56 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 133.12 -28.54 3.31 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 118.564 -1.779 . . . . 61.12 115.984 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 4.5 m -94.93 135.18 36.75 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 118.625 -1.23 . . . . 74.32 109.805 -177.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 63.5 t -118.35 137.29 52.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.851 -0.613 . . . . 72.41 110.267 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 68.9 m -91.86 113.29 25.52 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.426 0.632 . . . . 54.41 111.039 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 464' ' ' LEU . 3.6 mm? -101.36 122.41 43.68 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.657 -0.868 . . . . 73.53 108.657 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 36.9 tp -105.09 118.17 35.85 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.035 -1.469 . . . . 74.13 107.035 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 30.0 m -115.99 154.84 17.45 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 CA-C-O 121.042 0.449 . . . . 74.03 110.786 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.515 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 69.3 t80 -111.77 118.35 35.35 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.522 -0.918 . . . . 71.22 108.522 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 . . . . . 0 C--N 1.298 -1.649 0 N-CA-C 107.504 -1.295 . . . . 63.03 107.504 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt . . . . . 0 N--CA 1.428 -1.571 0 N-CA-C 109.596 -0.52 . . . . 74.3 109.596 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.464 ' HB3' HD11 ' A' ' 543' ' ' LEU . 41.7 mtm180 -111.18 150.89 28.88 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.89 -0.595 . . . . 73.45 109.745 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.9 mm? -131.62 137.33 48.34 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.339 -0.615 . . . . 55.45 109.339 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -103.3 123.56 47.0 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.273 -0.64 . . . . 72.52 109.273 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 76.0 mt -119.26 120.8 64.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.197 -0.668 . . . . 75.31 109.197 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.0 mt-30 -100.75 127.27 47.24 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.39 0.614 . . . . 74.53 111.723 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 502' ' ' ASP . 5.9 tp -114.96 140.33 49.11 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-N 114.655 -1.157 . . . . 72.12 108.281 -173.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.518 ' HA ' ' HE3' ' A' ' 465' ' ' LYS . 1.3 tpmt? -101.98 121.98 43.19 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.303 -0.999 . . . . 62.25 108.303 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -63.49 92.02 0.06 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.786 -0.643 . . . . 73.13 110.103 175.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -116.47 142.87 17.81 Favored Glycine 0 N--CA 1.428 -1.845 0 CA-C-N 115.667 -0.697 . . . . 50.54 111.766 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' THR . . . . . 0.5 HG23 ' H ' ' A' ' 469' ' ' GLU 0.354 10.0 t 52.03 -82.86 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.11 1.764 . . . . 72.21 114.885 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.5 ' H ' HG23 ' A' ' 468' ' ' THR . 32.9 tt0 -97.04 -15.02 21.23 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.847 0.832 . . . . 71.43 109.081 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.42 -155.85 51.67 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 114.981 -1.009 . . . . 75.33 113.419 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 540' ' ' VAL . 5.8 mp -48.12 104.5 0.06 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 113.517 0.932 . . . . 63.21 113.517 -170.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -118.56 54.58 0.62 Allowed Glycine 0 N--CA 1.422 -2.261 0 CA-C-N 114.567 -1.197 . . . . 72.15 111.174 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.525 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 16.2 p90 -136.64 142.24 43.24 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 109.292 -0.633 . . . . 75.55 109.292 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 37.1 p -115.26 153.41 30.94 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.948 -0.569 . . . . 74.02 109.963 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.41 151.3 21.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 121.076 0.465 . . . . 65.3 110.698 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.1 t -144.23 157.4 44.31 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.881 -0.599 . . . . 64.24 109.691 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 61.4 p . . . . . 0 N--CA 1.425 -1.721 0 N-CA-C 107.713 -1.217 . . . . 73.41 107.713 175.886 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.478 0.612 0 N-CA-C 114.601 0.962 . . . . 44.04 114.601 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.452 HG13 ' HB3' ' A' ' 519' ' ' LEU . 34.6 mm -87.55 130.28 37.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.163 -0.926 . . . . 74.02 108.956 -176.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -128.6 151.15 49.8 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 110.422 -0.214 . . . . 71.04 110.422 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 48.8 t -80.06 119.48 29.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.126 -1.064 . . . . 63.5 108.126 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -73.92 -60.74 2.12 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.102 -0.499 . . . . 74.25 110.536 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -145.51 158.04 43.9 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.369 0.604 . . . . 72.51 110.43 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 506' ' ' LYS . 30.2 mm -116.49 104.92 17.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 106.597 -1.631 . . . . 70.52 106.597 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.33 137.42 94.48 Favored Pre-proline 0 C--N 1.304 -1.37 0 CA-C-N 115.242 -0.89 . . . . 72.43 111.035 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -73.34 17.16 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 124.789 3.659 . . . . 70.11 117.0 -167.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -159.87 3.94 0.08 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 115.132 1.53 . . . . 74.14 115.132 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.499 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -98.69 -154.81 29.01 Favored Glycine 0 C--N 1.297 -1.623 0 C-N-CA 119.672 -1.251 . . . . 74.04 113.834 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.72 86.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.096 0.958 . . . . 44.04 111.616 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.451 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -58.11 -38.85 77.25 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.246 -0.888 . . . . 65.23 112.77 -176.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.5 tt -80.81 -32.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 112.286 0.476 . . . . 62.13 112.286 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 83.4 mm-40 -58.76 -41.92 87.72 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.998 0.428 . . . . 63.44 110.914 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.534 ' HB2' HD12 ' A' ' 464' ' ' LEU . 10.0 m-20 -89.35 -39.76 13.22 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.017 -0.538 . . . . 73.51 110.204 172.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 77.87 -19.18 4.39 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 115.639 1.016 . . . . 74.3 115.639 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -64.84 -23.38 67.22 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.234 0.54 . . . . 74.43 111.214 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.3 tp -92.72 135.64 33.93 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.143 -0.688 . . . . 64.24 109.143 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.51 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -138.4 170.44 16.02 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.199 -0.297 . . . . 74.31 110.199 176.727 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.489 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -86.9 160.03 18.85 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.211 -0.449 . . . . 61.15 110.646 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 103.7 -29.21 12.66 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 121.054 -0.593 . . . . 74.41 113.014 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.56 162.31 24.36 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-O 121.28 0.562 . . . . 74.31 111.929 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.524 ' HD2' HD11 ' A' ' 512' ' ' ILE . 20.0 ttm180 -90.13 126.98 35.99 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.023 -0.99 . . . . 64.03 109.23 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.59 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -88.28 123.7 33.14 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.012 -1.477 . . . . 71.25 107.012 178.454 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.543 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 35.5 mm -98.46 -47.63 12.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 120.956 0.408 . . . . 62.44 111.248 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -158.16 145.52 18.09 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.703 -0.68 . . . . 60.03 110.201 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 541' ' ' SER . 4.5 p -124.72 127.84 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 CA-C-O 121.276 0.56 . . . . 74.13 109.692 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 17.4 m120 59.46 15.6 4.6 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.873 1.269 . . . . 71.14 113.142 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.7 -7.77 33.99 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.682 -0.77 . . . . 63.33 113.854 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.471 ' HB ' HD21 ' A' ' 530' ' ' LEU . 67.3 t -97.77 127.09 50.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 117.563 0.681 . . . . 71.54 110.554 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.24 136.5 40.95 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 123.837 0.855 . . . . 73.14 111.423 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.59 HD11 HD12 ' A' ' 511' ' ' LEU . 13.4 mt -101.64 -23.81 14.2 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.649 0.738 . . . . 55.12 109.935 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.46 -24.56 35.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.498 -1.228 . . . . 52.15 111.47 -171.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -106.9 21.34 32.06 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.988 -0.625 . . . . 54.11 112.742 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.4 178.67 7.43 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.669 0.618 . . . . 75.1 112.669 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 523' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 527' ' ' VAL . 33.7 m -95.73 161.25 14.1 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.169 -0.469 . . . . 74.34 111.856 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.4 ' O ' HG13 ' A' ' 528' ' ' VAL . 42.3 mm-40 -51.33 -46.72 62.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.997 1.319 . . . . 74.12 113.679 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.497 ' HA ' HG22 ' A' ' 528' ' ' VAL . 37.1 mt-10 -60.35 -35.05 74.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.199 0.444 . . . . 74.23 112.199 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -67.22 -40.32 86.4 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.135 -0.691 . . . . 53.15 109.135 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.586 HG13 HD22 ' A' ' 519' ' ' LEU . 30.0 t -70.38 -39.5 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 115.422 -0.808 . . . . 74.21 110.293 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.635 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.6 m -66.37 -39.95 85.43 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 C-N-CA 119.67 -0.812 . . . . 65.2 110.401 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.9 t -62.14 -38.86 90.57 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.489 0.661 . . . . 74.32 109.899 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.471 HD21 ' HB ' ' A' ' 517' ' ' VAL . 59.1 tp -64.13 -39.64 94.47 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 123.861 0.865 . . . . 73.41 109.244 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 2.8 tt -66.61 -45.1 80.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.443 0.697 . . . . 75.33 111.241 173.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 29.3 mmm180 -62.58 -32.98 74.06 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.062 -0.517 . . . . 64.3 110.949 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.0 m -68.32 -30.5 69.5 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 116.111 -0.495 . . . . 72.32 110.572 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 534' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 535' ' ' LYS . 90.7 m 66.81 -86.93 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.301 -0.863 . . . . 74.35 111.462 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 534' ' ' THR . 25.6 tptp 162.92 154.37 0.02 OUTLIER 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.158 -2.164 . . . . 74.05 105.158 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 85.9 mtp -70.41 -20.99 62.88 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.44 0.564 . . . . 61.24 111.655 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.71 -13.98 43.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.355 0.598 . . . . 74.15 109.783 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 75.12 6.08 78.29 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.398 -0.819 . . . . 65.42 112.746 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 6.2 m -104.34 125.1 50.29 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.721 -1.215 . . . . 61.43 107.721 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.526 HG21 HD21 ' A' ' 471' ' ' LEU . 60.2 t -108.65 127.06 65.43 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 CA-C-N 115.673 -0.694 . . . . 72.15 109.329 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 14.9 m -102.12 111.95 24.42 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 119.907 -0.717 . . . . 75.41 109.114 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.525 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 2.5 mm? -99.43 119.27 37.71 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.8 -1.185 . . . . 71.31 107.8 177.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.536 HD12 ' HB ' ' A' ' 512' ' ' ILE . 2.6 tm? -104.6 117.96 35.41 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 105.963 -1.866 . . . . 74.41 105.963 177.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.69 160.51 14.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.287 -0.869 . . . . 43.32 110.196 -174.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.543 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 25.5 t80 -122.53 130.49 53.1 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.418 -1.327 . . . . 73.44 107.418 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 . . . . . 0 N--CA 1.422 -1.846 0 CA-C-O 121.266 0.555 . . . . 74.34 109.718 177.267 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt . . . . . 0 N--CA 1.422 -1.838 0 CA-C-O 120.742 0.306 . . . . 72.11 110.356 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 70.4 mtm180 -100.85 138.69 37.57 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 107.628 -1.249 . . . . 75.11 107.628 172.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 459' ' ' ARG . 6.1 mp -130.29 134.07 46.95 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 123.236 0.335 . . . . 72.4 110.221 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -94.38 115.71 27.96 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.66 -0.7 . . . . 71.53 109.189 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' ILE . . . . . 0.482 HG23 ' CG ' ' A' ' 504' ' ' ARG . 66.0 mt -120.92 141.92 39.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.659 -0.701 . . . . 74.5 110.356 -174.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 76.2 mt-30 -123.93 130.34 52.44 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.517 0.562 . . . . 75.54 112.517 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.615 HD23 HD23 ' A' ' 542' ' ' LEU . 4.2 mm? -115.6 133.48 55.99 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 124.122 0.969 . . . . 61.35 109.466 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 22.5 ttpp -102.82 134.96 45.36 Favored 'General case' 0 N--CA 1.397 -3.096 0 CA-C-O 121.437 0.637 . . . . 75.43 109.839 -177.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -58.88 126.7 28.78 Favored 'General case' 0 C--N 1.268 -2.952 0 CA-C-N 114.699 -1.137 . . . . 62.33 109.561 175.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' GLY . . . . . 0.588 ' H ' ' HA2' ' A' ' 470' ' ' GLY . . . -140.22 -138.18 3.57 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 115.722 -0.672 . . . . 74.31 111.494 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 468' ' ' THR . . . . . 0.499 HG23 ' H ' ' A' ' 469' ' ' GLU . 10.0 t -50.08 -70.72 0.08 Allowed 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 123.7 0.8 . . . . 72.31 113.057 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.499 ' H ' HG23 ' A' ' 468' ' ' THR . 0.6 OUTLIER -92.65 -2.62 55.94 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.451 -0.781 . . . . 73.54 110.351 175.038 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.588 ' HA2' ' H ' ' A' ' 467' ' ' GLY . . . 54.52 -149.23 19.65 Favored Glycine 0 C--O 1.2 -1.988 0 CA-C-N 114.603 -1.18 . . . . 23.04 113.264 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.544 HD11 HG21 ' A' ' 540' ' ' VAL . 66.2 mt -53.54 99.39 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 117.955 0.877 . . . . 54.25 111.324 -173.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -118.19 54.5 0.61 Allowed Glycine 0 N--CA 1.416 -2.673 0 CA-C-N 114.467 -1.242 . . . . 43.32 111.15 -174.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.462 ' HB3' HD13 ' A' ' 493' ' ' ILE . 20.4 p90 -137.56 141.28 41.36 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 114.984 -0.608 . . . . 74.53 109.441 173.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 36.7 m -118.41 148.92 42.05 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.489 -0.778 . . . . 63.54 109.508 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.3 pt -111.05 153.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.179 0.514 . . . . 74.12 111.822 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 491' ' ' LYS . 9.7 t -134.05 159.9 39.39 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.455 -1.313 . . . . 75.32 107.455 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 31.0 p . . . . . 0 C--N 1.285 -2.21 0 N-CA-C 109.845 -0.428 . . . . 73.01 109.845 178.857 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.533 ' HA ' HG12 ' A' ' 520' ' ' VAL . 14.9 Cg_endo . . . . . 0 N--CA 1.439 -1.677 0 CA-C-O 121.408 0.503 . . . . 62.53 112.311 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.501 ' O ' ' HG3' ' A' ' 510' ' ' ARG . 49.9 mm -97.19 136.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.515 -0.766 . . . . 73.13 109.5 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.605 ' CE1' ' HD3' ' A' ' 510' ' ' ARG . 95.1 m-85 -129.46 153.99 47.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 122.223 0.209 . . . . 71.44 111.003 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 44.6 t -80.15 119.47 29.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 107.733 -1.21 . . . . 72.44 107.733 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.425 ' HD2' ' HB ' ' A' ' 476' ' ' THR . 76.0 tttt -95.14 -46.6 6.71 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.52 0.676 . . . . 62.12 110.387 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -137.13 142.33 42.26 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.466 -0.788 . . . . 65.25 109.871 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.471 HG12 ' HB2' ' A' ' 507' ' ' ALA . 28.3 mm -123.93 101.9 10.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 N-CA-C 106.312 -1.736 . . . . 73.3 106.312 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.89 126.85 92.54 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 115.934 -0.575 . . . . 70.31 110.972 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.07 34.38 0.33 Allowed 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 125.011 3.807 . . . . 70.22 112.73 -175.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.432 ' HB2' ' OE2' ' A' ' 469' ' ' GLU . 3.3 ptp180 -164.42 -4.63 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.867 0.691 . . . . 72.22 112.867 -176.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.45 ' O ' HG22 ' A' ' 500' ' ' ILE . . . -92.8 -158.7 34.53 Favored Glycine 0 C--N 1.302 -1.336 0 C-N-CA 119.115 -1.517 . . . . 75.02 112.596 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.71 85.77 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 124.119 0.968 . . . . 70.34 109.591 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.47 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -57.49 -37.79 73.53 Favored 'General case' 0 C--O 1.204 -1.31 0 CA-C-N 114.506 -1.224 . . . . 73.23 112.913 -176.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 497' ' ' GLY . 10.8 tt -81.47 -35.8 14.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.764 0.316 . . . . 35.33 111.83 176.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -58.64 -46.08 87.89 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.984 -0.553 . . . . 75.34 110.185 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.555 ' HB2' HD13 ' A' ' 464' ' ' LEU . 16.4 m-20 -89.47 -36.1 15.6 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.43 -0.581 . . . . 74.35 109.43 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.77 24.88 70.14 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.894 -0.594 . . . . 72.53 113.551 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.482 ' CG ' HG23 ' A' ' 462' ' ' ILE . 8.9 tpt180 -96.26 -11.84 25.4 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.434 -0.507 . . . . 72.41 110.625 -176.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 47.6 tp -120.29 154.19 35.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.687 -0.233 . . . . 74.3 110.654 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.444 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.1 OUTLIER -144.84 159.02 43.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.284 0.634 . . . . 72.42 111.517 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.46 155.55 23.35 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 120.798 0.332 . . . . 75.53 111.103 -176.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.82 18.06 57.0 Favored Glycine 0 C--N 1.312 -0.784 0 N-CA-C 110.713 -0.955 . . . . 63.43 110.713 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 509' ' ' ASP . . . . . 0.645 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 16.3 t0 -108.74 165.54 11.47 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.99 -1.485 . . . . 72.22 106.99 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.605 ' HD3' ' CE1' ' A' ' 489' ' ' TYR . 44.9 ttp180 -107.64 122.29 46.4 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 118.572 0.624 . . . . 74.41 111.537 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.541 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.32 120.63 27.88 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 107.307 -1.368 . . . . 75.53 107.307 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.608 ' HB ' HD12 ' A' ' 543' ' ' LEU . 47.9 mm -98.39 -43.86 11.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 120.594 0.235 . . . . 74.41 111.579 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 9.3 pt-20 -156.99 148.05 21.89 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.833 -0.432 . . . . 72.04 109.833 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.494 HG12 HD21 ' A' ' 519' ' ' LEU . 5.7 p -129.57 128.44 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 109.77 -0.456 . . . . 75.42 109.77 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 58.61 21.24 8.49 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.137 0.975 . . . . 74.22 112.811 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.45 -5.97 60.89 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.192 -0.528 . . . . 70.45 113.25 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.88 132.37 39.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.608 -0.515 . . . . 63.15 109.608 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -77.3 144.37 38.15 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 123.862 0.726 . . . . 73.14 109.596 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.541 HD11 HD12 ' A' ' 511' ' ' LEU . 22.7 mt -101.36 -52.51 3.23 Favored 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 120.51 -0.476 . . . . 61.21 111.116 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 520' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 487' ' ' PRO . 27.8 m -69.46 97.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.696 0 CA-C-O 122.605 1.193 . . . . 32.45 111.011 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.29 -31.74 1.15 Allowed Glycine 0 N--CA 1.419 -2.498 0 CA-C-N 113.477 -1.692 . . . . 73.53 108.989 -173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.73 174.52 5.83 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.249 -0.476 . . . . 75.44 110.771 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 54.2 m -91.0 159.15 16.3 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.156 0.428 . . . . 75.55 112.156 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -56.95 -46.47 82.1 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.119 0.567 . . . . 72.13 111.752 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.511 ' HA ' HG22 ' A' ' 528' ' ' VAL . 45.0 mt-10 -58.86 -31.95 69.01 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.966 -0.561 . . . . 73.01 111.852 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.96 -41.73 90.87 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.709 -0.478 . . . . 73.25 109.709 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.71 -38.12 71.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.355 -0.839 . . . . 61.13 110.75 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.725 ' O ' ' HG3' ' A' ' 532' ' ' ARG . 19.7 m -65.26 -42.12 93.17 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.136 0 C-N-CA 119.443 -0.903 . . . . 64.45 110.135 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.0 m -62.31 -35.85 80.32 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.734 0.778 . . . . 65.42 109.813 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 22.8 tp -67.47 -36.28 80.84 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 124.941 1.296 . . . . 63.42 110.382 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.426 ' CD1' HD13 ' A' ' 471' ' ' LEU . 54.2 tp -76.36 -48.58 19.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.188 -0.46 . . . . 72.12 111.084 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.725 ' HG3' ' O ' ' A' ' 528' ' ' VAL . 20.4 mtm180 -54.7 -36.04 64.26 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.898 0.479 . . . . 65.22 111.013 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 34.1 t -66.45 -41.3 89.3 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.535 -0.757 . . . . 61.13 111.889 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 15.5 m 64.51 174.12 0.19 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 108.336 -0.987 . . . . 54.35 108.336 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.736 ' HE2' ' O ' ' A' ' 539' ' ' THR . 37.0 mtmt -91.83 168.72 11.25 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 120.651 -1.28 . . . . 71.03 108.023 175.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 83.6 mtp -74.83 -23.01 58.38 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.058 0.456 . . . . 75.4 109.851 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.63 -64.19 0.95 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.724 -1.584 . . . . 73.03 106.724 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 138.08 -19.77 3.25 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 119.971 -1.109 . . . . 75.04 114.393 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.736 ' O ' ' HE2' ' A' ' 535' ' ' LYS . 4.8 m -94.23 136.22 34.76 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.364 -0.976 . . . . 75.44 108.364 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.544 HG21 HD11 ' A' ' 471' ' ' LEU . 91.7 t -111.59 136.31 48.09 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 C-N-CA 123.103 0.561 . . . . 74.22 110.583 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 36.2 t -98.73 119.54 37.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.142 0.496 . . . . 73.42 110.983 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.615 HD23 HD23 ' A' ' 464' ' ' LEU . 2.6 mm? -113.56 123.16 49.31 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.019 -1.104 . . . . 72.23 108.019 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.608 HD12 ' HB ' ' A' ' 512' ' ' ILE . 3.0 tm? -104.84 120.07 40.52 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 105.979 -1.859 . . . . 64.0 105.979 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.645 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 33.6 m -115.03 161.6 13.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.601 -0.727 . . . . 64.12 111.124 -173.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -129.72 116.41 18.74 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.829 -0.623 . . . . 75.05 110.468 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 546' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' A' ' 509' ' ' ASP . 36.0 mtm-85 . . . . . 0 CA--C 1.498 -1.051 0 CA-C-N 116.139 -0.482 . . . . 61.15 111.238 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 120.886 0.374 . . . . 74.35 110.937 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 92.5 mtt180 -104.69 139.64 39.22 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.023 -0.535 . . . . 74.5 110.404 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -127.82 135.4 50.01 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.147 0.579 . . . . 72.22 110.08 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -96.46 124.8 40.57 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.199 0.523 . . . . 74.32 109.788 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 66.4 mt -125.19 139.06 52.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 123.787 0.835 . . . . 72.24 109.467 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.9 mt-30 -120.78 126.97 51.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.663 0.986 . . . . 70.32 113.663 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 499' ' ' ALA . 7.3 mp -118.15 150.29 39.62 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 124.833 1.253 . . . . 75.42 111.328 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -115.3 131.95 56.77 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.096 -1.075 . . . . 74.23 108.096 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.602 ' HE2' HG21 ' A' ' 534' ' ' THR . 24.0 ttmm -52.62 96.9 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 124.536 1.134 . . . . 71.11 112.086 177.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.14 -136.75 9.34 Favored Glycine 0 CA--C 1.519 0.32 0 CA-C-N 116.194 -0.457 . . . . 74.14 113.002 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 468' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 87.9 m -46.29 -65.42 0.56 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.641 1.176 . . . . 73.02 113.081 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.4 -2.18 52.43 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.226 -1.027 . . . . 75.2 108.226 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 60.56 -143.29 48.01 Favored Glycine 0 CA--C 1.473 -2.54 0 N-CA-C 108.885 -1.686 . . . . 32.14 108.885 -168.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.528 HD11 HG21 ' A' ' 540' ' ' VAL . 50.2 mt -53.0 99.27 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.824 1.312 . . . . 53.12 111.809 -174.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . -104.73 56.78 0.54 Allowed Glycine 0 CA--C 1.466 -2.971 0 CA-C-N 114.292 -1.322 . . . . 75.21 111.956 -172.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 14.9 p90 -149.87 142.13 24.16 Favored 'General case' 0 C--N 1.267 -3.017 0 N-CA-C 108.392 -0.966 . . . . 75.52 108.392 177.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 40.0 m -115.8 160.7 19.78 Favored 'General case' 0 C--N 1.271 -2.81 0 N-CA-C 107.977 -1.12 . . . . 75.2 107.977 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 20.7 pt -117.45 151.09 19.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.2 0.524 . . . . 70.1 111.472 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.1 t -138.21 159.1 42.93 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.551 -1.277 . . . . 74.32 107.551 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 53.9 p . . . . . 0 C--N 1.291 -1.961 0 N-CA-C 109.536 -0.542 . . . . 65.52 109.536 178.868 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 C--O 1.237 0.457 0 CA-C-O 121.128 0.387 . . . . 71.24 111.506 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 42.9 mm -95.4 129.51 45.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.528 -0.76 . . . . 72.31 109.603 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -128.24 153.66 46.7 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.559 -0.534 . . . . 74.02 109.559 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.78 118.97 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 107.671 -1.233 . . . . 74.5 107.671 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -81.29 -56.96 3.72 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.293 -0.867 . . . . 73.44 110.377 -175.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 492' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 64.7 t30 -147.3 157.77 43.71 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.824 -0.626 . . . . 61.34 109.427 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.511 HG12 ' HB2' ' A' ' 507' ' ' ALA . 29.8 mm -121.49 105.81 17.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.491 -1.299 . . . . 34.41 107.491 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.9 mp -55.93 133.92 73.51 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.49 -0.777 . . . . 60.43 111.987 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -66.55 6.92 0.45 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 124.896 3.731 . . . . 75.44 115.051 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.505 ' O ' ' HB ' ' A' ' 468' ' ' THR . 31.5 ptt180 -162.74 10.95 0.06 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.919 0.866 . . . . 61.12 111.752 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.526 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -85.84 -174.29 49.74 Favored Glycine 0 C--N 1.294 -1.758 0 CA-C-N 115.42 -0.809 . . . . 61.42 112.512 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -51.52 -38.27 53.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.453 1.101 . . . . 74.34 110.538 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.728 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -61.68 -42.95 99.63 Favored 'General case' 0 C--O 1.197 -1.71 0 CA-C-N 114.185 -1.371 . . . . 72.15 113.248 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.0 tt -80.05 -29.44 12.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 120.925 0.393 . . . . 65.43 111.166 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.9 mm100 -62.04 -46.31 89.72 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.89 -0.595 . . . . 74.34 109.633 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -84.65 -42.04 15.73 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 120.579 -0.448 . . . . 52.23 109.82 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 81.24 -14.66 27.0 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 116.753 1.461 . . . . 74.24 116.753 174.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -74.21 -16.69 60.96 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 117.77 0.785 . . . . 74.51 111.38 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.62 147.5 26.35 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.675 -0.491 . . . . 75.32 109.675 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.59 171.25 15.38 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.706 -0.479 . . . . 72.24 109.706 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -89.34 149.72 22.9 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 123.238 0.336 . . . . 72.01 110.529 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 107.0 5.27 35.49 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.55 -0.833 . . . . 21.1 113.504 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -113.74 156.18 24.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.942 0.371 . . . . 75.03 111.159 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -85.56 130.86 34.47 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.261 -0.427 . . . . 70.02 110.417 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.526 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.67 128.95 35.03 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.832 -1.544 . . . . 71.32 106.832 -179.454 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.5 mm -100.04 -49.59 11.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.05 0.452 . . . . 73.55 111.252 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.24 150.51 21.96 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.898 -0.592 . . . . 73.41 109.858 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 541' ' ' SER . 4.2 p -125.05 123.82 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 CA-C-O 121.38 0.61 . . . . 72.44 109.98 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 19.4 m120 56.09 18.16 3.04 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.23 1.412 . . . . 61.54 114.475 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.76 -7.83 29.76 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.257 -0.973 . . . . 54.31 112.999 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.51 123.12 45.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 108.561 -0.903 . . . . 72.05 108.561 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -90.91 133.38 35.3 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.225 -1.028 . . . . 72.32 108.225 -172.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.526 HD11 HD12 ' A' ' 511' ' ' LEU . 23.2 mt -86.33 -46.31 10.4 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 112.427 0.529 . . . . 70.14 112.427 -170.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.38 100.59 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.854 0.835 . . . . 72.04 110.503 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 141.59 -33.55 1.96 Allowed Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 109.629 -1.388 . . . . 52.41 109.629 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.94 166.52 10.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.614 -0.293 . . . . 71.01 110.722 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 58.3 m -88.65 162.55 16.26 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.719 0.295 . . . . 53.44 111.763 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -54.92 -46.47 74.92 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 123.897 0.879 . . . . 73.43 112.205 -175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.552 ' HA ' HG22 ' A' ' 528' ' ' VAL . 40.9 mm-40 -60.39 -31.05 69.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.888 0.699 . . . . 74.52 112.888 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.63 -37.48 86.69 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.491 0.662 . . . . 63.4 109.258 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.42 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 39.0 t -75.69 -34.94 29.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.69 -0.686 . . . . 73.33 110.04 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.616 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 13.5 m -66.5 -41.32 88.34 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 C-N-CA 119.953 -0.699 . . . . 63.34 110.687 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 40.5 t -59.67 -44.1 93.74 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.782 0.801 . . . . 70.2 109.327 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 25.3 tp -58.35 -41.97 85.85 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 125.487 1.515 . . . . 55.01 110.163 176.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.474 HD12 HD13 ' A' ' 471' ' ' LEU . 35.4 tp -69.27 -48.07 62.78 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.724 0.81 . . . . 74.24 110.383 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 4.2 mmp_? -55.1 -45.39 75.46 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.761 0.825 . . . . 43.13 112.355 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 32.1 m -71.53 -37.12 71.18 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 111.553 0.205 . . . . 74.14 111.553 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 534' ' ' THR . . . . . 0.602 HG21 ' HE2' ' A' ' 466' ' ' LYS . 26.3 m 70.42 152.45 0.11 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.057 0.943 . . . . 73.44 111.009 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.99 125.68 25.66 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.98 -1.489 . . . . 74.25 106.98 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.7 mtt -71.8 -6.3 40.49 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.269 0.841 . . . . 61.03 113.269 -173.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.55 -27.69 61.47 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.12 -1.067 . . . . 73.41 108.12 171.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 109.97 -25.16 17.22 Favored Glycine 0 N--CA 1.427 -1.965 0 CA-C-N 115.207 -0.906 . . . . 62.1 112.43 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.5 m -101.59 127.0 48.5 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 109.369 -0.604 . . . . 62.11 109.369 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.528 HG21 HD11 ' A' ' 471' ' ' LEU . 76.6 t -106.46 128.23 61.18 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.681 0 CA-C-N 115.744 -0.662 . . . . 64.35 110.363 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 20.2 m -100.9 114.02 27.51 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.575 -0.739 . . . . 44.55 109.519 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -104.77 128.23 52.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.802 -0.814 . . . . 51.0 108.802 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 37.3 tp -104.85 118.28 36.16 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 105.935 -1.876 . . . . 71.31 105.935 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 27.6 m -115.48 160.17 14.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 CA-C-O 120.966 0.412 . . . . 75.44 110.042 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -111.96 115.39 28.87 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-N 115.546 -0.752 . . . . 74.01 109.08 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.428 -1.567 0 N-CA-C 106.047 -1.834 . . . . 64.32 106.047 177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 458' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.432 -1.357 0 N-CA-C 109.319 -0.623 . . . . 74.25 109.319 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.415 ' HB3' HD21 ' A' ' 543' ' ' LEU . 84.5 mtm180 -102.03 149.4 24.29 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.166 -0.679 . . . . 75.54 109.166 174.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.4 mm? -133.98 150.53 51.27 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.358 -0.608 . . . . 71.55 109.358 -173.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.51 117.27 28.55 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.904 0.859 . . . . 75.11 110.935 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 54.7 mt -121.78 139.2 49.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 106.853 -1.536 . . . . 70.14 106.853 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 42.4 tt0 -125.66 126.58 44.92 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.895 -1.122 . . . . 72.11 108.512 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.552 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 6.4 mp -114.66 153.05 30.9 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.081 -0.647 . . . . 75.2 112.433 -177.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.716 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.2 OUTLIER -100.56 128.37 46.64 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.558 -0.904 . . . . 71.2 108.558 -177.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.631 ' HE3' HG21 ' A' ' 534' ' ' THR . 39.9 ttmt -60.1 113.28 2.26 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.952 -0.567 . . . . 53.24 110.182 172.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -104.58 -131.71 7.22 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 120.796 -0.716 . . . . 64.03 111.799 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 26.4 m -62.53 -64.97 0.76 Allowed 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.198 0.599 . . . . 75.5 111.947 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.558 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 11.8 mm-40 -85.24 -32.45 22.59 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.82 -0.752 . . . . 63.22 109.545 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.467 ' N ' ' HA2' ' A' ' 497' ' ' GLY . . . 70.77 141.63 0.21 Allowed Glycine 0 C--O 1.21 -1.352 0 CA-C-N 114.878 -1.055 . . . . 54.53 112.894 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.486 ' N ' ' H ' ' A' ' 498' ' ' ALA 0.25 4.9 mp 39.56 84.38 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.551 1.54 . . . . 72.45 114.118 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -94.04 54.14 2.2 Favored Glycine 0 CA--C 1.493 -1.297 0 CA-C-N 115.078 -0.965 . . . . 63.33 112.433 -173.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.539 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 3.7 p90 -146.67 142.05 27.48 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.177 0.513 . . . . 63.31 110.763 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 29.6 m -120.57 143.9 48.38 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.089 -1.448 . . . . 72.44 107.089 177.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 23.9 pt -109.59 158.85 9.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 121.441 0.638 . . . . 61.11 111.929 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.6 t -132.5 159.23 39.99 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.703 -1.591 . . . . 75.14 106.703 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 55.4 p . . . . . 0 C--N 1.269 -2.911 0 N-CA-C 108.953 -0.758 . . . . 73.23 108.953 179.747 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 C--O 1.249 1.068 0 CA-C-O 120.867 0.278 . . . . 64.35 111.702 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.46 ' O ' ' HG3' ' A' ' 510' ' ' ARG . 44.3 mm -109.56 136.59 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.966 -0.561 . . . . 74.23 109.976 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 91.9 m-85 -137.99 157.79 45.65 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.138 0.575 . . . . 70.22 110.468 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.462 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 13.0 t -74.68 121.41 26.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.108 -1.071 . . . . 70.14 108.108 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 24.2 ttmm -85.44 -58.9 2.48 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.728 -0.471 . . . . 74.15 109.728 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -146.61 147.83 31.47 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.042 -1.096 . . . . 63.22 108.042 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.538 HG13 ' HA ' ' A' ' 506' ' ' LYS . 26.1 mm -109.4 109.46 28.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.635 -0.876 . . . . 61.04 108.635 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 86.5 mt -53.69 154.69 6.52 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 114.838 -1.073 . . . . 74.33 111.168 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.17 -1.67 11.26 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 123.902 3.068 . . . . 51.13 111.657 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.568 ' HA ' HG21 ' A' ' 500' ' ' ILE . 99.5 mtt180 -150.39 -157.65 0.84 Allowed 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 115.12 -0.946 . . . . 65.32 108.559 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.558 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 82.98 -162.9 41.21 Favored Glycine 0 C--N 1.277 -2.735 0 N-CA-C 111.398 -0.681 . . . . 71.35 111.398 -176.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.489 ' O ' HD23 ' A' ' 464' ' ' LEU . . . -70.49 -27.78 64.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.885 0.342 . . . . 74.51 110.843 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.552 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -58.9 -41.37 87.05 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-N 115.182 -0.917 . . . . 71.22 112.057 -173.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.568 HG21 ' HA ' ' A' ' 496' ' ' ARG . 16.9 tt -79.48 -29.29 13.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.984 -0.553 . . . . 52.31 111.547 -179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 12.6 mm100 -62.37 -45.91 91.03 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.263 -0.643 . . . . 73.42 109.263 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.413 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 8.8 t70 -93.74 -34.88 13.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.291 -0.868 . . . . 51.43 110.048 -177.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 83.8 -27.65 4.27 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.622 1.409 . . . . 44.3 116.622 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -67.93 -13.59 62.29 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.191 1.182 . . . . 75.44 114.191 -174.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 46.7 tp -97.89 124.78 42.47 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 120.595 -0.442 . . . . 64.54 111.158 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.538 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.1 OUTLIER -135.27 164.07 28.55 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 111.809 0.3 . . . . 75.5 111.809 178.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.52 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -82.64 160.36 22.47 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 113.835 1.05 . . . . 64.34 113.835 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 78.93 46.77 8.14 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.234 -0.894 . . . . 32.41 112.247 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 509' ' ' ASP . . . . . 0.502 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 7.5 t70 -144.08 178.63 7.74 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.579 -1.637 . . . . 62.54 106.579 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.494 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 48.6 ttp85 -109.28 136.83 48.09 Favored 'General case' 0 C--O 1.212 -0.875 0 C-N-CA 119.176 -1.01 . . . . 71.24 113.217 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.734 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -88.02 121.31 30.28 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.196 -0.911 . . . . 70.02 110.781 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.458 HD11 ' CB ' ' A' ' 545' ' ' PHE . 1.9 mp -106.83 -48.47 8.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 109.447 -0.575 . . . . 55.31 109.447 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.42 143.0 31.43 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.302 -0.863 . . . . 62.2 109.543 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 541' ' ' SER . 7.5 p -145.03 122.41 4.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 CA-C-N 114.632 -1.167 . . . . 75.25 109.506 175.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 515' ' ' ASN . . . . . 0.613 ' ND2' HG13 ' A' ' 540' ' ' VAL . 49.0 m-80 66.65 21.94 10.54 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.113 0.965 . . . . 63.4 112.176 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 83.41 25.96 45.26 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 121.147 -0.549 . . . . 73.03 112.158 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.0 t -121.8 138.04 53.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 109.752 -0.462 . . . . 75.32 109.752 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.99 128.31 34.57 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.038 -0.727 . . . . 74.24 109.038 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.734 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 24.6 mt -96.55 -44.05 7.33 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 113.057 0.762 . . . . 74.14 113.057 -170.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 56.4 t -72.47 92.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.752 0.787 . . . . 74.05 110.448 -174.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.29 -25.77 1.24 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 109.889 -1.284 . . . . 63.23 109.889 -175.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.09 179.09 4.36 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.793 -0.203 . . . . 63.14 110.671 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 52.5 m -94.2 157.97 15.81 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-O 121.065 0.46 . . . . 61.43 111.75 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -52.8 -47.18 67.78 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.42 1.088 . . . . 73.21 112.156 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.54 ' HA ' HG22 ' A' ' 528' ' ' VAL . 42.9 mt-10 -60.87 -34.29 74.39 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.564 0.579 . . . . 35.35 112.564 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.99 -42.18 97.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.48 0.657 . . . . 73.32 109.536 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.52 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 44.5 t -71.06 -40.36 75.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.715 -1.129 . . . . 75.42 110.374 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 525' ' ' GLU . 12.7 m -68.62 -38.91 79.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 C-N-CA 119.041 -1.064 . . . . 63.3 110.371 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 25.8 t -62.04 -43.14 99.48 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.874 -0.603 . . . . 74.25 110.54 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.695 HD11 HG13 ' A' ' 514' ' ' VAL . 3.5 pp -67.19 -32.29 73.26 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.24 0.543 . . . . 75.43 109.656 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 530' ' ' LEU . 2.6 tt -65.15 -47.97 75.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.918 -1.037 . . . . 71.15 111.073 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.606 ' HA ' ' HE ' ' A' ' 532' ' ' ARG . 0.2 OUTLIER -63.28 -37.04 85.68 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.906 -0.588 . . . . 55.32 110.447 -177.632 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.4 m -73.61 -40.95 63.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.492 -0.322 . . . . 73.31 110.502 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 534' ' ' THR . . . . . 0.631 HG21 ' HE3' ' A' ' 466' ' ' LYS . 24.0 m 68.92 158.32 0.16 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.095 0.958 . . . . 61.32 111.261 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.493 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 16.5 tppt? -67.67 127.25 32.07 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.075 -1.454 . . . . 70.33 107.075 172.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.6 ptp -61.38 -18.0 56.71 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.279 0.562 . . . . 73.04 111.493 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 537' ' ' GLU . . . . . 0.493 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 39.6 tt0 -69.4 -24.17 63.82 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.888 0.875 . . . . 62.44 110.413 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 103.05 -29.09 13.19 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 116.053 -0.521 . . . . 54.43 112.684 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 0.6 OUTLIER -94.83 124.08 38.66 Favored 'General case' 0 N--CA 1.424 -1.733 0 C-N-CA 123.117 0.567 . . . . 54.53 112.372 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.613 HG13 ' ND2' ' A' ' 515' ' ' ASN . 72.1 t -104.3 129.74 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 108.565 -0.902 . . . . 74.13 108.565 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.706 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 47.2 t -91.1 134.0 34.88 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.506 -0.924 . . . . 45.5 108.506 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.539 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.4 mm? -122.93 118.21 27.32 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.952 -1.129 . . . . 73.23 107.952 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 4.2 tt -110.31 117.65 34.21 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 104.35 -2.463 . . . . 73.31 104.35 173.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.502 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 30.6 m -121.25 160.39 22.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-N 115.888 -0.596 . . . . 72.13 111.336 -175.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.458 ' CB ' HD11 ' A' ' 512' ' ' ILE . 76.4 t80 -125.56 119.38 28.0 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 120.966 0.412 . . . . 71.05 110.601 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 . . . . . 0 N--CA 1.401 -2.878 0 N-CA-C 108.191 -1.04 . . . . 71.22 108.191 174.928 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt . . . . . 0 N--CA 1.426 -1.646 0 CA-C-O 121.172 0.51 . . . . 74.02 110.181 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 62.8 mtm180 -101.37 137.14 40.09 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 106.252 -1.758 . . . . 75.43 106.252 172.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 16.4 tp -129.18 129.05 44.58 Favored 'General case' 0 C--N 1.265 -3.099 0 CA-C-N 116.019 -0.537 . . . . 75.0 109.822 -172.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -98.53 115.65 29.05 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 108.859 -0.793 . . . . 71.34 108.859 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' ILE . . . . . 0.54 HG23 ' HD3' ' A' ' 504' ' ' ARG . 67.4 mt -116.43 142.56 29.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.384 -0.969 . . . . 74.41 108.384 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 78.5 mt-30 -122.36 128.63 51.23 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 118.564 0.62 . . . . 73.32 112.152 176.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.593 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 9.3 mp -115.75 146.69 41.69 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 123.834 0.854 . . . . 64.41 111.634 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.768 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.2 OUTLIER -100.35 125.67 46.61 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 108.16 -1.052 . . . . 74.2 108.16 -178.219 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.88 114.97 2.32 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.249 -0.887 . . . . 63.12 110.358 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -87.08 -140.68 6.4 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.158 -1.177 . . . . 52.52 110.158 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 468' ' ' THR . . . . . 0.472 HG23 ' OE2' ' A' ' 469' ' ' GLU . 9.9 t -81.8 -31.61 31.7 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.834 -0.747 . . . . 64.24 111.359 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.601 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 12.0 mp0 -91.77 -42.8 9.91 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 107.79 -1.189 . . . . 72.44 107.79 173.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 84.57 -148.09 23.57 Favored Glycine 0 C--O 1.202 -1.866 0 CA-C-O 118.365 -1.242 . . . . 50.32 111.312 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.566 ' H ' HD22 ' A' ' 471' ' ' LEU . 1.7 mm? -45.95 108.07 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.478 1.139 . . . . 70.0 113.294 -169.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.87 45.62 1.28 Allowed Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.744 -1.117 . . . . 74.05 111.679 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.445 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 23.1 p90 -134.69 143.11 47.04 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.036 -0.727 . . . . 71.43 109.036 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 39.5 m -115.46 157.47 23.93 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.469 -1.308 . . . . 73.24 107.469 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 15.2 pt -126.03 160.08 33.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.364 0.602 . . . . 70.21 112.366 -176.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.413 ' HB ' ' CE ' ' A' ' 491' ' ' LYS . 10.1 t -152.26 158.26 42.57 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.218 -1.03 . . . . 62.41 108.218 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 35.3 p . . . . . 0 N--CA 1.422 -1.832 0 N-CA-C 106.446 -1.687 . . . . 51.5 106.446 174.451 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo . . . . . 0 C--O 1.246 0.895 0 CA-C-O 121.169 0.404 . . . . 55.54 112.039 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' A' ' 519' ' ' LEU . 39.2 mm -85.64 128.63 39.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 108.145 -1.057 . . . . 61.34 108.145 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -124.61 155.66 38.75 Favored 'General case' 0 CA--C 1.487 -1.455 0 O-C-N 122.117 -0.365 . . . . 73.42 110.962 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 49.4 t -74.04 125.91 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 108.592 -0.892 . . . . 72.12 108.592 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.413 ' CE ' ' HB ' ' A' ' 476' ' ' THR . 41.4 ttmt -82.54 -53.24 6.12 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.89 -0.781 . . . . 63.02 108.89 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -149.41 151.79 34.63 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.145 -0.934 . . . . 73.42 109.332 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.441 HG13 ' HA ' ' A' ' 506' ' ' LYS . 27.4 mm -114.39 106.83 21.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.175 -1.417 . . . . 71.25 107.175 175.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 495' ' ' PRO . 8.3 mp -50.55 157.79 1.2 Allowed Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 124.903 1.281 . . . . 55.24 113.124 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 494' ' ' LEU . 68.6 Cg_endo -72.21 -6.46 19.13 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 123.961 3.107 . . . . 41.33 111.979 -175.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.596 ' HA ' HG21 ' A' ' 500' ' ' ILE . 77.2 mtt180 -151.19 -161.05 1.25 Allowed 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.199 -0.91 . . . . 70.13 109.149 -174.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.601 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 81.48 -167.27 48.57 Favored Glycine 0 C--N 1.282 -2.461 0 CA-C-N 115.254 -0.885 . . . . 62.24 113.722 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.5 ' O ' HD23 ' A' ' 464' ' ' LEU . . . -65.76 -35.83 81.83 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 124.318 1.047 . . . . 63.53 110.377 -174.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.593 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -59.63 -39.62 84.91 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 115.089 -0.959 . . . . 53.41 112.331 -174.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.596 HG21 ' HA ' ' A' ' 496' ' ' ARG . 15.0 tt -80.09 -30.1 12.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 121.111 -0.235 . . . . 75.42 111.371 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 16.0 mm100 -60.89 -45.57 94.06 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.879 -0.6 . . . . 74.5 110.307 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.472 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 7.5 t70 -92.67 -35.75 13.33 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.779 -0.823 . . . . 52.15 108.779 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 56.54 25.39 50.01 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 115.551 0.98 . . . . 72.21 115.551 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.54 ' HD3' HG23 ' A' ' 462' ' ' ILE . 63.9 ttt180 -99.95 -6.69 26.21 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.92 0.867 . . . . 73.23 109.331 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 44.4 tp -109.5 138.91 45.17 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.738 -1.208 . . . . 72.23 107.738 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.525 ' HD2' ' OD2' ' A' ' 509' ' ' ASP . 0.0 OUTLIER -138.27 177.5 7.84 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.597 -0.841 . . . . 75.11 109.149 175.811 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -82.99 29.12 0.48 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.513 0.673 . . . . 72.21 112.037 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . -126.23 13.7 7.03 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.021 -0.832 . . . . 72.14 111.021 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 509' ' ' ASP . . . . . 0.525 ' OD2' ' HD2' ' A' ' 506' ' ' LYS . 42.6 m-20 -102.6 148.21 25.83 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 120.773 0.32 . . . . 74.45 110.694 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 544' ' ' VAL . 19.0 ttm180 -101.16 129.76 47.13 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 116.27 -0.423 . . . . 72.44 109.938 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.627 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.6 mm? -83.41 117.01 22.76 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 112.451 0.537 . . . . 61.24 112.451 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.4 HG13 ' HB2' ' A' ' 545' ' ' PHE . 45.9 mm -104.98 -39.63 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.69 0.757 . . . . 65.33 109.516 174.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 543' ' ' LEU . 30.8 tt0 -148.57 145.8 27.99 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 114.929 -1.032 . . . . 61.42 108.867 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.775 HG13 HD11 ' A' ' 530' ' ' LEU . 2.4 p -139.15 129.17 31.51 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.446 0 CA-C-N 115.051 -0.977 . . . . 72.34 108.375 174.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.3 t30 68.65 -58.92 0.47 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 127.712 2.405 . . . . 71.44 111.673 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 178.08 27.26 0.04 OUTLIER Glycine 0 C--N 1.296 -1.642 0 N-CA-C 110.081 -1.208 . . . . 54.12 110.081 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.88 136.76 57.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 109.829 -0.434 . . . . 63.31 109.829 -174.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.75 125.56 31.4 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.937 -0.764 . . . . 62.34 108.937 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 514' ' ' VAL . 32.5 mt -94.52 -35.2 12.38 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.01 -0.541 . . . . 74.3 112.061 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 41.5 t -75.98 87.95 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 122.072 0.939 . . . . 74.43 110.374 -173.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.66 -26.51 1.19 Allowed Glycine 0 N--CA 1.425 -2.042 0 CA-C-N 114.132 -1.395 . . . . 32.45 110.142 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.31 176.95 4.99 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.808 0.337 . . . . 71.44 111.78 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 22.2 m -90.23 160.54 16.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.293 0.568 . . . . 51.12 112.394 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -53.0 -47.48 68.22 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.67 1.188 . . . . 74.31 113.834 177.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.49 ' HA ' HG22 ' A' ' 528' ' ' VAL . 46.6 mt-10 -62.65 -32.24 73.25 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 120.781 -0.368 . . . . 62.24 111.844 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.71 -38.81 92.5 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.075 0.464 . . . . 71.35 110.406 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 21.6 t -73.74 -41.42 54.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.738 -0.665 . . . . 74.04 109.61 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.601 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 11.4 m -65.65 -40.29 87.51 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 C-N-CA 119.462 -0.895 . . . . 75.24 110.456 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 27.6 m -63.06 -38.3 90.65 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.791 -0.641 . . . . 73.34 111.705 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.775 HD11 HG13 ' A' ' 514' ' ' VAL . 2.1 pp -69.56 -33.06 72.2 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.613 -0.884 . . . . 63.14 108.613 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.2 tt -65.22 -48.18 74.26 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 115.329 -0.85 . . . . 64.1 110.071 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 30.5 mmm180 -61.2 -31.43 71.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.377 -0.828 . . . . 65.05 110.184 -177.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.0 t -76.39 -43.74 39.21 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.426 -0.806 . . . . 61.33 110.391 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 534' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 535' ' ' LYS . 12.6 m 64.49 177.41 0.18 Allowed 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 109.064 -0.717 . . . . 75.11 109.064 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.487 ' H ' HG22 ' A' ' 534' ' ' THR . 38.1 ttpt -102.33 139.5 37.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.833 -0.803 . . . . 51.33 108.833 175.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 88.1 mtp -65.36 -20.68 66.5 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.234 0.827 . . . . 53.21 113.234 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 537' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 33.4 tt0 -58.54 -39.07 79.17 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.431 -0.951 . . . . 71.14 108.431 172.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 115.96 -24.35 10.17 Favored Glycine 0 N--CA 1.431 -1.64 0 CA-C-N 114.878 -1.056 . . . . 75.55 112.443 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.485 ' O ' ' HE2' ' A' ' 535' ' ' LYS . 0.6 OUTLIER -96.17 140.69 30.51 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.707 -0.397 . . . . 70.33 109.944 -177.307 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 53.6 t -119.15 133.32 66.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 122.849 0.46 . . . . 64.2 111.544 174.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 462' ' ' ILE . 50.1 m -91.6 138.33 31.65 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.531 -0.759 . . . . 62.55 110.097 177.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.549 HD23 HD13 ' A' ' 464' ' ' LEU . 2.7 mm? -124.14 120.35 32.06 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 106.82 -1.548 . . . . 65.14 106.82 176.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 54.2 tp -104.88 117.07 33.12 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.027 -1.472 . . . . 64.3 107.027 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 510' ' ' ARG . 33.0 m -117.82 140.14 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.121 0 C-N-CA 119.907 -0.717 . . . . 74.01 111.701 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.429 ' HB3' ' HD2' ' A' ' 510' ' ' ARG . 62.2 t80 -111.3 116.79 31.6 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.138 -0.69 . . . . 70.32 109.138 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 546' ' ' ARG . . . . . 0.468 ' HD3' ' OD1' ' A' ' 509' ' ' ASP . 23.9 mtm180 . . . . . 0 C--N 1.289 -2.05 0 N-CA-C 108.292 -1.003 . . . . 73.22 108.292 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 51.1 mtpt . . . . . 0 N--CA 1.426 -1.626 0 N-CA-C 113.159 0.8 . . . . 74.15 113.159 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 98.8 mtt180 -107.69 126.79 53.03 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 113.883 -1.508 . . . . 75.35 107.227 169.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.2 mm? -115.9 132.57 56.61 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 109.116 -0.698 . . . . 74.23 109.116 -176.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -98.14 120.18 38.1 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.393 -0.965 . . . . 73.01 108.393 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 462' ' ' ILE . . . . . 0.45 ' HA ' ' NH1' ' A' ' 504' ' ' ARG . 45.7 mt -122.16 142.64 37.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.898 -1.149 . . . . 61.01 107.898 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.55 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 93.1 mt-30 -123.03 125.97 46.23 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.606 0.717 . . . . 73.12 112.701 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 7.9 mp -121.56 141.55 50.96 Favored 'General case' 0 CA--C 1.478 -1.802 0 CA-C-N 115.225 -0.898 . . . . 72.41 112.308 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 465' ' ' LYS . 39.7 ttmt -112.71 136.06 52.74 Favored 'General case' 0 N--CA 1.398 -3.031 0 CA-C-N 115.456 -0.793 . . . . 75.11 110.005 -176.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.543 ' HB2' HG21 ' A' ' 534' ' ' THR . 39.4 ttmt -65.93 113.74 4.62 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.724 -1.125 . . . . 73.42 111.865 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -93.1 -104.2 1.63 Allowed Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.142 -1.183 . . . . 62.01 110.142 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 41.5 m -90.73 -57.0 2.97 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 122.554 -0.38 . . . . 74.34 111.113 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -94.43 -33.51 13.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.933 -1.506 . . . . 62.33 106.933 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 79.51 -145.27 27.62 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 114.407 -1.27 . . . . 44.53 110.995 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.448 HD21 HG11 ' A' ' 540' ' ' VAL . 6.6 mp -43.43 97.64 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.205 1.187 . . . . 73.41 114.205 -172.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -103.79 50.08 0.9 Allowed Glycine 0 N--CA 1.433 -1.555 0 CA-C-N 114.432 -1.258 . . . . 63.0 112.417 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -133.39 146.67 51.45 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.537 -0.912 . . . . 71.33 108.537 175.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 47.1 m -116.03 156.97 25.39 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 108.465 -0.939 . . . . 54.11 108.465 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 12.2 pt -124.18 154.66 31.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.26 0.552 . . . . 72.22 111.799 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.8 t -142.07 159.03 43.04 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.05 -1.092 . . . . 70.22 108.05 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 64.4 p . . . . . 0 N--CA 1.421 -1.922 0 N-CA-C 107.65 -1.241 . . . . 73.22 107.65 174.444 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.443 ' HA ' HG22 ' A' ' 520' ' ' VAL . 2.4 Cg_endo . . . . . 0 N--CA 1.438 -1.743 0 N-CA-C 109.498 -1.001 . . . . 24.43 109.498 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.531 HG13 ' HB3' ' A' ' 519' ' ' LEU . 32.4 mm -89.95 131.37 37.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 116.135 -0.484 . . . . 74.24 109.971 -174.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 90.1 m-85 -129.97 161.63 30.48 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.091 0.556 . . . . 74.11 109.828 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 23.4 t -74.58 127.03 36.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.612 -0.884 . . . . 73.02 108.612 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -87.39 -51.18 6.08 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.741 -0.837 . . . . 73.33 108.741 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -159.0 157.84 32.04 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.282 -0.872 . . . . 73.34 109.307 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 507' ' ' ALA . 32.5 mm -121.07 109.33 24.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 106.523 -1.658 . . . . 73.21 106.523 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.411 ' HB3' ' HD2' ' A' ' 495' ' ' PRO . 3.7 mm? -56.12 158.95 6.47 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-N 115.575 -0.739 . . . . 74.31 111.761 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.422 ' HG2' ' HG2' ' A' ' 496' ' ' ARG . 26.5 Cg_endo -79.18 7.36 4.44 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 123.475 2.783 . . . . 72.43 111.453 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.665 ' HA ' HG21 ' A' ' 500' ' ' ILE . 17.3 ptp180 -159.41 -158.3 0.65 Allowed 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 115.728 -0.669 . . . . 75.15 110.371 -174.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 72.61 -157.46 52.66 Favored Glycine 0 C--N 1.287 -2.143 0 CA-C-N 114.954 -1.021 . . . . 74.55 111.013 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -69.85 -35.47 74.74 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 122.742 0.417 . . . . 74.21 111.242 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.515 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -58.07 -37.4 74.39 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 113.428 0.899 . . . . 70.14 113.428 -172.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.665 HG21 ' HA ' ' A' ' 496' ' ' ARG . 15.7 tt -79.71 -36.17 17.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 112.134 0.42 . . . . 65.41 112.134 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -63.75 -33.66 76.16 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.303 0.573 . . . . 74.24 110.789 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.407 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 16.5 t70 -89.75 -48.06 7.51 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.88 -0.6 . . . . 70.5 109.951 173.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 72.79 -3.49 27.04 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 117.559 1.784 . . . . 51.13 117.559 175.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.45 ' NH1' ' HA ' ' A' ' 462' ' ' ILE . 70.5 mtp180 -80.46 -15.06 57.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.882 1.341 . . . . 73.23 110.109 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 39.3 tp -96.49 134.47 39.64 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.282 -0.872 . . . . 61.24 108.949 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 506' ' ' LYS . 0.0 OUTLIER -142.76 175.41 9.83 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.765 -0.457 . . . . 65.01 109.765 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.531 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -102.4 82.74 2.21 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 120.351 -0.54 . . . . 42.33 110.676 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . -175.01 35.48 0.1 Allowed Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.306 -1.118 . . . . 61.24 110.306 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -153.76 177.19 11.26 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 122.96 0.504 . . . . 74.41 111.541 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.555 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 0.2 OUTLIER -115.19 142.31 46.83 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.358 0.503 . . . . 72.42 112.358 -174.478 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.628 ' HB3' HD12 ' A' ' 519' ' ' LEU . 4.6 mm? -85.3 128.06 34.56 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.889 -0.596 . . . . 70.23 112.599 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 36.6 mm -102.53 -58.77 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.062 0 CA-C-N 116.189 -0.46 . . . . 63.22 109.775 176.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.553 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.5 pt-20 -156.29 144.55 19.82 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 121.438 0.637 . . . . 51.55 111.056 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.738 HG12 HD21 ' A' ' 519' ' ' LEU . 2.6 p -130.61 135.2 60.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 N-CA-C 107.829 -1.174 . . . . 72.41 107.829 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 17.4 m120 66.47 9.91 6.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.52 0.728 . . . . 75.23 111.727 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 84.07 13.11 75.24 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 111.455 -0.658 . . . . 51.03 111.455 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.83 135.67 39.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.792 -0.818 . . . . 74.53 108.792 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.64 132.15 36.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.68 -0.489 . . . . 75.42 109.68 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.738 HD21 HG12 ' A' ' 514' ' ' VAL . 15.9 mt -97.76 -45.29 6.4 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 112.425 0.528 . . . . 71.45 112.425 -170.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 520' ' ' VAL . . . . . 0.531 HG21 HH21 ' A' ' 510' ' ' ARG . 59.8 t -78.41 99.9 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-O 121.787 0.803 . . . . 64.24 109.126 -175.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 143.68 -26.19 2.1 Favored Glycine 0 N--CA 1.414 -2.815 0 N-CA-C 109.249 -1.541 . . . . 74.11 109.249 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.01 179.71 4.25 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 110.163 -0.31 . . . . 73.33 110.163 175.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 46.5 t -87.3 155.02 20.24 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.268 0.556 . . . . 74.33 110.68 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 528' ' ' VAL . 28.8 mm-40 -54.55 -39.99 68.27 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.719 1.207 . . . . 74.02 111.41 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.443 ' HA ' HG22 ' A' ' 528' ' ' VAL . 42.9 mt-10 -66.81 -32.11 73.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.191 -0.459 . . . . 71.31 111.572 -176.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.18 -44.58 83.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.05 -0.523 . . . . 73.03 109.835 176.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 19.0 t -67.68 -43.56 86.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.665 -0.698 . . . . 61.34 109.634 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.524 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 10.2 m -64.91 -38.73 83.52 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.044 0 C-N-CA 119.774 -0.77 . . . . 73.51 110.265 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.1 t -63.05 -45.43 92.24 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.857 -0.61 . . . . 62.43 110.763 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.625 HD11 HG13 ' A' ' 514' ' ' VAL . 2.6 pp -66.27 -35.52 80.61 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.441 0.639 . . . . 71.04 109.434 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.525 HD23 ' HE ' ' A' ' 532' ' ' ARG . 2.5 tt -62.11 -47.97 82.22 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.054 -0.976 . . . . 70.33 111.607 175.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.525 ' HE ' HD23 ' A' ' 531' ' ' LEU . 1.4 mmp_? -63.95 -37.08 86.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.105 -0.498 . . . . 73.03 109.705 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.2 m -67.4 -39.86 85.57 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.575 -0.739 . . . . 71.04 109.238 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 534' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 466' ' ' LYS . 95.3 m 72.78 -85.7 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.804 0.842 . . . . 71.24 111.599 177.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.539 ' HG2' ' H ' ' A' ' 537' ' ' GLU . 39.9 ttmt 170.8 133.67 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.71 1.204 . . . . 71.34 107.864 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.2 mtt -65.97 -29.26 69.62 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.666 0.269 . . . . 62.41 111.141 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 537' ' ' GLU . . . . . 0.539 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 38.8 tt0 -74.07 -37.05 64.34 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.361 -0.381 . . . . 73.24 110.995 177.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 135.79 -45.48 1.09 Allowed Glycine 0 CA--C 1.539 1.584 0 N-CA-C 117.322 1.689 . . . . 75.31 117.322 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.411 ' CG2' ' HB3' ' A' ' 463' ' ' GLN . 5.5 m -101.95 140.19 36.58 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.442 1.121 . . . . 71.4 112.366 -172.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 69.2 t -113.52 140.28 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 124.037 0.935 . . . . 74.22 110.808 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 46.6 t -95.65 124.78 39.83 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.23 -0.656 . . . . 63.31 109.23 176.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.507 HD23 HD13 ' A' ' 464' ' ' LEU . 2.6 mm? -115.37 119.21 35.5 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.298 -1.371 . . . . 72.11 107.298 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 33.9 tp -108.54 117.37 34.0 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.074 -1.454 . . . . 71.53 107.074 174.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 35.6 m -116.17 150.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.803 -0.635 . . . . 71.32 110.837 -177.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 69.6 t80 -112.14 116.52 30.62 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.207 -1.035 . . . . 72.51 108.207 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 . . . . . 0 C--N 1.286 -2.165 0 CA-C-N 115.817 -0.628 . . . . 73.21 110.474 -178.99 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.904 0 N-CA-C 110.572 -1.011 . . . . 63.05 110.572 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 39.3 m -85.62 96.65 9.74 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.1 0.476 . . . . 73.32 110.925 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -123.37 105.85 10.17 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.028 -1.101 . . . . 74.52 108.028 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -142.95 112.07 6.59 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.445 -0.798 . . . . 62.23 109.62 -173.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 9.0 t -139.79 -35.88 0.52 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.216 -0.447 . . . . 61.12 110.548 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 65.0 mttp 64.22 89.74 0.09 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.53 1.132 . . . . 53.55 113.613 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -109.52 143.42 39.2 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.77 -1.196 . . . . 72.41 107.77 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.53 87.44 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.973 0.892 . . . . 74.21 109.615 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 159.2 138.66 2.51 Favored Glycine 0 C--N 1.294 -1.802 0 N-CA-C 108.494 -1.842 . . . . 72.51 108.494 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.405 ' HE2' ' CD1' ' A' ' 460' ' ' LEU . 21.7 ptmt -136.43 159.21 42.47 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 117.505 0.652 . . . . 73.1 111.216 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 76.4 mtm180 -103.16 145.12 30.4 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.179 -0.675 . . . . 55.34 109.179 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.6 mm? -124.29 126.26 45.74 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.054 -0.521 . . . . 75.41 110.064 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.62 115.58 28.16 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.051 0.929 . . . . 54.34 108.623 173.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 85.2 mt -124.72 121.71 61.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-N 115.409 -0.814 . . . . 73.02 111.221 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 75.2 mt-30 -104.33 130.22 52.18 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 120.288 -0.565 . . . . 65.21 110.551 172.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.584 ' HB3' ' HB1' ' A' ' 498' ' ' ALA . 94.8 mt -122.72 138.0 54.75 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.85 -1.068 . . . . 72.23 109.655 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 465' ' ' LYS . 20.2 ptmt -104.14 128.14 51.78 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-O 122.344 1.069 . . . . 72.33 112.63 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -53.12 115.15 1.73 Allowed 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 112.945 -1.934 . . . . 75.13 113.343 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' GLY . . . . . 0.438 ' H ' ' HA2' ' A' ' 470' ' ' GLY . . . -98.5 -139.22 10.68 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.922 -1.271 . . . . 73.54 109.922 171.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 31.3 m -68.99 -49.35 58.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.607 0.717 . . . . 75.55 109.679 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.67 56.1 0.95 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.101 -1.815 . . . . 74.25 106.101 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.438 ' HA2' ' H ' ' A' ' 467' ' ' GLY . . . -41.61 -63.83 1.55 Allowed Glycine 0 CA--C 1.478 -2.23 0 CA-C-N 113.393 -1.731 . . . . 63.33 115.145 -171.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.454 HD13 HD12 ' A' ' 531' ' ' LEU . 49.6 mt -85.43 82.26 8.38 Favored 'General case' 0 C--N 1.272 -2.79 0 C-N-CA 116.273 -2.171 . . . . 73.13 111.257 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -95.84 40.33 2.65 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 113.063 -1.88 . . . . 65.2 111.862 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 31.6 p90 -137.21 142.19 42.09 Favored 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 108.176 -1.046 . . . . 74.14 108.176 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.0 m -132.12 152.66 51.12 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 116.172 -0.467 . . . . 65.01 110.125 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 10.6 pt -109.51 160.8 8.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.612 -0.722 . . . . 72.4 112.544 -173.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.488 HG21 ' HD3' ' A' ' 491' ' ' LYS . 12.9 t -147.26 159.09 44.06 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.24 -1.022 . . . . 73.03 108.24 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.416 ' HB3' HE21 ' A' ' 524' ' ' GLN . 64.2 p -138.02 131.17 30.29 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.041 -1.096 . . . . 75.11 108.041 173.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -118.37 -83.76 0.65 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.218 -0.593 . . . . 73.41 111.88 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -138.28 154.32 49.04 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.25 -0.58 . . . . 75.11 109.86 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.507 ' HB ' ' HD3' ' A' ' 487' ' ' PRO . 9.9 p -108.69 131.96 57.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 116.439 -0.346 . . . . 53.34 110.326 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.5 t -117.62 131.82 56.6 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.492 -1.299 . . . . 72.22 107.492 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 65.7 mt 66.8 90.61 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-O 121.702 0.763 . . . . 73.35 109.724 -175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 127.52 -145.2 15.71 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 115.558 -0.746 . . . . 72.22 111.382 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 170.62 104.07 0.17 Allowed Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 111.391 -0.684 . . . . 52.31 111.391 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 27.0 t 173.39 -18.55 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.171 0.588 . . . . 54.03 110.027 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 480' ' ' VAL . . . 71.12 115.52 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.837 0.855 . . . . 75.32 110.626 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 480' ' ' VAL . 9.2 Cg_endo -85.52 153.09 10.43 Favored 'Trans proline' 0 N--CA 1.438 -1.763 0 C-N-CA 122.167 1.911 . . . . 64.41 112.476 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.422 HG23 HE22 ' A' ' 524' ' ' GLN . 42.8 mm -97.96 125.04 51.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.936 -1.135 . . . . 63.54 107.936 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -118.61 150.17 40.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 122.344 -0.222 . . . . 74.01 111.054 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 43.3 t -80.9 119.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 106.539 -1.652 . . . . 62.33 106.539 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.488 ' HD3' HG21 ' A' ' 476' ' ' THR . 55.0 tptt -91.3 -53.79 4.2 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.973 -0.558 . . . . 61.42 111.489 -174.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 492' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 14.1 t-20 -133.12 144.68 50.1 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.914 -0.714 . . . . 74.44 111.131 -171.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.538 HG12 ' HB2' ' A' ' 507' ' ' ALA . 31.9 mm -121.57 103.88 14.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.007 -0.997 . . . . 71.52 108.688 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.07 127.73 91.27 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.271 -0.877 . . . . 52.11 109.977 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.28 30.18 0.23 Allowed 'Trans proline' 0 N--CA 1.512 2.56 1 C-N-CA 125.373 4.049 . . . . 64.43 114.035 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.403 ' N ' HG21 ' A' ' 500' ' ' ILE . 13.3 ptp180 -159.7 -8.86 0.06 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 113.862 1.06 . . . . 72.43 113.862 -173.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 501' ' ' GLN . . . -91.62 -159.45 35.47 Favored Glycine 0 C--O 1.212 -1.229 0 C-N-CA 119.387 -1.387 . . . . 65.34 113.457 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 464' ' ' LEU . . . -63.43 -32.45 73.89 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 112.844 0.683 . . . . 73.12 112.844 -174.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.47 78.39 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 116.611 -0.268 . . . . 64.22 110.935 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.403 HG21 ' N ' ' A' ' 496' ' ' ARG . 5.9 tt -79.98 -30.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 123.637 0.775 . . . . 75.03 111.895 176.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.523 ' HB2' ' O ' ' A' ' 497' ' ' GLY . 0.0 OUTLIER -58.7 -45.34 89.75 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.758 0.823 . . . . 72.34 109.317 -177.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.448 ' HB2' ' CD2' ' A' ' 464' ' ' LEU . 23.8 m-20 -97.42 -21.14 17.33 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.441 -0.503 . . . . 65.4 109.68 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 68.67 35.39 80.42 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.487 -0.779 . . . . 73.24 113.97 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -108.31 -26.63 10.43 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.966 0.412 . . . . 70.2 111.962 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.403 ' CD1' HG11 ' A' ' 544' ' ' VAL . 49.8 tp -105.55 153.88 21.15 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.665 -0.414 . . . . 60.13 111.252 -174.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.34 170.27 17.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.84 -1.17 . . . . 74.22 107.84 177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.538 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -92.5 148.83 21.78 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 110.178 -0.304 . . . . 62.43 110.178 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 117.23 -34.99 4.33 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.951 -0.642 . . . . 65.21 111.886 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.5 153.66 43.18 Favored 'General case' 0 C--O 1.25 1.103 0 CA-C-O 121.32 0.581 . . . . 74.23 111.277 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 63.3 ttp180 -90.13 127.08 36.01 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.105 -1.072 . . . . 64.0 108.105 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.491 ' HG ' HD11 ' A' ' 519' ' ' LEU . 23.0 tp -80.74 131.88 35.48 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 107.624 -1.25 . . . . 75.03 107.624 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.0 mm -101.44 -44.96 11.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.177 0.513 . . . . 72.32 110.264 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.53 ' HG2' ' HB3' ' A' ' 543' ' ' LEU . 10.5 pt-20 -152.3 156.01 38.81 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.552 -0.907 . . . . 62.15 108.552 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.55 HG12 HD21 ' A' ' 519' ' ' LEU . 5.2 p -137.65 127.92 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.157 0 N-CA-C 108.515 -0.92 . . . . 71.31 108.515 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.2 t30 65.91 9.23 5.94 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 126.136 1.774 . . . . 64.44 111.392 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.68 3.56 40.08 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.303 -0.475 . . . . 63.11 113.167 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.95 139.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 122.419 -0.46 . . . . 75.43 110.536 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.72 134.73 37.06 Favored 'General case' 0 CA--C 1.484 -1.591 0 C-N-CA 123.518 0.727 . . . . 51.2 109.584 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.55 HD21 HG12 ' A' ' 514' ' ' VAL . 42.3 mt -90.19 -45.62 8.98 Favored 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 123.654 0.597 . . . . 73.53 112.03 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.67 99.94 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 121.743 0.782 . . . . 71.15 110.05 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 137.93 -21.46 3.17 Favored Glycine 0 N--CA 1.42 -2.417 0 CA-C-N 114.411 -1.268 . . . . 71.33 110.723 -175.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.24 163.86 14.67 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.67 0.271 . . . . 65.34 111.068 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 523' ' ' SER . . . . . 0.478 ' O ' HG23 ' A' ' 527' ' ' VAL . 34.1 m -92.58 164.19 13.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.01 -0.541 . . . . 63.01 111.09 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.537 ' O ' HG13 ' A' ' 528' ' ' VAL . 50.7 mm-40 -50.44 -47.76 56.66 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 113.55 0.944 . . . . 72.11 113.55 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.427 ' HA ' HG22 ' A' ' 528' ' ' VAL . 5.5 mp0 -59.87 -32.29 70.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.057 0.456 . . . . 75.35 111.454 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.24 -38.26 68.95 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.775 -0.648 . . . . 73.33 109.514 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 523' ' ' SER . 16.3 t -76.29 -37.46 31.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.953 -0.567 . . . . 75.11 110.333 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.65 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 12.3 m -65.64 -42.23 92.31 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 C-N-CA 120.722 -0.391 . . . . 53.14 110.601 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.8 p -68.78 -30.37 68.95 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.252 0.549 . . . . 55.43 111.067 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.33 -39.16 89.06 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.27 -0.877 . . . . 71.33 108.769 173.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.454 HD12 HD13 ' A' ' 471' ' ' LEU . 48.5 tp -69.91 -48.31 59.07 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.712 -0.677 . . . . 74.41 109.955 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.65 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -60.05 -27.68 67.15 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.117 0.567 . . . . 72.23 111.66 -177.555 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 33.8 t -69.82 -35.23 74.62 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 109.82 -0.437 . . . . 73.24 109.82 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 535' ' ' LYS . 31.1 m 69.19 -89.67 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.226 1.01 . . . . 70.53 110.546 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' A' ' 536' ' ' MET . 61.1 tttp 170.87 175.93 0.06 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.035 -2.209 . . . . 75.12 105.035 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 536' ' ' MET . . . . . 0.417 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 27.5 ttt -72.09 -50.72 25.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 119.138 0.881 . . . . 65.04 112.81 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -35.81 39.65 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 118.472 -1.291 . . . . 74.04 108.746 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 115.96 25.14 3.69 Favored Glycine 0 N--CA 1.411 -3.023 0 CA-C-N 115.03 -0.986 . . . . 64.03 113.187 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 3.8 m -107.44 119.87 40.59 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 118.627 -1.229 . . . . 41.52 108.093 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 65.1 t -106.91 131.72 56.1 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 CA-C-N 115.588 -0.733 . . . . 72.41 110.6 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 24.7 m -94.19 113.77 25.76 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.717 -0.674 . . . . 62.4 109.558 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.465 HD13 HG23 ' A' ' 514' ' ' VAL . 2.5 mm? -106.92 139.59 41.09 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.384 -0.969 . . . . 71.13 108.384 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.53 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 44.9 tp -118.79 117.84 29.96 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 105.863 -1.903 . . . . 75.11 105.863 171.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 27.1 m -118.06 158.05 19.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.841 0 C-N-CA 120.24 -0.584 . . . . 73.22 110.898 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -111.89 116.26 30.33 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.402 -0.962 . . . . 74.24 108.402 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.52 118.42 25.03 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 107.074 -1.454 . . . . 72.32 107.074 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -130.81 141.59 50.35 Favored 'General case' 0 C--N 1.267 -2.996 0 CA-C-N 114.948 -1.024 . . . . 72.31 110.238 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -119.08 76.44 1.11 Allowed 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.297 -1.001 . . . . 71.24 108.297 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 C--N 1.309 -1.19 0 CA-C-N 114.568 -1.196 . . . . 74.53 109.198 -176.464 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.888 0 N-CA-C 110.466 -1.054 . . . . 71.32 110.466 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 40.8 m -95.95 -0.02 51.27 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 117.258 0.529 . . . . 54.53 111.915 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 65.84 148.56 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.783 1.233 . . . . 73.32 113.785 175.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -85.67 -64.98 1.06 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.731 -0.84 . . . . 71.34 108.731 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 44.9 p -105.57 135.52 46.83 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.96 -0.564 . . . . 62.04 109.611 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? 63.57 86.87 0.11 Allowed 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.356 1.062 . . . . 73.13 109.883 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -79.08 115.35 18.69 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.529 -0.76 . . . . 74.14 109.14 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 63.7 mt -86.64 93.39 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 CA-C-N 115.464 -0.789 . . . . 75.05 110.81 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 546' ' ' ARG . . . 101.47 148.7 21.87 Favored Glycine 0 N--CA 1.416 -2.643 0 C-N-CA 120.339 -0.934 . . . . 73.44 114.395 173.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 28.3 mtpp -129.78 148.57 51.67 Favored 'General case' 0 CA--C 1.471 -2.06 0 CA-C-N 114.771 -0.715 . . . . 72.33 109.568 174.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.5 mtm180 -110.97 128.82 55.96 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 115.673 -0.694 . . . . 71.41 109.213 171.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.435 HD11 ' HE3' ' A' ' 458' ' ' LYS . 2.0 mm? -118.83 129.85 55.45 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 115.021 -0.991 . . . . 74.21 109.317 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -96.55 122.32 39.34 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.119 -0.697 . . . . 73.42 109.119 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 58.8 mt -127.56 142.51 43.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 123.46 0.704 . . . . 74.51 109.942 -174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 78.7 mt-30 -114.97 127.91 55.96 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.608 0.966 . . . . 62.42 113.608 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.537 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.1 mm? -116.61 134.54 54.71 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 124.588 1.155 . . . . 75.44 109.148 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 39.4 ttmt -108.88 135.71 49.63 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-O 121.513 0.673 . . . . 62.1 111.26 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.516 ' HA ' ' HA2' ' A' ' 470' ' ' GLY . 38.1 mtmt -73.08 100.57 3.06 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.063 -0.972 . . . . 62.4 110.866 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -108.03 -101.23 2.69 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.474 -0.87 . . . . 64.14 112.131 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' THR . . . . . 0.545 HG23 ' H ' ' A' ' 469' ' ' GLU . 8.3 t -66.87 -69.8 0.29 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 112.16 0.43 . . . . 55.31 112.16 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.545 ' H ' HG23 ' A' ' 468' ' ' THR . 25.6 mm-40 -98.29 -18.41 18.38 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.599 0.714 . . . . 70.53 109.14 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 69.27 -149.98 49.45 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 114.651 -1.159 . . . . 74.2 112.98 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.458 HD11 HG21 ' A' ' 540' ' ' VAL . 38.4 mt -51.65 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.478 0.918 . . . . 74.32 113.478 -169.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -107.72 56.19 0.49 Allowed Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 114.582 -1.19 . . . . 42.31 111.688 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.37 142.59 29.5 Favored 'General case' 0 C--N 1.281 -2.371 0 C-N-CA 123.369 0.668 . . . . 75.53 110.064 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.9 m -119.59 162.41 18.98 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.396 -0.82 . . . . 62.22 109.807 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 20.6 pt -117.88 158.09 18.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.129 0.49 . . . . 71.32 111.67 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.8 t -148.7 160.09 43.5 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.23 -0.896 . . . . 75.52 108.655 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 31.6 t -141.11 150.1 42.42 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 107.216 -1.401 . . . . 65.41 107.216 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -95.32 -68.24 0.81 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.392 -0.966 . . . . 53.51 108.392 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 16.0 t70 170.31 151.22 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 105.152 -2.166 . . . . 74.14 105.152 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 486' ' ' ALA . 12.5 p -88.45 -16.09 8.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 120.029 -0.669 . . . . 53.52 110.905 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 32.5 m 53.09 70.17 0.62 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.819 1.248 . . . . 62.04 111.355 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 12.1 tt 172.68 -23.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 114.654 -1.157 . . . . 62.12 108.937 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 94.48 99.24 1.65 Allowed Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.076 -1.21 . . . . 54.23 110.076 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -172.0 -144.93 4.7 Favored Glycine 0 N--CA 1.425 -2.059 0 C-N-CA 119.949 -1.12 . . . . 64.01 113.033 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 15.7 m -76.38 -35.45 58.65 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 123.482 0.713 . . . . 52.43 112.306 -174.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.479 ' HA ' ' HB ' ' A' ' 480' ' ' VAL . . . 77.03 110.77 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 124.638 1.175 . . . . 63.33 111.283 -177.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.31 135.85 66.7 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 123.233 2.622 . . . . 73.12 112.914 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 24.8 mm -92.81 128.81 44.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.314 -0.857 . . . . 74.51 108.795 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -127.95 158.71 37.1 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 121.887 -0.508 . . . . 74.44 111.479 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.43 HG22 HD21 ' A' ' 511' ' ' LEU . 21.7 t -74.31 129.55 36.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.206 -1.035 . . . . 75.1 108.206 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -93.27 -61.3 1.59 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.544 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -141.09 148.83 40.78 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.776 -0.647 . . . . 75.41 110.183 -174.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.474 HG12 ' HB2' ' A' ' 507' ' ' ALA . 36.4 mm -118.57 104.32 15.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.411 -1.329 . . . . 64.31 107.411 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 8.3 mp -54.72 152.06 13.77 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.187 -0.915 . . . . 70.11 112.73 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.493 ' O ' HD13 ' A' ' 500' ' ' ILE . 23.0 Cg_endo -77.89 -3.12 13.21 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 124.339 3.359 . . . . 73.24 111.64 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -158.64 110.88 2.24 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 124.582 1.153 . . . . 72.05 109.636 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 160.89 -168.5 36.27 Favored Glycine 1 C--N 1.237 -4.925 0 CA-C-N 112.846 -1.979 . . . . 73.44 111.145 178.537 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.418 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -57.23 -47.14 82.09 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 124.464 1.106 . . . . 54.13 110.54 -174.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -56.88 -44.11 81.93 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.006 -0.997 . . . . 65.14 111.853 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.493 HD13 ' O ' ' A' ' 495' ' ' PRO . 16.5 tt -80.96 -37.63 16.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.083 0.771 . . . . 65.54 113.083 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.3 mm100 -64.74 -41.83 95.65 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 120.867 0.365 . . . . 73.43 110.771 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.537 ' HB2' HD13 ' A' ' 464' ' ' LEU . 23.7 m-20 -84.95 -32.07 23.26 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.777 -0.823 . . . . 42.42 108.777 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 61.4 45.72 95.84 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.839 0.712 . . . . 65.35 113.864 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -115.07 -28.07 7.11 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.044 0.45 . . . . 62.15 112.18 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 57.0 tp -106.22 146.55 30.15 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.15 -0.685 . . . . 63.04 109.15 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.437 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -138.81 162.05 35.72 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.914 -0.773 . . . . 64.13 108.914 176.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.474 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.52 120.69 26.24 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.012 0.434 . . . . 71.34 111.382 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 508' ' ' GLY . . . . . 0.41 ' H ' ' HB ' ' A' ' 490' ' ' VAL . . . 145.04 -12.28 1.87 Allowed Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.706 -0.679 . . . . 45.12 112.213 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -94.22 172.87 7.94 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 120.975 0.416 . . . . 72.24 112.026 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 544' ' ' VAL . 41.1 ttm180 -102.83 137.99 40.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.637 -0.71 . . . . 72.44 110.269 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.688 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -86.08 119.13 26.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.951 -0.568 . . . . 74.41 110.463 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 47.8 mm -98.65 -47.33 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.849 -0.16 . . . . 73.52 110.588 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.524 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 10.2 pt-20 -149.0 148.61 29.95 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.358 -0.608 . . . . 64.43 109.358 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.677 HG12 HD21 ' A' ' 519' ' ' LEU . 3.6 p -132.56 119.36 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.394 0 CA-C-O 121.975 0.893 . . . . 64.4 109.254 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.72 23.91 11.53 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 126.242 1.817 . . . . 75.31 111.959 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.28 -18.46 33.2 Favored Glycine 0 C--O 1.237 0.289 0 C-N-CA 120.491 -0.861 . . . . 74.45 113.953 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.7 t -96.85 134.49 34.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 109.772 -0.455 . . . . 64.34 109.772 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -84.35 143.1 29.7 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.656 -0.498 . . . . 63.13 109.656 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.688 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 18.4 mt -103.78 -39.67 6.56 Favored 'General case' 0 CA--C 1.482 -1.639 0 CA-C-N 115.432 -0.804 . . . . 73.41 112.257 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 35.4 t -74.61 90.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 121.811 0.815 . . . . 72.41 109.48 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 154.13 -28.61 0.72 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 108.289 -1.925 . . . . 70.22 108.289 -175.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.411 ' HB2' ' CD ' ' A' ' 526' ' ' GLU . 0.1 OUTLIER -105.3 178.78 4.46 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.016 -0.592 . . . . 71.53 109.916 175.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 523' ' ' SER . . . . . 0.562 ' O ' HG23 ' A' ' 527' ' ' VAL . 60.7 p -95.84 164.33 12.78 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.501 0.556 . . . . 72.22 112.501 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.486 ' O ' HG13 ' A' ' 528' ' ' VAL . 8.0 mm100 -49.71 -43.23 47.41 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 124.705 1.202 . . . . 64.23 111.442 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.423 ' HA ' HG22 ' A' ' 528' ' ' VAL . 42.7 mt-10 -65.03 -35.74 82.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.408 0.623 . . . . 61.14 111.961 -174.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.411 ' CD ' ' HB2' ' A' ' 522' ' ' LYS . 43.9 mt-10 -69.74 -37.25 76.4 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.644 -0.707 . . . . 75.34 109.522 177.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 523' ' ' SER . 32.3 t -70.2 -41.46 78.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.528 -0.76 . . . . 64.4 109.556 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.687 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 12.5 m -64.57 -44.42 96.8 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 C-N-CA 120.021 -0.672 . . . . 63.44 110.054 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 49.1 m -57.87 -40.29 79.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.485 0.659 . . . . 52.34 110.232 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 50.7 tp -63.11 -47.25 83.62 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 124.545 1.138 . . . . 74.11 109.879 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.437 HD12 HD13 ' A' ' 471' ' ' LEU . 35.1 tp -65.2 -44.22 89.07 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.861 -0.609 . . . . 64.25 110.574 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.687 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -62.3 -33.51 74.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.155 0.582 . . . . 63.21 110.851 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.6 m -75.53 -41.01 56.16 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.032 -0.531 . . . . 62.44 110.882 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 534' ' ' THR . . . . . 0.482 HG23 ' CG2' ' A' ' 540' ' ' VAL . 32.5 m 66.65 -92.91 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.266 0.627 . . . . 73.25 110.121 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt 170.48 171.86 0.07 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.19 -1.411 . . . . 74.11 107.19 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 26.1 ttt -65.63 -38.6 89.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 111.603 0.223 . . . . 75.23 111.603 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.58 -79.26 0.08 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.461 -0.336 . . . . 75.41 110.473 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 151.56 -21.47 0.93 Allowed Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 118.708 -1.71 . . . . 25.42 114.618 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.489 HG22 ' HB3' ' A' ' 463' ' ' GLN . 3.0 m -94.83 125.24 39.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 118.433 1.117 . . . . 74.14 110.251 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 47.1 t -106.81 140.63 24.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.028 -0.987 . . . . 72.42 110.162 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.5 t -99.14 114.69 27.58 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.165 0.507 . . . . 74.22 109.815 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.533 HD23 HD23 ' A' ' 464' ' ' LEU . 3.4 mm? -101.77 122.33 43.74 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 124.538 1.135 . . . . 65.35 109.08 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 36.2 tp -104.98 118.97 37.87 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.376 -1.712 . . . . 72.54 106.376 174.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 36.0 m -115.03 145.55 20.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-O 121.179 0.514 . . . . 72.35 110.957 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 88.8 t80 -112.27 116.06 29.79 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.276 -0.875 . . . . 74.22 110.042 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 546' ' ' ARG . . . . . 0.586 ' O ' ' HA2' ' A' ' 457' ' ' GLY . 0.0 OUTLIER -101.57 118.19 36.45 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.478 -1.304 . . . . 55.45 107.478 175.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -89.36 121.27 31.45 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.231 -0.441 . . . . 63.15 111.317 -172.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 69.7 -177.49 0.21 Allowed 'General case' 0 N--CA 1.473 0.725 0 O-C-N 124.544 1.153 . . . . 72.13 110.4 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 C--N 1.305 -1.358 0 CA-C-O 118.856 -0.592 . . . . 65.44 109.783 179.072 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.762 0 N-CA-C 110.817 -0.913 . . . . 63.01 110.817 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 31.9 t -146.37 162.66 37.7 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.631 -0.877 . . . . 61.11 108.631 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -64.52 -51.18 64.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.308 0.575 . . . . 74.34 109.718 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -122.11 112.55 18.35 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.106 -1.442 . . . . 73.55 107.106 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 34.2 p -93.04 -73.18 0.57 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 112.086 0.402 . . . . 70.34 112.086 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -127.86 107.62 10.01 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.032 0.444 . . . . 75.42 110.487 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -89.14 126.06 35.3 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.004 -0.544 . . . . 74.1 111.162 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 11.7 tt -102.44 -41.62 8.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 120.963 0.411 . . . . 41.22 110.413 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -175.99 138.34 4.1 Favored Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 108.366 -1.894 . . . . 74.45 108.366 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.405 ' HE2' HD13 ' A' ' 460' ' ' LEU . 22.0 ptmt -137.21 165.26 26.53 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 120.269 -0.573 . . . . 45.53 110.467 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -106.16 154.51 20.59 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.413 -1.328 . . . . 64.43 107.413 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.8 mm? -125.33 130.89 52.88 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 110.002 -0.37 . . . . 73.32 110.002 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -96.25 116.19 28.62 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.655 -0.868 . . . . 73.03 108.655 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' ILE . . . . . 0.505 HG23 ' CG ' ' A' ' 504' ' ' ARG . 68.6 mt -123.28 121.16 62.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 115.601 -0.727 . . . . 72.12 110.202 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.2 mt-30 -99.94 128.94 45.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.786 0.662 . . . . 74.44 112.786 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.586 HD23 HD23 ' A' ' 542' ' ' LEU . 4.3 mm? -115.08 132.82 56.48 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-N 115.361 -0.836 . . . . 63.24 109.841 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.445 ' HE2' ' HB2' ' A' ' 465' ' ' LYS . 25.3 ttmm -101.17 131.9 46.91 Favored 'General case' 0 N--CA 1.394 -3.265 0 CA-C-O 121.936 0.874 . . . . 61.01 110.886 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.12 103.28 0.21 Allowed 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 113.146 -1.843 . . . . 73.13 111.485 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -136.5 137.05 8.78 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.781 -0.928 . . . . 74.32 110.781 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 73.2 m 63.24 -86.72 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.143 0.977 . . . . 62.32 112.642 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.481 ' HB3' ' HA2' ' A' ' 497' ' ' GLY . 8.6 tp10 -97.74 -13.93 21.14 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.238 -1.023 . . . . 74.3 108.238 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 70.09 -155.82 53.24 Favored Glycine 0 C--O 1.202 -1.867 0 CA-C-O 117.946 -1.474 . . . . 71.03 109.707 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.501 HD23 HD12 ' A' ' 531' ' ' LEU . 6.3 mp -43.83 96.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.707 1.254 . . . . 72.02 113.706 -173.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -106.22 63.58 0.3 Allowed Glycine 0 N--CA 1.411 -3.007 0 CA-C-N 113.546 -1.661 . . . . 71.42 110.448 -174.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 27.7 p90 -156.66 142.0 17.44 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 107.265 -1.383 . . . . 71.43 107.265 175.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 12.1 p -115.79 163.61 15.59 Favored 'General case' 0 C--N 1.263 -3.165 0 O-C-N 123.617 0.573 . . . . 73.3 109.868 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 12.6 pt -114.35 154.75 15.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.368 0.604 . . . . 71.03 112.04 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.7 t -137.95 149.33 46.06 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.679 -0.86 . . . . 71.31 108.679 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.46 ' HB3' ' OE1' ' A' ' 524' ' ' GLN . 66.9 p -117.32 133.15 56.31 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.193 -0.669 . . . . 64.11 109.193 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -95.14 -74.26 0.56 Allowed 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.242 -0.983 . . . . 70.24 112.433 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -150.32 128.96 12.31 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.272 -0.422 . . . . 65.53 109.932 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . 7.7 p -71.76 88.39 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-O 122.263 1.03 . . . . 61.53 113.056 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.407 ' O ' HG22 ' A' ' 481' ' ' THR . 89.0 m -108.44 13.1 25.73 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 123.38 1.562 . . . . 72.24 108.624 174.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 45.8 pt -116.06 171.5 5.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 114.17 -1.377 . . . . 73.33 108.766 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -87.18 66.58 3.49 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.667 -0.777 . . . . 24.23 111.872 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -158.8 -154.59 7.26 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 110.304 -1.118 . . . . 70.31 110.304 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 42.7 m -79.16 -40.26 31.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 117.231 0.516 . . . . 53.42 110.164 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -179.94 160.54 0.86 Allowed Pre-proline 0 C--N 1.332 -0.163 0 N-CA-C 107.484 -1.302 . . . . 61.03 107.484 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.415 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 1.0 OUTLIER -86.27 135.85 4.63 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 122.362 2.041 . . . . 54.43 109.673 174.196 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.56 HG13 ' HB3' ' A' ' 519' ' ' LEU . 18.2 mm -91.09 124.46 43.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 115.921 -0.581 . . . . 62.41 109.976 -172.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.415 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 88.1 m-85 -125.61 163.0 23.72 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 109.975 -0.38 . . . . 64.32 109.975 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 40.2 t -89.16 119.83 36.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.851 -0.425 . . . . 51.41 109.851 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -70.81 -63.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.47 1.108 . . . . 74.31 110.358 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 492' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 64.0 t30 -151.45 160.19 43.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.931 -0.577 . . . . 74.13 109.911 -174.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 507' ' ' ALA . 44.7 mm -110.28 105.71 19.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.874 -1.158 . . . . 72.35 107.874 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -65.15 128.4 93.75 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.585 -0.734 . . . . 61.23 111.344 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.14 24.68 0.26 Allowed 'Trans proline' 0 N--CA 1.503 2.048 1 C-N-CA 125.334 4.023 . . . . 61.02 114.964 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -160.29 7.02 0.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 113.251 0.834 . . . . 65.23 113.251 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 469' ' ' GLU . . . -99.8 -155.21 28.15 Favored Glycine 0 C--N 1.297 -1.631 0 C-N-CA 119.266 -1.445 . . . . 74.23 113.685 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.519 ' O ' HD12 ' A' ' 464' ' ' LEU . . . -66.12 -37.66 86.26 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 123.37 0.668 . . . . 52.41 109.559 -176.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -57.72 -41.76 82.42 Favored 'General case' 0 C--O 1.195 -1.778 0 CA-C-N 115.126 -0.943 . . . . 64.31 112.053 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.3 tt -80.3 -29.36 12.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 120.943 0.401 . . . . 71.54 111.625 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.05 -48.37 80.32 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.228 1.011 . . . . 74.13 108.666 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.531 ' HB2' HD13 ' A' ' 464' ' ' LEU . 12.9 m-20 -93.68 -31.73 14.34 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 120.345 -0.542 . . . . 61.03 110.412 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.29 27.82 72.14 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.879 -0.6 . . . . 44.42 112.967 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.505 ' CG ' HG23 ' A' ' 462' ' ' ILE . 33.0 tpt180 -101.92 -19.35 15.3 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.75 0.31 . . . . 71.41 111.148 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.516 ' HB2' HD21 ' A' ' 464' ' ' LEU . 52.7 tp -106.87 151.19 25.56 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.817 -0.438 . . . . 72.51 109.817 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.479 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -144.21 159.88 41.91 Favored 'General case' 0 N--CA 1.434 -1.258 0 O-C-N 123.176 0.298 . . . . 72.32 110.594 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.541 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -91.4 167.95 11.9 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.323 0.389 . . . . 71.32 111.773 -174.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.87 13.18 65.04 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.446 -0.797 . . . . 54.0 112.153 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -120.01 178.27 4.68 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 107.645 -1.243 . . . . 73.51 107.645 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.01 133.54 47.96 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-N 117.993 0.361 . . . . 74.14 110.646 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 511' ' ' LEU . 21.4 tp -96.04 117.05 29.91 Favored 'General case' 0 N--CA 1.394 -3.251 0 N-CA-C 108.339 -0.986 . . . . 72.24 108.339 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.444 ' HB ' HD12 ' A' ' 543' ' ' LEU . 1.9 mp -99.02 -35.19 4.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.121 0.486 . . . . 73.04 110.211 -177.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 543' ' ' LEU . 31.2 tt0 -150.34 144.78 25.73 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.716 -0.674 . . . . 64.35 110.551 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.524 HG12 HD21 ' A' ' 519' ' ' LEU . 2.6 p -135.03 123.35 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 N-CA-C 108.328 -0.99 . . . . 63.02 108.328 175.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 70.62 -66.22 0.3 Allowed 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 127.576 2.35 . . . . 71.42 111.231 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -174.02 29.64 0.09 OUTLIER Glycine 0 C--N 1.308 -0.994 0 N-CA-C 111.467 -0.653 . . . . 64.42 111.467 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.6 t -122.18 139.1 50.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 110.155 -0.313 . . . . 74.25 110.155 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -83.18 130.53 35.1 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.575 -0.898 . . . . 45.34 108.575 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.56 ' HB3' HG13 ' A' ' 488' ' ' ILE . 47.5 mt -100.89 -36.0 9.21 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.986 -0.552 . . . . 74.1 112.117 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.48 89.53 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 121.855 0.836 . . . . 60.23 110.205 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 147.95 -32.8 1.29 Allowed Glycine 0 N--CA 1.427 -1.94 0 CA-C-N 114.369 -1.287 . . . . 53.5 110.178 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.6 -177.63 4.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.407 0.521 . . . . 75.24 112.407 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 523' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 527' ' ' VAL . 5.0 m -95.24 156.11 16.46 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.909 -0.587 . . . . 75.32 111.244 -175.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.46 ' OE1' ' HB3' ' A' ' 477' ' ' SER . 8.1 mm100 -56.16 -46.36 79.34 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.808 0.843 . . . . 53.14 111.239 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.43 ' HA ' HG22 ' A' ' 528' ' ' VAL . 1.1 mp0 -57.85 -31.86 67.09 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.127 0.489 . . . . 71.13 111.951 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -69.64 -37.24 76.69 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.967 -0.56 . . . . 52.02 110.037 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 523' ' ' SER . 17.6 t -75.93 -36.03 31.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.325 -0.852 . . . . 70.41 109.653 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.671 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.3 m -64.98 -40.61 89.65 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.267 0 C-N-CA 120.052 -0.659 . . . . 72.12 111.07 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.9 t -59.46 -44.98 92.86 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.652 0.739 . . . . 44.13 109.277 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 31.8 tp -60.4 -38.72 84.86 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 125.229 1.412 . . . . 72.43 110.398 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.501 HD12 HD23 ' A' ' 471' ' ' LEU . 16.6 tp -70.17 -48.63 56.43 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.484 -0.78 . . . . 63.42 109.959 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.8 OUTLIER -60.27 -44.56 95.21 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.767 0.827 . . . . 74.14 111.382 -176.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 33.7 t -69.23 -31.92 70.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.16 -0.473 . . . . 70.01 111.037 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 84.9 m 66.3 -87.03 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.926 0.49 . . . . 54.2 111.552 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? 165.58 158.26 0.03 OUTLIER 'General case' 0 C--O 1.244 0.774 0 N-CA-C 105.89 -1.893 . . . . 44.52 105.89 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 65.9 mtt -58.84 -50.3 74.49 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.206 0.316 . . . . 73.15 111.416 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -62.49 -65.49 0.68 Allowed 'General case' 0 C--O 1.24 0.576 0 N-CA-C 110.049 -0.352 . . . . 74.13 110.049 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 135.28 -14.3 4.28 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 118.353 -1.88 . . . . 64.4 116.072 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.4 m -94.38 128.11 40.7 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 118.904 1.352 . . . . 63.45 108.534 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 66.7 t -114.79 137.32 48.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 CA-C-N 115.816 -0.629 . . . . 71.54 110.393 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 54.8 m -91.88 113.94 26.35 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.187 0.518 . . . . 72.53 110.467 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.586 HD23 HD23 ' A' ' 464' ' ' LEU . 3.3 mm? -102.36 119.34 38.65 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.556 -0.905 . . . . 65.35 108.556 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 3.1 tm? -110.68 117.06 32.45 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 107.907 -1.146 . . . . 72.52 107.907 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 33.1 m -119.98 162.64 18.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 114.768 -1.105 . . . . 62.4 110.325 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -116.96 114.8 24.32 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 109.495 -0.557 . . . . 73.13 109.495 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -102.24 118.6 37.24 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 120.013 -0.675 . . . . 75.4 111.817 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -79.71 137.49 37.06 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.902 -1.518 . . . . 64.31 106.902 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -91.92 138.88 31.18 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 120.248 -0.581 . . . . 72.43 109.84 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 C--N 1.312 -1.035 0 CA-C-O 118.533 -0.746 . . . . 72.44 110.718 -178.94 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.807 0 N-CA-C 110.973 -0.851 . . . . 72.22 110.973 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 67.4 m -145.12 91.8 2.18 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.352 0.596 . . . . 71.32 111.048 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -107.12 128.01 54.0 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 115.558 -0.746 . . . . 75.31 109.375 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -114.24 91.27 3.57 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.317 -0.623 . . . . 53.42 109.317 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 50.0 m -121.37 114.03 20.73 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.399 -0.963 . . . . 73.42 108.399 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -68.39 105.77 2.28 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.358 0.599 . . . . 73.15 109.673 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -99.13 114.41 27.14 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 109.211 -0.663 . . . . 54.45 109.211 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' ILE . . . . . 0.461 ' H ' HD13 ' A' ' 456' ' ' ILE . 0.2 OUTLIER -139.14 1.37 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.828 -1.545 . . . . 75.42 106.828 174.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 147.11 174.23 18.99 Favored Glycine 1 N--CA 1.386 -4.68 0 N-CA-C 106.796 -2.522 . . . . 71.21 106.796 -173.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 458' ' ' LYS . 43.9 mtpt -130.78 163.39 27.45 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-O 121.791 0.805 . . . . 70.03 112.874 178.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 98.3 mtt180 -107.89 131.66 54.28 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-N 113.427 -1.715 . . . . 75.51 106.505 170.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -120.98 133.27 55.27 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 109.486 -0.561 . . . . 63.54 109.486 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -93.09 115.2 27.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.492 0.663 . . . . 73.14 109.278 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' ILE . . . . . 0.458 HG23 ' HD3' ' A' ' 504' ' ' ARG . 59.7 mt -121.72 122.67 67.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.655 -0.702 . . . . 70.0 109.977 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 73.4 mt-30 -102.42 129.22 48.85 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.99 0.424 . . . . 74.43 111.901 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.463 HD23 HD23 ' A' ' 542' ' ' LEU . 3.1 mm? -115.09 135.52 54.11 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.542 0.737 . . . . 43.11 109.879 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.764 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.1 OUTLIER -98.89 137.07 37.99 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.993 -1.114 . . . . 55.31 107.993 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.443 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 36.9 ttmt -59.73 106.1 0.44 Allowed 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.377 -0.829 . . . . 71.31 110.655 174.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -92.67 -138.71 8.69 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.846 -0.901 . . . . 43.31 110.846 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 10.2 t -65.87 -46.55 78.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.859 0.329 . . . . 42.44 110.454 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -121.53 83.42 2.08 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 107.043 -1.466 . . . . 75.41 107.043 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.443 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . -58.63 140.87 46.94 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 120.356 -0.926 . . . . 74.42 113.594 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.564 HD11 HG21 ' A' ' 540' ' ' VAL . 18.2 mt 57.37 89.1 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 125.434 1.494 . . . . 65.22 112.166 -174.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -103.45 56.76 0.58 Allowed Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 114.72 -1.127 . . . . 50.23 111.213 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.605 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 6.4 p90 -144.75 144.78 31.36 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.024 -0.732 . . . . 74.53 109.024 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.2 m -120.88 149.63 42.31 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.97 -1.122 . . . . 52.34 107.97 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 15.4 pt -109.85 155.27 11.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 112.895 0.702 . . . . 73.51 112.895 -175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 7.5 t -129.16 159.83 34.78 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.063 -1.088 . . . . 72.43 108.063 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 33.9 p -131.09 136.68 48.62 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 109.077 -0.712 . . . . 55.31 109.077 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.427 ' HG2' ' CD2' ' A' ' 489' ' ' TYR . 34.5 mmt180 -91.8 -2.91 56.7 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.659 -0.416 . . . . 72.45 110.307 -177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 21.2 t70 70.44 148.9 0.08 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.592 1.157 . . . . 62.41 110.509 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 10.8 p -86.56 4.06 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.745 0.784 . . . . 75.33 110.499 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . 0.267 73.8 p 63.4 85.64 0.13 Allowed 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 125.457 1.503 . . . . 33.34 112.026 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 65.1 mt 71.28 86.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 114.243 -1.344 . . . . 71.02 109.687 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 161.61 -156.36 27.83 Favored Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 114.77 -1.105 . . . . 64.1 110.434 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -136.49 -177.45 15.02 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.643 -0.789 . . . . 60.44 112.281 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 45.0 m 74.79 -61.06 0.5 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.13 1.372 . . . . 75.34 111.989 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 69.36 147.12 0.11 Allowed Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 124.367 1.067 . . . . 75.41 113.399 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.7 135.33 23.62 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 121.911 1.741 . . . . 60.21 110.027 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.43 ' HB ' HD13 ' A' ' 519' ' ' LEU . 48.3 mm -102.62 136.16 36.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.983 -0.553 . . . . 72.41 110.298 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.427 ' CD2' ' HG2' ' A' ' 478' ' ' ARG . 95.6 m-85 -134.82 162.48 32.25 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.326 -0.62 . . . . 75.53 109.326 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 23.2 t -82.23 122.89 37.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 109.141 -0.689 . . . . 61.25 109.141 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -89.87 -55.27 3.69 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.817 -0.628 . . . . 75.2 110.674 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -146.48 151.02 36.72 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.191 -0.67 . . . . 64.12 109.191 -175.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.634 HG12 ' HB2' ' A' ' 507' ' ' ALA . 35.3 mm -111.2 110.98 34.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.002 -1.11 . . . . 50.3 108.002 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.24 123.52 78.65 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 115.775 -0.648 . . . . 64.45 109.298 176.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.02 22.19 0.15 Allowed 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.945 3.763 . . . . 75.33 114.836 -171.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -160.07 -2.98 0.07 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.819 0.674 . . . . 75.11 112.819 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.602 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -84.55 -167.97 43.61 Favored Glycine 0 C--O 1.216 -0.971 0 C-N-CA 119.788 -1.196 . . . . 44.41 112.515 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.461 ' CB ' ' H ' ' A' ' 471' ' ' LEU . . . -57.11 -34.77 68.69 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.014 0.907 . . . . 53.13 111.759 -175.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.79 86.14 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.61 -0.723 . . . . 74.04 112.261 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 8.8 tt -79.03 -31.3 14.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 O-C-N 123.233 0.333 . . . . 63.4 111.388 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 71.1 mm-40 -62.39 -43.28 99.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.763 -0.458 . . . . 73.14 109.763 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.406 ' HB2' HD13 ' A' ' 464' ' ' LEU . 11.0 t70 -82.77 -41.64 18.93 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.865 -1.531 . . . . 64.2 106.865 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.56 -7.52 76.1 Favored Glycine 0 N--CA 1.426 -1.973 0 CA-C-N 115.372 -0.831 . . . . 75.23 115.118 174.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.458 ' HD3' HG23 ' A' ' 462' ' ' ILE . 73.4 ttt180 -85.83 -19.16 31.06 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 120.974 0.416 . . . . 63.02 111.727 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 62.1 tp -101.19 130.48 47.29 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.091 -0.337 . . . . 73.32 110.091 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.527 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -134.83 171.77 13.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.657 0.265 . . . . 74.02 111.448 176.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.634 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -96.82 130.8 44.03 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.35 -0.386 . . . . 73.33 111.107 -176.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 144.13 -23.27 2.08 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.659 -0.701 . . . . 61.44 111.465 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -93.29 172.23 8.42 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-O 120.942 0.401 . . . . 74.33 111.099 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -93.75 138.75 31.61 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.679 -0.692 . . . . 74.34 110.308 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.525 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -89.77 127.96 36.05 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 105.892 -1.892 . . . . 73.15 105.892 177.59 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.0 mm -96.16 -50.78 11.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.861 -0.524 . . . . 74.32 109.97 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -157.54 145.76 19.14 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.694 -0.685 . . . . 75.44 109.267 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.433 HG23 HD13 ' A' ' 542' ' ' LEU . 4.8 p -126.04 130.37 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.308 0 CA-C-O 121.359 0.599 . . . . 74.45 109.69 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 62.05 20.08 11.32 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 126.208 1.803 . . . . 71.44 111.389 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 95.47 2.09 61.94 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.78 -0.724 . . . . 63.31 113.473 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.99 138.21 38.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.639 -0.504 . . . . 74.24 109.639 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -84.35 148.22 26.75 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 123.571 0.544 . . . . 75.02 110.036 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.525 HD11 HD12 ' A' ' 511' ' ' LEU . 28.1 mt -90.48 -50.98 5.64 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.773 -0.649 . . . . 55.51 112.003 -173.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.12 86.32 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 122.623 1.202 . . . . 75.51 111.305 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 166.2 -24.34 0.14 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 108.278 -1.929 . . . . 44.14 108.278 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.58 172.49 7.31 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.793 -0.817 . . . . 74.31 108.793 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 42.4 m -91.88 165.15 13.39 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 110.256 -0.275 . . . . 72.42 110.256 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -53.96 -44.97 71.18 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.572 0.749 . . . . 73.0 111.847 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.609 ' HA ' HG22 ' A' ' 528' ' ' VAL . 39.4 mt-10 -61.58 -31.55 71.61 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 112.463 0.542 . . . . 75.53 112.463 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.75 -34.01 69.15 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.291 -0.633 . . . . 54.31 109.291 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 47.6 t -70.45 -38.22 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.559 -0.746 . . . . 75.42 109.372 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.715 ' O ' ' HG3' ' A' ' 532' ' ' ARG . 19.9 m -69.57 -36.64 71.9 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.893 0 C-N-CA 119.099 -1.04 . . . . 73.42 110.676 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.8 t -59.28 -44.11 92.49 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 109.226 -0.657 . . . . 53.34 109.226 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 34.4 tp -58.82 -41.9 87.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.843 1.257 . . . . 75.22 109.594 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 471' ' ' LEU . 3.2 tt -64.98 -48.05 75.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.323 -0.853 . . . . 63.53 111.944 174.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.715 ' HG3' ' O ' ' A' ' 528' ' ' VAL . 23.0 mtm180 -61.41 -31.11 71.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.49 -0.323 . . . . 62.5 110.837 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.5 t -65.56 -44.43 86.79 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.253 -0.431 . . . . 53.41 110.006 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 24.6 m 63.85 -2.88 0.49 Allowed 'General case' 0 CA--C 1.578 2.026 0 C-N-CA 123.797 0.839 . . . . 62.41 112.812 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.586 ' HE3' ' OE1' ' A' ' 537' ' ' GLU . 61.6 tttp 70.13 146.4 0.06 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.215 1.006 . . . . 62.23 111.912 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 46.7 ttm -63.3 -32.37 73.77 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 116.569 2.062 . . . . 51.2 116.569 -167.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 537' ' ' GLU . . . . . 0.586 ' OE1' ' HE3' ' A' ' 535' ' ' LYS . 0.0 OUTLIER -78.24 -28.24 47.76 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 118.021 -1.472 . . . . 63.2 108.782 178.117 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 99.86 30.98 6.18 Favored Glycine 0 N--CA 1.415 -2.733 0 CA-C-N 114.771 -1.104 . . . . 54.02 113.613 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 4.0 m -128.58 132.22 48.2 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.034 -1.099 . . . . 45.14 108.034 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.564 HG21 HD11 ' A' ' 471' ' ' LEU . 61.5 t -120.07 134.34 63.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 116.178 -0.465 . . . . 61.14 111.239 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.7 m -91.76 114.4 26.93 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.199 -0.91 . . . . 71.12 110.047 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.605 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.2 mm? -104.04 121.24 42.77 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.744 -1.206 . . . . 71.32 107.744 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 41.8 tp -104.51 117.92 35.32 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.252 -1.759 . . . . 52.31 106.252 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 35.3 m -115.31 148.47 18.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 C-N-CA 120.503 -0.479 . . . . 54.23 110.827 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -111.97 122.32 47.44 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.829 -0.623 . . . . 74.22 109.655 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -122.13 124.76 44.65 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 114.59 -1.186 . . . . 63.31 109.436 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -79.21 133.71 36.69 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.594 -0.73 . . . . 75.32 109.596 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -134.34 127.67 32.16 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.177 -0.465 . . . . 72.31 109.875 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 C--N 1.304 -1.408 0 N-CA-C 108.891 -0.781 . . . . 52.35 108.891 179.733 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.935 0 N-CA-C 110.833 -0.907 . . . . 60.34 110.833 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 47.5 m -127.78 124.03 36.68 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.513 -0.551 . . . . 61.02 109.513 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -76.06 -31.17 58.67 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.106 -1.072 . . . . 70.41 108.106 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -109.78 100.94 9.86 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.414 -1.266 . . . . 71.31 108.409 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 27.9 m -97.09 114.62 26.3 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.527 -0.916 . . . . 71.35 108.527 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -131.74 88.27 2.55 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 113.956 1.095 . . . . 64.34 113.956 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -123.1 157.86 31.92 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 104.254 -2.498 . . . . 64.31 104.254 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 548' ' ' GLU . 26.3 pt -84.13 74.93 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 118.031 -1.468 . . . . 64.03 110.343 175.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 143.05 139.27 3.54 Favored Glycine 0 N--CA 1.419 -2.491 0 CA-C-N 113.726 -1.579 . . . . 51.32 109.693 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -122.82 160.63 25.63 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.28 -1.007 . . . . 65.44 108.28 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 43.8 mtm180 -100.67 145.57 28.27 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 110.005 -0.368 . . . . 73.41 110.005 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.0 mm? -124.12 131.91 53.59 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.124 -0.695 . . . . 72.43 109.124 -174.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -104.89 115.27 30.0 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.655 0.74 . . . . 70.11 109.093 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 50.0 mt -122.51 142.6 38.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 115.318 -0.855 . . . . 73.15 110.506 -171.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 43.5 mt-30 -114.99 128.24 56.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.901 0.381 . . . . 74.2 111.279 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 539' ' ' THR . 6.3 mp -119.04 152.47 36.38 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.108 0.963 . . . . 71.45 111.885 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -115.81 129.04 56.28 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.323 -0.992 . . . . 75.11 108.323 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.633 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 23.8 ttmm -60.81 88.01 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.419 0.628 . . . . 72.23 112.044 176.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -90.45 -128.47 3.81 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.63 -0.714 . . . . 73.3 112.277 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' THR . . . . . 0.723 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 17.1 m -48.99 -72.73 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.322 1.049 . . . . 64.22 111.507 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.601 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 46.1 mm-40 -82.36 -38.54 24.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.245 -1.391 . . . . 72.14 107.245 171.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.633 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . 65.78 109.09 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.179 -1.373 . . . . 70.31 112.096 -174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.664 ' H ' ' CB ' ' A' ' 498' ' ' ALA . 33.9 mt 69.16 85.51 0.14 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 125.64 1.576 . . . . 71.3 108.076 -168.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . -103.18 56.76 0.59 Allowed Glycine 0 CA--C 1.471 -2.698 0 CA-C-N 114.393 -1.276 . . . . 45.3 112.151 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 2.9 p90 -147.72 142.94 27.21 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.01 0.433 . . . . 73.11 110.253 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 19.9 m -114.69 145.2 42.32 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 107.237 -1.394 . . . . 72.33 107.237 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.86 153.94 14.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 112.812 0.671 . . . . 52.21 112.812 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.655 ' HB ' ' HE3' ' A' ' 491' ' ' LYS . 8.2 t -143.33 149.43 37.76 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.119 -0.946 . . . . 43.33 109.563 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 21.4 p -106.31 132.07 52.79 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 108.092 -1.077 . . . . 72.22 108.092 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -122.53 -176.02 3.28 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 121.015 0.436 . . . . 64.43 111.764 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -46.47 109.14 0.17 Allowed 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 125.999 1.719 . . . . 43.03 112.359 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 486' ' ' ALA . 34.7 m -50.59 138.34 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.555 -1.202 . . . . 60.23 112.723 177.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.9 t -121.41 16.05 11.31 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.388 -1.708 . . . . 65.1 106.388 174.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.438 ' O ' ' HB ' ' A' ' 480' ' ' VAL . 10.4 tt -150.77 155.68 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 N-CA-C 105.95 -1.87 . . . . 73.24 105.95 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -67.87 109.6 2.99 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.634 -0.793 . . . . 44.4 111.24 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 78.53 -151.23 35.87 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 110.657 -0.977 . . . . 74.33 110.657 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 42.6 t 72.0 -61.02 0.51 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.099 0.96 . . . . 73.43 112.386 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 480' ' ' VAL . . . 59.73 90.74 0.09 OUTLIER Pre-proline 0 C--O 1.243 0.727 0 N-CA-C 108.663 -0.866 . . . . 30.42 108.663 -172.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.51 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 43.5 Cg_exo -54.93 135.4 68.18 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.942 2.428 . . . . 74.33 113.285 -174.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.494 HG13 ' HB3' ' A' ' 519' ' ' LEU . 38.9 mm -87.98 120.82 37.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.963 -1.017 . . . . 71.12 108.883 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 66.3 m-85 -120.51 150.47 40.79 Favored 'General case' 0 CA--C 1.483 -1.613 0 CA-C-O 120.804 0.335 . . . . 74.01 111.897 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.43 119.42 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 107.185 -1.413 . . . . 70.52 107.185 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.655 ' HE3' ' HB ' ' A' ' 476' ' ' THR . 41.0 ttmt -87.87 -53.82 4.56 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.312 0.577 . . . . 61.42 111.078 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 61.5 t30 -142.04 149.68 40.27 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.287 -0.87 . . . . 71.0 110.446 -171.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 507' ' ' ALA . 32.2 mm -115.87 106.54 20.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 124.149 0.906 . . . . 74.13 109.26 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -53.09 131.11 50.47 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.551 -0.749 . . . . 74.55 111.069 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -70.01 15.15 0.25 Allowed 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 124.557 3.505 . . . . 74.31 114.095 -173.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.723 ' O ' ' HB ' ' A' ' 468' ' ' THR . 12.1 ptt180 -164.35 12.68 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.109 0.957 . . . . 74.41 111.097 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.601 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . -84.83 -174.84 50.52 Favored Glycine 0 C--N 1.286 -2.209 0 C-N-CA 120.013 -1.089 . . . . 60.23 111.565 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.664 ' CB ' ' H ' ' A' ' 471' ' ' LEU . . . -62.21 -28.12 69.46 Favored 'General case' 0 C--O 1.198 -1.633 0 CA-C-N 117.999 0.9 . . . . 72.34 110.934 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.424 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -58.93 -41.62 87.81 Favored 'General case' 0 C--O 1.204 -1.302 0 CA-C-N 116.069 -0.514 . . . . 53.03 111.697 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.4 tt -79.84 -36.99 17.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.877 0.37 . . . . 73.14 111.546 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 9.1 mm-40 -66.85 -39.94 87.76 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.69 -0.686 . . . . 62.11 110.219 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.471 ' HB2' ' HG ' ' A' ' 464' ' ' LEU . 10.8 m-20 -92.45 -22.66 19.49 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.594 -0.73 . . . . 71.33 111.455 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.87 -57.36 5.01 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 116.647 1.419 . . . . 43.44 116.647 171.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -46.13 -30.8 2.06 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.519 1.674 . . . . 73.51 115.519 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 59.4 tp -98.02 132.05 43.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 117.824 0.284 . . . . 71.22 111.173 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.454 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -143.91 164.89 29.26 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 121.046 -0.261 . . . . 72.24 110.963 174.589 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.524 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.7 98.8 9.85 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.266 0.555 . . . . 71.35 111.963 -174.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 174.1 29.38 0.03 OUTLIER Glycine 0 C--N 1.304 -1.228 0 N-CA-C 111.107 -0.797 . . . . 51.24 111.107 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -148.18 177.79 9.1 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 120.748 0.309 . . . . 74.42 110.979 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -106.82 129.25 54.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.527 -0.76 . . . . 72.41 109.43 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' A' ' 519' ' ' LEU . 28.2 tp -83.46 120.77 26.32 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 107.957 -1.127 . . . . 74.21 107.957 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 543' ' ' LEU . 49.1 mm -97.93 -45.84 12.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 120.911 0.386 . . . . 71.22 111.129 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.491 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 10.2 pt-20 -154.02 146.02 23.6 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.123 -0.49 . . . . 72.33 110.145 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.458 HG13 HD21 ' A' ' 530' ' ' LEU . 2.6 p -130.65 129.13 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.458 0 N-CA-C 107.401 -1.333 . . . . 71.02 107.401 176.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 68.01 4.8 4.22 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.82 0.848 . . . . 74.33 112.667 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 104.56 -6.96 45.68 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 121.065 -0.588 . . . . 53.55 112.075 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.3 t -87.14 125.75 40.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.776 -0.453 . . . . 35.42 109.776 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -79.75 134.25 36.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.982 -0.554 . . . . 73.15 110.512 -176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.494 ' HB3' HG13 ' A' ' 488' ' ' ILE . 17.3 mt -98.63 -22.87 15.71 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.864 -0.607 . . . . 44.54 110.658 -174.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.31 9.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 125.413 1.485 . . . . 63.42 113.84 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -144.05 18.45 2.14 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 110.875 -0.89 . . . . 44.54 110.875 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 174.6 10.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.466 0.543 . . . . 72.31 112.466 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 523' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 527' ' ' VAL . 32.4 m -93.34 159.8 15.1 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.757 -0.656 . . . . 75.34 112.731 -175.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.507 ' O ' HG13 ' A' ' 528' ' ' VAL . 36.9 mm-40 -50.19 -47.68 54.47 Favored 'General case' 0 C--O 1.209 -1.046 0 C-N-CA 124.472 1.109 . . . . 73.11 113.626 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' A' ' 525' ' ' GLU . 4.1 mp0 -59.1 -34.28 71.82 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.235 0.54 . . . . 75.22 111.185 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.85 -39.2 83.82 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.673 -0.694 . . . . 65.42 109.73 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 523' ' ' SER . 15.2 t -75.48 -36.78 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 115.571 -0.74 . . . . 74.44 109.762 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.664 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 7.5 m -66.11 -42.55 91.58 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.049 0 C-N-CA 120.214 -0.595 . . . . 50.21 110.127 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 29.7 m -59.57 -44.05 93.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.454 0.645 . . . . 74.12 109.84 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.458 HD21 HG13 ' A' ' 514' ' ' VAL . 25.2 tp -58.32 -46.55 85.94 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 124.916 1.287 . . . . 74.2 109.658 176.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.569 HD12 HD13 ' A' ' 471' ' ' LEU . 30.2 tp -62.9 -48.39 79.16 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.522 -0.763 . . . . 64.31 110.533 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 29.7 mmm180 -60.97 -38.27 85.33 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.87 -0.604 . . . . 61.14 110.908 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 22.4 m -70.94 -40.49 72.0 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 115.986 -0.552 . . . . 73.01 110.226 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 534' ' ' THR . . . . . 0.514 HG21 ' HE2' ' A' ' 466' ' ' LYS . 61.9 m 69.72 -84.47 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.882 0.873 . . . . 70.12 111.577 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt 174.45 167.96 0.24 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.948 -1.501 . . . . 71.33 106.948 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 88.2 mtp -59.49 -51.22 70.8 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.398 0.888 . . . . 64.32 113.398 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.81 -64.65 1.13 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.503 -0.879 . . . . 55.13 109.307 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 150.19 18.07 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 118.721 -1.704 . . . . 43.54 115.691 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.1 m -100.22 130.36 46.34 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 119.036 1.418 . . . . 63.53 108.373 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 51.9 t -124.0 135.52 63.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 112.154 0.427 . . . . 63.12 112.154 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 42.9 m -94.18 115.24 27.5 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.073 -0.967 . . . . 74.32 110.289 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.57 121.21 44.18 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.091 -1.078 . . . . 72.32 108.091 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 2.8 tm? -110.0 116.48 31.66 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 105.854 -1.906 . . . . 73.42 105.854 174.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.8 m -118.25 157.79 19.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 115.057 -0.974 . . . . 71.12 111.206 -174.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -123.6 116.36 22.99 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.915 -0.584 . . . . 62.1 109.988 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -109.23 125.65 52.47 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.332 -0.988 . . . . 71.02 108.332 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -85.39 128.71 34.81 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.255 0.55 . . . . 70.13 110.374 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 548' ' ' GLU . . . . . 0.422 ' O ' ' HB ' ' A' ' 456' ' ' ILE . 46.1 mt-10 -100.78 88.61 3.62 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.765 -0.828 . . . . 62.04 108.765 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--N 1.303 -1.445 0 CA-C-N 115.1 -0.955 . . . . 63.53 108.733 -175.628 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.754 0 N-CA-C 111.261 -0.736 . . . . 34.14 111.261 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 23.6 p -105.85 -68.66 0.86 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.155 0.502 . . . . 65.32 110.189 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -130.49 84.02 2.17 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.662 0.744 . . . . 73.33 110.423 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -88.87 -55.49 3.67 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.174 -1.375 . . . . 72.03 111.44 -175.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 38.8 p -94.47 117.34 29.97 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 112.66 0.615 . . . . 73.41 112.66 -174.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 454' ' ' LYS . 3.9 mptp? -95.34 99.65 11.55 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.856 -0.794 . . . . 73.04 108.856 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -85.73 168.4 14.39 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.912 -0.403 . . . . 63.12 109.912 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 57.9 mt -74.64 98.88 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 108.343 -0.984 . . . . 62.21 108.343 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 143.1 116.13 1.13 Allowed Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 108.68 -1.768 . . . . 65.23 108.68 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 29.1 mtpp -89.17 156.81 18.56 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.3 0.571 . . . . 73.13 111.963 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 94.3 mtt180 -118.6 126.09 51.21 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.069 -1.826 . . . . 75.25 106.069 170.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.9 mp -124.74 136.76 54.15 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 116.468 -0.333 . . . . 71.13 110.934 -175.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -99.6 115.14 28.7 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 123.988 0.805 . . . . 64.12 108.956 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 55.4 mt -121.85 142.69 37.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.685 -0.857 . . . . 53.55 108.685 -176.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.47 ' HB3' HG22 ' A' ' 539' ' ' THR . 76.5 mt-30 -117.3 127.06 53.7 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.424 0.527 . . . . 64.52 112.424 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.454 HD23 HD23 ' A' ' 542' ' ' LEU . 3.9 mm? -115.57 133.19 56.27 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 124.46 1.104 . . . . 73.44 109.586 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 37.4 ttpt -108.15 136.35 47.97 Favored 'General case' 0 N--CA 1.401 -2.897 0 N-CA-C 108.815 -0.809 . . . . 62.45 108.815 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.451 ' HA ' ' HA2' ' A' ' 470' ' ' GLY . 48.8 mtmt -54.7 99.3 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 124.066 0.854 . . . . 71.41 111.506 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -131.19 136.82 9.04 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.696 -0.962 . . . . 51.43 110.696 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 64.5 m 63.1 -88.13 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.235 1.014 . . . . 73.05 111.446 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.428 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 31.0 mm-40 -98.01 -5.73 33.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.556 0.693 . . . . 64.15 109.364 177.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 69.17 -154.61 53.32 Favored Glycine 0 CA--C 1.486 -1.767 0 CA-C-O 118.109 -1.384 . . . . 73.42 110.842 -177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 540' ' ' VAL . 48.1 mt -43.76 101.52 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.425 1.112 . . . . 60.42 112.348 -173.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -111.98 56.26 0.47 Allowed Glycine 0 CA--C 1.477 -2.282 0 CA-C-N 114.739 -1.119 . . . . 62.24 112.329 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.597 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 5.3 p90 -144.45 142.12 30.07 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.055 -1.091 . . . . 75.03 108.055 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 28.9 p -116.57 162.36 17.74 Favored 'General case' 0 C--N 1.272 -2.797 0 N-CA-C 108.44 -0.948 . . . . 54.4 108.44 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.28 159.39 35.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.316 0.579 . . . . 74.3 111.505 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.8 t -148.12 153.73 39.24 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.358 -1.719 . . . . 62.42 106.358 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 34.8 p -106.22 140.14 39.63 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.595 -0.891 . . . . 70.24 108.595 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 478' ' ' ARG . 37.3 mmt180 -114.55 -93.15 0.49 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 114.61 1.337 . . . . 72.54 114.61 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -87.56 76.43 8.94 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.397 -0.921 . . . . 70.34 113.142 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 486' ' ' ALA . 7.6 p -67.43 137.97 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 114.569 -1.196 . . . . 74.42 110.271 174.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 23.7 p -97.18 153.96 17.67 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.85 -0.796 . . . . 71.01 108.85 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 24.2 pt -63.74 110.16 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.353 0.597 . . . . 71.34 110.103 176.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 157.63 -41.48 0.53 Allowed Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 110.779 -0.929 . . . . 34.32 110.779 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 135.4 -17.63 4.0 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.018 -1.087 . . . . 53.03 111.378 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 45.7 m -82.49 85.81 6.88 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 122.144 0.973 . . . . 72.55 112.828 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 480' ' ' VAL . . . -84.69 116.3 64.61 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 113.932 -1.485 . . . . 73.22 108.782 171.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.97 135.43 44.11 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 122.127 1.885 . . . . 52.13 110.957 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 43.1 mm -93.74 130.64 42.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.644 -0.707 . . . . 71.14 109.235 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -127.51 153.46 46.31 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.255 0.222 . . . . 63.32 110.474 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 28.2 t -73.36 122.72 26.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.572 -0.899 . . . . 61.24 108.572 177.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -80.68 -62.26 1.72 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.437 -0.579 . . . . 72.14 109.437 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -143.05 163.71 32.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.368 -0.975 . . . . 71.41 108.368 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 506' ' ' LYS . 26.4 mm -123.42 110.16 25.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 124.805 1.242 . . . . 61.3 108.445 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.02 125.4 73.97 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.217 -0.901 . . . . 72.34 110.633 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.28 21.33 0.23 Allowed 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 124.895 3.73 . . . . 71.42 114.6 -172.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -165.35 7.25 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.241 0.543 . . . . 75.02 112.424 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -89.48 -161.79 37.82 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 120.18 -1.009 . . . . 31.44 112.782 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -61.61 -39.84 92.69 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 123.817 0.847 . . . . 61.14 109.968 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.65 -41.4 81.39 Favored 'General case' 0 C--O 1.201 -1.461 0 CA-C-N 114.625 -1.171 . . . . 70.02 112.696 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.1 tt -79.48 -31.02 13.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 111.628 0.233 . . . . 72.12 111.628 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 30.9 mm-40 -59.71 -43.15 94.23 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.167 0.508 . . . . 61.14 109.65 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.42 -50.93 7.34 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.787 -0.642 . . . . 70.25 110.385 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 101.2 -36.09 4.44 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.044 -1.55 . . . . 32.02 116.235 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -65.87 -32.83 74.56 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.564 0.682 . . . . 64.53 112.232 -173.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 61.7 tp -84.44 102.7 12.99 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.921 -0.581 . . . . 73.23 110.508 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.488 ' HA ' HG13 ' A' ' 493' ' ' ILE . 10.3 ptmm? -113.69 177.0 4.79 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.181 -0.463 . . . . 74.14 111.52 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.447 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -87.43 147.52 25.39 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.997 -0.547 . . . . 62.43 110.371 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 110.11 -27.19 12.12 Favored Glycine 0 C--N 1.311 -0.852 0 C-N-CA 120.702 -0.761 . . . . 61.21 112.775 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -79.98 163.22 24.42 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 120.62 0.248 . . . . 62.4 110.945 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 31.6 ttm180 -96.8 142.5 28.73 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-O 120.796 0.331 . . . . 71.21 111.48 -178.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.703 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -90.54 126.96 36.1 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.902 0.881 . . . . 72.14 111.288 175.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 33.4 mt -103.33 -45.68 10.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.156 -0.683 . . . . 73.33 109.156 173.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.551 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 0.5 OUTLIER -150.96 155.15 38.5 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 109.716 -0.476 . . . . 73.33 109.716 176.326 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.672 HG12 HD21 ' A' ' 519' ' ' LEU . 7.1 p -143.3 130.58 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 O-C-N 123.827 0.705 . . . . 55.24 109.232 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 49.9 t30 64.78 15.42 9.8 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 125.918 1.687 . . . . 73.31 112.521 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 100.37 7.67 51.33 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.499 -0.858 . . . . 34.53 113.578 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 57.9 t -121.1 142.93 35.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 117.2 0.5 . . . . 63.45 110.415 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -73.96 144.5 45.21 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.472 0.709 . . . . 72.35 110.138 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.703 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 15.2 mt -108.43 -42.79 4.48 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.677 -0.409 . . . . 73.44 112.0 -175.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.34 -26.95 37.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 116.054 -0.521 . . . . 71.11 111.373 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -78.55 -18.52 75.56 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.747 -0.739 . . . . 63.55 112.416 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.441 ' HD3' ' CB ' ' A' ' 526' ' ' GLU . 0.1 OUTLIER -110.62 -175.55 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.328 -0.513 . . . . 73.32 111.802 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 523' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 527' ' ' VAL . 11.3 m -87.32 158.75 18.98 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.901 -0.591 . . . . 71.43 111.183 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.71 -47.71 84.55 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.854 1.262 . . . . 44.31 109.843 -175.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 528' ' ' VAL . 47.1 mt-10 -68.5 -30.36 69.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.694 0.998 . . . . 74.12 113.694 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.441 ' CB ' ' HD3' ' A' ' 522' ' ' LYS . 49.4 mt-10 -59.98 -37.59 80.08 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.515 -0.55 . . . . 60.23 109.515 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.471 HG13 HD22 ' A' ' 519' ' ' LEU . 43.4 t -65.64 -36.92 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.74 -0.663 . . . . 73.13 110.276 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.673 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 25.0 m -70.53 -39.09 75.74 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 C-N-CA 118.977 -1.089 . . . . 74.33 110.403 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 37.4 t -61.29 -37.41 83.09 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.017 -0.538 . . . . 42.23 109.873 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 33.7 tp -64.14 -42.52 96.75 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.876 1.27 . . . . 54.43 109.951 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 tt -64.7 -44.15 91.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.337 -0.847 . . . . 73.15 111.928 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 31.3 mmm180 -64.63 -27.08 68.69 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.054 -0.521 . . . . 71.32 112.055 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 23.2 p -82.53 -45.84 14.15 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 113.447 0.906 . . . . 70.12 113.447 -176.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' THR . . . . . 0.416 HG21 ' CD ' ' A' ' 466' ' ' LYS . 88.4 m 59.4 133.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.296 0.57 . . . . 44.22 112.466 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -64.96 152.56 42.96 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.053 -1.029 . . . . 62.43 109.68 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 50.9 ttm -54.76 -32.23 59.65 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 123.473 0.709 . . . . 71.31 112.784 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.56 -15.89 53.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.649 0.611 . . . . 74.2 112.649 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 85.93 -20.35 20.69 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.666 -0.778 . . . . 43.25 113.923 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 463' ' ' GLN . 3.9 m -104.09 129.07 51.76 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.48 0.657 . . . . 62.33 109.756 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.477 HG21 HD11 ' A' ' 471' ' ' LEU . 77.1 t -111.68 141.77 26.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.935 -1.029 . . . . 65.13 110.83 -176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 34.3 t -91.15 132.95 35.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.743 -0.662 . . . . 54.0 109.444 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.597 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.7 mm? -120.77 118.57 30.36 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.692 -1.225 . . . . 74.41 107.692 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.514 ' CB ' ' HG3' ' A' ' 513' ' ' GLU . 51.1 tp -104.63 117.66 34.67 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 105.213 -2.143 . . . . 71.44 105.213 172.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 28.6 m -115.98 151.78 17.73 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.135 0 C-N-CA 120.233 -0.587 . . . . 73.34 111.143 -176.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.536 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 85.6 t80 -110.92 116.14 30.7 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.68 -1.97 . . . . 74.12 105.68 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -115.87 118.42 32.93 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.865 -0.791 . . . . 72.4 108.865 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.69 122.89 33.85 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 105.82 -1.919 . . . . 71.41 105.82 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -80.08 121.09 25.1 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.569 -0.287 . . . . 72.14 110.747 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 . . . . . 0 C--O 1.245 0.841 0 C-N-CA 123.886 0.874 . . . . 51.23 110.559 -179.113 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.765 0 N-CA-C 111.24 -0.744 . . . . 55.11 111.24 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 29.9 p -93.02 125.69 37.74 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.155 0.502 . . . . 71.22 111.941 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -100.35 -3.42 31.22 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.148 -0.478 . . . . 73.34 110.386 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -78.63 155.42 29.57 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.004 0.431 . . . . 72.41 110.527 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 88.1 m -147.17 100.61 3.31 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.573 -0.528 . . . . 71.11 109.573 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -79.31 98.57 6.74 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 108.99 -0.744 . . . . 65.32 108.99 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -98.84 130.36 45.25 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.639 -1.164 . . . . 72.34 109.978 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' ILE . . . . . 0.522 ' O ' HD12 ' A' ' 456' ' ' ILE . 2.6 pp -83.53 126.01 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-O 121.279 0.562 . . . . 52.44 109.675 173.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 98.12 65.63 0.88 Allowed Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 108.368 -1.893 . . . . 64.41 108.368 -173.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -87.66 137.14 32.59 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 113.786 1.032 . . . . 74.35 113.786 -175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 89.2 mtm180 -105.81 138.66 41.63 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 113.743 -1.571 . . . . 71.23 107.395 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.43 ' O ' HD12 ' A' ' 543' ' ' LEU . 6.0 mp -123.4 128.24 49.58 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 120.989 0.424 . . . . 72.1 110.705 -177.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -96.27 116.26 28.73 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.042 -0.981 . . . . 72.53 109.787 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 53.6 mt -123.67 144.21 34.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 114.783 -1.099 . . . . 60.32 110.414 -172.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.3 mt-30 -119.98 129.99 54.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.594 0.59 . . . . 53.24 112.594 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.599 HD23 HD23 ' A' ' 542' ' ' LEU . 3.8 mm? -116.85 153.03 33.23 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 124.962 1.305 . . . . 74.24 110.189 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -113.16 129.34 56.54 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 108.159 -1.052 . . . . 64.24 108.159 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -60.24 102.91 0.19 Allowed 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.547 -0.751 . . . . 73.23 109.664 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -146.16 150.45 22.69 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.369 -0.692 . . . . 44.32 111.369 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 50.1 m 65.21 -78.56 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.241 1.017 . . . . 60.42 111.131 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -119.48 -6.68 10.24 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.035 -0.728 . . . . 61.12 109.035 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 69.24 -151.08 50.79 Favored Glycine 0 C--O 1.206 -1.598 0 CA-C-O 118.673 -1.07 . . . . 70.13 110.784 -175.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 7.8 mp -46.83 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.217 1.192 . . . . 50.21 114.217 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -104.06 43.66 1.63 Allowed Glycine 0 N--CA 1.428 -1.847 0 CA-C-N 113.951 -1.477 . . . . 62.53 112.044 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -129.17 142.16 50.95 Favored 'General case' 0 N--CA 1.409 -2.518 0 N-CA-C 108.596 -0.89 . . . . 64.42 108.596 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 45.0 t -115.0 148.53 38.71 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.401 -1.333 . . . . 72.31 107.401 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.434 HG21 HD12 ' A' ' 511' ' ' LEU . 14.9 pt -116.62 156.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.474 0.654 . . . . 72.32 112.611 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.4 t -138.21 159.85 40.98 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.934 -1.506 . . . . 72.21 106.934 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 14.9 p -120.96 131.28 54.23 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.666 -0.494 . . . . 73.12 109.666 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -117.55 117.47 29.51 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.537 -0.912 . . . . 72.5 108.537 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' ASP . . . . . 0.505 ' HA ' ' HB2' ' A' ' 486' ' ' ALA . 33.7 t70 -61.05 121.7 13.11 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 123.939 0.774 . . . . 74.21 110.09 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 486' ' ' ALA . 14.7 p -85.36 128.94 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 121.017 0.437 . . . . 74.13 111.797 -174.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.8 m -76.64 -42.99 40.0 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.776 0.798 . . . . 72.05 109.531 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 19.5 pt -89.19 83.05 2.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-N 114.338 -1.301 . . . . 63.15 111.217 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 128.76 -157.34 21.47 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 109.998 -1.241 . . . . 74.31 109.998 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -163.78 94.86 0.12 Allowed Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.088 -0.805 . . . . 34.21 111.088 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 43.8 t -172.29 -44.17 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.817 -0.438 . . . . 62.11 109.817 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.558 ' H ' HG12 ' A' ' 480' ' ' VAL . . . 72.79 94.09 0.05 OUTLIER Pre-proline 0 C--O 1.247 0.927 0 C-N-CA 124.345 1.058 . . . . 75.11 110.427 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.464 ' HD3' ' HB ' ' A' ' 480' ' ' VAL . 19.5 Cg_exo -66.71 160.0 48.49 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 123.058 2.505 . . . . 74.43 112.847 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.427 HG13 HG21 ' A' ' 527' ' ' VAL . 47.8 mm -97.74 135.6 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 115.01 -0.995 . . . . 65.14 108.728 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 97.7 m-85 -127.22 155.98 42.59 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 116.68 -0.236 . . . . 73.14 110.66 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.418 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 32.6 t -82.72 119.0 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 N-CA-C 107.665 -1.235 . . . . 55.32 107.665 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.434 ' HG2' ' OD1' ' A' ' 492' ' ' ASN . 61.2 tttm -85.14 -54.81 4.39 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.561 -0.745 . . . . 73.31 109.461 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 492' ' ' ASN . . . . . 0.434 ' OD1' ' HG2' ' A' ' 491' ' ' LYS . 18.4 m120 -136.98 157.08 47.55 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 115.447 -0.797 . . . . 63.4 112.55 -176.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 507' ' ' ALA . 26.6 mm -120.53 115.59 47.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.314 -1.736 . . . . 61.21 106.314 172.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 495' ' ' PRO . 9.3 mp -62.92 163.11 17.5 Favored Pre-proline 0 C--N 1.304 -1.399 0 C-N-CA 123.839 0.855 . . . . 72.41 112.146 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 494' ' ' LEU . 43.6 Cg_endo -74.75 -5.22 16.55 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 123.645 2.896 . . . . 71.35 111.219 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.443 ' HA ' HG21 ' A' ' 500' ' ' ILE . 97.9 mtt180 -157.97 174.3 15.45 Favored 'General case' 0 N--CA 1.41 -2.437 0 C-N-CA 125.113 1.365 . . . . 73.03 107.843 -172.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 106.74 -175.93 21.11 Favored Glycine 1 C--N 1.251 -4.176 0 CA-C-N 114.659 -1.155 . . . . 53.51 112.262 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.51 81.39 Favored 'General case' 0 N--CA 1.422 -1.828 0 C-N-CA 123.783 0.833 . . . . 61.41 110.872 -175.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.31 -41.89 80.77 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 114.655 -1.157 . . . . 70.31 112.788 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.443 HG21 ' HA ' ' A' ' 496' ' ' ARG . 13.6 tt -81.08 -43.66 20.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.955 0.724 . . . . 62.53 112.955 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -59.02 -37.79 77.75 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 112.436 0.532 . . . . 74.24 112.436 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.568 ' HB2' HD13 ' A' ' 464' ' ' LEU . 3.6 m-20 -89.48 -33.36 16.81 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.211 -0.596 . . . . 73.41 109.778 173.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 62.16 50.79 61.84 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.759 -0.655 . . . . 53.05 113.74 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -117.08 -18.7 9.99 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.714 -0.795 . . . . 71.03 111.415 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.467 HD12 ' HG ' ' A' ' 542' ' ' LEU . 6.8 tt -119.84 138.96 53.07 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.988 -0.745 . . . . 73.45 108.988 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.427 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -132.05 160.91 34.53 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.41 0.892 . . . . 63.4 113.41 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.525 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -79.13 166.7 21.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.511 0.724 . . . . 65.43 111.912 -174.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 73.43 20.33 79.84 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.857 -0.897 . . . . 54.0 110.857 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.519 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 4.4 t70 -117.94 172.58 7.3 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.685 -1.228 . . . . 70.12 107.685 -176.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 30.3 ttm180 -107.3 135.25 49.12 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.311 -0.556 . . . . 73.22 110.951 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.434 HD12 HG21 ' A' ' 475' ' ' ILE . 27.4 mt -95.46 126.4 40.73 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 120.493 -0.483 . . . . 72.14 110.798 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.47 -45.39 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 116.019 -0.537 . . . . 75.12 111.203 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.436 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.0 pt-20 -156.63 155.08 31.19 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.329 -0.619 . . . . 73.45 109.329 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.47 HG12 HD21 ' A' ' 519' ' ' LEU . 6.4 p -132.6 125.03 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.726 0.774 . . . . 65.12 108.975 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 66.09 7.46 4.78 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 126.737 2.015 . . . . 74.23 112.65 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.53 -10.46 16.6 Favored Glycine 0 CA--C 1.508 -0.371 0 C-N-CA 120.484 -0.865 . . . . 75.4 112.734 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.484 ' HB ' HD21 ' A' ' 530' ' ' LEU . 79.6 t -96.05 127.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.633 -0.506 . . . . 60.31 109.633 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.08 142.07 43.73 Favored 'General case' 0 CA--C 1.491 -1.324 0 O-C-N 123.868 0.73 . . . . 72.15 111.409 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.47 HD21 HG12 ' A' ' 514' ' ' VAL . 18.2 mt -100.08 -39.79 7.93 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 115.533 -0.758 . . . . 71.04 110.5 -176.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 38.6 t -73.92 98.75 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 108.587 -0.894 . . . . 75.02 108.587 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 136.52 -15.89 3.85 Favored Glycine 0 N--CA 1.424 -2.101 0 CA-C-N 114.313 -1.312 . . . . 73.21 110.173 -174.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.29 176.57 5.09 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-O 120.904 0.383 . . . . 71.34 111.681 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 37.3 m -91.11 161.09 15.24 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.889 -0.596 . . . . 71.1 111.235 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -55.42 -47.93 75.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.991 0.916 . . . . 71.31 111.694 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.481 ' HA ' HG22 ' A' ' 528' ' ' VAL . 36.3 mt-10 -62.42 -31.71 72.45 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 123.885 0.874 . . . . 71.14 112.429 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.85 -41.41 95.73 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.132 -0.692 . . . . 61.43 109.132 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.465 HG13 HD22 ' A' ' 519' ' ' LEU . 35.0 t -71.37 -39.44 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.993 -1.003 . . . . 72.11 110.389 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.663 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.9 m -65.18 -42.07 93.25 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.303 0 C-N-CA 119.347 -0.941 . . . . 71.13 110.164 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 36.8 m -62.09 -41.81 98.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.343 0.592 . . . . 72.42 110.199 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.484 HD21 ' HB ' ' A' ' 517' ' ' VAL . 54.7 tp -61.43 -46.26 90.84 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 124.125 0.97 . . . . 73.55 109.694 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.2 tt -63.39 -44.96 93.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.452 0.701 . . . . 74.23 112.408 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 28.0 mmm180 -63.06 -32.82 74.27 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.349 0.595 . . . . 72.2 109.943 -177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 43.2 t -72.31 -44.39 62.77 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-N 115.076 -0.965 . . . . 74.31 109.779 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 86.3 m 69.6 -70.57 0.14 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.886 0.874 . . . . 65.53 110.839 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.594 ' HA ' ' HE3' ' A' ' 535' ' ' LYS . 1.3 tpmt? 168.6 166.49 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 104.245 -2.502 . . . . 73.35 104.245 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 86.8 mtp -87.69 -28.59 21.71 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.025 -0.67 . . . . 64.34 109.257 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.66 -77.06 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.271 -0.877 . . . . 71.5 111.624 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 156.46 -29.31 0.56 Allowed Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 119.502 -1.332 . . . . 64.23 112.934 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 4.3 m -94.19 141.3 28.71 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.208 -1.405 . . . . 71.21 107.208 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 5.0 p -124.61 136.49 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 N-CA-C 109.223 -0.658 . . . . 74.11 109.223 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.4 m -92.25 132.87 36.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.937 -0.394 . . . . 71.01 109.937 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.599 HD23 HD23 ' A' ' 464' ' ' LEU . 1.3 mm? -124.18 138.56 54.4 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.096 -1.446 . . . . 74.14 107.096 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 39.2 tp -119.03 122.35 41.95 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 106.765 -1.569 . . . . 63.2 106.765 173.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.519 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 31.9 m -114.74 161.56 13.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 109.371 -0.604 . . . . 73.22 109.371 -177.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.443 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 84.4 t80 -132.96 129.2 37.94 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.405 0.621 . . . . 74.23 111.307 -177.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -122.13 140.87 52.03 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.194 -1.039 . . . . 75.44 108.194 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -77.35 135.97 38.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.969 -1.493 . . . . 74.31 106.969 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 65.48 -160.56 0.27 Allowed 'General case' 0 C--O 1.24 0.588 0 O-C-N 124.165 0.915 . . . . 62.41 109.379 -172.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--N 1.305 -1.368 0 C-N-CA 120.052 -0.659 . . . . 75.02 110.268 -177.959 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.078 0 N-CA-C 110.165 -1.174 . . . . 53.05 110.165 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 43.5 m -87.12 84.22 7.31 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 117.674 0.737 . . . . 74.14 112.798 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -142.35 87.38 2.01 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 108.533 -0.914 . . . . 72.23 108.533 173.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -148.56 133.89 18.48 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.679 -0.691 . . . . 72.13 110.022 -177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 25.7 m -114.68 95.39 5.22 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.956 -1.127 . . . . 64.14 107.956 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -79.38 103.86 9.59 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.443 -0.947 . . . . 71.35 108.443 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -136.79 144.97 44.0 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.699 -1.137 . . . . 75.31 108.24 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.81 112.07 23.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.519 -0.919 . . . . 71.42 108.519 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 121.32 96.48 1.46 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 108.175 -1.97 . . . . 73.14 108.175 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.576 ' HA ' ' HE3' ' A' ' 458' ' ' LYS . 0.4 OUTLIER -92.75 132.7 36.72 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 120.909 0.385 . . . . 64.12 110.111 -172.045 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 79.7 mtm180 -100.55 142.38 32.11 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.998 -1.112 . . . . 75.52 107.998 172.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -132.48 132.43 42.7 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 109.264 -0.643 . . . . 65.41 109.264 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -95.55 115.71 27.81 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.753 -1.573 . . . . 54.22 106.753 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.36 142.84 38.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.689 -0.856 . . . . 53.33 108.689 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.515 ' HB3' HG22 ' A' ' 539' ' ' THR . 75.7 mt-30 -120.32 127.22 52.15 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.446 -0.502 . . . . 71.51 111.666 176.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.657 HD13 ' HB2' ' A' ' 502' ' ' ASP . 3.9 mm? -114.7 132.29 56.46 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.377 -0.972 . . . . 74.54 108.377 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 39.6 ttmt -105.19 136.13 45.27 Favored 'General case' 0 N--CA 1.401 -2.892 0 CA-C-O 121.832 0.825 . . . . 72.21 110.768 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.449 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 37.5 ttpt -72.8 102.44 3.39 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 113.937 -1.483 . . . . 71.55 109.471 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -137.9 -84.28 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.422 -1.071 . . . . 43.23 110.422 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' THR . . . . . 0.52 ' O ' ' HA2' ' A' ' 497' ' ' GLY . 26.9 m -91.25 123.95 35.08 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.661 -1.607 . . . . 73.32 106.661 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.638 ' HB3' ' CA ' ' A' ' 497' ' ' GLY . 10.9 tp10 39.17 52.85 2.14 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 125.157 1.383 . . . . 61.4 108.214 -174.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.449 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . -53.14 127.88 36.79 Favored Glycine 0 N--CA 1.416 -2.681 0 CA-C-N 113.393 -1.731 . . . . 63.14 114.144 -171.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.646 ' H ' ' HB2' ' A' ' 498' ' ' ALA . 43.4 mt 65.95 74.34 0.36 Allowed 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 126.351 1.86 . . . . 74.13 110.475 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -92.51 57.15 2.69 Favored Glycine 0 N--CA 1.422 -2.24 0 CA-C-N 113.862 -1.517 . . . . 43.13 111.619 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.597 ' CE2' HD11 ' A' ' 542' ' ' LEU . 33.1 p90 -150.03 142.94 24.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.026 0.441 . . . . 52.3 111.558 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 46.4 p -128.7 164.75 22.27 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.826 -1.079 . . . . 54.25 108.742 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 511' ' ' LEU . 22.7 pt -121.75 153.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 113.409 0.892 . . . . 71.22 113.409 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.8 t -137.18 141.33 42.17 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.178 -0.919 . . . . 63.01 109.567 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.4 m -142.33 131.82 23.78 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.58 -1.267 . . . . 61.15 107.58 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -122.57 -63.74 1.25 Allowed 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.967 -0.693 . . . . 75.05 110.636 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -138.37 152.67 48.64 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 116.301 -0.409 . . . . 74.41 110.175 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 5.2 p -53.72 117.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.784 0.802 . . . . 71.32 110.842 172.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 16.5 p -130.34 -78.18 0.54 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.607 -0.724 . . . . 73.3 111.268 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 62.8 mt -93.07 -43.33 13.57 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 114.873 -1.058 . . . . 74.34 109.857 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -96.08 -150.05 26.44 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.676 -0.773 . . . . 75.1 112.897 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -73.9 -160.01 6.43 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-O 119.972 -0.349 . . . . 75.44 112.837 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 52.6 m -45.46 -40.22 8.06 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.817 0.847 . . . . 72.1 113.265 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -142.22 97.64 6.23 Favored Pre-proline 0 N--CA 1.431 -1.384 0 N-CA-C 108.457 -0.942 . . . . 50.44 108.457 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.477 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 5.2 Cg_exo -78.09 138.91 16.65 Favored 'Trans proline' 0 N--CA 1.441 -1.569 0 C-N-CA 122.089 1.859 . . . . 70.2 111.301 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 47.9 mm -86.42 120.61 36.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.943 -0.571 . . . . 72.43 109.954 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 90.6 m-85 -121.22 150.11 41.83 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 122.288 -0.257 . . . . 74.44 110.352 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 41.1 t -72.05 119.82 19.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.931 -0.766 . . . . 75.21 108.931 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -84.65 -57.47 3.12 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.357 -0.838 . . . . 72.34 110.897 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -136.81 151.94 49.73 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.899 -0.591 . . . . 71.51 109.781 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.441 HG13 ' HA ' ' A' ' 506' ' ' LYS . 27.8 mm -123.08 106.94 18.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.881 -1.155 . . . . 74.24 107.881 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.72 113.99 11.84 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 108.982 -0.748 . . . . 75.04 108.982 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.21 29.52 0.39 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 124.903 3.736 . . . . 61.4 112.55 -172.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -154.5 1.98 0.21 Allowed 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 115.568 -0.742 . . . . 71.11 112.133 -175.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.638 ' CA ' ' HB3' ' A' ' 469' ' ' GLU . . . -113.94 -146.63 9.44 Favored Glycine 0 C--O 1.218 -0.849 0 C-N-CA 119.124 -1.512 . . . . 75.4 115.296 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.646 ' HB2' ' H ' ' A' ' 471' ' ' LEU . . . -59.79 -40.49 88.47 Favored 'General case' 0 C--N 1.364 1.225 0 CA-C-N 118.24 1.02 . . . . 63.51 110.563 -173.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.61 -37.82 73.89 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 115.091 -0.959 . . . . 62.44 112.864 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.6 tt -80.14 -35.58 15.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.01 0.374 . . . . 65.12 112.01 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -58.79 -47.28 85.27 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.017 0.437 . . . . 73.35 110.28 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.657 ' HB2' HD13 ' A' ' 464' ' ' LEU . 21.1 m-20 -89.86 -30.19 18.07 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.443 -0.503 . . . . 72.34 110.275 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 76.27 -23.63 1.83 Allowed Glycine 0 CA--C 1.529 0.933 0 N-CA-C 118.075 1.99 . . . . 52.0 118.075 170.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -67.33 -17.46 64.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.834 1.049 . . . . 74.53 113.834 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 42.8 tp -101.76 132.3 47.57 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 122.134 -0.354 . . . . 65.11 111.672 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.441 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.261 0.0 OUTLIER -135.79 146.44 47.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 113.379 0.881 . . . . 62.35 113.379 176.657 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.422 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -65.07 123.39 19.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.306 -0.861 . . . . 53.4 110.609 -177.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 131.67 -18.87 4.82 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 111.064 -0.814 . . . . 50.41 111.064 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -81.05 156.78 25.69 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 109.212 -0.662 . . . . 72.43 109.212 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -95.57 136.49 35.89 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.775 -0.454 . . . . 64.44 109.775 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 519' ' ' LEU . 24.8 mt -85.7 136.01 33.53 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 119.707 -0.797 . . . . 73.53 110.708 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.36 -45.64 10.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.318 -0.623 . . . . 72.31 109.318 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.428 ' HG3' ' HB3' ' A' ' 543' ' ' LEU . 0.0 OUTLIER -155.35 157.13 36.65 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.06 -0.718 . . . . 72.33 109.06 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.642 HG12 HD21 ' A' ' 519' ' ' LEU . 7.6 p -144.46 136.22 21.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-N 116.021 -0.536 . . . . 63.55 109.931 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.3 t30 65.96 12.32 8.34 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 125.505 1.522 . . . . 71.52 111.734 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 92.7 14.05 55.85 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 120.857 -0.687 . . . . 35.42 111.959 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 37.3 t -121.1 146.45 26.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.921 -0.77 . . . . 62.23 108.921 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 518' ' ' ASP . . . . . 0.572 ' O ' ' HE2' ' A' ' 522' ' ' LYS . 5.3 p-10 -88.51 152.66 21.72 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 109.232 -0.655 . . . . 63.44 109.232 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.642 HD21 HG12 ' A' ' 514' ' ' VAL . 18.7 mt -100.53 -52.54 3.32 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.369 -0.532 . . . . 75.31 111.731 -172.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.25 110.01 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.938 0.875 . . . . 70.24 110.503 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 135.42 -33.94 2.36 Favored Glycine 0 N--CA 1.418 -2.534 0 N-CA-C 109.285 -1.526 . . . . 70.5 109.285 -174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.572 ' HE2' ' O ' ' A' ' 518' ' ' ASP . 0.1 OUTLIER -107.93 161.54 14.84 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 109.79 -0.448 . . . . 62.32 109.79 178.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 29.4 m -87.22 162.4 17.48 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.659 -0.246 . . . . 72.32 111.498 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.445 ' O ' HG13 ' A' ' 528' ' ' VAL . 53.8 mt-30 -51.74 -46.92 64.22 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.372 0.669 . . . . 74.33 112.32 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.417 ' HA ' HG22 ' A' ' 528' ' ' VAL . 40.4 mt-10 -60.01 -32.39 70.83 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.209 0.448 . . . . 64.12 112.209 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.13 -39.87 68.51 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.42 -0.585 . . . . 53.13 109.42 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 49.0 t -67.04 -41.75 87.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 74.43 109.584 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.665 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 8.6 m -66.7 -40.94 87.29 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.152 0 C-N-CA 119.209 -0.996 . . . . 74.31 110.012 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.8 m -60.41 -44.1 96.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.296 -0.411 . . . . 61.25 111.382 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.612 HD11 HG13 ' A' ' 514' ' ' VAL . 3.5 pp -67.46 -30.29 69.97 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.299 0.571 . . . . 62.23 110.232 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.44 ' CD1' HD13 ' A' ' 471' ' ' LEU . 65.2 tp -69.85 -48.22 59.71 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.679 -0.691 . . . . 73.23 109.576 175.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 27.6 mmm180 -61.11 -39.11 88.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.642 -0.708 . . . . 72.54 111.85 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 30.6 t -65.25 -38.7 91.17 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.384 -0.598 . . . . 42.32 109.384 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 17.6 m 69.92 166.57 0.28 Allowed 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.474 0.71 . . . . 60.52 111.432 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -81.41 150.98 28.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.653 -1.61 . . . . 75.44 106.653 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 91.9 mmm -63.86 -31.95 73.31 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.772 1.027 . . . . 73.2 113.772 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.27 -32.33 73.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 122.007 0.908 . . . . 72.04 108.675 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 105.68 -14.01 46.21 Favored Glycine 0 N--CA 1.422 -2.28 0 CA-C-N 114.778 -1.101 . . . . 72.24 111.453 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.515 HG22 ' HB3' ' A' ' 463' ' ' GLN . 1.8 m -96.7 129.08 44.17 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.336 -0.616 . . . . 63.34 109.336 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 86.9 t -106.76 133.5 51.15 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 115.532 -0.758 . . . . 73.2 109.915 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 21.8 t -91.48 129.59 37.44 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 109.075 -0.713 . . . . 52.25 109.075 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.597 HD11 ' CE2' ' A' ' 473' ' ' PHE . 3.8 mm? -117.56 130.33 56.34 Favored 'General case' 0 C--N 1.283 -2.309 0 C-N-CA 124.607 1.163 . . . . 74.52 108.846 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 513' ' ' GLU . 54.6 tp -112.8 117.91 33.49 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.733 -1.951 . . . . 63.12 105.733 169.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 25.9 m -115.73 150.98 17.54 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.788 0 C-N-CA 120.133 -0.627 . . . . 74.12 110.075 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -111.77 115.8 29.66 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 106.509 -1.663 . . . . 63.22 106.509 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -109.29 122.81 48.15 Favored 'General case' 0 N--CA 1.399 -3.023 0 CA-C-N 115.213 -0.903 . . . . 74.22 109.093 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -79.35 138.4 37.68 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.358 -0.837 . . . . 70.51 110.02 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -111.96 105.7 14.19 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.836 -0.802 . . . . 71.24 108.836 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 . . . . . 0 CA--C 1.494 -1.203 0 N-CA-C 108.564 -0.902 . . . . 75.13 108.564 179.267 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.82 0 N-CA-C 110.469 -1.052 . . . . 63.14 110.469 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 51.1 m 67.82 113.68 0.04 OUTLIER 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.881 1.273 . . . . 73.21 112.622 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -79.67 88.12 5.18 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.786 0.803 . . . . 70.2 110.674 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -142.24 111.49 6.49 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.665 -1.606 . . . . 63.45 106.665 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 40.5 p -92.42 174.12 7.45 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 116.18 -0.464 . . . . 45.45 111.718 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -80.17 87.71 5.49 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.216 0.532 . . . . 71.33 109.96 175.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -80.29 115.57 19.9 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.425 -1.694 . . . . 51.14 106.425 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 38.2 pt -67.4 -31.45 52.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 113.24 0.83 . . . . 71.24 113.24 -172.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -166.97 -175.21 36.88 Favored Glycine 1 N--CA 1.386 -4.674 0 C-N-CA 119.462 -1.351 . . . . 71.5 111.68 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -125.67 134.59 51.79 Favored 'General case' 0 C--N 1.261 -3.255 0 CA-C-N 114.265 -0.967 . . . . 71.5 109.182 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 97.5 mtt180 -99.36 132.46 44.67 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.246 -1.761 . . . . 53.13 106.246 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 15.6 tp -126.44 132.72 51.42 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.286 -0.566 . . . . 64.52 110.153 -171.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -98.63 114.61 27.15 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-O 121.97 0.89 . . . . 72.23 108.952 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.05 133.54 60.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 CA-C-N 115.074 -0.966 . . . . 64.44 109.754 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 48.4 mt-30 -106.76 128.97 54.68 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.999 -0.68 . . . . 74.33 112.177 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.582 HD23 HD23 ' A' ' 542' ' ' LEU . 4.5 mm? -112.9 150.0 32.39 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.811 -1.086 . . . . 71.33 108.697 175.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 465' ' ' LYS . 35.5 ttpt -107.54 136.37 47.43 Favored 'General case' 0 N--CA 1.389 -3.485 0 O-C-N 124.017 0.823 . . . . 61.3 109.931 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -70.82 85.12 0.67 Allowed 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 115.117 -0.947 . . . . 74.33 108.765 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -84.84 -129.98 2.07 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.45 -0.795 . . . . 62.13 112.253 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 8.7 t -66.91 -57.7 6.43 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.495 0.554 . . . . 65.44 112.495 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.82 -6.82 35.12 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.811 -0.556 . . . . 74.14 110.751 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 58.72 -153.18 29.76 Favored Glycine 0 C--O 1.207 -1.545 0 CA-C-O 118.669 -1.073 . . . . 70.12 112.184 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.576 HD11 HG21 ' A' ' 540' ' ' VAL . 61.1 mt -47.25 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.996 0.903 . . . . 74.53 112.903 -171.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.36 62.12 0.35 Allowed Glycine 0 CA--C 1.475 -2.433 0 CA-C-N 114.399 -1.273 . . . . 75.23 111.003 -176.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -155.58 142.59 19.12 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.932 -0.766 . . . . 63.41 108.932 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.3 m -117.84 158.35 24.98 Favored 'General case' 0 C--N 1.281 -2.4 0 O-C-N 124.112 0.883 . . . . 75.43 109.226 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 17.0 pt -116.73 157.31 17.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.275 0.56 . . . . 72.23 111.469 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.7 t -140.2 155.99 46.69 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 107.898 -1.149 . . . . 72.24 107.898 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 62.7 p -136.41 149.9 48.51 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.924 -0.769 . . . . 70.31 108.924 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -134.94 166.37 23.17 Favored 'General case' 0 N--CA 1.405 -2.687 0 N-CA-C 109.77 -0.455 . . . . 74.22 109.77 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -60.93 137.59 58.21 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 124.373 1.046 . . . . 65.51 108.941 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.34 129.04 50.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-O 121.053 0.454 . . . . 64.12 111.75 -174.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 29.1 m -129.12 10.0 5.79 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 122.843 1.306 . . . . 65.23 109.005 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.2 mp -81.73 -31.7 11.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.659 -1.155 . . . . 61.41 109.865 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 114.76 57.66 0.37 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.835 -0.906 . . . . 55.41 110.835 -176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -160.29 -155.05 7.59 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 111.296 -0.722 . . . . 43.35 111.296 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 38.1 t -124.45 83.37 2.14 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.097 0.448 . . . . 71.13 110.88 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 45.05 99.47 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.378 0 C-N-CA 125.806 1.642 . . . . 62.51 114.946 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.61 138.55 26.87 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.32 2.013 . . . . 65.42 112.465 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 46.0 mm -93.57 136.42 25.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.778 -0.823 . . . . 43.35 108.778 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -131.18 159.33 38.03 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 121.986 0.114 . . . . 73.32 110.776 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.33 121.34 26.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.017 -0.734 . . . . 72.15 109.017 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -83.16 -57.15 3.4 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.303 0.573 . . . . 72.34 110.113 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -147.0 153.73 40.4 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.701 -0.681 . . . . 71.42 109.935 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.539 HG12 ' HB2' ' A' ' 507' ' ' ALA . 33.7 mm -114.06 106.48 20.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.081 -1.081 . . . . 63.54 108.081 175.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.2 mp -61.47 122.37 70.23 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 109.085 -0.709 . . . . 51.2 109.085 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.449 ' C ' HG21 ' A' ' 500' ' ' ILE . 87.7 Cg_endo -69.86 28.42 0.18 Allowed 'Trans proline' 0 N--CA 1.521 3.127 1 C-N-CA 125.733 4.289 . . . . 75.23 115.038 -170.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.505 ' N ' HG21 ' A' ' 500' ' ' ILE . 13.6 ptm180 -163.51 -0.81 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 113.179 0.807 . . . . 72.32 113.179 -175.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -97.33 -166.16 32.45 Favored Glycine 0 C--N 1.306 -1.103 0 C-N-CA 119.613 -1.279 . . . . 72.44 112.421 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.458 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -49.55 -48.6 48.3 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 125.451 1.5 . . . . 74.12 112.758 -172.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.473 ' HA ' HD11 ' A' ' 464' ' ' LEU . . . -56.74 -47.16 80.66 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 115.492 -0.777 . . . . 62.35 112.108 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.505 HG21 ' N ' ' A' ' 496' ' ' ARG . 0.0 OUTLIER -81.33 -35.99 14.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 123.488 0.715 . . . . 72.55 112.908 179.283 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.8 mm100 -67.79 -37.73 82.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.014 0.435 . . . . 73.31 110.929 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.473 ' HB2' HD13 ' A' ' 464' ' ' LEU . 10.0 m-20 -87.77 -30.41 20.3 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.531 -0.914 . . . . 61.34 108.531 174.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 68.75 49.26 44.03 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.311 -0.859 . . . . 62.23 113.537 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -118.04 -38.51 3.21 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.361 -0.935 . . . . 64.43 111.497 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 58.6 tp -109.01 148.47 30.72 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.529 -0.305 . . . . 71.25 110.39 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.492 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -137.46 170.75 15.55 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 123.306 0.378 . . . . 72.33 110.021 177.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.539 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -88.2 85.18 6.89 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.956 0.725 . . . . 71.24 112.956 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 176.4 19.44 0.02 OUTLIER Glycine 0 C--N 1.293 -1.806 0 CA-C-N 114.658 -1.156 . . . . 54.11 110.254 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -116.82 153.25 32.81 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-O 121.02 0.438 . . . . 75.12 110.983 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.453 HH21 HG21 ' A' ' 520' ' ' VAL . 38.4 ttt180 -94.27 134.65 36.52 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.485 -0.779 . . . . 73.24 110.201 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.693 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.2 mm? -83.21 129.59 35.02 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.016 -0.993 . . . . 74.01 110.16 174.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 545' ' ' PHE . 36.2 mm -107.52 -43.64 6.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.152 0.501 . . . . 64.41 109.971 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 517' ' ' VAL . 28.9 tt0 -158.49 155.02 27.73 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.554 -0.748 . . . . 74.32 110.02 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 541' ' ' SER . 3.5 p -143.49 125.52 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 109.484 -0.562 . . . . 74.35 109.484 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 515' ' ' ASN . . . . . 0.419 ' HA ' ' OG ' ' A' ' 541' ' ' SER . 27.5 m120 62.48 12.79 5.64 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 125.367 1.467 . . . . 62.11 114.029 -176.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 101.69 15.55 26.62 Favored Glycine 0 C--N 1.31 -0.91 0 C-N-CA 120.201 -0.999 . . . . 63.43 112.875 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 513' ' ' GLU . 61.1 t -116.48 128.75 73.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.614 -0.884 . . . . 72.41 108.614 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.22 144.14 29.13 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.172 -0.677 . . . . 71.21 109.172 -173.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.693 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 33.6 mt -97.86 -49.54 4.76 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.762 0.652 . . . . 71.33 112.762 -171.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 520' ' ' VAL . . . . . 0.453 HG21 HH21 ' A' ' 510' ' ' ARG . 95.7 t -70.81 96.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 122.274 1.035 . . . . 64.35 111.087 -175.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 145.62 -23.44 1.83 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 109.143 -1.583 . . . . 71.34 109.143 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.57 178.02 4.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 120.666 0.27 . . . . 61.03 111.172 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 6.5 m -89.8 159.54 16.97 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.613 -0.721 . . . . 73.13 109.48 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -60.58 -43.97 96.74 Favored 'General case' 0 C--O 1.222 -0.347 0 O-C-N 123.089 0.243 . . . . 73.13 111.341 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.52 ' HA ' HG22 ' A' ' 528' ' ' VAL . 1.6 mp0 -56.86 -35.83 69.34 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.037 -0.529 . . . . 73.13 111.337 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -62.52 -38.69 90.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.818 -0.628 . . . . 74.32 109.703 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.12 -36.72 31.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.452 -0.795 . . . . 60.1 110.144 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.57 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 14.8 m -65.29 -41.4 91.33 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 C-N-CA 119.718 -0.793 . . . . 71.33 110.424 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 46.0 t -60.93 -40.07 91.87 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.494 0.664 . . . . 72.22 110.02 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.443 ' CD2' HG13 ' A' ' 514' ' ' VAL . 36.8 tp -64.33 -36.47 84.24 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 124.371 1.068 . . . . 71.42 109.814 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 471' ' ' LEU . 25.6 tp -70.9 -45.31 64.54 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.682 -0.69 . . . . 73.33 109.333 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -59.69 -39.86 85.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.164 0.986 . . . . 71.44 110.891 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 29.1 t -64.77 -41.52 95.82 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.393 -0.821 . . . . 71.31 109.923 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 87.4 m 63.73 -91.05 0.03 OUTLIER 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.477 0.711 . . . . 33.51 111.072 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt 166.98 145.89 0.02 OUTLIER 'General case' 0 C--O 1.25 1.1 0 N-CA-C 105.757 -1.942 . . . . 71.33 105.757 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.5 mtt -66.37 -40.81 89.97 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.982 -0.287 . . . . 73.24 111.537 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.4 -79.84 0.06 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 119.248 -0.406 . . . . 73.12 111.944 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 178.66 -25.98 0.05 OUTLIER Glycine 0 C--O 1.218 -0.89 0 C-N-CA 116.634 -2.698 . . . . 55.04 116.562 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 1.3 p -94.78 120.37 34.89 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 114.926 1.454 . . . . 74.55 114.926 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 471' ' ' LEU . 98.7 t -107.95 131.98 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 114.239 -1.346 . . . . 72.55 108.646 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 24.2 p -95.39 114.58 26.36 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.256 0.551 . . . . 64.15 111.193 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.582 HD23 HD23 ' A' ' 464' ' ' LEU . 2.9 mm? -103.76 122.94 46.12 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.161 -1.052 . . . . 53.14 108.161 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 44.3 tp -103.92 117.92 35.46 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 106.445 -1.687 . . . . 63.42 106.445 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 29.0 m -116.79 161.22 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 120.63 -0.428 . . . . 71.22 110.789 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.528 ' HB2' HD11 ' A' ' 512' ' ' ILE . 91.9 t80 -111.33 117.48 33.25 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.367 0.604 . . . . 73.42 109.59 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -105.71 138.22 42.26 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.354 -1.35 . . . . 60.44 107.354 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -95.09 120.09 34.72 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.349 -0.982 . . . . 63.12 108.349 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -101.35 88.97 3.6 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.821 -0.807 . . . . 74.21 108.821 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 11.4 t70 . . . . . 0 C--N 1.303 -1.413 0 CA-C-N 114.958 -1.019 . . . . 63.13 109.268 -176.366 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.428 0 N-CA-C 111.979 -0.448 . . . . 74.03 111.979 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 67.5 m -156.36 165.76 35.41 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.707 -0.849 . . . . 71.34 108.707 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -85.24 136.25 33.59 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.671 -1.233 . . . . 73.35 107.671 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -64.3 110.26 2.18 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.171 0.434 . . . . 72.32 112.171 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 28.8 m -73.21 -40.36 64.78 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.537 -1.283 . . . . 70.01 107.537 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -98.55 98.74 9.88 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.735 -1.121 . . . . 61.41 109.915 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -139.3 137.32 35.74 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.999 -1.111 . . . . 73.21 107.999 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 11.0 tt -114.38 116.12 51.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 120.544 -0.462 . . . . 73.53 110.898 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 74.81 172.84 30.26 Favored Glycine 0 N--CA 1.398 -3.868 0 CA-C-O 122.261 0.923 . . . . 52.42 113.318 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -122.08 133.86 54.77 Favored 'General case' 0 C--N 1.264 -3.129 0 CA-C-N 114.022 -1.089 . . . . 73.11 111.968 176.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 93.5 mtt180 -104.66 135.4 46.13 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.331 -0.988 . . . . 72.53 108.331 175.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 6.4 mp -131.76 142.01 49.65 Favored 'General case' 0 CA--C 1.48 -1.742 0 CA-C-O 120.735 0.303 . . . . 74.42 110.953 -172.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -98.01 115.98 29.3 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.263 -0.88 . . . . 73.01 108.693 174.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' ILE . . . . . 0.413 HG23 ' HG2' ' A' ' 504' ' ' ARG . 71.0 mt -123.77 123.17 66.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.13 -0.941 . . . . 63.12 110.12 -175.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.502 ' HB3' ' CG2' ' A' ' 539' ' ' THR . 87.6 mt-30 -100.41 137.29 39.03 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.836 -0.746 . . . . 74.43 112.558 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 505' ' ' LEU . 4.3 mm? -116.66 136.26 53.11 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 115.112 -0.949 . . . . 74.51 110.228 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.8 120.48 42.38 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 106.861 -1.533 . . . . 72.13 106.861 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -45.73 100.9 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.753 1.221 . . . . 74.12 111.465 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -92.96 -121.59 3.07 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.5 -0.773 . . . . 72.31 112.953 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' THR . . . . . 0.717 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 36.3 m -59.87 -56.97 15.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.943 0.497 . . . . 64.34 111.737 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -112.32 -6.69 14.03 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.672 0.749 . . . . 63.13 111.58 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 77.79 -156.51 44.34 Favored Glycine 0 C--O 1.199 -2.088 0 CA-C-O 118.377 -1.235 . . . . 55.51 110.949 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.473 HD11 HG21 ' A' ' 540' ' ' VAL . 41.6 mt -50.41 102.36 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.71 1.255 . . . . 71.44 112.9 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -122.35 53.64 0.72 Allowed Glycine 0 N--CA 1.422 -2.281 0 CA-C-N 114.488 -1.233 . . . . 62.22 111.257 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.633 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 6.1 p90 -126.51 145.16 50.62 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.746 -1.576 . . . . 74.5 106.746 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 38.9 m -114.97 138.33 50.97 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 109.033 -0.728 . . . . 62.13 109.033 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 14.2 pt -109.72 152.58 11.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-O 121.421 0.629 . . . . 75.12 111.786 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.418 HG21 ' HE3' ' A' ' 491' ' ' LYS . 9.1 t -136.34 159.61 41.23 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.27 -1.382 . . . . 74.42 107.27 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.647 ' HB3' ' OE1' ' A' ' 524' ' ' GLN . 33.3 p -118.82 142.47 47.69 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 109.021 -0.733 . . . . 54.15 109.021 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -109.36 115.63 30.32 Favored 'General case' 0 N--CA 1.418 -2.028 0 C-N-CA 119.673 -0.811 . . . . 72.23 108.964 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -41.18 126.28 2.63 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 125.448 1.499 . . . . 62.4 113.135 -174.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 9.4 p -80.29 -20.2 11.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.238 -0.892 . . . . 71.3 110.716 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 29.4 m 62.51 78.18 0.3 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.452 -0.795 . . . . 71.03 110.245 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 51.4 mm 64.98 94.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 114.378 -1.283 . . . . 72.52 110.567 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -170.29 -103.3 0.16 Allowed Glycine 0 CA--C 1.492 -1.352 0 C-N-CA 120.666 -0.778 . . . . 72.43 112.147 -177.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -170.59 112.06 0.44 Allowed Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 120.606 -0.807 . . . . 74.04 112.097 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 53.2 m 72.31 -44.74 0.6 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.482 1.66 . . . . 53.12 115.482 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 78.59 143.14 0.09 OUTLIER Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 124.638 1.175 . . . . 62.25 110.366 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.22 144.72 92.46 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 122.796 2.331 . . . . 71.43 113.449 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.411 HG13 ' HB3' ' A' ' 519' ' ' LEU . 24.2 mm -95.58 133.51 36.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.156 -0.929 . . . . 74.25 109.014 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.05 151.76 51.08 Favored 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 122.079 -0.388 . . . . 75.2 110.642 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 56.2 t -84.52 119.02 32.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.709 -0.849 . . . . 54.21 108.709 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.418 ' HE3' HG21 ' A' ' 476' ' ' THR . 5.2 tppp? -83.1 -55.86 4.12 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.629 0.772 . . . . 74.21 110.167 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -141.65 152.89 44.34 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.487 -0.778 . . . . 63.33 110.49 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.495 HG12 ' HB2' ' A' ' 507' ' ' ALA . 30.0 mm -117.11 105.09 17.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.735 -1.58 . . . . 74.34 106.735 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.09 146.36 88.19 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 116.114 -0.494 . . . . 60.45 111.463 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.447 ' C ' HG21 ' A' ' 500' ' ' ILE . 84.9 Cg_endo -74.82 12.28 1.21 Allowed 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 124.579 3.519 . . . . 62.43 116.189 -172.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.717 ' O ' ' HB ' ' A' ' 468' ' ' THR . 13.0 ptp180 -155.37 3.48 0.19 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 115.361 1.615 . . . . 74.22 115.361 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.519 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -83.92 -161.14 31.78 Favored Glycine 0 C--N 1.286 -2.195 0 C-N-CA 119.265 -1.445 . . . . 75.42 112.625 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -69.1 -39.35 79.04 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 123.414 0.686 . . . . 73.02 110.001 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -56.86 -42.76 80.31 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 114.441 -1.254 . . . . 73.53 111.827 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.56 HG21 ' N ' ' A' ' 496' ' ' ARG . 0.0 OUTLIER -80.03 -37.15 17.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 112.571 0.582 . . . . 73.15 112.571 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.5 mm100 -61.13 -40.85 95.36 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.814 0.34 . . . . 72.42 110.641 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.511 ' HB2' HD13 ' A' ' 464' ' ' LEU . 6.4 m-20 -84.11 -43.3 15.17 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.21 -0.45 . . . . 50.14 109.969 174.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 70.44 13.97 71.46 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 121.346 -0.454 . . . . 63.21 113.62 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.413 ' HG2' HG23 ' A' ' 462' ' ' ILE . 77.6 ttt180 -88.16 -14.06 39.63 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.433 0.635 . . . . 70.02 109.686 -178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.542 ' HB2' HD21 ' A' ' 464' ' ' LEU . 49.2 tp -114.83 138.39 50.83 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.88 -1.156 . . . . 64.31 107.88 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.466 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -140.98 169.34 17.81 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.811 0.671 . . . . 61.42 112.811 178.483 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.495 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -82.55 161.9 22.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.013 -0.539 . . . . 62.4 111.938 -173.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 74.96 42.21 30.63 Favored Glycine 0 CA--C 1.506 -0.485 0 N-CA-C 110.802 -0.919 . . . . 74.05 110.802 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -146.68 149.11 32.81 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.959 -1.497 . . . . 73.34 106.959 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.453 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 41.6 ttm180 -87.7 138.22 31.66 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 118.095 0.407 . . . . 73.23 111.385 -174.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.494 ' HG ' HD11 ' A' ' 519' ' ' LEU . 25.9 tp -100.23 127.38 46.52 Favored 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 108.442 -0.948 . . . . 73.23 108.442 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.542 ' HB ' HD12 ' A' ' 543' ' ' LEU . 34.5 mm -100.97 -47.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.096 0.474 . . . . 74.54 110.966 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 543' ' ' LEU . 10.5 pt-20 -157.13 149.35 22.9 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 109.022 -0.733 . . . . 62.44 109.022 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 541' ' ' SER . 7.1 p -137.57 134.43 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 CA-C-O 121.254 0.55 . . . . 73.14 109.727 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 515' ' ' ASN . . . . . 0.449 HD22 ' HD2' ' A' ' 535' ' ' LYS . 0.1 OUTLIER 58.81 23.21 11.0 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 127.003 2.121 . . . . 53.14 112.944 -179.292 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 89.72 15.4 58.21 Favored Glycine 0 CA--C 1.502 -0.752 0 C-N-CA 121.036 -0.602 . . . . 63.24 112.538 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.5 t -115.38 131.41 67.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 O-C-N 122.709 -0.289 . . . . 71.14 110.308 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.73 130.48 35.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.343 0.657 . . . . 70.02 110.364 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.494 HD11 ' HG ' ' A' ' 511' ' ' LEU . 10.7 mt -95.87 -30.5 13.62 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.587 0.708 . . . . 72.32 110.205 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 55.3 t -58.83 -34.74 53.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.133 -1.394 . . . . 64.44 112.049 -171.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -99.38 20.68 48.81 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.929 -0.653 . . . . 51.21 113.831 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.422 ' HB2' ' CD ' ' A' ' 526' ' ' GLU . 0.1 OUTLIER -138.46 -179.83 6.03 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 117.797 0.798 . . . . 70.02 111.954 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 32.6 m -92.16 163.21 14.02 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.649 0.261 . . . . 63.51 111.471 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.647 ' OE1' ' HB3' ' A' ' 477' ' ' SER . 43.6 tp60 -59.7 -44.93 93.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.329 1.052 . . . . 75.13 110.694 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.491 ' HA ' HG22 ' A' ' 528' ' ' VAL . 47.8 mt-10 -62.32 -31.95 72.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.695 0.628 . . . . 64.12 112.695 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.422 ' CD ' ' HB2' ' A' ' 522' ' ' LYS . 50.1 mt-10 -63.81 -36.83 85.2 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.651 -0.5 . . . . 64.41 109.651 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.464 HG13 HD22 ' A' ' 519' ' ' LEU . 17.3 t -73.68 -36.51 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 115.588 -0.733 . . . . 74.44 109.478 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 13.9 m -69.45 -39.39 78.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.417 0 C-N-CA 119.592 -0.843 . . . . 63.15 111.177 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.9 t -62.33 -43.3 99.14 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.196 0.522 . . . . 64.05 109.661 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.85 -41.84 78.66 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.811 1.244 . . . . 61.31 109.383 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 473' ' ' PHE . 3.2 tt -69.0 -45.13 71.32 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.921 -1.036 . . . . 73.12 112.58 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.537 ' HA ' ' HE ' ' A' ' 532' ' ' ARG . 1.1 mmp_? -62.15 -43.72 98.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.554 -0.294 . . . . 73.14 110.48 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.1 m -68.54 -32.36 72.25 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.226 -0.443 . . . . 71.04 111.434 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 51.4 m 68.49 -94.88 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.02 0.528 . . . . 55.55 111.348 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.449 ' HD2' HD22 ' A' ' 515' ' ' ASN . 86.1 tttt 169.26 141.17 0.02 OUTLIER 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.435 -1.32 . . . . 74.04 107.435 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 86.8 mtp -68.75 -31.87 71.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.646 0.26 . . . . 71.43 111.598 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -59.61 -38.33 80.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.315 0.578 . . . . 71.21 110.288 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 112.02 -29.74 8.22 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.159 -1.02 . . . . 74.22 114.129 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 463' ' ' GLN . 6.4 m -103.93 136.3 43.84 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.973 -0.691 . . . . 61.44 109.238 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 471' ' ' LEU . 61.3 t -118.92 138.24 50.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.915 -0.584 . . . . 41.44 110.039 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 69.2 m -91.93 115.0 27.7 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-O 121.077 0.465 . . . . 63.54 111.478 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.633 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.3 mm? -102.09 119.73 39.27 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.8 -1.185 . . . . 75.22 107.8 176.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.542 HD12 ' HB ' ' A' ' 512' ' ' ILE . 2.8 tm? -108.23 117.07 33.2 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 104.832 -2.284 . . . . 52.14 104.832 173.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 33.5 m -115.9 161.33 14.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 115.379 -0.828 . . . . 74.1 111.624 -173.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.453 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 66.4 t80 -120.87 116.55 25.38 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.514 -0.921 . . . . 73.22 108.514 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -102.39 130.49 49.17 Favored 'General case' 0 N--CA 1.396 -3.146 0 CA-C-N 115.054 -0.975 . . . . 74.01 108.77 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.6 142.43 35.65 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 114.598 1.333 . . . . 62.41 114.598 -172.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -153.08 93.11 1.69 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.84 -1.073 . . . . 73.53 108.628 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 19.6 t70 . . . . . 0 C--N 1.301 -1.532 0 N-CA-C 107.841 -1.17 . . . . 71.33 107.841 -179.68 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.492 0 N-CA-C 111.037 -0.825 . . . . 74.33 111.037 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 46.6 m 64.84 -176.93 0.17 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.658 0.783 . . . . 73.44 111.912 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 72.73 -51.32 0.71 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.145 1.165 . . . . 75.41 114.145 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -88.22 91.18 8.68 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.019 0.914 . . . . 74.45 108.891 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 37.2 m -75.11 -39.85 60.35 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.172 -0.922 . . . . 73.21 108.833 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.449 ' HB3' ' HZ3' ' A' ' 454' ' ' LYS . 9.1 mtpm? -94.82 161.65 14.08 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 122.005 0.907 . . . . 65.35 112.093 178.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -140.21 169.52 17.53 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 104.707 -2.331 . . . . 53.15 104.707 176.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.65 85.17 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 105.276 -2.12 . . . . 71.21 105.276 168.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 126.7 161.66 10.97 Favored Glycine 0 N--CA 1.41 -3.063 0 N-CA-C 107.538 -2.225 . . . . 73.43 107.538 -172.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 29.5 mtpp -124.77 151.79 44.68 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 117.721 0.76 . . . . 71.11 111.962 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 95.0 mtt180 -116.17 126.22 53.38 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.821 -1.178 . . . . 62.44 107.821 167.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.2 mp -123.93 142.08 51.46 Favored 'General case' 0 CA--C 1.465 -2.29 0 CA-C-N 116.536 -0.302 . . . . 52.42 110.49 -172.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -98.19 114.95 27.35 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 115.104 -0.953 . . . . 70.23 108.929 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' ILE . . . . . 0.457 HG23 ' CG ' ' A' ' 504' ' ' ARG . 54.9 mt -118.86 129.58 74.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-N 114.893 -1.049 . . . . 72.12 109.463 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.2 mt-30 -115.86 127.94 55.41 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 113.046 0.758 . . . . 72.34 113.046 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.562 HD23 HD23 ' A' ' 542' ' ' LEU . 3.9 mm? -115.64 137.86 51.65 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 115.009 -0.996 . . . . 60.13 109.769 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.46 ' HE2' ' HB3' ' A' ' 465' ' ' LYS . 34.5 ttpt -107.48 135.96 48.08 Favored 'General case' 0 N--CA 1.4 -2.939 0 N-CA-C 108.867 -0.79 . . . . 75.42 108.867 -177.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.451 ' HB2' HG21 ' A' ' 534' ' ' THR . 39.4 ttmt -61.76 98.59 0.1 Allowed 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.639 0.733 . . . . 55.34 111.601 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -130.86 139.55 11.04 Favored Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 108.375 -1.89 . . . . 61.51 108.375 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 469' ' ' GLU 0.365 7.3 t 52.75 -81.55 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.104 1.361 . . . . 62.22 113.819 -175.217 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.43 ' OE1' ' HG3' ' A' ' 496' ' ' ARG . 37.9 mt-10 -106.79 -7.68 17.09 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.732 0.697 . . . . 63.33 110.858 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 67.8 -157.04 52.42 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.255 -0.884 . . . . 72.43 111.826 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 498' ' ' ALA . 5.3 mp -44.4 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.32 1.23 . . . . 63.12 114.32 -170.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -97.54 65.11 0.89 Allowed Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.018 -1.446 . . . . 52.4 111.291 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.446 ' HB3' HD13 ' A' ' 493' ' ' ILE . 27.1 p90 -155.44 147.84 23.88 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.193 -0.504 . . . . 75.15 110.184 176.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -126.27 162.77 24.69 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.474 -0.785 . . . . 35.13 109.446 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.2 pt -119.68 155.46 22.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 120.95 0.405 . . . . 51.41 111.703 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.9 t -135.68 129.53 32.87 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.877 -0.601 . . . . 74.02 110.239 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 24.0 t -143.67 130.75 20.63 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.621 -0.881 . . . . 75.21 108.621 173.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -126.29 38.41 4.14 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 107.297 -1.371 . . . . 72.21 107.297 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' ASP . . . . . 0.581 ' HA ' ' CB ' ' A' ' 486' ' ' ALA . 9.2 t70 69.26 -163.03 0.18 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 112.522 -2.126 . . . . 73.44 108.171 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.495 HG12 ' HD3' ' A' ' 487' ' ' PRO . 33.6 m -91.4 16.67 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.959 -1.126 . . . . 65.12 107.959 177.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 23.7 m 77.83 73.56 0.06 Allowed 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 125.539 1.536 . . . . 62.45 108.575 -173.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 54.0 mt 65.41 90.64 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 113.482 -1.69 . . . . 51.0 111.296 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -167.05 -52.65 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.888 -0.672 . . . . 72.3 112.429 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.8 -27.66 6.42 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.301 -0.476 . . . . 72.14 112.644 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 9.9 p -86.72 40.26 0.89 Allowed 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.131 0.972 . . . . 64.12 111.731 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.581 ' CB ' ' HA ' ' A' ' 479' ' ' ASP . . . -43.12 117.93 2.38 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 125.267 1.427 . . . . 61.15 114.444 -175.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.495 ' HD3' HG12 ' A' ' 480' ' ' VAL . 55.6 Cg_endo -89.13 143.33 4.75 Favored 'Trans proline' 0 N--CA 1.436 -1.895 0 C-N-CA 122.515 2.143 . . . . 75.22 109.998 174.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 511' ' ' LEU . 41.9 mm -96.24 139.65 18.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 109.325 -0.62 . . . . 74.13 109.325 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.17 153.4 48.59 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 122.311 -0.243 . . . . 73.15 110.575 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.408 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 26.3 t -73.74 121.32 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.86 -1.163 . . . . 73.44 107.86 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -90.38 -52.44 4.92 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.563 0.697 . . . . 73.4 110.976 -176.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -146.32 150.89 36.6 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.414 -0.812 . . . . 53.15 110.3 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.522 HG12 ' HB2' ' A' ' 507' ' ' ALA . 34.6 mm -119.96 104.83 16.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 107.444 -1.317 . . . . 62.44 107.444 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -62.9 122.62 75.87 Favored Pre-proline 0 C--N 1.307 -1.253 0 CA-C-N 115.585 -0.734 . . . . 71.31 109.83 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.36 22.79 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 124.768 3.645 . . . . 74.23 114.3 -171.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.43 ' HG3' ' OE1' ' A' ' 469' ' ' GLU . 8.3 ptp180 -157.43 6.99 0.15 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 113.437 0.903 . . . . 72.43 113.437 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -101.14 -149.96 23.54 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 119.814 -1.184 . . . . 74.14 112.449 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 471' ' ' LEU . . . -64.09 -40.29 95.9 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.156 0.582 . . . . 70.0 111.207 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.415 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . -57.08 -36.8 71.01 Favored 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 115.545 -0.752 . . . . 73.31 112.635 -174.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.8 tt -80.72 -42.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.445 0.535 . . . . 62.31 112.445 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 501' ' ' GLN . 14.7 mm-40 -61.46 -37.73 84.66 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.057 0.392 . . . . 73.31 112.057 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.521 ' HB2' HD13 ' A' ' 464' ' ' LEU . 17.5 m-20 -94.93 -28.98 14.9 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 109.442 -0.577 . . . . 72.24 109.442 175.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 499' ' ' ALA . . . 57.7 28.7 60.45 Favored Glycine 0 CA--C 1.496 -1.1 0 CA-C-N 115.467 -0.788 . . . . 74.13 114.36 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.457 ' CG ' HG23 ' A' ' 462' ' ' ILE . 26.7 tpt180 -99.4 -13.94 19.36 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.248 -0.581 . . . . 73.13 110.772 -174.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 49.7 tp -123.41 148.1 46.46 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.541 0.21 . . . . 74.43 110.449 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 506' ' ' LYS . 0.0 OUTLIER -141.98 165.41 27.53 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.764 -0.828 . . . . 71.24 108.764 177.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.522 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -85.39 130.62 34.55 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.48 -0.563 . . . . 62.4 109.48 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 140.85 -20.28 2.71 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.211 -0.756 . . . . 60.43 111.211 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -89.17 165.76 14.26 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-O 121.132 0.491 . . . . 74.52 111.419 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.571 ' NH1' HD13 ' A' ' 512' ' ' ILE . 2.2 tmt_? -107.79 141.03 39.98 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 116.042 -0.526 . . . . 64.02 110.026 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.648 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.6 mm? -86.79 129.09 35.01 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.861 -0.609 . . . . 70.04 112.29 -175.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.571 HD13 ' NH1' ' A' ' 510' ' ' ARG . 32.8 mm -106.69 -59.17 3.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.405 -0.361 . . . . 74.14 110.141 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -158.81 149.27 19.8 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.393 0.433 . . . . 75.14 110.38 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 6.0 p -123.03 129.91 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 109.115 -0.698 . . . . 61.45 109.115 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 60.91 2.77 0.57 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.539 1.135 . . . . 71.54 113.746 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 113.57 -4.28 24.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 121.051 -0.595 . . . . 73.22 112.511 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.5 t -93.22 134.73 30.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.385 -0.598 . . . . 72.02 109.385 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -77.63 145.72 36.56 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 123.601 0.563 . . . . 62.51 110.145 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.648 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 18.8 mt -101.48 -38.14 8.12 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.901 -0.778 . . . . 73.45 108.901 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.22 104.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 115.185 -0.916 . . . . 74.31 108.561 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 136.33 -21.19 3.48 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 108.934 -1.666 . . . . 73.24 108.934 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.97 172.83 7.27 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.514 -0.343 . . . . 74.21 110.511 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 23.8 m -89.24 161.77 16.24 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.326 -0.397 . . . . 75.13 111.226 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -57.83 -46.63 84.46 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 123.005 0.522 . . . . 71.12 111.563 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.535 ' HA ' HG22 ' A' ' 528' ' ' VAL . 48.5 mt-10 -58.18 -32.89 68.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.178 -0.465 . . . . 70.34 112.118 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.13 -41.62 90.22 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.325 -0.62 . . . . 73.42 109.325 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 44.2 t -70.28 -37.34 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 115.495 -0.775 . . . . 44.43 110.199 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.662 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.1 m -66.29 -41.26 88.73 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.439 0 C-N-CA 119.731 -0.788 . . . . 54.13 110.514 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.6 t -63.19 -42.95 99.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.205 0.526 . . . . 71.31 109.718 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 29.1 tp -59.96 -34.93 73.94 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.838 1.255 . . . . 73.11 110.099 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.45 ' CD1' HD23 ' A' ' 471' ' ' LEU . 26.5 tp -77.64 -47.98 17.95 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.856 -0.611 . . . . 54.24 110.312 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 4.8 mmp_? -57.79 -41.06 81.31 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.005 0.522 . . . . 74.34 110.887 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 46.0 m -60.34 -30.2 69.38 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.878 -0.601 . . . . 64.12 111.562 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 534' ' ' THR . . . . . 0.451 HG21 ' HB2' ' A' ' 466' ' ' LYS . 40.8 m 67.26 -91.14 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.399 0.68 . . . . 71.23 111.76 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 537' ' ' GLU . 88.6 tttt 164.93 144.35 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 104.535 -2.394 . . . . 74.24 104.535 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 85.0 mtp -66.91 -25.49 66.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.769 0.713 . . . . 63.34 111.444 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 537' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 0.9 OUTLIER -64.87 -65.65 0.65 Allowed 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.053 -1.091 . . . . 75.1 108.053 172.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 143.39 -31.56 1.92 Allowed Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 119.084 -1.532 . . . . 64.12 114.662 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 465' ' ' LYS . 1.8 m -94.57 142.19 27.73 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.344 -0.943 . . . . 64.13 109.214 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 58.2 t -122.43 142.16 39.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 123.575 0.75 . . . . 75.33 109.062 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.7 m -105.76 113.4 26.94 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.44 0.638 . . . . 74.44 110.674 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.562 HD23 HD23 ' A' ' 464' ' ' LEU . 2.6 mm? -102.36 119.03 38.13 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.899 -1.148 . . . . 74.14 107.899 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 2.9 tm? -104.77 115.95 31.19 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 105.216 -2.142 . . . . 75.22 105.216 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 32.7 m -117.41 161.01 16.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.024 -0.989 . . . . 73.44 111.328 -174.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 86.9 t80 -112.06 117.96 34.1 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 108.399 -0.963 . . . . 55.23 108.399 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -105.82 131.9 52.59 Favored 'General case' 0 N--CA 1.411 -2.382 0 N-CA-C 107.968 -1.123 . . . . 74.14 107.968 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -78.94 134.97 36.82 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 116.117 -0.492 . . . . 65.1 110.218 -175.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -107.57 101.97 11.26 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.502 0.668 . . . . 73.4 109.678 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 C--N 1.292 -1.934 0 N-CA-C 107.687 -1.227 . . . . 74.33 107.687 179.852 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.997 0 N-CA-C 110.308 -1.117 . . . . 55.14 110.308 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 23.1 p -89.72 88.79 7.51 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.381 0.61 . . . . 73.52 111.414 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -87.19 101.6 13.66 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.547 -0.908 . . . . 74.4 108.547 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -128.06 100.28 5.81 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.244 -0.435 . . . . 72.12 110.69 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 23.6 p -98.54 142.93 29.52 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.84 -0.618 . . . . 65.15 109.951 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -82.54 -34.11 27.95 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.157 0.503 . . . . 72.14 110.281 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -105.25 149.56 25.88 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.504 -0.924 . . . . 74.12 108.504 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 10.6 tt -100.63 85.3 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 122.094 0.95 . . . . 72.14 112.032 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 546' ' ' ARG . . . -112.87 92.12 0.61 Allowed Glycine 0 CA--C 1.485 -1.829 0 N-CA-C 108.607 -1.797 . . . . 54.41 108.607 174.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -136.86 169.64 17.43 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.822 0.344 . . . . 61.15 110.819 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 71.3 mtm180 -100.43 148.78 24.36 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.633 -0.712 . . . . 73.34 109.306 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -130.95 134.22 46.54 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.283 -0.636 . . . . 65.33 109.283 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -92.88 115.47 28.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.909 -1.145 . . . . 74.34 107.909 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' ILE . . . . . 0.415 HG23 ' CG ' ' A' ' 504' ' ' ARG . 60.6 mt -119.94 137.64 53.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 115.746 -0.661 . . . . 70.12 109.844 -174.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.0 mt-30 -120.83 127.52 52.0 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.744 0.646 . . . . 73.04 112.744 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.584 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.2 mm? -113.8 142.13 46.45 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 114.895 -1.048 . . . . 63.55 111.002 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -101.34 127.33 48.01 Favored 'General case' 0 N--CA 1.398 -3.029 0 N-CA-C 107.584 -1.265 . . . . 72.2 107.584 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.11 95.6 0.13 Allowed 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.903 -0.59 . . . . 61.52 109.594 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -136.95 153.51 21.79 Favored Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 115.511 -0.768 . . . . 32.45 111.856 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 22.0 m 59.28 -91.74 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.945 1.298 . . . . 74.22 111.497 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -101.84 -3.98 27.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.291 0.567 . . . . 75.11 109.918 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.29 -161.22 54.21 Favored Glycine 0 C--O 1.205 -1.706 0 CA-C-O 118.922 -0.932 . . . . 70.44 111.595 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.507 HD11 HG21 ' A' ' 540' ' ' VAL . 66.4 mt -48.36 99.94 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.832 0.825 . . . . 72.25 112.712 -171.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -111.28 61.0 0.31 Allowed Glycine 0 CA--C 1.479 -2.184 0 CA-C-N 114.567 -1.197 . . . . 44.23 111.641 -174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -150.13 142.26 24.06 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 109.138 -0.69 . . . . 65.33 109.138 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.5 p -115.53 155.19 28.0 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.943 -0.571 . . . . 60.43 110.58 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.6 pt -116.33 150.34 18.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.059 0.457 . . . . 64.23 111.757 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.415 ' CB ' ' HE3' ' A' ' 491' ' ' LYS . 9.0 t -136.22 147.07 47.43 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.476 -0.784 . . . . 72.54 109.987 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 57.9 p -142.41 131.74 23.53 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.862 -0.792 . . . . 63.03 108.862 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -107.86 -68.87 0.88 Allowed 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.618 -0.433 . . . . 63.33 112.069 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -152.28 144.11 23.66 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.215 -1.032 . . . . 70.44 108.215 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.586 HG21 ' H ' ' A' ' 484' ' ' GLY . 13.7 p -72.25 125.24 30.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.549 0.69 . . . . 74.43 112.174 -176.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 30.0 m -109.61 78.7 1.15 Allowed 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 108.492 -0.929 . . . . 71.4 108.492 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 62.1 mt 58.75 98.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.482 1.113 . . . . 70.34 112.289 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 173.94 -59.09 0.13 Allowed Glycine 0 C--N 1.318 -0.456 0 C-N-CA 120.222 -0.99 . . . . 43.24 113.05 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' GLY . . . . . 0.586 ' H ' HG21 ' A' ' 480' ' ' VAL . . . -176.68 -121.5 0.67 Allowed Glycine 0 C--N 1.312 -0.75 0 C-N-CA 120.856 -0.688 . . . . 24.11 111.615 -177.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 485' ' ' SER . . . . . 0.418 ' O ' ' HB ' ' A' ' 480' ' ' VAL . 50.1 m -73.78 -59.08 2.88 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.939 0.4 . . . . 70.44 111.336 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -161.96 153.81 15.97 Favored Pre-proline 0 N--CA 1.438 -1.039 0 N-CA-C 108.293 -1.003 . . . . 62.03 108.293 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.564 ' HD3' ' HA ' ' A' ' 480' ' ' VAL . 9.6 Cg_endo -93.61 134.68 1.0 Allowed 'Trans proline' 0 N--CA 1.433 -2.061 0 C-N-CA 122.369 2.046 . . . . 71.31 109.974 176.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.19 132.14 41.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.34 -0.615 . . . . 54.31 109.34 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 90.8 m-85 -129.02 152.76 48.28 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 110.31 -0.255 . . . . 55.22 110.31 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.39 119.51 30.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.469 -0.937 . . . . 75.04 108.469 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.415 ' HE3' ' CB ' ' A' ' 476' ' ' THR . 4.7 tppp? -82.15 -59.62 2.5 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.791 -0.64 . . . . 74.14 110.722 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -140.16 155.49 46.93 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 120.316 -0.554 . . . . 61.35 110.675 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.534 HG12 ' HB2' ' A' ' 507' ' ' ALA . 33.8 mm -119.2 104.8 16.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.306 -1.368 . . . . 62.3 107.306 177.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.23 130.53 89.5 Favored Pre-proline 0 C--N 1.307 -1.282 0 CA-C-N 116.022 -0.535 . . . . 55.41 111.084 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.81 18.03 0.2 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 125.027 3.818 . . . . 73.12 115.45 -171.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -161.13 6.81 0.07 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 113.916 1.08 . . . . 72.11 113.916 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -91.63 -155.86 32.17 Favored Glycine 0 C--N 1.294 -1.754 0 C-N-CA 119.464 -1.35 . . . . 73.12 113.085 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.416 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -63.39 -41.6 98.78 Favored 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 123.942 0.897 . . . . 72.03 109.876 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.542 ' HA ' HD11 ' A' ' 464' ' ' LEU . . . -56.65 -43.81 80.69 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 114.856 -1.065 . . . . 75.43 112.074 -173.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.1 tt -80.49 -29.34 12.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 112.19 0.441 . . . . 65.42 112.19 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -48.26 81.3 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.226 -1.028 . . . . 71.01 108.226 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.584 ' HB2' HD13 ' A' ' 464' ' ' LEU . 10.2 m-20 -87.08 -34.23 19.22 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 109.789 -0.449 . . . . 62.4 109.789 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 62.45 39.59 98.0 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.504 -0.771 . . . . 65.32 112.538 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.415 ' CG ' HG23 ' A' ' 462' ' ' ILE . 30.0 tpt180 -111.36 -4.89 14.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.33 0.586 . . . . 71.21 109.917 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 57.7 tp -125.73 142.74 51.36 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.857 -0.611 . . . . 71.51 110.546 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.492 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.28 0.0 OUTLIER -138.51 164.55 29.14 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.17 -0.468 . . . . 70.13 111.854 175.451 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.534 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.46 156.43 22.89 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.655 0.613 . . . . 75.21 112.655 -171.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.5 8.0 55.17 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.99 -0.624 . . . . 73.25 113.682 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -113.33 164.96 12.91 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 117.388 0.594 . . . . 63.42 110.191 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.408 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 43.1 ttm180 -89.95 129.32 36.3 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 123.095 0.247 . . . . 74.31 110.624 -177.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.93 124.33 33.02 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 106.069 -1.826 . . . . 75.31 106.069 177.346 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 50.7 mm -96.3 -51.11 11.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 120.562 0.22 . . . . 53.54 111.258 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -157.99 148.85 20.9 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 116.102 -0.499 . . . . 74.24 109.66 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 541' ' ' SER . 3.7 p -130.05 125.51 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.523 0 CA-C-N 116.025 -0.534 . . . . 71.32 109.566 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 59.51 26.9 15.94 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 114.864 -1.062 . . . . 75.41 112.067 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.54 -4.8 73.41 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.748 -0.66 . . . . 63.33 113.367 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.44 124.84 47.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.393 -0.595 . . . . 71.13 109.393 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -84.01 141.69 31.01 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.727 0.642 . . . . 74.35 109.382 -173.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.535 HD11 HD12 ' A' ' 511' ' ' LEU . 19.0 mt -99.72 -42.96 6.63 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.161 0.8 . . . . 73.21 113.161 -171.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.14 89.08 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-O 122.23 1.014 . . . . 74.24 110.629 -174.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 151.03 -13.87 0.85 Allowed Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 113.994 -1.457 . . . . 73.24 109.693 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.82 177.78 4.65 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 122.85 -0.206 . . . . 74.44 110.89 175.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 48.9 m -88.61 156.68 18.9 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.514 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.419 ' O ' HG13 ' A' ' 528' ' ' VAL . 24.2 tt0 -58.76 -44.38 90.59 Favored 'General case' 0 C--O 1.21 -0.996 0 C-N-CA 122.487 0.315 . . . . 71.14 110.514 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.519 ' HA ' HG22 ' A' ' 528' ' ' VAL . 28.3 mm-40 -57.72 -31.46 66.44 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 112.661 0.615 . . . . 61.55 112.661 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -66.58 -39.8 88.62 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.188 -0.671 . . . . 71.22 109.188 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 33.8 t -75.48 -36.39 35.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.135 -0.938 . . . . 73.24 110.285 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.704 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 10.7 m -63.67 -44.81 98.58 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 C-N-CA 120.351 -0.54 . . . . 65.3 109.933 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.7 m -64.51 -36.98 85.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.4 0.619 . . . . 74.5 110.267 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 32.6 tp -61.03 -43.6 98.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.736 1.214 . . . . 63.32 109.428 175.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.45 HD12 HD13 ' A' ' 471' ' ' LEU . 35.2 tp -67.3 -48.03 68.83 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.75 -0.659 . . . . 74.24 109.845 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.704 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 32.2 mmm180 -57.41 -30.11 64.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.731 0.813 . . . . 64.42 111.192 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 61.2 m -73.6 -43.64 59.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.925 -0.579 . . . . 61.21 111.532 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 40.4 m 68.26 142.2 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.664 0.786 . . . . 74.14 111.311 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.523 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 60.4 tptt -59.9 132.17 53.12 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.636 -0.711 . . . . 74.42 109.641 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -63.35 -20.11 65.22 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.513 0.725 . . . . 64.23 111.938 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 537' ' ' GLU . . . . . 0.523 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 38.4 tt0 -73.89 -15.17 61.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.492 0.663 . . . . 70.31 110.253 177.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 94.69 -20.29 49.37 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.085 -0.579 . . . . 71.11 112.333 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 463' ' ' GLN . 2.7 m -114.19 128.79 56.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.748 -1.204 . . . . 72.23 107.748 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.521 HG22 ' H ' ' A' ' 535' ' ' LYS . 57.4 t -105.23 134.19 47.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 C-N-CA 122.816 0.446 . . . . 61.14 110.5 -176.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 29.9 m -98.48 115.14 27.9 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.744 -0.662 . . . . 54.2 110.832 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.484 HD23 HD23 ' A' ' 464' ' ' LEU . 2.7 mm? -110.95 124.68 52.6 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.4 -0.963 . . . . 60.1 108.4 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 53.0 tp -104.23 118.34 36.41 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.534 -1.654 . . . . 64.32 106.534 174.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.4 m -116.06 145.59 21.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 120.293 -0.563 . . . . 74.24 111.27 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -112.02 116.42 30.53 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.066 -1.086 . . . . 65.02 108.066 175.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 546' ' ' ARG . . . . . 0.494 ' O ' ' HA2' ' A' ' 457' ' ' GLY . 0.0 OUTLIER -103.7 120.89 41.85 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 108.2 -1.037 . . . . 73.44 108.2 178.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -98.37 143.53 28.73 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.993 -0.549 . . . . 74.14 109.843 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 548' ' ' GLU . . . . . 0.428 ' HB2' ' NH1' ' A' ' 546' ' ' ARG . 31.4 tt0 -116.88 110.18 18.01 Favored 'General case' 0 N--CA 1.418 -2.034 0 C-N-CA 120.468 -0.493 . . . . 64.2 110.065 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--O 1.25 1.104 0 CA-C-N 114.682 -1.144 . . . . 74.44 111.149 -177.817 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.544 0 N-CA-C 111.497 -0.641 . . . . 44.14 111.497 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 40.7 t -73.05 -42.21 63.36 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.765 -0.828 . . . . 74.13 108.765 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -144.65 154.27 42.62 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 107.373 -1.343 . . . . 71.13 107.373 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -79.0 113.21 16.94 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 120.43 -0.508 . . . . 65.13 109.928 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 27.4 m -75.84 99.32 4.42 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.783 -0.821 . . . . 61.45 108.783 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -110.21 98.96 8.1 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 116.17 -0.468 . . . . 74.44 111.418 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -137.05 115.1 11.52 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.703 -0.851 . . . . 72.23 108.703 176.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 38.0 pt -90.77 1.81 7.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 122.483 1.135 . . . . 72.3 108.639 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 158.76 145.17 4.16 Favored Glycine 1 N--CA 1.395 -4.039 0 N-CA-C 108.355 -1.898 . . . . 65.53 108.355 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.785 ' HE2' ' H ' ' A' ' 458' ' ' LYS . 0.0 OUTLIER -137.83 170.64 15.7 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 109.538 -0.542 . . . . 62.54 109.538 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 97.6 mtt180 -99.13 142.28 30.82 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.881 -0.785 . . . . 74.21 108.881 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.1 mm? -123.72 133.71 53.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.189 -0.671 . . . . 73.11 109.189 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -100.07 116.62 32.51 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.454 -0.943 . . . . 64.35 108.454 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' ILE . . . . . 0.434 HG21 ' HB3' ' A' ' 504' ' ' ARG . 57.0 mt -123.3 125.02 71.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.61 -0.723 . . . . 73.54 110.959 -173.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.8 mt-30 -91.52 126.78 36.72 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.993 0.738 . . . . 61.42 112.993 178.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.1 mm? -115.79 144.34 44.12 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.4 1.08 . . . . 71.33 110.332 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -103.03 136.67 42.41 Favored 'General case' 0 N--CA 1.404 -2.75 0 N-CA-C 107.833 -1.173 . . . . 73.51 107.833 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.491 ' HA ' ' HA2' ' A' ' 470' ' ' GLY . 23.5 ttmm -54.44 99.58 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.766 0.794 . . . . 72.14 111.328 175.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -85.3 -147.57 9.49 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 114.943 -1.026 . . . . 73.32 111.454 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 16.7 m -55.41 -45.41 76.72 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.978 0.511 . . . . 61.21 110.946 -177.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.59 9.81 17.98 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 120.691 0.281 . . . . 62.32 111.137 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 58.01 -141.96 44.71 Favored Glycine 0 C--O 1.185 -2.967 0 CA-C-O 117.17 -1.905 . . . . 63.23 109.804 -170.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.538 ' H ' HD22 ' A' ' 471' ' ' LEU . 2.5 mm? -44.08 108.61 0.12 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.54 1.67 . . . . 70.51 112.459 -173.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -100.19 47.78 1.25 Allowed Glycine 0 N--CA 1.421 -2.311 0 CA-C-N 114.55 -1.204 . . . . 53.42 112.433 -173.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -140.92 144.8 35.39 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 109.356 -0.609 . . . . 71.32 109.356 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 18.8 m -114.6 139.38 49.66 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.889 -1.523 . . . . 52.32 106.889 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 489' ' ' TYR . 14.8 pt -111.46 151.24 13.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-O 120.976 0.417 . . . . 62.51 112.072 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -144.73 151.17 38.49 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.888 -0.596 . . . . 73.23 109.618 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 78.3 p -142.67 129.88 20.94 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.138 -0.69 . . . . 54.41 109.138 175.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -153.28 14.97 0.52 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.008 0.908 . . . . 61.12 109.065 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -106.46 11.29 30.9 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.709 -1.132 . . . . 72.34 108.78 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 486' ' ' ALA . 7.6 p -79.48 84.7 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-O 122.032 0.92 . . . . 70.41 111.431 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.4 t -145.8 4.91 1.0 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.481 -0.781 . . . . 65.4 110.435 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 482' ' ' ILE . 2.7 mp -103.93 10.32 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 N-CA-C 106.803 -1.554 . . . . 74.23 106.803 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 140.73 -120.62 1.77 Allowed Glycine 0 N--CA 1.427 -1.951 0 CA-C-N 114.607 -1.178 . . . . 63.05 110.246 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -121.72 9.25 9.91 Favored Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 108.142 -1.983 . . . . 74.05 108.142 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 13.6 p -79.73 65.01 4.76 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.487 -0.856 . . . . 75.3 110.721 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . . . -69.81 112.11 11.24 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-N 114.644 -1.162 . . . . 74.41 109.22 174.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.579 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 3.2 Cg_exo -77.41 135.25 14.69 Favored 'Trans proline' 0 N--CA 1.427 -2.422 0 C-N-CA 121.144 1.229 . . . . 64.12 110.166 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.568 HG13 ' HB3' ' A' ' 519' ' ' LEU . 34.2 mm -90.52 119.94 38.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.286 -1.005 . . . . 64.42 108.286 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 78.8 m-85 -121.63 152.95 38.75 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 122.281 -0.262 . . . . 74.52 111.492 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 47.2 t -78.56 119.06 26.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.973 -0.751 . . . . 74.11 108.973 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -84.52 -53.84 5.15 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.78 -0.646 . . . . 75.55 109.425 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -143.13 154.04 43.5 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.327 -0.852 . . . . 64.42 109.044 -175.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.502 HG12 ' HB2' ' A' ' 507' ' ' ALA . 26.2 mm -110.44 110.2 31.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.842 -1.17 . . . . 71.12 107.842 174.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.0 mp -52.82 128.04 44.92 Favored Pre-proline 0 C--N 1.321 -0.665 0 O-C-N 123.941 0.776 . . . . 73.51 110.372 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.49 20.48 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 124.668 3.578 . . . . 71.32 114.908 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.44 ' O ' ' HB ' ' A' ' 468' ' ' THR . 14.2 ptp180 -168.82 5.9 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.323 0.583 . . . . 65.23 112.459 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -83.86 -167.87 42.81 Favored Glycine 0 C--N 1.298 -1.561 0 C-N-CA 119.893 -1.146 . . . . 65.43 112.663 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 464' ' ' LEU . . . -55.86 -47.4 77.39 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 124.932 1.293 . . . . 75.31 111.151 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.23 -40.6 77.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.743 -1.117 . . . . 72.53 112.559 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 8.5 tt -79.94 -40.43 20.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 112.57 0.582 . . . . 63.14 112.57 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 8.2 mm-40 -67.43 -37.87 83.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 72.34 110.841 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.567 ' HB2' HD13 ' A' ' 464' ' ' LEU . 7.8 m-20 -91.56 -21.95 20.59 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 116.116 -0.493 . . . . 63.55 109.87 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 63.92 55.78 22.46 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 120.742 -0.742 . . . . 54.54 114.803 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.434 ' HB3' HG21 ' A' ' 462' ' ' ILE . 14.3 mmm180 -123.85 -73.53 0.64 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.873 -0.731 . . . . 73.54 110.796 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.537 HD13 HG11 ' A' ' 544' ' ' VAL . 67.4 tp -73.68 137.7 44.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.778 0.323 . . . . 64.13 111.807 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.464 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.267 0.0 OUTLIER -126.32 174.26 8.7 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.717 -0.674 . . . . 74.13 112.403 177.061 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.502 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.18 138.8 33.49 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 113.435 0.902 . . . . 62.13 113.435 -171.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 105.39 13.88 23.43 Favored Glycine 0 C--N 1.321 -0.253 0 CA-C-N 115.583 -0.735 . . . . 71.5 112.577 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.63 162.44 13.96 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 122.678 0.391 . . . . 74.3 110.398 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -101.45 134.36 44.66 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 120.81 -0.356 . . . . 74.04 110.649 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.597 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 3.6 mm? -86.97 132.99 33.63 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.553 -0.749 . . . . 62.01 110.171 174.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.426 HG21 ' HD3' ' A' ' 459' ' ' ARG . 49.7 mm -111.72 -39.07 3.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.06 -0.718 . . . . 74.42 109.06 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 543' ' ' LEU . 32.7 tt0 -154.72 148.43 25.42 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.517 -0.765 . . . . 61.12 109.156 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.597 HG13 HD11 ' A' ' 530' ' ' LEU . 6.8 p -136.51 125.47 37.07 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.077 0 N-CA-C 107.397 -1.334 . . . . 63.3 107.397 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 72.33 -52.27 0.7 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 125.982 1.713 . . . . 73.23 111.963 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 163.29 30.61 0.02 OUTLIER Glycine 0 C--N 1.287 -2.146 0 N-CA-C 109.519 -1.432 . . . . 72.21 109.519 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.1 t -122.5 134.43 65.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.305 -0.447 . . . . 64.2 109.902 -175.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.0 148.77 36.06 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.704 -0.48 . . . . 72.42 109.704 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.597 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 60.5 mt -111.51 -45.81 3.34 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 113.338 0.866 . . . . 73.32 113.338 -171.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.68 -1.31 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 113.146 0.795 . . . . 70.44 113.146 -172.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -112.41 12.18 25.95 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 111.616 -0.594 . . . . 63.13 111.616 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.413 ' NZ ' ' HB3' ' A' ' 522' ' ' LYS . 0.2 OUTLIER -146.53 -177.59 5.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 117.172 0.486 . . . . 53.52 111.505 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 523' ' ' SER . . . . . 0.466 ' O ' HG23 ' A' ' 527' ' ' VAL . 76.3 p -96.17 163.3 13.16 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.214 0.53 . . . . 74.22 111.998 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.522 ' O ' HG13 ' A' ' 528' ' ' VAL . 37.9 mm-40 -55.24 -41.91 72.74 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.987 -1.006 . . . . 75.25 111.962 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.44 ' HA ' HG22 ' A' ' 528' ' ' VAL . 43.2 mt-10 -63.08 -31.81 73.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.105 0.479 . . . . 73.34 112.178 -175.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.88 -36.03 67.28 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.737 -0.665 . . . . 75.01 110.529 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.567 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 17.5 t -75.39 -41.5 42.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.393 -0.595 . . . . 73.31 109.393 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.709 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.3 m -62.18 -43.46 97.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 120.356 -0.538 . . . . 64.25 110.942 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.9 t -64.5 -37.06 86.22 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.451 -0.341 . . . . 73.31 111.325 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.597 HD11 HG13 ' A' ' 514' ' ' VAL . 1.2 pp -68.07 -37.54 81.39 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.011 -1.107 . . . . 73.53 108.011 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 471' ' ' LEU . 3.6 tt -62.98 -46.49 87.47 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.894 -1.048 . . . . 55.44 111.175 176.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.709 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 27.1 mmm180 -61.68 -33.63 74.32 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.127 -0.488 . . . . 73.13 110.409 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.0 m -82.96 -30.71 28.09 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.073 0.464 . . . . 74.12 110.685 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 534' ' ' THR . . . . . 0.476 HG21 ' HE2' ' A' ' 466' ' ' LYS . 30.5 m 71.98 -83.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.606 1.162 . . . . 64.15 112.115 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.543 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 17.3 tppt? 167.27 157.64 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 106.405 -1.702 . . . . 75.53 106.405 -176.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.94 6.45 18.55 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.77 0.795 . . . . 72.03 110.212 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 537' ' ' GLU . . . . . 0.543 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 13.3 tp10 -96.88 -54.3 3.24 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.039 -1.096 . . . . 75.2 108.039 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 116.39 -20.21 12.54 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.322 -0.942 . . . . 72.51 112.587 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 3.4 m -104.7 136.23 44.6 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.987 -0.745 . . . . 72.3 108.987 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 87.2 t -123.43 136.69 59.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 123.139 0.575 . . . . 73.33 110.743 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.8 t -92.15 114.61 27.2 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.364 -0.606 . . . . 60.24 109.364 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.467 HD13 HD22 ' A' ' 505' ' ' LEU . 43.6 mt -99.51 119.72 38.48 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.498 -0.927 . . . . 61.44 108.498 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.595 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 45.5 tp -104.61 116.93 32.91 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.747 -1.575 . . . . 73.14 106.747 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 31.1 m -122.67 157.96 27.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.924 -0.58 . . . . 64.33 111.886 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -114.4 116.69 29.31 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.863 -0.608 . . . . 73.41 109.703 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -119.84 135.58 54.82 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.699 -0.682 . . . . 71.01 109.463 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -93.37 133.22 36.86 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.599 0.562 . . . . 73.12 111.583 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -102.21 133.02 47.75 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.475 -0.935 . . . . 74.15 108.475 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 C--N 1.292 -1.928 0 N-CA-C 108.992 -0.744 . . . . 73.3 108.992 -177.917 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.439 0 N-CA-C 110.88 -0.888 . . . . 34.04 110.88 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 51.5 m 64.36 86.49 0.12 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.778 0.831 . . . . 64.35 112.519 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -84.06 -52.95 5.89 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.94 -1.133 . . . . 72.23 107.94 175.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 16.2 m120 63.76 22.13 12.95 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.736 -1.12 . . . . 41.2 110.931 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 18.7 p -66.57 -39.02 88.27 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.893 -0.594 . . . . 70.53 110.323 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.92 95.77 10.24 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 109.118 -0.697 . . . . 74.25 109.118 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -132.22 158.2 42.37 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.247 -0.433 . . . . 73.33 110.127 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 11.8 tt -77.56 81.03 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 122.343 1.068 . . . . 74.45 110.767 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . 99.62 131.5 7.36 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 114.364 -1.289 . . . . 42.31 111.976 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 26.7 mtpp -103.5 157.51 16.99 Favored 'General case' 0 CA--C 1.478 -1.791 0 CA-C-O 121.363 0.601 . . . . 74.54 111.185 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 62.2 mtm180 -112.04 129.6 56.15 Favored 'General case' 0 N--CA 1.406 -2.663 0 N-CA-C 107.579 -1.267 . . . . 65.13 107.579 170.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -116.21 131.73 56.86 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.636 -0.875 . . . . 71.23 108.636 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -95.86 115.34 27.29 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.787 -0.82 . . . . 73.24 108.787 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' ILE . . . . . 0.437 HG22 ' CD2' ' A' ' 464' ' ' LEU . 60.8 mt -119.38 123.91 72.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 115.357 -0.838 . . . . 74.43 109.853 -175.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 47.6 mt-30 -102.37 130.55 49.15 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 121.824 -0.547 . . . . 53.31 112.282 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 542' ' ' LEU . 4.3 mm? -115.06 139.48 49.84 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.848 -0.614 . . . . 73.2 111.958 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -91.04 132.67 35.87 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 123.849 0.859 . . . . 72.21 110.481 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -72.87 105.21 4.3 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 114.593 -1.185 . . . . 63.35 109.402 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -144.53 137.33 7.2 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.82 -0.627 . . . . 63.22 111.741 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 35.5 m 64.54 -79.11 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.468 1.107 . . . . 73.55 112.048 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.412 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 5.7 mm-40 -102.28 -11.34 18.79 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.127 -0.694 . . . . 74.21 109.127 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 66.8 -144.51 45.37 Favored Glycine 0 CA--C 1.473 -2.582 0 CA-C-O 117.528 -1.707 . . . . 55.42 108.924 -172.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 531' ' ' LEU . 43.4 mt -52.25 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.316 1.558 . . . . 45.05 112.275 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . -102.43 59.64 0.55 Allowed Glycine 0 CA--C 1.464 -3.122 0 CA-C-N 114.256 -1.338 . . . . 54.11 111.237 -173.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.467 ' HB3' HD13 ' A' ' 493' ' ' ILE . 18.7 p90 -148.01 142.52 26.45 Favored 'General case' 0 C--N 1.258 -3.387 0 N-CA-C 108.117 -1.068 . . . . 72.21 108.117 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 20.0 m -115.0 143.81 44.6 Favored 'General case' 0 C--N 1.271 -2.843 0 N-CA-C 108.157 -1.053 . . . . 71.31 108.157 -176.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 10.2 pt -109.81 156.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-O 121.209 0.528 . . . . 54.4 111.502 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.486 HG21 ' HE2' ' A' ' 491' ' ' LYS . 9.1 t -136.63 141.21 43.21 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.908 -0.775 . . . . 72.14 108.908 176.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 59.3 p -114.44 130.7 56.73 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.749 -1.575 . . . . 43.03 106.749 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -155.91 -18.4 0.1 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 113.939 1.088 . . . . 74.25 113.939 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' ASP . . . . . 0.473 ' HB3' ' HD2' ' A' ' 487' ' ' PRO . 29.8 t70 -81.5 -5.04 57.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.279 1.038 . . . . 74.41 109.846 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 4.4 p -74.91 108.1 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-N 114.7 -1.137 . . . . 74.41 109.631 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.8 t -111.41 3.05 17.88 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.716 -0.674 . . . . 70.51 111.054 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 12.5 tt -153.42 -46.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 116.228 -0.442 . . . . 74.4 110.909 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 137.78 159.31 8.13 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 111.03 -0.828 . . . . 74.41 111.03 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 85.22 -61.74 4.6 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.676 -0.97 . . . . 74.42 110.676 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 26.6 m -87.18 84.02 7.32 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 108.442 -0.947 . . . . 74.11 108.442 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -122.57 98.8 43.02 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.835 -0.62 . . . . 74.43 111.372 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 479' ' ' ASP . 9.6 Cg_exo -74.92 134.93 18.56 Favored 'Trans proline' 0 C--O 1.255 1.347 0 C-N-CA 121.815 1.676 . . . . 74.14 109.464 172.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.534 HD12 ' OE1' ' A' ' 524' ' ' GLN . 41.1 mm -101.32 145.02 12.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.559 -1.275 . . . . 75.54 107.559 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -130.26 149.67 51.85 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 122.214 -0.304 . . . . 64.12 110.357 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 47.3 t -81.52 119.55 31.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.187 -1.042 . . . . 52.4 108.187 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.486 ' HE2' HG21 ' A' ' 476' ' ' THR . 17.8 tppt? -90.44 -52.51 4.88 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.237 0.615 . . . . 63.53 111.272 -177.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 492' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 64.4 t30 -130.18 150.25 51.52 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.076 -0.649 . . . . 75.22 111.327 -173.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 507' ' ' ALA . 28.7 mm -121.22 104.97 15.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.624 -1.25 . . . . 51.1 107.624 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.49 133.97 95.85 Favored Pre-proline 0 C--N 1.311 -1.101 0 CA-C-N 115.437 -0.801 . . . . 64.31 111.283 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.82 14.09 0.55 Allowed 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 124.624 3.549 . . . . 74.31 114.952 -172.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.441 ' HA ' HG21 ' A' ' 500' ' ' ILE . 18.8 ptt180 -156.63 6.09 0.17 Allowed 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 120.016 -0.673 . . . . 71.42 112.606 -176.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.612 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -91.23 -163.01 38.43 Favored Glycine 0 C--N 1.291 -1.936 0 C-N-CA 120.096 -1.049 . . . . 64.41 111.984 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.452 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -55.92 -40.9 73.76 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 125.016 1.326 . . . . 70.35 110.374 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.0 76.21 Favored 'General case' 0 C--O 1.194 -1.861 0 CA-C-N 114.5 -1.227 . . . . 74.23 112.515 -174.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.441 HG21 ' HA ' ' A' ' 496' ' ' ARG . 11.5 tt -80.47 -29.57 12.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 112.216 0.45 . . . . 61.24 112.216 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 73.5 mm-40 -58.53 -45.75 88.22 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.333 -0.617 . . . . 62.24 109.333 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.504 ' HB2' HD13 ' A' ' 464' ' ' LEU . 3.3 m-20 -93.49 -38.28 11.49 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.486 -0.779 . . . . 71.03 110.561 175.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 71.8 17.11 76.54 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.847 -0.692 . . . . 73.21 113.304 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.429 ' CG ' HG23 ' A' ' 462' ' ' ILE . 27.5 tpt180 -91.32 -18.93 23.53 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.172 0.51 . . . . 75.33 110.822 -175.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 46.9 tp -108.52 150.49 27.38 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 110.159 -0.311 . . . . 74.11 110.159 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.41 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -143.98 170.25 16.28 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.38 -0.6 . . . . 74.3 109.38 178.048 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.564 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -89.33 150.2 22.68 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.982 0.42 . . . . 64.43 110.765 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 113.36 -30.56 7.21 Favored Glycine 0 C--N 1.303 -1.303 0 N-CA-C 111.088 -0.805 . . . . 70.15 111.088 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -68.37 146.99 52.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.112 0.482 . . . . 72.01 111.375 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 25.0 ttm180 -85.52 128.68 34.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.165 -0.679 . . . . 53.04 109.165 177.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.471 ' HG ' HD11 ' A' ' 519' ' ' LEU . 22.4 tp -90.03 127.72 36.12 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 108.494 -0.928 . . . . 73.12 108.494 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.454 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.2 mm -98.15 -41.54 10.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.079 0.466 . . . . 74.02 110.247 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -158.65 159.12 35.01 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.602 -0.726 . . . . 61.21 109.778 176.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.29 130.52 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 109.149 -0.685 . . . . 74.13 109.149 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.3 t30 70.05 -48.1 0.62 Allowed 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 127.919 2.488 . . . . 71.13 111.867 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 169.49 8.3 0.03 OUTLIER Glycine 0 C--N 1.293 -1.81 0 CA-C-N 116.101 -0.5 . . . . 45.15 112.159 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 29.2 t -115.08 138.8 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.89 -0.781 . . . . 73.53 108.89 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -83.48 155.83 23.18 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 123.755 0.659 . . . . 75.42 110.28 -174.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.471 HD11 ' HG ' ' A' ' 511' ' ' LEU . 21.7 mt -104.79 -42.24 5.43 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.621 -0.718 . . . . 72.34 111.648 -174.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.7 t -72.37 91.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 115.571 -0.74 . . . . 55.14 109.747 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 144.63 -7.23 1.72 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 110.07 -1.212 . . . . 72.42 110.07 -174.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.442 ' HD3' ' HB2' ' A' ' 526' ' ' GLU . 17.5 ptpt -130.65 -178.46 4.8 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 110.021 -0.363 . . . . 74.13 110.021 175.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 523' ' ' SER . . . . . 0.431 ' O ' HG23 ' A' ' 527' ' ' VAL . 46.2 t -95.56 162.61 13.56 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.113 0.482 . . . . 63.11 111.014 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.534 ' OE1' HD12 ' A' ' 488' ' ' ILE . 7.3 tp60 -58.37 -38.88 78.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.946 -1.024 . . . . 75.32 110.328 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.99 -31.62 72.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.489 -0.778 . . . . 74.25 111.428 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.442 ' HB2' ' HD3' ' A' ' 522' ' ' LYS . 15.1 mm-40 -71.31 -39.89 71.14 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.893 -0.78 . . . . 75.22 108.893 177.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 523' ' ' SER . 18.4 t -69.34 -40.5 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.365 -0.834 . . . . 52.23 110.012 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.609 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.0 m -62.46 -42.56 96.16 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.111 0 C-N-CA 120.16 -0.616 . . . . 74.21 110.383 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.2 t -62.68 -43.31 99.12 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 116.203 -0.453 . . . . 65.21 110.133 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 46.8 tp -58.27 -45.99 86.86 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.522 1.129 . . . . 65.43 109.566 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 471' ' ' LEU . 2.4 tt -62.94 -45.45 92.43 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.391 -0.822 . . . . 72.42 112.362 175.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.7 OUTLIER -58.17 -39.58 79.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.243 0.544 . . . . 71.42 110.416 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.2 t -63.9 -43.57 95.61 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.211 -0.904 . . . . 55.31 110.672 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 63.0 m 67.51 -88.41 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.249 0.62 . . . . 60.42 110.811 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 40.5 tttm 172.74 153.74 0.08 Allowed 'General case' 0 C--O 1.251 1.164 0 N-CA-C 106.685 -1.598 . . . . 64.23 106.685 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 16.0 tpt -75.03 -35.71 61.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.418 -0.513 . . . . 72.42 109.946 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.11 -48.67 56.63 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.977 -0.556 . . . . 71.44 110.56 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 133.12 -28.54 3.31 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 118.564 -1.779 . . . . 61.12 115.984 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 4.5 m -94.93 135.18 36.75 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 118.625 -1.23 . . . . 74.32 109.805 -177.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 63.5 t -118.35 137.29 52.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.851 -0.613 . . . . 72.41 110.267 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 68.9 m -91.86 113.29 25.52 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.426 0.632 . . . . 54.41 111.039 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 464' ' ' LEU . 3.6 mm? -101.36 122.41 43.68 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.657 -0.868 . . . . 73.53 108.657 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 36.9 tp -105.09 118.17 35.85 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.035 -1.469 . . . . 74.13 107.035 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 30.0 m -115.99 154.84 17.45 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 CA-C-O 121.042 0.449 . . . . 74.03 110.786 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.515 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 69.3 t80 -111.77 118.35 35.35 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.522 -0.918 . . . . 71.22 108.522 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -131.15 139.38 49.78 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.504 -1.295 . . . . 63.03 107.504 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -129.4 120.42 25.51 Favored 'General case' 0 C--N 1.269 -2.902 0 C-N-CA 120.298 -0.561 . . . . 64.21 109.823 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.67 99.03 4.91 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.256 -1.387 . . . . 62.24 107.256 173.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 108.958 -0.756 . . . . 71.44 108.958 -176.113 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.482 0 N-CA-C 111.566 -0.613 . . . . 20.33 111.566 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 35.2 p -76.21 146.46 39.07 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 122.229 0.212 . . . . 73.51 110.448 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -79.87 -67.39 0.77 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.938 -0.393 . . . . 71.23 109.938 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -148.96 103.37 3.35 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.791 -0.448 . . . . 41.54 109.791 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 29.3 p -119.74 155.98 31.44 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.328 -0.396 . . . . 73.52 111.898 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt 62.34 34.87 15.43 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.181 0.992 . . . . 72.13 111.81 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -75.48 144.49 42.03 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.463 -0.569 . . . . 61.34 109.463 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 29.6 pt -80.73 -17.2 12.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 112.208 0.447 . . . . 60.14 112.208 -174.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -133.57 109.26 0.8 Allowed Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 120.26 -0.971 . . . . 51.25 112.144 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -113.62 153.23 29.21 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 109.596 -0.52 . . . . 74.3 109.596 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.464 ' HB3' HD11 ' A' ' 543' ' ' LEU . 41.7 mtm180 -111.18 150.89 28.88 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.89 -0.595 . . . . 73.45 109.745 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.9 mm? -131.62 137.33 48.34 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.339 -0.615 . . . . 55.45 109.339 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -103.3 123.56 47.0 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.273 -0.64 . . . . 72.52 109.273 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 76.0 mt -119.26 120.8 64.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.197 -0.668 . . . . 75.31 109.197 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.0 mt-30 -100.75 127.27 47.24 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.39 0.614 . . . . 74.53 111.723 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 502' ' ' ASP . 5.9 tp -114.96 140.33 49.11 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-N 114.655 -1.157 . . . . 72.12 108.281 -173.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.518 ' HA ' ' HE3' ' A' ' 465' ' ' LYS . 1.3 tpmt? -101.98 121.98 43.19 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.303 -0.999 . . . . 62.25 108.303 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -63.49 92.02 0.06 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.786 -0.643 . . . . 73.13 110.103 175.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -116.47 142.87 17.81 Favored Glycine 0 N--CA 1.428 -1.845 0 CA-C-N 115.667 -0.697 . . . . 50.54 111.766 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' THR . . . . . 0.5 HG23 ' H ' ' A' ' 469' ' ' GLU 0.354 10.0 t 52.03 -82.86 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.11 1.764 . . . . 72.21 114.885 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.5 ' H ' HG23 ' A' ' 468' ' ' THR . 32.9 tt0 -97.04 -15.02 21.23 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.847 0.832 . . . . 71.43 109.081 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.42 -155.85 51.67 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 114.981 -1.009 . . . . 75.33 113.419 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 540' ' ' VAL . 5.8 mp -48.12 104.5 0.06 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 113.517 0.932 . . . . 63.21 113.517 -170.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -118.56 54.58 0.62 Allowed Glycine 0 N--CA 1.422 -2.261 0 CA-C-N 114.567 -1.197 . . . . 72.15 111.174 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.525 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 16.2 p90 -136.64 142.24 43.24 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 109.292 -0.633 . . . . 75.55 109.292 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 37.1 p -115.26 153.41 30.94 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.948 -0.569 . . . . 74.02 109.963 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.41 151.3 21.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 121.076 0.465 . . . . 65.3 110.698 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.1 t -144.23 157.4 44.31 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.881 -0.599 . . . . 64.24 109.691 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 61.4 p -141.47 131.87 25.19 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.713 -1.217 . . . . 73.41 107.713 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -118.8 -60.2 1.79 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.94 0.4 . . . . 64.03 110.955 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -157.4 162.62 39.01 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.574 -0.898 . . . . 72.54 108.574 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.613 ' HA ' ' HD2' ' A' ' 487' ' ' PRO . 46.1 t -76.2 96.75 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-O 121.815 0.817 . . . . 64.12 109.889 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.6 p -85.32 -11.19 55.24 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.263 -1.335 . . . . 74.43 112.015 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.424 HG21 ' CZ ' ' A' ' 510' ' ' ARG . 6.4 tp -150.75 -59.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.547 -0.751 . . . . 63.13 112.075 -176.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 483' ' ' GLY . . . . . 0.408 ' H ' HG23 ' A' ' 482' ' ' ILE . . . 177.46 148.62 7.38 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.398 -1.081 . . . . 74.02 110.398 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.34 174.85 15.37 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.792 -0.923 . . . . 70.22 110.792 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 14.8 m -83.25 77.1 9.83 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.355 -0.98 . . . . 71.31 108.355 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.408 ' HA ' ' HD2' ' A' ' 487' ' ' PRO . . . 59.33 80.16 0.28 Allowed Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 114.414 -1.266 . . . . 75.31 109.691 -174.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.613 ' HD2' ' HA ' ' A' ' 480' ' ' VAL . 6.1 Cg_exo -36.43 134.96 0.3 Allowed 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 124.43 3.42 . . . . 44.04 114.601 -177.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.452 HG13 ' HB3' ' A' ' 519' ' ' LEU . 34.6 mm -87.55 130.28 37.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.163 -0.926 . . . . 74.02 108.956 -176.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -128.6 151.15 49.8 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 110.422 -0.214 . . . . 71.04 110.422 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 48.8 t -80.06 119.48 29.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.126 -1.064 . . . . 63.5 108.126 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -73.92 -60.74 2.12 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.102 -0.499 . . . . 74.25 110.536 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -145.51 158.04 43.9 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.369 0.604 . . . . 72.51 110.43 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 506' ' ' LYS . 30.2 mm -116.49 104.92 17.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 106.597 -1.631 . . . . 70.52 106.597 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.33 137.42 94.48 Favored Pre-proline 0 C--N 1.304 -1.37 0 CA-C-N 115.242 -0.89 . . . . 72.43 111.035 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -73.34 17.16 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 124.789 3.659 . . . . 70.11 117.0 -167.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -159.87 3.94 0.08 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 115.132 1.53 . . . . 74.14 115.132 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.499 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -98.69 -154.81 29.01 Favored Glycine 0 C--N 1.297 -1.623 0 C-N-CA 119.672 -1.251 . . . . 74.04 113.834 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.72 86.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.096 0.958 . . . . 44.04 111.616 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.451 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -58.11 -38.85 77.25 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.246 -0.888 . . . . 65.23 112.77 -176.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.5 tt -80.81 -32.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 112.286 0.476 . . . . 62.13 112.286 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 83.4 mm-40 -58.76 -41.92 87.72 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.998 0.428 . . . . 63.44 110.914 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.534 ' HB2' HD12 ' A' ' 464' ' ' LEU . 10.0 m-20 -89.35 -39.76 13.22 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.017 -0.538 . . . . 73.51 110.204 172.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 77.87 -19.18 4.39 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 115.639 1.016 . . . . 74.3 115.639 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -64.84 -23.38 67.22 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.234 0.54 . . . . 74.43 111.214 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.3 tp -92.72 135.64 33.93 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.143 -0.688 . . . . 64.24 109.143 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.51 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -138.4 170.44 16.02 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.199 -0.297 . . . . 74.31 110.199 176.727 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.489 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -86.9 160.03 18.85 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.211 -0.449 . . . . 61.15 110.646 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 103.7 -29.21 12.66 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 121.054 -0.593 . . . . 74.41 113.014 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.56 162.31 24.36 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-O 121.28 0.562 . . . . 74.31 111.929 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.524 ' HD2' HD11 ' A' ' 512' ' ' ILE . 20.0 ttm180 -90.13 126.98 35.99 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.023 -0.99 . . . . 64.03 109.23 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.59 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -88.28 123.7 33.14 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.012 -1.477 . . . . 71.25 107.012 178.454 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.543 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 35.5 mm -98.46 -47.63 12.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 120.956 0.408 . . . . 62.44 111.248 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -158.16 145.52 18.09 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.703 -0.68 . . . . 60.03 110.201 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 541' ' ' SER . 4.5 p -124.72 127.84 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 CA-C-O 121.276 0.56 . . . . 74.13 109.692 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 17.4 m120 59.46 15.6 4.6 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.873 1.269 . . . . 71.14 113.142 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.7 -7.77 33.99 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.682 -0.77 . . . . 63.33 113.854 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.471 ' HB ' HD21 ' A' ' 530' ' ' LEU . 67.3 t -97.77 127.09 50.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 117.563 0.681 . . . . 71.54 110.554 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.24 136.5 40.95 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 123.837 0.855 . . . . 73.14 111.423 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.59 HD11 HD12 ' A' ' 511' ' ' LEU . 13.4 mt -101.64 -23.81 14.2 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.649 0.738 . . . . 55.12 109.935 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.46 -24.56 35.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.498 -1.228 . . . . 52.15 111.47 -171.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -106.9 21.34 32.06 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.988 -0.625 . . . . 54.11 112.742 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.4 178.67 7.43 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.669 0.618 . . . . 75.1 112.669 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 523' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 527' ' ' VAL . 33.7 m -95.73 161.25 14.1 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.169 -0.469 . . . . 74.34 111.856 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.4 ' O ' HG13 ' A' ' 528' ' ' VAL . 42.3 mm-40 -51.33 -46.72 62.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.997 1.319 . . . . 74.12 113.679 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.497 ' HA ' HG22 ' A' ' 528' ' ' VAL . 37.1 mt-10 -60.35 -35.05 74.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.199 0.444 . . . . 74.23 112.199 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -67.22 -40.32 86.4 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.135 -0.691 . . . . 53.15 109.135 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.586 HG13 HD22 ' A' ' 519' ' ' LEU . 30.0 t -70.38 -39.5 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 115.422 -0.808 . . . . 74.21 110.293 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.635 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.6 m -66.37 -39.95 85.43 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 C-N-CA 119.67 -0.812 . . . . 65.2 110.401 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.9 t -62.14 -38.86 90.57 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.489 0.661 . . . . 74.32 109.899 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.471 HD21 ' HB ' ' A' ' 517' ' ' VAL . 59.1 tp -64.13 -39.64 94.47 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 123.861 0.865 . . . . 73.41 109.244 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 2.8 tt -66.61 -45.1 80.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.443 0.697 . . . . 75.33 111.241 173.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 29.3 mmm180 -62.58 -32.98 74.06 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.062 -0.517 . . . . 64.3 110.949 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.0 m -68.32 -30.5 69.5 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 116.111 -0.495 . . . . 72.32 110.572 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 534' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 535' ' ' LYS . 90.7 m 66.81 -86.93 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.301 -0.863 . . . . 74.35 111.462 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 534' ' ' THR . 25.6 tptp 162.92 154.37 0.02 OUTLIER 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.158 -2.164 . . . . 74.05 105.158 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 85.9 mtp -70.41 -20.99 62.88 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.44 0.564 . . . . 61.24 111.655 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.71 -13.98 43.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.355 0.598 . . . . 74.15 109.783 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 75.12 6.08 78.29 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.398 -0.819 . . . . 65.42 112.746 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 6.2 m -104.34 125.1 50.29 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.721 -1.215 . . . . 61.43 107.721 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.526 HG21 HD21 ' A' ' 471' ' ' LEU . 60.2 t -108.65 127.06 65.43 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 CA-C-N 115.673 -0.694 . . . . 72.15 109.329 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 14.9 m -102.12 111.95 24.42 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 119.907 -0.717 . . . . 75.41 109.114 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.525 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 2.5 mm? -99.43 119.27 37.71 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.8 -1.185 . . . . 71.31 107.8 177.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.536 HD12 ' HB ' ' A' ' 512' ' ' ILE . 2.6 tm? -104.6 117.96 35.41 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 105.963 -1.866 . . . . 74.41 105.963 177.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.69 160.51 14.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.287 -0.869 . . . . 43.32 110.196 -174.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.543 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 25.5 t80 -122.53 130.49 53.1 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.418 -1.327 . . . . 73.44 107.418 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -129.87 118.27 21.46 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.266 0.555 . . . . 74.34 109.718 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -101.59 142.89 32.26 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.017 -0.992 . . . . 70.13 112.858 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -71.77 139.29 48.97 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 107.938 -1.134 . . . . 73.32 107.938 175.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 27.7 t70 . . . . . 0 C--N 1.304 -1.398 0 N-CA-C 109.273 -0.639 . . . . 71.43 109.273 -177.379 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.083 0 N-CA-C 110.314 -1.114 . . . . 61.31 110.314 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 39.6 m -125.51 85.99 2.48 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 121.034 0.445 . . . . 75.54 110.559 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -140.08 77.66 1.62 Allowed 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.398 -0.819 . . . . 74.31 110.544 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -137.92 104.18 5.19 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.112 -1.07 . . . . 74.15 108.112 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 86.9 m 75.47 -18.42 0.45 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.505 0.722 . . . . 73.43 111.762 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp 71.56 155.25 0.15 Allowed 'General case' 0 C--O 1.245 0.854 0 C-N-CA 124.567 1.147 . . . . 74.51 112.045 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -102.86 115.71 31.14 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 105.804 -1.924 . . . . 72.52 105.804 169.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 456' ' ' ILE . 2.1 mp -78.15 105.34 7.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.403 -0.591 . . . . 74.13 109.403 -174.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 126.37 135.6 4.26 Favored Glycine 0 N--CA 1.419 -2.49 0 CA-C-N 115.74 -0.664 . . . . 71.55 112.47 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -100.79 133.83 44.67 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 123.552 0.741 . . . . 72.11 110.356 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 70.4 mtm180 -100.85 138.69 37.57 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 107.628 -1.249 . . . . 75.11 107.628 172.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 459' ' ' ARG . 6.1 mp -130.29 134.07 46.95 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 123.236 0.335 . . . . 72.4 110.221 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -94.38 115.71 27.96 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.66 -0.7 . . . . 71.53 109.189 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' ILE . . . . . 0.482 HG23 ' CG ' ' A' ' 504' ' ' ARG . 66.0 mt -120.92 141.92 39.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.659 -0.701 . . . . 74.5 110.356 -174.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 76.2 mt-30 -123.93 130.34 52.44 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.517 0.562 . . . . 75.54 112.517 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.615 HD23 HD23 ' A' ' 542' ' ' LEU . 4.2 mm? -115.6 133.48 55.99 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 124.122 0.969 . . . . 61.35 109.466 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 22.5 ttpp -102.82 134.96 45.36 Favored 'General case' 0 N--CA 1.397 -3.096 0 CA-C-O 121.437 0.637 . . . . 75.43 109.839 -177.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -58.88 126.7 28.78 Favored 'General case' 0 C--N 1.268 -2.952 0 CA-C-N 114.699 -1.137 . . . . 62.33 109.561 175.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' GLY . . . . . 0.588 ' H ' ' HA2' ' A' ' 470' ' ' GLY . . . -140.22 -138.18 3.57 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 115.722 -0.672 . . . . 74.31 111.494 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 468' ' ' THR . . . . . 0.499 HG23 ' H ' ' A' ' 469' ' ' GLU . 10.0 t -50.08 -70.72 0.08 Allowed 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 123.7 0.8 . . . . 72.31 113.057 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.499 ' H ' HG23 ' A' ' 468' ' ' THR . 0.6 OUTLIER -92.65 -2.62 55.94 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.451 -0.781 . . . . 73.54 110.351 175.038 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.588 ' HA2' ' H ' ' A' ' 467' ' ' GLY . . . 54.52 -149.23 19.65 Favored Glycine 0 C--O 1.2 -1.988 0 CA-C-N 114.603 -1.18 . . . . 23.04 113.264 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.544 HD11 HG21 ' A' ' 540' ' ' VAL . 66.2 mt -53.54 99.39 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 117.955 0.877 . . . . 54.25 111.324 -173.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -118.19 54.5 0.61 Allowed Glycine 0 N--CA 1.416 -2.673 0 CA-C-N 114.467 -1.242 . . . . 43.32 111.15 -174.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.462 ' HB3' HD13 ' A' ' 493' ' ' ILE . 20.4 p90 -137.56 141.28 41.36 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 114.984 -0.608 . . . . 74.53 109.441 173.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 36.7 m -118.41 148.92 42.05 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.489 -0.778 . . . . 63.54 109.508 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.3 pt -111.05 153.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.179 0.514 . . . . 74.12 111.822 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 491' ' ' LYS . 9.7 t -134.05 159.9 39.39 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.455 -1.313 . . . . 75.32 107.455 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 31.0 p -130.29 154.62 47.44 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.845 -0.428 . . . . 73.01 109.845 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.442 ' O ' ' HD2' ' A' ' 487' ' ' PRO . 26.5 mtm180 -132.56 167.18 20.48 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 106.071 -1.826 . . . . 75.51 106.071 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -72.63 136.72 45.75 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.104 -1.073 . . . . 72.45 108.104 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 484' ' ' GLY . 14.6 p -65.79 129.88 30.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 114.433 1.272 . . . . 64.42 114.433 -171.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 26.8 m -124.06 86.29 2.55 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 106.444 -1.687 . . . . 75.33 106.444 171.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 mp 68.28 103.07 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 124.135 0.974 . . . . 72.12 111.218 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 167.19 -30.34 0.18 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 119.962 -1.113 . . . . 74.34 113.732 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' GLY . . . . . 0.406 ' O ' HG21 ' A' ' 480' ' ' VAL . . . 132.59 -144.7 16.59 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.605 -0.998 . . . . 75.11 110.605 -177.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 30.2 m -89.59 87.5 7.06 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.949 -0.7 . . . . 71.45 111.663 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.472 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . . . 67.57 120.55 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 124.872 1.269 . . . . 73.21 113.577 176.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.533 ' HA ' HG12 ' A' ' 520' ' ' VAL . 14.9 Cg_endo -88.68 135.86 3.05 Favored 'Trans proline' 0 N--CA 1.439 -1.677 0 C-N-CA 122.199 1.933 . . . . 62.53 112.311 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.501 ' O ' ' HG3' ' A' ' 510' ' ' ARG . 49.9 mm -97.19 136.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.515 -0.766 . . . . 73.13 109.5 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.605 ' CE1' ' HD3' ' A' ' 510' ' ' ARG . 95.1 m-85 -129.46 153.99 47.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 122.223 0.209 . . . . 71.44 111.003 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 44.6 t -80.15 119.47 29.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 107.733 -1.21 . . . . 72.44 107.733 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.425 ' HD2' ' HB ' ' A' ' 476' ' ' THR . 76.0 tttt -95.14 -46.6 6.71 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.52 0.676 . . . . 62.12 110.387 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -137.13 142.33 42.26 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.466 -0.788 . . . . 65.25 109.871 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.471 HG12 ' HB2' ' A' ' 507' ' ' ALA . 28.3 mm -123.93 101.9 10.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 N-CA-C 106.312 -1.736 . . . . 73.3 106.312 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.89 126.85 92.54 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 115.934 -0.575 . . . . 70.31 110.972 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.07 34.38 0.33 Allowed 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 125.011 3.807 . . . . 70.22 112.73 -175.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.432 ' HB2' ' OE2' ' A' ' 469' ' ' GLU . 3.3 ptp180 -164.42 -4.63 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.867 0.691 . . . . 72.22 112.867 -176.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.45 ' O ' HG22 ' A' ' 500' ' ' ILE . . . -92.8 -158.7 34.53 Favored Glycine 0 C--N 1.302 -1.336 0 C-N-CA 119.115 -1.517 . . . . 75.02 112.596 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.71 85.77 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 124.119 0.968 . . . . 70.34 109.591 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.47 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -57.49 -37.79 73.53 Favored 'General case' 0 C--O 1.204 -1.31 0 CA-C-N 114.506 -1.224 . . . . 73.23 112.913 -176.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 497' ' ' GLY . 10.8 tt -81.47 -35.8 14.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.764 0.316 . . . . 35.33 111.83 176.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -58.64 -46.08 87.89 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.984 -0.553 . . . . 75.34 110.185 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.555 ' HB2' HD13 ' A' ' 464' ' ' LEU . 16.4 m-20 -89.47 -36.1 15.6 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.43 -0.581 . . . . 74.35 109.43 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.77 24.88 70.14 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.894 -0.594 . . . . 72.53 113.551 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.482 ' CG ' HG23 ' A' ' 462' ' ' ILE . 8.9 tpt180 -96.26 -11.84 25.4 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.434 -0.507 . . . . 72.41 110.625 -176.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 47.6 tp -120.29 154.19 35.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.687 -0.233 . . . . 74.3 110.654 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.444 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.1 OUTLIER -144.84 159.02 43.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.284 0.634 . . . . 72.42 111.517 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.46 155.55 23.35 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 120.798 0.332 . . . . 75.53 111.103 -176.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.82 18.06 57.0 Favored Glycine 0 C--N 1.312 -0.784 0 N-CA-C 110.713 -0.955 . . . . 63.43 110.713 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.645 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 16.3 t0 -108.74 165.54 11.47 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.99 -1.485 . . . . 72.22 106.99 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.605 ' HD3' ' CE1' ' A' ' 489' ' ' TYR . 44.9 ttp180 -107.64 122.29 46.4 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 118.572 0.624 . . . . 74.41 111.537 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.541 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.32 120.63 27.88 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 107.307 -1.368 . . . . 75.53 107.307 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.608 ' HB ' HD12 ' A' ' 543' ' ' LEU . 47.9 mm -98.39 -43.86 11.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 120.594 0.235 . . . . 74.41 111.579 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 9.3 pt-20 -156.99 148.05 21.89 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.833 -0.432 . . . . 72.04 109.833 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.494 HG12 HD21 ' A' ' 519' ' ' LEU . 5.7 p -129.57 128.44 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 109.77 -0.456 . . . . 75.42 109.77 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 58.61 21.24 8.49 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.137 0.975 . . . . 74.22 112.811 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.45 -5.97 60.89 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.192 -0.528 . . . . 70.45 113.25 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.88 132.37 39.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.608 -0.515 . . . . 63.15 109.608 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -77.3 144.37 38.15 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 123.862 0.726 . . . . 73.14 109.596 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.541 HD11 HD12 ' A' ' 511' ' ' LEU . 22.7 mt -101.36 -52.51 3.23 Favored 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 120.51 -0.476 . . . . 61.21 111.116 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 520' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 487' ' ' PRO . 27.8 m -69.46 97.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.696 0 CA-C-O 122.605 1.193 . . . . 32.45 111.011 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.29 -31.74 1.15 Allowed Glycine 0 N--CA 1.419 -2.498 0 CA-C-N 113.477 -1.692 . . . . 73.53 108.989 -173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.73 174.52 5.83 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.249 -0.476 . . . . 75.44 110.771 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 54.2 m -91.0 159.15 16.3 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.156 0.428 . . . . 75.55 112.156 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -56.95 -46.47 82.1 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.119 0.567 . . . . 72.13 111.752 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.511 ' HA ' HG22 ' A' ' 528' ' ' VAL . 45.0 mt-10 -58.86 -31.95 69.01 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.966 -0.561 . . . . 73.01 111.852 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.96 -41.73 90.87 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.709 -0.478 . . . . 73.25 109.709 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.71 -38.12 71.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.355 -0.839 . . . . 61.13 110.75 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.725 ' O ' ' HG3' ' A' ' 532' ' ' ARG . 19.7 m -65.26 -42.12 93.17 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.136 0 C-N-CA 119.443 -0.903 . . . . 64.45 110.135 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.0 m -62.31 -35.85 80.32 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.734 0.778 . . . . 65.42 109.813 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 22.8 tp -67.47 -36.28 80.84 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 124.941 1.296 . . . . 63.42 110.382 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.426 ' CD1' HD13 ' A' ' 471' ' ' LEU . 54.2 tp -76.36 -48.58 19.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.188 -0.46 . . . . 72.12 111.084 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.725 ' HG3' ' O ' ' A' ' 528' ' ' VAL . 20.4 mtm180 -54.7 -36.04 64.26 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.898 0.479 . . . . 65.22 111.013 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 34.1 t -66.45 -41.3 89.3 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.535 -0.757 . . . . 61.13 111.889 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 15.5 m 64.51 174.12 0.19 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 108.336 -0.987 . . . . 54.35 108.336 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.736 ' HE2' ' O ' ' A' ' 539' ' ' THR . 37.0 mtmt -91.83 168.72 11.25 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 120.651 -1.28 . . . . 71.03 108.023 175.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 83.6 mtp -74.83 -23.01 58.38 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.058 0.456 . . . . 75.4 109.851 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.63 -64.19 0.95 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.724 -1.584 . . . . 73.03 106.724 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 138.08 -19.77 3.25 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 119.971 -1.109 . . . . 75.04 114.393 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.736 ' O ' ' HE2' ' A' ' 535' ' ' LYS . 4.8 m -94.23 136.22 34.76 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.364 -0.976 . . . . 75.44 108.364 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.544 HG21 HD11 ' A' ' 471' ' ' LEU . 91.7 t -111.59 136.31 48.09 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 C-N-CA 123.103 0.561 . . . . 74.22 110.583 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 36.2 t -98.73 119.54 37.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.142 0.496 . . . . 73.42 110.983 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.615 HD23 HD23 ' A' ' 464' ' ' LEU . 2.6 mm? -113.56 123.16 49.31 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.019 -1.104 . . . . 72.23 108.019 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.608 HD12 ' HB ' ' A' ' 512' ' ' ILE . 3.0 tm? -104.84 120.07 40.52 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 105.979 -1.859 . . . . 64.0 105.979 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.645 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 33.6 m -115.03 161.6 13.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.601 -0.727 . . . . 64.12 111.124 -173.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -129.72 116.41 18.74 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.829 -0.623 . . . . 75.05 110.468 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 546' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' A' ' 509' ' ' ASP . 36.0 mtm-85 -129.2 137.45 51.14 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 116.139 -0.482 . . . . 61.15 111.238 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -132.56 143.44 49.72 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.868 -0.605 . . . . 72.25 109.857 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.43 92.45 4.61 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.265 -0.643 . . . . 64.05 109.265 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 C--O 1.251 1.182 0 CA-C-N 114.634 -1.166 . . . . 74.05 108.746 -176.21 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.086 0 N-CA-C 110.564 -1.014 . . . . 72.35 110.564 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 23.2 p -135.52 129.84 33.69 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.286 0.565 . . . . 73.13 111.495 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -101.04 -36.23 9.07 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.628 -0.714 . . . . 72.03 110.738 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -75.55 -19.42 59.32 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.737 -0.665 . . . . 74.22 112.427 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 21.9 p -72.34 -70.82 0.32 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.265 0.555 . . . . 73.31 112.437 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -125.53 139.92 53.19 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.868 -0.606 . . . . 75.13 109.82 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -115.67 122.77 46.56 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.063 -0.718 . . . . 75.24 109.063 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 15.6 tt -142.42 25.44 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-O 123.528 1.632 . . . . 63.53 106.775 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 154.2 144.3 3.88 Favored Glycine 0 N--CA 1.426 -2.008 0 CA-C-N 112.839 -1.982 . . . . 73.24 109.552 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -137.27 168.57 19.37 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 117.812 0.806 . . . . 74.35 110.937 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 92.5 mtt180 -104.69 139.64 39.22 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.023 -0.535 . . . . 74.5 110.404 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -127.82 135.4 50.01 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.147 0.579 . . . . 72.22 110.08 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -96.46 124.8 40.57 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.199 0.523 . . . . 74.32 109.788 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 66.4 mt -125.19 139.06 52.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 123.787 0.835 . . . . 72.24 109.467 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.9 mt-30 -120.78 126.97 51.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.663 0.986 . . . . 70.32 113.663 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 499' ' ' ALA . 7.3 mp -118.15 150.29 39.62 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 124.833 1.253 . . . . 75.42 111.328 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -115.3 131.95 56.77 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.096 -1.075 . . . . 74.23 108.096 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.602 ' HE2' HG21 ' A' ' 534' ' ' THR . 24.0 ttmm -52.62 96.9 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 124.536 1.134 . . . . 71.11 112.086 177.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.14 -136.75 9.34 Favored Glycine 0 CA--C 1.519 0.32 0 CA-C-N 116.194 -0.457 . . . . 74.14 113.002 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 87.9 m -46.29 -65.42 0.56 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.641 1.176 . . . . 73.02 113.081 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.4 -2.18 52.43 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.226 -1.027 . . . . 75.2 108.226 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 60.56 -143.29 48.01 Favored Glycine 0 CA--C 1.473 -2.54 0 N-CA-C 108.885 -1.686 . . . . 32.14 108.885 -168.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.528 HD11 HG21 ' A' ' 540' ' ' VAL . 50.2 mt -53.0 99.27 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.824 1.312 . . . . 53.12 111.809 -174.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . -104.73 56.78 0.54 Allowed Glycine 0 CA--C 1.466 -2.971 0 CA-C-N 114.292 -1.322 . . . . 75.21 111.956 -172.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 14.9 p90 -149.87 142.13 24.16 Favored 'General case' 0 C--N 1.267 -3.017 0 N-CA-C 108.392 -0.966 . . . . 75.52 108.392 177.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 40.0 m -115.8 160.7 19.78 Favored 'General case' 0 C--N 1.271 -2.81 0 N-CA-C 107.977 -1.12 . . . . 75.2 107.977 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 20.7 pt -117.45 151.09 19.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.2 0.524 . . . . 70.1 111.472 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.1 t -138.21 159.1 42.93 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.551 -1.277 . . . . 74.32 107.551 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 53.9 p -141.13 137.48 32.79 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.536 -0.542 . . . . 65.52 109.536 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.508 ' O ' ' HB2' ' A' ' 479' ' ' ASP . 4.2 tmm_? -71.43 -70.59 0.31 Allowed 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 106.772 -1.566 . . . . 63.41 106.772 176.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 479' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 478' ' ' ARG . 5.3 t70 165.72 -176.45 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 106.096 -1.816 . . . . 73.31 106.096 171.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.414 ' C ' ' H ' ' A' ' 482' ' ' ILE . 8.7 p -140.69 -17.7 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 109.697 -0.483 . . . . 61.13 109.697 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . 0.26 75.6 p 65.09 -17.1 0.09 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.385 1.874 . . . . 61.32 115.247 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 480' ' ' VAL . 32.8 pt -126.29 131.21 71.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 115.846 -0.615 . . . . 73.22 110.309 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 88.67 -81.35 1.55 Allowed Glycine 0 C--N 1.306 -1.117 0 C-N-CA 120.532 -0.842 . . . . 71.42 111.938 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 134.25 12.1 1.48 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.196 -1.002 . . . . 62.12 113.925 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 40.0 t -75.26 -61.51 1.88 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.32 0.56 . . . . 73.31 109.688 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 72.55 126.28 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.736 0 C-N-CA 124.694 1.198 . . . . 71.21 110.852 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.69 134.14 58.72 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.973 1.782 . . . . 71.24 111.506 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 42.9 mm -95.4 129.51 45.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.528 -0.76 . . . . 72.31 109.603 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -128.24 153.66 46.7 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.559 -0.534 . . . . 74.02 109.559 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.78 118.97 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 107.671 -1.233 . . . . 74.5 107.671 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -81.29 -56.96 3.72 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.293 -0.867 . . . . 73.44 110.377 -175.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 492' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 64.7 t30 -147.3 157.77 43.71 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.824 -0.626 . . . . 61.34 109.427 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.511 HG12 ' HB2' ' A' ' 507' ' ' ALA . 29.8 mm -121.49 105.81 17.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.491 -1.299 . . . . 34.41 107.491 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.9 mp -55.93 133.92 73.51 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.49 -0.777 . . . . 60.43 111.987 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -66.55 6.92 0.45 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 124.896 3.731 . . . . 75.44 115.051 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.505 ' O ' ' HB ' ' A' ' 468' ' ' THR . 31.5 ptt180 -162.74 10.95 0.06 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.919 0.866 . . . . 61.12 111.752 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.526 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -85.84 -174.29 49.74 Favored Glycine 0 C--N 1.294 -1.758 0 CA-C-N 115.42 -0.809 . . . . 61.42 112.512 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -51.52 -38.27 53.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.453 1.101 . . . . 74.34 110.538 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.728 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -61.68 -42.95 99.63 Favored 'General case' 0 C--O 1.197 -1.71 0 CA-C-N 114.185 -1.371 . . . . 72.15 113.248 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.0 tt -80.05 -29.44 12.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 120.925 0.393 . . . . 65.43 111.166 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.9 mm100 -62.04 -46.31 89.72 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.89 -0.595 . . . . 74.34 109.633 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -84.65 -42.04 15.73 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 120.579 -0.448 . . . . 52.23 109.82 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 81.24 -14.66 27.0 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 116.753 1.461 . . . . 74.24 116.753 174.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -74.21 -16.69 60.96 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 117.77 0.785 . . . . 74.51 111.38 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.62 147.5 26.35 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.675 -0.491 . . . . 75.32 109.675 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.59 171.25 15.38 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.706 -0.479 . . . . 72.24 109.706 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -89.34 149.72 22.9 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 123.238 0.336 . . . . 72.01 110.529 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 107.0 5.27 35.49 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.55 -0.833 . . . . 21.1 113.504 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -113.74 156.18 24.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.942 0.371 . . . . 75.03 111.159 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -85.56 130.86 34.47 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.261 -0.427 . . . . 70.02 110.417 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.526 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.67 128.95 35.03 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.832 -1.544 . . . . 71.32 106.832 -179.454 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.5 mm -100.04 -49.59 11.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.05 0.452 . . . . 73.55 111.252 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.24 150.51 21.96 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.898 -0.592 . . . . 73.41 109.858 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 541' ' ' SER . 4.2 p -125.05 123.82 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 CA-C-O 121.38 0.61 . . . . 72.44 109.98 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 19.4 m120 56.09 18.16 3.04 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.23 1.412 . . . . 61.54 114.475 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.76 -7.83 29.76 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.257 -0.973 . . . . 54.31 112.999 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.51 123.12 45.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 108.561 -0.903 . . . . 72.05 108.561 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -90.91 133.38 35.3 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.225 -1.028 . . . . 72.32 108.225 -172.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.526 HD11 HD12 ' A' ' 511' ' ' LEU . 23.2 mt -86.33 -46.31 10.4 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 112.427 0.529 . . . . 70.14 112.427 -170.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.38 100.59 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.854 0.835 . . . . 72.04 110.503 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 141.59 -33.55 1.96 Allowed Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 109.629 -1.388 . . . . 52.41 109.629 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.94 166.52 10.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.614 -0.293 . . . . 71.01 110.722 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 58.3 m -88.65 162.55 16.26 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.719 0.295 . . . . 53.44 111.763 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -54.92 -46.47 74.92 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 123.897 0.879 . . . . 73.43 112.205 -175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.552 ' HA ' HG22 ' A' ' 528' ' ' VAL . 40.9 mm-40 -60.39 -31.05 69.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.888 0.699 . . . . 74.52 112.888 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.63 -37.48 86.69 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.491 0.662 . . . . 63.4 109.258 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.42 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 39.0 t -75.69 -34.94 29.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.69 -0.686 . . . . 73.33 110.04 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.616 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 13.5 m -66.5 -41.32 88.34 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 C-N-CA 119.953 -0.699 . . . . 63.34 110.687 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 40.5 t -59.67 -44.1 93.74 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.782 0.801 . . . . 70.2 109.327 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 25.3 tp -58.35 -41.97 85.85 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 125.487 1.515 . . . . 55.01 110.163 176.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.474 HD12 HD13 ' A' ' 471' ' ' LEU . 35.4 tp -69.27 -48.07 62.78 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.724 0.81 . . . . 74.24 110.383 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 4.2 mmp_? -55.1 -45.39 75.46 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.761 0.825 . . . . 43.13 112.355 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 32.1 m -71.53 -37.12 71.18 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 111.553 0.205 . . . . 74.14 111.553 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 534' ' ' THR . . . . . 0.602 HG21 ' HE2' ' A' ' 466' ' ' LYS . 26.3 m 70.42 152.45 0.11 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.057 0.943 . . . . 73.44 111.009 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.99 125.68 25.66 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.98 -1.489 . . . . 74.25 106.98 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.7 mtt -71.8 -6.3 40.49 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.269 0.841 . . . . 61.03 113.269 -173.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.55 -27.69 61.47 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.12 -1.067 . . . . 73.41 108.12 171.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 109.97 -25.16 17.22 Favored Glycine 0 N--CA 1.427 -1.965 0 CA-C-N 115.207 -0.906 . . . . 62.1 112.43 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.5 m -101.59 127.0 48.5 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 109.369 -0.604 . . . . 62.11 109.369 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.528 HG21 HD11 ' A' ' 471' ' ' LEU . 76.6 t -106.46 128.23 61.18 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.681 0 CA-C-N 115.744 -0.662 . . . . 64.35 110.363 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 20.2 m -100.9 114.02 27.51 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.575 -0.739 . . . . 44.55 109.519 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -104.77 128.23 52.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.802 -0.814 . . . . 51.0 108.802 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 37.3 tp -104.85 118.28 36.16 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 105.935 -1.876 . . . . 71.31 105.935 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 27.6 m -115.48 160.17 14.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 CA-C-O 120.966 0.412 . . . . 75.44 110.042 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -111.96 115.39 28.87 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-N 115.546 -0.752 . . . . 74.01 109.08 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.51 118.16 26.8 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 106.047 -1.834 . . . . 64.32 106.047 177.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -99.88 122.78 43.33 Favored 'General case' 0 C--N 1.26 -3.284 0 CA-C-N 115.306 -0.861 . . . . 75.33 109.863 -174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -93.54 86.92 5.36 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 122.052 0.929 . . . . 74.41 109.284 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--N 1.292 -1.903 0 CA-C-N 114.638 -1.164 . . . . 73.41 109.881 -178.148 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.958 0 N-CA-C 110.971 -0.852 . . . . 74.54 110.971 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 37.3 p -160.39 110.13 1.77 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.21 -0.663 . . . . 72.53 109.21 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -146.76 133.08 19.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.769 -0.456 . . . . 72.2 109.769 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -90.19 98.62 11.88 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.364 -0.606 . . . . 55.42 109.364 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 72.2 p -67.3 129.5 40.11 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.533 -0.758 . . . . 72.43 110.99 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -86.38 118.53 25.87 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.022 -0.733 . . . . 75.42 109.022 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -107.39 168.62 9.11 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.519 -0.919 . . . . 54.55 108.519 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 11.3 tt -121.84 90.19 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 122.284 1.04 . . . . 63.43 111.131 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 547' ' ' GLN . . . 139.06 142.55 4.29 Favored Glycine 0 N--CA 1.42 -2.417 0 CA-C-N 114.892 -1.049 . . . . 62.44 111.635 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 458' ' ' LYS . 0.5 OUTLIER -126.24 133.0 51.6 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.319 -0.623 . . . . 74.25 109.319 -179.014 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.415 ' HB3' HD21 ' A' ' 543' ' ' LEU . 84.5 mtm180 -102.03 149.4 24.29 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.166 -0.679 . . . . 75.54 109.166 174.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.4 mm? -133.98 150.53 51.27 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.358 -0.608 . . . . 71.55 109.358 -173.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.51 117.27 28.55 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.904 0.859 . . . . 75.11 110.935 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 54.7 mt -121.78 139.2 49.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 106.853 -1.536 . . . . 70.14 106.853 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 42.4 tt0 -125.66 126.58 44.92 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.895 -1.122 . . . . 72.11 108.512 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.552 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 6.4 mp -114.66 153.05 30.9 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.081 -0.647 . . . . 75.2 112.433 -177.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.716 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.2 OUTLIER -100.56 128.37 46.64 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.558 -0.904 . . . . 71.2 108.558 -177.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.631 ' HE3' HG21 ' A' ' 534' ' ' THR . 39.9 ttmt -60.1 113.28 2.26 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.952 -0.567 . . . . 53.24 110.182 172.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -104.58 -131.71 7.22 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 120.796 -0.716 . . . . 64.03 111.799 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 26.4 m -62.53 -64.97 0.76 Allowed 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.198 0.599 . . . . 75.5 111.947 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.558 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 11.8 mm-40 -85.24 -32.45 22.59 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.82 -0.752 . . . . 63.22 109.545 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.467 ' N ' ' HA2' ' A' ' 497' ' ' GLY . . . 70.77 141.63 0.21 Allowed Glycine 0 C--O 1.21 -1.352 0 CA-C-N 114.878 -1.055 . . . . 54.53 112.894 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.486 ' N ' ' H ' ' A' ' 498' ' ' ALA 0.25 4.9 mp 39.56 84.38 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.551 1.54 . . . . 72.45 114.118 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -94.04 54.14 2.2 Favored Glycine 0 CA--C 1.493 -1.297 0 CA-C-N 115.078 -0.965 . . . . 63.33 112.433 -173.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.539 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 3.7 p90 -146.67 142.05 27.48 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.177 0.513 . . . . 63.31 110.763 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 29.6 m -120.57 143.9 48.38 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.089 -1.448 . . . . 72.44 107.089 177.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 23.9 pt -109.59 158.85 9.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 121.441 0.638 . . . . 61.11 111.929 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.6 t -132.5 159.23 39.99 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.703 -1.591 . . . . 75.14 106.703 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 55.4 p -129.32 144.74 51.35 Favored 'General case' 0 C--N 1.269 -2.911 0 N-CA-C 108.953 -0.758 . . . . 73.23 108.953 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -83.37 -6.06 59.34 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.069 -1.086 . . . . 70.44 108.069 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 17.6 t70 69.08 156.26 0.13 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 112.894 -1.957 . . . . 65.54 111.932 172.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.509 HG22 ' H ' ' A' ' 482' ' ' ILE . 8.0 p -83.64 136.07 23.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 115.709 -0.678 . . . . 61.13 109.741 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.6 t -88.03 -8.09 56.09 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.892 -0.723 . . . . 73.14 111.715 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.509 ' H ' HG22 ' A' ' 480' ' ' VAL . 63.1 mt -116.15 -75.01 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 115.85 -0.614 . . . . 64.51 109.492 175.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 166.43 118.46 0.44 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.069 -0.813 . . . . 64.13 111.069 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' GLY . . . . . 0.445 ' H ' HG11 ' A' ' 480' ' ' VAL . . . 127.9 -88.89 0.33 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.324 -0.941 . . . . 60.44 112.705 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 32.6 t -79.88 89.27 5.27 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.476 0.655 . . . . 45.33 112.077 -174.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -92.57 128.94 42.34 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 115.487 -0.778 . . . . 42.33 110.136 175.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.85 134.97 20.7 Favored 'Trans proline' 0 C--O 1.249 1.068 0 C-N-CA 121.976 1.784 . . . . 64.35 111.702 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.46 ' O ' ' HG3' ' A' ' 510' ' ' ARG . 44.3 mm -109.56 136.59 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.966 -0.561 . . . . 74.23 109.976 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 91.9 m-85 -137.99 157.79 45.65 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.138 0.575 . . . . 70.22 110.468 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.462 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 13.0 t -74.68 121.41 26.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.108 -1.071 . . . . 70.14 108.108 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 24.2 ttmm -85.44 -58.9 2.48 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.728 -0.471 . . . . 74.15 109.728 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -146.61 147.83 31.47 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.042 -1.096 . . . . 63.22 108.042 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.538 HG13 ' HA ' ' A' ' 506' ' ' LYS . 26.1 mm -109.4 109.46 28.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.635 -0.876 . . . . 61.04 108.635 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 86.5 mt -53.69 154.69 6.52 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 114.838 -1.073 . . . . 74.33 111.168 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.17 -1.67 11.26 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 123.902 3.068 . . . . 51.13 111.657 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.568 ' HA ' HG21 ' A' ' 500' ' ' ILE . 99.5 mtt180 -150.39 -157.65 0.84 Allowed 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 115.12 -0.946 . . . . 65.32 108.559 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.558 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 82.98 -162.9 41.21 Favored Glycine 0 C--N 1.277 -2.735 0 N-CA-C 111.398 -0.681 . . . . 71.35 111.398 -176.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.489 ' O ' HD23 ' A' ' 464' ' ' LEU . . . -70.49 -27.78 64.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.885 0.342 . . . . 74.51 110.843 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.552 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -58.9 -41.37 87.05 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-N 115.182 -0.917 . . . . 71.22 112.057 -173.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.568 HG21 ' HA ' ' A' ' 496' ' ' ARG . 16.9 tt -79.48 -29.29 13.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.984 -0.553 . . . . 52.31 111.547 -179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 12.6 mm100 -62.37 -45.91 91.03 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.263 -0.643 . . . . 73.42 109.263 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.413 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 8.8 t70 -93.74 -34.88 13.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.291 -0.868 . . . . 51.43 110.048 -177.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 83.8 -27.65 4.27 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.622 1.409 . . . . 44.3 116.622 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -67.93 -13.59 62.29 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.191 1.182 . . . . 75.44 114.191 -174.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 46.7 tp -97.89 124.78 42.47 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 120.595 -0.442 . . . . 64.54 111.158 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.538 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.1 OUTLIER -135.27 164.07 28.55 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 111.809 0.3 . . . . 75.5 111.809 178.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.52 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -82.64 160.36 22.47 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 113.835 1.05 . . . . 64.34 113.835 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 78.93 46.77 8.14 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.234 -0.894 . . . . 32.41 112.247 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.502 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 7.5 t70 -144.08 178.63 7.74 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.579 -1.637 . . . . 62.54 106.579 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.494 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 48.6 ttp85 -109.28 136.83 48.09 Favored 'General case' 0 C--O 1.212 -0.875 0 C-N-CA 119.176 -1.01 . . . . 71.24 113.217 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.734 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -88.02 121.31 30.28 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.196 -0.911 . . . . 70.02 110.781 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.458 HD11 ' CB ' ' A' ' 545' ' ' PHE . 1.9 mp -106.83 -48.47 8.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 109.447 -0.575 . . . . 55.31 109.447 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.42 143.0 31.43 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.302 -0.863 . . . . 62.2 109.543 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 541' ' ' SER . 7.5 p -145.03 122.41 4.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 CA-C-N 114.632 -1.167 . . . . 75.25 109.506 175.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 515' ' ' ASN . . . . . 0.613 ' ND2' HG13 ' A' ' 540' ' ' VAL . 49.0 m-80 66.65 21.94 10.54 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.113 0.965 . . . . 63.4 112.176 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 83.41 25.96 45.26 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 121.147 -0.549 . . . . 73.03 112.158 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.0 t -121.8 138.04 53.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 109.752 -0.462 . . . . 75.32 109.752 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.99 128.31 34.57 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.038 -0.727 . . . . 74.24 109.038 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.734 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 24.6 mt -96.55 -44.05 7.33 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 113.057 0.762 . . . . 74.14 113.057 -170.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 56.4 t -72.47 92.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.752 0.787 . . . . 74.05 110.448 -174.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.29 -25.77 1.24 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 109.889 -1.284 . . . . 63.23 109.889 -175.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.09 179.09 4.36 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.793 -0.203 . . . . 63.14 110.671 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 52.5 m -94.2 157.97 15.81 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-O 121.065 0.46 . . . . 61.43 111.75 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -52.8 -47.18 67.78 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.42 1.088 . . . . 73.21 112.156 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.54 ' HA ' HG22 ' A' ' 528' ' ' VAL . 42.9 mt-10 -60.87 -34.29 74.39 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.564 0.579 . . . . 35.35 112.564 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.99 -42.18 97.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.48 0.657 . . . . 73.32 109.536 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.52 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 44.5 t -71.06 -40.36 75.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.715 -1.129 . . . . 75.42 110.374 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 525' ' ' GLU . 12.7 m -68.62 -38.91 79.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 C-N-CA 119.041 -1.064 . . . . 63.3 110.371 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 25.8 t -62.04 -43.14 99.48 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.874 -0.603 . . . . 74.25 110.54 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.695 HD11 HG13 ' A' ' 514' ' ' VAL . 3.5 pp -67.19 -32.29 73.26 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.24 0.543 . . . . 75.43 109.656 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 530' ' ' LEU . 2.6 tt -65.15 -47.97 75.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.918 -1.037 . . . . 71.15 111.073 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.606 ' HA ' ' HE ' ' A' ' 532' ' ' ARG . 0.2 OUTLIER -63.28 -37.04 85.68 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.906 -0.588 . . . . 55.32 110.447 -177.632 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.4 m -73.61 -40.95 63.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.492 -0.322 . . . . 73.31 110.502 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 534' ' ' THR . . . . . 0.631 HG21 ' HE3' ' A' ' 466' ' ' LYS . 24.0 m 68.92 158.32 0.16 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.095 0.958 . . . . 61.32 111.261 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.493 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 16.5 tppt? -67.67 127.25 32.07 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.075 -1.454 . . . . 70.33 107.075 172.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.6 ptp -61.38 -18.0 56.71 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.279 0.562 . . . . 73.04 111.493 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 537' ' ' GLU . . . . . 0.493 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 39.6 tt0 -69.4 -24.17 63.82 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.888 0.875 . . . . 62.44 110.413 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 103.05 -29.09 13.19 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 116.053 -0.521 . . . . 54.43 112.684 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 0.6 OUTLIER -94.83 124.08 38.66 Favored 'General case' 0 N--CA 1.424 -1.733 0 C-N-CA 123.117 0.567 . . . . 54.53 112.372 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.613 HG13 ' ND2' ' A' ' 515' ' ' ASN . 72.1 t -104.3 129.74 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 108.565 -0.902 . . . . 74.13 108.565 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.706 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 47.2 t -91.1 134.0 34.88 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.506 -0.924 . . . . 45.5 108.506 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.539 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.4 mm? -122.93 118.21 27.32 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.952 -1.129 . . . . 73.23 107.952 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 4.2 tt -110.31 117.65 34.21 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 104.35 -2.463 . . . . 73.31 104.35 173.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.502 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 30.6 m -121.25 160.39 22.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-N 115.888 -0.596 . . . . 72.13 111.336 -175.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.458 ' CB ' HD11 ' A' ' 512' ' ' ILE . 76.4 t80 -125.56 119.38 28.0 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 120.966 0.412 . . . . 71.05 110.601 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -119.62 123.3 43.54 Favored 'General case' 0 N--CA 1.401 -2.878 0 N-CA-C 108.191 -1.04 . . . . 71.22 108.191 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 547' ' ' GLN . . . . . 0.606 ' HA ' ' HA2' ' A' ' 457' ' ' GLY . 53.6 tt0 -79.78 119.98 23.43 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.426 -0.806 . . . . 70.34 109.861 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -76.03 102.1 5.52 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 106.575 -1.639 . . . . 64.23 106.575 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--N 1.289 -2.023 0 N-CA-C 107.181 -1.414 . . . . 37.36 107.181 -174.224 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.176 0 N-CA-C 111.961 -0.456 . . . . 65.32 111.961 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 34.1 p -87.0 124.1 32.82 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 112.2 0.444 . . . . 63.3 112.2 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -127.34 115.19 18.6 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 122.852 0.461 . . . . 65.42 110.362 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -122.37 103.23 8.6 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.315 -0.624 . . . . 73.23 109.315 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 9.9 t -87.49 98.95 11.67 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.982 0.896 . . . . 71.55 110.338 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -88.57 104.59 16.98 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.053 -0.721 . . . . 62.23 109.053 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -84.39 125.89 32.73 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.062 -0.718 . . . . 73.12 109.062 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 2.0 mp -77.74 106.33 7.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.714 -1.217 . . . . 65.23 107.714 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 547' ' ' GLN . . . 108.57 107.76 3.17 Favored Glycine 0 N--CA 1.421 -2.358 0 N-CA-C 109.636 -1.386 . . . . 63.52 109.636 -173.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -91.72 133.31 35.71 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 120.146 -0.622 . . . . 74.02 110.181 -178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 62.8 mtm180 -101.37 137.14 40.09 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 106.252 -1.758 . . . . 75.43 106.252 172.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 16.4 tp -129.18 129.05 44.58 Favored 'General case' 0 C--N 1.265 -3.099 0 CA-C-N 116.019 -0.537 . . . . 75.0 109.822 -172.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -98.53 115.65 29.05 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 108.859 -0.793 . . . . 71.34 108.859 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' ILE . . . . . 0.54 HG23 ' HD3' ' A' ' 504' ' ' ARG . 67.4 mt -116.43 142.56 29.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.384 -0.969 . . . . 74.41 108.384 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 78.5 mt-30 -122.36 128.63 51.23 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 118.564 0.62 . . . . 73.32 112.152 176.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.593 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 9.3 mp -115.75 146.69 41.69 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 123.834 0.854 . . . . 64.41 111.634 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.768 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.2 OUTLIER -100.35 125.67 46.61 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 108.16 -1.052 . . . . 74.2 108.16 -178.219 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.88 114.97 2.32 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.249 -0.887 . . . . 63.12 110.358 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -87.08 -140.68 6.4 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.158 -1.177 . . . . 52.52 110.158 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' THR . . . . . 0.472 HG23 ' OE2' ' A' ' 469' ' ' GLU . 9.9 t -81.8 -31.61 31.7 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.834 -0.747 . . . . 64.24 111.359 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.601 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 12.0 mp0 -91.77 -42.8 9.91 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 107.79 -1.189 . . . . 72.44 107.79 173.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 84.57 -148.09 23.57 Favored Glycine 0 C--O 1.202 -1.866 0 CA-C-O 118.365 -1.242 . . . . 50.32 111.312 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.566 ' H ' HD22 ' A' ' 471' ' ' LEU . 1.7 mm? -45.95 108.07 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.478 1.139 . . . . 70.0 113.294 -169.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.87 45.62 1.28 Allowed Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.744 -1.117 . . . . 74.05 111.679 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.445 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 23.1 p90 -134.69 143.11 47.04 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.036 -0.727 . . . . 71.43 109.036 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 39.5 m -115.46 157.47 23.93 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.469 -1.308 . . . . 73.24 107.469 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 15.2 pt -126.03 160.08 33.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.364 0.602 . . . . 70.21 112.366 -176.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.413 ' HB ' ' CE ' ' A' ' 491' ' ' LYS . 10.1 t -152.26 158.26 42.57 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.218 -1.03 . . . . 62.41 108.218 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 35.3 p -106.98 129.24 54.81 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 106.446 -1.687 . . . . 51.5 106.446 174.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -146.76 88.93 1.78 Allowed 'General case' 0 N--CA 1.41 -2.474 0 C-N-CA 119.713 -0.795 . . . . 71.41 111.941 -174.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 66.0 140.51 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.209 1.404 . . . . 73.54 114.656 177.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 485' ' ' SER . 7.6 p -85.82 107.53 16.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.552 -0.749 . . . . 70.4 112.13 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 32.7 m -124.37 96.55 4.95 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.064 -1.458 . . . . 52.3 107.064 173.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 1.9 mp 65.55 96.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.526 0.679 . . . . 64.33 109.358 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 160.34 -155.92 27.13 Favored Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 111.25 -0.74 . . . . 64.41 111.25 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -100.93 -92.66 2.14 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.372 -0.918 . . . . 61.3 112.55 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' SER . . . . . 0.482 ' O ' ' HB ' ' A' ' 480' ' ' VAL . 19.8 m -89.39 -52.25 5.13 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.129 0.49 . . . . 71.14 110.282 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -168.34 114.98 0.59 Allowed Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.195 -0.669 . . . . 74.53 109.195 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 480' ' ' VAL . 38.0 Cg_exo -62.47 149.79 89.72 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.433 2.089 . . . . 55.54 112.039 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' A' ' 519' ' ' LEU . 39.2 mm -85.64 128.63 39.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 108.145 -1.057 . . . . 61.34 108.145 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -124.61 155.66 38.75 Favored 'General case' 0 CA--C 1.487 -1.455 0 O-C-N 122.117 -0.365 . . . . 73.42 110.962 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 49.4 t -74.04 125.91 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 108.592 -0.892 . . . . 72.12 108.592 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.413 ' CE ' ' HB ' ' A' ' 476' ' ' THR . 41.4 ttmt -82.54 -53.24 6.12 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.89 -0.781 . . . . 63.02 108.89 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -149.41 151.79 34.63 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.145 -0.934 . . . . 73.42 109.332 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.441 HG13 ' HA ' ' A' ' 506' ' ' LYS . 27.4 mm -114.39 106.83 21.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.175 -1.417 . . . . 71.25 107.175 175.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 495' ' ' PRO . 8.3 mp -50.55 157.79 1.2 Allowed Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 124.903 1.281 . . . . 55.24 113.124 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 494' ' ' LEU . 68.6 Cg_endo -72.21 -6.46 19.13 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 123.961 3.107 . . . . 41.33 111.979 -175.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.596 ' HA ' HG21 ' A' ' 500' ' ' ILE . 77.2 mtt180 -151.19 -161.05 1.25 Allowed 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.199 -0.91 . . . . 70.13 109.149 -174.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.601 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 81.48 -167.27 48.57 Favored Glycine 0 C--N 1.282 -2.461 0 CA-C-N 115.254 -0.885 . . . . 62.24 113.722 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.5 ' O ' HD23 ' A' ' 464' ' ' LEU . . . -65.76 -35.83 81.83 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 124.318 1.047 . . . . 63.53 110.377 -174.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.593 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -59.63 -39.62 84.91 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 115.089 -0.959 . . . . 53.41 112.331 -174.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.596 HG21 ' HA ' ' A' ' 496' ' ' ARG . 15.0 tt -80.09 -30.1 12.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 121.111 -0.235 . . . . 75.42 111.371 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 16.0 mm100 -60.89 -45.57 94.06 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.879 -0.6 . . . . 74.5 110.307 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.472 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 7.5 t70 -92.67 -35.75 13.33 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.779 -0.823 . . . . 52.15 108.779 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 56.54 25.39 50.01 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 115.551 0.98 . . . . 72.21 115.551 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.54 ' HD3' HG23 ' A' ' 462' ' ' ILE . 63.9 ttt180 -99.95 -6.69 26.21 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.92 0.867 . . . . 73.23 109.331 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 44.4 tp -109.5 138.91 45.17 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.738 -1.208 . . . . 72.23 107.738 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.525 ' HD2' ' OD2' ' A' ' 509' ' ' ASP . 0.0 OUTLIER -138.27 177.5 7.84 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.597 -0.841 . . . . 75.11 109.149 175.811 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -82.99 29.12 0.48 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.513 0.673 . . . . 72.21 112.037 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . -126.23 13.7 7.03 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.021 -0.832 . . . . 72.14 111.021 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.525 ' OD2' ' HD2' ' A' ' 506' ' ' LYS . 42.6 m-20 -102.6 148.21 25.83 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 120.773 0.32 . . . . 74.45 110.694 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 544' ' ' VAL . 19.0 ttm180 -101.16 129.76 47.13 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 116.27 -0.423 . . . . 72.44 109.938 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.627 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.6 mm? -83.41 117.01 22.76 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 112.451 0.537 . . . . 61.24 112.451 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.4 HG13 ' HB2' ' A' ' 545' ' ' PHE . 45.9 mm -104.98 -39.63 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.69 0.757 . . . . 65.33 109.516 174.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 543' ' ' LEU . 30.8 tt0 -148.57 145.8 27.99 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 114.929 -1.032 . . . . 61.42 108.867 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.775 HG13 HD11 ' A' ' 530' ' ' LEU . 2.4 p -139.15 129.17 31.51 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.446 0 CA-C-N 115.051 -0.977 . . . . 72.34 108.375 174.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.3 t30 68.65 -58.92 0.47 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 127.712 2.405 . . . . 71.44 111.673 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 178.08 27.26 0.04 OUTLIER Glycine 0 C--N 1.296 -1.642 0 N-CA-C 110.081 -1.208 . . . . 54.12 110.081 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.88 136.76 57.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 109.829 -0.434 . . . . 63.31 109.829 -174.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.75 125.56 31.4 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.937 -0.764 . . . . 62.34 108.937 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 514' ' ' VAL . 32.5 mt -94.52 -35.2 12.38 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.01 -0.541 . . . . 74.3 112.061 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 41.5 t -75.98 87.95 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 122.072 0.939 . . . . 74.43 110.374 -173.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.66 -26.51 1.19 Allowed Glycine 0 N--CA 1.425 -2.042 0 CA-C-N 114.132 -1.395 . . . . 32.45 110.142 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.31 176.95 4.99 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.808 0.337 . . . . 71.44 111.78 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 22.2 m -90.23 160.54 16.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.293 0.568 . . . . 51.12 112.394 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -53.0 -47.48 68.22 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.67 1.188 . . . . 74.31 113.834 177.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.49 ' HA ' HG22 ' A' ' 528' ' ' VAL . 46.6 mt-10 -62.65 -32.24 73.25 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 120.781 -0.368 . . . . 62.24 111.844 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.71 -38.81 92.5 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.075 0.464 . . . . 71.35 110.406 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 21.6 t -73.74 -41.42 54.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.738 -0.665 . . . . 74.04 109.61 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.601 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 11.4 m -65.65 -40.29 87.51 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 C-N-CA 119.462 -0.895 . . . . 75.24 110.456 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 27.6 m -63.06 -38.3 90.65 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.791 -0.641 . . . . 73.34 111.705 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.775 HD11 HG13 ' A' ' 514' ' ' VAL . 2.1 pp -69.56 -33.06 72.2 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.613 -0.884 . . . . 63.14 108.613 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.2 tt -65.22 -48.18 74.26 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 115.329 -0.85 . . . . 64.1 110.071 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 30.5 mmm180 -61.2 -31.43 71.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.377 -0.828 . . . . 65.05 110.184 -177.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.0 t -76.39 -43.74 39.21 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.426 -0.806 . . . . 61.33 110.391 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 534' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 535' ' ' LYS . 12.6 m 64.49 177.41 0.18 Allowed 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 109.064 -0.717 . . . . 75.11 109.064 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.487 ' H ' HG22 ' A' ' 534' ' ' THR . 38.1 ttpt -102.33 139.5 37.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.833 -0.803 . . . . 51.33 108.833 175.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 88.1 mtp -65.36 -20.68 66.5 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.234 0.827 . . . . 53.21 113.234 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 537' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 33.4 tt0 -58.54 -39.07 79.17 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.431 -0.951 . . . . 71.14 108.431 172.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 115.96 -24.35 10.17 Favored Glycine 0 N--CA 1.431 -1.64 0 CA-C-N 114.878 -1.056 . . . . 75.55 112.443 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.485 ' O ' ' HE2' ' A' ' 535' ' ' LYS . 0.6 OUTLIER -96.17 140.69 30.51 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.707 -0.397 . . . . 70.33 109.944 -177.307 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 53.6 t -119.15 133.32 66.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 122.849 0.46 . . . . 64.2 111.544 174.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 462' ' ' ILE . 50.1 m -91.6 138.33 31.65 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.531 -0.759 . . . . 62.55 110.097 177.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.549 HD23 HD13 ' A' ' 464' ' ' LEU . 2.7 mm? -124.14 120.35 32.06 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 106.82 -1.548 . . . . 65.14 106.82 176.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 54.2 tp -104.88 117.07 33.12 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.027 -1.472 . . . . 64.3 107.027 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 510' ' ' ARG . 33.0 m -117.82 140.14 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.121 0 C-N-CA 119.907 -0.717 . . . . 74.01 111.701 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.429 ' HB3' ' HD2' ' A' ' 510' ' ' ARG . 62.2 t80 -111.3 116.79 31.6 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.138 -0.69 . . . . 70.32 109.138 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 546' ' ' ARG . . . . . 0.468 ' HD3' ' OD1' ' A' ' 509' ' ' ASP . 23.9 mtm180 -127.89 122.1 31.68 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.292 -1.003 . . . . 73.22 108.292 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 547' ' ' GLN . . . . . 0.51 ' HA ' ' HA2' ' A' ' 457' ' ' GLY . 9.9 tt0 -97.19 119.17 35.2 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.722 -1.214 . . . . 74.2 107.722 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 548' ' ' GLU . . . . . 0.502 ' HG2' ' H ' ' A' ' 549' ' ' ASP . 32.5 tt0 60.38 179.38 0.1 Allowed 'General case' 0 CA--C 1.564 1.509 0 O-C-N 124.408 1.067 . . . . 73.12 109.051 -174.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 549' ' ' ASP . . . . . 0.502 ' H ' ' HG2' ' A' ' 548' ' ' GLU . 31.2 t70 . . . . . 0 C--N 1.292 -1.932 0 O-C-N 121.29 -0.881 . . . . 54.42 108.797 175.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.293 0 N-CA-C 110.255 -1.138 . . . . 53.14 110.255 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 25.5 p -80.88 100.56 8.93 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 121.153 0.501 . . . . 73.43 110.949 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -162.42 109.53 1.3 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.788 -0.642 . . . . 72.24 110.315 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -102.18 136.6 41.74 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.501 -1.296 . . . . 73.14 107.501 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 40.2 p -80.18 95.02 6.15 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.994 0.902 . . . . 52.12 110.03 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -110.17 9.04 23.96 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.806 -1.088 . . . . 74.01 109.643 -173.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -120.77 165.52 15.02 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.53 -0.759 . . . . 73.31 110.372 -176.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 49.4 mm 54.01 97.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.242 1.417 . . . . 64.5 112.905 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 60.62 91.23 0.02 OUTLIER Glycine 0 CA--C 1.519 0.344 0 CA-C-N 116.182 -0.463 . . . . 44.35 112.537 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 51.1 mtpt -96.13 151.96 18.99 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 113.159 0.8 . . . . 74.15 113.159 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 98.8 mtt180 -107.69 126.79 53.03 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 113.883 -1.508 . . . . 75.35 107.227 169.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.2 mm? -115.9 132.57 56.61 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 109.116 -0.698 . . . . 74.23 109.116 -176.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -98.14 120.18 38.1 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.393 -0.965 . . . . 73.01 108.393 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' ILE . . . . . 0.45 ' HA ' ' NH1' ' A' ' 504' ' ' ARG . 45.7 mt -122.16 142.64 37.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.898 -1.149 . . . . 61.01 107.898 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.55 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 93.1 mt-30 -123.03 125.97 46.23 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.606 0.717 . . . . 73.12 112.701 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 7.9 mp -121.56 141.55 50.96 Favored 'General case' 0 CA--C 1.478 -1.802 0 CA-C-N 115.225 -0.898 . . . . 72.41 112.308 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 465' ' ' LYS . 39.7 ttmt -112.71 136.06 52.74 Favored 'General case' 0 N--CA 1.398 -3.031 0 CA-C-N 115.456 -0.793 . . . . 75.11 110.005 -176.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.543 ' HB2' HG21 ' A' ' 534' ' ' THR . 39.4 ttmt -65.93 113.74 4.62 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.724 -1.125 . . . . 73.42 111.865 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -93.1 -104.2 1.63 Allowed Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.142 -1.183 . . . . 62.01 110.142 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 41.5 m -90.73 -57.0 2.97 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 122.554 -0.38 . . . . 74.34 111.113 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -94.43 -33.51 13.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.933 -1.506 . . . . 62.33 106.933 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 79.51 -145.27 27.62 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 114.407 -1.27 . . . . 44.53 110.995 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.448 HD21 HG11 ' A' ' 540' ' ' VAL . 6.6 mp -43.43 97.64 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.205 1.187 . . . . 73.41 114.205 -172.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -103.79 50.08 0.9 Allowed Glycine 0 N--CA 1.433 -1.555 0 CA-C-N 114.432 -1.258 . . . . 63.0 112.417 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -133.39 146.67 51.45 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.537 -0.912 . . . . 71.33 108.537 175.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 47.1 m -116.03 156.97 25.39 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 108.465 -0.939 . . . . 54.11 108.465 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 12.2 pt -124.18 154.66 31.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.26 0.552 . . . . 72.22 111.799 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.8 t -142.07 159.03 43.04 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.05 -1.092 . . . . 70.22 108.05 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 64.4 p -107.97 134.42 50.91 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 107.65 -1.241 . . . . 73.22 107.65 174.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -88.11 -69.12 0.72 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.912 0.386 . . . . 60.33 110.398 -176.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -173.88 139.36 0.67 Allowed 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 106.412 -1.699 . . . . 74.23 106.412 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.487 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . 8.5 p -68.58 83.89 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 122.653 1.215 . . . . 71.43 112.855 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 38.2 p -93.32 -33.07 14.06 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.445 -1.252 . . . . 70.05 109.72 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 8.6 tp -141.42 140.57 31.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 CA-C-N 113.63 -1.623 . . . . 72.14 108.268 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 88.65 -164.16 32.77 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.716 -0.754 . . . . 45.45 111.273 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -119.12 146.3 18.28 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.805 -0.712 . . . . 75.13 111.703 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 57.1 m 70.31 -70.58 0.15 Allowed 'General case' 0 C--O 1.246 0.916 0 C-N-CA 124.461 1.104 . . . . 74.42 113.229 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . . . -163.29 129.62 2.34 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 110.393 -0.225 . . . . 42.31 110.393 -176.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 480' ' ' VAL . 2.4 Cg_endo -82.44 136.09 8.52 Favored 'Trans proline' 0 N--CA 1.438 -1.743 0 C-N-CA 122.151 1.901 . . . . 24.43 109.498 173.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.531 HG13 ' HB3' ' A' ' 519' ' ' LEU . 32.4 mm -89.95 131.37 37.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 116.135 -0.484 . . . . 74.24 109.971 -174.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 90.1 m-85 -129.97 161.63 30.48 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.091 0.556 . . . . 74.11 109.828 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 23.4 t -74.58 127.03 36.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.612 -0.884 . . . . 73.02 108.612 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -87.39 -51.18 6.08 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.741 -0.837 . . . . 73.33 108.741 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -159.0 157.84 32.04 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.282 -0.872 . . . . 73.34 109.307 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 507' ' ' ALA . 32.5 mm -121.07 109.33 24.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 106.523 -1.658 . . . . 73.21 106.523 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.411 ' HB3' ' HD2' ' A' ' 495' ' ' PRO . 3.7 mm? -56.12 158.95 6.47 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-N 115.575 -0.739 . . . . 74.31 111.761 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.422 ' HG2' ' HG2' ' A' ' 496' ' ' ARG . 26.5 Cg_endo -79.18 7.36 4.44 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 123.475 2.783 . . . . 72.43 111.453 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.665 ' HA ' HG21 ' A' ' 500' ' ' ILE . 17.3 ptp180 -159.41 -158.3 0.65 Allowed 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 115.728 -0.669 . . . . 75.15 110.371 -174.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 72.61 -157.46 52.66 Favored Glycine 0 C--N 1.287 -2.143 0 CA-C-N 114.954 -1.021 . . . . 74.55 111.013 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -69.85 -35.47 74.74 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 122.742 0.417 . . . . 74.21 111.242 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.515 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -58.07 -37.4 74.39 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 113.428 0.899 . . . . 70.14 113.428 -172.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.665 HG21 ' HA ' ' A' ' 496' ' ' ARG . 15.7 tt -79.71 -36.17 17.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 112.134 0.42 . . . . 65.41 112.134 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -63.75 -33.66 76.16 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.303 0.573 . . . . 74.24 110.789 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.407 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 16.5 t70 -89.75 -48.06 7.51 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.88 -0.6 . . . . 70.5 109.951 173.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 72.79 -3.49 27.04 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 117.559 1.784 . . . . 51.13 117.559 175.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.45 ' NH1' ' HA ' ' A' ' 462' ' ' ILE . 70.5 mtp180 -80.46 -15.06 57.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.882 1.341 . . . . 73.23 110.109 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 39.3 tp -96.49 134.47 39.64 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.282 -0.872 . . . . 61.24 108.949 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 506' ' ' LYS . 0.0 OUTLIER -142.76 175.41 9.83 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.765 -0.457 . . . . 65.01 109.765 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.531 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -102.4 82.74 2.21 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 120.351 -0.54 . . . . 42.33 110.676 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . -175.01 35.48 0.1 Allowed Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.306 -1.118 . . . . 61.24 110.306 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -153.76 177.19 11.26 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 122.96 0.504 . . . . 74.41 111.541 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.555 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 0.2 OUTLIER -115.19 142.31 46.83 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.358 0.503 . . . . 72.42 112.358 -174.478 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.628 ' HB3' HD12 ' A' ' 519' ' ' LEU . 4.6 mm? -85.3 128.06 34.56 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.889 -0.596 . . . . 70.23 112.599 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 36.6 mm -102.53 -58.77 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.062 0 CA-C-N 116.189 -0.46 . . . . 63.22 109.775 176.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.553 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.5 pt-20 -156.29 144.55 19.82 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 121.438 0.637 . . . . 51.55 111.056 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.738 HG12 HD21 ' A' ' 519' ' ' LEU . 2.6 p -130.61 135.2 60.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 N-CA-C 107.829 -1.174 . . . . 72.41 107.829 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 17.4 m120 66.47 9.91 6.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.52 0.728 . . . . 75.23 111.727 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 84.07 13.11 75.24 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 111.455 -0.658 . . . . 51.03 111.455 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.83 135.67 39.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.792 -0.818 . . . . 74.53 108.792 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.64 132.15 36.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.68 -0.489 . . . . 75.42 109.68 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.738 HD21 HG12 ' A' ' 514' ' ' VAL . 15.9 mt -97.76 -45.29 6.4 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 112.425 0.528 . . . . 71.45 112.425 -170.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 520' ' ' VAL . . . . . 0.531 HG21 HH21 ' A' ' 510' ' ' ARG . 59.8 t -78.41 99.9 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-O 121.787 0.803 . . . . 64.24 109.126 -175.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 143.68 -26.19 2.1 Favored Glycine 0 N--CA 1.414 -2.815 0 N-CA-C 109.249 -1.541 . . . . 74.11 109.249 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.01 179.71 4.25 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 110.163 -0.31 . . . . 73.33 110.163 175.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 46.5 t -87.3 155.02 20.24 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.268 0.556 . . . . 74.33 110.68 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 528' ' ' VAL . 28.8 mm-40 -54.55 -39.99 68.27 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.719 1.207 . . . . 74.02 111.41 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.443 ' HA ' HG22 ' A' ' 528' ' ' VAL . 42.9 mt-10 -66.81 -32.11 73.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.191 -0.459 . . . . 71.31 111.572 -176.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.18 -44.58 83.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.05 -0.523 . . . . 73.03 109.835 176.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 19.0 t -67.68 -43.56 86.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.665 -0.698 . . . . 61.34 109.634 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.524 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 10.2 m -64.91 -38.73 83.52 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.044 0 C-N-CA 119.774 -0.77 . . . . 73.51 110.265 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.1 t -63.05 -45.43 92.24 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.857 -0.61 . . . . 62.43 110.763 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.625 HD11 HG13 ' A' ' 514' ' ' VAL . 2.6 pp -66.27 -35.52 80.61 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.441 0.639 . . . . 71.04 109.434 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.525 HD23 ' HE ' ' A' ' 532' ' ' ARG . 2.5 tt -62.11 -47.97 82.22 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.054 -0.976 . . . . 70.33 111.607 175.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.525 ' HE ' HD23 ' A' ' 531' ' ' LEU . 1.4 mmp_? -63.95 -37.08 86.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.105 -0.498 . . . . 73.03 109.705 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.2 m -67.4 -39.86 85.57 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.575 -0.739 . . . . 71.04 109.238 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 534' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 466' ' ' LYS . 95.3 m 72.78 -85.7 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.804 0.842 . . . . 71.24 111.599 177.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.539 ' HG2' ' H ' ' A' ' 537' ' ' GLU . 39.9 ttmt 170.8 133.67 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.71 1.204 . . . . 71.34 107.864 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.2 mtt -65.97 -29.26 69.62 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.666 0.269 . . . . 62.41 111.141 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 537' ' ' GLU . . . . . 0.539 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 38.8 tt0 -74.07 -37.05 64.34 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.361 -0.381 . . . . 73.24 110.995 177.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 135.79 -45.48 1.09 Allowed Glycine 0 CA--C 1.539 1.584 0 N-CA-C 117.322 1.689 . . . . 75.31 117.322 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.411 ' CG2' ' HB3' ' A' ' 463' ' ' GLN . 5.5 m -101.95 140.19 36.58 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.442 1.121 . . . . 71.4 112.366 -172.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 69.2 t -113.52 140.28 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 124.037 0.935 . . . . 74.22 110.808 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 46.6 t -95.65 124.78 39.83 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.23 -0.656 . . . . 63.31 109.23 176.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.507 HD23 HD13 ' A' ' 464' ' ' LEU . 2.6 mm? -115.37 119.21 35.5 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.298 -1.371 . . . . 72.11 107.298 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 33.9 tp -108.54 117.37 34.0 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.074 -1.454 . . . . 71.53 107.074 174.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 35.6 m -116.17 150.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.803 -0.635 . . . . 71.32 110.837 -177.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 69.6 t80 -112.14 116.52 30.62 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.207 -1.035 . . . . 72.51 108.207 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -116.57 130.74 56.92 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.817 -0.628 . . . . 73.21 110.474 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -82.9 128.07 34.1 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.01 -1.107 . . . . 73.55 108.01 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 64.61 -173.84 0.17 Allowed 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.126 0.97 . . . . 75.14 111.506 -175.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--N 1.302 -1.463 0 N-CA-C 109.018 -0.734 . . . . 74.52 109.018 -178.42 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.405 ' HE2' ' CD1' ' A' ' 460' ' ' LEU . 21.7 ptmt . . . . . 0 CA--C 1.5 -0.956 0 CA-C-O 120.873 0.368 . . . . 73.1 111.216 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 76.4 mtm180 -103.16 145.12 30.4 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.179 -0.675 . . . . 55.34 109.179 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.6 mm? -124.29 126.26 45.74 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.054 -0.521 . . . . 75.41 110.064 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -91.62 115.58 28.16 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.051 0.929 . . . . 54.34 108.623 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 85.2 mt -124.72 121.71 61.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-N 115.409 -0.814 . . . . 73.02 111.221 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 75.2 mt-30 -104.33 130.22 52.18 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 120.288 -0.565 . . . . 65.21 110.551 172.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.584 ' HB3' ' HB1' ' A' ' 498' ' ' ALA . 94.8 mt -122.72 138.0 54.75 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.85 -1.068 . . . . 72.23 109.655 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 465' ' ' LYS . 20.2 ptmt -104.14 128.14 51.78 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-O 122.344 1.069 . . . . 72.33 112.63 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -53.12 115.15 1.73 Allowed 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 112.945 -1.934 . . . . 75.13 113.343 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . 0.438 ' H ' ' HA2' ' A' ' 470' ' ' GLY . . . -98.5 -139.22 10.68 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.922 -1.271 . . . . 73.54 109.922 171.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 31.3 m -68.99 -49.35 58.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.607 0.717 . . . . 75.55 109.679 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.67 56.1 0.95 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.101 -1.815 . . . . 74.25 106.101 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.438 ' HA2' ' H ' ' A' ' 467' ' ' GLY . . . -41.61 -63.83 1.55 Allowed Glycine 0 CA--C 1.478 -2.23 0 CA-C-N 113.393 -1.731 . . . . 63.33 115.145 -171.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.454 HD13 HD12 ' A' ' 531' ' ' LEU . 49.6 mt -85.43 82.26 8.38 Favored 'General case' 0 C--N 1.272 -2.79 0 C-N-CA 116.273 -2.171 . . . . 73.13 111.257 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -95.84 40.33 2.65 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 113.063 -1.88 . . . . 65.2 111.862 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 31.6 p90 -137.21 142.19 42.09 Favored 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 108.176 -1.046 . . . . 74.14 108.176 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.0 m -132.12 152.66 51.12 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 116.172 -0.467 . . . . 65.01 110.125 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 10.6 pt -109.51 160.8 8.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.612 -0.722 . . . . 72.4 112.544 -173.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.488 HG21 ' HD3' ' A' ' 491' ' ' LYS . 12.9 t -147.26 159.09 44.06 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.24 -1.022 . . . . 73.03 108.24 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.416 ' HB3' HE21 ' A' ' 524' ' ' GLN . 64.2 p . . . . . 0 C--N 1.299 -1.613 0 N-CA-C 108.041 -1.096 . . . . 75.11 108.041 173.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo . . . . . 0 N--CA 1.438 -1.763 0 CA-C-O 121.362 0.484 . . . . 64.41 112.476 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.422 HG23 HE22 ' A' ' 524' ' ' GLN . 42.8 mm -97.96 125.04 51.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.936 -1.135 . . . . 63.54 107.936 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -118.61 150.17 40.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 122.344 -0.222 . . . . 74.01 111.054 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 43.3 t -80.9 119.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 106.539 -1.652 . . . . 62.33 106.539 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.488 ' HD3' HG21 ' A' ' 476' ' ' THR . 55.0 tptt -91.3 -53.79 4.2 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.973 -0.558 . . . . 61.42 111.489 -174.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . 0.574 HD22 HD12 ' A' ' 494' ' ' LEU . 6.1 t30 -133.12 144.68 50.1 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.914 -0.714 . . . . 74.44 111.131 -171.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.538 HG12 ' HB2' ' A' ' 507' ' ' ALA . 31.9 mm -121.57 103.88 14.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.007 -0.997 . . . . 71.52 108.688 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.574 HD12 HD22 ' A' ' 492' ' ' ASN . 6.7 mp -63.07 127.73 91.27 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.271 -0.877 . . . . 52.11 109.977 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.28 30.18 0.23 Allowed 'Trans proline' 0 N--CA 1.512 2.56 1 C-N-CA 125.373 4.049 . . . . 64.43 114.035 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.403 ' N ' HG21 ' A' ' 500' ' ' ILE . 13.3 ptp180 -159.7 -8.86 0.06 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 113.862 1.06 . . . . 72.43 113.862 -173.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 501' ' ' GLN . . . -91.62 -159.45 35.47 Favored Glycine 0 C--O 1.212 -1.229 0 C-N-CA 119.387 -1.387 . . . . 65.34 113.457 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 464' ' ' LEU . . . -63.43 -32.45 73.89 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 112.844 0.683 . . . . 73.12 112.844 -174.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.47 78.39 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 116.611 -0.268 . . . . 64.22 110.935 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.403 HG21 ' N ' ' A' ' 496' ' ' ARG . 5.9 tt -79.98 -30.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 123.637 0.775 . . . . 75.03 111.895 176.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.523 ' HB2' ' O ' ' A' ' 497' ' ' GLY . 0.0 OUTLIER -58.7 -45.34 89.75 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.758 0.823 . . . . 72.34 109.317 -177.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.448 ' HB2' ' CD2' ' A' ' 464' ' ' LEU . 23.8 m-20 -97.42 -21.14 17.33 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.441 -0.503 . . . . 65.4 109.68 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 68.67 35.39 80.42 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.487 -0.779 . . . . 73.24 113.97 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -108.31 -26.63 10.43 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.966 0.412 . . . . 70.2 111.962 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.403 ' CD1' HG11 ' A' ' 544' ' ' VAL . 49.8 tp -105.55 153.88 21.15 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.665 -0.414 . . . . 60.13 111.252 -174.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.34 170.27 17.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.84 -1.17 . . . . 74.22 107.84 177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.538 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -92.5 148.83 21.78 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 110.178 -0.304 . . . . 62.43 110.178 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 117.23 -34.99 4.33 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.951 -0.642 . . . . 65.21 111.886 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.5 153.66 43.18 Favored 'General case' 0 C--O 1.25 1.103 0 CA-C-O 121.32 0.581 . . . . 74.23 111.277 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 63.3 ttp180 -90.13 127.08 36.01 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.105 -1.072 . . . . 64.0 108.105 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.491 ' HG ' HD11 ' A' ' 519' ' ' LEU . 23.0 tp -80.74 131.88 35.48 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 107.624 -1.25 . . . . 75.03 107.624 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.0 mm -101.44 -44.96 11.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.177 0.513 . . . . 72.32 110.264 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.53 ' HG2' ' HB3' ' A' ' 543' ' ' LEU . 10.5 pt-20 -152.3 156.01 38.81 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.552 -0.907 . . . . 62.15 108.552 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.55 HG12 HD21 ' A' ' 519' ' ' LEU . 5.2 p -137.65 127.92 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.157 0 N-CA-C 108.515 -0.92 . . . . 71.31 108.515 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 65.91 9.23 5.94 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 126.136 1.774 . . . . 64.44 111.392 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.68 3.56 40.08 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.303 -0.475 . . . . 63.11 113.167 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.95 139.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 122.419 -0.46 . . . . 75.43 110.536 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.72 134.73 37.06 Favored 'General case' 0 CA--C 1.484 -1.591 0 C-N-CA 123.518 0.727 . . . . 51.2 109.584 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.55 HD21 HG12 ' A' ' 514' ' ' VAL . 42.3 mt -90.19 -45.62 8.98 Favored 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 123.654 0.597 . . . . 73.53 112.03 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.67 99.94 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 121.743 0.782 . . . . 71.15 110.05 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 137.93 -21.46 3.17 Favored Glycine 0 N--CA 1.42 -2.417 0 CA-C-N 114.411 -1.268 . . . . 71.33 110.723 -175.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.24 163.86 14.67 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.67 0.271 . . . . 65.34 111.068 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . 0.478 ' O ' HG23 ' A' ' 527' ' ' VAL . 34.1 m -92.58 164.19 13.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.01 -0.541 . . . . 63.01 111.09 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.537 ' O ' HG13 ' A' ' 528' ' ' VAL . 50.7 mm-40 -50.44 -47.76 56.66 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 113.55 0.944 . . . . 72.11 113.55 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.427 ' HA ' HG22 ' A' ' 528' ' ' VAL . 5.5 mp0 -59.87 -32.29 70.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.057 0.456 . . . . 75.35 111.454 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.24 -38.26 68.95 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.775 -0.648 . . . . 73.33 109.514 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 523' ' ' SER . 16.3 t -76.29 -37.46 31.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.953 -0.567 . . . . 75.11 110.333 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.65 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 12.3 m -65.64 -42.23 92.31 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 C-N-CA 120.722 -0.391 . . . . 53.14 110.601 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.8 p -68.78 -30.37 68.95 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.252 0.549 . . . . 55.43 111.067 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.33 -39.16 89.06 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.27 -0.877 . . . . 71.33 108.769 173.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.454 HD12 HD13 ' A' ' 471' ' ' LEU . 48.5 tp -69.91 -48.31 59.07 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.712 -0.677 . . . . 74.41 109.955 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.65 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -60.05 -27.68 67.15 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.117 0.567 . . . . 72.23 111.66 -177.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 33.8 t -69.82 -35.23 74.62 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 109.82 -0.437 . . . . 73.24 109.82 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 535' ' ' LYS . 31.1 m 69.19 -89.67 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.226 1.01 . . . . 70.53 110.546 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' A' ' 536' ' ' MET . 61.1 tttp 170.87 175.93 0.06 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.035 -2.209 . . . . 75.12 105.035 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . 0.417 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 27.5 ttt -72.09 -50.72 25.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 119.138 0.881 . . . . 65.04 112.81 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -35.81 39.65 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 118.472 -1.291 . . . . 74.04 108.746 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 115.96 25.14 3.69 Favored Glycine 0 N--CA 1.411 -3.023 0 CA-C-N 115.03 -0.986 . . . . 64.03 113.187 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 3.8 m -107.44 119.87 40.59 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 118.627 -1.229 . . . . 41.52 108.093 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 65.1 t -106.91 131.72 56.1 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 CA-C-N 115.588 -0.733 . . . . 72.41 110.6 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 24.7 m -94.19 113.77 25.76 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.717 -0.674 . . . . 62.4 109.558 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.465 HD13 HG23 ' A' ' 514' ' ' VAL . 2.5 mm? -106.92 139.59 41.09 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.384 -0.969 . . . . 71.13 108.384 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.53 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 44.9 tp -118.79 117.84 29.96 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 105.863 -1.903 . . . . 75.11 105.863 171.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 27.1 m -118.06 158.05 19.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.841 0 C-N-CA 120.24 -0.584 . . . . 73.22 110.898 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -111.89 116.26 30.33 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.402 -0.962 . . . . 74.24 108.402 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.476 -1.88 0 N-CA-C 107.074 -1.454 . . . . 72.32 107.074 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 28.3 mtpp . . . . . 0 CA--C 1.471 -2.06 0 N-CA-C 109.568 -0.53 . . . . 72.33 109.568 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.5 mtm180 -110.97 128.82 55.96 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 115.673 -0.694 . . . . 71.41 109.213 171.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.435 HD11 ' HE3' ' A' ' 458' ' ' LYS . 2.0 mm? -118.83 129.85 55.45 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 115.021 -0.991 . . . . 74.21 109.317 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -96.55 122.32 39.34 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.119 -0.697 . . . . 73.42 109.119 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 58.8 mt -127.56 142.51 43.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 123.46 0.704 . . . . 74.51 109.942 -174.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 78.7 mt-30 -114.97 127.91 55.96 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.608 0.966 . . . . 62.42 113.608 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.537 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.1 mm? -116.61 134.54 54.71 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 124.588 1.155 . . . . 75.44 109.148 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 39.4 ttmt -108.88 135.71 49.63 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-O 121.513 0.673 . . . . 62.1 111.26 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.516 ' HA ' ' HA2' ' A' ' 470' ' ' GLY . 38.1 mtmt -73.08 100.57 3.06 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.063 -0.972 . . . . 62.4 110.866 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -108.03 -101.23 2.69 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.474 -0.87 . . . . 64.14 112.131 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . 0.545 HG23 ' H ' ' A' ' 469' ' ' GLU . 8.3 t -66.87 -69.8 0.29 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 112.16 0.43 . . . . 55.31 112.16 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.545 ' H ' HG23 ' A' ' 468' ' ' THR . 25.6 mm-40 -98.29 -18.41 18.38 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.599 0.714 . . . . 70.53 109.14 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 69.27 -149.98 49.45 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 114.651 -1.159 . . . . 74.2 112.98 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.458 HD11 HG21 ' A' ' 540' ' ' VAL . 38.4 mt -51.65 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.478 0.918 . . . . 74.32 113.478 -169.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -107.72 56.19 0.49 Allowed Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 114.582 -1.19 . . . . 42.31 111.688 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.37 142.59 29.5 Favored 'General case' 0 C--N 1.281 -2.371 0 C-N-CA 123.369 0.668 . . . . 75.53 110.064 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.9 m -119.59 162.41 18.98 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.396 -0.82 . . . . 62.22 109.807 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 20.6 pt -117.88 158.09 18.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.129 0.49 . . . . 71.32 111.67 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.8 t -148.7 160.09 43.5 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.23 -0.896 . . . . 75.52 108.655 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 31.6 t . . . . . 0 N--CA 1.411 -2.383 0 N-CA-C 107.216 -1.401 . . . . 65.41 107.216 174.777 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 C--O 1.239 0.536 0 CA-C-O 121.192 0.413 . . . . 73.12 112.914 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.667 HD12 HE21 ' A' ' 524' ' ' GLN . 24.8 mm -92.81 128.81 44.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.314 -0.857 . . . . 74.51 108.795 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -127.95 158.71 37.1 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 121.887 -0.508 . . . . 74.44 111.479 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.43 HG22 HD21 ' A' ' 511' ' ' LEU . 21.7 t -74.31 129.55 36.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.206 -1.035 . . . . 75.1 108.206 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -93.27 -61.3 1.59 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.544 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -141.09 148.83 40.78 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.776 -0.647 . . . . 75.41 110.183 -174.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.474 HG12 ' HB2' ' A' ' 507' ' ' ALA . 36.4 mm -118.57 104.32 15.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.411 -1.329 . . . . 64.31 107.411 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 8.3 mp -54.72 152.06 13.77 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.187 -0.915 . . . . 70.11 112.73 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.493 ' O ' HD13 ' A' ' 500' ' ' ILE . 23.0 Cg_endo -77.89 -3.12 13.21 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 124.339 3.359 . . . . 73.24 111.64 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -158.64 110.88 2.24 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 124.582 1.153 . . . . 72.05 109.636 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 160.89 -168.5 36.27 Favored Glycine 1 C--N 1.237 -4.925 0 CA-C-N 112.846 -1.979 . . . . 73.44 111.145 178.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.418 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -57.23 -47.14 82.09 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 124.464 1.106 . . . . 54.13 110.54 -174.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -56.88 -44.11 81.93 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.006 -0.997 . . . . 65.14 111.853 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.493 HD13 ' O ' ' A' ' 495' ' ' PRO . 16.5 tt -80.96 -37.63 16.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.083 0.771 . . . . 65.54 113.083 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.3 mm100 -64.74 -41.83 95.65 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 120.867 0.365 . . . . 73.43 110.771 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.537 ' HB2' HD13 ' A' ' 464' ' ' LEU . 23.7 m-20 -84.95 -32.07 23.26 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.777 -0.823 . . . . 42.42 108.777 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 61.4 45.72 95.84 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.839 0.712 . . . . 65.35 113.864 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -115.07 -28.07 7.11 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.044 0.45 . . . . 62.15 112.18 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 57.0 tp -106.22 146.55 30.15 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.15 -0.685 . . . . 63.04 109.15 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.437 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -138.81 162.05 35.72 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.914 -0.773 . . . . 64.13 108.914 176.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.474 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.52 120.69 26.24 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.012 0.434 . . . . 71.34 111.382 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . 0.41 ' H ' ' HB ' ' A' ' 490' ' ' VAL . . . 145.04 -12.28 1.87 Allowed Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.706 -0.679 . . . . 45.12 112.213 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -94.22 172.87 7.94 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 120.975 0.416 . . . . 72.24 112.026 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 544' ' ' VAL . 41.1 ttm180 -102.83 137.99 40.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.637 -0.71 . . . . 72.44 110.269 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.688 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -86.08 119.13 26.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.951 -0.568 . . . . 74.41 110.463 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 47.8 mm -98.65 -47.33 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.849 -0.16 . . . . 73.52 110.588 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.524 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 10.2 pt-20 -149.0 148.61 29.95 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.358 -0.608 . . . . 64.43 109.358 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.677 HG12 HD21 ' A' ' 519' ' ' LEU . 3.6 p -132.56 119.36 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.394 0 CA-C-O 121.975 0.893 . . . . 64.4 109.254 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.72 23.91 11.53 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 126.242 1.817 . . . . 75.31 111.959 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.28 -18.46 33.2 Favored Glycine 0 C--O 1.237 0.289 0 C-N-CA 120.491 -0.861 . . . . 74.45 113.953 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.7 t -96.85 134.49 34.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 109.772 -0.455 . . . . 64.34 109.772 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -84.35 143.1 29.7 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.656 -0.498 . . . . 63.13 109.656 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.688 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 18.4 mt -103.78 -39.67 6.56 Favored 'General case' 0 CA--C 1.482 -1.639 0 CA-C-N 115.432 -0.804 . . . . 73.41 112.257 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 35.4 t -74.61 90.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 121.811 0.815 . . . . 72.41 109.48 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 154.13 -28.61 0.72 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 108.289 -1.925 . . . . 70.22 108.289 -175.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.411 ' HB2' ' CD ' ' A' ' 526' ' ' GLU . 0.1 OUTLIER -105.3 178.78 4.46 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.016 -0.592 . . . . 71.53 109.916 175.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . 0.562 ' O ' HG23 ' A' ' 527' ' ' VAL . 60.7 p -95.84 164.33 12.78 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.501 0.556 . . . . 72.22 112.501 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.667 HE21 HD12 ' A' ' 488' ' ' ILE . 15.8 mm-40 -49.71 -43.23 47.41 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 124.705 1.202 . . . . 64.23 111.442 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.423 ' HA ' HG22 ' A' ' 528' ' ' VAL . 42.7 mt-10 -65.03 -35.74 82.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.408 0.623 . . . . 61.14 111.961 -174.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.411 ' CD ' ' HB2' ' A' ' 522' ' ' LYS . 43.9 mt-10 -69.74 -37.25 76.4 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.644 -0.707 . . . . 75.34 109.522 177.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 523' ' ' SER . 32.3 t -70.2 -41.46 78.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.528 -0.76 . . . . 64.4 109.556 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.687 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 12.5 m -64.57 -44.42 96.8 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 C-N-CA 120.021 -0.672 . . . . 63.44 110.054 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 49.1 m -57.87 -40.29 79.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.485 0.659 . . . . 52.34 110.232 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 50.7 tp -63.11 -47.25 83.62 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 124.545 1.138 . . . . 74.11 109.879 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.437 HD12 HD13 ' A' ' 471' ' ' LEU . 35.1 tp -65.2 -44.22 89.07 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.861 -0.609 . . . . 64.25 110.574 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.687 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -62.3 -33.51 74.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.155 0.582 . . . . 63.21 110.851 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.6 m -75.53 -41.01 56.16 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.032 -0.531 . . . . 62.44 110.882 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . 0.482 HG23 ' CG2' ' A' ' 540' ' ' VAL . 32.5 m 66.65 -92.91 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.266 0.627 . . . . 73.25 110.121 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt 170.48 171.86 0.07 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.19 -1.411 . . . . 74.11 107.19 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 26.1 ttt -65.63 -38.6 89.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 111.603 0.223 . . . . 75.23 111.603 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.58 -79.26 0.08 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.461 -0.336 . . . . 75.41 110.473 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 151.56 -21.47 0.93 Allowed Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 118.708 -1.71 . . . . 25.42 114.618 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.489 HG22 ' HB3' ' A' ' 463' ' ' GLN . 3.0 m -94.83 125.24 39.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 118.433 1.117 . . . . 74.14 110.251 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 47.1 t -106.81 140.63 24.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.028 -0.987 . . . . 72.42 110.162 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.5 t -99.14 114.69 27.58 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.165 0.507 . . . . 74.22 109.815 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.533 HD23 HD23 ' A' ' 464' ' ' LEU . 3.4 mm? -101.77 122.33 43.74 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 124.538 1.135 . . . . 65.35 109.08 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 36.2 tp -104.98 118.97 37.87 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.376 -1.712 . . . . 72.54 106.376 174.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 36.0 m -115.03 145.55 20.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-O 121.179 0.514 . . . . 72.35 110.957 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 88.8 t80 -112.27 116.06 29.79 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.276 -0.875 . . . . 74.22 110.042 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . 0.536 ' O ' ' HD3' ' A' ' 546' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.29 -1.997 0 N-CA-C 107.478 -1.304 . . . . 55.45 107.478 175.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.405 ' HE2' HD13 ' A' ' 460' ' ' LEU . 22.0 ptmt . . . . . 0 N--CA 1.435 -1.209 0 CA-C-O 120.974 0.416 . . . . 45.53 110.467 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -106.16 154.51 20.59 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.413 -1.328 . . . . 64.43 107.413 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.8 mm? -125.33 130.89 52.88 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 110.002 -0.37 . . . . 73.32 110.002 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -96.25 116.19 28.62 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.655 -0.868 . . . . 73.03 108.655 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . 0.505 HG23 ' CG ' ' A' ' 504' ' ' ARG . 68.6 mt -123.28 121.16 62.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 115.601 -0.727 . . . . 72.12 110.202 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.2 mt-30 -99.94 128.94 45.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.786 0.662 . . . . 74.44 112.786 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.586 HD23 HD23 ' A' ' 542' ' ' LEU . 4.3 mm? -115.08 132.82 56.48 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-N 115.361 -0.836 . . . . 63.24 109.841 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.445 ' HE2' ' HB2' ' A' ' 465' ' ' LYS . 25.3 ttmm -101.17 131.9 46.91 Favored 'General case' 0 N--CA 1.394 -3.265 0 CA-C-O 121.936 0.874 . . . . 61.01 110.886 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.12 103.28 0.21 Allowed 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 113.146 -1.843 . . . . 73.13 111.485 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -136.5 137.05 8.78 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.781 -0.928 . . . . 74.32 110.781 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 73.2 m 63.24 -86.72 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.143 0.977 . . . . 62.32 112.642 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.481 ' HB3' ' HA2' ' A' ' 497' ' ' GLY . 8.6 tp10 -97.74 -13.93 21.14 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.238 -1.023 . . . . 74.3 108.238 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 70.09 -155.82 53.24 Favored Glycine 0 C--O 1.202 -1.867 0 CA-C-O 117.946 -1.474 . . . . 71.03 109.707 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.501 HD23 HD12 ' A' ' 531' ' ' LEU . 6.3 mp -43.83 96.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.707 1.254 . . . . 72.02 113.706 -173.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -106.22 63.58 0.3 Allowed Glycine 0 N--CA 1.411 -3.007 0 CA-C-N 113.546 -1.661 . . . . 71.42 110.448 -174.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 27.7 p90 -156.66 142.0 17.44 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 107.265 -1.383 . . . . 71.43 107.265 175.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 12.1 p -115.79 163.61 15.59 Favored 'General case' 0 C--N 1.263 -3.165 0 O-C-N 123.617 0.573 . . . . 73.3 109.868 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 12.6 pt -114.35 154.75 15.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.368 0.604 . . . . 71.03 112.04 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.7 t -137.95 149.33 46.06 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.679 -0.86 . . . . 71.31 108.679 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.46 ' HB3' ' OE1' ' A' ' 524' ' ' GLN . 66.9 p . . . . . 0 C--N 1.308 -1.225 0 N-CA-C 109.193 -0.669 . . . . 64.11 109.193 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.415 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -1.192 0 N-CA-C 109.673 -0.933 . . . . 54.43 109.673 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.56 HG13 ' HB3' ' A' ' 519' ' ' LEU . 18.2 mm -91.09 124.46 43.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 115.921 -0.581 . . . . 62.41 109.976 -172.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.415 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 88.1 m-85 -125.61 163.0 23.72 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 109.975 -0.38 . . . . 64.32 109.975 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 40.2 t -89.16 119.83 36.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.851 -0.425 . . . . 51.41 109.851 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -70.81 -63.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.47 1.108 . . . . 74.31 110.358 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 64.0 t30 -151.45 160.19 43.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.931 -0.577 . . . . 74.13 109.911 -174.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 507' ' ' ALA . 44.7 mm -110.28 105.71 19.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.874 -1.158 . . . . 72.35 107.874 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -65.15 128.4 93.75 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.585 -0.734 . . . . 61.23 111.344 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.14 24.68 0.26 Allowed 'Trans proline' 0 N--CA 1.503 2.048 1 C-N-CA 125.334 4.023 . . . . 61.02 114.964 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -160.29 7.02 0.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 113.251 0.834 . . . . 65.23 113.251 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 469' ' ' GLU . . . -99.8 -155.21 28.15 Favored Glycine 0 C--N 1.297 -1.631 0 C-N-CA 119.266 -1.445 . . . . 74.23 113.685 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.519 ' O ' HD12 ' A' ' 464' ' ' LEU . . . -66.12 -37.66 86.26 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 123.37 0.668 . . . . 52.41 109.559 -176.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -57.72 -41.76 82.42 Favored 'General case' 0 C--O 1.195 -1.778 0 CA-C-N 115.126 -0.943 . . . . 64.31 112.053 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.3 tt -80.3 -29.36 12.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 120.943 0.401 . . . . 71.54 111.625 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.05 -48.37 80.32 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.228 1.011 . . . . 74.13 108.666 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.531 ' HB2' HD13 ' A' ' 464' ' ' LEU . 12.9 m-20 -93.68 -31.73 14.34 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 120.345 -0.542 . . . . 61.03 110.412 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.29 27.82 72.14 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.879 -0.6 . . . . 44.42 112.967 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.505 ' CG ' HG23 ' A' ' 462' ' ' ILE . 33.0 tpt180 -101.92 -19.35 15.3 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.75 0.31 . . . . 71.41 111.148 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.516 ' HB2' HD21 ' A' ' 464' ' ' LEU . 52.7 tp -106.87 151.19 25.56 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.817 -0.438 . . . . 72.51 109.817 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.479 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -144.21 159.88 41.91 Favored 'General case' 0 N--CA 1.434 -1.258 0 O-C-N 123.176 0.298 . . . . 72.32 110.594 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.541 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -91.4 167.95 11.9 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.323 0.389 . . . . 71.32 111.773 -174.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.87 13.18 65.04 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.446 -0.797 . . . . 54.0 112.153 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -120.01 178.27 4.68 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 107.645 -1.243 . . . . 73.51 107.645 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.01 133.54 47.96 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-N 117.993 0.361 . . . . 74.14 110.646 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 511' ' ' LEU . 21.4 tp -96.04 117.05 29.91 Favored 'General case' 0 N--CA 1.394 -3.251 0 N-CA-C 108.339 -0.986 . . . . 72.24 108.339 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.444 ' HB ' HD12 ' A' ' 543' ' ' LEU . 1.9 mp -99.02 -35.19 4.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.121 0.486 . . . . 73.04 110.211 -177.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 543' ' ' LEU . 31.2 tt0 -150.34 144.78 25.73 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.716 -0.674 . . . . 64.35 110.551 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.524 HG12 HD21 ' A' ' 519' ' ' LEU . 2.6 p -135.03 123.35 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 N-CA-C 108.328 -0.99 . . . . 63.02 108.328 175.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 70.62 -66.22 0.3 Allowed 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 127.576 2.35 . . . . 71.42 111.231 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -174.02 29.64 0.09 OUTLIER Glycine 0 C--N 1.308 -0.994 0 N-CA-C 111.467 -0.653 . . . . 64.42 111.467 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.6 t -122.18 139.1 50.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 110.155 -0.313 . . . . 74.25 110.155 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -83.18 130.53 35.1 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.575 -0.898 . . . . 45.34 108.575 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.56 ' HB3' HG13 ' A' ' 488' ' ' ILE . 47.5 mt -100.89 -36.0 9.21 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.986 -0.552 . . . . 74.1 112.117 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.48 89.53 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 121.855 0.836 . . . . 60.23 110.205 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 147.95 -32.8 1.29 Allowed Glycine 0 N--CA 1.427 -1.94 0 CA-C-N 114.369 -1.287 . . . . 53.5 110.178 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.6 -177.63 4.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.407 0.521 . . . . 75.24 112.407 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 527' ' ' VAL . 5.0 m -95.24 156.11 16.46 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.909 -0.587 . . . . 75.32 111.244 -175.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.46 ' OE1' ' HB3' ' A' ' 477' ' ' SER . 8.1 mm100 -56.16 -46.36 79.34 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.808 0.843 . . . . 53.14 111.239 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.43 ' HA ' HG22 ' A' ' 528' ' ' VAL . 1.1 mp0 -57.85 -31.86 67.09 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.127 0.489 . . . . 71.13 111.951 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -69.64 -37.24 76.69 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.967 -0.56 . . . . 52.02 110.037 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 523' ' ' SER . 17.6 t -75.93 -36.03 31.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.325 -0.852 . . . . 70.41 109.653 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.671 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.3 m -64.98 -40.61 89.65 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.267 0 C-N-CA 120.052 -0.659 . . . . 72.12 111.07 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.9 t -59.46 -44.98 92.86 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.652 0.739 . . . . 44.13 109.277 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 31.8 tp -60.4 -38.72 84.86 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 125.229 1.412 . . . . 72.43 110.398 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.501 HD12 HD23 ' A' ' 471' ' ' LEU . 16.6 tp -70.17 -48.63 56.43 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.484 -0.78 . . . . 63.42 109.959 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.8 OUTLIER -60.27 -44.56 95.21 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.767 0.827 . . . . 74.14 111.382 -176.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 33.7 t -69.23 -31.92 70.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.16 -0.473 . . . . 70.01 111.037 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 84.9 m 66.3 -87.03 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.926 0.49 . . . . 54.2 111.552 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? 165.58 158.26 0.03 OUTLIER 'General case' 0 C--O 1.244 0.774 0 N-CA-C 105.89 -1.893 . . . . 44.52 105.89 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 65.9 mtt -58.84 -50.3 74.49 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.206 0.316 . . . . 73.15 111.416 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -62.49 -65.49 0.68 Allowed 'General case' 0 C--O 1.24 0.576 0 N-CA-C 110.049 -0.352 . . . . 74.13 110.049 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 135.28 -14.3 4.28 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 118.353 -1.88 . . . . 64.4 116.072 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.4 m -94.38 128.11 40.7 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 118.904 1.352 . . . . 63.45 108.534 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 66.7 t -114.79 137.32 48.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 CA-C-N 115.816 -0.629 . . . . 71.54 110.393 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 54.8 m -91.88 113.94 26.35 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.187 0.518 . . . . 72.53 110.467 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.586 HD23 HD23 ' A' ' 464' ' ' LEU . 3.3 mm? -102.36 119.34 38.65 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.556 -0.905 . . . . 65.35 108.556 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 3.1 tm? -110.68 117.06 32.45 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 107.907 -1.146 . . . . 72.52 107.907 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 33.1 m -119.98 162.64 18.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 114.768 -1.105 . . . . 62.4 110.325 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -116.96 114.8 24.32 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 109.495 -0.557 . . . . 73.13 109.495 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 . . . . . 0 N--CA 1.416 -2.142 0 C-N-CA 120.013 -0.675 . . . . 75.4 111.817 -177.391 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 458' ' ' LYS . 43.9 mtpt . . . . . 0 CA--C 1.471 -2.07 0 CA-C-O 121.791 0.805 . . . . 70.03 112.874 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 98.3 mtt180 -107.89 131.66 54.28 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-N 113.427 -1.715 . . . . 75.51 106.505 170.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -120.98 133.27 55.27 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 109.486 -0.561 . . . . 63.54 109.486 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -93.09 115.2 27.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.492 0.663 . . . . 73.14 109.278 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . 0.458 HG23 ' HD3' ' A' ' 504' ' ' ARG . 59.7 mt -121.72 122.67 67.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.655 -0.702 . . . . 70.0 109.977 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 27.9 mt-30 -102.42 129.22 48.85 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.99 0.424 . . . . 74.43 111.901 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.463 HD23 HD23 ' A' ' 542' ' ' LEU . 3.1 mm? -115.09 135.52 54.11 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.542 0.737 . . . . 43.11 109.879 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.764 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.1 OUTLIER -98.89 137.07 37.99 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.993 -1.114 . . . . 55.31 107.993 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.443 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 36.9 ttmt -59.73 106.1 0.44 Allowed 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.377 -0.829 . . . . 71.31 110.655 174.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -92.67 -138.71 8.69 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.846 -0.901 . . . . 43.31 110.846 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 10.2 t -65.87 -46.55 78.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.859 0.329 . . . . 42.44 110.454 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -121.53 83.42 2.08 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 107.043 -1.466 . . . . 75.41 107.043 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.443 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . -58.63 140.87 46.94 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 120.356 -0.926 . . . . 74.42 113.594 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.564 HD11 HG21 ' A' ' 540' ' ' VAL . 18.2 mt 57.37 89.1 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 125.434 1.494 . . . . 65.22 112.166 -174.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -103.45 56.76 0.58 Allowed Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 114.72 -1.127 . . . . 50.23 111.213 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.605 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 6.4 p90 -144.75 144.78 31.36 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.024 -0.732 . . . . 74.53 109.024 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.2 m -120.88 149.63 42.31 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.97 -1.122 . . . . 52.34 107.97 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 15.4 pt -109.85 155.27 11.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 112.895 0.702 . . . . 73.51 112.895 -175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 7.5 t -129.16 159.83 34.78 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.063 -1.088 . . . . 72.43 108.063 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 33.9 p . . . . . 0 C--N 1.29 -1.998 0 N-CA-C 109.077 -0.712 . . . . 55.31 109.077 178.685 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--O 1.253 1.243 0 N-CA-C 110.027 -0.797 . . . . 60.21 110.027 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.43 ' HB ' HD13 ' A' ' 519' ' ' LEU . 48.3 mm -102.62 136.16 36.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.983 -0.553 . . . . 72.41 110.298 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -134.82 162.48 32.25 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.326 -0.62 . . . . 75.53 109.326 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 23.2 t -82.23 122.89 37.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 109.141 -0.689 . . . . 61.25 109.141 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -89.87 -55.27 3.69 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.817 -0.628 . . . . 75.2 110.674 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -146.48 151.02 36.72 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.191 -0.67 . . . . 64.12 109.191 -175.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.634 HG12 ' HB2' ' A' ' 507' ' ' ALA . 35.3 mm -111.2 110.98 34.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.002 -1.11 . . . . 50.3 108.002 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.24 123.52 78.65 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 115.775 -0.648 . . . . 64.45 109.298 176.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.02 22.19 0.15 Allowed 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.945 3.763 . . . . 75.33 114.836 -171.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -160.07 -2.98 0.07 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.819 0.674 . . . . 75.11 112.819 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.602 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -84.55 -167.97 43.61 Favored Glycine 0 C--O 1.216 -0.971 0 C-N-CA 119.788 -1.196 . . . . 44.41 112.515 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.461 ' CB ' ' H ' ' A' ' 471' ' ' LEU . . . -57.11 -34.77 68.69 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.014 0.907 . . . . 53.13 111.759 -175.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.79 86.14 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.61 -0.723 . . . . 74.04 112.261 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 8.8 tt -79.03 -31.3 14.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 O-C-N 123.233 0.333 . . . . 63.4 111.388 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 71.1 mm-40 -62.39 -43.28 99.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.763 -0.458 . . . . 73.14 109.763 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.406 ' HB2' HD13 ' A' ' 464' ' ' LEU . 11.0 t70 -82.77 -41.64 18.93 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.865 -1.531 . . . . 64.2 106.865 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.56 -7.52 76.1 Favored Glycine 0 N--CA 1.426 -1.973 0 CA-C-N 115.372 -0.831 . . . . 75.23 115.118 174.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.458 ' HD3' HG23 ' A' ' 462' ' ' ILE . 73.4 ttt180 -85.83 -19.16 31.06 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 120.974 0.416 . . . . 63.02 111.727 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 62.1 tp -101.19 130.48 47.29 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.091 -0.337 . . . . 73.32 110.091 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.527 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -134.83 171.77 13.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.657 0.265 . . . . 74.02 111.448 176.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.634 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -96.82 130.8 44.03 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.35 -0.386 . . . . 73.33 111.107 -176.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 144.13 -23.27 2.08 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.659 -0.701 . . . . 61.44 111.465 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -93.29 172.23 8.42 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-O 120.942 0.401 . . . . 74.33 111.099 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -93.75 138.75 31.61 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.679 -0.692 . . . . 74.34 110.308 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.525 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -89.77 127.96 36.05 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 105.892 -1.892 . . . . 73.15 105.892 177.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.0 mm -96.16 -50.78 11.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.861 -0.524 . . . . 74.32 109.97 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -157.54 145.76 19.14 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.694 -0.685 . . . . 75.44 109.267 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.433 HG23 HD13 ' A' ' 542' ' ' LEU . 4.8 p -126.04 130.37 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.308 0 CA-C-O 121.359 0.599 . . . . 74.45 109.69 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 62.05 20.08 11.32 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 126.208 1.803 . . . . 71.44 111.389 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 95.47 2.09 61.94 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.78 -0.724 . . . . 63.31 113.473 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.99 138.21 38.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.639 -0.504 . . . . 74.24 109.639 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -84.35 148.22 26.75 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 123.571 0.544 . . . . 75.02 110.036 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.525 HD11 HD12 ' A' ' 511' ' ' LEU . 28.1 mt -90.48 -50.98 5.64 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.773 -0.649 . . . . 55.51 112.003 -173.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.12 86.32 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 122.623 1.202 . . . . 75.51 111.305 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 166.2 -24.34 0.14 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 108.278 -1.929 . . . . 44.14 108.278 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.58 172.49 7.31 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.793 -0.817 . . . . 74.31 108.793 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 42.4 m -91.88 165.15 13.39 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 110.256 -0.275 . . . . 72.42 110.256 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -53.96 -44.97 71.18 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.572 0.749 . . . . 73.0 111.847 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.609 ' HA ' HG22 ' A' ' 528' ' ' VAL . 39.4 mt-10 -61.58 -31.55 71.61 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 112.463 0.542 . . . . 75.53 112.463 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.75 -34.01 69.15 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.291 -0.633 . . . . 54.31 109.291 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 47.6 t -70.45 -38.22 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.559 -0.746 . . . . 75.42 109.372 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.715 ' O ' ' HG3' ' A' ' 532' ' ' ARG . 19.9 m -69.57 -36.64 71.9 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.893 0 C-N-CA 119.099 -1.04 . . . . 73.42 110.676 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.8 t -59.28 -44.11 92.49 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 109.226 -0.657 . . . . 53.34 109.226 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 34.4 tp -58.82 -41.9 87.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.843 1.257 . . . . 75.22 109.594 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 471' ' ' LEU . 3.2 tt -64.98 -48.05 75.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.323 -0.853 . . . . 63.53 111.944 174.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.715 ' HG3' ' O ' ' A' ' 528' ' ' VAL . 23.0 mtm180 -61.41 -31.11 71.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.49 -0.323 . . . . 62.5 110.837 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.5 t -65.56 -44.43 86.79 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.253 -0.431 . . . . 53.41 110.006 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 24.6 m 63.85 -2.88 0.49 Allowed 'General case' 0 CA--C 1.578 2.026 0 C-N-CA 123.797 0.839 . . . . 62.41 112.812 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.586 ' HE3' ' OE1' ' A' ' 537' ' ' GLU . 61.6 tttp 70.13 146.4 0.06 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.215 1.006 . . . . 62.23 111.912 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 46.7 ttm -63.3 -32.37 73.77 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 116.569 2.062 . . . . 51.2 116.569 -167.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . 0.586 ' OE1' ' HE3' ' A' ' 535' ' ' LYS . 0.0 OUTLIER -78.24 -28.24 47.76 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 118.021 -1.472 . . . . 63.2 108.782 178.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 99.86 30.98 6.18 Favored Glycine 0 N--CA 1.415 -2.733 0 CA-C-N 114.771 -1.104 . . . . 54.02 113.613 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 4.0 m -128.58 132.22 48.2 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.034 -1.099 . . . . 45.14 108.034 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.564 HG21 HD11 ' A' ' 471' ' ' LEU . 61.5 t -120.07 134.34 63.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 116.178 -0.465 . . . . 61.14 111.239 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.7 m -91.76 114.4 26.93 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.199 -0.91 . . . . 71.12 110.047 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.605 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.2 mm? -104.04 121.24 42.77 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.744 -1.206 . . . . 71.32 107.744 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 41.8 tp -104.51 117.92 35.32 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.252 -1.759 . . . . 52.31 106.252 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 35.3 m -115.31 148.47 18.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 C-N-CA 120.503 -0.479 . . . . 54.23 110.827 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -111.97 122.32 47.44 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.829 -0.623 . . . . 74.22 109.655 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 . . . . . 0 N--CA 1.409 -2.519 0 CA-C-N 114.59 -1.186 . . . . 63.31 109.436 179.767 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt . . . . . 0 N--CA 1.42 -1.974 0 N-CA-C 108.28 -1.007 . . . . 65.44 108.28 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 43.8 mtm180 -100.67 145.57 28.27 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 110.005 -0.368 . . . . 73.41 110.005 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.0 mm? -124.12 131.91 53.59 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.124 -0.695 . . . . 72.43 109.124 -174.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -104.89 115.27 30.0 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.655 0.74 . . . . 70.11 109.093 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 50.0 mt -122.51 142.6 38.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 115.318 -0.855 . . . . 73.15 110.506 -171.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 43.5 mt-30 -114.99 128.24 56.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.901 0.381 . . . . 74.2 111.279 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 539' ' ' THR . 6.3 mp -119.04 152.47 36.38 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.108 0.963 . . . . 71.45 111.885 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -115.81 129.04 56.28 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.323 -0.992 . . . . 75.11 108.323 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.633 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 23.8 ttmm -60.81 88.01 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.419 0.628 . . . . 72.23 112.044 176.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -90.45 -128.47 3.81 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.63 -0.714 . . . . 73.3 112.277 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . 0.723 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 17.1 m -48.99 -72.73 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.322 1.049 . . . . 64.22 111.507 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.601 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 46.1 mm-40 -82.36 -38.54 24.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.245 -1.391 . . . . 72.14 107.245 171.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.633 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . 65.78 109.09 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.179 -1.373 . . . . 70.31 112.096 -174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.664 ' H ' ' CB ' ' A' ' 498' ' ' ALA . 33.9 mt 69.16 85.51 0.14 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 125.64 1.576 . . . . 71.3 108.076 -168.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . -103.18 56.76 0.59 Allowed Glycine 0 CA--C 1.471 -2.698 0 CA-C-N 114.393 -1.276 . . . . 45.3 112.151 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 2.9 p90 -147.72 142.94 27.21 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.01 0.433 . . . . 73.11 110.253 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 19.9 m -114.69 145.2 42.32 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 107.237 -1.394 . . . . 72.33 107.237 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.86 153.94 14.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 112.812 0.671 . . . . 52.21 112.812 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.655 ' HB ' ' HE3' ' A' ' 491' ' ' LYS . 8.2 t -143.33 149.43 37.76 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.119 -0.946 . . . . 43.33 109.563 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.424 -1.732 0 N-CA-C 108.092 -1.077 . . . . 72.22 108.092 174.964 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.51 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 43.5 Cg_exo . . . . . 0 C--O 1.245 0.872 0 CA-C-O 121.379 0.491 . . . . 74.33 113.285 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.494 HG13 ' HB3' ' A' ' 519' ' ' LEU . 38.9 mm -87.98 120.82 37.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.963 -1.017 . . . . 71.12 108.883 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 66.3 m-85 -120.51 150.47 40.79 Favored 'General case' 0 CA--C 1.483 -1.613 0 CA-C-O 120.804 0.335 . . . . 74.01 111.897 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.43 119.42 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 107.185 -1.413 . . . . 70.52 107.185 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.655 ' HE3' ' HB ' ' A' ' 476' ' ' THR . 41.0 ttmt -87.87 -53.82 4.56 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.312 0.577 . . . . 61.42 111.078 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 61.5 t30 -142.04 149.68 40.27 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.287 -0.87 . . . . 71.0 110.446 -171.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 507' ' ' ALA . 32.2 mm -115.87 106.54 20.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 124.149 0.906 . . . . 74.13 109.26 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -53.09 131.11 50.47 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.551 -0.749 . . . . 74.55 111.069 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -70.01 15.15 0.25 Allowed 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 124.557 3.505 . . . . 74.31 114.095 -173.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.723 ' O ' ' HB ' ' A' ' 468' ' ' THR . 12.1 ptt180 -164.35 12.68 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.109 0.957 . . . . 74.41 111.097 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.601 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . -84.83 -174.84 50.52 Favored Glycine 0 C--N 1.286 -2.209 0 C-N-CA 120.013 -1.089 . . . . 60.23 111.565 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.664 ' CB ' ' H ' ' A' ' 471' ' ' LEU . . . -62.21 -28.12 69.46 Favored 'General case' 0 C--O 1.198 -1.633 0 CA-C-N 117.999 0.9 . . . . 72.34 110.934 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.424 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -58.93 -41.62 87.81 Favored 'General case' 0 C--O 1.204 -1.302 0 CA-C-N 116.069 -0.514 . . . . 53.03 111.697 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.4 tt -79.84 -36.99 17.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.877 0.37 . . . . 73.14 111.546 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 9.1 mm-40 -66.85 -39.94 87.76 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.69 -0.686 . . . . 62.11 110.219 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.471 ' HB2' ' HG ' ' A' ' 464' ' ' LEU . 10.8 m-20 -92.45 -22.66 19.49 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.594 -0.73 . . . . 71.33 111.455 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.87 -57.36 5.01 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 116.647 1.419 . . . . 43.44 116.647 171.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -46.13 -30.8 2.06 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.519 1.674 . . . . 73.51 115.519 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 59.4 tp -98.02 132.05 43.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 117.824 0.284 . . . . 71.22 111.173 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.454 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -143.91 164.89 29.26 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 121.046 -0.261 . . . . 72.24 110.963 174.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.524 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.7 98.8 9.85 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.266 0.555 . . . . 71.35 111.963 -174.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 174.1 29.38 0.03 OUTLIER Glycine 0 C--N 1.304 -1.228 0 N-CA-C 111.107 -0.797 . . . . 51.24 111.107 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -148.18 177.79 9.1 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 120.748 0.309 . . . . 74.42 110.979 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -106.82 129.25 54.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.527 -0.76 . . . . 72.41 109.43 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' A' ' 519' ' ' LEU . 28.2 tp -83.46 120.77 26.32 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 107.957 -1.127 . . . . 74.21 107.957 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 543' ' ' LEU . 49.1 mm -97.93 -45.84 12.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 120.911 0.386 . . . . 71.22 111.129 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.491 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 10.2 pt-20 -154.02 146.02 23.6 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.123 -0.49 . . . . 72.33 110.145 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.458 HG13 HD21 ' A' ' 530' ' ' LEU . 2.6 p -130.65 129.13 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.458 0 N-CA-C 107.401 -1.333 . . . . 71.02 107.401 176.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 10.6 m120 68.01 4.8 4.22 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.82 0.848 . . . . 74.33 112.667 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 104.56 -6.96 45.68 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 121.065 -0.588 . . . . 53.55 112.075 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.3 t -87.14 125.75 40.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.776 -0.453 . . . . 35.42 109.776 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -79.75 134.25 36.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.982 -0.554 . . . . 73.15 110.512 -176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.494 ' HB3' HG13 ' A' ' 488' ' ' ILE . 17.3 mt -98.63 -22.87 15.71 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.864 -0.607 . . . . 44.54 110.658 -174.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.31 9.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 125.413 1.485 . . . . 63.42 113.84 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -144.05 18.45 2.14 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 110.875 -0.89 . . . . 44.54 110.875 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 174.6 10.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.466 0.543 . . . . 72.31 112.466 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 527' ' ' VAL . 32.4 m -93.34 159.8 15.1 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.757 -0.656 . . . . 75.34 112.731 -175.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.507 ' O ' HG13 ' A' ' 528' ' ' VAL . 36.9 mm-40 -50.19 -47.68 54.47 Favored 'General case' 0 C--O 1.209 -1.046 0 C-N-CA 124.472 1.109 . . . . 73.11 113.626 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' A' ' 525' ' ' GLU . 4.1 mp0 -59.1 -34.28 71.82 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.235 0.54 . . . . 75.22 111.185 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.85 -39.2 83.82 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.673 -0.694 . . . . 65.42 109.73 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 523' ' ' SER . 15.2 t -75.48 -36.78 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 115.571 -0.74 . . . . 74.44 109.762 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.664 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 7.5 m -66.11 -42.55 91.58 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.049 0 C-N-CA 120.214 -0.595 . . . . 50.21 110.127 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 29.7 m -59.57 -44.05 93.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.454 0.645 . . . . 74.12 109.84 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.458 HD21 HG13 ' A' ' 514' ' ' VAL . 25.2 tp -58.32 -46.55 85.94 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 124.916 1.287 . . . . 74.2 109.658 176.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.569 HD12 HD13 ' A' ' 471' ' ' LEU . 30.2 tp -62.9 -48.39 79.16 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.522 -0.763 . . . . 64.31 110.533 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 29.7 mmm180 -60.97 -38.27 85.33 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.87 -0.604 . . . . 61.14 110.908 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 22.4 m -70.94 -40.49 72.0 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 115.986 -0.552 . . . . 73.01 110.226 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . 0.514 HG21 ' HE2' ' A' ' 466' ' ' LYS . 61.9 m 69.72 -84.47 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.882 0.873 . . . . 70.12 111.577 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt 174.45 167.96 0.24 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.948 -1.501 . . . . 71.33 106.948 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 88.2 mtp -59.49 -51.22 70.8 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.398 0.888 . . . . 64.32 113.398 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.81 -64.65 1.13 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.503 -0.879 . . . . 55.13 109.307 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 150.19 18.07 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 118.721 -1.704 . . . . 43.54 115.691 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.1 m -100.22 130.36 46.34 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 119.036 1.418 . . . . 63.53 108.373 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 51.9 t -124.0 135.52 63.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 112.154 0.427 . . . . 63.12 112.154 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 42.9 m -94.18 115.24 27.5 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.073 -0.967 . . . . 74.32 110.289 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.57 121.21 44.18 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.091 -1.078 . . . . 72.32 108.091 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 2.8 tm? -110.0 116.48 31.66 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 105.854 -1.906 . . . . 73.42 105.854 174.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.8 m -118.25 157.79 19.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 115.057 -0.974 . . . . 71.12 111.206 -174.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -123.6 116.36 22.99 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.915 -0.584 . . . . 62.1 109.988 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 . . . . . 0 C--N 1.294 -1.835 0 N-CA-C 108.332 -0.988 . . . . 71.02 108.332 175.657 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 29.1 mtpp . . . . . 0 N--CA 1.423 -1.799 0 CA-C-O 121.3 0.571 . . . . 73.13 111.963 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 94.3 mtt180 -118.6 126.09 51.21 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.069 -1.826 . . . . 75.25 106.069 170.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.9 mp -124.74 136.76 54.15 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 116.468 -0.333 . . . . 71.13 110.934 -175.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -99.6 115.14 28.7 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 123.988 0.805 . . . . 64.12 108.956 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 55.4 mt -121.85 142.69 37.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.685 -0.857 . . . . 53.55 108.685 -176.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.47 ' HB3' HG22 ' A' ' 539' ' ' THR . 76.5 mt-30 -117.3 127.06 53.7 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.424 0.527 . . . . 64.52 112.424 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.454 HD23 HD23 ' A' ' 542' ' ' LEU . 3.9 mm? -115.57 133.19 56.27 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 124.46 1.104 . . . . 73.44 109.586 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 37.4 ttpt -108.15 136.35 47.97 Favored 'General case' 0 N--CA 1.401 -2.897 0 N-CA-C 108.815 -0.809 . . . . 62.45 108.815 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.451 ' HA ' ' HA2' ' A' ' 470' ' ' GLY . 48.8 mtmt -54.7 99.3 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 124.066 0.854 . . . . 71.41 111.506 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -131.19 136.82 9.04 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.696 -0.962 . . . . 51.43 110.696 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 64.5 m 63.1 -88.13 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.235 1.014 . . . . 73.05 111.446 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.428 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 31.0 mm-40 -98.01 -5.73 33.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.556 0.693 . . . . 64.15 109.364 177.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 69.17 -154.61 53.32 Favored Glycine 0 CA--C 1.486 -1.767 0 CA-C-O 118.109 -1.384 . . . . 73.42 110.842 -177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 540' ' ' VAL . 48.1 mt -43.76 101.52 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.425 1.112 . . . . 60.42 112.348 -173.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -111.98 56.26 0.47 Allowed Glycine 0 CA--C 1.477 -2.282 0 CA-C-N 114.739 -1.119 . . . . 62.24 112.329 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.597 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 5.3 p90 -144.45 142.12 30.07 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.055 -1.091 . . . . 75.03 108.055 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 28.9 p -116.57 162.36 17.74 Favored 'General case' 0 C--N 1.272 -2.797 0 N-CA-C 108.44 -0.948 . . . . 54.4 108.44 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.438 HG13 HE22 ' A' ' 524' ' ' GLN . 24.2 pt -126.28 159.39 35.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.316 0.579 . . . . 74.3 111.505 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.8 t -148.12 153.73 39.24 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.358 -1.719 . . . . 62.42 106.358 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 C--N 1.293 -1.851 0 N-CA-C 108.595 -0.891 . . . . 70.24 108.595 178.632 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 C--O 1.249 1.072 0 N-CA-C 110.957 -0.44 . . . . 52.13 110.957 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 43.1 mm -93.74 130.64 42.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.644 -0.707 . . . . 71.14 109.235 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -127.51 153.46 46.31 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.255 0.222 . . . . 63.32 110.474 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 28.2 t -73.36 122.72 26.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.572 -0.899 . . . . 61.24 108.572 177.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -80.68 -62.26 1.72 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.437 -0.579 . . . . 72.14 109.437 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -143.05 163.71 32.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.368 -0.975 . . . . 71.41 108.368 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 506' ' ' LYS . 26.4 mm -123.42 110.16 25.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 124.805 1.242 . . . . 61.3 108.445 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.02 125.4 73.97 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.217 -0.901 . . . . 72.34 110.633 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.28 21.33 0.23 Allowed 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 124.895 3.73 . . . . 71.42 114.6 -172.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -165.35 7.25 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.241 0.543 . . . . 75.02 112.424 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -89.48 -161.79 37.82 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 120.18 -1.009 . . . . 31.44 112.782 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -61.61 -39.84 92.69 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 123.817 0.847 . . . . 61.14 109.968 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.65 -41.4 81.39 Favored 'General case' 0 C--O 1.201 -1.461 0 CA-C-N 114.625 -1.171 . . . . 70.02 112.696 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.1 tt -79.48 -31.02 13.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 111.628 0.233 . . . . 72.12 111.628 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 30.9 mm-40 -59.71 -43.15 94.23 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.167 0.508 . . . . 61.14 109.65 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.42 -50.93 7.34 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.787 -0.642 . . . . 70.25 110.385 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 101.2 -36.09 4.44 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.044 -1.55 . . . . 32.02 116.235 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -65.87 -32.83 74.56 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.564 0.682 . . . . 64.53 112.232 -173.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 61.7 tp -84.44 102.7 12.99 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.921 -0.581 . . . . 73.23 110.508 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.488 ' HA ' HG13 ' A' ' 493' ' ' ILE . 10.3 ptmm? -113.69 177.0 4.79 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.181 -0.463 . . . . 74.14 111.52 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.447 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -87.43 147.52 25.39 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.997 -0.547 . . . . 62.43 110.371 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 110.11 -27.19 12.12 Favored Glycine 0 C--N 1.311 -0.852 0 C-N-CA 120.702 -0.761 . . . . 61.21 112.775 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -79.98 163.22 24.42 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 120.62 0.248 . . . . 62.4 110.945 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 31.6 ttm180 -96.8 142.5 28.73 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-O 120.796 0.331 . . . . 71.21 111.48 -178.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.703 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -90.54 126.96 36.1 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.902 0.881 . . . . 72.14 111.288 175.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 33.4 mt -103.33 -45.68 10.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.156 -0.683 . . . . 73.33 109.156 173.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.551 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 0.5 OUTLIER -150.96 155.15 38.5 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 109.716 -0.476 . . . . 73.33 109.716 176.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.672 HG12 HD21 ' A' ' 519' ' ' LEU . 7.1 p -143.3 130.58 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 O-C-N 123.827 0.705 . . . . 55.24 109.232 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . 0.539 HD21 ' HG2' ' A' ' 535' ' ' LYS . 1.4 t-20 64.78 15.42 9.8 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 125.918 1.687 . . . . 73.31 112.521 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 100.37 7.67 51.33 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.499 -0.858 . . . . 34.53 113.578 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 57.9 t -121.1 142.93 35.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 117.2 0.5 . . . . 63.45 110.415 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -73.96 144.5 45.21 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.472 0.709 . . . . 72.35 110.138 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.703 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 15.2 mt -108.43 -42.79 4.48 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.677 -0.409 . . . . 73.44 112.0 -175.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.34 -26.95 37.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 116.054 -0.521 . . . . 71.11 111.373 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -78.55 -18.52 75.56 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.747 -0.739 . . . . 63.55 112.416 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.441 ' HD3' ' CB ' ' A' ' 526' ' ' GLU . 0.1 OUTLIER -110.62 -175.55 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.328 -0.513 . . . . 73.32 111.802 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 527' ' ' VAL . 11.3 m -87.32 158.75 18.98 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.901 -0.591 . . . . 71.43 111.183 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.438 HE22 HG13 ' A' ' 475' ' ' ILE . 8.7 tm0? -59.71 -47.71 84.55 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.854 1.262 . . . . 44.31 109.843 -175.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 528' ' ' VAL . 47.1 mt-10 -68.5 -30.36 69.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.694 0.998 . . . . 74.12 113.694 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.441 ' CB ' ' HD3' ' A' ' 522' ' ' LYS . 49.4 mt-10 -59.98 -37.59 80.08 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.515 -0.55 . . . . 60.23 109.515 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.471 HG13 HD22 ' A' ' 519' ' ' LEU . 43.4 t -65.64 -36.92 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.74 -0.663 . . . . 73.13 110.276 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.673 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 25.0 m -70.53 -39.09 75.74 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 C-N-CA 118.977 -1.089 . . . . 74.33 110.403 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 37.4 t -61.29 -37.41 83.09 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.017 -0.538 . . . . 42.23 109.873 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 33.7 tp -64.14 -42.52 96.75 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.876 1.27 . . . . 54.43 109.951 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 tt -64.7 -44.15 91.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.337 -0.847 . . . . 73.15 111.928 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 31.3 mmm180 -64.63 -27.08 68.69 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.054 -0.521 . . . . 71.32 112.055 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 23.2 p -82.53 -45.84 14.15 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 113.447 0.906 . . . . 70.12 113.447 -176.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . 0.416 HG21 ' CD ' ' A' ' 466' ' ' LYS . 88.4 m 59.4 133.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.296 0.57 . . . . 44.22 112.466 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.539 ' HG2' HD21 ' A' ' 515' ' ' ASN . 18.2 ptpt -64.96 152.56 42.96 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.053 -1.029 . . . . 62.43 109.68 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 50.9 ttm -54.76 -32.23 59.65 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 123.473 0.709 . . . . 71.31 112.784 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.56 -15.89 53.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.649 0.611 . . . . 74.2 112.649 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 85.93 -20.35 20.69 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.666 -0.778 . . . . 43.25 113.923 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 463' ' ' GLN . 3.9 m -104.09 129.07 51.76 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.48 0.657 . . . . 62.33 109.756 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.477 HG21 HD11 ' A' ' 471' ' ' LEU . 77.1 t -111.68 141.77 26.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.935 -1.029 . . . . 65.13 110.83 -176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 34.3 t -91.15 132.95 35.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.743 -0.662 . . . . 54.0 109.444 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.597 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.7 mm? -120.77 118.57 30.36 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.692 -1.225 . . . . 74.41 107.692 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.514 ' CB ' ' HG3' ' A' ' 513' ' ' GLU . 51.1 tp -104.63 117.66 34.67 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 105.213 -2.143 . . . . 71.44 105.213 172.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 28.6 m -115.98 151.78 17.73 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.135 0 C-N-CA 120.233 -0.587 . . . . 73.34 111.143 -176.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.536 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 85.6 t80 -110.92 116.14 30.7 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.68 -1.97 . . . . 74.12 105.68 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 . . . . . 0 C--N 1.287 -2.136 0 N-CA-C 108.865 -0.791 . . . . 72.4 108.865 -174.219 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt . . . . . 0 CA--C 1.487 -1.469 0 N-CA-C 113.786 1.032 . . . . 74.35 113.786 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 89.2 mtm180 -105.81 138.66 41.63 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 113.743 -1.571 . . . . 71.23 107.395 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.43 ' O ' HD12 ' A' ' 543' ' ' LEU . 6.0 mp -123.4 128.24 49.58 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 120.989 0.424 . . . . 72.1 110.705 -177.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -96.27 116.26 28.73 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.042 -0.981 . . . . 72.53 109.787 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 53.6 mt -123.67 144.21 34.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 114.783 -1.099 . . . . 60.32 110.414 -172.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.3 mt-30 -119.98 129.99 54.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.594 0.59 . . . . 53.24 112.594 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.599 HD23 HD23 ' A' ' 542' ' ' LEU . 3.8 mm? -116.85 153.03 33.23 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 124.962 1.305 . . . . 74.24 110.189 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -113.16 129.34 56.54 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 108.159 -1.052 . . . . 64.24 108.159 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -60.24 102.91 0.19 Allowed 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.547 -0.751 . . . . 73.23 109.664 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -146.16 150.45 22.69 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.369 -0.692 . . . . 44.32 111.369 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 50.1 m 65.21 -78.56 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.241 1.017 . . . . 60.42 111.131 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -119.48 -6.68 10.24 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.035 -0.728 . . . . 61.12 109.035 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 69.24 -151.08 50.79 Favored Glycine 0 C--O 1.206 -1.598 0 CA-C-O 118.673 -1.07 . . . . 70.13 110.784 -175.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 7.8 mp -46.83 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.217 1.192 . . . . 50.21 114.217 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -104.06 43.66 1.63 Allowed Glycine 0 N--CA 1.428 -1.847 0 CA-C-N 113.951 -1.477 . . . . 62.53 112.044 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -129.17 142.16 50.95 Favored 'General case' 0 N--CA 1.409 -2.518 0 N-CA-C 108.596 -0.89 . . . . 64.42 108.596 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 45.0 t -115.0 148.53 38.71 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.401 -1.333 . . . . 72.31 107.401 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.434 HG21 HD12 ' A' ' 511' ' ' LEU . 14.9 pt -116.62 156.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.474 0.654 . . . . 72.32 112.611 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.4 t -138.21 159.85 40.98 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.934 -1.506 . . . . 72.21 106.934 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 14.9 p . . . . . 0 C--N 1.285 -2.236 0 N-CA-C 109.666 -0.494 . . . . 73.12 109.666 -178.49 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo . . . . . 0 C--O 1.247 0.972 0 CA-C-O 121.712 0.63 . . . . 74.43 112.847 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.427 HG13 HG21 ' A' ' 527' ' ' VAL . 47.8 mm -97.74 135.6 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 115.01 -0.995 . . . . 65.14 108.728 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 97.7 m-85 -127.22 155.98 42.59 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 116.68 -0.236 . . . . 73.14 110.66 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.418 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 32.6 t -82.72 119.0 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 N-CA-C 107.665 -1.235 . . . . 55.32 107.665 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.434 ' HG2' ' OD1' ' A' ' 492' ' ' ASN . 61.2 tttm -85.14 -54.81 4.39 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.561 -0.745 . . . . 73.31 109.461 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . 0.434 ' OD1' ' HG2' ' A' ' 491' ' ' LYS . 18.4 m120 -136.98 157.08 47.55 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 115.447 -0.797 . . . . 63.4 112.55 -176.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 507' ' ' ALA . 26.6 mm -120.53 115.59 47.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.314 -1.736 . . . . 61.21 106.314 172.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 495' ' ' PRO . 9.3 mp -62.92 163.11 17.5 Favored Pre-proline 0 C--N 1.304 -1.399 0 C-N-CA 123.839 0.855 . . . . 72.41 112.146 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 494' ' ' LEU . 43.6 Cg_endo -74.75 -5.22 16.55 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 123.645 2.896 . . . . 71.35 111.219 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.443 ' HA ' HG21 ' A' ' 500' ' ' ILE . 97.9 mtt180 -157.97 174.3 15.45 Favored 'General case' 0 N--CA 1.41 -2.437 0 C-N-CA 125.113 1.365 . . . . 73.03 107.843 -172.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 106.74 -175.93 21.11 Favored Glycine 1 C--N 1.251 -4.176 0 CA-C-N 114.659 -1.155 . . . . 53.51 112.262 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.51 81.39 Favored 'General case' 0 N--CA 1.422 -1.828 0 C-N-CA 123.783 0.833 . . . . 61.41 110.872 -175.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.31 -41.89 80.77 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 114.655 -1.157 . . . . 70.31 112.788 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.443 HG21 ' HA ' ' A' ' 496' ' ' ARG . 13.6 tt -81.08 -43.66 20.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.955 0.724 . . . . 62.53 112.955 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -59.02 -37.79 77.75 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 112.436 0.532 . . . . 74.24 112.436 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.568 ' HB2' HD13 ' A' ' 464' ' ' LEU . 3.6 m-20 -89.48 -33.36 16.81 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.211 -0.596 . . . . 73.41 109.778 173.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 62.16 50.79 61.84 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.759 -0.655 . . . . 53.05 113.74 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -117.08 -18.7 9.99 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.714 -0.795 . . . . 71.03 111.415 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.467 HD12 ' HG ' ' A' ' 542' ' ' LEU . 6.8 tt -119.84 138.96 53.07 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.988 -0.745 . . . . 73.45 108.988 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.427 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -132.05 160.91 34.53 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.41 0.892 . . . . 63.4 113.41 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.525 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -79.13 166.7 21.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.511 0.724 . . . . 65.43 111.912 -174.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 73.43 20.33 79.84 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.857 -0.897 . . . . 54.0 110.857 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . 0.519 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 4.4 t70 -117.94 172.58 7.3 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.685 -1.228 . . . . 70.12 107.685 -176.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 30.3 ttm180 -107.3 135.25 49.12 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.311 -0.556 . . . . 73.22 110.951 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.434 HD12 HG21 ' A' ' 475' ' ' ILE . 27.4 mt -95.46 126.4 40.73 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 120.493 -0.483 . . . . 72.14 110.798 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.47 -45.39 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 116.019 -0.537 . . . . 75.12 111.203 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.436 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.0 pt-20 -156.63 155.08 31.19 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.329 -0.619 . . . . 73.45 109.329 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.47 HG12 HD21 ' A' ' 519' ' ' LEU . 6.4 p -132.6 125.03 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.726 0.774 . . . . 65.12 108.975 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 66.09 7.46 4.78 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 126.737 2.015 . . . . 74.23 112.65 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.53 -10.46 16.6 Favored Glycine 0 CA--C 1.508 -0.371 0 C-N-CA 120.484 -0.865 . . . . 75.4 112.734 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.484 ' HB ' HD21 ' A' ' 530' ' ' LEU . 79.6 t -96.05 127.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.633 -0.506 . . . . 60.31 109.633 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.08 142.07 43.73 Favored 'General case' 0 CA--C 1.491 -1.324 0 O-C-N 123.868 0.73 . . . . 72.15 111.409 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.47 HD21 HG12 ' A' ' 514' ' ' VAL . 18.2 mt -100.08 -39.79 7.93 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 115.533 -0.758 . . . . 71.04 110.5 -176.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 38.6 t -73.92 98.75 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 108.587 -0.894 . . . . 75.02 108.587 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 136.52 -15.89 3.85 Favored Glycine 0 N--CA 1.424 -2.101 0 CA-C-N 114.313 -1.312 . . . . 73.21 110.173 -174.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.29 176.57 5.09 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-O 120.904 0.383 . . . . 71.34 111.681 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 37.3 m -91.11 161.09 15.24 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.889 -0.596 . . . . 71.1 111.235 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -55.42 -47.93 75.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.991 0.916 . . . . 71.31 111.694 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.481 ' HA ' HG22 ' A' ' 528' ' ' VAL . 36.3 mt-10 -62.42 -31.71 72.45 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 123.885 0.874 . . . . 71.14 112.429 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.85 -41.41 95.73 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.132 -0.692 . . . . 61.43 109.132 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.465 HG13 HD22 ' A' ' 519' ' ' LEU . 35.0 t -71.37 -39.44 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.993 -1.003 . . . . 72.11 110.389 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.663 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.9 m -65.18 -42.07 93.25 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.303 0 C-N-CA 119.347 -0.941 . . . . 71.13 110.164 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 36.8 m -62.09 -41.81 98.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.343 0.592 . . . . 72.42 110.199 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.484 HD21 ' HB ' ' A' ' 517' ' ' VAL . 54.7 tp -61.43 -46.26 90.84 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 124.125 0.97 . . . . 73.55 109.694 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.2 tt -63.39 -44.96 93.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.452 0.701 . . . . 74.23 112.408 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 28.0 mmm180 -63.06 -32.82 74.27 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.349 0.595 . . . . 72.2 109.943 -177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 43.2 t -72.31 -44.39 62.77 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-N 115.076 -0.965 . . . . 74.31 109.779 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 86.3 m 69.6 -70.57 0.14 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.886 0.874 . . . . 65.53 110.839 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.594 ' HA ' ' HE3' ' A' ' 535' ' ' LYS . 1.3 tpmt? 168.6 166.49 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 104.245 -2.502 . . . . 73.35 104.245 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 86.8 mtp -87.69 -28.59 21.71 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.025 -0.67 . . . . 64.34 109.257 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.66 -77.06 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.271 -0.877 . . . . 71.5 111.624 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 156.46 -29.31 0.56 Allowed Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 119.502 -1.332 . . . . 64.23 112.934 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 4.3 m -94.19 141.3 28.71 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.208 -1.405 . . . . 71.21 107.208 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 5.0 p -124.61 136.49 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 N-CA-C 109.223 -0.658 . . . . 74.11 109.223 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.4 m -92.25 132.87 36.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.937 -0.394 . . . . 71.01 109.937 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.599 HD23 HD23 ' A' ' 464' ' ' LEU . 1.3 mm? -124.18 138.56 54.4 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.096 -1.446 . . . . 74.14 107.096 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 39.2 tp -119.03 122.35 41.95 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 106.765 -1.569 . . . . 63.2 106.765 173.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.519 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 31.9 m -114.74 161.56 13.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 109.371 -0.604 . . . . 73.22 109.371 -177.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.443 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 84.4 t80 -132.96 129.2 37.94 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.405 0.621 . . . . 74.23 111.307 -177.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 . . . . . 0 C--N 1.292 -1.927 0 N-CA-C 108.194 -1.039 . . . . 75.44 108.194 177.293 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.576 ' HA ' ' HE3' ' A' ' 458' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.422 -1.844 0 CA-C-O 120.909 0.385 . . . . 64.12 110.111 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 79.7 mtm180 -100.55 142.38 32.11 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.998 -1.112 . . . . 75.52 107.998 172.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -132.48 132.43 42.7 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 109.264 -0.643 . . . . 65.41 109.264 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -95.55 115.71 27.81 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.753 -1.573 . . . . 54.22 106.753 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.36 142.84 38.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.689 -0.856 . . . . 53.33 108.689 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.515 ' HB3' HG22 ' A' ' 539' ' ' THR . 75.7 mt-30 -120.32 127.22 52.15 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.446 -0.502 . . . . 71.51 111.666 176.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.657 HD13 ' HB2' ' A' ' 502' ' ' ASP . 3.9 mm? -114.7 132.29 56.46 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.377 -0.972 . . . . 74.54 108.377 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 39.6 ttmt -105.19 136.13 45.27 Favored 'General case' 0 N--CA 1.401 -2.892 0 CA-C-O 121.832 0.825 . . . . 72.21 110.768 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.449 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 37.5 ttpt -72.8 102.44 3.39 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 113.937 -1.483 . . . . 71.55 109.471 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -137.9 -84.28 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.422 -1.071 . . . . 43.23 110.422 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . 0.52 ' O ' ' HA2' ' A' ' 497' ' ' GLY . 26.9 m -91.25 123.95 35.08 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.661 -1.607 . . . . 73.32 106.661 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.638 ' HB3' ' CA ' ' A' ' 497' ' ' GLY . 10.9 tp10 39.17 52.85 2.14 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 125.157 1.383 . . . . 61.4 108.214 -174.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.449 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . -53.14 127.88 36.79 Favored Glycine 0 N--CA 1.416 -2.681 0 CA-C-N 113.393 -1.731 . . . . 63.14 114.144 -171.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.646 ' H ' ' HB2' ' A' ' 498' ' ' ALA . 43.4 mt 65.95 74.34 0.36 Allowed 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 126.351 1.86 . . . . 74.13 110.475 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -92.51 57.15 2.69 Favored Glycine 0 N--CA 1.422 -2.24 0 CA-C-N 113.862 -1.517 . . . . 43.13 111.619 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.597 ' CE2' HD11 ' A' ' 542' ' ' LEU . 33.1 p90 -150.03 142.94 24.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.026 0.441 . . . . 52.3 111.558 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 46.4 p -128.7 164.75 22.27 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.826 -1.079 . . . . 54.25 108.742 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 511' ' ' LEU . 22.7 pt -121.75 153.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 113.409 0.892 . . . . 71.22 113.409 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.8 t -137.18 141.33 42.17 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.178 -0.919 . . . . 63.01 109.567 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--N 1.306 -1.306 0 N-CA-C 107.58 -1.267 . . . . 61.15 107.58 177.435 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.477 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 5.2 Cg_exo . . . . . 0 N--CA 1.441 -1.569 0 CA-C-O 121.189 0.412 . . . . 70.2 111.301 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 47.9 mm -86.42 120.61 36.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.943 -0.571 . . . . 72.43 109.954 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 90.6 m-85 -121.22 150.11 41.83 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 122.288 -0.257 . . . . 74.44 110.352 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 41.1 t -72.05 119.82 19.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.931 -0.766 . . . . 75.21 108.931 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -84.65 -57.47 3.12 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.357 -0.838 . . . . 72.34 110.897 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -136.81 151.94 49.73 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.899 -0.591 . . . . 71.51 109.781 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.441 HG13 ' HA ' ' A' ' 506' ' ' LYS . 27.8 mm -123.08 106.94 18.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.881 -1.155 . . . . 74.24 107.881 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.72 113.99 11.84 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 108.982 -0.748 . . . . 75.04 108.982 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.21 29.52 0.39 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 124.903 3.736 . . . . 61.4 112.55 -172.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -154.5 1.98 0.21 Allowed 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 115.568 -0.742 . . . . 71.11 112.133 -175.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.638 ' CA ' ' HB3' ' A' ' 469' ' ' GLU . . . -113.94 -146.63 9.44 Favored Glycine 0 C--O 1.218 -0.849 0 C-N-CA 119.124 -1.512 . . . . 75.4 115.296 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.646 ' HB2' ' H ' ' A' ' 471' ' ' LEU . . . -59.79 -40.49 88.47 Favored 'General case' 0 C--N 1.364 1.225 0 CA-C-N 118.24 1.02 . . . . 63.51 110.563 -173.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.61 -37.82 73.89 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 115.091 -0.959 . . . . 62.44 112.864 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.6 tt -80.14 -35.58 15.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.01 0.374 . . . . 65.12 112.01 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -58.79 -47.28 85.27 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.017 0.437 . . . . 73.35 110.28 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.657 ' HB2' HD13 ' A' ' 464' ' ' LEU . 21.1 m-20 -89.86 -30.19 18.07 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.443 -0.503 . . . . 72.34 110.275 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 76.27 -23.63 1.83 Allowed Glycine 0 CA--C 1.529 0.933 0 N-CA-C 118.075 1.99 . . . . 52.0 118.075 170.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -67.33 -17.46 64.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.834 1.049 . . . . 74.53 113.834 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 42.8 tp -101.76 132.3 47.57 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 122.134 -0.354 . . . . 65.11 111.672 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.441 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.261 0.0 OUTLIER -135.79 146.44 47.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 113.379 0.881 . . . . 62.35 113.379 176.657 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.422 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -65.07 123.39 19.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.306 -0.861 . . . . 53.4 110.609 -177.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 131.67 -18.87 4.82 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 111.064 -0.814 . . . . 50.41 111.064 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -81.05 156.78 25.69 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 109.212 -0.662 . . . . 72.43 109.212 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -95.57 136.49 35.89 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.775 -0.454 . . . . 64.44 109.775 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 519' ' ' LEU . 24.8 mt -85.7 136.01 33.53 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 119.707 -0.797 . . . . 73.53 110.708 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.36 -45.64 10.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.318 -0.623 . . . . 72.31 109.318 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.428 ' HG3' ' HB3' ' A' ' 543' ' ' LEU . 0.0 OUTLIER -155.35 157.13 36.65 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.06 -0.718 . . . . 72.33 109.06 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.642 HG12 HD21 ' A' ' 519' ' ' LEU . 7.6 p -144.46 136.22 21.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-N 116.021 -0.536 . . . . 63.55 109.931 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . 0.466 HD22 HG13 ' A' ' 540' ' ' VAL . 5.3 t-20 65.96 12.32 8.34 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 125.505 1.522 . . . . 71.52 111.734 176.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 92.7 14.05 55.85 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 120.857 -0.687 . . . . 35.42 111.959 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 37.3 t -121.1 146.45 26.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.921 -0.77 . . . . 62.23 108.921 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . 0.572 ' O ' ' HE2' ' A' ' 522' ' ' LYS . 5.3 p-10 -88.51 152.66 21.72 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 109.232 -0.655 . . . . 63.44 109.232 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.642 HD21 HG12 ' A' ' 514' ' ' VAL . 18.7 mt -100.53 -52.54 3.32 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.369 -0.532 . . . . 75.31 111.731 -172.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.25 110.01 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.938 0.875 . . . . 70.24 110.503 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 135.42 -33.94 2.36 Favored Glycine 0 N--CA 1.418 -2.534 0 N-CA-C 109.285 -1.526 . . . . 70.5 109.285 -174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.572 ' HE2' ' O ' ' A' ' 518' ' ' ASP . 0.1 OUTLIER -107.93 161.54 14.84 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 109.79 -0.448 . . . . 62.32 109.79 178.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 29.4 m -87.22 162.4 17.48 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.659 -0.246 . . . . 72.32 111.498 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.445 ' O ' HG13 ' A' ' 528' ' ' VAL . 53.8 mt-30 -51.74 -46.92 64.22 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.372 0.669 . . . . 74.33 112.32 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.417 ' HA ' HG22 ' A' ' 528' ' ' VAL . 40.4 mt-10 -60.01 -32.39 70.83 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.209 0.448 . . . . 64.12 112.209 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.13 -39.87 68.51 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.42 -0.585 . . . . 53.13 109.42 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 49.0 t -67.04 -41.75 87.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 74.43 109.584 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.665 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 8.6 m -66.7 -40.94 87.29 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.152 0 C-N-CA 119.209 -0.996 . . . . 74.31 110.012 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.8 m -60.41 -44.1 96.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.296 -0.411 . . . . 61.25 111.382 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.612 HD11 HG13 ' A' ' 514' ' ' VAL . 3.5 pp -67.46 -30.29 69.97 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.299 0.571 . . . . 62.23 110.232 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.44 ' CD1' HD13 ' A' ' 471' ' ' LEU . 65.2 tp -69.85 -48.22 59.71 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.679 -0.691 . . . . 73.23 109.576 175.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 27.6 mmm180 -61.11 -39.11 88.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.642 -0.708 . . . . 72.54 111.85 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 30.6 t -65.25 -38.7 91.17 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.384 -0.598 . . . . 42.32 109.384 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 17.6 m 69.92 166.57 0.28 Allowed 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.474 0.71 . . . . 60.52 111.432 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -81.41 150.98 28.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.653 -1.61 . . . . 75.44 106.653 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 91.9 mmm -63.86 -31.95 73.31 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.772 1.027 . . . . 73.2 113.772 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.27 -32.33 73.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 122.007 0.908 . . . . 72.04 108.675 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 105.68 -14.01 46.21 Favored Glycine 0 N--CA 1.422 -2.28 0 CA-C-N 114.778 -1.101 . . . . 72.24 111.453 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.515 HG22 ' HB3' ' A' ' 463' ' ' GLN . 1.8 m -96.7 129.08 44.17 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.336 -0.616 . . . . 63.34 109.336 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.466 HG13 HD22 ' A' ' 515' ' ' ASN . 86.9 t -106.76 133.5 51.15 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 115.532 -0.758 . . . . 73.2 109.915 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 21.8 t -91.48 129.59 37.44 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 109.075 -0.713 . . . . 52.25 109.075 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.597 HD11 ' CE2' ' A' ' 473' ' ' PHE . 3.8 mm? -117.56 130.33 56.34 Favored 'General case' 0 C--N 1.283 -2.309 0 C-N-CA 124.607 1.163 . . . . 74.52 108.846 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 513' ' ' GLU . 54.6 tp -112.8 117.91 33.49 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.733 -1.951 . . . . 63.12 105.733 169.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 25.9 m -115.73 150.98 17.54 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.788 0 C-N-CA 120.133 -0.627 . . . . 74.12 110.075 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -111.77 115.8 29.66 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 106.509 -1.663 . . . . 63.22 106.509 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 N--CA 1.399 -3.023 0 CA-C-N 115.213 -0.903 . . . . 74.22 109.093 -178.87 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 N--CA 1.409 -2.488 0 N-CA-C 109.182 -0.673 . . . . 71.5 109.182 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 97.5 mtt180 -99.36 132.46 44.67 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.246 -1.761 . . . . 53.13 106.246 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 15.6 tp -126.44 132.72 51.42 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.286 -0.566 . . . . 64.52 110.153 -171.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -98.63 114.61 27.15 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-O 121.97 0.89 . . . . 72.23 108.952 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.05 133.54 60.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 CA-C-N 115.074 -0.966 . . . . 64.44 109.754 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 48.4 mt-30 -106.76 128.97 54.68 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.999 -0.68 . . . . 74.33 112.177 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.582 HD23 HD23 ' A' ' 542' ' ' LEU . 4.5 mm? -112.9 150.0 32.39 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.811 -1.086 . . . . 71.33 108.697 175.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 465' ' ' LYS . 35.5 ttpt -107.54 136.37 47.43 Favored 'General case' 0 N--CA 1.389 -3.485 0 O-C-N 124.017 0.823 . . . . 61.3 109.931 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -70.82 85.12 0.67 Allowed 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 115.117 -0.947 . . . . 74.33 108.765 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -84.84 -129.98 2.07 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.45 -0.795 . . . . 62.13 112.253 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 8.7 t -66.91 -57.7 6.43 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.495 0.554 . . . . 65.44 112.495 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.82 -6.82 35.12 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.811 -0.556 . . . . 74.14 110.751 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 58.72 -153.18 29.76 Favored Glycine 0 C--O 1.207 -1.545 0 CA-C-O 118.669 -1.073 . . . . 70.12 112.184 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.576 HD11 HG21 ' A' ' 540' ' ' VAL . 61.1 mt -47.25 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.996 0.903 . . . . 74.53 112.903 -171.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.36 62.12 0.35 Allowed Glycine 0 CA--C 1.475 -2.433 0 CA-C-N 114.399 -1.273 . . . . 75.23 111.003 -176.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -155.58 142.59 19.12 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.932 -0.766 . . . . 63.41 108.932 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.3 m -117.84 158.35 24.98 Favored 'General case' 0 C--N 1.281 -2.4 0 O-C-N 124.112 0.883 . . . . 75.43 109.226 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 17.0 pt -116.73 157.31 17.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.275 0.56 . . . . 72.23 111.469 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.7 t -140.2 155.99 46.69 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 107.898 -1.149 . . . . 72.24 107.898 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 62.7 p . . . . . 0 C--N 1.306 -1.298 0 N-CA-C 108.924 -0.769 . . . . 70.31 108.924 -179.83 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 C--O 1.243 0.767 0 CA-C-O 121.392 0.497 . . . . 65.42 112.465 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 46.0 mm -93.57 136.42 25.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.778 -0.823 . . . . 43.35 108.778 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -131.18 159.33 38.03 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 121.986 0.114 . . . . 73.32 110.776 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.33 121.34 26.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.017 -0.734 . . . . 72.15 109.017 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -83.16 -57.15 3.4 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.303 0.573 . . . . 72.34 110.113 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -147.0 153.73 40.4 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.701 -0.681 . . . . 71.42 109.935 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.539 HG12 ' HB2' ' A' ' 507' ' ' ALA . 33.7 mm -114.06 106.48 20.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.081 -1.081 . . . . 63.54 108.081 175.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.2 mp -61.47 122.37 70.23 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 109.085 -0.709 . . . . 51.2 109.085 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.449 ' C ' HG21 ' A' ' 500' ' ' ILE . 87.7 Cg_endo -69.86 28.42 0.18 Allowed 'Trans proline' 0 N--CA 1.521 3.127 1 C-N-CA 125.733 4.289 . . . . 75.23 115.038 -170.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.505 ' N ' HG21 ' A' ' 500' ' ' ILE . 13.6 ptm180 -163.51 -0.81 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 113.179 0.807 . . . . 72.32 113.179 -175.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -97.33 -166.16 32.45 Favored Glycine 0 C--N 1.306 -1.103 0 C-N-CA 119.613 -1.279 . . . . 72.44 112.421 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.458 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -49.55 -48.6 48.3 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 125.451 1.5 . . . . 74.12 112.758 -172.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.473 ' HA ' HD11 ' A' ' 464' ' ' LEU . . . -56.74 -47.16 80.66 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 115.492 -0.777 . . . . 62.35 112.108 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.505 HG21 ' N ' ' A' ' 496' ' ' ARG . 0.0 OUTLIER -81.33 -35.99 14.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 123.488 0.715 . . . . 72.55 112.908 179.283 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.8 mm100 -67.79 -37.73 82.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.014 0.435 . . . . 73.31 110.929 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.473 ' HB2' HD13 ' A' ' 464' ' ' LEU . 10.0 m-20 -87.77 -30.41 20.3 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.531 -0.914 . . . . 61.34 108.531 174.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 68.75 49.26 44.03 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.311 -0.859 . . . . 62.23 113.537 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -118.04 -38.51 3.21 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.361 -0.935 . . . . 64.43 111.497 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 58.6 tp -109.01 148.47 30.72 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.529 -0.305 . . . . 71.25 110.39 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.492 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -137.46 170.75 15.55 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 123.306 0.378 . . . . 72.33 110.021 177.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.539 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -88.2 85.18 6.89 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.956 0.725 . . . . 71.24 112.956 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 176.4 19.44 0.02 OUTLIER Glycine 0 C--N 1.293 -1.806 0 CA-C-N 114.658 -1.156 . . . . 54.11 110.254 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -116.82 153.25 32.81 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-O 121.02 0.438 . . . . 75.12 110.983 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.453 HH21 HG21 ' A' ' 520' ' ' VAL . 38.4 ttt180 -94.27 134.65 36.52 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.485 -0.779 . . . . 73.24 110.201 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.693 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.2 mm? -83.21 129.59 35.02 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.016 -0.993 . . . . 74.01 110.16 174.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 545' ' ' PHE . 36.2 mm -107.52 -43.64 6.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.152 0.501 . . . . 64.41 109.971 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 517' ' ' VAL . 28.9 tt0 -158.49 155.02 27.73 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.554 -0.748 . . . . 74.32 110.02 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 541' ' ' SER . 3.5 p -143.49 125.52 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 109.484 -0.562 . . . . 74.35 109.484 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . 0.515 HD21 HG13 ' A' ' 540' ' ' VAL . 61.0 m-80 62.48 12.79 5.64 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 125.367 1.467 . . . . 62.11 114.029 -176.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 101.69 15.55 26.62 Favored Glycine 0 C--N 1.31 -0.91 0 C-N-CA 120.201 -0.999 . . . . 63.43 112.875 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 513' ' ' GLU . 61.1 t -116.48 128.75 73.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.614 -0.884 . . . . 72.41 108.614 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.22 144.14 29.13 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.172 -0.677 . . . . 71.21 109.172 -173.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.693 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 33.6 mt -97.86 -49.54 4.76 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.762 0.652 . . . . 71.33 112.762 -171.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . 0.453 HG21 HH21 ' A' ' 510' ' ' ARG . 95.7 t -70.81 96.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 122.274 1.035 . . . . 64.35 111.087 -175.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 145.62 -23.44 1.83 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 109.143 -1.583 . . . . 71.34 109.143 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.57 178.02 4.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 120.666 0.27 . . . . 61.03 111.172 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 6.5 m -89.8 159.54 16.97 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.613 -0.721 . . . . 73.13 109.48 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -60.58 -43.97 96.74 Favored 'General case' 0 C--O 1.222 -0.347 0 O-C-N 123.089 0.243 . . . . 73.13 111.341 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.52 ' HA ' HG22 ' A' ' 528' ' ' VAL . 1.6 mp0 -56.86 -35.83 69.34 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.037 -0.529 . . . . 73.13 111.337 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -62.52 -38.69 90.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.818 -0.628 . . . . 74.32 109.703 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.12 -36.72 31.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.452 -0.795 . . . . 60.1 110.144 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.57 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 14.8 m -65.29 -41.4 91.33 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 C-N-CA 119.718 -0.793 . . . . 71.33 110.424 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 46.0 t -60.93 -40.07 91.87 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.494 0.664 . . . . 72.22 110.02 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.443 ' CD2' HG13 ' A' ' 514' ' ' VAL . 36.8 tp -64.33 -36.47 84.24 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 124.371 1.068 . . . . 71.42 109.814 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 471' ' ' LEU . 25.6 tp -70.9 -45.31 64.54 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.682 -0.69 . . . . 73.33 109.333 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -59.69 -39.86 85.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.164 0.986 . . . . 71.44 110.891 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 29.1 t -64.77 -41.52 95.82 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.393 -0.821 . . . . 71.31 109.923 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 87.4 m 63.73 -91.05 0.03 OUTLIER 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.477 0.711 . . . . 33.51 111.072 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt 166.98 145.89 0.02 OUTLIER 'General case' 0 C--O 1.25 1.1 0 N-CA-C 105.757 -1.942 . . . . 71.33 105.757 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.5 mtt -66.37 -40.81 89.97 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.982 -0.287 . . . . 73.24 111.537 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.4 -79.84 0.06 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 119.248 -0.406 . . . . 73.12 111.944 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 178.66 -25.98 0.05 OUTLIER Glycine 0 C--O 1.218 -0.89 0 C-N-CA 116.634 -2.698 . . . . 55.04 116.562 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 1.3 p -94.78 120.37 34.89 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 114.926 1.454 . . . . 74.55 114.926 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 471' ' ' LEU . 98.7 t -107.95 131.98 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 114.239 -1.346 . . . . 72.55 108.646 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 24.2 p -95.39 114.58 26.36 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.256 0.551 . . . . 64.15 111.193 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.582 HD23 HD23 ' A' ' 464' ' ' LEU . 2.9 mm? -103.76 122.94 46.12 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.161 -1.052 . . . . 53.14 108.161 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 44.3 tp -103.92 117.92 35.46 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 106.445 -1.687 . . . . 63.42 106.445 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 29.0 m -116.79 161.22 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 120.63 -0.428 . . . . 71.22 110.789 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.528 ' HB2' HD11 ' A' ' 512' ' ' ILE . 91.9 t80 -111.33 117.48 33.25 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.367 0.604 . . . . 73.42 109.59 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 . . . . . 0 C--N 1.287 -2.148 0 N-CA-C 107.354 -1.35 . . . . 60.44 107.354 177.562 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm . . . . . 0 CA--C 1.489 -1.394 0 CA-C-O 120.928 0.394 . . . . 73.11 111.968 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 93.5 mtt180 -104.66 135.4 46.13 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.331 -0.988 . . . . 72.53 108.331 175.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 6.4 mp -131.76 142.01 49.65 Favored 'General case' 0 CA--C 1.48 -1.742 0 CA-C-O 120.735 0.303 . . . . 74.42 110.953 -172.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -98.01 115.98 29.3 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.263 -0.88 . . . . 73.01 108.693 174.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . 0.413 HG23 ' HG2' ' A' ' 504' ' ' ARG . 71.0 mt -123.77 123.17 66.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.13 -0.941 . . . . 63.12 110.12 -175.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.502 ' HB3' ' CG2' ' A' ' 539' ' ' THR . 25.6 mt-30 -100.41 137.29 39.03 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.836 -0.746 . . . . 74.43 112.558 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 505' ' ' LEU . 4.3 mm? -116.66 136.26 53.11 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 115.112 -0.949 . . . . 74.51 110.228 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.8 120.48 42.38 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 106.861 -1.533 . . . . 72.13 106.861 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -45.73 100.9 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.753 1.221 . . . . 74.12 111.465 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -92.96 -121.59 3.07 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.5 -0.773 . . . . 72.31 112.953 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . 0.717 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 36.3 m -59.87 -56.97 15.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.943 0.497 . . . . 64.34 111.737 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -112.32 -6.69 14.03 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.672 0.749 . . . . 63.13 111.58 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 77.79 -156.51 44.34 Favored Glycine 0 C--O 1.199 -2.088 0 CA-C-O 118.377 -1.235 . . . . 55.51 110.949 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.473 HD11 HG21 ' A' ' 540' ' ' VAL . 41.6 mt -50.41 102.36 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.71 1.255 . . . . 71.44 112.9 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -122.35 53.64 0.72 Allowed Glycine 0 N--CA 1.422 -2.281 0 CA-C-N 114.488 -1.233 . . . . 62.22 111.257 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.633 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 6.1 p90 -126.51 145.16 50.62 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.746 -1.576 . . . . 74.5 106.746 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 38.9 m -114.97 138.33 50.97 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 109.033 -0.728 . . . . 62.13 109.033 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 14.2 pt -109.72 152.58 11.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-O 121.421 0.629 . . . . 75.12 111.786 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.418 HG21 ' HE3' ' A' ' 491' ' ' LYS . 9.1 t -136.34 159.61 41.23 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.27 -1.382 . . . . 74.42 107.27 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.647 ' HB3' ' OE1' ' A' ' 524' ' ' GLN . 33.3 p . . . . . 0 C--N 1.282 -2.357 0 N-CA-C 109.021 -0.733 . . . . 54.15 109.021 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo . . . . . 0 C--O 1.245 0.856 0 N-CA-C 113.449 0.519 . . . . 71.43 113.449 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.411 HG13 ' HB3' ' A' ' 519' ' ' LEU . 24.2 mm -95.58 133.51 36.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.156 -0.929 . . . . 74.25 109.014 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.05 151.76 51.08 Favored 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 122.079 -0.388 . . . . 75.2 110.642 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 56.2 t -84.52 119.02 32.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.709 -0.849 . . . . 54.21 108.709 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.418 ' HE3' HG21 ' A' ' 476' ' ' THR . 5.2 tppp? -83.1 -55.86 4.12 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.629 0.772 . . . . 74.21 110.167 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -141.65 152.89 44.34 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.487 -0.778 . . . . 63.33 110.49 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.495 HG12 ' HB2' ' A' ' 507' ' ' ALA . 30.0 mm -117.11 105.09 17.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.735 -1.58 . . . . 74.34 106.735 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.09 146.36 88.19 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 116.114 -0.494 . . . . 60.45 111.463 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.447 ' C ' HG21 ' A' ' 500' ' ' ILE . 84.9 Cg_endo -74.82 12.28 1.21 Allowed 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 124.579 3.519 . . . . 62.43 116.189 -172.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.717 ' O ' ' HB ' ' A' ' 468' ' ' THR . 13.0 ptp180 -155.37 3.48 0.19 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 115.361 1.615 . . . . 74.22 115.361 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.519 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -83.92 -161.14 31.78 Favored Glycine 0 C--N 1.286 -2.195 0 C-N-CA 119.265 -1.445 . . . . 75.42 112.625 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -69.1 -39.35 79.04 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 123.414 0.686 . . . . 73.02 110.001 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -56.86 -42.76 80.31 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 114.441 -1.254 . . . . 73.53 111.827 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.56 HG21 ' N ' ' A' ' 496' ' ' ARG . 0.0 OUTLIER -80.03 -37.15 17.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 112.571 0.582 . . . . 73.15 112.571 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.5 mm100 -61.13 -40.85 95.36 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.814 0.34 . . . . 72.42 110.641 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.511 ' HB2' HD13 ' A' ' 464' ' ' LEU . 6.4 m-20 -84.11 -43.3 15.17 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.21 -0.45 . . . . 50.14 109.969 174.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 70.44 13.97 71.46 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 121.346 -0.454 . . . . 63.21 113.62 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.413 ' HG2' HG23 ' A' ' 462' ' ' ILE . 77.6 ttt180 -88.16 -14.06 39.63 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.433 0.635 . . . . 70.02 109.686 -178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.542 ' HB2' HD21 ' A' ' 464' ' ' LEU . 49.2 tp -114.83 138.39 50.83 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.88 -1.156 . . . . 64.31 107.88 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.466 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -140.98 169.34 17.81 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.811 0.671 . . . . 61.42 112.811 178.483 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.495 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -82.55 161.9 22.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.013 -0.539 . . . . 62.4 111.938 -173.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 74.96 42.21 30.63 Favored Glycine 0 CA--C 1.506 -0.485 0 N-CA-C 110.802 -0.919 . . . . 74.05 110.802 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -146.68 149.11 32.81 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.959 -1.497 . . . . 73.34 106.959 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.453 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 41.6 ttm180 -87.7 138.22 31.66 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 118.095 0.407 . . . . 73.23 111.385 -174.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.494 ' HG ' HD11 ' A' ' 519' ' ' LEU . 25.9 tp -100.23 127.38 46.52 Favored 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 108.442 -0.948 . . . . 73.23 108.442 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.542 ' HB ' HD12 ' A' ' 543' ' ' LEU . 34.5 mm -100.97 -47.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.096 0.474 . . . . 74.54 110.966 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 543' ' ' LEU . 10.5 pt-20 -157.13 149.35 22.9 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 109.022 -0.733 . . . . 62.44 109.022 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 541' ' ' SER . 7.1 p -137.57 134.43 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 CA-C-O 121.254 0.55 . . . . 73.14 109.727 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . 0.52 HD21 ' HB2' ' A' ' 535' ' ' LYS . 4.1 t-20 58.81 23.21 11.0 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 127.003 2.121 . . . . 53.14 112.944 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 89.72 15.4 58.21 Favored Glycine 0 CA--C 1.502 -0.752 0 C-N-CA 121.036 -0.602 . . . . 63.24 112.538 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.5 t -115.38 131.41 67.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 O-C-N 122.709 -0.289 . . . . 71.14 110.308 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.73 130.48 35.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.343 0.657 . . . . 70.02 110.364 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.494 HD11 ' HG ' ' A' ' 511' ' ' LEU . 10.7 mt -95.87 -30.5 13.62 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.587 0.708 . . . . 72.32 110.205 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 55.3 t -58.83 -34.74 53.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.133 -1.394 . . . . 64.44 112.049 -171.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -99.38 20.68 48.81 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.929 -0.653 . . . . 51.21 113.831 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.422 ' HB2' ' CD ' ' A' ' 526' ' ' GLU . 0.1 OUTLIER -138.46 -179.83 6.03 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 117.797 0.798 . . . . 70.02 111.954 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 32.6 m -92.16 163.21 14.02 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.649 0.261 . . . . 63.51 111.471 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.647 ' OE1' ' HB3' ' A' ' 477' ' ' SER . 43.6 tp60 -59.7 -44.93 93.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.329 1.052 . . . . 75.13 110.694 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.491 ' HA ' HG22 ' A' ' 528' ' ' VAL . 47.8 mt-10 -62.32 -31.95 72.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.695 0.628 . . . . 64.12 112.695 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.422 ' CD ' ' HB2' ' A' ' 522' ' ' LYS . 50.1 mt-10 -63.81 -36.83 85.2 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.651 -0.5 . . . . 64.41 109.651 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.464 HG13 HD22 ' A' ' 519' ' ' LEU . 17.3 t -73.68 -36.51 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 115.588 -0.733 . . . . 74.44 109.478 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 13.9 m -69.45 -39.39 78.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.417 0 C-N-CA 119.592 -0.843 . . . . 63.15 111.177 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.9 t -62.33 -43.3 99.14 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.196 0.522 . . . . 64.05 109.661 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.85 -41.84 78.66 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.811 1.244 . . . . 61.31 109.383 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 473' ' ' PHE . 3.2 tt -69.0 -45.13 71.32 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.921 -1.036 . . . . 73.12 112.58 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.537 ' HA ' ' HE ' ' A' ' 532' ' ' ARG . 1.1 mmp_? -62.15 -43.72 98.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.554 -0.294 . . . . 73.14 110.48 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.1 m -68.54 -32.36 72.25 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.226 -0.443 . . . . 71.04 111.434 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 51.4 m 68.49 -94.88 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.02 0.528 . . . . 55.55 111.348 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.52 ' HB2' HD21 ' A' ' 515' ' ' ASN . 86.1 tttt 169.26 141.17 0.02 OUTLIER 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.435 -1.32 . . . . 74.04 107.435 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 86.8 mtp -68.75 -31.87 71.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.646 0.26 . . . . 71.43 111.598 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -59.61 -38.33 80.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.315 0.578 . . . . 71.21 110.288 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 112.02 -29.74 8.22 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.159 -1.02 . . . . 74.22 114.129 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 463' ' ' GLN . 6.4 m -103.93 136.3 43.84 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.973 -0.691 . . . . 61.44 109.238 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 471' ' ' LEU . 61.3 t -118.92 138.24 50.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.915 -0.584 . . . . 41.44 110.039 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 69.2 m -91.93 115.0 27.7 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-O 121.077 0.465 . . . . 63.54 111.478 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.633 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.3 mm? -102.09 119.73 39.27 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.8 -1.185 . . . . 75.22 107.8 176.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.542 HD12 ' HB ' ' A' ' 512' ' ' ILE . 2.8 tm? -108.23 117.07 33.2 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 104.832 -2.284 . . . . 52.14 104.832 173.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 33.5 m -115.9 161.33 14.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 115.379 -0.828 . . . . 74.1 111.624 -173.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.453 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 66.4 t80 -120.87 116.55 25.38 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.514 -0.921 . . . . 73.22 108.514 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 . . . . . 0 N--CA 1.396 -3.146 0 CA-C-N 115.054 -0.975 . . . . 74.01 108.77 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 29.5 mtpp . . . . . 0 CA--C 1.482 -1.661 0 CA-C-O 121.224 0.535 . . . . 71.11 111.962 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 95.0 mtt180 -116.17 126.22 53.38 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.821 -1.178 . . . . 62.44 107.821 167.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.2 mp -123.93 142.08 51.46 Favored 'General case' 0 CA--C 1.465 -2.29 0 CA-C-N 116.536 -0.302 . . . . 52.42 110.49 -172.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -98.19 114.95 27.35 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 115.104 -0.953 . . . . 70.23 108.929 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . 0.457 HG23 ' CG ' ' A' ' 504' ' ' ARG . 54.9 mt -118.86 129.58 74.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-N 114.893 -1.049 . . . . 72.12 109.463 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.2 mt-30 -115.86 127.94 55.41 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 113.046 0.758 . . . . 72.34 113.046 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.562 HD23 HD23 ' A' ' 542' ' ' LEU . 3.9 mm? -115.64 137.86 51.65 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 115.009 -0.996 . . . . 60.13 109.769 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.46 ' HE2' ' HB3' ' A' ' 465' ' ' LYS . 34.5 ttpt -107.48 135.96 48.08 Favored 'General case' 0 N--CA 1.4 -2.939 0 N-CA-C 108.867 -0.79 . . . . 75.42 108.867 -177.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.451 ' HB2' HG21 ' A' ' 534' ' ' THR . 39.4 ttmt -61.76 98.59 0.1 Allowed 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.639 0.733 . . . . 55.34 111.601 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -130.86 139.55 11.04 Favored Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 108.375 -1.89 . . . . 61.51 108.375 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 469' ' ' GLU 0.365 7.3 t 52.75 -81.55 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.104 1.361 . . . . 62.22 113.819 -175.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.43 ' OE1' ' HG3' ' A' ' 496' ' ' ARG . 37.9 mt-10 -106.79 -7.68 17.09 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.732 0.697 . . . . 63.33 110.858 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 67.8 -157.04 52.42 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.255 -0.884 . . . . 72.43 111.826 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 498' ' ' ALA . 5.3 mp -44.4 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.32 1.23 . . . . 63.12 114.32 -170.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -97.54 65.11 0.89 Allowed Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.018 -1.446 . . . . 52.4 111.291 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.446 ' HB3' HD13 ' A' ' 493' ' ' ILE . 27.1 p90 -155.44 147.84 23.88 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.193 -0.504 . . . . 75.15 110.184 176.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -126.27 162.77 24.69 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.474 -0.785 . . . . 35.13 109.446 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.2 pt -119.68 155.46 22.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 120.95 0.405 . . . . 51.41 111.703 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.9 t -135.68 129.53 32.87 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.877 -0.601 . . . . 74.02 110.239 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 24.0 t . . . . . 0 N--CA 1.423 -1.796 0 N-CA-C 108.621 -0.881 . . . . 75.21 108.621 173.92 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.436 -1.895 0 N-CA-C 109.998 -0.808 . . . . 75.22 109.998 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 511' ' ' LEU . 41.9 mm -96.24 139.65 18.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 109.325 -0.62 . . . . 74.13 109.325 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.17 153.4 48.59 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 122.311 -0.243 . . . . 73.15 110.575 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.408 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 26.3 t -73.74 121.32 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.86 -1.163 . . . . 73.44 107.86 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -90.38 -52.44 4.92 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.563 0.697 . . . . 73.4 110.976 -176.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -146.32 150.89 36.6 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.414 -0.812 . . . . 53.15 110.3 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.522 HG12 ' HB2' ' A' ' 507' ' ' ALA . 34.6 mm -119.96 104.83 16.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 107.444 -1.317 . . . . 62.44 107.444 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -62.9 122.62 75.87 Favored Pre-proline 0 C--N 1.307 -1.253 0 CA-C-N 115.585 -0.734 . . . . 71.31 109.83 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.36 22.79 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 124.768 3.645 . . . . 74.23 114.3 -171.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.43 ' HG3' ' OE1' ' A' ' 469' ' ' GLU . 8.3 ptp180 -157.43 6.99 0.15 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 113.437 0.903 . . . . 72.43 113.437 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -101.14 -149.96 23.54 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 119.814 -1.184 . . . . 74.14 112.449 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 471' ' ' LEU . . . -64.09 -40.29 95.9 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.156 0.582 . . . . 70.0 111.207 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.415 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . -57.08 -36.8 71.01 Favored 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 115.545 -0.752 . . . . 73.31 112.635 -174.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.8 tt -80.72 -42.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.445 0.535 . . . . 62.31 112.445 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 501' ' ' GLN . 14.7 mm-40 -61.46 -37.73 84.66 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.057 0.392 . . . . 73.31 112.057 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.521 ' HB2' HD13 ' A' ' 464' ' ' LEU . 17.5 m-20 -94.93 -28.98 14.9 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 109.442 -0.577 . . . . 72.24 109.442 175.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 499' ' ' ALA . . . 57.7 28.7 60.45 Favored Glycine 0 CA--C 1.496 -1.1 0 CA-C-N 115.467 -0.788 . . . . 74.13 114.36 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.457 ' CG ' HG23 ' A' ' 462' ' ' ILE . 26.7 tpt180 -99.4 -13.94 19.36 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.248 -0.581 . . . . 73.13 110.772 -174.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 49.7 tp -123.41 148.1 46.46 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.541 0.21 . . . . 74.43 110.449 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 506' ' ' LYS . 0.0 OUTLIER -141.98 165.41 27.53 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.764 -0.828 . . . . 71.24 108.764 177.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.522 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -85.39 130.62 34.55 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.48 -0.563 . . . . 62.4 109.48 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 140.85 -20.28 2.71 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.211 -0.756 . . . . 60.43 111.211 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -89.17 165.76 14.26 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-O 121.132 0.491 . . . . 74.52 111.419 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.571 ' NH1' HD13 ' A' ' 512' ' ' ILE . 2.2 tmt_? -107.79 141.03 39.98 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 116.042 -0.526 . . . . 64.02 110.026 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.648 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.6 mm? -86.79 129.09 35.01 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.861 -0.609 . . . . 70.04 112.29 -175.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.571 HD13 ' NH1' ' A' ' 510' ' ' ARG . 32.8 mm -106.69 -59.17 3.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.405 -0.361 . . . . 74.14 110.141 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -158.81 149.27 19.8 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.393 0.433 . . . . 75.14 110.38 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 6.0 p -123.03 129.91 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 109.115 -0.698 . . . . 61.45 109.115 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 60.91 2.77 0.57 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.539 1.135 . . . . 71.54 113.746 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 113.57 -4.28 24.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 121.051 -0.595 . . . . 73.22 112.511 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.5 t -93.22 134.73 30.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.385 -0.598 . . . . 72.02 109.385 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -77.63 145.72 36.56 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 123.601 0.563 . . . . 62.51 110.145 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.648 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 18.8 mt -101.48 -38.14 8.12 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.901 -0.778 . . . . 73.45 108.901 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.22 104.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 115.185 -0.916 . . . . 74.31 108.561 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 136.33 -21.19 3.48 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 108.934 -1.666 . . . . 73.24 108.934 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.97 172.83 7.27 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.514 -0.343 . . . . 74.21 110.511 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 23.8 m -89.24 161.77 16.24 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.326 -0.397 . . . . 75.13 111.226 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -57.83 -46.63 84.46 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 123.005 0.522 . . . . 71.12 111.563 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.535 ' HA ' HG22 ' A' ' 528' ' ' VAL . 48.5 mt-10 -58.18 -32.89 68.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.178 -0.465 . . . . 70.34 112.118 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.13 -41.62 90.22 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.325 -0.62 . . . . 73.42 109.325 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 44.2 t -70.28 -37.34 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 115.495 -0.775 . . . . 44.43 110.199 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.662 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.1 m -66.29 -41.26 88.73 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.439 0 C-N-CA 119.731 -0.788 . . . . 54.13 110.514 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.6 t -63.19 -42.95 99.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.205 0.526 . . . . 71.31 109.718 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 29.1 tp -59.96 -34.93 73.94 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.838 1.255 . . . . 73.11 110.099 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.45 ' CD1' HD23 ' A' ' 471' ' ' LEU . 26.5 tp -77.64 -47.98 17.95 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.856 -0.611 . . . . 54.24 110.312 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 4.8 mmp_? -57.79 -41.06 81.31 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.005 0.522 . . . . 74.34 110.887 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 46.0 m -60.34 -30.2 69.38 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.878 -0.601 . . . . 64.12 111.562 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . 0.451 HG21 ' HB2' ' A' ' 466' ' ' LYS . 40.8 m 67.26 -91.14 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.399 0.68 . . . . 71.23 111.76 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 537' ' ' GLU . 88.6 tttt 164.93 144.35 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 104.535 -2.394 . . . . 74.24 104.535 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 85.0 mtp -66.91 -25.49 66.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.769 0.713 . . . . 63.34 111.444 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 0.9 OUTLIER -64.87 -65.65 0.65 Allowed 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.053 -1.091 . . . . 75.1 108.053 172.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 143.39 -31.56 1.92 Allowed Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 119.084 -1.532 . . . . 64.12 114.662 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 465' ' ' LYS . 1.8 m -94.57 142.19 27.73 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.344 -0.943 . . . . 64.13 109.214 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 58.2 t -122.43 142.16 39.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 123.575 0.75 . . . . 75.33 109.062 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.7 m -105.76 113.4 26.94 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.44 0.638 . . . . 74.44 110.674 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.562 HD23 HD23 ' A' ' 464' ' ' LEU . 2.6 mm? -102.36 119.03 38.13 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.899 -1.148 . . . . 74.14 107.899 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 2.9 tm? -104.77 115.95 31.19 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 105.216 -2.142 . . . . 75.22 105.216 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 32.7 m -117.41 161.01 16.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.024 -0.989 . . . . 73.44 111.328 -174.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 86.9 t80 -112.06 117.96 34.1 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 108.399 -0.963 . . . . 55.23 108.399 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 . . . . . 0 N--CA 1.411 -2.382 0 N-CA-C 107.968 -1.123 . . . . 74.14 107.968 176.726 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt . . . . . 0 N--CA 1.437 -1.101 0 CA-C-O 120.822 0.344 . . . . 61.15 110.819 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 71.3 mtm180 -100.43 148.78 24.36 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.633 -0.712 . . . . 73.34 109.306 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -130.95 134.22 46.54 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.283 -0.636 . . . . 65.33 109.283 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -92.88 115.47 28.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.909 -1.145 . . . . 74.34 107.909 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . 0.415 HG23 ' CG ' ' A' ' 504' ' ' ARG . 60.6 mt -119.94 137.64 53.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 115.746 -0.661 . . . . 70.12 109.844 -174.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.0 mt-30 -120.83 127.52 52.0 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.744 0.646 . . . . 73.04 112.744 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.584 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.2 mm? -113.8 142.13 46.45 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 114.895 -1.048 . . . . 63.55 111.002 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -101.34 127.33 48.01 Favored 'General case' 0 N--CA 1.398 -3.029 0 N-CA-C 107.584 -1.265 . . . . 72.2 107.584 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.11 95.6 0.13 Allowed 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.903 -0.59 . . . . 61.52 109.594 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -136.95 153.51 21.79 Favored Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 115.511 -0.768 . . . . 32.45 111.856 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 22.0 m 59.28 -91.74 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.945 1.298 . . . . 74.22 111.497 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -101.84 -3.98 27.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.291 0.567 . . . . 75.11 109.918 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.29 -161.22 54.21 Favored Glycine 0 C--O 1.205 -1.706 0 CA-C-O 118.922 -0.932 . . . . 70.44 111.595 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.507 HD11 HG21 ' A' ' 540' ' ' VAL . 66.4 mt -48.36 99.94 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.832 0.825 . . . . 72.25 112.712 -171.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -111.28 61.0 0.31 Allowed Glycine 0 CA--C 1.479 -2.184 0 CA-C-N 114.567 -1.197 . . . . 44.23 111.641 -174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -150.13 142.26 24.06 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 109.138 -0.69 . . . . 65.33 109.138 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.5 p -115.53 155.19 28.0 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.943 -0.571 . . . . 60.43 110.58 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.6 pt -116.33 150.34 18.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.059 0.457 . . . . 64.23 111.757 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.415 ' CB ' ' HE3' ' A' ' 491' ' ' LYS . 9.0 t -136.22 147.07 47.43 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.476 -0.784 . . . . 72.54 109.987 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 57.9 p . . . . . 0 N--CA 1.439 -0.984 0 N-CA-C 108.862 -0.792 . . . . 63.03 108.862 176.935 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.42 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 9.6 Cg_endo . . . . . 0 N--CA 1.433 -2.061 0 N-CA-C 109.974 -0.818 . . . . 71.31 109.974 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.19 132.14 41.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.34 -0.615 . . . . 54.31 109.34 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 90.8 m-85 -129.02 152.76 48.28 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 110.31 -0.255 . . . . 55.22 110.31 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.39 119.51 30.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.469 -0.937 . . . . 75.04 108.469 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.415 ' HE3' ' CB ' ' A' ' 476' ' ' THR . 4.7 tppp? -82.15 -59.62 2.5 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.791 -0.64 . . . . 74.14 110.722 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -140.16 155.49 46.93 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 120.316 -0.554 . . . . 61.35 110.675 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.534 HG12 ' HB2' ' A' ' 507' ' ' ALA . 33.8 mm -119.2 104.8 16.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.306 -1.368 . . . . 62.3 107.306 177.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.23 130.53 89.5 Favored Pre-proline 0 C--N 1.307 -1.282 0 CA-C-N 116.022 -0.535 . . . . 55.41 111.084 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.81 18.03 0.2 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 125.027 3.818 . . . . 73.12 115.45 -171.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -161.13 6.81 0.07 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 113.916 1.08 . . . . 72.11 113.916 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -91.63 -155.86 32.17 Favored Glycine 0 C--N 1.294 -1.754 0 C-N-CA 119.464 -1.35 . . . . 73.12 113.085 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.416 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -63.39 -41.6 98.78 Favored 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 123.942 0.897 . . . . 72.03 109.876 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.542 ' HA ' HD11 ' A' ' 464' ' ' LEU . . . -56.65 -43.81 80.69 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 114.856 -1.065 . . . . 75.43 112.074 -173.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.1 tt -80.49 -29.34 12.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 112.19 0.441 . . . . 65.42 112.19 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -48.26 81.3 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.226 -1.028 . . . . 71.01 108.226 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.584 ' HB2' HD13 ' A' ' 464' ' ' LEU . 10.2 m-20 -87.08 -34.23 19.22 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 109.789 -0.449 . . . . 62.4 109.789 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 62.45 39.59 98.0 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.504 -0.771 . . . . 65.32 112.538 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.415 ' CG ' HG23 ' A' ' 462' ' ' ILE . 30.0 tpt180 -111.36 -4.89 14.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.33 0.586 . . . . 71.21 109.917 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 57.7 tp -125.73 142.74 51.36 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.857 -0.611 . . . . 71.51 110.546 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.492 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.28 0.0 OUTLIER -138.51 164.55 29.14 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.17 -0.468 . . . . 70.13 111.854 175.451 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.534 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.46 156.43 22.89 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.655 0.613 . . . . 75.21 112.655 -171.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.5 8.0 55.17 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.99 -0.624 . . . . 73.25 113.682 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -113.33 164.96 12.91 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 117.388 0.594 . . . . 63.42 110.191 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.408 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 43.1 ttm180 -89.95 129.32 36.3 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 123.095 0.247 . . . . 74.31 110.624 -177.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.93 124.33 33.02 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 106.069 -1.826 . . . . 75.31 106.069 177.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 50.7 mm -96.3 -51.11 11.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 120.562 0.22 . . . . 53.54 111.258 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -157.99 148.85 20.9 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 116.102 -0.499 . . . . 74.24 109.66 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 541' ' ' SER . 3.7 p -130.05 125.51 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.523 0 CA-C-N 116.025 -0.534 . . . . 71.32 109.566 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 59.51 26.9 15.94 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 114.864 -1.062 . . . . 75.41 112.067 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.54 -4.8 73.41 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.748 -0.66 . . . . 63.33 113.367 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.44 124.84 47.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.393 -0.595 . . . . 71.13 109.393 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -84.01 141.69 31.01 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.727 0.642 . . . . 74.35 109.382 -173.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.535 HD11 HD12 ' A' ' 511' ' ' LEU . 19.0 mt -99.72 -42.96 6.63 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.161 0.8 . . . . 73.21 113.161 -171.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.14 89.08 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-O 122.23 1.014 . . . . 74.24 110.629 -174.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 151.03 -13.87 0.85 Allowed Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 113.994 -1.457 . . . . 73.24 109.693 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.82 177.78 4.65 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 122.85 -0.206 . . . . 74.44 110.89 175.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 48.9 m -88.61 156.68 18.9 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.514 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.419 ' O ' HG13 ' A' ' 528' ' ' VAL . 34.2 tt0 -58.76 -44.38 90.59 Favored 'General case' 0 C--O 1.21 -0.996 0 C-N-CA 122.487 0.315 . . . . 71.14 110.514 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.519 ' HA ' HG22 ' A' ' 528' ' ' VAL . 28.3 mm-40 -57.72 -31.46 66.44 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 112.661 0.615 . . . . 61.55 112.661 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -66.58 -39.8 88.62 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.188 -0.671 . . . . 71.22 109.188 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 33.8 t -75.48 -36.39 35.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.135 -0.938 . . . . 73.24 110.285 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.704 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 10.7 m -63.67 -44.81 98.58 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 C-N-CA 120.351 -0.54 . . . . 65.3 109.933 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.7 m -64.51 -36.98 85.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.4 0.619 . . . . 74.5 110.267 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 32.6 tp -61.03 -43.6 98.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.736 1.214 . . . . 63.32 109.428 175.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.45 HD12 HD13 ' A' ' 471' ' ' LEU . 35.2 tp -67.3 -48.03 68.83 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.75 -0.659 . . . . 74.24 109.845 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.704 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 32.2 mmm180 -57.41 -30.11 64.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.731 0.813 . . . . 64.42 111.192 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 61.2 m -73.6 -43.64 59.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.925 -0.579 . . . . 61.21 111.532 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 40.4 m 68.26 142.2 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.664 0.786 . . . . 74.14 111.311 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.523 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 60.4 tptt -59.9 132.17 53.12 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.636 -0.711 . . . . 74.42 109.641 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -63.35 -20.11 65.22 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.513 0.725 . . . . 64.23 111.938 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . 0.523 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 38.4 tt0 -73.89 -15.17 61.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.492 0.663 . . . . 70.31 110.253 177.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 94.69 -20.29 49.37 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.085 -0.579 . . . . 71.11 112.333 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 463' ' ' GLN . 2.7 m -114.19 128.79 56.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.748 -1.204 . . . . 72.23 107.748 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.521 HG22 ' H ' ' A' ' 535' ' ' LYS . 57.4 t -105.23 134.19 47.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 C-N-CA 122.816 0.446 . . . . 61.14 110.5 -176.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 29.9 m -98.48 115.14 27.9 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.744 -0.662 . . . . 54.2 110.832 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.484 HD23 HD23 ' A' ' 464' ' ' LEU . 2.7 mm? -110.95 124.68 52.6 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.4 -0.963 . . . . 60.1 108.4 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 53.0 tp -104.23 118.34 36.41 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.534 -1.654 . . . . 64.32 106.534 174.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.4 m -116.06 145.59 21.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 120.293 -0.563 . . . . 74.24 111.27 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -112.02 116.42 30.53 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.066 -1.086 . . . . 65.02 108.066 175.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . 0.455 ' O ' ' HD3' ' A' ' 546' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.406 -2.651 0 N-CA-C 108.2 -1.037 . . . . 73.44 108.2 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.576 ' N ' ' HE2' ' A' ' 458' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.448 0 N-CA-C 109.538 -0.542 . . . . 62.54 109.538 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 97.6 mtt180 -99.13 142.28 30.82 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.881 -0.785 . . . . 74.21 108.881 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.1 mm? -123.72 133.71 53.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.189 -0.671 . . . . 73.11 109.189 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -100.07 116.62 32.51 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.454 -0.943 . . . . 64.35 108.454 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . 0.434 HG21 ' HB3' ' A' ' 504' ' ' ARG . 57.0 mt -123.3 125.02 71.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.61 -0.723 . . . . 73.54 110.959 -173.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.8 mt-30 -91.52 126.78 36.72 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.993 0.738 . . . . 61.42 112.993 178.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.1 mm? -115.79 144.34 44.12 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.4 1.08 . . . . 71.33 110.332 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -103.03 136.67 42.41 Favored 'General case' 0 N--CA 1.404 -2.75 0 N-CA-C 107.833 -1.173 . . . . 73.51 107.833 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.491 ' HA ' ' HA2' ' A' ' 470' ' ' GLY . 23.5 ttmm -54.44 99.58 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.766 0.794 . . . . 72.14 111.328 175.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -85.3 -147.57 9.49 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 114.943 -1.026 . . . . 73.32 111.454 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 16.7 m -55.41 -45.41 76.72 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.978 0.511 . . . . 61.21 110.946 -177.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.59 9.81 17.98 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 120.691 0.281 . . . . 62.32 111.137 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 58.01 -141.96 44.71 Favored Glycine 0 C--O 1.185 -2.967 0 CA-C-O 117.17 -1.905 . . . . 63.23 109.804 -170.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.538 ' H ' HD22 ' A' ' 471' ' ' LEU . 2.5 mm? -44.08 108.61 0.12 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.54 1.67 . . . . 70.51 112.459 -173.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -100.19 47.78 1.25 Allowed Glycine 0 N--CA 1.421 -2.311 0 CA-C-N 114.55 -1.204 . . . . 53.42 112.433 -173.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -140.92 144.8 35.39 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 109.356 -0.609 . . . . 71.32 109.356 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 18.8 m -114.6 139.38 49.66 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.889 -1.523 . . . . 52.32 106.889 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 489' ' ' TYR . 14.8 pt -111.46 151.24 13.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-O 120.976 0.417 . . . . 62.51 112.072 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -144.73 151.17 38.49 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.888 -0.596 . . . . 73.23 109.618 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.437 -1.096 0 N-CA-C 109.138 -0.69 . . . . 54.41 109.138 175.932 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.579 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 3.2 Cg_exo . . . . . 0 N--CA 1.427 -2.422 0 N-CA-C 110.166 -0.744 . . . . 64.12 110.166 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.568 HG13 ' HB3' ' A' ' 519' ' ' LEU . 34.2 mm -90.52 119.94 38.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.286 -1.005 . . . . 64.42 108.286 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 78.8 m-85 -121.63 152.95 38.75 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 122.281 -0.262 . . . . 74.52 111.492 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 47.2 t -78.56 119.06 26.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.973 -0.751 . . . . 74.11 108.973 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -84.52 -53.84 5.15 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.78 -0.646 . . . . 75.55 109.425 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -143.13 154.04 43.5 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.327 -0.852 . . . . 64.42 109.044 -175.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.502 HG12 ' HB2' ' A' ' 507' ' ' ALA . 26.2 mm -110.44 110.2 31.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.842 -1.17 . . . . 71.12 107.842 174.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.0 mp -52.82 128.04 44.92 Favored Pre-proline 0 C--N 1.321 -0.665 0 O-C-N 123.941 0.776 . . . . 73.51 110.372 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.49 20.48 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 124.668 3.578 . . . . 71.32 114.908 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.44 ' O ' ' HB ' ' A' ' 468' ' ' THR . 14.2 ptp180 -168.82 5.9 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.323 0.583 . . . . 65.23 112.459 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -83.86 -167.87 42.81 Favored Glycine 0 C--N 1.298 -1.561 0 C-N-CA 119.893 -1.146 . . . . 65.43 112.663 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 464' ' ' LEU . . . -55.86 -47.4 77.39 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 124.932 1.293 . . . . 75.31 111.151 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.23 -40.6 77.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.743 -1.117 . . . . 72.53 112.559 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 8.5 tt -79.94 -40.43 20.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 112.57 0.582 . . . . 63.14 112.57 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 8.2 mm-40 -67.43 -37.87 83.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 72.34 110.841 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.567 ' HB2' HD13 ' A' ' 464' ' ' LEU . 7.8 m-20 -91.56 -21.95 20.59 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 116.116 -0.493 . . . . 63.55 109.87 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 63.92 55.78 22.46 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 120.742 -0.742 . . . . 54.54 114.803 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.434 ' HB3' HG21 ' A' ' 462' ' ' ILE . 14.3 mmm180 -123.85 -73.53 0.64 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.873 -0.731 . . . . 73.54 110.796 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.537 HD13 HG11 ' A' ' 544' ' ' VAL . 67.4 tp -73.68 137.7 44.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.778 0.323 . . . . 64.13 111.807 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.464 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.267 0.0 OUTLIER -126.32 174.26 8.7 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.717 -0.674 . . . . 74.13 112.403 177.061 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.502 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.18 138.8 33.49 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 113.435 0.902 . . . . 62.13 113.435 -171.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 105.39 13.88 23.43 Favored Glycine 0 C--N 1.321 -0.253 0 CA-C-N 115.583 -0.735 . . . . 71.5 112.577 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.63 162.44 13.96 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 122.678 0.391 . . . . 74.3 110.398 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -101.45 134.36 44.66 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 120.81 -0.356 . . . . 74.04 110.649 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.597 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 3.6 mm? -86.97 132.99 33.63 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.553 -0.749 . . . . 62.01 110.171 174.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.426 HG21 ' HD3' ' A' ' 459' ' ' ARG . 49.7 mm -111.72 -39.07 3.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.06 -0.718 . . . . 74.42 109.06 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 543' ' ' LEU . 32.7 tt0 -154.72 148.43 25.42 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.517 -0.765 . . . . 61.12 109.156 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.597 HG13 HD11 ' A' ' 530' ' ' LEU . 6.8 p -136.51 125.47 37.07 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.077 0 N-CA-C 107.397 -1.334 . . . . 63.3 107.397 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 72.33 -52.27 0.7 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 125.982 1.713 . . . . 73.23 111.963 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 163.29 30.61 0.02 OUTLIER Glycine 0 C--N 1.287 -2.146 0 N-CA-C 109.519 -1.432 . . . . 72.21 109.519 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.1 t -122.5 134.43 65.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.305 -0.447 . . . . 64.2 109.902 -175.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.0 148.77 36.06 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.704 -0.48 . . . . 72.42 109.704 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.597 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 60.5 mt -111.51 -45.81 3.34 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 113.338 0.866 . . . . 73.32 113.338 -171.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.68 -1.31 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 113.146 0.795 . . . . 70.44 113.146 -172.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -112.41 12.18 25.95 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 111.616 -0.594 . . . . 63.13 111.616 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.413 ' NZ ' ' HB3' ' A' ' 522' ' ' LYS . 0.2 OUTLIER -146.53 -177.59 5.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 117.172 0.486 . . . . 53.52 111.505 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . 0.466 ' O ' HG23 ' A' ' 527' ' ' VAL . 76.3 p -96.17 163.3 13.16 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.214 0.53 . . . . 74.22 111.998 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.522 ' O ' HG13 ' A' ' 528' ' ' VAL . 37.9 mm-40 -55.24 -41.91 72.74 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.987 -1.006 . . . . 75.25 111.962 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.44 ' HA ' HG22 ' A' ' 528' ' ' VAL . 43.2 mt-10 -63.08 -31.81 73.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.105 0.479 . . . . 73.34 112.178 -175.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.88 -36.03 67.28 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.737 -0.665 . . . . 75.01 110.529 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.567 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 17.5 t -75.39 -41.5 42.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.393 -0.595 . . . . 73.31 109.393 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.709 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.3 m -62.18 -43.46 97.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 120.356 -0.538 . . . . 64.25 110.942 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.9 t -64.5 -37.06 86.22 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.451 -0.341 . . . . 73.31 111.325 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.597 HD11 HG13 ' A' ' 514' ' ' VAL . 1.2 pp -68.07 -37.54 81.39 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.011 -1.107 . . . . 73.53 108.011 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 471' ' ' LEU . 3.6 tt -62.98 -46.49 87.47 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.894 -1.048 . . . . 55.44 111.175 176.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.709 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 27.1 mmm180 -61.68 -33.63 74.32 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.127 -0.488 . . . . 73.13 110.409 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.0 m -82.96 -30.71 28.09 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.073 0.464 . . . . 74.12 110.685 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . 0.476 HG21 ' HE2' ' A' ' 466' ' ' LYS . 30.5 m 71.98 -83.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.606 1.162 . . . . 64.15 112.115 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.543 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 17.3 tppt? 167.27 157.64 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 106.405 -1.702 . . . . 75.53 106.405 -176.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.94 6.45 18.55 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.77 0.795 . . . . 72.03 110.212 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . 0.543 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 13.3 tp10 -96.88 -54.3 3.24 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.039 -1.096 . . . . 75.2 108.039 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 116.39 -20.21 12.54 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.322 -0.942 . . . . 72.51 112.587 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 3.4 m -104.7 136.23 44.6 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.987 -0.745 . . . . 72.3 108.987 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 87.2 t -123.43 136.69 59.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 123.139 0.575 . . . . 73.33 110.743 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.8 t -92.15 114.61 27.2 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.364 -0.606 . . . . 60.24 109.364 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.467 HD13 HD22 ' A' ' 505' ' ' LEU . 43.6 mt -99.51 119.72 38.48 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.498 -0.927 . . . . 61.44 108.498 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.595 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 45.5 tp -104.61 116.93 32.91 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.747 -1.575 . . . . 73.14 106.747 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 31.1 m -122.67 157.96 27.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.924 -0.58 . . . . 64.33 111.886 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -114.4 116.69 29.31 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.863 -0.608 . . . . 73.41 109.703 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 . . . . . 0 C--N 1.302 -1.466 0 CA-C-N 115.699 -0.682 . . . . 71.01 109.463 179.428 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 26.7 mtpp . . . . . 0 CA--C 1.478 -1.791 0 CA-C-O 121.363 0.601 . . . . 74.54 111.185 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 62.2 mtm180 -112.04 129.6 56.15 Favored 'General case' 0 N--CA 1.406 -2.663 0 N-CA-C 107.579 -1.267 . . . . 65.13 107.579 170.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -116.21 131.73 56.86 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.636 -0.875 . . . . 71.23 108.636 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -95.86 115.34 27.29 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.787 -0.82 . . . . 73.24 108.787 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . 0.437 HG22 ' CD2' ' A' ' 464' ' ' LEU . 60.8 mt -119.38 123.91 72.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 115.357 -0.838 . . . . 74.43 109.853 -175.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 47.6 mt-30 -102.37 130.55 49.15 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 121.824 -0.547 . . . . 53.31 112.282 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 542' ' ' LEU . 4.3 mm? -115.06 139.48 49.84 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.848 -0.614 . . . . 73.2 111.958 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -91.04 132.67 35.87 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 123.849 0.859 . . . . 72.21 110.481 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -72.87 105.21 4.3 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 114.593 -1.185 . . . . 63.35 109.402 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -144.53 137.33 7.2 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.82 -0.627 . . . . 63.22 111.741 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 35.5 m 64.54 -79.11 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.468 1.107 . . . . 73.55 112.048 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.412 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 5.7 mm-40 -102.28 -11.34 18.79 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.127 -0.694 . . . . 74.21 109.127 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 66.8 -144.51 45.37 Favored Glycine 0 CA--C 1.473 -2.582 0 CA-C-O 117.528 -1.707 . . . . 55.42 108.924 -172.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 531' ' ' LEU . 43.4 mt -52.25 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.316 1.558 . . . . 45.05 112.275 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . -102.43 59.64 0.55 Allowed Glycine 0 CA--C 1.464 -3.122 0 CA-C-N 114.256 -1.338 . . . . 54.11 111.237 -173.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.467 ' HB3' HD13 ' A' ' 493' ' ' ILE . 18.7 p90 -148.01 142.52 26.45 Favored 'General case' 0 C--N 1.258 -3.387 0 N-CA-C 108.117 -1.068 . . . . 72.21 108.117 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 20.0 m -115.0 143.81 44.6 Favored 'General case' 0 C--N 1.271 -2.843 0 N-CA-C 108.157 -1.053 . . . . 71.31 108.157 -176.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 10.2 pt -109.81 156.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-O 121.209 0.528 . . . . 54.4 111.502 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.486 HG21 ' HE2' ' A' ' 491' ' ' LYS . 9.1 t -136.63 141.21 43.21 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.908 -0.775 . . . . 72.14 108.908 176.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 59.3 p . . . . . 0 C--N 1.293 -1.881 0 N-CA-C 106.749 -1.575 . . . . 43.03 106.749 174.401 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo . . . . . 0 C--O 1.255 1.347 0 N-CA-C 109.464 -1.014 . . . . 74.14 109.464 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.534 HD12 ' OE1' ' A' ' 524' ' ' GLN . 41.1 mm -101.32 145.02 12.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.559 -1.275 . . . . 75.54 107.559 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -130.26 149.67 51.85 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 122.214 -0.304 . . . . 64.12 110.357 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 47.3 t -81.52 119.55 31.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.187 -1.042 . . . . 52.4 108.187 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.486 ' HE2' HG21 ' A' ' 476' ' ' THR . 17.8 tppt? -90.44 -52.51 4.88 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.237 0.615 . . . . 63.53 111.272 -177.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 64.4 t30 -130.18 150.25 51.52 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.076 -0.649 . . . . 75.22 111.327 -173.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 507' ' ' ALA . 28.7 mm -121.22 104.97 15.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.624 -1.25 . . . . 51.1 107.624 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.49 133.97 95.85 Favored Pre-proline 0 C--N 1.311 -1.101 0 CA-C-N 115.437 -0.801 . . . . 64.31 111.283 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.82 14.09 0.55 Allowed 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 124.624 3.549 . . . . 74.31 114.952 -172.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.441 ' HA ' HG21 ' A' ' 500' ' ' ILE . 18.8 ptt180 -156.63 6.09 0.17 Allowed 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 120.016 -0.673 . . . . 71.42 112.606 -176.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.612 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -91.23 -163.01 38.43 Favored Glycine 0 C--N 1.291 -1.936 0 C-N-CA 120.096 -1.049 . . . . 64.41 111.984 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.452 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -55.92 -40.9 73.76 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 125.016 1.326 . . . . 70.35 110.374 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.0 76.21 Favored 'General case' 0 C--O 1.194 -1.861 0 CA-C-N 114.5 -1.227 . . . . 74.23 112.515 -174.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.441 HG21 ' HA ' ' A' ' 496' ' ' ARG . 11.5 tt -80.47 -29.57 12.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 112.216 0.45 . . . . 61.24 112.216 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 73.5 mm-40 -58.53 -45.75 88.22 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.333 -0.617 . . . . 62.24 109.333 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.504 ' HB2' HD13 ' A' ' 464' ' ' LEU . 3.3 m-20 -93.49 -38.28 11.49 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.486 -0.779 . . . . 71.03 110.561 175.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 71.8 17.11 76.54 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.847 -0.692 . . . . 73.21 113.304 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.429 ' CG ' HG23 ' A' ' 462' ' ' ILE . 27.5 tpt180 -91.32 -18.93 23.53 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.172 0.51 . . . . 75.33 110.822 -175.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 46.9 tp -108.52 150.49 27.38 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 110.159 -0.311 . . . . 74.11 110.159 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.41 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -143.98 170.25 16.28 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.38 -0.6 . . . . 74.3 109.38 178.048 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.564 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -89.33 150.2 22.68 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.982 0.42 . . . . 64.43 110.765 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 113.36 -30.56 7.21 Favored Glycine 0 C--N 1.303 -1.303 0 N-CA-C 111.088 -0.805 . . . . 70.15 111.088 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -68.37 146.99 52.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.112 0.482 . . . . 72.01 111.375 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 25.0 ttm180 -85.52 128.68 34.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.165 -0.679 . . . . 53.04 109.165 177.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.471 ' HG ' HD11 ' A' ' 519' ' ' LEU . 22.4 tp -90.03 127.72 36.12 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 108.494 -0.928 . . . . 73.12 108.494 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.454 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.2 mm -98.15 -41.54 10.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.079 0.466 . . . . 74.02 110.247 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -158.65 159.12 35.01 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.602 -0.726 . . . . 61.21 109.778 176.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.29 130.52 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 109.149 -0.685 . . . . 74.13 109.149 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 70.05 -48.1 0.62 Allowed 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 127.919 2.488 . . . . 71.13 111.867 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 169.49 8.3 0.03 OUTLIER Glycine 0 C--N 1.293 -1.81 0 CA-C-N 116.101 -0.5 . . . . 45.15 112.159 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 29.2 t -115.08 138.8 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.89 -0.781 . . . . 73.53 108.89 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -83.48 155.83 23.18 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 123.755 0.659 . . . . 75.42 110.28 -174.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.471 HD11 ' HG ' ' A' ' 511' ' ' LEU . 21.7 mt -104.79 -42.24 5.43 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.621 -0.718 . . . . 72.34 111.648 -174.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.7 t -72.37 91.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 115.571 -0.74 . . . . 55.14 109.747 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 144.63 -7.23 1.72 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 110.07 -1.212 . . . . 72.42 110.07 -174.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.442 ' HD3' ' HB2' ' A' ' 526' ' ' GLU . 17.5 ptpt -130.65 -178.46 4.8 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 110.021 -0.363 . . . . 74.13 110.021 175.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . 0.431 ' O ' HG23 ' A' ' 527' ' ' VAL . 46.2 t -95.56 162.61 13.56 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.113 0.482 . . . . 63.11 111.014 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.534 ' OE1' HD12 ' A' ' 488' ' ' ILE . 7.3 tp60 -58.37 -38.88 78.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.946 -1.024 . . . . 75.32 110.328 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.99 -31.62 72.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.489 -0.778 . . . . 74.25 111.428 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.442 ' HB2' ' HD3' ' A' ' 522' ' ' LYS . 15.1 mm-40 -71.31 -39.89 71.14 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.893 -0.78 . . . . 75.22 108.893 177.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 523' ' ' SER . 18.4 t -69.34 -40.5 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.365 -0.834 . . . . 52.23 110.012 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.609 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.0 m -62.46 -42.56 96.16 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.111 0 C-N-CA 120.16 -0.616 . . . . 74.21 110.383 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.2 t -62.68 -43.31 99.12 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 116.203 -0.453 . . . . 65.21 110.133 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 46.8 tp -58.27 -45.99 86.86 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.522 1.129 . . . . 65.43 109.566 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 471' ' ' LEU . 2.4 tt -62.94 -45.45 92.43 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.391 -0.822 . . . . 72.42 112.362 175.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.7 OUTLIER -58.17 -39.58 79.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.243 0.544 . . . . 71.42 110.416 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.2 t -63.9 -43.57 95.61 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.211 -0.904 . . . . 55.31 110.672 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 63.0 m 67.51 -88.41 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.249 0.62 . . . . 60.42 110.811 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 40.5 tttm 172.74 153.74 0.08 Allowed 'General case' 0 C--O 1.251 1.164 0 N-CA-C 106.685 -1.598 . . . . 64.23 106.685 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 16.0 tpt -75.03 -35.71 61.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.418 -0.513 . . . . 72.42 109.946 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.11 -48.67 56.63 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.977 -0.556 . . . . 71.44 110.56 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 133.12 -28.54 3.31 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 118.564 -1.779 . . . . 61.12 115.984 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 4.5 m -94.93 135.18 36.75 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 118.625 -1.23 . . . . 74.32 109.805 -177.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 63.5 t -118.35 137.29 52.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.851 -0.613 . . . . 72.41 110.267 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 68.9 m -91.86 113.29 25.52 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.426 0.632 . . . . 54.41 111.039 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 464' ' ' LEU . 3.6 mm? -101.36 122.41 43.68 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.657 -0.868 . . . . 73.53 108.657 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 36.9 tp -105.09 118.17 35.85 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.035 -1.469 . . . . 74.13 107.035 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 30.0 m -115.99 154.84 17.45 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 CA-C-O 121.042 0.449 . . . . 74.03 110.786 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.515 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 69.3 t80 -111.77 118.35 35.35 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.522 -0.918 . . . . 71.22 108.522 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 . . . . . 0 C--N 1.298 -1.649 0 N-CA-C 107.504 -1.295 . . . . 63.03 107.504 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt . . . . . 0 N--CA 1.428 -1.571 0 N-CA-C 109.596 -0.52 . . . . 74.3 109.596 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.464 ' HB3' HD11 ' A' ' 543' ' ' LEU . 41.7 mtm180 -111.18 150.89 28.88 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.89 -0.595 . . . . 73.45 109.745 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.9 mm? -131.62 137.33 48.34 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.339 -0.615 . . . . 55.45 109.339 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -103.3 123.56 47.0 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.273 -0.64 . . . . 72.52 109.273 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 76.0 mt -119.26 120.8 64.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.197 -0.668 . . . . 75.31 109.197 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.0 mt-30 -100.75 127.27 47.24 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.39 0.614 . . . . 74.53 111.723 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 502' ' ' ASP . 5.9 tp -114.96 140.33 49.11 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-N 114.655 -1.157 . . . . 72.12 108.281 -173.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.518 ' HA ' ' HE3' ' A' ' 465' ' ' LYS . 1.3 tpmt? -101.98 121.98 43.19 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.303 -0.999 . . . . 62.25 108.303 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -63.49 92.02 0.06 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.786 -0.643 . . . . 73.13 110.103 175.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -116.47 142.87 17.81 Favored Glycine 0 N--CA 1.428 -1.845 0 CA-C-N 115.667 -0.697 . . . . 50.54 111.766 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . 0.5 HG23 ' H ' ' A' ' 469' ' ' GLU 0.354 10.0 t 52.03 -82.86 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.11 1.764 . . . . 72.21 114.885 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.5 ' H ' HG23 ' A' ' 468' ' ' THR . 32.9 tt0 -97.04 -15.02 21.23 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.847 0.832 . . . . 71.43 109.081 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.42 -155.85 51.67 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 114.981 -1.009 . . . . 75.33 113.419 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 540' ' ' VAL . 5.8 mp -48.12 104.5 0.06 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 113.517 0.932 . . . . 63.21 113.517 -170.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -118.56 54.58 0.62 Allowed Glycine 0 N--CA 1.422 -2.261 0 CA-C-N 114.567 -1.197 . . . . 72.15 111.174 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.525 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 16.2 p90 -136.64 142.24 43.24 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 109.292 -0.633 . . . . 75.55 109.292 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 37.1 p -115.26 153.41 30.94 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.948 -0.569 . . . . 74.02 109.963 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.41 151.3 21.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 121.076 0.465 . . . . 65.3 110.698 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.1 t -144.23 157.4 44.31 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.881 -0.599 . . . . 64.24 109.691 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 61.4 p . . . . . 0 N--CA 1.425 -1.721 0 N-CA-C 107.713 -1.217 . . . . 73.41 107.713 175.886 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.478 0.612 0 N-CA-C 114.601 0.962 . . . . 44.04 114.601 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.452 HG13 ' HB3' ' A' ' 519' ' ' LEU . 34.6 mm -87.55 130.28 37.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.163 -0.926 . . . . 74.02 108.956 -176.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -128.6 151.15 49.8 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 110.422 -0.214 . . . . 71.04 110.422 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 48.8 t -80.06 119.48 29.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.126 -1.064 . . . . 63.5 108.126 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -73.92 -60.74 2.12 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.102 -0.499 . . . . 74.25 110.536 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -145.51 158.04 43.9 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.369 0.604 . . . . 72.51 110.43 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 506' ' ' LYS . 30.2 mm -116.49 104.92 17.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 106.597 -1.631 . . . . 70.52 106.597 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.33 137.42 94.48 Favored Pre-proline 0 C--N 1.304 -1.37 0 CA-C-N 115.242 -0.89 . . . . 72.43 111.035 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -73.34 17.16 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 124.789 3.659 . . . . 70.11 117.0 -167.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -159.87 3.94 0.08 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 115.132 1.53 . . . . 74.14 115.132 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.499 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -98.69 -154.81 29.01 Favored Glycine 0 C--N 1.297 -1.623 0 C-N-CA 119.672 -1.251 . . . . 74.04 113.834 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.72 86.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.096 0.958 . . . . 44.04 111.616 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.451 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -58.11 -38.85 77.25 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.246 -0.888 . . . . 65.23 112.77 -176.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.5 tt -80.81 -32.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 112.286 0.476 . . . . 62.13 112.286 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 83.4 mm-40 -58.76 -41.92 87.72 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.998 0.428 . . . . 63.44 110.914 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.534 ' HB2' HD12 ' A' ' 464' ' ' LEU . 10.0 m-20 -89.35 -39.76 13.22 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.017 -0.538 . . . . 73.51 110.204 172.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 77.87 -19.18 4.39 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 115.639 1.016 . . . . 74.3 115.639 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -64.84 -23.38 67.22 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.234 0.54 . . . . 74.43 111.214 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.3 tp -92.72 135.64 33.93 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.143 -0.688 . . . . 64.24 109.143 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.51 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -138.4 170.44 16.02 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.199 -0.297 . . . . 74.31 110.199 176.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.489 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -86.9 160.03 18.85 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.211 -0.449 . . . . 61.15 110.646 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 103.7 -29.21 12.66 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 121.054 -0.593 . . . . 74.41 113.014 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.56 162.31 24.36 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-O 121.28 0.562 . . . . 74.31 111.929 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.524 ' HD2' HD11 ' A' ' 512' ' ' ILE . 20.0 ttm180 -90.13 126.98 35.99 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.023 -0.99 . . . . 64.03 109.23 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.59 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -88.28 123.7 33.14 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.012 -1.477 . . . . 71.25 107.012 178.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.543 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 35.5 mm -98.46 -47.63 12.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 120.956 0.408 . . . . 62.44 111.248 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -158.16 145.52 18.09 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.703 -0.68 . . . . 60.03 110.201 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 541' ' ' SER . 4.5 p -124.72 127.84 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 CA-C-O 121.276 0.56 . . . . 74.13 109.692 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 17.4 m120 59.46 15.6 4.6 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.873 1.269 . . . . 71.14 113.142 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.7 -7.77 33.99 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.682 -0.77 . . . . 63.33 113.854 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.471 ' HB ' HD21 ' A' ' 530' ' ' LEU . 67.3 t -97.77 127.09 50.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 117.563 0.681 . . . . 71.54 110.554 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.24 136.5 40.95 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 123.837 0.855 . . . . 73.14 111.423 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.59 HD11 HD12 ' A' ' 511' ' ' LEU . 13.4 mt -101.64 -23.81 14.2 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.649 0.738 . . . . 55.12 109.935 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.46 -24.56 35.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.498 -1.228 . . . . 52.15 111.47 -171.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -106.9 21.34 32.06 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.988 -0.625 . . . . 54.11 112.742 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.4 178.67 7.43 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.669 0.618 . . . . 75.1 112.669 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 527' ' ' VAL . 33.7 m -95.73 161.25 14.1 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.169 -0.469 . . . . 74.34 111.856 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.4 ' O ' HG13 ' A' ' 528' ' ' VAL . 42.3 mm-40 -51.33 -46.72 62.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.997 1.319 . . . . 74.12 113.679 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.497 ' HA ' HG22 ' A' ' 528' ' ' VAL . 37.1 mt-10 -60.35 -35.05 74.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.199 0.444 . . . . 74.23 112.199 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -67.22 -40.32 86.4 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.135 -0.691 . . . . 53.15 109.135 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.586 HG13 HD22 ' A' ' 519' ' ' LEU . 30.0 t -70.38 -39.5 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 115.422 -0.808 . . . . 74.21 110.293 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.635 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.6 m -66.37 -39.95 85.43 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 C-N-CA 119.67 -0.812 . . . . 65.2 110.401 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.9 t -62.14 -38.86 90.57 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.489 0.661 . . . . 74.32 109.899 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.471 HD21 ' HB ' ' A' ' 517' ' ' VAL . 59.1 tp -64.13 -39.64 94.47 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 123.861 0.865 . . . . 73.41 109.244 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 2.8 tt -66.61 -45.1 80.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.443 0.697 . . . . 75.33 111.241 173.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 29.3 mmm180 -62.58 -32.98 74.06 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.062 -0.517 . . . . 64.3 110.949 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.0 m -68.32 -30.5 69.5 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 116.111 -0.495 . . . . 72.32 110.572 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 535' ' ' LYS . 90.7 m 66.81 -86.93 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.301 -0.863 . . . . 74.35 111.462 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 534' ' ' THR . 25.6 tptp 162.92 154.37 0.02 OUTLIER 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.158 -2.164 . . . . 74.05 105.158 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 85.9 mtp -70.41 -20.99 62.88 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.44 0.564 . . . . 61.24 111.655 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.71 -13.98 43.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.355 0.598 . . . . 74.15 109.783 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 75.12 6.08 78.29 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.398 -0.819 . . . . 65.42 112.746 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 6.2 m -104.34 125.1 50.29 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.721 -1.215 . . . . 61.43 107.721 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.526 HG21 HD21 ' A' ' 471' ' ' LEU . 60.2 t -108.65 127.06 65.43 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 CA-C-N 115.673 -0.694 . . . . 72.15 109.329 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 14.9 m -102.12 111.95 24.42 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 119.907 -0.717 . . . . 75.41 109.114 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.525 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 2.5 mm? -99.43 119.27 37.71 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.8 -1.185 . . . . 71.31 107.8 177.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.536 HD12 ' HB ' ' A' ' 512' ' ' ILE . 2.6 tm? -104.6 117.96 35.41 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 105.963 -1.866 . . . . 74.41 105.963 177.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.69 160.51 14.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.287 -0.869 . . . . 43.32 110.196 -174.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.543 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 25.5 t80 -122.53 130.49 53.1 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.418 -1.327 . . . . 73.44 107.418 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 . . . . . 0 N--CA 1.422 -1.846 0 CA-C-O 121.266 0.555 . . . . 74.34 109.718 177.267 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt . . . . . 0 N--CA 1.422 -1.838 0 CA-C-O 120.742 0.306 . . . . 72.11 110.356 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 70.4 mtm180 -100.85 138.69 37.57 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 107.628 -1.249 . . . . 75.11 107.628 172.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 459' ' ' ARG . 6.1 mp -130.29 134.07 46.95 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 123.236 0.335 . . . . 72.4 110.221 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -94.38 115.71 27.96 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.66 -0.7 . . . . 71.53 109.189 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . 0.482 HG23 ' CG ' ' A' ' 504' ' ' ARG . 66.0 mt -120.92 141.92 39.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.659 -0.701 . . . . 74.5 110.356 -174.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 76.2 mt-30 -123.93 130.34 52.44 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.517 0.562 . . . . 75.54 112.517 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.615 HD23 HD23 ' A' ' 542' ' ' LEU . 4.2 mm? -115.6 133.48 55.99 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 124.122 0.969 . . . . 61.35 109.466 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 22.5 ttpp -102.82 134.96 45.36 Favored 'General case' 0 N--CA 1.397 -3.096 0 CA-C-O 121.437 0.637 . . . . 75.43 109.839 -177.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -58.88 126.7 28.78 Favored 'General case' 0 C--N 1.268 -2.952 0 CA-C-N 114.699 -1.137 . . . . 62.33 109.561 175.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . 0.588 ' H ' ' HA2' ' A' ' 470' ' ' GLY . . . -140.22 -138.18 3.57 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 115.722 -0.672 . . . . 74.31 111.494 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . 0.499 HG23 ' H ' ' A' ' 469' ' ' GLU . 10.0 t -50.08 -70.72 0.08 Allowed 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 123.7 0.8 . . . . 72.31 113.057 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.499 ' H ' HG23 ' A' ' 468' ' ' THR . 0.6 OUTLIER -92.65 -2.62 55.94 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.451 -0.781 . . . . 73.54 110.351 175.038 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.588 ' HA2' ' H ' ' A' ' 467' ' ' GLY . . . 54.52 -149.23 19.65 Favored Glycine 0 C--O 1.2 -1.988 0 CA-C-N 114.603 -1.18 . . . . 23.04 113.264 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.544 HD11 HG21 ' A' ' 540' ' ' VAL . 66.2 mt -53.54 99.39 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 117.955 0.877 . . . . 54.25 111.324 -173.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -118.19 54.5 0.61 Allowed Glycine 0 N--CA 1.416 -2.673 0 CA-C-N 114.467 -1.242 . . . . 43.32 111.15 -174.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.462 ' HB3' HD13 ' A' ' 493' ' ' ILE . 20.4 p90 -137.56 141.28 41.36 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 114.984 -0.608 . . . . 74.53 109.441 173.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 36.7 m -118.41 148.92 42.05 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.489 -0.778 . . . . 63.54 109.508 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.3 pt -111.05 153.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.179 0.514 . . . . 74.12 111.822 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 491' ' ' LYS . 9.7 t -134.05 159.9 39.39 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.455 -1.313 . . . . 75.32 107.455 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 31.0 p . . . . . 0 C--N 1.285 -2.21 0 N-CA-C 109.845 -0.428 . . . . 73.01 109.845 178.857 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.533 ' HA ' HG12 ' A' ' 520' ' ' VAL . 14.9 Cg_endo . . . . . 0 N--CA 1.439 -1.677 0 CA-C-O 121.408 0.503 . . . . 62.53 112.311 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.501 ' O ' ' HG3' ' A' ' 510' ' ' ARG . 49.9 mm -97.19 136.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.515 -0.766 . . . . 73.13 109.5 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.605 ' CE1' ' HD3' ' A' ' 510' ' ' ARG . 95.1 m-85 -129.46 153.99 47.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 122.223 0.209 . . . . 71.44 111.003 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 44.6 t -80.15 119.47 29.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 107.733 -1.21 . . . . 72.44 107.733 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.425 ' HD2' ' HB ' ' A' ' 476' ' ' THR . 76.0 tttt -95.14 -46.6 6.71 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.52 0.676 . . . . 62.12 110.387 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -137.13 142.33 42.26 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.466 -0.788 . . . . 65.25 109.871 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.471 HG12 ' HB2' ' A' ' 507' ' ' ALA . 28.3 mm -123.93 101.9 10.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 N-CA-C 106.312 -1.736 . . . . 73.3 106.312 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.89 126.85 92.54 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 115.934 -0.575 . . . . 70.31 110.972 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.07 34.38 0.33 Allowed 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 125.011 3.807 . . . . 70.22 112.73 -175.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.432 ' HB2' ' OE2' ' A' ' 469' ' ' GLU . 3.3 ptp180 -164.42 -4.63 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.867 0.691 . . . . 72.22 112.867 -176.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.45 ' O ' HG22 ' A' ' 500' ' ' ILE . . . -92.8 -158.7 34.53 Favored Glycine 0 C--N 1.302 -1.336 0 C-N-CA 119.115 -1.517 . . . . 75.02 112.596 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.71 85.77 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 124.119 0.968 . . . . 70.34 109.591 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.47 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -57.49 -37.79 73.53 Favored 'General case' 0 C--O 1.204 -1.31 0 CA-C-N 114.506 -1.224 . . . . 73.23 112.913 -176.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 497' ' ' GLY . 10.8 tt -81.47 -35.8 14.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.764 0.316 . . . . 35.33 111.83 176.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -58.64 -46.08 87.89 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.984 -0.553 . . . . 75.34 110.185 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.555 ' HB2' HD13 ' A' ' 464' ' ' LEU . 16.4 m-20 -89.47 -36.1 15.6 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.43 -0.581 . . . . 74.35 109.43 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.77 24.88 70.14 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.894 -0.594 . . . . 72.53 113.551 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.482 ' CG ' HG23 ' A' ' 462' ' ' ILE . 8.9 tpt180 -96.26 -11.84 25.4 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.434 -0.507 . . . . 72.41 110.625 -176.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 47.6 tp -120.29 154.19 35.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.687 -0.233 . . . . 74.3 110.654 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.444 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.1 OUTLIER -144.84 159.02 43.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.284 0.634 . . . . 72.42 111.517 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.46 155.55 23.35 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 120.798 0.332 . . . . 75.53 111.103 -176.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.82 18.06 57.0 Favored Glycine 0 C--N 1.312 -0.784 0 N-CA-C 110.713 -0.955 . . . . 63.43 110.713 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . 0.645 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 16.3 t0 -108.74 165.54 11.47 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.99 -1.485 . . . . 72.22 106.99 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.605 ' HD3' ' CE1' ' A' ' 489' ' ' TYR . 44.9 ttp180 -107.64 122.29 46.4 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 118.572 0.624 . . . . 74.41 111.537 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.541 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.32 120.63 27.88 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 107.307 -1.368 . . . . 75.53 107.307 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.608 ' HB ' HD12 ' A' ' 543' ' ' LEU . 47.9 mm -98.39 -43.86 11.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 120.594 0.235 . . . . 74.41 111.579 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 9.3 pt-20 -156.99 148.05 21.89 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.833 -0.432 . . . . 72.04 109.833 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.494 HG12 HD21 ' A' ' 519' ' ' LEU . 5.7 p -129.57 128.44 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 109.77 -0.456 . . . . 75.42 109.77 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 58.61 21.24 8.49 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.137 0.975 . . . . 74.22 112.811 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.45 -5.97 60.89 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.192 -0.528 . . . . 70.45 113.25 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.88 132.37 39.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.608 -0.515 . . . . 63.15 109.608 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -77.3 144.37 38.15 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 123.862 0.726 . . . . 73.14 109.596 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.541 HD11 HD12 ' A' ' 511' ' ' LEU . 22.7 mt -101.36 -52.51 3.23 Favored 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 120.51 -0.476 . . . . 61.21 111.116 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 487' ' ' PRO . 27.8 m -69.46 97.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.696 0 CA-C-O 122.605 1.193 . . . . 32.45 111.011 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.29 -31.74 1.15 Allowed Glycine 0 N--CA 1.419 -2.498 0 CA-C-N 113.477 -1.692 . . . . 73.53 108.989 -173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.73 174.52 5.83 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.249 -0.476 . . . . 75.44 110.771 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 54.2 m -91.0 159.15 16.3 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.156 0.428 . . . . 75.55 112.156 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -56.95 -46.47 82.1 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.119 0.567 . . . . 72.13 111.752 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.511 ' HA ' HG22 ' A' ' 528' ' ' VAL . 45.0 mt-10 -58.86 -31.95 69.01 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.966 -0.561 . . . . 73.01 111.852 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.96 -41.73 90.87 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.709 -0.478 . . . . 73.25 109.709 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.71 -38.12 71.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.355 -0.839 . . . . 61.13 110.75 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.725 ' O ' ' HG3' ' A' ' 532' ' ' ARG . 19.7 m -65.26 -42.12 93.17 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.136 0 C-N-CA 119.443 -0.903 . . . . 64.45 110.135 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.0 m -62.31 -35.85 80.32 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.734 0.778 . . . . 65.42 109.813 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 22.8 tp -67.47 -36.28 80.84 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 124.941 1.296 . . . . 63.42 110.382 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.426 ' CD1' HD13 ' A' ' 471' ' ' LEU . 54.2 tp -76.36 -48.58 19.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.188 -0.46 . . . . 72.12 111.084 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.725 ' HG3' ' O ' ' A' ' 528' ' ' VAL . 20.4 mtm180 -54.7 -36.04 64.26 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.898 0.479 . . . . 65.22 111.013 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 34.1 t -66.45 -41.3 89.3 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.535 -0.757 . . . . 61.13 111.889 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 15.5 m 64.51 174.12 0.19 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 108.336 -0.987 . . . . 54.35 108.336 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.736 ' HE2' ' O ' ' A' ' 539' ' ' THR . 37.0 mtmt -91.83 168.72 11.25 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 120.651 -1.28 . . . . 71.03 108.023 175.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 83.6 mtp -74.83 -23.01 58.38 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.058 0.456 . . . . 75.4 109.851 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.63 -64.19 0.95 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.724 -1.584 . . . . 73.03 106.724 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 138.08 -19.77 3.25 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 119.971 -1.109 . . . . 75.04 114.393 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.736 ' O ' ' HE2' ' A' ' 535' ' ' LYS . 4.8 m -94.23 136.22 34.76 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.364 -0.976 . . . . 75.44 108.364 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.544 HG21 HD11 ' A' ' 471' ' ' LEU . 91.7 t -111.59 136.31 48.09 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 C-N-CA 123.103 0.561 . . . . 74.22 110.583 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 36.2 t -98.73 119.54 37.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.142 0.496 . . . . 73.42 110.983 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.615 HD23 HD23 ' A' ' 464' ' ' LEU . 2.6 mm? -113.56 123.16 49.31 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.019 -1.104 . . . . 72.23 108.019 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.608 HD12 ' HB ' ' A' ' 512' ' ' ILE . 3.0 tm? -104.84 120.07 40.52 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 105.979 -1.859 . . . . 64.0 105.979 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.645 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 33.6 m -115.03 161.6 13.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.601 -0.727 . . . . 64.12 111.124 -173.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -129.72 116.41 18.74 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.829 -0.623 . . . . 75.05 110.468 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' A' ' 509' ' ' ASP . 36.0 mtm-85 . . . . . 0 CA--C 1.498 -1.051 0 CA-C-N 116.139 -0.482 . . . . 61.15 111.238 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 120.886 0.374 . . . . 74.35 110.937 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 92.5 mtt180 -104.69 139.64 39.22 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.023 -0.535 . . . . 74.5 110.404 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -127.82 135.4 50.01 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.147 0.579 . . . . 72.22 110.08 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -96.46 124.8 40.57 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.199 0.523 . . . . 74.32 109.788 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 66.4 mt -125.19 139.06 52.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 123.787 0.835 . . . . 72.24 109.467 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.9 mt-30 -120.78 126.97 51.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.663 0.986 . . . . 70.32 113.663 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 499' ' ' ALA . 7.3 mp -118.15 150.29 39.62 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 124.833 1.253 . . . . 75.42 111.328 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -115.3 131.95 56.77 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.096 -1.075 . . . . 74.23 108.096 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.602 ' HE2' HG21 ' A' ' 534' ' ' THR . 24.0 ttmm -52.62 96.9 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 124.536 1.134 . . . . 71.11 112.086 177.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.14 -136.75 9.34 Favored Glycine 0 CA--C 1.519 0.32 0 CA-C-N 116.194 -0.457 . . . . 74.14 113.002 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 87.9 m -46.29 -65.42 0.56 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.641 1.176 . . . . 73.02 113.081 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.4 -2.18 52.43 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.226 -1.027 . . . . 75.2 108.226 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 60.56 -143.29 48.01 Favored Glycine 0 CA--C 1.473 -2.54 0 N-CA-C 108.885 -1.686 . . . . 32.14 108.885 -168.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.528 HD11 HG21 ' A' ' 540' ' ' VAL . 50.2 mt -53.0 99.27 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.824 1.312 . . . . 53.12 111.809 -174.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . -104.73 56.78 0.54 Allowed Glycine 0 CA--C 1.466 -2.971 0 CA-C-N 114.292 -1.322 . . . . 75.21 111.956 -172.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 14.9 p90 -149.87 142.13 24.16 Favored 'General case' 0 C--N 1.267 -3.017 0 N-CA-C 108.392 -0.966 . . . . 75.52 108.392 177.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 40.0 m -115.8 160.7 19.78 Favored 'General case' 0 C--N 1.271 -2.81 0 N-CA-C 107.977 -1.12 . . . . 75.2 107.977 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 20.7 pt -117.45 151.09 19.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.2 0.524 . . . . 70.1 111.472 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.1 t -138.21 159.1 42.93 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.551 -1.277 . . . . 74.32 107.551 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 53.9 p . . . . . 0 C--N 1.291 -1.961 0 N-CA-C 109.536 -0.542 . . . . 65.52 109.536 178.868 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 C--O 1.237 0.457 0 CA-C-O 121.128 0.387 . . . . 71.24 111.506 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 42.9 mm -95.4 129.51 45.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.528 -0.76 . . . . 72.31 109.603 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -128.24 153.66 46.7 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.559 -0.534 . . . . 74.02 109.559 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.78 118.97 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 107.671 -1.233 . . . . 74.5 107.671 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -81.29 -56.96 3.72 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.293 -0.867 . . . . 73.44 110.377 -175.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 64.7 t30 -147.3 157.77 43.71 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.824 -0.626 . . . . 61.34 109.427 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.511 HG12 ' HB2' ' A' ' 507' ' ' ALA . 29.8 mm -121.49 105.81 17.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.491 -1.299 . . . . 34.41 107.491 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.9 mp -55.93 133.92 73.51 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.49 -0.777 . . . . 60.43 111.987 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -66.55 6.92 0.45 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 124.896 3.731 . . . . 75.44 115.051 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.505 ' O ' ' HB ' ' A' ' 468' ' ' THR . 31.5 ptt180 -162.74 10.95 0.06 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.919 0.866 . . . . 61.12 111.752 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.526 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -85.84 -174.29 49.74 Favored Glycine 0 C--N 1.294 -1.758 0 CA-C-N 115.42 -0.809 . . . . 61.42 112.512 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -51.52 -38.27 53.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.453 1.101 . . . . 74.34 110.538 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.728 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -61.68 -42.95 99.63 Favored 'General case' 0 C--O 1.197 -1.71 0 CA-C-N 114.185 -1.371 . . . . 72.15 113.248 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.454 HG23 HE21 ' A' ' 501' ' ' GLN . 12.0 tt -80.05 -29.44 12.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 120.925 0.393 . . . . 65.43 111.166 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 28.9 mm-40 -62.04 -46.31 89.72 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.89 -0.595 . . . . 74.34 109.633 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -84.65 -42.04 15.73 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 120.579 -0.448 . . . . 52.23 109.82 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 81.24 -14.66 27.0 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 116.753 1.461 . . . . 74.24 116.753 174.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -74.21 -16.69 60.96 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 117.77 0.785 . . . . 74.51 111.38 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.62 147.5 26.35 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.675 -0.491 . . . . 75.32 109.675 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.59 171.25 15.38 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.706 -0.479 . . . . 72.24 109.706 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -89.34 149.72 22.9 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 123.238 0.336 . . . . 72.01 110.529 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 107.0 5.27 35.49 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.55 -0.833 . . . . 21.1 113.504 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -113.74 156.18 24.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.942 0.371 . . . . 75.03 111.159 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -85.56 130.86 34.47 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.261 -0.427 . . . . 70.02 110.417 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.526 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.67 128.95 35.03 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.832 -1.544 . . . . 71.32 106.832 -179.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.5 mm -100.04 -49.59 11.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.05 0.452 . . . . 73.55 111.252 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.24 150.51 21.96 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.898 -0.592 . . . . 73.41 109.858 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 541' ' ' SER . 4.2 p -125.05 123.82 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 CA-C-O 121.38 0.61 . . . . 72.44 109.98 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 19.4 m120 56.09 18.16 3.04 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.23 1.412 . . . . 61.54 114.475 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.76 -7.83 29.76 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.257 -0.973 . . . . 54.31 112.999 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.51 123.12 45.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 108.561 -0.903 . . . . 72.05 108.561 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -90.91 133.38 35.3 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.225 -1.028 . . . . 72.32 108.225 -172.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.526 HD11 HD12 ' A' ' 511' ' ' LEU . 23.2 mt -86.33 -46.31 10.4 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 112.427 0.529 . . . . 70.14 112.427 -170.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.38 100.59 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.854 0.835 . . . . 72.04 110.503 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 141.59 -33.55 1.96 Allowed Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 109.629 -1.388 . . . . 52.41 109.629 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.94 166.52 10.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.614 -0.293 . . . . 71.01 110.722 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 58.3 m -88.65 162.55 16.26 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.719 0.295 . . . . 53.44 111.763 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -54.92 -46.47 74.92 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 123.897 0.879 . . . . 73.43 112.205 -175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.552 ' HA ' HG22 ' A' ' 528' ' ' VAL . 40.9 mm-40 -60.39 -31.05 69.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.888 0.699 . . . . 74.52 112.888 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.63 -37.48 86.69 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.491 0.662 . . . . 63.4 109.258 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.42 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 39.0 t -75.69 -34.94 29.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.69 -0.686 . . . . 73.33 110.04 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.616 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 13.5 m -66.5 -41.32 88.34 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 C-N-CA 119.953 -0.699 . . . . 63.34 110.687 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 40.5 t -59.67 -44.1 93.74 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.782 0.801 . . . . 70.2 109.327 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 25.3 tp -58.35 -41.97 85.85 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 125.487 1.515 . . . . 55.01 110.163 176.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.474 HD12 HD13 ' A' ' 471' ' ' LEU . 35.4 tp -69.27 -48.07 62.78 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.724 0.81 . . . . 74.24 110.383 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 4.2 mmp_? -55.1 -45.39 75.46 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.761 0.825 . . . . 43.13 112.355 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 32.1 m -71.53 -37.12 71.18 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 111.553 0.205 . . . . 74.14 111.553 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . 0.602 HG21 ' HE2' ' A' ' 466' ' ' LYS . 26.3 m 70.42 152.45 0.11 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.057 0.943 . . . . 73.44 111.009 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.99 125.68 25.66 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.98 -1.489 . . . . 74.25 106.98 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.7 mtt -71.8 -6.3 40.49 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.269 0.841 . . . . 61.03 113.269 -173.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.55 -27.69 61.47 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.12 -1.067 . . . . 73.41 108.12 171.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 109.97 -25.16 17.22 Favored Glycine 0 N--CA 1.427 -1.965 0 CA-C-N 115.207 -0.906 . . . . 62.1 112.43 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.5 m -101.59 127.0 48.5 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 109.369 -0.604 . . . . 62.11 109.369 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.528 HG21 HD11 ' A' ' 471' ' ' LEU . 76.6 t -106.46 128.23 61.18 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.681 0 CA-C-N 115.744 -0.662 . . . . 64.35 110.363 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 20.2 m -100.9 114.02 27.51 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.575 -0.739 . . . . 44.55 109.519 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -104.77 128.23 52.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.802 -0.814 . . . . 51.0 108.802 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 37.3 tp -104.85 118.28 36.16 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 105.935 -1.876 . . . . 71.31 105.935 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 27.6 m -115.48 160.17 14.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 CA-C-O 120.966 0.412 . . . . 75.44 110.042 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -111.96 115.39 28.87 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-N 115.546 -0.752 . . . . 74.01 109.08 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.428 -1.567 0 N-CA-C 106.047 -1.834 . . . . 64.32 106.047 177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 458' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.432 -1.357 0 N-CA-C 109.319 -0.623 . . . . 74.25 109.319 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.415 ' HB3' HD21 ' A' ' 543' ' ' LEU . 84.5 mtm180 -102.03 149.4 24.29 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.166 -0.679 . . . . 75.54 109.166 174.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.4 mm? -133.98 150.53 51.27 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.358 -0.608 . . . . 71.55 109.358 -173.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.51 117.27 28.55 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.904 0.859 . . . . 75.11 110.935 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 54.7 mt -121.78 139.2 49.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 106.853 -1.536 . . . . 70.14 106.853 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 42.4 tt0 -125.66 126.58 44.92 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.895 -1.122 . . . . 72.11 108.512 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.552 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 6.4 mp -114.66 153.05 30.9 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.081 -0.647 . . . . 75.2 112.433 -177.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.716 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.2 OUTLIER -100.56 128.37 46.64 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.558 -0.904 . . . . 71.2 108.558 -177.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.631 ' HE3' HG21 ' A' ' 534' ' ' THR . 39.9 ttmt -60.1 113.28 2.26 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.952 -0.567 . . . . 53.24 110.182 172.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -104.58 -131.71 7.22 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 120.796 -0.716 . . . . 64.03 111.799 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 26.4 m -62.53 -64.97 0.76 Allowed 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.198 0.599 . . . . 75.5 111.947 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.558 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 11.8 mm-40 -85.24 -32.45 22.59 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.82 -0.752 . . . . 63.22 109.545 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.467 ' N ' ' HA2' ' A' ' 497' ' ' GLY . . . 70.77 141.63 0.21 Allowed Glycine 0 C--O 1.21 -1.352 0 CA-C-N 114.878 -1.055 . . . . 54.53 112.894 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.486 ' N ' ' H ' ' A' ' 498' ' ' ALA 0.25 4.9 mp 39.56 84.38 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.551 1.54 . . . . 72.45 114.118 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -94.04 54.14 2.2 Favored Glycine 0 CA--C 1.493 -1.297 0 CA-C-N 115.078 -0.965 . . . . 63.33 112.433 -173.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.539 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 3.7 p90 -146.67 142.05 27.48 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.177 0.513 . . . . 63.31 110.763 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 29.6 m -120.57 143.9 48.38 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.089 -1.448 . . . . 72.44 107.089 177.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 23.9 pt -109.59 158.85 9.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 121.441 0.638 . . . . 61.11 111.929 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.6 t -132.5 159.23 39.99 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.703 -1.591 . . . . 75.14 106.703 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 55.4 p . . . . . 0 C--N 1.269 -2.911 0 N-CA-C 108.953 -0.758 . . . . 73.23 108.953 179.747 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 C--O 1.249 1.068 0 CA-C-O 120.867 0.278 . . . . 64.35 111.702 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.46 ' O ' ' HG3' ' A' ' 510' ' ' ARG . 44.3 mm -109.56 136.59 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.966 -0.561 . . . . 74.23 109.976 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 91.9 m-85 -137.99 157.79 45.65 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.138 0.575 . . . . 70.22 110.468 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.462 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 13.0 t -74.68 121.41 26.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.108 -1.071 . . . . 70.14 108.108 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 24.2 ttmm -85.44 -58.9 2.48 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.728 -0.471 . . . . 74.15 109.728 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -146.61 147.83 31.47 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.042 -1.096 . . . . 63.22 108.042 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.538 HG13 ' HA ' ' A' ' 506' ' ' LYS . 26.1 mm -109.4 109.46 28.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.635 -0.876 . . . . 61.04 108.635 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 86.5 mt -53.69 154.69 6.52 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 114.838 -1.073 . . . . 74.33 111.168 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.17 -1.67 11.26 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 123.902 3.068 . . . . 51.13 111.657 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.568 ' HA ' HG21 ' A' ' 500' ' ' ILE . 99.5 mtt180 -150.39 -157.65 0.84 Allowed 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 115.12 -0.946 . . . . 65.32 108.559 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.558 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 82.98 -162.9 41.21 Favored Glycine 0 C--N 1.277 -2.735 0 N-CA-C 111.398 -0.681 . . . . 71.35 111.398 -176.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.489 ' O ' HD23 ' A' ' 464' ' ' LEU . . . -70.49 -27.78 64.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.885 0.342 . . . . 74.51 110.843 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.552 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -58.9 -41.37 87.05 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-N 115.182 -0.917 . . . . 71.22 112.057 -173.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.568 HG21 ' HA ' ' A' ' 496' ' ' ARG . 16.9 tt -79.48 -29.29 13.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.984 -0.553 . . . . 52.31 111.547 -179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 12.6 mm100 -62.37 -45.91 91.03 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.263 -0.643 . . . . 73.42 109.263 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.413 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 8.8 t70 -93.74 -34.88 13.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.291 -0.868 . . . . 51.43 110.048 -177.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 83.8 -27.65 4.27 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.622 1.409 . . . . 44.3 116.622 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -67.93 -13.59 62.29 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.191 1.182 . . . . 75.44 114.191 -174.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 46.7 tp -97.89 124.78 42.47 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 120.595 -0.442 . . . . 64.54 111.158 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.538 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.1 OUTLIER -135.27 164.07 28.55 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 111.809 0.3 . . . . 75.5 111.809 178.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.52 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -82.64 160.36 22.47 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 113.835 1.05 . . . . 64.34 113.835 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 78.93 46.77 8.14 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.234 -0.894 . . . . 32.41 112.247 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . 0.502 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 7.5 t70 -144.08 178.63 7.74 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.579 -1.637 . . . . 62.54 106.579 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.494 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 48.6 ttp85 -109.28 136.83 48.09 Favored 'General case' 0 C--O 1.212 -0.875 0 C-N-CA 119.176 -1.01 . . . . 71.24 113.217 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.734 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -88.02 121.31 30.28 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.196 -0.911 . . . . 70.02 110.781 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.458 HD11 ' CB ' ' A' ' 545' ' ' PHE . 1.9 mp -106.83 -48.47 8.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 109.447 -0.575 . . . . 55.31 109.447 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.42 143.0 31.43 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.302 -0.863 . . . . 62.2 109.543 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 541' ' ' SER . 7.5 p -145.03 122.41 4.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 CA-C-N 114.632 -1.167 . . . . 75.25 109.506 175.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . 0.613 ' ND2' HG13 ' A' ' 540' ' ' VAL . 49.0 m-80 66.65 21.94 10.54 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.113 0.965 . . . . 63.4 112.176 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 83.41 25.96 45.26 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 121.147 -0.549 . . . . 73.03 112.158 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.0 t -121.8 138.04 53.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 109.752 -0.462 . . . . 75.32 109.752 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.99 128.31 34.57 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.038 -0.727 . . . . 74.24 109.038 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.734 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 24.6 mt -96.55 -44.05 7.33 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 113.057 0.762 . . . . 74.14 113.057 -170.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 56.4 t -72.47 92.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.752 0.787 . . . . 74.05 110.448 -174.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.29 -25.77 1.24 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 109.889 -1.284 . . . . 63.23 109.889 -175.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.09 179.09 4.36 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.793 -0.203 . . . . 63.14 110.671 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 52.5 m -94.2 157.97 15.81 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-O 121.065 0.46 . . . . 61.43 111.75 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -52.8 -47.18 67.78 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.42 1.088 . . . . 73.21 112.156 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.54 ' HA ' HG22 ' A' ' 528' ' ' VAL . 42.9 mt-10 -60.87 -34.29 74.39 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.564 0.579 . . . . 35.35 112.564 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.99 -42.18 97.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.48 0.657 . . . . 73.32 109.536 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.52 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 44.5 t -71.06 -40.36 75.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.715 -1.129 . . . . 75.42 110.374 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 525' ' ' GLU . 12.7 m -68.62 -38.91 79.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 C-N-CA 119.041 -1.064 . . . . 63.3 110.371 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 25.8 t -62.04 -43.14 99.48 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.874 -0.603 . . . . 74.25 110.54 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.695 HD11 HG13 ' A' ' 514' ' ' VAL . 3.5 pp -67.19 -32.29 73.26 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.24 0.543 . . . . 75.43 109.656 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 530' ' ' LEU . 2.6 tt -65.15 -47.97 75.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.918 -1.037 . . . . 71.15 111.073 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.606 ' HA ' ' HE ' ' A' ' 532' ' ' ARG . 0.2 OUTLIER -63.28 -37.04 85.68 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.906 -0.588 . . . . 55.32 110.447 -177.632 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.4 m -73.61 -40.95 63.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.492 -0.322 . . . . 73.31 110.502 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . 0.631 HG21 ' HE3' ' A' ' 466' ' ' LYS . 24.0 m 68.92 158.32 0.16 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.095 0.958 . . . . 61.32 111.261 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.493 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 16.5 tppt? -67.67 127.25 32.07 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.075 -1.454 . . . . 70.33 107.075 172.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.6 ptp -61.38 -18.0 56.71 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.279 0.562 . . . . 73.04 111.493 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . 0.493 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 39.6 tt0 -69.4 -24.17 63.82 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.888 0.875 . . . . 62.44 110.413 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 103.05 -29.09 13.19 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 116.053 -0.521 . . . . 54.43 112.684 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 0.6 OUTLIER -94.83 124.08 38.66 Favored 'General case' 0 N--CA 1.424 -1.733 0 C-N-CA 123.117 0.567 . . . . 54.53 112.372 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.613 HG13 ' ND2' ' A' ' 515' ' ' ASN . 72.1 t -104.3 129.74 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 108.565 -0.902 . . . . 74.13 108.565 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.706 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 47.2 t -91.1 134.0 34.88 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.506 -0.924 . . . . 45.5 108.506 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.539 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.4 mm? -122.93 118.21 27.32 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.952 -1.129 . . . . 73.23 107.952 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 4.2 tt -110.31 117.65 34.21 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 104.35 -2.463 . . . . 73.31 104.35 173.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.502 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 30.6 m -121.25 160.39 22.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-N 115.888 -0.596 . . . . 72.13 111.336 -175.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.458 ' CB ' HD11 ' A' ' 512' ' ' ILE . 76.4 t80 -125.56 119.38 28.0 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 120.966 0.412 . . . . 71.05 110.601 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 . . . . . 0 N--CA 1.401 -2.878 0 N-CA-C 108.191 -1.04 . . . . 71.22 108.191 174.928 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt . . . . . 0 N--CA 1.426 -1.646 0 CA-C-O 121.172 0.51 . . . . 74.02 110.181 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 62.8 mtm180 -101.37 137.14 40.09 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 106.252 -1.758 . . . . 75.43 106.252 172.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 16.4 tp -129.18 129.05 44.58 Favored 'General case' 0 C--N 1.265 -3.099 0 CA-C-N 116.019 -0.537 . . . . 75.0 109.822 -172.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -98.53 115.65 29.05 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 108.859 -0.793 . . . . 71.34 108.859 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . 0.54 HG23 ' HD3' ' A' ' 504' ' ' ARG . 67.4 mt -116.43 142.56 29.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.384 -0.969 . . . . 74.41 108.384 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 78.5 mt-30 -122.36 128.63 51.23 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 118.564 0.62 . . . . 73.32 112.152 176.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.593 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 9.3 mp -115.75 146.69 41.69 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 123.834 0.854 . . . . 64.41 111.634 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.768 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.2 OUTLIER -100.35 125.67 46.61 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 108.16 -1.052 . . . . 74.2 108.16 -178.219 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.88 114.97 2.32 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.249 -0.887 . . . . 63.12 110.358 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -87.08 -140.68 6.4 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.158 -1.177 . . . . 52.52 110.158 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . 0.472 HG23 ' OE2' ' A' ' 469' ' ' GLU . 9.9 t -81.8 -31.61 31.7 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.834 -0.747 . . . . 64.24 111.359 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.601 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 12.0 mp0 -91.77 -42.8 9.91 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 107.79 -1.189 . . . . 72.44 107.79 173.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 84.57 -148.09 23.57 Favored Glycine 0 C--O 1.202 -1.866 0 CA-C-O 118.365 -1.242 . . . . 50.32 111.312 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.566 ' H ' HD22 ' A' ' 471' ' ' LEU . 1.7 mm? -45.95 108.07 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.478 1.139 . . . . 70.0 113.294 -169.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.87 45.62 1.28 Allowed Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.744 -1.117 . . . . 74.05 111.679 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.445 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 23.1 p90 -134.69 143.11 47.04 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.036 -0.727 . . . . 71.43 109.036 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 39.5 m -115.46 157.47 23.93 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.469 -1.308 . . . . 73.24 107.469 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 15.2 pt -126.03 160.08 33.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.364 0.602 . . . . 70.21 112.366 -176.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.413 ' HB ' ' CE ' ' A' ' 491' ' ' LYS . 10.1 t -152.26 158.26 42.57 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.218 -1.03 . . . . 62.41 108.218 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 35.3 p . . . . . 0 N--CA 1.422 -1.832 0 N-CA-C 106.446 -1.687 . . . . 51.5 106.446 174.451 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo . . . . . 0 C--O 1.246 0.895 0 CA-C-O 121.169 0.404 . . . . 55.54 112.039 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' A' ' 519' ' ' LEU . 39.2 mm -85.64 128.63 39.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 108.145 -1.057 . . . . 61.34 108.145 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -124.61 155.66 38.75 Favored 'General case' 0 CA--C 1.487 -1.455 0 O-C-N 122.117 -0.365 . . . . 73.42 110.962 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 49.4 t -74.04 125.91 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 108.592 -0.892 . . . . 72.12 108.592 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.413 ' CE ' ' HB ' ' A' ' 476' ' ' THR . 41.4 ttmt -82.54 -53.24 6.12 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.89 -0.781 . . . . 63.02 108.89 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -149.41 151.79 34.63 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.145 -0.934 . . . . 73.42 109.332 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.441 HG13 ' HA ' ' A' ' 506' ' ' LYS . 27.4 mm -114.39 106.83 21.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.175 -1.417 . . . . 71.25 107.175 175.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 495' ' ' PRO . 8.3 mp -50.55 157.79 1.2 Allowed Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 124.903 1.281 . . . . 55.24 113.124 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 494' ' ' LEU . 68.6 Cg_endo -72.21 -6.46 19.13 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 123.961 3.107 . . . . 41.33 111.979 -175.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.596 ' HA ' HG21 ' A' ' 500' ' ' ILE . 77.2 mtt180 -151.19 -161.05 1.25 Allowed 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.199 -0.91 . . . . 70.13 109.149 -174.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.601 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 81.48 -167.27 48.57 Favored Glycine 0 C--N 1.282 -2.461 0 CA-C-N 115.254 -0.885 . . . . 62.24 113.722 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.5 ' O ' HD23 ' A' ' 464' ' ' LEU . . . -65.76 -35.83 81.83 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 124.318 1.047 . . . . 63.53 110.377 -174.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.593 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -59.63 -39.62 84.91 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 115.089 -0.959 . . . . 53.41 112.331 -174.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.596 HG21 ' HA ' ' A' ' 496' ' ' ARG . 15.0 tt -80.09 -30.1 12.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 121.111 -0.235 . . . . 75.42 111.371 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 31.6 mm-40 -60.89 -45.57 94.06 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.879 -0.6 . . . . 74.5 110.307 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.472 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 7.5 t70 -92.67 -35.75 13.33 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.779 -0.823 . . . . 52.15 108.779 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 56.54 25.39 50.01 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 115.551 0.98 . . . . 72.21 115.551 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.54 ' HD3' HG23 ' A' ' 462' ' ' ILE . 63.9 ttt180 -99.95 -6.69 26.21 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.92 0.867 . . . . 73.23 109.331 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 44.4 tp -109.5 138.91 45.17 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.738 -1.208 . . . . 72.23 107.738 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.525 ' HD2' ' OD2' ' A' ' 509' ' ' ASP . 0.0 OUTLIER -138.27 177.5 7.84 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.597 -0.841 . . . . 75.11 109.149 175.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -82.99 29.12 0.48 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.513 0.673 . . . . 72.21 112.037 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . -126.23 13.7 7.03 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.021 -0.832 . . . . 72.14 111.021 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . 0.525 ' OD2' ' HD2' ' A' ' 506' ' ' LYS . 42.6 m-20 -102.6 148.21 25.83 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 120.773 0.32 . . . . 74.45 110.694 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 544' ' ' VAL . 19.0 ttm180 -101.16 129.76 47.13 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 116.27 -0.423 . . . . 72.44 109.938 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.627 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.6 mm? -83.41 117.01 22.76 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 112.451 0.537 . . . . 61.24 112.451 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.4 HG13 ' HB2' ' A' ' 545' ' ' PHE . 45.9 mm -104.98 -39.63 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.69 0.757 . . . . 65.33 109.516 174.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 543' ' ' LEU . 30.8 tt0 -148.57 145.8 27.99 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 114.929 -1.032 . . . . 61.42 108.867 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.775 HG13 HD11 ' A' ' 530' ' ' LEU . 2.4 p -139.15 129.17 31.51 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.446 0 CA-C-N 115.051 -0.977 . . . . 72.34 108.375 174.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . 0.569 HD21 ' HB2' ' A' ' 535' ' ' LYS . 6.3 t-20 68.65 -58.92 0.47 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 127.712 2.405 . . . . 71.44 111.673 -176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 178.08 27.26 0.04 OUTLIER Glycine 0 C--N 1.296 -1.642 0 N-CA-C 110.081 -1.208 . . . . 54.12 110.081 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.88 136.76 57.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 109.829 -0.434 . . . . 63.31 109.829 -174.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.75 125.56 31.4 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.937 -0.764 . . . . 62.34 108.937 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 514' ' ' VAL . 32.5 mt -94.52 -35.2 12.38 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.01 -0.541 . . . . 74.3 112.061 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 41.5 t -75.98 87.95 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 122.072 0.939 . . . . 74.43 110.374 -173.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.66 -26.51 1.19 Allowed Glycine 0 N--CA 1.425 -2.042 0 CA-C-N 114.132 -1.395 . . . . 32.45 110.142 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.31 176.95 4.99 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.808 0.337 . . . . 71.44 111.78 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 22.2 m -90.23 160.54 16.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.293 0.568 . . . . 51.12 112.394 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -53.0 -47.48 68.22 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.67 1.188 . . . . 74.31 113.834 177.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.49 ' HA ' HG22 ' A' ' 528' ' ' VAL . 46.6 mt-10 -62.65 -32.24 73.25 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 120.781 -0.368 . . . . 62.24 111.844 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.71 -38.81 92.5 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.075 0.464 . . . . 71.35 110.406 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 21.6 t -73.74 -41.42 54.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.738 -0.665 . . . . 74.04 109.61 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.601 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 11.4 m -65.65 -40.29 87.51 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 C-N-CA 119.462 -0.895 . . . . 75.24 110.456 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 27.6 m -63.06 -38.3 90.65 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.791 -0.641 . . . . 73.34 111.705 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.775 HD11 HG13 ' A' ' 514' ' ' VAL . 2.1 pp -69.56 -33.06 72.2 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.613 -0.884 . . . . 63.14 108.613 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.2 tt -65.22 -48.18 74.26 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 115.329 -0.85 . . . . 64.1 110.071 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 30.5 mmm180 -61.2 -31.43 71.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.377 -0.828 . . . . 65.05 110.184 -177.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.0 t -76.39 -43.74 39.21 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.426 -0.806 . . . . 61.33 110.391 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 535' ' ' LYS . 12.6 m 64.49 177.41 0.18 Allowed 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 109.064 -0.717 . . . . 75.11 109.064 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.569 ' HB2' HD21 ' A' ' 515' ' ' ASN . 38.1 ttpt -102.33 139.5 37.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.833 -0.803 . . . . 51.33 108.833 175.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 88.1 mtp -65.36 -20.68 66.5 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.234 0.827 . . . . 53.21 113.234 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 33.4 tt0 -58.54 -39.07 79.17 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.431 -0.951 . . . . 71.14 108.431 172.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 115.96 -24.35 10.17 Favored Glycine 0 N--CA 1.431 -1.64 0 CA-C-N 114.878 -1.056 . . . . 75.55 112.443 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.485 ' O ' ' HE2' ' A' ' 535' ' ' LYS . 0.6 OUTLIER -96.17 140.69 30.51 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.707 -0.397 . . . . 70.33 109.944 -177.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 53.6 t -119.15 133.32 66.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 122.849 0.46 . . . . 64.2 111.544 174.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 462' ' ' ILE . 50.1 m -91.6 138.33 31.65 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.531 -0.759 . . . . 62.55 110.097 177.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.549 HD23 HD13 ' A' ' 464' ' ' LEU . 2.7 mm? -124.14 120.35 32.06 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 106.82 -1.548 . . . . 65.14 106.82 176.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 54.2 tp -104.88 117.07 33.12 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.027 -1.472 . . . . 64.3 107.027 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 510' ' ' ARG . 33.0 m -117.82 140.14 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.121 0 C-N-CA 119.907 -0.717 . . . . 74.01 111.701 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.429 ' HB3' ' HD2' ' A' ' 510' ' ' ARG . 62.2 t80 -111.3 116.79 31.6 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.138 -0.69 . . . . 70.32 109.138 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . 0.468 ' HD3' ' OD1' ' A' ' 509' ' ' ASP . 23.9 mtm180 . . . . . 0 C--N 1.289 -2.05 0 N-CA-C 108.292 -1.003 . . . . 73.22 108.292 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 51.1 mtpt . . . . . 0 N--CA 1.426 -1.626 0 N-CA-C 113.159 0.8 . . . . 74.15 113.159 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 98.8 mtt180 -107.69 126.79 53.03 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 113.883 -1.508 . . . . 75.35 107.227 169.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.2 mm? -115.9 132.57 56.61 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 109.116 -0.698 . . . . 74.23 109.116 -176.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -98.14 120.18 38.1 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.393 -0.965 . . . . 73.01 108.393 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . 0.45 ' HA ' ' NH1' ' A' ' 504' ' ' ARG . 45.7 mt -122.16 142.64 37.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.898 -1.149 . . . . 61.01 107.898 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.55 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 93.1 mt-30 -123.03 125.97 46.23 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.606 0.717 . . . . 73.12 112.701 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 7.9 mp -121.56 141.55 50.96 Favored 'General case' 0 CA--C 1.478 -1.802 0 CA-C-N 115.225 -0.898 . . . . 72.41 112.308 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 465' ' ' LYS . 39.7 ttmt -112.71 136.06 52.74 Favored 'General case' 0 N--CA 1.398 -3.031 0 CA-C-N 115.456 -0.793 . . . . 75.11 110.005 -176.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.543 ' HB2' HG21 ' A' ' 534' ' ' THR . 39.4 ttmt -65.93 113.74 4.62 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.724 -1.125 . . . . 73.42 111.865 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -93.1 -104.2 1.63 Allowed Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.142 -1.183 . . . . 62.01 110.142 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 41.5 m -90.73 -57.0 2.97 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 122.554 -0.38 . . . . 74.34 111.113 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -94.43 -33.51 13.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.933 -1.506 . . . . 62.33 106.933 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 79.51 -145.27 27.62 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 114.407 -1.27 . . . . 44.53 110.995 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.448 HD21 HG11 ' A' ' 540' ' ' VAL . 6.6 mp -43.43 97.64 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.205 1.187 . . . . 73.41 114.205 -172.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -103.79 50.08 0.9 Allowed Glycine 0 N--CA 1.433 -1.555 0 CA-C-N 114.432 -1.258 . . . . 63.0 112.417 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -133.39 146.67 51.45 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.537 -0.912 . . . . 71.33 108.537 175.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 47.1 m -116.03 156.97 25.39 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 108.465 -0.939 . . . . 54.11 108.465 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 12.2 pt -124.18 154.66 31.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.26 0.552 . . . . 72.22 111.799 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.8 t -142.07 159.03 43.04 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.05 -1.092 . . . . 70.22 108.05 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 64.4 p . . . . . 0 N--CA 1.421 -1.922 0 N-CA-C 107.65 -1.241 . . . . 73.22 107.65 174.444 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.443 ' HA ' HG22 ' A' ' 520' ' ' VAL . 2.4 Cg_endo . . . . . 0 N--CA 1.438 -1.743 0 N-CA-C 109.498 -1.001 . . . . 24.43 109.498 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.531 HG13 ' HB3' ' A' ' 519' ' ' LEU . 32.4 mm -89.95 131.37 37.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 116.135 -0.484 . . . . 74.24 109.971 -174.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 90.1 m-85 -129.97 161.63 30.48 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.091 0.556 . . . . 74.11 109.828 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 23.4 t -74.58 127.03 36.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.612 -0.884 . . . . 73.02 108.612 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -87.39 -51.18 6.08 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.741 -0.837 . . . . 73.33 108.741 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -159.0 157.84 32.04 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.282 -0.872 . . . . 73.34 109.307 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 507' ' ' ALA . 32.5 mm -121.07 109.33 24.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 106.523 -1.658 . . . . 73.21 106.523 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.411 ' HB3' ' HD2' ' A' ' 495' ' ' PRO . 3.7 mm? -56.12 158.95 6.47 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-N 115.575 -0.739 . . . . 74.31 111.761 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.422 ' HG2' ' HG2' ' A' ' 496' ' ' ARG . 26.5 Cg_endo -79.18 7.36 4.44 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 123.475 2.783 . . . . 72.43 111.453 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.665 ' HA ' HG21 ' A' ' 500' ' ' ILE . 17.3 ptp180 -159.41 -158.3 0.65 Allowed 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 115.728 -0.669 . . . . 75.15 110.371 -174.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 72.61 -157.46 52.66 Favored Glycine 0 C--N 1.287 -2.143 0 CA-C-N 114.954 -1.021 . . . . 74.55 111.013 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -69.85 -35.47 74.74 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 122.742 0.417 . . . . 74.21 111.242 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.515 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -58.07 -37.4 74.39 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 113.428 0.899 . . . . 70.14 113.428 -172.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.665 HG21 ' HA ' ' A' ' 496' ' ' ARG . 15.7 tt -79.71 -36.17 17.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 112.134 0.42 . . . . 65.41 112.134 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.51 HE21 HG23 ' A' ' 500' ' ' ILE . 28.9 mm-40 -63.75 -33.66 76.16 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.303 0.573 . . . . 74.24 110.789 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.407 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 16.5 t70 -89.75 -48.06 7.51 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.88 -0.6 . . . . 70.5 109.951 173.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 72.79 -3.49 27.04 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 117.559 1.784 . . . . 51.13 117.559 175.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.45 ' NH1' ' HA ' ' A' ' 462' ' ' ILE . 70.5 mtp180 -80.46 -15.06 57.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.882 1.341 . . . . 73.23 110.109 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 39.3 tp -96.49 134.47 39.64 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.282 -0.872 . . . . 61.24 108.949 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 506' ' ' LYS . 0.0 OUTLIER -142.76 175.41 9.83 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.765 -0.457 . . . . 65.01 109.765 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.531 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -102.4 82.74 2.21 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 120.351 -0.54 . . . . 42.33 110.676 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . -175.01 35.48 0.1 Allowed Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.306 -1.118 . . . . 61.24 110.306 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -153.76 177.19 11.26 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 122.96 0.504 . . . . 74.41 111.541 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.555 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 0.2 OUTLIER -115.19 142.31 46.83 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.358 0.503 . . . . 72.42 112.358 -174.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.628 ' HB3' HD12 ' A' ' 519' ' ' LEU . 4.6 mm? -85.3 128.06 34.56 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.889 -0.596 . . . . 70.23 112.599 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 36.6 mm -102.53 -58.77 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.062 0 CA-C-N 116.189 -0.46 . . . . 63.22 109.775 176.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.553 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.5 pt-20 -156.29 144.55 19.82 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 121.438 0.637 . . . . 51.55 111.056 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.738 HG12 HD21 ' A' ' 519' ' ' LEU . 2.6 p -130.61 135.2 60.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 N-CA-C 107.829 -1.174 . . . . 72.41 107.829 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 17.4 m120 66.47 9.91 6.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.52 0.728 . . . . 75.23 111.727 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 84.07 13.11 75.24 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 111.455 -0.658 . . . . 51.03 111.455 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.83 135.67 39.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.792 -0.818 . . . . 74.53 108.792 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.64 132.15 36.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.68 -0.489 . . . . 75.42 109.68 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.738 HD21 HG12 ' A' ' 514' ' ' VAL . 15.9 mt -97.76 -45.29 6.4 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 112.425 0.528 . . . . 71.45 112.425 -170.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' VAL . . . . . 0.531 HG21 HH21 ' A' ' 510' ' ' ARG . 59.8 t -78.41 99.9 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-O 121.787 0.803 . . . . 64.24 109.126 -175.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 143.68 -26.19 2.1 Favored Glycine 0 N--CA 1.414 -2.815 0 N-CA-C 109.249 -1.541 . . . . 74.11 109.249 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.01 179.71 4.25 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 110.163 -0.31 . . . . 73.33 110.163 175.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 46.5 t -87.3 155.02 20.24 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.268 0.556 . . . . 74.33 110.68 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 528' ' ' VAL . 28.8 mm-40 -54.55 -39.99 68.27 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.719 1.207 . . . . 74.02 111.41 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.443 ' HA ' HG22 ' A' ' 528' ' ' VAL . 42.9 mt-10 -66.81 -32.11 73.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.191 -0.459 . . . . 71.31 111.572 -176.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.18 -44.58 83.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.05 -0.523 . . . . 73.03 109.835 176.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 19.0 t -67.68 -43.56 86.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.665 -0.698 . . . . 61.34 109.634 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.524 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 10.2 m -64.91 -38.73 83.52 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.044 0 C-N-CA 119.774 -0.77 . . . . 73.51 110.265 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.1 t -63.05 -45.43 92.24 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.857 -0.61 . . . . 62.43 110.763 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.625 HD11 HG13 ' A' ' 514' ' ' VAL . 2.6 pp -66.27 -35.52 80.61 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.441 0.639 . . . . 71.04 109.434 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.525 HD23 ' HE ' ' A' ' 532' ' ' ARG . 2.5 tt -62.11 -47.97 82.22 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.054 -0.976 . . . . 70.33 111.607 175.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.525 ' HE ' HD23 ' A' ' 531' ' ' LEU . 1.4 mmp_? -63.95 -37.08 86.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.105 -0.498 . . . . 73.03 109.705 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.2 m -67.4 -39.86 85.57 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.575 -0.739 . . . . 71.04 109.238 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 466' ' ' LYS . 95.3 m 72.78 -85.7 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.804 0.842 . . . . 71.24 111.599 177.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.539 ' HG2' ' H ' ' A' ' 537' ' ' GLU . 39.9 ttmt 170.8 133.67 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.71 1.204 . . . . 71.34 107.864 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.2 mtt -65.97 -29.26 69.62 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.666 0.269 . . . . 62.41 111.141 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . 0.539 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 38.8 tt0 -74.07 -37.05 64.34 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.361 -0.381 . . . . 73.24 110.995 177.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 135.79 -45.48 1.09 Allowed Glycine 0 CA--C 1.539 1.584 0 N-CA-C 117.322 1.689 . . . . 75.31 117.322 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.411 ' CG2' ' HB3' ' A' ' 463' ' ' GLN . 5.5 m -101.95 140.19 36.58 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.442 1.121 . . . . 71.4 112.366 -172.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 69.2 t -113.52 140.28 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 124.037 0.935 . . . . 74.22 110.808 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 46.6 t -95.65 124.78 39.83 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.23 -0.656 . . . . 63.31 109.23 176.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.507 HD23 HD13 ' A' ' 464' ' ' LEU . 2.6 mm? -115.37 119.21 35.5 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.298 -1.371 . . . . 72.11 107.298 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 33.9 tp -108.54 117.37 34.0 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.074 -1.454 . . . . 71.53 107.074 174.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 35.6 m -116.17 150.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.803 -0.635 . . . . 71.32 110.837 -177.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 69.6 t80 -112.14 116.52 30.62 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.207 -1.035 . . . . 72.51 108.207 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 . . . . . 0 C--N 1.286 -2.165 0 CA-C-N 115.817 -0.628 . . . . 73.21 110.474 -178.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.904 0 N-CA-C 110.572 -1.011 . . . . 63.05 110.572 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 39.3 m -85.62 96.65 9.74 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.1 0.476 . . . . 73.32 110.925 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -123.37 105.85 10.17 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.028 -1.101 . . . . 74.52 108.028 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -142.95 112.07 6.59 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.445 -0.798 . . . . 62.23 109.62 -173.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 9.0 t -139.79 -35.88 0.52 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.216 -0.447 . . . . 61.12 110.548 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 65.0 mttp 64.22 89.74 0.09 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.53 1.132 . . . . 53.55 113.613 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -109.52 143.42 39.2 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.77 -1.196 . . . . 72.41 107.77 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.53 87.44 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.973 0.892 . . . . 74.21 109.615 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 159.2 138.66 2.51 Favored Glycine 0 C--N 1.294 -1.802 0 N-CA-C 108.494 -1.842 . . . . 72.51 108.494 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.405 ' HE2' ' CD1' ' A' ' 460' ' ' LEU . 21.7 ptmt -136.43 159.21 42.47 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 117.505 0.652 . . . . 73.1 111.216 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 76.4 mtm180 -103.16 145.12 30.4 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.179 -0.675 . . . . 55.34 109.179 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.6 mm? -124.29 126.26 45.74 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.054 -0.521 . . . . 75.41 110.064 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -91.62 115.58 28.16 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.051 0.929 . . . . 54.34 108.623 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 85.2 mt -124.72 121.71 61.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-N 115.409 -0.814 . . . . 73.02 111.221 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 75.2 mt-30 -104.33 130.22 52.18 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 120.288 -0.565 . . . . 65.21 110.551 172.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.584 ' HB3' ' HB1' ' A' ' 498' ' ' ALA . 94.8 mt -122.72 138.0 54.75 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.85 -1.068 . . . . 72.23 109.655 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 465' ' ' LYS . 20.2 ptmt -104.14 128.14 51.78 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-O 122.344 1.069 . . . . 72.33 112.63 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -53.12 115.15 1.73 Allowed 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 112.945 -1.934 . . . . 75.13 113.343 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . 0.438 ' H ' ' HA2' ' A' ' 470' ' ' GLY . . . -98.5 -139.22 10.68 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.922 -1.271 . . . . 73.54 109.922 171.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 31.3 m -68.99 -49.35 58.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.607 0.717 . . . . 75.55 109.679 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.67 56.1 0.95 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.101 -1.815 . . . . 74.25 106.101 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.438 ' HA2' ' H ' ' A' ' 467' ' ' GLY . . . -41.61 -63.83 1.55 Allowed Glycine 0 CA--C 1.478 -2.23 0 CA-C-N 113.393 -1.731 . . . . 63.33 115.145 -171.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.454 HD13 HD12 ' A' ' 531' ' ' LEU . 49.6 mt -85.43 82.26 8.38 Favored 'General case' 0 C--N 1.272 -2.79 0 C-N-CA 116.273 -2.171 . . . . 73.13 111.257 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -95.84 40.33 2.65 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 113.063 -1.88 . . . . 65.2 111.862 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 31.6 p90 -137.21 142.19 42.09 Favored 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 108.176 -1.046 . . . . 74.14 108.176 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.0 m -132.12 152.66 51.12 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 116.172 -0.467 . . . . 65.01 110.125 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 10.6 pt -109.51 160.8 8.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.612 -0.722 . . . . 72.4 112.544 -173.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.488 HG21 ' HD3' ' A' ' 491' ' ' LYS . 12.9 t -147.26 159.09 44.06 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.24 -1.022 . . . . 73.03 108.24 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.416 ' HB3' HE21 ' A' ' 524' ' ' GLN . 64.2 p -138.02 131.17 30.29 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.041 -1.096 . . . . 75.11 108.041 173.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -118.37 -83.76 0.65 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.218 -0.593 . . . . 73.41 111.88 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -138.28 154.32 49.04 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.25 -0.58 . . . . 75.11 109.86 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.507 ' HB ' ' HD3' ' A' ' 487' ' ' PRO . 9.9 p -108.69 131.96 57.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 116.439 -0.346 . . . . 53.34 110.326 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.5 t -117.62 131.82 56.6 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.492 -1.299 . . . . 72.22 107.492 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 65.7 mt 66.8 90.61 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-O 121.702 0.763 . . . . 73.35 109.724 -175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 127.52 -145.2 15.71 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 115.558 -0.746 . . . . 72.22 111.382 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 170.62 104.07 0.17 Allowed Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 111.391 -0.684 . . . . 52.31 111.391 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 27.0 t 173.39 -18.55 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.171 0.588 . . . . 54.03 110.027 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 480' ' ' VAL . . . 71.12 115.52 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.837 0.855 . . . . 75.32 110.626 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 480' ' ' VAL . 9.2 Cg_endo -85.52 153.09 10.43 Favored 'Trans proline' 0 N--CA 1.438 -1.763 0 C-N-CA 122.167 1.911 . . . . 64.41 112.476 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.422 HG23 HE22 ' A' ' 524' ' ' GLN . 42.8 mm -97.96 125.04 51.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.936 -1.135 . . . . 63.54 107.936 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -118.61 150.17 40.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 122.344 -0.222 . . . . 74.01 111.054 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 43.3 t -80.9 119.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 106.539 -1.652 . . . . 62.33 106.539 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.488 ' HD3' HG21 ' A' ' 476' ' ' THR . 55.0 tptt -91.3 -53.79 4.2 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.973 -0.558 . . . . 61.42 111.489 -174.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . 0.574 HD22 HD12 ' A' ' 494' ' ' LEU . 6.1 t30 -133.12 144.68 50.1 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.914 -0.714 . . . . 74.44 111.131 -171.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.538 HG12 ' HB2' ' A' ' 507' ' ' ALA . 31.9 mm -121.57 103.88 14.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.007 -0.997 . . . . 71.52 108.688 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.574 HD12 HD22 ' A' ' 492' ' ' ASN . 6.7 mp -63.07 127.73 91.27 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.271 -0.877 . . . . 52.11 109.977 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.28 30.18 0.23 Allowed 'Trans proline' 0 N--CA 1.512 2.56 1 C-N-CA 125.373 4.049 . . . . 64.43 114.035 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.403 ' N ' HG21 ' A' ' 500' ' ' ILE . 13.3 ptp180 -159.7 -8.86 0.06 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 113.862 1.06 . . . . 72.43 113.862 -173.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 501' ' ' GLN . . . -91.62 -159.45 35.47 Favored Glycine 0 C--O 1.212 -1.229 0 C-N-CA 119.387 -1.387 . . . . 65.34 113.457 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 464' ' ' LEU . . . -63.43 -32.45 73.89 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 112.844 0.683 . . . . 73.12 112.844 -174.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.47 78.39 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 116.611 -0.268 . . . . 64.22 110.935 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.403 HG21 ' N ' ' A' ' 496' ' ' ARG . 5.9 tt -79.98 -30.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 123.637 0.775 . . . . 75.03 111.895 176.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.523 ' HB2' ' O ' ' A' ' 497' ' ' GLY . 0.0 OUTLIER -58.7 -45.34 89.75 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.758 0.823 . . . . 72.34 109.317 -177.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.448 ' HB2' ' CD2' ' A' ' 464' ' ' LEU . 23.8 m-20 -97.42 -21.14 17.33 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.441 -0.503 . . . . 65.4 109.68 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 68.67 35.39 80.42 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.487 -0.779 . . . . 73.24 113.97 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -108.31 -26.63 10.43 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.966 0.412 . . . . 70.2 111.962 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.403 ' CD1' HG11 ' A' ' 544' ' ' VAL . 49.8 tp -105.55 153.88 21.15 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.665 -0.414 . . . . 60.13 111.252 -174.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.34 170.27 17.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.84 -1.17 . . . . 74.22 107.84 177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.538 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -92.5 148.83 21.78 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 110.178 -0.304 . . . . 62.43 110.178 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 117.23 -34.99 4.33 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.951 -0.642 . . . . 65.21 111.886 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.5 153.66 43.18 Favored 'General case' 0 C--O 1.25 1.103 0 CA-C-O 121.32 0.581 . . . . 74.23 111.277 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 63.3 ttp180 -90.13 127.08 36.01 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.105 -1.072 . . . . 64.0 108.105 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.491 ' HG ' HD11 ' A' ' 519' ' ' LEU . 23.0 tp -80.74 131.88 35.48 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 107.624 -1.25 . . . . 75.03 107.624 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.0 mm -101.44 -44.96 11.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.177 0.513 . . . . 72.32 110.264 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.53 ' HG2' ' HB3' ' A' ' 543' ' ' LEU . 10.5 pt-20 -152.3 156.01 38.81 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.552 -0.907 . . . . 62.15 108.552 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.55 HG12 HD21 ' A' ' 519' ' ' LEU . 5.2 p -137.65 127.92 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.157 0 N-CA-C 108.515 -0.92 . . . . 71.31 108.515 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 65.91 9.23 5.94 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 126.136 1.774 . . . . 64.44 111.392 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.68 3.56 40.08 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.303 -0.475 . . . . 63.11 113.167 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.95 139.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 122.419 -0.46 . . . . 75.43 110.536 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.72 134.73 37.06 Favored 'General case' 0 CA--C 1.484 -1.591 0 C-N-CA 123.518 0.727 . . . . 51.2 109.584 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.55 HD21 HG12 ' A' ' 514' ' ' VAL . 42.3 mt -90.19 -45.62 8.98 Favored 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 123.654 0.597 . . . . 73.53 112.03 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.67 99.94 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 121.743 0.782 . . . . 71.15 110.05 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 137.93 -21.46 3.17 Favored Glycine 0 N--CA 1.42 -2.417 0 CA-C-N 114.411 -1.268 . . . . 71.33 110.723 -175.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.24 163.86 14.67 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.67 0.271 . . . . 65.34 111.068 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . 0.478 ' O ' HG23 ' A' ' 527' ' ' VAL . 34.1 m -92.58 164.19 13.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.01 -0.541 . . . . 63.01 111.09 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.537 ' O ' HG13 ' A' ' 528' ' ' VAL . 50.7 mm-40 -50.44 -47.76 56.66 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 113.55 0.944 . . . . 72.11 113.55 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.427 ' HA ' HG22 ' A' ' 528' ' ' VAL . 5.5 mp0 -59.87 -32.29 70.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.057 0.456 . . . . 75.35 111.454 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.24 -38.26 68.95 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.775 -0.648 . . . . 73.33 109.514 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 523' ' ' SER . 16.3 t -76.29 -37.46 31.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.953 -0.567 . . . . 75.11 110.333 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.65 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 12.3 m -65.64 -42.23 92.31 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 C-N-CA 120.722 -0.391 . . . . 53.14 110.601 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.8 p -68.78 -30.37 68.95 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.252 0.549 . . . . 55.43 111.067 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.33 -39.16 89.06 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.27 -0.877 . . . . 71.33 108.769 173.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.454 HD12 HD13 ' A' ' 471' ' ' LEU . 48.5 tp -69.91 -48.31 59.07 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.712 -0.677 . . . . 74.41 109.955 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.65 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -60.05 -27.68 67.15 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.117 0.567 . . . . 72.23 111.66 -177.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 33.8 t -69.82 -35.23 74.62 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 109.82 -0.437 . . . . 73.24 109.82 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 535' ' ' LYS . 31.1 m 69.19 -89.67 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.226 1.01 . . . . 70.53 110.546 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' A' ' 536' ' ' MET . 61.1 tttp 170.87 175.93 0.06 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.035 -2.209 . . . . 75.12 105.035 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . 0.417 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 27.5 ttt -72.09 -50.72 25.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 119.138 0.881 . . . . 65.04 112.81 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -35.81 39.65 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 118.472 -1.291 . . . . 74.04 108.746 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 115.96 25.14 3.69 Favored Glycine 0 N--CA 1.411 -3.023 0 CA-C-N 115.03 -0.986 . . . . 64.03 113.187 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 3.8 m -107.44 119.87 40.59 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 118.627 -1.229 . . . . 41.52 108.093 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 65.1 t -106.91 131.72 56.1 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 CA-C-N 115.588 -0.733 . . . . 72.41 110.6 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 24.7 m -94.19 113.77 25.76 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.717 -0.674 . . . . 62.4 109.558 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.465 HD13 HG23 ' A' ' 514' ' ' VAL . 2.5 mm? -106.92 139.59 41.09 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.384 -0.969 . . . . 71.13 108.384 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.53 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 44.9 tp -118.79 117.84 29.96 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 105.863 -1.903 . . . . 75.11 105.863 171.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 27.1 m -118.06 158.05 19.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.841 0 C-N-CA 120.24 -0.584 . . . . 73.22 110.898 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -111.89 116.26 30.33 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.402 -0.962 . . . . 74.24 108.402 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.52 118.42 25.03 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 107.074 -1.454 . . . . 72.32 107.074 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -130.81 141.59 50.35 Favored 'General case' 0 C--N 1.267 -2.996 0 CA-C-N 114.948 -1.024 . . . . 72.31 110.238 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -119.08 76.44 1.11 Allowed 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.297 -1.001 . . . . 71.24 108.297 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 C--N 1.309 -1.19 0 CA-C-N 114.568 -1.196 . . . . 74.53 109.198 -176.464 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.888 0 N-CA-C 110.466 -1.054 . . . . 71.32 110.466 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 40.8 m -95.95 -0.02 51.27 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 117.258 0.529 . . . . 54.53 111.915 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 65.84 148.56 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.783 1.233 . . . . 73.32 113.785 175.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -85.67 -64.98 1.06 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.731 -0.84 . . . . 71.34 108.731 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 44.9 p -105.57 135.52 46.83 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.96 -0.564 . . . . 62.04 109.611 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? 63.57 86.87 0.11 Allowed 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.356 1.062 . . . . 73.13 109.883 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -79.08 115.35 18.69 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.529 -0.76 . . . . 74.14 109.14 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 63.7 mt -86.64 93.39 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 CA-C-N 115.464 -0.789 . . . . 75.05 110.81 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 546' ' ' ARG . . . 101.47 148.7 21.87 Favored Glycine 0 N--CA 1.416 -2.643 0 C-N-CA 120.339 -0.934 . . . . 73.44 114.395 173.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 28.3 mtpp -129.78 148.57 51.67 Favored 'General case' 0 CA--C 1.471 -2.06 0 CA-C-N 114.771 -0.715 . . . . 72.33 109.568 174.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.5 mtm180 -110.97 128.82 55.96 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 115.673 -0.694 . . . . 71.41 109.213 171.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.435 HD11 ' HE3' ' A' ' 458' ' ' LYS . 2.0 mm? -118.83 129.85 55.45 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 115.021 -0.991 . . . . 74.21 109.317 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -96.55 122.32 39.34 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.119 -0.697 . . . . 73.42 109.119 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 58.8 mt -127.56 142.51 43.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 123.46 0.704 . . . . 74.51 109.942 -174.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 78.7 mt-30 -114.97 127.91 55.96 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.608 0.966 . . . . 62.42 113.608 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.537 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.1 mm? -116.61 134.54 54.71 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 124.588 1.155 . . . . 75.44 109.148 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 39.4 ttmt -108.88 135.71 49.63 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-O 121.513 0.673 . . . . 62.1 111.26 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.516 ' HA ' ' HA2' ' A' ' 470' ' ' GLY . 38.1 mtmt -73.08 100.57 3.06 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.063 -0.972 . . . . 62.4 110.866 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -108.03 -101.23 2.69 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.474 -0.87 . . . . 64.14 112.131 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . 0.545 HG23 ' H ' ' A' ' 469' ' ' GLU . 8.3 t -66.87 -69.8 0.29 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 112.16 0.43 . . . . 55.31 112.16 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.545 ' H ' HG23 ' A' ' 468' ' ' THR . 25.6 mm-40 -98.29 -18.41 18.38 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.599 0.714 . . . . 70.53 109.14 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 69.27 -149.98 49.45 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 114.651 -1.159 . . . . 74.2 112.98 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.458 HD11 HG21 ' A' ' 540' ' ' VAL . 38.4 mt -51.65 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.478 0.918 . . . . 74.32 113.478 -169.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -107.72 56.19 0.49 Allowed Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 114.582 -1.19 . . . . 42.31 111.688 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.37 142.59 29.5 Favored 'General case' 0 C--N 1.281 -2.371 0 C-N-CA 123.369 0.668 . . . . 75.53 110.064 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.9 m -119.59 162.41 18.98 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.396 -0.82 . . . . 62.22 109.807 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 20.6 pt -117.88 158.09 18.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.129 0.49 . . . . 71.32 111.67 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.8 t -148.7 160.09 43.5 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.23 -0.896 . . . . 75.52 108.655 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 31.6 t -141.11 150.1 42.42 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 107.216 -1.401 . . . . 65.41 107.216 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -95.32 -68.24 0.81 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.392 -0.966 . . . . 53.51 108.392 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 16.0 t70 170.31 151.22 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 105.152 -2.166 . . . . 74.14 105.152 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 486' ' ' ALA . 12.5 p -88.45 -16.09 8.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 120.029 -0.669 . . . . 53.52 110.905 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 32.5 m 53.09 70.17 0.62 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.819 1.248 . . . . 62.04 111.355 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 12.1 tt 172.68 -23.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 114.654 -1.157 . . . . 62.12 108.937 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 94.48 99.24 1.65 Allowed Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.076 -1.21 . . . . 54.23 110.076 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -172.0 -144.93 4.7 Favored Glycine 0 N--CA 1.425 -2.059 0 C-N-CA 119.949 -1.12 . . . . 64.01 113.033 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 15.7 m -76.38 -35.45 58.65 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 123.482 0.713 . . . . 52.43 112.306 -174.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.479 ' HA ' ' HB ' ' A' ' 480' ' ' VAL . . . 77.03 110.77 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 124.638 1.175 . . . . 63.33 111.283 -177.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.31 135.85 66.7 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 123.233 2.622 . . . . 73.12 112.914 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.667 HD12 HE21 ' A' ' 524' ' ' GLN . 24.8 mm -92.81 128.81 44.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.314 -0.857 . . . . 74.51 108.795 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -127.95 158.71 37.1 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 121.887 -0.508 . . . . 74.44 111.479 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.43 HG22 HD21 ' A' ' 511' ' ' LEU . 21.7 t -74.31 129.55 36.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.206 -1.035 . . . . 75.1 108.206 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -93.27 -61.3 1.59 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.544 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -141.09 148.83 40.78 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.776 -0.647 . . . . 75.41 110.183 -174.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.474 HG12 ' HB2' ' A' ' 507' ' ' ALA . 36.4 mm -118.57 104.32 15.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.411 -1.329 . . . . 64.31 107.411 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 8.3 mp -54.72 152.06 13.77 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.187 -0.915 . . . . 70.11 112.73 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.493 ' O ' HD13 ' A' ' 500' ' ' ILE . 23.0 Cg_endo -77.89 -3.12 13.21 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 124.339 3.359 . . . . 73.24 111.64 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -158.64 110.88 2.24 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 124.582 1.153 . . . . 72.05 109.636 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 160.89 -168.5 36.27 Favored Glycine 1 C--N 1.237 -4.925 0 CA-C-N 112.846 -1.979 . . . . 73.44 111.145 178.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.418 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -57.23 -47.14 82.09 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 124.464 1.106 . . . . 54.13 110.54 -174.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -56.88 -44.11 81.93 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.006 -0.997 . . . . 65.14 111.853 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.493 HD13 ' O ' ' A' ' 495' ' ' PRO . 16.5 tt -80.96 -37.63 16.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.083 0.771 . . . . 65.54 113.083 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.3 mm100 -64.74 -41.83 95.65 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 120.867 0.365 . . . . 73.43 110.771 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.537 ' HB2' HD13 ' A' ' 464' ' ' LEU . 23.7 m-20 -84.95 -32.07 23.26 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.777 -0.823 . . . . 42.42 108.777 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 61.4 45.72 95.84 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.839 0.712 . . . . 65.35 113.864 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -115.07 -28.07 7.11 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.044 0.45 . . . . 62.15 112.18 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 57.0 tp -106.22 146.55 30.15 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.15 -0.685 . . . . 63.04 109.15 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.437 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -138.81 162.05 35.72 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.914 -0.773 . . . . 64.13 108.914 176.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.474 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.52 120.69 26.24 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.012 0.434 . . . . 71.34 111.382 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . 0.41 ' H ' ' HB ' ' A' ' 490' ' ' VAL . . . 145.04 -12.28 1.87 Allowed Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.706 -0.679 . . . . 45.12 112.213 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -94.22 172.87 7.94 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 120.975 0.416 . . . . 72.24 112.026 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 544' ' ' VAL . 41.1 ttm180 -102.83 137.99 40.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.637 -0.71 . . . . 72.44 110.269 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.688 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -86.08 119.13 26.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.951 -0.568 . . . . 74.41 110.463 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 47.8 mm -98.65 -47.33 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.849 -0.16 . . . . 73.52 110.588 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.524 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 10.2 pt-20 -149.0 148.61 29.95 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.358 -0.608 . . . . 64.43 109.358 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.677 HG12 HD21 ' A' ' 519' ' ' LEU . 3.6 p -132.56 119.36 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.394 0 CA-C-O 121.975 0.893 . . . . 64.4 109.254 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.72 23.91 11.53 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 126.242 1.817 . . . . 75.31 111.959 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.28 -18.46 33.2 Favored Glycine 0 C--O 1.237 0.289 0 C-N-CA 120.491 -0.861 . . . . 74.45 113.953 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.7 t -96.85 134.49 34.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 109.772 -0.455 . . . . 64.34 109.772 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -84.35 143.1 29.7 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.656 -0.498 . . . . 63.13 109.656 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.688 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 18.4 mt -103.78 -39.67 6.56 Favored 'General case' 0 CA--C 1.482 -1.639 0 CA-C-N 115.432 -0.804 . . . . 73.41 112.257 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 35.4 t -74.61 90.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 121.811 0.815 . . . . 72.41 109.48 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 154.13 -28.61 0.72 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 108.289 -1.925 . . . . 70.22 108.289 -175.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.411 ' HB2' ' CD ' ' A' ' 526' ' ' GLU . 0.1 OUTLIER -105.3 178.78 4.46 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.016 -0.592 . . . . 71.53 109.916 175.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . 0.562 ' O ' HG23 ' A' ' 527' ' ' VAL . 60.7 p -95.84 164.33 12.78 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.501 0.556 . . . . 72.22 112.501 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.667 HE21 HD12 ' A' ' 488' ' ' ILE . 15.8 mm-40 -49.71 -43.23 47.41 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 124.705 1.202 . . . . 64.23 111.442 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.423 ' HA ' HG22 ' A' ' 528' ' ' VAL . 42.7 mt-10 -65.03 -35.74 82.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.408 0.623 . . . . 61.14 111.961 -174.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.411 ' CD ' ' HB2' ' A' ' 522' ' ' LYS . 43.9 mt-10 -69.74 -37.25 76.4 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.644 -0.707 . . . . 75.34 109.522 177.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 523' ' ' SER . 32.3 t -70.2 -41.46 78.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.528 -0.76 . . . . 64.4 109.556 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.687 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 12.5 m -64.57 -44.42 96.8 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 C-N-CA 120.021 -0.672 . . . . 63.44 110.054 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 49.1 m -57.87 -40.29 79.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.485 0.659 . . . . 52.34 110.232 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 50.7 tp -63.11 -47.25 83.62 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 124.545 1.138 . . . . 74.11 109.879 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.437 HD12 HD13 ' A' ' 471' ' ' LEU . 35.1 tp -65.2 -44.22 89.07 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.861 -0.609 . . . . 64.25 110.574 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.687 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -62.3 -33.51 74.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.155 0.582 . . . . 63.21 110.851 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.6 m -75.53 -41.01 56.16 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.032 -0.531 . . . . 62.44 110.882 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . 0.482 HG23 ' CG2' ' A' ' 540' ' ' VAL . 32.5 m 66.65 -92.91 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.266 0.627 . . . . 73.25 110.121 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt 170.48 171.86 0.07 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.19 -1.411 . . . . 74.11 107.19 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 26.1 ttt -65.63 -38.6 89.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 111.603 0.223 . . . . 75.23 111.603 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.58 -79.26 0.08 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.461 -0.336 . . . . 75.41 110.473 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 151.56 -21.47 0.93 Allowed Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 118.708 -1.71 . . . . 25.42 114.618 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.489 HG22 ' HB3' ' A' ' 463' ' ' GLN . 3.0 m -94.83 125.24 39.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 118.433 1.117 . . . . 74.14 110.251 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 47.1 t -106.81 140.63 24.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.028 -0.987 . . . . 72.42 110.162 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.5 t -99.14 114.69 27.58 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.165 0.507 . . . . 74.22 109.815 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.533 HD23 HD23 ' A' ' 464' ' ' LEU . 3.4 mm? -101.77 122.33 43.74 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 124.538 1.135 . . . . 65.35 109.08 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 36.2 tp -104.98 118.97 37.87 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.376 -1.712 . . . . 72.54 106.376 174.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 36.0 m -115.03 145.55 20.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-O 121.179 0.514 . . . . 72.35 110.957 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 88.8 t80 -112.27 116.06 29.79 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.276 -0.875 . . . . 74.22 110.042 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . 0.586 ' O ' ' HA2' ' A' ' 457' ' ' GLY . 0.0 OUTLIER -101.57 118.19 36.45 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.478 -1.304 . . . . 55.45 107.478 175.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -89.36 121.27 31.45 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.231 -0.441 . . . . 63.15 111.317 -172.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 69.7 -177.49 0.21 Allowed 'General case' 0 N--CA 1.473 0.725 0 O-C-N 124.544 1.153 . . . . 72.13 110.4 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 C--N 1.305 -1.358 0 CA-C-O 118.856 -0.592 . . . . 65.44 109.783 179.072 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.762 0 N-CA-C 110.817 -0.913 . . . . 63.01 110.817 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 31.9 t -146.37 162.66 37.7 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.631 -0.877 . . . . 61.11 108.631 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -64.52 -51.18 64.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.308 0.575 . . . . 74.34 109.718 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -122.11 112.55 18.35 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.106 -1.442 . . . . 73.55 107.106 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 34.2 p -93.04 -73.18 0.57 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 112.086 0.402 . . . . 70.34 112.086 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -127.86 107.62 10.01 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.032 0.444 . . . . 75.42 110.487 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -89.14 126.06 35.3 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.004 -0.544 . . . . 74.1 111.162 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 11.7 tt -102.44 -41.62 8.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 120.963 0.411 . . . . 41.22 110.413 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -175.99 138.34 4.1 Favored Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 108.366 -1.894 . . . . 74.45 108.366 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.405 ' HE2' HD13 ' A' ' 460' ' ' LEU . 22.0 ptmt -137.21 165.26 26.53 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 120.269 -0.573 . . . . 45.53 110.467 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -106.16 154.51 20.59 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.413 -1.328 . . . . 64.43 107.413 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.8 mm? -125.33 130.89 52.88 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 110.002 -0.37 . . . . 73.32 110.002 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -96.25 116.19 28.62 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.655 -0.868 . . . . 73.03 108.655 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . 0.505 HG23 ' CG ' ' A' ' 504' ' ' ARG . 68.6 mt -123.28 121.16 62.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 115.601 -0.727 . . . . 72.12 110.202 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.2 mt-30 -99.94 128.94 45.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.786 0.662 . . . . 74.44 112.786 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.586 HD23 HD23 ' A' ' 542' ' ' LEU . 4.3 mm? -115.08 132.82 56.48 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-N 115.361 -0.836 . . . . 63.24 109.841 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.445 ' HE2' ' HB2' ' A' ' 465' ' ' LYS . 25.3 ttmm -101.17 131.9 46.91 Favored 'General case' 0 N--CA 1.394 -3.265 0 CA-C-O 121.936 0.874 . . . . 61.01 110.886 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.12 103.28 0.21 Allowed 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 113.146 -1.843 . . . . 73.13 111.485 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -136.5 137.05 8.78 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.781 -0.928 . . . . 74.32 110.781 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 73.2 m 63.24 -86.72 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.143 0.977 . . . . 62.32 112.642 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.481 ' HB3' ' HA2' ' A' ' 497' ' ' GLY . 8.6 tp10 -97.74 -13.93 21.14 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.238 -1.023 . . . . 74.3 108.238 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 70.09 -155.82 53.24 Favored Glycine 0 C--O 1.202 -1.867 0 CA-C-O 117.946 -1.474 . . . . 71.03 109.707 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.501 HD23 HD12 ' A' ' 531' ' ' LEU . 6.3 mp -43.83 96.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.707 1.254 . . . . 72.02 113.706 -173.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -106.22 63.58 0.3 Allowed Glycine 0 N--CA 1.411 -3.007 0 CA-C-N 113.546 -1.661 . . . . 71.42 110.448 -174.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 27.7 p90 -156.66 142.0 17.44 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 107.265 -1.383 . . . . 71.43 107.265 175.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 12.1 p -115.79 163.61 15.59 Favored 'General case' 0 C--N 1.263 -3.165 0 O-C-N 123.617 0.573 . . . . 73.3 109.868 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 12.6 pt -114.35 154.75 15.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.368 0.604 . . . . 71.03 112.04 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.7 t -137.95 149.33 46.06 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.679 -0.86 . . . . 71.31 108.679 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.46 ' HB3' ' OE1' ' A' ' 524' ' ' GLN . 66.9 p -117.32 133.15 56.31 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.193 -0.669 . . . . 64.11 109.193 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -95.14 -74.26 0.56 Allowed 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.242 -0.983 . . . . 70.24 112.433 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -150.32 128.96 12.31 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.272 -0.422 . . . . 65.53 109.932 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . 7.7 p -71.76 88.39 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-O 122.263 1.03 . . . . 61.53 113.056 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.407 ' O ' HG22 ' A' ' 481' ' ' THR . 89.0 m -108.44 13.1 25.73 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 123.38 1.562 . . . . 72.24 108.624 174.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 45.8 pt -116.06 171.5 5.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 114.17 -1.377 . . . . 73.33 108.766 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -87.18 66.58 3.49 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.667 -0.777 . . . . 24.23 111.872 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -158.8 -154.59 7.26 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 110.304 -1.118 . . . . 70.31 110.304 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 42.7 m -79.16 -40.26 31.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 117.231 0.516 . . . . 53.42 110.164 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -179.94 160.54 0.86 Allowed Pre-proline 0 C--N 1.332 -0.163 0 N-CA-C 107.484 -1.302 . . . . 61.03 107.484 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.415 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 1.0 OUTLIER -86.27 135.85 4.63 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 122.362 2.041 . . . . 54.43 109.673 174.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.56 HG13 ' HB3' ' A' ' 519' ' ' LEU . 18.2 mm -91.09 124.46 43.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 115.921 -0.581 . . . . 62.41 109.976 -172.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.415 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 88.1 m-85 -125.61 163.0 23.72 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 109.975 -0.38 . . . . 64.32 109.975 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 40.2 t -89.16 119.83 36.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.851 -0.425 . . . . 51.41 109.851 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -70.81 -63.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.47 1.108 . . . . 74.31 110.358 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 64.0 t30 -151.45 160.19 43.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.931 -0.577 . . . . 74.13 109.911 -174.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 507' ' ' ALA . 44.7 mm -110.28 105.71 19.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.874 -1.158 . . . . 72.35 107.874 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -65.15 128.4 93.75 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.585 -0.734 . . . . 61.23 111.344 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.14 24.68 0.26 Allowed 'Trans proline' 0 N--CA 1.503 2.048 1 C-N-CA 125.334 4.023 . . . . 61.02 114.964 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -160.29 7.02 0.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 113.251 0.834 . . . . 65.23 113.251 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 469' ' ' GLU . . . -99.8 -155.21 28.15 Favored Glycine 0 C--N 1.297 -1.631 0 C-N-CA 119.266 -1.445 . . . . 74.23 113.685 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.519 ' O ' HD12 ' A' ' 464' ' ' LEU . . . -66.12 -37.66 86.26 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 123.37 0.668 . . . . 52.41 109.559 -176.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -57.72 -41.76 82.42 Favored 'General case' 0 C--O 1.195 -1.778 0 CA-C-N 115.126 -0.943 . . . . 64.31 112.053 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.3 tt -80.3 -29.36 12.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 120.943 0.401 . . . . 71.54 111.625 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.05 -48.37 80.32 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.228 1.011 . . . . 74.13 108.666 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.531 ' HB2' HD13 ' A' ' 464' ' ' LEU . 12.9 m-20 -93.68 -31.73 14.34 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 120.345 -0.542 . . . . 61.03 110.412 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.29 27.82 72.14 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.879 -0.6 . . . . 44.42 112.967 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.505 ' CG ' HG23 ' A' ' 462' ' ' ILE . 33.0 tpt180 -101.92 -19.35 15.3 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.75 0.31 . . . . 71.41 111.148 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.516 ' HB2' HD21 ' A' ' 464' ' ' LEU . 52.7 tp -106.87 151.19 25.56 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.817 -0.438 . . . . 72.51 109.817 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.479 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -144.21 159.88 41.91 Favored 'General case' 0 N--CA 1.434 -1.258 0 O-C-N 123.176 0.298 . . . . 72.32 110.594 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.541 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -91.4 167.95 11.9 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.323 0.389 . . . . 71.32 111.773 -174.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.87 13.18 65.04 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.446 -0.797 . . . . 54.0 112.153 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -120.01 178.27 4.68 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 107.645 -1.243 . . . . 73.51 107.645 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.01 133.54 47.96 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-N 117.993 0.361 . . . . 74.14 110.646 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 511' ' ' LEU . 21.4 tp -96.04 117.05 29.91 Favored 'General case' 0 N--CA 1.394 -3.251 0 N-CA-C 108.339 -0.986 . . . . 72.24 108.339 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.444 ' HB ' HD12 ' A' ' 543' ' ' LEU . 1.9 mp -99.02 -35.19 4.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.121 0.486 . . . . 73.04 110.211 -177.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 543' ' ' LEU . 31.2 tt0 -150.34 144.78 25.73 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.716 -0.674 . . . . 64.35 110.551 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.524 HG12 HD21 ' A' ' 519' ' ' LEU . 2.6 p -135.03 123.35 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 N-CA-C 108.328 -0.99 . . . . 63.02 108.328 175.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 70.62 -66.22 0.3 Allowed 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 127.576 2.35 . . . . 71.42 111.231 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -174.02 29.64 0.09 OUTLIER Glycine 0 C--N 1.308 -0.994 0 N-CA-C 111.467 -0.653 . . . . 64.42 111.467 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.6 t -122.18 139.1 50.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 110.155 -0.313 . . . . 74.25 110.155 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -83.18 130.53 35.1 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.575 -0.898 . . . . 45.34 108.575 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.56 ' HB3' HG13 ' A' ' 488' ' ' ILE . 47.5 mt -100.89 -36.0 9.21 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.986 -0.552 . . . . 74.1 112.117 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.48 89.53 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 121.855 0.836 . . . . 60.23 110.205 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 147.95 -32.8 1.29 Allowed Glycine 0 N--CA 1.427 -1.94 0 CA-C-N 114.369 -1.287 . . . . 53.5 110.178 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.6 -177.63 4.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.407 0.521 . . . . 75.24 112.407 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 527' ' ' VAL . 5.0 m -95.24 156.11 16.46 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.909 -0.587 . . . . 75.32 111.244 -175.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.46 ' OE1' ' HB3' ' A' ' 477' ' ' SER . 8.1 mm100 -56.16 -46.36 79.34 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.808 0.843 . . . . 53.14 111.239 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.43 ' HA ' HG22 ' A' ' 528' ' ' VAL . 1.1 mp0 -57.85 -31.86 67.09 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.127 0.489 . . . . 71.13 111.951 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -69.64 -37.24 76.69 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.967 -0.56 . . . . 52.02 110.037 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 523' ' ' SER . 17.6 t -75.93 -36.03 31.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.325 -0.852 . . . . 70.41 109.653 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.671 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.3 m -64.98 -40.61 89.65 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.267 0 C-N-CA 120.052 -0.659 . . . . 72.12 111.07 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.9 t -59.46 -44.98 92.86 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.652 0.739 . . . . 44.13 109.277 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 31.8 tp -60.4 -38.72 84.86 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 125.229 1.412 . . . . 72.43 110.398 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.501 HD12 HD23 ' A' ' 471' ' ' LEU . 16.6 tp -70.17 -48.63 56.43 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.484 -0.78 . . . . 63.42 109.959 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.8 OUTLIER -60.27 -44.56 95.21 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.767 0.827 . . . . 74.14 111.382 -176.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 33.7 t -69.23 -31.92 70.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.16 -0.473 . . . . 70.01 111.037 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 84.9 m 66.3 -87.03 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.926 0.49 . . . . 54.2 111.552 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? 165.58 158.26 0.03 OUTLIER 'General case' 0 C--O 1.244 0.774 0 N-CA-C 105.89 -1.893 . . . . 44.52 105.89 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 65.9 mtt -58.84 -50.3 74.49 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.206 0.316 . . . . 73.15 111.416 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -62.49 -65.49 0.68 Allowed 'General case' 0 C--O 1.24 0.576 0 N-CA-C 110.049 -0.352 . . . . 74.13 110.049 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 135.28 -14.3 4.28 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 118.353 -1.88 . . . . 64.4 116.072 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.4 m -94.38 128.11 40.7 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 118.904 1.352 . . . . 63.45 108.534 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 66.7 t -114.79 137.32 48.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 CA-C-N 115.816 -0.629 . . . . 71.54 110.393 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 54.8 m -91.88 113.94 26.35 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.187 0.518 . . . . 72.53 110.467 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.586 HD23 HD23 ' A' ' 464' ' ' LEU . 3.3 mm? -102.36 119.34 38.65 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.556 -0.905 . . . . 65.35 108.556 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 3.1 tm? -110.68 117.06 32.45 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 107.907 -1.146 . . . . 72.52 107.907 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 33.1 m -119.98 162.64 18.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 114.768 -1.105 . . . . 62.4 110.325 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -116.96 114.8 24.32 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 109.495 -0.557 . . . . 73.13 109.495 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -102.24 118.6 37.24 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 120.013 -0.675 . . . . 75.4 111.817 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -79.71 137.49 37.06 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.902 -1.518 . . . . 64.31 106.902 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -91.92 138.88 31.18 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 120.248 -0.581 . . . . 72.43 109.84 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 C--N 1.312 -1.035 0 CA-C-O 118.533 -0.746 . . . . 72.44 110.718 -178.94 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.807 0 N-CA-C 110.973 -0.851 . . . . 72.22 110.973 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 67.4 m -145.12 91.8 2.18 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.352 0.596 . . . . 71.32 111.048 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -107.12 128.01 54.0 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 115.558 -0.746 . . . . 75.31 109.375 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -114.24 91.27 3.57 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.317 -0.623 . . . . 53.42 109.317 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 50.0 m -121.37 114.03 20.73 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.399 -0.963 . . . . 73.42 108.399 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -68.39 105.77 2.28 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.358 0.599 . . . . 73.15 109.673 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -99.13 114.41 27.14 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 109.211 -0.663 . . . . 54.45 109.211 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . 0.461 ' H ' HD13 ' A' ' 456' ' ' ILE . 0.2 OUTLIER -139.14 1.37 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.828 -1.545 . . . . 75.42 106.828 174.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 147.11 174.23 18.99 Favored Glycine 1 N--CA 1.386 -4.68 0 N-CA-C 106.796 -2.522 . . . . 71.21 106.796 -173.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 458' ' ' LYS . 43.9 mtpt -130.78 163.39 27.45 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-O 121.791 0.805 . . . . 70.03 112.874 178.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 98.3 mtt180 -107.89 131.66 54.28 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-N 113.427 -1.715 . . . . 75.51 106.505 170.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -120.98 133.27 55.27 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 109.486 -0.561 . . . . 63.54 109.486 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -93.09 115.2 27.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.492 0.663 . . . . 73.14 109.278 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . 0.458 HG23 ' HD3' ' A' ' 504' ' ' ARG . 59.7 mt -121.72 122.67 67.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.655 -0.702 . . . . 70.0 109.977 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 27.9 mt-30 -102.42 129.22 48.85 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.99 0.424 . . . . 74.43 111.901 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.463 HD23 HD23 ' A' ' 542' ' ' LEU . 3.1 mm? -115.09 135.52 54.11 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.542 0.737 . . . . 43.11 109.879 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.764 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.1 OUTLIER -98.89 137.07 37.99 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.993 -1.114 . . . . 55.31 107.993 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.443 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 36.9 ttmt -59.73 106.1 0.44 Allowed 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.377 -0.829 . . . . 71.31 110.655 174.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -92.67 -138.71 8.69 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.846 -0.901 . . . . 43.31 110.846 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 10.2 t -65.87 -46.55 78.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.859 0.329 . . . . 42.44 110.454 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -121.53 83.42 2.08 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 107.043 -1.466 . . . . 75.41 107.043 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.443 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . -58.63 140.87 46.94 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 120.356 -0.926 . . . . 74.42 113.594 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.564 HD11 HG21 ' A' ' 540' ' ' VAL . 18.2 mt 57.37 89.1 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 125.434 1.494 . . . . 65.22 112.166 -174.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -103.45 56.76 0.58 Allowed Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 114.72 -1.127 . . . . 50.23 111.213 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.605 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 6.4 p90 -144.75 144.78 31.36 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.024 -0.732 . . . . 74.53 109.024 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.2 m -120.88 149.63 42.31 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.97 -1.122 . . . . 52.34 107.97 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 15.4 pt -109.85 155.27 11.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 112.895 0.702 . . . . 73.51 112.895 -175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 7.5 t -129.16 159.83 34.78 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.063 -1.088 . . . . 72.43 108.063 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 33.9 p -131.09 136.68 48.62 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 109.077 -0.712 . . . . 55.31 109.077 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.427 ' HG2' ' CD2' ' A' ' 489' ' ' TYR . 34.5 mmt180 -91.8 -2.91 56.7 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.659 -0.416 . . . . 72.45 110.307 -177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 21.2 t70 70.44 148.9 0.08 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.592 1.157 . . . . 62.41 110.509 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 10.8 p -86.56 4.06 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.745 0.784 . . . . 75.33 110.499 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . 0.267 73.8 p 63.4 85.64 0.13 Allowed 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 125.457 1.503 . . . . 33.34 112.026 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 65.1 mt 71.28 86.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 114.243 -1.344 . . . . 71.02 109.687 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 161.61 -156.36 27.83 Favored Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 114.77 -1.105 . . . . 64.1 110.434 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -136.49 -177.45 15.02 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.643 -0.789 . . . . 60.44 112.281 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 45.0 m 74.79 -61.06 0.5 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.13 1.372 . . . . 75.34 111.989 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 69.36 147.12 0.11 Allowed Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 124.367 1.067 . . . . 75.41 113.399 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.7 135.33 23.62 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 121.911 1.741 . . . . 60.21 110.027 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.43 ' HB ' HD13 ' A' ' 519' ' ' LEU . 48.3 mm -102.62 136.16 36.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.983 -0.553 . . . . 72.41 110.298 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.427 ' CD2' ' HG2' ' A' ' 478' ' ' ARG . 95.6 m-85 -134.82 162.48 32.25 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.326 -0.62 . . . . 75.53 109.326 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 23.2 t -82.23 122.89 37.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 109.141 -0.689 . . . . 61.25 109.141 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -89.87 -55.27 3.69 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.817 -0.628 . . . . 75.2 110.674 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -146.48 151.02 36.72 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.191 -0.67 . . . . 64.12 109.191 -175.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.634 HG12 ' HB2' ' A' ' 507' ' ' ALA . 35.3 mm -111.2 110.98 34.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.002 -1.11 . . . . 50.3 108.002 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.24 123.52 78.65 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 115.775 -0.648 . . . . 64.45 109.298 176.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.02 22.19 0.15 Allowed 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 124.945 3.763 . . . . 75.33 114.836 -171.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -160.07 -2.98 0.07 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.819 0.674 . . . . 75.11 112.819 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.602 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -84.55 -167.97 43.61 Favored Glycine 0 C--O 1.216 -0.971 0 C-N-CA 119.788 -1.196 . . . . 44.41 112.515 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.461 ' CB ' ' H ' ' A' ' 471' ' ' LEU . . . -57.11 -34.77 68.69 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.014 0.907 . . . . 53.13 111.759 -175.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.79 86.14 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.61 -0.723 . . . . 74.04 112.261 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 8.8 tt -79.03 -31.3 14.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 O-C-N 123.233 0.333 . . . . 63.4 111.388 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 71.1 mm-40 -62.39 -43.28 99.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.763 -0.458 . . . . 73.14 109.763 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.406 ' HB2' HD13 ' A' ' 464' ' ' LEU . 11.0 t70 -82.77 -41.64 18.93 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.865 -1.531 . . . . 64.2 106.865 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.56 -7.52 76.1 Favored Glycine 0 N--CA 1.426 -1.973 0 CA-C-N 115.372 -0.831 . . . . 75.23 115.118 174.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.458 ' HD3' HG23 ' A' ' 462' ' ' ILE . 73.4 ttt180 -85.83 -19.16 31.06 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 120.974 0.416 . . . . 63.02 111.727 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 62.1 tp -101.19 130.48 47.29 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.091 -0.337 . . . . 73.32 110.091 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.527 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -134.83 171.77 13.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.657 0.265 . . . . 74.02 111.448 176.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.634 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -96.82 130.8 44.03 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.35 -0.386 . . . . 73.33 111.107 -176.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 144.13 -23.27 2.08 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.659 -0.701 . . . . 61.44 111.465 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -93.29 172.23 8.42 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-O 120.942 0.401 . . . . 74.33 111.099 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -93.75 138.75 31.61 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.679 -0.692 . . . . 74.34 110.308 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.525 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -89.77 127.96 36.05 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 105.892 -1.892 . . . . 73.15 105.892 177.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.0 mm -96.16 -50.78 11.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.861 -0.524 . . . . 74.32 109.97 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -157.54 145.76 19.14 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.694 -0.685 . . . . 75.44 109.267 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.433 HG23 HD13 ' A' ' 542' ' ' LEU . 4.8 p -126.04 130.37 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.308 0 CA-C-O 121.359 0.599 . . . . 74.45 109.69 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 62.05 20.08 11.32 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 126.208 1.803 . . . . 71.44 111.389 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 95.47 2.09 61.94 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.78 -0.724 . . . . 63.31 113.473 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.99 138.21 38.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.639 -0.504 . . . . 74.24 109.639 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -84.35 148.22 26.75 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 123.571 0.544 . . . . 75.02 110.036 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.525 HD11 HD12 ' A' ' 511' ' ' LEU . 28.1 mt -90.48 -50.98 5.64 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.773 -0.649 . . . . 55.51 112.003 -173.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.12 86.32 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 122.623 1.202 . . . . 75.51 111.305 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 166.2 -24.34 0.14 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 108.278 -1.929 . . . . 44.14 108.278 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.58 172.49 7.31 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.793 -0.817 . . . . 74.31 108.793 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 42.4 m -91.88 165.15 13.39 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 110.256 -0.275 . . . . 72.42 110.256 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -53.96 -44.97 71.18 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.572 0.749 . . . . 73.0 111.847 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.609 ' HA ' HG22 ' A' ' 528' ' ' VAL . 39.4 mt-10 -61.58 -31.55 71.61 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 112.463 0.542 . . . . 75.53 112.463 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.75 -34.01 69.15 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.291 -0.633 . . . . 54.31 109.291 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 47.6 t -70.45 -38.22 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.559 -0.746 . . . . 75.42 109.372 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.715 ' O ' ' HG3' ' A' ' 532' ' ' ARG . 19.9 m -69.57 -36.64 71.9 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.893 0 C-N-CA 119.099 -1.04 . . . . 73.42 110.676 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.8 t -59.28 -44.11 92.49 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 109.226 -0.657 . . . . 53.34 109.226 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 34.4 tp -58.82 -41.9 87.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.843 1.257 . . . . 75.22 109.594 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 471' ' ' LEU . 3.2 tt -64.98 -48.05 75.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.323 -0.853 . . . . 63.53 111.944 174.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.715 ' HG3' ' O ' ' A' ' 528' ' ' VAL . 23.0 mtm180 -61.41 -31.11 71.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.49 -0.323 . . . . 62.5 110.837 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.5 t -65.56 -44.43 86.79 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.253 -0.431 . . . . 53.41 110.006 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 24.6 m 63.85 -2.88 0.49 Allowed 'General case' 0 CA--C 1.578 2.026 0 C-N-CA 123.797 0.839 . . . . 62.41 112.812 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.586 ' HE3' ' OE1' ' A' ' 537' ' ' GLU . 61.6 tttp 70.13 146.4 0.06 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.215 1.006 . . . . 62.23 111.912 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 46.7 ttm -63.3 -32.37 73.77 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 116.569 2.062 . . . . 51.2 116.569 -167.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . 0.586 ' OE1' ' HE3' ' A' ' 535' ' ' LYS . 0.0 OUTLIER -78.24 -28.24 47.76 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 118.021 -1.472 . . . . 63.2 108.782 178.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 99.86 30.98 6.18 Favored Glycine 0 N--CA 1.415 -2.733 0 CA-C-N 114.771 -1.104 . . . . 54.02 113.613 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 4.0 m -128.58 132.22 48.2 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.034 -1.099 . . . . 45.14 108.034 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.564 HG21 HD11 ' A' ' 471' ' ' LEU . 61.5 t -120.07 134.34 63.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 116.178 -0.465 . . . . 61.14 111.239 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.7 m -91.76 114.4 26.93 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.199 -0.91 . . . . 71.12 110.047 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.605 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.2 mm? -104.04 121.24 42.77 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.744 -1.206 . . . . 71.32 107.744 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 41.8 tp -104.51 117.92 35.32 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.252 -1.759 . . . . 52.31 106.252 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 35.3 m -115.31 148.47 18.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 C-N-CA 120.503 -0.479 . . . . 54.23 110.827 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -111.97 122.32 47.44 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.829 -0.623 . . . . 74.22 109.655 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -122.13 124.76 44.65 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 114.59 -1.186 . . . . 63.31 109.436 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -79.21 133.71 36.69 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.594 -0.73 . . . . 75.32 109.596 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -134.34 127.67 32.16 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.177 -0.465 . . . . 72.31 109.875 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 C--N 1.304 -1.408 0 N-CA-C 108.891 -0.781 . . . . 52.35 108.891 179.733 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.935 0 N-CA-C 110.833 -0.907 . . . . 60.34 110.833 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 47.5 m -127.78 124.03 36.68 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.513 -0.551 . . . . 61.02 109.513 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -76.06 -31.17 58.67 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.106 -1.072 . . . . 70.41 108.106 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -109.78 100.94 9.86 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.414 -1.266 . . . . 71.31 108.409 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 27.9 m -97.09 114.62 26.3 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.527 -0.916 . . . . 71.35 108.527 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -131.74 88.27 2.55 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 113.956 1.095 . . . . 64.34 113.956 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -123.1 157.86 31.92 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 104.254 -2.498 . . . . 64.31 104.254 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 548' ' ' GLU . 26.3 pt -84.13 74.93 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 118.031 -1.468 . . . . 64.03 110.343 175.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 143.05 139.27 3.54 Favored Glycine 0 N--CA 1.419 -2.491 0 CA-C-N 113.726 -1.579 . . . . 51.32 109.693 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -122.82 160.63 25.63 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.28 -1.007 . . . . 65.44 108.28 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 43.8 mtm180 -100.67 145.57 28.27 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 110.005 -0.368 . . . . 73.41 110.005 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.0 mm? -124.12 131.91 53.59 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.124 -0.695 . . . . 72.43 109.124 -174.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -104.89 115.27 30.0 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.655 0.74 . . . . 70.11 109.093 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 50.0 mt -122.51 142.6 38.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 115.318 -0.855 . . . . 73.15 110.506 -171.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 43.5 mt-30 -114.99 128.24 56.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.901 0.381 . . . . 74.2 111.279 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 539' ' ' THR . 6.3 mp -119.04 152.47 36.38 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.108 0.963 . . . . 71.45 111.885 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -115.81 129.04 56.28 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.323 -0.992 . . . . 75.11 108.323 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.633 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 23.8 ttmm -60.81 88.01 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.419 0.628 . . . . 72.23 112.044 176.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -90.45 -128.47 3.81 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.63 -0.714 . . . . 73.3 112.277 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . 0.723 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 17.1 m -48.99 -72.73 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.322 1.049 . . . . 64.22 111.507 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.601 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 46.1 mm-40 -82.36 -38.54 24.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.245 -1.391 . . . . 72.14 107.245 171.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.633 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . 65.78 109.09 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.179 -1.373 . . . . 70.31 112.096 -174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.664 ' H ' ' CB ' ' A' ' 498' ' ' ALA . 33.9 mt 69.16 85.51 0.14 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 125.64 1.576 . . . . 71.3 108.076 -168.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . -103.18 56.76 0.59 Allowed Glycine 0 CA--C 1.471 -2.698 0 CA-C-N 114.393 -1.276 . . . . 45.3 112.151 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 2.9 p90 -147.72 142.94 27.21 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.01 0.433 . . . . 73.11 110.253 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 19.9 m -114.69 145.2 42.32 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 107.237 -1.394 . . . . 72.33 107.237 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.86 153.94 14.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 112.812 0.671 . . . . 52.21 112.812 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.655 ' HB ' ' HE3' ' A' ' 491' ' ' LYS . 8.2 t -143.33 149.43 37.76 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.119 -0.946 . . . . 43.33 109.563 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 21.4 p -106.31 132.07 52.79 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 108.092 -1.077 . . . . 72.22 108.092 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -122.53 -176.02 3.28 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 121.015 0.436 . . . . 64.43 111.764 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -46.47 109.14 0.17 Allowed 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 125.999 1.719 . . . . 43.03 112.359 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 486' ' ' ALA . 34.7 m -50.59 138.34 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.555 -1.202 . . . . 60.23 112.723 177.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.9 t -121.41 16.05 11.31 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.388 -1.708 . . . . 65.1 106.388 174.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.438 ' O ' ' HB ' ' A' ' 480' ' ' VAL . 10.4 tt -150.77 155.68 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 N-CA-C 105.95 -1.87 . . . . 73.24 105.95 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -67.87 109.6 2.99 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.634 -0.793 . . . . 44.4 111.24 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 78.53 -151.23 35.87 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 110.657 -0.977 . . . . 74.33 110.657 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 42.6 t 72.0 -61.02 0.51 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.099 0.96 . . . . 73.43 112.386 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 480' ' ' VAL . . . 59.73 90.74 0.09 OUTLIER Pre-proline 0 C--O 1.243 0.727 0 N-CA-C 108.663 -0.866 . . . . 30.42 108.663 -172.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.51 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 43.5 Cg_exo -54.93 135.4 68.18 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.942 2.428 . . . . 74.33 113.285 -174.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.494 HG13 ' HB3' ' A' ' 519' ' ' LEU . 38.9 mm -87.98 120.82 37.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.963 -1.017 . . . . 71.12 108.883 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 66.3 m-85 -120.51 150.47 40.79 Favored 'General case' 0 CA--C 1.483 -1.613 0 CA-C-O 120.804 0.335 . . . . 74.01 111.897 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.43 119.42 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 107.185 -1.413 . . . . 70.52 107.185 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.655 ' HE3' ' HB ' ' A' ' 476' ' ' THR . 41.0 ttmt -87.87 -53.82 4.56 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.312 0.577 . . . . 61.42 111.078 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 61.5 t30 -142.04 149.68 40.27 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.287 -0.87 . . . . 71.0 110.446 -171.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 507' ' ' ALA . 32.2 mm -115.87 106.54 20.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 124.149 0.906 . . . . 74.13 109.26 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -53.09 131.11 50.47 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.551 -0.749 . . . . 74.55 111.069 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -70.01 15.15 0.25 Allowed 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 124.557 3.505 . . . . 74.31 114.095 -173.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.723 ' O ' ' HB ' ' A' ' 468' ' ' THR . 12.1 ptt180 -164.35 12.68 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.109 0.957 . . . . 74.41 111.097 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.601 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . -84.83 -174.84 50.52 Favored Glycine 0 C--N 1.286 -2.209 0 C-N-CA 120.013 -1.089 . . . . 60.23 111.565 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.664 ' CB ' ' H ' ' A' ' 471' ' ' LEU . . . -62.21 -28.12 69.46 Favored 'General case' 0 C--O 1.198 -1.633 0 CA-C-N 117.999 0.9 . . . . 72.34 110.934 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.424 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -58.93 -41.62 87.81 Favored 'General case' 0 C--O 1.204 -1.302 0 CA-C-N 116.069 -0.514 . . . . 53.03 111.697 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.4 tt -79.84 -36.99 17.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.877 0.37 . . . . 73.14 111.546 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 9.1 mm-40 -66.85 -39.94 87.76 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.69 -0.686 . . . . 62.11 110.219 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.471 ' HB2' ' HG ' ' A' ' 464' ' ' LEU . 10.8 m-20 -92.45 -22.66 19.49 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.594 -0.73 . . . . 71.33 111.455 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.87 -57.36 5.01 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 116.647 1.419 . . . . 43.44 116.647 171.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -46.13 -30.8 2.06 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.519 1.674 . . . . 73.51 115.519 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 59.4 tp -98.02 132.05 43.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 117.824 0.284 . . . . 71.22 111.173 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.454 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -143.91 164.89 29.26 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 121.046 -0.261 . . . . 72.24 110.963 174.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.524 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.7 98.8 9.85 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.266 0.555 . . . . 71.35 111.963 -174.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 174.1 29.38 0.03 OUTLIER Glycine 0 C--N 1.304 -1.228 0 N-CA-C 111.107 -0.797 . . . . 51.24 111.107 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -148.18 177.79 9.1 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 120.748 0.309 . . . . 74.42 110.979 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -106.82 129.25 54.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.527 -0.76 . . . . 72.41 109.43 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' A' ' 519' ' ' LEU . 28.2 tp -83.46 120.77 26.32 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 107.957 -1.127 . . . . 74.21 107.957 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 543' ' ' LEU . 49.1 mm -97.93 -45.84 12.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 120.911 0.386 . . . . 71.22 111.129 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.491 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 10.2 pt-20 -154.02 146.02 23.6 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.123 -0.49 . . . . 72.33 110.145 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.458 HG13 HD21 ' A' ' 530' ' ' LEU . 2.6 p -130.65 129.13 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.458 0 N-CA-C 107.401 -1.333 . . . . 71.02 107.401 176.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 10.6 m120 68.01 4.8 4.22 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.82 0.848 . . . . 74.33 112.667 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 104.56 -6.96 45.68 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 121.065 -0.588 . . . . 53.55 112.075 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.3 t -87.14 125.75 40.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.776 -0.453 . . . . 35.42 109.776 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -79.75 134.25 36.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.982 -0.554 . . . . 73.15 110.512 -176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.494 ' HB3' HG13 ' A' ' 488' ' ' ILE . 17.3 mt -98.63 -22.87 15.71 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.864 -0.607 . . . . 44.54 110.658 -174.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.31 9.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 125.413 1.485 . . . . 63.42 113.84 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -144.05 18.45 2.14 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 110.875 -0.89 . . . . 44.54 110.875 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 174.6 10.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.466 0.543 . . . . 72.31 112.466 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 527' ' ' VAL . 32.4 m -93.34 159.8 15.1 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.757 -0.656 . . . . 75.34 112.731 -175.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.507 ' O ' HG13 ' A' ' 528' ' ' VAL . 36.9 mm-40 -50.19 -47.68 54.47 Favored 'General case' 0 C--O 1.209 -1.046 0 C-N-CA 124.472 1.109 . . . . 73.11 113.626 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' A' ' 525' ' ' GLU . 4.1 mp0 -59.1 -34.28 71.82 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.235 0.54 . . . . 75.22 111.185 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.85 -39.2 83.82 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.673 -0.694 . . . . 65.42 109.73 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 523' ' ' SER . 15.2 t -75.48 -36.78 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 115.571 -0.74 . . . . 74.44 109.762 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.664 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 7.5 m -66.11 -42.55 91.58 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.049 0 C-N-CA 120.214 -0.595 . . . . 50.21 110.127 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 29.7 m -59.57 -44.05 93.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.454 0.645 . . . . 74.12 109.84 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.458 HD21 HG13 ' A' ' 514' ' ' VAL . 25.2 tp -58.32 -46.55 85.94 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 124.916 1.287 . . . . 74.2 109.658 176.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.569 HD12 HD13 ' A' ' 471' ' ' LEU . 30.2 tp -62.9 -48.39 79.16 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.522 -0.763 . . . . 64.31 110.533 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 29.7 mmm180 -60.97 -38.27 85.33 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.87 -0.604 . . . . 61.14 110.908 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 22.4 m -70.94 -40.49 72.0 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 115.986 -0.552 . . . . 73.01 110.226 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . 0.514 HG21 ' HE2' ' A' ' 466' ' ' LYS . 61.9 m 69.72 -84.47 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.882 0.873 . . . . 70.12 111.577 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt 174.45 167.96 0.24 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.948 -1.501 . . . . 71.33 106.948 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 88.2 mtp -59.49 -51.22 70.8 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.398 0.888 . . . . 64.32 113.398 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.81 -64.65 1.13 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.503 -0.879 . . . . 55.13 109.307 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 150.19 18.07 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 118.721 -1.704 . . . . 43.54 115.691 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.1 m -100.22 130.36 46.34 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 119.036 1.418 . . . . 63.53 108.373 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 51.9 t -124.0 135.52 63.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 112.154 0.427 . . . . 63.12 112.154 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 42.9 m -94.18 115.24 27.5 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.073 -0.967 . . . . 74.32 110.289 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.57 121.21 44.18 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.091 -1.078 . . . . 72.32 108.091 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 2.8 tm? -110.0 116.48 31.66 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 105.854 -1.906 . . . . 73.42 105.854 174.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.8 m -118.25 157.79 19.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 115.057 -0.974 . . . . 71.12 111.206 -174.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -123.6 116.36 22.99 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.915 -0.584 . . . . 62.1 109.988 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -109.23 125.65 52.47 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.332 -0.988 . . . . 71.02 108.332 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -85.39 128.71 34.81 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.255 0.55 . . . . 70.13 110.374 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . 0.422 ' O ' ' HB ' ' A' ' 456' ' ' ILE . 46.1 mt-10 -100.78 88.61 3.62 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.765 -0.828 . . . . 62.04 108.765 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--N 1.303 -1.445 0 CA-C-N 115.1 -0.955 . . . . 63.53 108.733 -175.628 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.754 0 N-CA-C 111.261 -0.736 . . . . 34.14 111.261 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 23.6 p -105.85 -68.66 0.86 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.155 0.502 . . . . 65.32 110.189 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -130.49 84.02 2.17 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.662 0.744 . . . . 73.33 110.423 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -88.87 -55.49 3.67 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.174 -1.375 . . . . 72.03 111.44 -175.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 38.8 p -94.47 117.34 29.97 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 112.66 0.615 . . . . 73.41 112.66 -174.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 454' ' ' LYS . 3.9 mptp? -95.34 99.65 11.55 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.856 -0.794 . . . . 73.04 108.856 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -85.73 168.4 14.39 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.912 -0.403 . . . . 63.12 109.912 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 57.9 mt -74.64 98.88 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 108.343 -0.984 . . . . 62.21 108.343 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 143.1 116.13 1.13 Allowed Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 108.68 -1.768 . . . . 65.23 108.68 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 29.1 mtpp -89.17 156.81 18.56 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.3 0.571 . . . . 73.13 111.963 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 94.3 mtt180 -118.6 126.09 51.21 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.069 -1.826 . . . . 75.25 106.069 170.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.9 mp -124.74 136.76 54.15 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 116.468 -0.333 . . . . 71.13 110.934 -175.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -99.6 115.14 28.7 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 123.988 0.805 . . . . 64.12 108.956 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 55.4 mt -121.85 142.69 37.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.685 -0.857 . . . . 53.55 108.685 -176.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.47 ' HB3' HG22 ' A' ' 539' ' ' THR . 76.5 mt-30 -117.3 127.06 53.7 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.424 0.527 . . . . 64.52 112.424 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.454 HD23 HD23 ' A' ' 542' ' ' LEU . 3.9 mm? -115.57 133.19 56.27 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 124.46 1.104 . . . . 73.44 109.586 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 37.4 ttpt -108.15 136.35 47.97 Favored 'General case' 0 N--CA 1.401 -2.897 0 N-CA-C 108.815 -0.809 . . . . 62.45 108.815 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.451 ' HA ' ' HA2' ' A' ' 470' ' ' GLY . 48.8 mtmt -54.7 99.3 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 124.066 0.854 . . . . 71.41 111.506 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -131.19 136.82 9.04 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.696 -0.962 . . . . 51.43 110.696 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 64.5 m 63.1 -88.13 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.235 1.014 . . . . 73.05 111.446 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.428 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 31.0 mm-40 -98.01 -5.73 33.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.556 0.693 . . . . 64.15 109.364 177.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 69.17 -154.61 53.32 Favored Glycine 0 CA--C 1.486 -1.767 0 CA-C-O 118.109 -1.384 . . . . 73.42 110.842 -177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 540' ' ' VAL . 48.1 mt -43.76 101.52 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.425 1.112 . . . . 60.42 112.348 -173.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -111.98 56.26 0.47 Allowed Glycine 0 CA--C 1.477 -2.282 0 CA-C-N 114.739 -1.119 . . . . 62.24 112.329 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.597 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 5.3 p90 -144.45 142.12 30.07 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.055 -1.091 . . . . 75.03 108.055 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 28.9 p -116.57 162.36 17.74 Favored 'General case' 0 C--N 1.272 -2.797 0 N-CA-C 108.44 -0.948 . . . . 54.4 108.44 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.438 HG13 HE22 ' A' ' 524' ' ' GLN . 24.2 pt -126.28 159.39 35.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.316 0.579 . . . . 74.3 111.505 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.8 t -148.12 153.73 39.24 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.358 -1.719 . . . . 62.42 106.358 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 34.8 p -106.22 140.14 39.63 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.595 -0.891 . . . . 70.24 108.595 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 478' ' ' ARG . 37.3 mmt180 -114.55 -93.15 0.49 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 114.61 1.337 . . . . 72.54 114.61 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -87.56 76.43 8.94 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.397 -0.921 . . . . 70.34 113.142 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 486' ' ' ALA . 7.6 p -67.43 137.97 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 114.569 -1.196 . . . . 74.42 110.271 174.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 23.7 p -97.18 153.96 17.67 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.85 -0.796 . . . . 71.01 108.85 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 24.2 pt -63.74 110.16 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.353 0.597 . . . . 71.34 110.103 176.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 157.63 -41.48 0.53 Allowed Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 110.779 -0.929 . . . . 34.32 110.779 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 135.4 -17.63 4.0 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.018 -1.087 . . . . 53.03 111.378 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 45.7 m -82.49 85.81 6.88 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 122.144 0.973 . . . . 72.55 112.828 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 480' ' ' VAL . . . -84.69 116.3 64.61 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 113.932 -1.485 . . . . 73.22 108.782 171.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.97 135.43 44.11 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 122.127 1.885 . . . . 52.13 110.957 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 43.1 mm -93.74 130.64 42.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.644 -0.707 . . . . 71.14 109.235 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -127.51 153.46 46.31 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.255 0.222 . . . . 63.32 110.474 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 28.2 t -73.36 122.72 26.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.572 -0.899 . . . . 61.24 108.572 177.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -80.68 -62.26 1.72 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.437 -0.579 . . . . 72.14 109.437 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -143.05 163.71 32.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.368 -0.975 . . . . 71.41 108.368 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 506' ' ' LYS . 26.4 mm -123.42 110.16 25.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 124.805 1.242 . . . . 61.3 108.445 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.02 125.4 73.97 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.217 -0.901 . . . . 72.34 110.633 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.28 21.33 0.23 Allowed 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 124.895 3.73 . . . . 71.42 114.6 -172.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -165.35 7.25 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.241 0.543 . . . . 75.02 112.424 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -89.48 -161.79 37.82 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 120.18 -1.009 . . . . 31.44 112.782 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -61.61 -39.84 92.69 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 123.817 0.847 . . . . 61.14 109.968 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.65 -41.4 81.39 Favored 'General case' 0 C--O 1.201 -1.461 0 CA-C-N 114.625 -1.171 . . . . 70.02 112.696 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.1 tt -79.48 -31.02 13.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 111.628 0.233 . . . . 72.12 111.628 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 30.9 mm-40 -59.71 -43.15 94.23 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.167 0.508 . . . . 61.14 109.65 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.42 -50.93 7.34 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.787 -0.642 . . . . 70.25 110.385 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 101.2 -36.09 4.44 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.044 -1.55 . . . . 32.02 116.235 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -65.87 -32.83 74.56 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.564 0.682 . . . . 64.53 112.232 -173.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 61.7 tp -84.44 102.7 12.99 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.921 -0.581 . . . . 73.23 110.508 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.488 ' HA ' HG13 ' A' ' 493' ' ' ILE . 10.3 ptmm? -113.69 177.0 4.79 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.181 -0.463 . . . . 74.14 111.52 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.447 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -87.43 147.52 25.39 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.997 -0.547 . . . . 62.43 110.371 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 110.11 -27.19 12.12 Favored Glycine 0 C--N 1.311 -0.852 0 C-N-CA 120.702 -0.761 . . . . 61.21 112.775 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -79.98 163.22 24.42 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 120.62 0.248 . . . . 62.4 110.945 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 31.6 ttm180 -96.8 142.5 28.73 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-O 120.796 0.331 . . . . 71.21 111.48 -178.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.703 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -90.54 126.96 36.1 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.902 0.881 . . . . 72.14 111.288 175.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 33.4 mt -103.33 -45.68 10.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.156 -0.683 . . . . 73.33 109.156 173.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.551 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 0.5 OUTLIER -150.96 155.15 38.5 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 109.716 -0.476 . . . . 73.33 109.716 176.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.672 HG12 HD21 ' A' ' 519' ' ' LEU . 7.1 p -143.3 130.58 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 O-C-N 123.827 0.705 . . . . 55.24 109.232 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . 0.539 HD21 ' HG2' ' A' ' 535' ' ' LYS . 1.4 t-20 64.78 15.42 9.8 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 125.918 1.687 . . . . 73.31 112.521 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 100.37 7.67 51.33 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.499 -0.858 . . . . 34.53 113.578 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 57.9 t -121.1 142.93 35.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 117.2 0.5 . . . . 63.45 110.415 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -73.96 144.5 45.21 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.472 0.709 . . . . 72.35 110.138 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.703 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 15.2 mt -108.43 -42.79 4.48 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 120.677 -0.409 . . . . 73.44 112.0 -175.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.34 -26.95 37.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 116.054 -0.521 . . . . 71.11 111.373 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -78.55 -18.52 75.56 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.747 -0.739 . . . . 63.55 112.416 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.441 ' HD3' ' CB ' ' A' ' 526' ' ' GLU . 0.1 OUTLIER -110.62 -175.55 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.328 -0.513 . . . . 73.32 111.802 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 527' ' ' VAL . 11.3 m -87.32 158.75 18.98 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.901 -0.591 . . . . 71.43 111.183 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.438 HE22 HG13 ' A' ' 475' ' ' ILE . 8.7 tm0? -59.71 -47.71 84.55 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.854 1.262 . . . . 44.31 109.843 -175.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 528' ' ' VAL . 47.1 mt-10 -68.5 -30.36 69.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.694 0.998 . . . . 74.12 113.694 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.441 ' CB ' ' HD3' ' A' ' 522' ' ' LYS . 49.4 mt-10 -59.98 -37.59 80.08 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.515 -0.55 . . . . 60.23 109.515 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.471 HG13 HD22 ' A' ' 519' ' ' LEU . 43.4 t -65.64 -36.92 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.74 -0.663 . . . . 73.13 110.276 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.673 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 25.0 m -70.53 -39.09 75.74 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 C-N-CA 118.977 -1.089 . . . . 74.33 110.403 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 37.4 t -61.29 -37.41 83.09 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.017 -0.538 . . . . 42.23 109.873 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 33.7 tp -64.14 -42.52 96.75 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.876 1.27 . . . . 54.43 109.951 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 tt -64.7 -44.15 91.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.337 -0.847 . . . . 73.15 111.928 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 31.3 mmm180 -64.63 -27.08 68.69 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.054 -0.521 . . . . 71.32 112.055 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 23.2 p -82.53 -45.84 14.15 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 113.447 0.906 . . . . 70.12 113.447 -176.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . 0.416 HG21 ' CD ' ' A' ' 466' ' ' LYS . 88.4 m 59.4 133.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.296 0.57 . . . . 44.22 112.466 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.539 ' HG2' HD21 ' A' ' 515' ' ' ASN . 18.2 ptpt -64.96 152.56 42.96 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.053 -1.029 . . . . 62.43 109.68 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 50.9 ttm -54.76 -32.23 59.65 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 123.473 0.709 . . . . 71.31 112.784 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.56 -15.89 53.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.649 0.611 . . . . 74.2 112.649 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 85.93 -20.35 20.69 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.666 -0.778 . . . . 43.25 113.923 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 463' ' ' GLN . 3.9 m -104.09 129.07 51.76 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.48 0.657 . . . . 62.33 109.756 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.477 HG21 HD11 ' A' ' 471' ' ' LEU . 77.1 t -111.68 141.77 26.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.935 -1.029 . . . . 65.13 110.83 -176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 34.3 t -91.15 132.95 35.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.743 -0.662 . . . . 54.0 109.444 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.597 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.7 mm? -120.77 118.57 30.36 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.692 -1.225 . . . . 74.41 107.692 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.514 ' CB ' ' HG3' ' A' ' 513' ' ' GLU . 51.1 tp -104.63 117.66 34.67 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 105.213 -2.143 . . . . 71.44 105.213 172.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 28.6 m -115.98 151.78 17.73 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.135 0 C-N-CA 120.233 -0.587 . . . . 73.34 111.143 -176.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.536 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 85.6 t80 -110.92 116.14 30.7 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.68 -1.97 . . . . 74.12 105.68 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -115.87 118.42 32.93 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.865 -0.791 . . . . 72.4 108.865 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.69 122.89 33.85 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 105.82 -1.919 . . . . 71.41 105.82 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -80.08 121.09 25.1 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.569 -0.287 . . . . 72.14 110.747 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 . . . . . 0 C--O 1.245 0.841 0 C-N-CA 123.886 0.874 . . . . 51.23 110.559 -179.113 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.765 0 N-CA-C 111.24 -0.744 . . . . 55.11 111.24 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 29.9 p -93.02 125.69 37.74 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.155 0.502 . . . . 71.22 111.941 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -100.35 -3.42 31.22 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.148 -0.478 . . . . 73.34 110.386 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -78.63 155.42 29.57 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.004 0.431 . . . . 72.41 110.527 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 88.1 m -147.17 100.61 3.31 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.573 -0.528 . . . . 71.11 109.573 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -79.31 98.57 6.74 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 108.99 -0.744 . . . . 65.32 108.99 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -98.84 130.36 45.25 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.639 -1.164 . . . . 72.34 109.978 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . 0.522 ' O ' HD12 ' A' ' 456' ' ' ILE . 2.6 pp -83.53 126.01 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-O 121.279 0.562 . . . . 52.44 109.675 173.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 98.12 65.63 0.88 Allowed Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 108.368 -1.893 . . . . 64.41 108.368 -173.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -87.66 137.14 32.59 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 113.786 1.032 . . . . 74.35 113.786 -175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 89.2 mtm180 -105.81 138.66 41.63 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 113.743 -1.571 . . . . 71.23 107.395 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.43 ' O ' HD12 ' A' ' 543' ' ' LEU . 6.0 mp -123.4 128.24 49.58 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 120.989 0.424 . . . . 72.1 110.705 -177.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -96.27 116.26 28.73 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.042 -0.981 . . . . 72.53 109.787 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 53.6 mt -123.67 144.21 34.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 114.783 -1.099 . . . . 60.32 110.414 -172.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.3 mt-30 -119.98 129.99 54.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.594 0.59 . . . . 53.24 112.594 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.599 HD23 HD23 ' A' ' 542' ' ' LEU . 3.8 mm? -116.85 153.03 33.23 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 124.962 1.305 . . . . 74.24 110.189 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -113.16 129.34 56.54 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 108.159 -1.052 . . . . 64.24 108.159 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -60.24 102.91 0.19 Allowed 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.547 -0.751 . . . . 73.23 109.664 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -146.16 150.45 22.69 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.369 -0.692 . . . . 44.32 111.369 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 50.1 m 65.21 -78.56 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.241 1.017 . . . . 60.42 111.131 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -119.48 -6.68 10.24 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.035 -0.728 . . . . 61.12 109.035 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 69.24 -151.08 50.79 Favored Glycine 0 C--O 1.206 -1.598 0 CA-C-O 118.673 -1.07 . . . . 70.13 110.784 -175.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 7.8 mp -46.83 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.217 1.192 . . . . 50.21 114.217 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -104.06 43.66 1.63 Allowed Glycine 0 N--CA 1.428 -1.847 0 CA-C-N 113.951 -1.477 . . . . 62.53 112.044 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -129.17 142.16 50.95 Favored 'General case' 0 N--CA 1.409 -2.518 0 N-CA-C 108.596 -0.89 . . . . 64.42 108.596 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 45.0 t -115.0 148.53 38.71 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.401 -1.333 . . . . 72.31 107.401 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.434 HG21 HD12 ' A' ' 511' ' ' LEU . 14.9 pt -116.62 156.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.474 0.654 . . . . 72.32 112.611 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.4 t -138.21 159.85 40.98 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.934 -1.506 . . . . 72.21 106.934 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 14.9 p -120.96 131.28 54.23 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.666 -0.494 . . . . 73.12 109.666 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -117.55 117.47 29.51 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.537 -0.912 . . . . 72.5 108.537 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . 0.505 ' HA ' ' HB2' ' A' ' 486' ' ' ALA . 33.7 t70 -61.05 121.7 13.11 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 123.939 0.774 . . . . 74.21 110.09 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 486' ' ' ALA . 14.7 p -85.36 128.94 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 121.017 0.437 . . . . 74.13 111.797 -174.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.8 m -76.64 -42.99 40.0 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.776 0.798 . . . . 72.05 109.531 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 19.5 pt -89.19 83.05 2.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-N 114.338 -1.301 . . . . 63.15 111.217 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 128.76 -157.34 21.47 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 109.998 -1.241 . . . . 74.31 109.998 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -163.78 94.86 0.12 Allowed Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.088 -0.805 . . . . 34.21 111.088 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 43.8 t -172.29 -44.17 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.817 -0.438 . . . . 62.11 109.817 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.558 ' H ' HG12 ' A' ' 480' ' ' VAL . . . 72.79 94.09 0.05 OUTLIER Pre-proline 0 C--O 1.247 0.927 0 C-N-CA 124.345 1.058 . . . . 75.11 110.427 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.464 ' HD3' ' HB ' ' A' ' 480' ' ' VAL . 19.5 Cg_exo -66.71 160.0 48.49 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 123.058 2.505 . . . . 74.43 112.847 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.427 HG13 HG21 ' A' ' 527' ' ' VAL . 47.8 mm -97.74 135.6 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 115.01 -0.995 . . . . 65.14 108.728 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 97.7 m-85 -127.22 155.98 42.59 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 116.68 -0.236 . . . . 73.14 110.66 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.418 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 32.6 t -82.72 119.0 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 N-CA-C 107.665 -1.235 . . . . 55.32 107.665 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.434 ' HG2' ' OD1' ' A' ' 492' ' ' ASN . 61.2 tttm -85.14 -54.81 4.39 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.561 -0.745 . . . . 73.31 109.461 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . 0.434 ' OD1' ' HG2' ' A' ' 491' ' ' LYS . 18.4 m120 -136.98 157.08 47.55 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 115.447 -0.797 . . . . 63.4 112.55 -176.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 507' ' ' ALA . 26.6 mm -120.53 115.59 47.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.314 -1.736 . . . . 61.21 106.314 172.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 495' ' ' PRO . 9.3 mp -62.92 163.11 17.5 Favored Pre-proline 0 C--N 1.304 -1.399 0 C-N-CA 123.839 0.855 . . . . 72.41 112.146 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 494' ' ' LEU . 43.6 Cg_endo -74.75 -5.22 16.55 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 123.645 2.896 . . . . 71.35 111.219 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.443 ' HA ' HG21 ' A' ' 500' ' ' ILE . 97.9 mtt180 -157.97 174.3 15.45 Favored 'General case' 0 N--CA 1.41 -2.437 0 C-N-CA 125.113 1.365 . . . . 73.03 107.843 -172.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 106.74 -175.93 21.11 Favored Glycine 1 C--N 1.251 -4.176 0 CA-C-N 114.659 -1.155 . . . . 53.51 112.262 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.51 81.39 Favored 'General case' 0 N--CA 1.422 -1.828 0 C-N-CA 123.783 0.833 . . . . 61.41 110.872 -175.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.31 -41.89 80.77 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 114.655 -1.157 . . . . 70.31 112.788 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.443 HG21 ' HA ' ' A' ' 496' ' ' ARG . 13.6 tt -81.08 -43.66 20.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.955 0.724 . . . . 62.53 112.955 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -59.02 -37.79 77.75 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 112.436 0.532 . . . . 74.24 112.436 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.568 ' HB2' HD13 ' A' ' 464' ' ' LEU . 3.6 m-20 -89.48 -33.36 16.81 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.211 -0.596 . . . . 73.41 109.778 173.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 62.16 50.79 61.84 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.759 -0.655 . . . . 53.05 113.74 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -117.08 -18.7 9.99 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.714 -0.795 . . . . 71.03 111.415 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.467 HD12 ' HG ' ' A' ' 542' ' ' LEU . 6.8 tt -119.84 138.96 53.07 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.988 -0.745 . . . . 73.45 108.988 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.427 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -132.05 160.91 34.53 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.41 0.892 . . . . 63.4 113.41 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.525 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -79.13 166.7 21.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.511 0.724 . . . . 65.43 111.912 -174.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 73.43 20.33 79.84 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.857 -0.897 . . . . 54.0 110.857 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.519 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 4.4 t70 -117.94 172.58 7.3 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.685 -1.228 . . . . 70.12 107.685 -176.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 30.3 ttm180 -107.3 135.25 49.12 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.311 -0.556 . . . . 73.22 110.951 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.434 HD12 HG21 ' A' ' 475' ' ' ILE . 27.4 mt -95.46 126.4 40.73 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 120.493 -0.483 . . . . 72.14 110.798 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.47 -45.39 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 116.019 -0.537 . . . . 75.12 111.203 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.436 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.0 pt-20 -156.63 155.08 31.19 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.329 -0.619 . . . . 73.45 109.329 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.47 HG12 HD21 ' A' ' 519' ' ' LEU . 6.4 p -132.6 125.03 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.726 0.774 . . . . 65.12 108.975 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 66.09 7.46 4.78 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 126.737 2.015 . . . . 74.23 112.65 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.53 -10.46 16.6 Favored Glycine 0 CA--C 1.508 -0.371 0 C-N-CA 120.484 -0.865 . . . . 75.4 112.734 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.484 ' HB ' HD21 ' A' ' 530' ' ' LEU . 79.6 t -96.05 127.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.633 -0.506 . . . . 60.31 109.633 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.08 142.07 43.73 Favored 'General case' 0 CA--C 1.491 -1.324 0 O-C-N 123.868 0.73 . . . . 72.15 111.409 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.47 HD21 HG12 ' A' ' 514' ' ' VAL . 18.2 mt -100.08 -39.79 7.93 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 115.533 -0.758 . . . . 71.04 110.5 -176.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 38.6 t -73.92 98.75 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 108.587 -0.894 . . . . 75.02 108.587 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 136.52 -15.89 3.85 Favored Glycine 0 N--CA 1.424 -2.101 0 CA-C-N 114.313 -1.312 . . . . 73.21 110.173 -174.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.29 176.57 5.09 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-O 120.904 0.383 . . . . 71.34 111.681 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 37.3 m -91.11 161.09 15.24 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.889 -0.596 . . . . 71.1 111.235 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -55.42 -47.93 75.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.991 0.916 . . . . 71.31 111.694 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.481 ' HA ' HG22 ' A' ' 528' ' ' VAL . 36.3 mt-10 -62.42 -31.71 72.45 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 123.885 0.874 . . . . 71.14 112.429 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.85 -41.41 95.73 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.132 -0.692 . . . . 61.43 109.132 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.465 HG13 HD22 ' A' ' 519' ' ' LEU . 35.0 t -71.37 -39.44 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.993 -1.003 . . . . 72.11 110.389 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.663 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.9 m -65.18 -42.07 93.25 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.303 0 C-N-CA 119.347 -0.941 . . . . 71.13 110.164 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 36.8 m -62.09 -41.81 98.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.343 0.592 . . . . 72.42 110.199 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.484 HD21 ' HB ' ' A' ' 517' ' ' VAL . 54.7 tp -61.43 -46.26 90.84 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 124.125 0.97 . . . . 73.55 109.694 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.2 tt -63.39 -44.96 93.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.452 0.701 . . . . 74.23 112.408 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 28.0 mmm180 -63.06 -32.82 74.27 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.349 0.595 . . . . 72.2 109.943 -177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 43.2 t -72.31 -44.39 62.77 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-N 115.076 -0.965 . . . . 74.31 109.779 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 86.3 m 69.6 -70.57 0.14 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.886 0.874 . . . . 65.53 110.839 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.594 ' HA ' ' HE3' ' A' ' 535' ' ' LYS . 1.3 tpmt? 168.6 166.49 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 104.245 -2.502 . . . . 73.35 104.245 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 86.8 mtp -87.69 -28.59 21.71 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.025 -0.67 . . . . 64.34 109.257 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.66 -77.06 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.271 -0.877 . . . . 71.5 111.624 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 156.46 -29.31 0.56 Allowed Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 119.502 -1.332 . . . . 64.23 112.934 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 4.3 m -94.19 141.3 28.71 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.208 -1.405 . . . . 71.21 107.208 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 5.0 p -124.61 136.49 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 N-CA-C 109.223 -0.658 . . . . 74.11 109.223 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.4 m -92.25 132.87 36.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.937 -0.394 . . . . 71.01 109.937 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.599 HD23 HD23 ' A' ' 464' ' ' LEU . 1.3 mm? -124.18 138.56 54.4 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.096 -1.446 . . . . 74.14 107.096 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 39.2 tp -119.03 122.35 41.95 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 106.765 -1.569 . . . . 63.2 106.765 173.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.519 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 31.9 m -114.74 161.56 13.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 109.371 -0.604 . . . . 73.22 109.371 -177.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.443 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 84.4 t80 -132.96 129.2 37.94 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.405 0.621 . . . . 74.23 111.307 -177.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -122.13 140.87 52.03 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.194 -1.039 . . . . 75.44 108.194 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -77.35 135.97 38.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.969 -1.493 . . . . 74.31 106.969 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 65.48 -160.56 0.27 Allowed 'General case' 0 C--O 1.24 0.588 0 O-C-N 124.165 0.915 . . . . 62.41 109.379 -172.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--N 1.305 -1.368 0 C-N-CA 120.052 -0.659 . . . . 75.02 110.268 -177.959 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.078 0 N-CA-C 110.165 -1.174 . . . . 53.05 110.165 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 43.5 m -87.12 84.22 7.31 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 117.674 0.737 . . . . 74.14 112.798 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -142.35 87.38 2.01 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 108.533 -0.914 . . . . 72.23 108.533 173.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -148.56 133.89 18.48 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.679 -0.691 . . . . 72.13 110.022 -177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 25.7 m -114.68 95.39 5.22 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.956 -1.127 . . . . 64.14 107.956 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -79.38 103.86 9.59 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.443 -0.947 . . . . 71.35 108.443 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -136.79 144.97 44.0 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.699 -1.137 . . . . 75.31 108.24 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.81 112.07 23.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.519 -0.919 . . . . 71.42 108.519 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 121.32 96.48 1.46 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 108.175 -1.97 . . . . 73.14 108.175 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.576 ' HA ' ' HE3' ' A' ' 458' ' ' LYS . 0.4 OUTLIER -92.75 132.7 36.72 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 120.909 0.385 . . . . 64.12 110.111 -172.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 79.7 mtm180 -100.55 142.38 32.11 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.998 -1.112 . . . . 75.52 107.998 172.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -132.48 132.43 42.7 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 109.264 -0.643 . . . . 65.41 109.264 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -95.55 115.71 27.81 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.753 -1.573 . . . . 54.22 106.753 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.36 142.84 38.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.689 -0.856 . . . . 53.33 108.689 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.515 ' HB3' HG22 ' A' ' 539' ' ' THR . 75.7 mt-30 -120.32 127.22 52.15 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.446 -0.502 . . . . 71.51 111.666 176.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.657 HD13 ' HB2' ' A' ' 502' ' ' ASP . 3.9 mm? -114.7 132.29 56.46 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.377 -0.972 . . . . 74.54 108.377 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 39.6 ttmt -105.19 136.13 45.27 Favored 'General case' 0 N--CA 1.401 -2.892 0 CA-C-O 121.832 0.825 . . . . 72.21 110.768 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.449 ' HG3' ' HA3' ' A' ' 470' ' ' GLY . 37.5 ttpt -72.8 102.44 3.39 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 113.937 -1.483 . . . . 71.55 109.471 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -137.9 -84.28 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.422 -1.071 . . . . 43.23 110.422 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . 0.52 ' O ' ' HA2' ' A' ' 497' ' ' GLY . 26.9 m -91.25 123.95 35.08 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.661 -1.607 . . . . 73.32 106.661 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.638 ' HB3' ' CA ' ' A' ' 497' ' ' GLY . 10.9 tp10 39.17 52.85 2.14 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 125.157 1.383 . . . . 61.4 108.214 -174.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.449 ' HA3' ' HG3' ' A' ' 466' ' ' LYS . . . -53.14 127.88 36.79 Favored Glycine 0 N--CA 1.416 -2.681 0 CA-C-N 113.393 -1.731 . . . . 63.14 114.144 -171.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.646 ' H ' ' HB2' ' A' ' 498' ' ' ALA . 43.4 mt 65.95 74.34 0.36 Allowed 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 126.351 1.86 . . . . 74.13 110.475 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -92.51 57.15 2.69 Favored Glycine 0 N--CA 1.422 -2.24 0 CA-C-N 113.862 -1.517 . . . . 43.13 111.619 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.597 ' CE2' HD11 ' A' ' 542' ' ' LEU . 33.1 p90 -150.03 142.94 24.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.026 0.441 . . . . 52.3 111.558 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 46.4 p -128.7 164.75 22.27 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.826 -1.079 . . . . 54.25 108.742 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 511' ' ' LEU . 22.7 pt -121.75 153.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 113.409 0.892 . . . . 71.22 113.409 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.8 t -137.18 141.33 42.17 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.178 -0.919 . . . . 63.01 109.567 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.4 m -142.33 131.82 23.78 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.58 -1.267 . . . . 61.15 107.58 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -122.57 -63.74 1.25 Allowed 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.967 -0.693 . . . . 75.05 110.636 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -138.37 152.67 48.64 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 116.301 -0.409 . . . . 74.41 110.175 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 5.2 p -53.72 117.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.784 0.802 . . . . 71.32 110.842 172.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 16.5 p -130.34 -78.18 0.54 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.607 -0.724 . . . . 73.3 111.268 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 62.8 mt -93.07 -43.33 13.57 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 114.873 -1.058 . . . . 74.34 109.857 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -96.08 -150.05 26.44 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.676 -0.773 . . . . 75.1 112.897 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -73.9 -160.01 6.43 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-O 119.972 -0.349 . . . . 75.44 112.837 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 52.6 m -45.46 -40.22 8.06 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.817 0.847 . . . . 72.1 113.265 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -142.22 97.64 6.23 Favored Pre-proline 0 N--CA 1.431 -1.384 0 N-CA-C 108.457 -0.942 . . . . 50.44 108.457 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.477 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 5.2 Cg_exo -78.09 138.91 16.65 Favored 'Trans proline' 0 N--CA 1.441 -1.569 0 C-N-CA 122.089 1.859 . . . . 70.2 111.301 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 47.9 mm -86.42 120.61 36.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.943 -0.571 . . . . 72.43 109.954 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 90.6 m-85 -121.22 150.11 41.83 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 122.288 -0.257 . . . . 74.44 110.352 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 41.1 t -72.05 119.82 19.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.931 -0.766 . . . . 75.21 108.931 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -84.65 -57.47 3.12 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.357 -0.838 . . . . 72.34 110.897 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -136.81 151.94 49.73 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.899 -0.591 . . . . 71.51 109.781 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.441 HG13 ' HA ' ' A' ' 506' ' ' LYS . 27.8 mm -123.08 106.94 18.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.881 -1.155 . . . . 74.24 107.881 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.72 113.99 11.84 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 108.982 -0.748 . . . . 75.04 108.982 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.21 29.52 0.39 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 124.903 3.736 . . . . 61.4 112.55 -172.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -154.5 1.98 0.21 Allowed 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 115.568 -0.742 . . . . 71.11 112.133 -175.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.638 ' CA ' ' HB3' ' A' ' 469' ' ' GLU . . . -113.94 -146.63 9.44 Favored Glycine 0 C--O 1.218 -0.849 0 C-N-CA 119.124 -1.512 . . . . 75.4 115.296 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.646 ' HB2' ' H ' ' A' ' 471' ' ' LEU . . . -59.79 -40.49 88.47 Favored 'General case' 0 C--N 1.364 1.225 0 CA-C-N 118.24 1.02 . . . . 63.51 110.563 -173.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.61 -37.82 73.89 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 115.091 -0.959 . . . . 62.44 112.864 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.6 tt -80.14 -35.58 15.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.01 0.374 . . . . 65.12 112.01 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -58.79 -47.28 85.27 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.017 0.437 . . . . 73.35 110.28 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.657 ' HB2' HD13 ' A' ' 464' ' ' LEU . 21.1 m-20 -89.86 -30.19 18.07 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.443 -0.503 . . . . 72.34 110.275 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 76.27 -23.63 1.83 Allowed Glycine 0 CA--C 1.529 0.933 0 N-CA-C 118.075 1.99 . . . . 52.0 118.075 170.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -67.33 -17.46 64.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.834 1.049 . . . . 74.53 113.834 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 42.8 tp -101.76 132.3 47.57 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 122.134 -0.354 . . . . 65.11 111.672 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.441 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.261 0.0 OUTLIER -135.79 146.44 47.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 113.379 0.881 . . . . 62.35 113.379 176.657 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.422 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -65.07 123.39 19.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.306 -0.861 . . . . 53.4 110.609 -177.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 131.67 -18.87 4.82 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 111.064 -0.814 . . . . 50.41 111.064 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -81.05 156.78 25.69 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 109.212 -0.662 . . . . 72.43 109.212 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -95.57 136.49 35.89 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.775 -0.454 . . . . 64.44 109.775 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 519' ' ' LEU . 24.8 mt -85.7 136.01 33.53 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 119.707 -0.797 . . . . 73.53 110.708 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.36 -45.64 10.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.318 -0.623 . . . . 72.31 109.318 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.428 ' HG3' ' HB3' ' A' ' 543' ' ' LEU . 0.0 OUTLIER -155.35 157.13 36.65 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.06 -0.718 . . . . 72.33 109.06 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.642 HG12 HD21 ' A' ' 519' ' ' LEU . 7.6 p -144.46 136.22 21.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-N 116.021 -0.536 . . . . 63.55 109.931 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . 0.466 HD22 HG13 ' A' ' 540' ' ' VAL . 5.3 t-20 65.96 12.32 8.34 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 125.505 1.522 . . . . 71.52 111.734 176.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 92.7 14.05 55.85 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 120.857 -0.687 . . . . 35.42 111.959 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 37.3 t -121.1 146.45 26.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.921 -0.77 . . . . 62.23 108.921 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . 0.572 ' O ' ' HE2' ' A' ' 522' ' ' LYS . 5.3 p-10 -88.51 152.66 21.72 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 109.232 -0.655 . . . . 63.44 109.232 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.642 HD21 HG12 ' A' ' 514' ' ' VAL . 18.7 mt -100.53 -52.54 3.32 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.369 -0.532 . . . . 75.31 111.731 -172.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.25 110.01 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.938 0.875 . . . . 70.24 110.503 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 135.42 -33.94 2.36 Favored Glycine 0 N--CA 1.418 -2.534 0 N-CA-C 109.285 -1.526 . . . . 70.5 109.285 -174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.572 ' HE2' ' O ' ' A' ' 518' ' ' ASP . 0.1 OUTLIER -107.93 161.54 14.84 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 109.79 -0.448 . . . . 62.32 109.79 178.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 29.4 m -87.22 162.4 17.48 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.659 -0.246 . . . . 72.32 111.498 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.445 ' O ' HG13 ' A' ' 528' ' ' VAL . 53.8 mt-30 -51.74 -46.92 64.22 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.372 0.669 . . . . 74.33 112.32 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.417 ' HA ' HG22 ' A' ' 528' ' ' VAL . 40.4 mt-10 -60.01 -32.39 70.83 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.209 0.448 . . . . 64.12 112.209 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.13 -39.87 68.51 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.42 -0.585 . . . . 53.13 109.42 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 49.0 t -67.04 -41.75 87.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 74.43 109.584 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.665 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 8.6 m -66.7 -40.94 87.29 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.152 0 C-N-CA 119.209 -0.996 . . . . 74.31 110.012 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.8 m -60.41 -44.1 96.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.296 -0.411 . . . . 61.25 111.382 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.612 HD11 HG13 ' A' ' 514' ' ' VAL . 3.5 pp -67.46 -30.29 69.97 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.299 0.571 . . . . 62.23 110.232 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.44 ' CD1' HD13 ' A' ' 471' ' ' LEU . 65.2 tp -69.85 -48.22 59.71 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.679 -0.691 . . . . 73.23 109.576 175.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 27.6 mmm180 -61.11 -39.11 88.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.642 -0.708 . . . . 72.54 111.85 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 30.6 t -65.25 -38.7 91.17 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.384 -0.598 . . . . 42.32 109.384 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 17.6 m 69.92 166.57 0.28 Allowed 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.474 0.71 . . . . 60.52 111.432 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -81.41 150.98 28.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.653 -1.61 . . . . 75.44 106.653 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 91.9 mmm -63.86 -31.95 73.31 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.772 1.027 . . . . 73.2 113.772 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.27 -32.33 73.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 122.007 0.908 . . . . 72.04 108.675 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 105.68 -14.01 46.21 Favored Glycine 0 N--CA 1.422 -2.28 0 CA-C-N 114.778 -1.101 . . . . 72.24 111.453 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.515 HG22 ' HB3' ' A' ' 463' ' ' GLN . 1.8 m -96.7 129.08 44.17 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.336 -0.616 . . . . 63.34 109.336 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.466 HG13 HD22 ' A' ' 515' ' ' ASN . 86.9 t -106.76 133.5 51.15 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 115.532 -0.758 . . . . 73.2 109.915 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 21.8 t -91.48 129.59 37.44 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 109.075 -0.713 . . . . 52.25 109.075 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.597 HD11 ' CE2' ' A' ' 473' ' ' PHE . 3.8 mm? -117.56 130.33 56.34 Favored 'General case' 0 C--N 1.283 -2.309 0 C-N-CA 124.607 1.163 . . . . 74.52 108.846 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 513' ' ' GLU . 54.6 tp -112.8 117.91 33.49 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.733 -1.951 . . . . 63.12 105.733 169.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 25.9 m -115.73 150.98 17.54 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.788 0 C-N-CA 120.133 -0.627 . . . . 74.12 110.075 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -111.77 115.8 29.66 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 106.509 -1.663 . . . . 63.22 106.509 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -109.29 122.81 48.15 Favored 'General case' 0 N--CA 1.399 -3.023 0 CA-C-N 115.213 -0.903 . . . . 74.22 109.093 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -79.35 138.4 37.68 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.358 -0.837 . . . . 70.51 110.02 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -111.96 105.7 14.19 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.836 -0.802 . . . . 71.24 108.836 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 . . . . . 0 CA--C 1.494 -1.203 0 N-CA-C 108.564 -0.902 . . . . 75.13 108.564 179.267 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.82 0 N-CA-C 110.469 -1.052 . . . . 63.14 110.469 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 51.1 m 67.82 113.68 0.04 OUTLIER 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.881 1.273 . . . . 73.21 112.622 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -79.67 88.12 5.18 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.786 0.803 . . . . 70.2 110.674 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -142.24 111.49 6.49 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.665 -1.606 . . . . 63.45 106.665 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 40.5 p -92.42 174.12 7.45 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 116.18 -0.464 . . . . 45.45 111.718 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -80.17 87.71 5.49 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.216 0.532 . . . . 71.33 109.96 175.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -80.29 115.57 19.9 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.425 -1.694 . . . . 51.14 106.425 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 38.2 pt -67.4 -31.45 52.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 113.24 0.83 . . . . 71.24 113.24 -172.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -166.97 -175.21 36.88 Favored Glycine 1 N--CA 1.386 -4.674 0 C-N-CA 119.462 -1.351 . . . . 71.5 111.68 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -125.67 134.59 51.79 Favored 'General case' 0 C--N 1.261 -3.255 0 CA-C-N 114.265 -0.967 . . . . 71.5 109.182 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 97.5 mtt180 -99.36 132.46 44.67 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.246 -1.761 . . . . 53.13 106.246 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 15.6 tp -126.44 132.72 51.42 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.286 -0.566 . . . . 64.52 110.153 -171.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -98.63 114.61 27.15 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-O 121.97 0.89 . . . . 72.23 108.952 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.05 133.54 60.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 CA-C-N 115.074 -0.966 . . . . 64.44 109.754 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 48.4 mt-30 -106.76 128.97 54.68 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.999 -0.68 . . . . 74.33 112.177 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.582 HD23 HD23 ' A' ' 542' ' ' LEU . 4.5 mm? -112.9 150.0 32.39 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.811 -1.086 . . . . 71.33 108.697 175.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 465' ' ' LYS . 35.5 ttpt -107.54 136.37 47.43 Favored 'General case' 0 N--CA 1.389 -3.485 0 O-C-N 124.017 0.823 . . . . 61.3 109.931 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -70.82 85.12 0.67 Allowed 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 115.117 -0.947 . . . . 74.33 108.765 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -84.84 -129.98 2.07 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.45 -0.795 . . . . 62.13 112.253 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 8.7 t -66.91 -57.7 6.43 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.495 0.554 . . . . 65.44 112.495 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.82 -6.82 35.12 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.811 -0.556 . . . . 74.14 110.751 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 58.72 -153.18 29.76 Favored Glycine 0 C--O 1.207 -1.545 0 CA-C-O 118.669 -1.073 . . . . 70.12 112.184 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.576 HD11 HG21 ' A' ' 540' ' ' VAL . 61.1 mt -47.25 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.996 0.903 . . . . 74.53 112.903 -171.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.36 62.12 0.35 Allowed Glycine 0 CA--C 1.475 -2.433 0 CA-C-N 114.399 -1.273 . . . . 75.23 111.003 -176.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -155.58 142.59 19.12 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.932 -0.766 . . . . 63.41 108.932 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 49.3 m -117.84 158.35 24.98 Favored 'General case' 0 C--N 1.281 -2.4 0 O-C-N 124.112 0.883 . . . . 75.43 109.226 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 17.0 pt -116.73 157.31 17.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.275 0.56 . . . . 72.23 111.469 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.7 t -140.2 155.99 46.69 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 107.898 -1.149 . . . . 72.24 107.898 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 62.7 p -136.41 149.9 48.51 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.924 -0.769 . . . . 70.31 108.924 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -134.94 166.37 23.17 Favored 'General case' 0 N--CA 1.405 -2.687 0 N-CA-C 109.77 -0.455 . . . . 74.22 109.77 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -60.93 137.59 58.21 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 124.373 1.046 . . . . 65.51 108.941 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.34 129.04 50.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-O 121.053 0.454 . . . . 64.12 111.75 -174.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 29.1 m -129.12 10.0 5.79 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 122.843 1.306 . . . . 65.23 109.005 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.2 mp -81.73 -31.7 11.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.659 -1.155 . . . . 61.41 109.865 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 114.76 57.66 0.37 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.835 -0.906 . . . . 55.41 110.835 -176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -160.29 -155.05 7.59 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 111.296 -0.722 . . . . 43.35 111.296 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 38.1 t -124.45 83.37 2.14 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.097 0.448 . . . . 71.13 110.88 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 45.05 99.47 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.378 0 C-N-CA 125.806 1.642 . . . . 62.51 114.946 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.61 138.55 26.87 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.32 2.013 . . . . 65.42 112.465 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 46.0 mm -93.57 136.42 25.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.778 -0.823 . . . . 43.35 108.778 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -131.18 159.33 38.03 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 121.986 0.114 . . . . 73.32 110.776 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.33 121.34 26.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.017 -0.734 . . . . 72.15 109.017 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -83.16 -57.15 3.4 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.303 0.573 . . . . 72.34 110.113 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -147.0 153.73 40.4 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.701 -0.681 . . . . 71.42 109.935 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.539 HG12 ' HB2' ' A' ' 507' ' ' ALA . 33.7 mm -114.06 106.48 20.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.081 -1.081 . . . . 63.54 108.081 175.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.2 mp -61.47 122.37 70.23 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 109.085 -0.709 . . . . 51.2 109.085 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.449 ' C ' HG21 ' A' ' 500' ' ' ILE . 87.7 Cg_endo -69.86 28.42 0.18 Allowed 'Trans proline' 0 N--CA 1.521 3.127 1 C-N-CA 125.733 4.289 . . . . 75.23 115.038 -170.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.505 ' N ' HG21 ' A' ' 500' ' ' ILE . 13.6 ptm180 -163.51 -0.81 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 113.179 0.807 . . . . 72.32 113.179 -175.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -97.33 -166.16 32.45 Favored Glycine 0 C--N 1.306 -1.103 0 C-N-CA 119.613 -1.279 . . . . 72.44 112.421 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.458 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -49.55 -48.6 48.3 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 125.451 1.5 . . . . 74.12 112.758 -172.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.473 ' HA ' HD11 ' A' ' 464' ' ' LEU . . . -56.74 -47.16 80.66 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 115.492 -0.777 . . . . 62.35 112.108 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.505 HG21 ' N ' ' A' ' 496' ' ' ARG . 0.0 OUTLIER -81.33 -35.99 14.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 123.488 0.715 . . . . 72.55 112.908 179.283 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.8 mm100 -67.79 -37.73 82.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.014 0.435 . . . . 73.31 110.929 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.473 ' HB2' HD13 ' A' ' 464' ' ' LEU . 10.0 m-20 -87.77 -30.41 20.3 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.531 -0.914 . . . . 61.34 108.531 174.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 68.75 49.26 44.03 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.311 -0.859 . . . . 62.23 113.537 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -118.04 -38.51 3.21 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.361 -0.935 . . . . 64.43 111.497 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 58.6 tp -109.01 148.47 30.72 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.529 -0.305 . . . . 71.25 110.39 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.492 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -137.46 170.75 15.55 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 123.306 0.378 . . . . 72.33 110.021 177.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.539 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -88.2 85.18 6.89 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.956 0.725 . . . . 71.24 112.956 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 176.4 19.44 0.02 OUTLIER Glycine 0 C--N 1.293 -1.806 0 CA-C-N 114.658 -1.156 . . . . 54.11 110.254 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -116.82 153.25 32.81 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-O 121.02 0.438 . . . . 75.12 110.983 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.453 HH21 HG21 ' A' ' 520' ' ' VAL . 38.4 ttt180 -94.27 134.65 36.52 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.485 -0.779 . . . . 73.24 110.201 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.693 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.2 mm? -83.21 129.59 35.02 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.016 -0.993 . . . . 74.01 110.16 174.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 545' ' ' PHE . 36.2 mm -107.52 -43.64 6.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.152 0.501 . . . . 64.41 109.971 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 517' ' ' VAL . 28.9 tt0 -158.49 155.02 27.73 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.554 -0.748 . . . . 74.32 110.02 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 541' ' ' SER . 3.5 p -143.49 125.52 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 109.484 -0.562 . . . . 74.35 109.484 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . 0.515 HD21 HG13 ' A' ' 540' ' ' VAL . 61.0 m-80 62.48 12.79 5.64 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 125.367 1.467 . . . . 62.11 114.029 -176.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 101.69 15.55 26.62 Favored Glycine 0 C--N 1.31 -0.91 0 C-N-CA 120.201 -0.999 . . . . 63.43 112.875 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 513' ' ' GLU . 61.1 t -116.48 128.75 73.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.614 -0.884 . . . . 72.41 108.614 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.22 144.14 29.13 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.172 -0.677 . . . . 71.21 109.172 -173.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.693 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 33.6 mt -97.86 -49.54 4.76 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.762 0.652 . . . . 71.33 112.762 -171.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . 0.453 HG21 HH21 ' A' ' 510' ' ' ARG . 95.7 t -70.81 96.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 122.274 1.035 . . . . 64.35 111.087 -175.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 145.62 -23.44 1.83 Allowed Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 109.143 -1.583 . . . . 71.34 109.143 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.57 178.02 4.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 120.666 0.27 . . . . 61.03 111.172 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 6.5 m -89.8 159.54 16.97 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.613 -0.721 . . . . 73.13 109.48 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -60.58 -43.97 96.74 Favored 'General case' 0 C--O 1.222 -0.347 0 O-C-N 123.089 0.243 . . . . 73.13 111.341 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.52 ' HA ' HG22 ' A' ' 528' ' ' VAL . 1.6 mp0 -56.86 -35.83 69.34 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.037 -0.529 . . . . 73.13 111.337 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -62.52 -38.69 90.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.818 -0.628 . . . . 74.32 109.703 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.12 -36.72 31.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.452 -0.795 . . . . 60.1 110.144 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.57 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 14.8 m -65.29 -41.4 91.33 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 C-N-CA 119.718 -0.793 . . . . 71.33 110.424 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 46.0 t -60.93 -40.07 91.87 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.494 0.664 . . . . 72.22 110.02 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.443 ' CD2' HG13 ' A' ' 514' ' ' VAL . 36.8 tp -64.33 -36.47 84.24 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 124.371 1.068 . . . . 71.42 109.814 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 471' ' ' LEU . 25.6 tp -70.9 -45.31 64.54 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.682 -0.69 . . . . 73.33 109.333 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.5 OUTLIER -59.69 -39.86 85.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.164 0.986 . . . . 71.44 110.891 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 29.1 t -64.77 -41.52 95.82 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.393 -0.821 . . . . 71.31 109.923 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 87.4 m 63.73 -91.05 0.03 OUTLIER 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.477 0.711 . . . . 33.51 111.072 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt 166.98 145.89 0.02 OUTLIER 'General case' 0 C--O 1.25 1.1 0 N-CA-C 105.757 -1.942 . . . . 71.33 105.757 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.5 mtt -66.37 -40.81 89.97 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.982 -0.287 . . . . 73.24 111.537 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.4 -79.84 0.06 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 119.248 -0.406 . . . . 73.12 111.944 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 178.66 -25.98 0.05 OUTLIER Glycine 0 C--O 1.218 -0.89 0 C-N-CA 116.634 -2.698 . . . . 55.04 116.562 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 1.3 p -94.78 120.37 34.89 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 114.926 1.454 . . . . 74.55 114.926 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 471' ' ' LEU . 98.7 t -107.95 131.98 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 114.239 -1.346 . . . . 72.55 108.646 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 24.2 p -95.39 114.58 26.36 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.256 0.551 . . . . 64.15 111.193 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.582 HD23 HD23 ' A' ' 464' ' ' LEU . 2.9 mm? -103.76 122.94 46.12 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.161 -1.052 . . . . 53.14 108.161 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 44.3 tp -103.92 117.92 35.46 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 106.445 -1.687 . . . . 63.42 106.445 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 29.0 m -116.79 161.22 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 120.63 -0.428 . . . . 71.22 110.789 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.528 ' HB2' HD11 ' A' ' 512' ' ' ILE . 91.9 t80 -111.33 117.48 33.25 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.367 0.604 . . . . 73.42 109.59 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -105.71 138.22 42.26 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.354 -1.35 . . . . 60.44 107.354 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -95.09 120.09 34.72 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.349 -0.982 . . . . 63.12 108.349 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -101.35 88.97 3.6 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.821 -0.807 . . . . 74.21 108.821 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 11.4 t70 . . . . . 0 C--N 1.303 -1.413 0 CA-C-N 114.958 -1.019 . . . . 63.13 109.268 -176.366 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.428 0 N-CA-C 111.979 -0.448 . . . . 74.03 111.979 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 67.5 m -156.36 165.76 35.41 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.707 -0.849 . . . . 71.34 108.707 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -85.24 136.25 33.59 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.671 -1.233 . . . . 73.35 107.671 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -64.3 110.26 2.18 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.171 0.434 . . . . 72.32 112.171 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 28.8 m -73.21 -40.36 64.78 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.537 -1.283 . . . . 70.01 107.537 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -98.55 98.74 9.88 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.735 -1.121 . . . . 61.41 109.915 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -139.3 137.32 35.74 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.999 -1.111 . . . . 73.21 107.999 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 11.0 tt -114.38 116.12 51.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 120.544 -0.462 . . . . 73.53 110.898 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 74.81 172.84 30.26 Favored Glycine 0 N--CA 1.398 -3.868 0 CA-C-O 122.261 0.923 . . . . 52.42 113.318 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -122.08 133.86 54.77 Favored 'General case' 0 C--N 1.264 -3.129 0 CA-C-N 114.022 -1.089 . . . . 73.11 111.968 176.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 93.5 mtt180 -104.66 135.4 46.13 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.331 -0.988 . . . . 72.53 108.331 175.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 6.4 mp -131.76 142.01 49.65 Favored 'General case' 0 CA--C 1.48 -1.742 0 CA-C-O 120.735 0.303 . . . . 74.42 110.953 -172.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -98.01 115.98 29.3 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.263 -0.88 . . . . 73.01 108.693 174.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . 0.413 HG23 ' HG2' ' A' ' 504' ' ' ARG . 71.0 mt -123.77 123.17 66.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.13 -0.941 . . . . 63.12 110.12 -175.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.502 ' HB3' ' CG2' ' A' ' 539' ' ' THR . 25.6 mt-30 -100.41 137.29 39.03 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.836 -0.746 . . . . 74.43 112.558 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 505' ' ' LEU . 4.3 mm? -116.66 136.26 53.11 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 115.112 -0.949 . . . . 74.51 110.228 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.8 120.48 42.38 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 106.861 -1.533 . . . . 72.13 106.861 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -45.73 100.9 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.753 1.221 . . . . 74.12 111.465 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -92.96 -121.59 3.07 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.5 -0.773 . . . . 72.31 112.953 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . 0.717 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 36.3 m -59.87 -56.97 15.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.943 0.497 . . . . 64.34 111.737 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -112.32 -6.69 14.03 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.672 0.749 . . . . 63.13 111.58 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 77.79 -156.51 44.34 Favored Glycine 0 C--O 1.199 -2.088 0 CA-C-O 118.377 -1.235 . . . . 55.51 110.949 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.473 HD11 HG21 ' A' ' 540' ' ' VAL . 41.6 mt -50.41 102.36 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.71 1.255 . . . . 71.44 112.9 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -122.35 53.64 0.72 Allowed Glycine 0 N--CA 1.422 -2.281 0 CA-C-N 114.488 -1.233 . . . . 62.22 111.257 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.633 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 6.1 p90 -126.51 145.16 50.62 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.746 -1.576 . . . . 74.5 106.746 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 38.9 m -114.97 138.33 50.97 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 109.033 -0.728 . . . . 62.13 109.033 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 14.2 pt -109.72 152.58 11.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-O 121.421 0.629 . . . . 75.12 111.786 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.418 HG21 ' HE3' ' A' ' 491' ' ' LYS . 9.1 t -136.34 159.61 41.23 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.27 -1.382 . . . . 74.42 107.27 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.647 ' HB3' ' OE1' ' A' ' 524' ' ' GLN . 33.3 p -118.82 142.47 47.69 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 109.021 -0.733 . . . . 54.15 109.021 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -109.36 115.63 30.32 Favored 'General case' 0 N--CA 1.418 -2.028 0 C-N-CA 119.673 -0.811 . . . . 72.23 108.964 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -41.18 126.28 2.63 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 125.448 1.499 . . . . 62.4 113.135 -174.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 9.4 p -80.29 -20.2 11.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.238 -0.892 . . . . 71.3 110.716 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 29.4 m 62.51 78.18 0.3 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.452 -0.795 . . . . 71.03 110.245 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 51.4 mm 64.98 94.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 114.378 -1.283 . . . . 72.52 110.567 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -170.29 -103.3 0.16 Allowed Glycine 0 CA--C 1.492 -1.352 0 C-N-CA 120.666 -0.778 . . . . 72.43 112.147 -177.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -170.59 112.06 0.44 Allowed Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 120.606 -0.807 . . . . 74.04 112.097 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 53.2 m 72.31 -44.74 0.6 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.482 1.66 . . . . 53.12 115.482 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 78.59 143.14 0.09 OUTLIER Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 124.638 1.175 . . . . 62.25 110.366 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.22 144.72 92.46 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 122.796 2.331 . . . . 71.43 113.449 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.411 HG13 ' HB3' ' A' ' 519' ' ' LEU . 24.2 mm -95.58 133.51 36.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.156 -0.929 . . . . 74.25 109.014 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.05 151.76 51.08 Favored 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 122.079 -0.388 . . . . 75.2 110.642 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 56.2 t -84.52 119.02 32.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.709 -0.849 . . . . 54.21 108.709 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.418 ' HE3' HG21 ' A' ' 476' ' ' THR . 5.2 tppp? -83.1 -55.86 4.12 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.629 0.772 . . . . 74.21 110.167 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -141.65 152.89 44.34 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.487 -0.778 . . . . 63.33 110.49 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.495 HG12 ' HB2' ' A' ' 507' ' ' ALA . 30.0 mm -117.11 105.09 17.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.735 -1.58 . . . . 74.34 106.735 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.09 146.36 88.19 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 116.114 -0.494 . . . . 60.45 111.463 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.447 ' C ' HG21 ' A' ' 500' ' ' ILE . 84.9 Cg_endo -74.82 12.28 1.21 Allowed 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 124.579 3.519 . . . . 62.43 116.189 -172.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.717 ' O ' ' HB ' ' A' ' 468' ' ' THR . 13.0 ptp180 -155.37 3.48 0.19 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 115.361 1.615 . . . . 74.22 115.361 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.519 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -83.92 -161.14 31.78 Favored Glycine 0 C--N 1.286 -2.195 0 C-N-CA 119.265 -1.445 . . . . 75.42 112.625 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -69.1 -39.35 79.04 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 123.414 0.686 . . . . 73.02 110.001 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -56.86 -42.76 80.31 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 114.441 -1.254 . . . . 73.53 111.827 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.56 HG21 ' N ' ' A' ' 496' ' ' ARG . 0.0 OUTLIER -80.03 -37.15 17.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 112.571 0.582 . . . . 73.15 112.571 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.5 mm100 -61.13 -40.85 95.36 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.814 0.34 . . . . 72.42 110.641 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.511 ' HB2' HD13 ' A' ' 464' ' ' LEU . 6.4 m-20 -84.11 -43.3 15.17 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.21 -0.45 . . . . 50.14 109.969 174.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 70.44 13.97 71.46 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 121.346 -0.454 . . . . 63.21 113.62 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.413 ' HG2' HG23 ' A' ' 462' ' ' ILE . 77.6 ttt180 -88.16 -14.06 39.63 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.433 0.635 . . . . 70.02 109.686 -178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.542 ' HB2' HD21 ' A' ' 464' ' ' LEU . 49.2 tp -114.83 138.39 50.83 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.88 -1.156 . . . . 64.31 107.88 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.466 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -140.98 169.34 17.81 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.811 0.671 . . . . 61.42 112.811 178.483 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.495 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -82.55 161.9 22.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.013 -0.539 . . . . 62.4 111.938 -173.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 74.96 42.21 30.63 Favored Glycine 0 CA--C 1.506 -0.485 0 N-CA-C 110.802 -0.919 . . . . 74.05 110.802 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -146.68 149.11 32.81 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.959 -1.497 . . . . 73.34 106.959 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.453 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 41.6 ttm180 -87.7 138.22 31.66 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 118.095 0.407 . . . . 73.23 111.385 -174.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.494 ' HG ' HD11 ' A' ' 519' ' ' LEU . 25.9 tp -100.23 127.38 46.52 Favored 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 108.442 -0.948 . . . . 73.23 108.442 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.542 ' HB ' HD12 ' A' ' 543' ' ' LEU . 34.5 mm -100.97 -47.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.096 0.474 . . . . 74.54 110.966 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 543' ' ' LEU . 10.5 pt-20 -157.13 149.35 22.9 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 109.022 -0.733 . . . . 62.44 109.022 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 541' ' ' SER . 7.1 p -137.57 134.43 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 CA-C-O 121.254 0.55 . . . . 73.14 109.727 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . 0.52 HD21 ' HB2' ' A' ' 535' ' ' LYS . 4.1 t-20 58.81 23.21 11.0 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 127.003 2.121 . . . . 53.14 112.944 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 89.72 15.4 58.21 Favored Glycine 0 CA--C 1.502 -0.752 0 C-N-CA 121.036 -0.602 . . . . 63.24 112.538 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.5 t -115.38 131.41 67.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 O-C-N 122.709 -0.289 . . . . 71.14 110.308 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.73 130.48 35.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.343 0.657 . . . . 70.02 110.364 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.494 HD11 ' HG ' ' A' ' 511' ' ' LEU . 10.7 mt -95.87 -30.5 13.62 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.587 0.708 . . . . 72.32 110.205 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 55.3 t -58.83 -34.74 53.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.133 -1.394 . . . . 64.44 112.049 -171.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -99.38 20.68 48.81 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.929 -0.653 . . . . 51.21 113.831 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.422 ' HB2' ' CD ' ' A' ' 526' ' ' GLU . 0.1 OUTLIER -138.46 -179.83 6.03 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 117.797 0.798 . . . . 70.02 111.954 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 32.6 m -92.16 163.21 14.02 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.649 0.261 . . . . 63.51 111.471 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.647 ' OE1' ' HB3' ' A' ' 477' ' ' SER . 43.6 tp60 -59.7 -44.93 93.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.329 1.052 . . . . 75.13 110.694 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.491 ' HA ' HG22 ' A' ' 528' ' ' VAL . 47.8 mt-10 -62.32 -31.95 72.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.695 0.628 . . . . 64.12 112.695 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.422 ' CD ' ' HB2' ' A' ' 522' ' ' LYS . 50.1 mt-10 -63.81 -36.83 85.2 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.651 -0.5 . . . . 64.41 109.651 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.464 HG13 HD22 ' A' ' 519' ' ' LEU . 17.3 t -73.68 -36.51 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 115.588 -0.733 . . . . 74.44 109.478 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 13.9 m -69.45 -39.39 78.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.417 0 C-N-CA 119.592 -0.843 . . . . 63.15 111.177 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.9 t -62.33 -43.3 99.14 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.196 0.522 . . . . 64.05 109.661 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.85 -41.84 78.66 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.811 1.244 . . . . 61.31 109.383 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 473' ' ' PHE . 3.2 tt -69.0 -45.13 71.32 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.921 -1.036 . . . . 73.12 112.58 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.537 ' HA ' ' HE ' ' A' ' 532' ' ' ARG . 1.1 mmp_? -62.15 -43.72 98.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.554 -0.294 . . . . 73.14 110.48 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.1 m -68.54 -32.36 72.25 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.226 -0.443 . . . . 71.04 111.434 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 51.4 m 68.49 -94.88 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.02 0.528 . . . . 55.55 111.348 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.52 ' HB2' HD21 ' A' ' 515' ' ' ASN . 86.1 tttt 169.26 141.17 0.02 OUTLIER 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.435 -1.32 . . . . 74.04 107.435 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 86.8 mtp -68.75 -31.87 71.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.646 0.26 . . . . 71.43 111.598 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -59.61 -38.33 80.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.315 0.578 . . . . 71.21 110.288 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 112.02 -29.74 8.22 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.159 -1.02 . . . . 74.22 114.129 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 463' ' ' GLN . 6.4 m -103.93 136.3 43.84 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.973 -0.691 . . . . 61.44 109.238 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 471' ' ' LEU . 61.3 t -118.92 138.24 50.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.915 -0.584 . . . . 41.44 110.039 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 69.2 m -91.93 115.0 27.7 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-O 121.077 0.465 . . . . 63.54 111.478 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.633 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.3 mm? -102.09 119.73 39.27 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.8 -1.185 . . . . 75.22 107.8 176.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.542 HD12 ' HB ' ' A' ' 512' ' ' ILE . 2.8 tm? -108.23 117.07 33.2 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 104.832 -2.284 . . . . 52.14 104.832 173.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 33.5 m -115.9 161.33 14.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 115.379 -0.828 . . . . 74.1 111.624 -173.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.453 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 66.4 t80 -120.87 116.55 25.38 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.514 -0.921 . . . . 73.22 108.514 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -102.39 130.49 49.17 Favored 'General case' 0 N--CA 1.396 -3.146 0 CA-C-N 115.054 -0.975 . . . . 74.01 108.77 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.6 142.43 35.65 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 114.598 1.333 . . . . 62.41 114.598 -172.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -153.08 93.11 1.69 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.84 -1.073 . . . . 73.53 108.628 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 19.6 t70 . . . . . 0 C--N 1.301 -1.532 0 N-CA-C 107.841 -1.17 . . . . 71.33 107.841 -179.68 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.492 0 N-CA-C 111.037 -0.825 . . . . 74.33 111.037 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 46.6 m 64.84 -176.93 0.17 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.658 0.783 . . . . 73.44 111.912 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 72.73 -51.32 0.71 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.145 1.165 . . . . 75.41 114.145 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -88.22 91.18 8.68 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.019 0.914 . . . . 74.45 108.891 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 37.2 m -75.11 -39.85 60.35 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.172 -0.922 . . . . 73.21 108.833 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.449 ' HB3' ' HZ3' ' A' ' 454' ' ' LYS . 9.1 mtpm? -94.82 161.65 14.08 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 122.005 0.907 . . . . 65.35 112.093 178.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -140.21 169.52 17.53 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 104.707 -2.331 . . . . 53.15 104.707 176.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.65 85.17 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 105.276 -2.12 . . . . 71.21 105.276 168.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 126.7 161.66 10.97 Favored Glycine 0 N--CA 1.41 -3.063 0 N-CA-C 107.538 -2.225 . . . . 73.43 107.538 -172.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 29.5 mtpp -124.77 151.79 44.68 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 117.721 0.76 . . . . 71.11 111.962 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 95.0 mtt180 -116.17 126.22 53.38 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.821 -1.178 . . . . 62.44 107.821 167.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.2 mp -123.93 142.08 51.46 Favored 'General case' 0 CA--C 1.465 -2.29 0 CA-C-N 116.536 -0.302 . . . . 52.42 110.49 -172.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -98.19 114.95 27.35 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 115.104 -0.953 . . . . 70.23 108.929 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . 0.457 HG23 ' CG ' ' A' ' 504' ' ' ARG . 54.9 mt -118.86 129.58 74.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-N 114.893 -1.049 . . . . 72.12 109.463 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.2 mt-30 -115.86 127.94 55.41 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 113.046 0.758 . . . . 72.34 113.046 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.562 HD23 HD23 ' A' ' 542' ' ' LEU . 3.9 mm? -115.64 137.86 51.65 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 115.009 -0.996 . . . . 60.13 109.769 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.46 ' HE2' ' HB3' ' A' ' 465' ' ' LYS . 34.5 ttpt -107.48 135.96 48.08 Favored 'General case' 0 N--CA 1.4 -2.939 0 N-CA-C 108.867 -0.79 . . . . 75.42 108.867 -177.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.451 ' HB2' HG21 ' A' ' 534' ' ' THR . 39.4 ttmt -61.76 98.59 0.1 Allowed 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.639 0.733 . . . . 55.34 111.601 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -130.86 139.55 11.04 Favored Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 108.375 -1.89 . . . . 61.51 108.375 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 469' ' ' GLU 0.365 7.3 t 52.75 -81.55 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.104 1.361 . . . . 62.22 113.819 -175.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.43 ' OE1' ' HG3' ' A' ' 496' ' ' ARG . 37.9 mt-10 -106.79 -7.68 17.09 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.732 0.697 . . . . 63.33 110.858 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 67.8 -157.04 52.42 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.255 -0.884 . . . . 72.43 111.826 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 498' ' ' ALA . 5.3 mp -44.4 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.32 1.23 . . . . 63.12 114.32 -170.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -97.54 65.11 0.89 Allowed Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.018 -1.446 . . . . 52.4 111.291 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.446 ' HB3' HD13 ' A' ' 493' ' ' ILE . 27.1 p90 -155.44 147.84 23.88 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.193 -0.504 . . . . 75.15 110.184 176.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -126.27 162.77 24.69 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.474 -0.785 . . . . 35.13 109.446 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.2 pt -119.68 155.46 22.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 120.95 0.405 . . . . 51.41 111.703 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.9 t -135.68 129.53 32.87 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.877 -0.601 . . . . 74.02 110.239 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 24.0 t -143.67 130.75 20.63 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.621 -0.881 . . . . 75.21 108.621 173.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -126.29 38.41 4.14 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 107.297 -1.371 . . . . 72.21 107.297 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . 0.581 ' HA ' ' CB ' ' A' ' 486' ' ' ALA . 9.2 t70 69.26 -163.03 0.18 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 112.522 -2.126 . . . . 73.44 108.171 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.495 HG12 ' HD3' ' A' ' 487' ' ' PRO . 33.6 m -91.4 16.67 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.959 -1.126 . . . . 65.12 107.959 177.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 23.7 m 77.83 73.56 0.06 Allowed 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 125.539 1.536 . . . . 62.45 108.575 -173.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 54.0 mt 65.41 90.64 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 113.482 -1.69 . . . . 51.0 111.296 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -167.05 -52.65 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.888 -0.672 . . . . 72.3 112.429 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.8 -27.66 6.42 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.301 -0.476 . . . . 72.14 112.644 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 9.9 p -86.72 40.26 0.89 Allowed 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.131 0.972 . . . . 64.12 111.731 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.581 ' CB ' ' HA ' ' A' ' 479' ' ' ASP . . . -43.12 117.93 2.38 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 125.267 1.427 . . . . 61.15 114.444 -175.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.495 ' HD3' HG12 ' A' ' 480' ' ' VAL . 55.6 Cg_endo -89.13 143.33 4.75 Favored 'Trans proline' 0 N--CA 1.436 -1.895 0 C-N-CA 122.515 2.143 . . . . 75.22 109.998 174.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 511' ' ' LEU . 41.9 mm -96.24 139.65 18.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 109.325 -0.62 . . . . 74.13 109.325 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.17 153.4 48.59 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 122.311 -0.243 . . . . 73.15 110.575 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.408 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 26.3 t -73.74 121.32 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.86 -1.163 . . . . 73.44 107.86 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -90.38 -52.44 4.92 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.563 0.697 . . . . 73.4 110.976 -176.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -146.32 150.89 36.6 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.414 -0.812 . . . . 53.15 110.3 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.522 HG12 ' HB2' ' A' ' 507' ' ' ALA . 34.6 mm -119.96 104.83 16.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 107.444 -1.317 . . . . 62.44 107.444 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -62.9 122.62 75.87 Favored Pre-proline 0 C--N 1.307 -1.253 0 CA-C-N 115.585 -0.734 . . . . 71.31 109.83 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.36 22.79 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 124.768 3.645 . . . . 74.23 114.3 -171.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.43 ' HG3' ' OE1' ' A' ' 469' ' ' GLU . 8.3 ptp180 -157.43 6.99 0.15 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 113.437 0.903 . . . . 72.43 113.437 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -101.14 -149.96 23.54 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 119.814 -1.184 . . . . 74.14 112.449 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 471' ' ' LEU . . . -64.09 -40.29 95.9 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.156 0.582 . . . . 70.0 111.207 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.415 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . -57.08 -36.8 71.01 Favored 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 115.545 -0.752 . . . . 73.31 112.635 -174.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.8 tt -80.72 -42.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.445 0.535 . . . . 62.31 112.445 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 501' ' ' GLN . 14.7 mm-40 -61.46 -37.73 84.66 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.057 0.392 . . . . 73.31 112.057 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.521 ' HB2' HD13 ' A' ' 464' ' ' LEU . 17.5 m-20 -94.93 -28.98 14.9 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 109.442 -0.577 . . . . 72.24 109.442 175.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 499' ' ' ALA . . . 57.7 28.7 60.45 Favored Glycine 0 CA--C 1.496 -1.1 0 CA-C-N 115.467 -0.788 . . . . 74.13 114.36 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.457 ' CG ' HG23 ' A' ' 462' ' ' ILE . 26.7 tpt180 -99.4 -13.94 19.36 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.248 -0.581 . . . . 73.13 110.772 -174.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 49.7 tp -123.41 148.1 46.46 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.541 0.21 . . . . 74.43 110.449 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 506' ' ' LYS . 0.0 OUTLIER -141.98 165.41 27.53 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.764 -0.828 . . . . 71.24 108.764 177.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.522 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -85.39 130.62 34.55 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.48 -0.563 . . . . 62.4 109.48 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 140.85 -20.28 2.71 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.211 -0.756 . . . . 60.43 111.211 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -89.17 165.76 14.26 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-O 121.132 0.491 . . . . 74.52 111.419 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.571 ' NH1' HD13 ' A' ' 512' ' ' ILE . 2.2 tmt_? -107.79 141.03 39.98 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 116.042 -0.526 . . . . 64.02 110.026 -177.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.648 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.6 mm? -86.79 129.09 35.01 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.861 -0.609 . . . . 70.04 112.29 -175.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.571 HD13 ' NH1' ' A' ' 510' ' ' ARG . 32.8 mm -106.69 -59.17 3.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.405 -0.361 . . . . 74.14 110.141 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -158.81 149.27 19.8 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.393 0.433 . . . . 75.14 110.38 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 6.0 p -123.03 129.91 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 109.115 -0.698 . . . . 61.45 109.115 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 60.91 2.77 0.57 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.539 1.135 . . . . 71.54 113.746 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 113.57 -4.28 24.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 121.051 -0.595 . . . . 73.22 112.511 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.5 t -93.22 134.73 30.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.385 -0.598 . . . . 72.02 109.385 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -77.63 145.72 36.56 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 123.601 0.563 . . . . 62.51 110.145 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.648 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 18.8 mt -101.48 -38.14 8.12 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.901 -0.778 . . . . 73.45 108.901 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.22 104.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 115.185 -0.916 . . . . 74.31 108.561 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 136.33 -21.19 3.48 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 108.934 -1.666 . . . . 73.24 108.934 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.97 172.83 7.27 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.514 -0.343 . . . . 74.21 110.511 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 23.8 m -89.24 161.77 16.24 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.326 -0.397 . . . . 75.13 111.226 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -57.83 -46.63 84.46 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 123.005 0.522 . . . . 71.12 111.563 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.535 ' HA ' HG22 ' A' ' 528' ' ' VAL . 48.5 mt-10 -58.18 -32.89 68.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.178 -0.465 . . . . 70.34 112.118 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.13 -41.62 90.22 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.325 -0.62 . . . . 73.42 109.325 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 44.2 t -70.28 -37.34 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 115.495 -0.775 . . . . 44.43 110.199 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.662 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.1 m -66.29 -41.26 88.73 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.439 0 C-N-CA 119.731 -0.788 . . . . 54.13 110.514 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.6 t -63.19 -42.95 99.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.205 0.526 . . . . 71.31 109.718 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 29.1 tp -59.96 -34.93 73.94 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.838 1.255 . . . . 73.11 110.099 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.45 ' CD1' HD23 ' A' ' 471' ' ' LEU . 26.5 tp -77.64 -47.98 17.95 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.856 -0.611 . . . . 54.24 110.312 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 4.8 mmp_? -57.79 -41.06 81.31 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.005 0.522 . . . . 74.34 110.887 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 46.0 m -60.34 -30.2 69.38 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.878 -0.601 . . . . 64.12 111.562 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . 0.451 HG21 ' HB2' ' A' ' 466' ' ' LYS . 40.8 m 67.26 -91.14 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.399 0.68 . . . . 71.23 111.76 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 537' ' ' GLU . 88.6 tttt 164.93 144.35 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 104.535 -2.394 . . . . 74.24 104.535 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 85.0 mtp -66.91 -25.49 66.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.769 0.713 . . . . 63.34 111.444 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 0.9 OUTLIER -64.87 -65.65 0.65 Allowed 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.053 -1.091 . . . . 75.1 108.053 172.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 143.39 -31.56 1.92 Allowed Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 119.084 -1.532 . . . . 64.12 114.662 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 465' ' ' LYS . 1.8 m -94.57 142.19 27.73 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.344 -0.943 . . . . 64.13 109.214 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 58.2 t -122.43 142.16 39.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 123.575 0.75 . . . . 75.33 109.062 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.7 m -105.76 113.4 26.94 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.44 0.638 . . . . 74.44 110.674 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.562 HD23 HD23 ' A' ' 464' ' ' LEU . 2.6 mm? -102.36 119.03 38.13 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.899 -1.148 . . . . 74.14 107.899 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 2.9 tm? -104.77 115.95 31.19 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 105.216 -2.142 . . . . 75.22 105.216 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 32.7 m -117.41 161.01 16.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.024 -0.989 . . . . 73.44 111.328 -174.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 86.9 t80 -112.06 117.96 34.1 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 108.399 -0.963 . . . . 55.23 108.399 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -105.82 131.9 52.59 Favored 'General case' 0 N--CA 1.411 -2.382 0 N-CA-C 107.968 -1.123 . . . . 74.14 107.968 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -78.94 134.97 36.82 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 116.117 -0.492 . . . . 65.1 110.218 -175.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -107.57 101.97 11.26 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.502 0.668 . . . . 73.4 109.678 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 C--N 1.292 -1.934 0 N-CA-C 107.687 -1.227 . . . . 74.33 107.687 179.852 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.997 0 N-CA-C 110.308 -1.117 . . . . 55.14 110.308 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 23.1 p -89.72 88.79 7.51 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.381 0.61 . . . . 73.52 111.414 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -87.19 101.6 13.66 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.547 -0.908 . . . . 74.4 108.547 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -128.06 100.28 5.81 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.244 -0.435 . . . . 72.12 110.69 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 23.6 p -98.54 142.93 29.52 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.84 -0.618 . . . . 65.15 109.951 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -82.54 -34.11 27.95 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.157 0.503 . . . . 72.14 110.281 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -105.25 149.56 25.88 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.504 -0.924 . . . . 74.12 108.504 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 10.6 tt -100.63 85.3 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 122.094 0.95 . . . . 72.14 112.032 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 546' ' ' ARG . . . -112.87 92.12 0.61 Allowed Glycine 0 CA--C 1.485 -1.829 0 N-CA-C 108.607 -1.797 . . . . 54.41 108.607 174.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -136.86 169.64 17.43 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.822 0.344 . . . . 61.15 110.819 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 71.3 mtm180 -100.43 148.78 24.36 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.633 -0.712 . . . . 73.34 109.306 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -130.95 134.22 46.54 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.283 -0.636 . . . . 65.33 109.283 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -92.88 115.47 28.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.909 -1.145 . . . . 74.34 107.909 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . 0.415 HG23 ' CG ' ' A' ' 504' ' ' ARG . 60.6 mt -119.94 137.64 53.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 115.746 -0.661 . . . . 70.12 109.844 -174.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.0 mt-30 -120.83 127.52 52.0 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.744 0.646 . . . . 73.04 112.744 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.584 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.2 mm? -113.8 142.13 46.45 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 114.895 -1.048 . . . . 63.55 111.002 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -101.34 127.33 48.01 Favored 'General case' 0 N--CA 1.398 -3.029 0 N-CA-C 107.584 -1.265 . . . . 72.2 107.584 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.11 95.6 0.13 Allowed 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.903 -0.59 . . . . 61.52 109.594 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -136.95 153.51 21.79 Favored Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 115.511 -0.768 . . . . 32.45 111.856 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 22.0 m 59.28 -91.74 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.945 1.298 . . . . 74.22 111.497 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -101.84 -3.98 27.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.291 0.567 . . . . 75.11 109.918 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.29 -161.22 54.21 Favored Glycine 0 C--O 1.205 -1.706 0 CA-C-O 118.922 -0.932 . . . . 70.44 111.595 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.507 HD11 HG21 ' A' ' 540' ' ' VAL . 66.4 mt -48.36 99.94 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.832 0.825 . . . . 72.25 112.712 -171.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -111.28 61.0 0.31 Allowed Glycine 0 CA--C 1.479 -2.184 0 CA-C-N 114.567 -1.197 . . . . 44.23 111.641 -174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -150.13 142.26 24.06 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 109.138 -0.69 . . . . 65.33 109.138 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.5 p -115.53 155.19 28.0 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.943 -0.571 . . . . 60.43 110.58 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.6 pt -116.33 150.34 18.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.059 0.457 . . . . 64.23 111.757 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.415 ' CB ' ' HE3' ' A' ' 491' ' ' LYS . 9.0 t -136.22 147.07 47.43 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.476 -0.784 . . . . 72.54 109.987 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 57.9 p -142.41 131.74 23.53 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.862 -0.792 . . . . 63.03 108.862 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -107.86 -68.87 0.88 Allowed 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.618 -0.433 . . . . 63.33 112.069 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -152.28 144.11 23.66 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.215 -1.032 . . . . 70.44 108.215 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.586 HG21 ' H ' ' A' ' 484' ' ' GLY . 13.7 p -72.25 125.24 30.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.549 0.69 . . . . 74.43 112.174 -176.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 30.0 m -109.61 78.7 1.15 Allowed 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 108.492 -0.929 . . . . 71.4 108.492 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 62.1 mt 58.75 98.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.482 1.113 . . . . 70.34 112.289 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 173.94 -59.09 0.13 Allowed Glycine 0 C--N 1.318 -0.456 0 C-N-CA 120.222 -0.99 . . . . 43.24 113.05 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . 0.586 ' H ' HG21 ' A' ' 480' ' ' VAL . . . -176.68 -121.5 0.67 Allowed Glycine 0 C--N 1.312 -0.75 0 C-N-CA 120.856 -0.688 . . . . 24.11 111.615 -177.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . 0.418 ' O ' ' HB ' ' A' ' 480' ' ' VAL . 50.1 m -73.78 -59.08 2.88 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.939 0.4 . . . . 70.44 111.336 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -161.96 153.81 15.97 Favored Pre-proline 0 N--CA 1.438 -1.039 0 N-CA-C 108.293 -1.003 . . . . 62.03 108.293 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.564 ' HD3' ' HA ' ' A' ' 480' ' ' VAL . 9.6 Cg_endo -93.61 134.68 1.0 Allowed 'Trans proline' 0 N--CA 1.433 -2.061 0 C-N-CA 122.369 2.046 . . . . 71.31 109.974 176.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.19 132.14 41.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.34 -0.615 . . . . 54.31 109.34 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 90.8 m-85 -129.02 152.76 48.28 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 110.31 -0.255 . . . . 55.22 110.31 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.39 119.51 30.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.469 -0.937 . . . . 75.04 108.469 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.415 ' HE3' ' CB ' ' A' ' 476' ' ' THR . 4.7 tppp? -82.15 -59.62 2.5 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.791 -0.64 . . . . 74.14 110.722 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -140.16 155.49 46.93 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 120.316 -0.554 . . . . 61.35 110.675 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.534 HG12 ' HB2' ' A' ' 507' ' ' ALA . 33.8 mm -119.2 104.8 16.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.306 -1.368 . . . . 62.3 107.306 177.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.23 130.53 89.5 Favored Pre-proline 0 C--N 1.307 -1.282 0 CA-C-N 116.022 -0.535 . . . . 55.41 111.084 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.81 18.03 0.2 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 125.027 3.818 . . . . 73.12 115.45 -171.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -161.13 6.81 0.07 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 113.916 1.08 . . . . 72.11 113.916 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -91.63 -155.86 32.17 Favored Glycine 0 C--N 1.294 -1.754 0 C-N-CA 119.464 -1.35 . . . . 73.12 113.085 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.416 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -63.39 -41.6 98.78 Favored 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 123.942 0.897 . . . . 72.03 109.876 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.542 ' HA ' HD11 ' A' ' 464' ' ' LEU . . . -56.65 -43.81 80.69 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 114.856 -1.065 . . . . 75.43 112.074 -173.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.1 tt -80.49 -29.34 12.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 112.19 0.441 . . . . 65.42 112.19 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -48.26 81.3 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.226 -1.028 . . . . 71.01 108.226 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.584 ' HB2' HD13 ' A' ' 464' ' ' LEU . 10.2 m-20 -87.08 -34.23 19.22 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 109.789 -0.449 . . . . 62.4 109.789 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 62.45 39.59 98.0 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.504 -0.771 . . . . 65.32 112.538 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.415 ' CG ' HG23 ' A' ' 462' ' ' ILE . 30.0 tpt180 -111.36 -4.89 14.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.33 0.586 . . . . 71.21 109.917 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 57.7 tp -125.73 142.74 51.36 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.857 -0.611 . . . . 71.51 110.546 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.492 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.28 0.0 OUTLIER -138.51 164.55 29.14 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.17 -0.468 . . . . 70.13 111.854 175.451 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.534 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.46 156.43 22.89 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.655 0.613 . . . . 75.21 112.655 -171.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.5 8.0 55.17 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.99 -0.624 . . . . 73.25 113.682 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -113.33 164.96 12.91 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 117.388 0.594 . . . . 63.42 110.191 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.408 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 43.1 ttm180 -89.95 129.32 36.3 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 123.095 0.247 . . . . 74.31 110.624 -177.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.93 124.33 33.02 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 106.069 -1.826 . . . . 75.31 106.069 177.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 50.7 mm -96.3 -51.11 11.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 120.562 0.22 . . . . 53.54 111.258 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -157.99 148.85 20.9 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 116.102 -0.499 . . . . 74.24 109.66 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 541' ' ' SER . 3.7 p -130.05 125.51 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.523 0 CA-C-N 116.025 -0.534 . . . . 71.32 109.566 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 59.51 26.9 15.94 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 114.864 -1.062 . . . . 75.41 112.067 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.54 -4.8 73.41 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.748 -0.66 . . . . 63.33 113.367 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.44 124.84 47.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.393 -0.595 . . . . 71.13 109.393 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -84.01 141.69 31.01 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.727 0.642 . . . . 74.35 109.382 -173.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.535 HD11 HD12 ' A' ' 511' ' ' LEU . 19.0 mt -99.72 -42.96 6.63 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.161 0.8 . . . . 73.21 113.161 -171.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.14 89.08 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-O 122.23 1.014 . . . . 74.24 110.629 -174.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 151.03 -13.87 0.85 Allowed Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 113.994 -1.457 . . . . 73.24 109.693 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.82 177.78 4.65 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 122.85 -0.206 . . . . 74.44 110.89 175.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 48.9 m -88.61 156.68 18.9 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.514 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.419 ' O ' HG13 ' A' ' 528' ' ' VAL . 34.2 tt0 -58.76 -44.38 90.59 Favored 'General case' 0 C--O 1.21 -0.996 0 C-N-CA 122.487 0.315 . . . . 71.14 110.514 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.519 ' HA ' HG22 ' A' ' 528' ' ' VAL . 28.3 mm-40 -57.72 -31.46 66.44 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 112.661 0.615 . . . . 61.55 112.661 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -66.58 -39.8 88.62 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.188 -0.671 . . . . 71.22 109.188 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 33.8 t -75.48 -36.39 35.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.135 -0.938 . . . . 73.24 110.285 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.704 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 10.7 m -63.67 -44.81 98.58 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 C-N-CA 120.351 -0.54 . . . . 65.3 109.933 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.7 m -64.51 -36.98 85.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.4 0.619 . . . . 74.5 110.267 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 32.6 tp -61.03 -43.6 98.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.736 1.214 . . . . 63.32 109.428 175.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.45 HD12 HD13 ' A' ' 471' ' ' LEU . 35.2 tp -67.3 -48.03 68.83 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.75 -0.659 . . . . 74.24 109.845 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.704 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 32.2 mmm180 -57.41 -30.11 64.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.731 0.813 . . . . 64.42 111.192 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 61.2 m -73.6 -43.64 59.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.925 -0.579 . . . . 61.21 111.532 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 40.4 m 68.26 142.2 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.664 0.786 . . . . 74.14 111.311 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.523 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 60.4 tptt -59.9 132.17 53.12 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.636 -0.711 . . . . 74.42 109.641 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -63.35 -20.11 65.22 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.513 0.725 . . . . 64.23 111.938 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . 0.523 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 38.4 tt0 -73.89 -15.17 61.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.492 0.663 . . . . 70.31 110.253 177.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 94.69 -20.29 49.37 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.085 -0.579 . . . . 71.11 112.333 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 463' ' ' GLN . 2.7 m -114.19 128.79 56.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.748 -1.204 . . . . 72.23 107.748 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.521 HG22 ' H ' ' A' ' 535' ' ' LYS . 57.4 t -105.23 134.19 47.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 C-N-CA 122.816 0.446 . . . . 61.14 110.5 -176.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 29.9 m -98.48 115.14 27.9 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.744 -0.662 . . . . 54.2 110.832 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.484 HD23 HD23 ' A' ' 464' ' ' LEU . 2.7 mm? -110.95 124.68 52.6 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.4 -0.963 . . . . 60.1 108.4 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 53.0 tp -104.23 118.34 36.41 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.534 -1.654 . . . . 64.32 106.534 174.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.4 m -116.06 145.59 21.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 120.293 -0.563 . . . . 74.24 111.27 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -112.02 116.42 30.53 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.066 -1.086 . . . . 65.02 108.066 175.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . 0.494 ' O ' ' HA2' ' A' ' 457' ' ' GLY . 0.0 OUTLIER -103.7 120.89 41.85 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 108.2 -1.037 . . . . 73.44 108.2 178.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -98.37 143.53 28.73 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.993 -0.549 . . . . 74.14 109.843 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . 0.428 ' HB2' ' NH1' ' A' ' 546' ' ' ARG . 31.4 tt0 -116.88 110.18 18.01 Favored 'General case' 0 N--CA 1.418 -2.034 0 C-N-CA 120.468 -0.493 . . . . 64.2 110.065 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--O 1.25 1.104 0 CA-C-N 114.682 -1.144 . . . . 74.44 111.149 -177.817 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.544 0 N-CA-C 111.497 -0.641 . . . . 44.14 111.497 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 40.7 t -73.05 -42.21 63.36 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.765 -0.828 . . . . 74.13 108.765 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -144.65 154.27 42.62 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 107.373 -1.343 . . . . 71.13 107.373 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -79.0 113.21 16.94 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 120.43 -0.508 . . . . 65.13 109.928 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 27.4 m -75.84 99.32 4.42 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.783 -0.821 . . . . 61.45 108.783 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -110.21 98.96 8.1 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 116.17 -0.468 . . . . 74.44 111.418 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -137.05 115.1 11.52 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.703 -0.851 . . . . 72.23 108.703 176.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 38.0 pt -90.77 1.81 7.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 122.483 1.135 . . . . 72.3 108.639 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 158.76 145.17 4.16 Favored Glycine 1 N--CA 1.395 -4.039 0 N-CA-C 108.355 -1.898 . . . . 65.53 108.355 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.785 ' HE2' ' H ' ' A' ' 458' ' ' LYS . 0.0 OUTLIER -137.83 170.64 15.7 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 109.538 -0.542 . . . . 62.54 109.538 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 97.6 mtt180 -99.13 142.28 30.82 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.881 -0.785 . . . . 74.21 108.881 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.1 mm? -123.72 133.71 53.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.189 -0.671 . . . . 73.11 109.189 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -100.07 116.62 32.51 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.454 -0.943 . . . . 64.35 108.454 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . 0.434 HG21 ' HB3' ' A' ' 504' ' ' ARG . 57.0 mt -123.3 125.02 71.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.61 -0.723 . . . . 73.54 110.959 -173.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.8 mt-30 -91.52 126.78 36.72 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.993 0.738 . . . . 61.42 112.993 178.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 502' ' ' ASP . 4.1 mm? -115.79 144.34 44.12 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.4 1.08 . . . . 71.33 110.332 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -103.03 136.67 42.41 Favored 'General case' 0 N--CA 1.404 -2.75 0 N-CA-C 107.833 -1.173 . . . . 73.51 107.833 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.491 ' HA ' ' HA2' ' A' ' 470' ' ' GLY . 23.5 ttmm -54.44 99.58 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.766 0.794 . . . . 72.14 111.328 175.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -85.3 -147.57 9.49 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 114.943 -1.026 . . . . 73.32 111.454 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 16.7 m -55.41 -45.41 76.72 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.978 0.511 . . . . 61.21 110.946 -177.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.59 9.81 17.98 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 120.691 0.281 . . . . 62.32 111.137 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 466' ' ' LYS . . . 58.01 -141.96 44.71 Favored Glycine 0 C--O 1.185 -2.967 0 CA-C-O 117.17 -1.905 . . . . 63.23 109.804 -170.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.538 ' H ' HD22 ' A' ' 471' ' ' LEU . 2.5 mm? -44.08 108.61 0.12 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.54 1.67 . . . . 70.51 112.459 -173.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -100.19 47.78 1.25 Allowed Glycine 0 N--CA 1.421 -2.311 0 CA-C-N 114.55 -1.204 . . . . 53.42 112.433 -173.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -140.92 144.8 35.39 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 109.356 -0.609 . . . . 71.32 109.356 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 18.8 m -114.6 139.38 49.66 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.889 -1.523 . . . . 52.32 106.889 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 489' ' ' TYR . 14.8 pt -111.46 151.24 13.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-O 120.976 0.417 . . . . 62.51 112.072 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -144.73 151.17 38.49 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.888 -0.596 . . . . 73.23 109.618 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 78.3 p -142.67 129.88 20.94 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.138 -0.69 . . . . 54.41 109.138 175.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -153.28 14.97 0.52 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.008 0.908 . . . . 61.12 109.065 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -106.46 11.29 30.9 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.709 -1.132 . . . . 72.34 108.78 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 486' ' ' ALA . 7.6 p -79.48 84.7 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-O 122.032 0.92 . . . . 70.41 111.431 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.4 t -145.8 4.91 1.0 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.481 -0.781 . . . . 65.4 110.435 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 482' ' ' ILE . 2.7 mp -103.93 10.32 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 N-CA-C 106.803 -1.554 . . . . 74.23 106.803 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 140.73 -120.62 1.77 Allowed Glycine 0 N--CA 1.427 -1.951 0 CA-C-N 114.607 -1.178 . . . . 63.05 110.246 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -121.72 9.25 9.91 Favored Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 108.142 -1.983 . . . . 74.05 108.142 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 13.6 p -79.73 65.01 4.76 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.487 -0.856 . . . . 75.3 110.721 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' A' ' 480' ' ' VAL . . . -69.81 112.11 11.24 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-N 114.644 -1.162 . . . . 74.41 109.22 174.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.579 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 3.2 Cg_exo -77.41 135.25 14.69 Favored 'Trans proline' 0 N--CA 1.427 -2.422 0 C-N-CA 121.144 1.229 . . . . 64.12 110.166 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.568 HG13 ' HB3' ' A' ' 519' ' ' LEU . 34.2 mm -90.52 119.94 38.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.286 -1.005 . . . . 64.42 108.286 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 78.8 m-85 -121.63 152.95 38.75 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 122.281 -0.262 . . . . 74.52 111.492 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 47.2 t -78.56 119.06 26.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.973 -0.751 . . . . 74.11 108.973 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -84.52 -53.84 5.15 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.78 -0.646 . . . . 75.55 109.425 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -143.13 154.04 43.5 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.327 -0.852 . . . . 64.42 109.044 -175.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.502 HG12 ' HB2' ' A' ' 507' ' ' ALA . 26.2 mm -110.44 110.2 31.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.842 -1.17 . . . . 71.12 107.842 174.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.0 mp -52.82 128.04 44.92 Favored Pre-proline 0 C--N 1.321 -0.665 0 O-C-N 123.941 0.776 . . . . 73.51 110.372 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.49 20.48 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 124.668 3.578 . . . . 71.32 114.908 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.44 ' O ' ' HB ' ' A' ' 468' ' ' THR . 14.2 ptp180 -168.82 5.9 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.323 0.583 . . . . 65.23 112.459 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -83.86 -167.87 42.81 Favored Glycine 0 C--N 1.298 -1.561 0 C-N-CA 119.893 -1.146 . . . . 65.43 112.663 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 464' ' ' LEU . . . -55.86 -47.4 77.39 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 124.932 1.293 . . . . 75.31 111.151 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.23 -40.6 77.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.743 -1.117 . . . . 72.53 112.559 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 8.5 tt -79.94 -40.43 20.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 112.57 0.582 . . . . 63.14 112.57 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 8.2 mm-40 -67.43 -37.87 83.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 72.34 110.841 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.567 ' HB2' HD13 ' A' ' 464' ' ' LEU . 7.8 m-20 -91.56 -21.95 20.59 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 116.116 -0.493 . . . . 63.55 109.87 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 63.92 55.78 22.46 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 120.742 -0.742 . . . . 54.54 114.803 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.434 ' HB3' HG21 ' A' ' 462' ' ' ILE . 14.3 mmm180 -123.85 -73.53 0.64 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.873 -0.731 . . . . 73.54 110.796 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.537 HD13 HG11 ' A' ' 544' ' ' VAL . 67.4 tp -73.68 137.7 44.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.778 0.323 . . . . 64.13 111.807 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.464 ' HA ' HG13 ' A' ' 493' ' ' ILE 0.267 0.0 OUTLIER -126.32 174.26 8.7 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.717 -0.674 . . . . 74.13 112.403 177.061 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.502 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.18 138.8 33.49 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 113.435 0.902 . . . . 62.13 113.435 -171.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 105.39 13.88 23.43 Favored Glycine 0 C--N 1.321 -0.253 0 CA-C-N 115.583 -0.735 . . . . 71.5 112.577 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.63 162.44 13.96 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 122.678 0.391 . . . . 74.3 110.398 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -101.45 134.36 44.66 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 120.81 -0.356 . . . . 74.04 110.649 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.597 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 3.6 mm? -86.97 132.99 33.63 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.553 -0.749 . . . . 62.01 110.171 174.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.426 HG21 ' HD3' ' A' ' 459' ' ' ARG . 49.7 mm -111.72 -39.07 3.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.06 -0.718 . . . . 74.42 109.06 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 543' ' ' LEU . 32.7 tt0 -154.72 148.43 25.42 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.517 -0.765 . . . . 61.12 109.156 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.597 HG13 HD11 ' A' ' 530' ' ' LEU . 6.8 p -136.51 125.47 37.07 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.077 0 N-CA-C 107.397 -1.334 . . . . 63.3 107.397 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 72.33 -52.27 0.7 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 125.982 1.713 . . . . 73.23 111.963 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 163.29 30.61 0.02 OUTLIER Glycine 0 C--N 1.287 -2.146 0 N-CA-C 109.519 -1.432 . . . . 72.21 109.519 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.1 t -122.5 134.43 65.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.305 -0.447 . . . . 64.2 109.902 -175.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.0 148.77 36.06 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.704 -0.48 . . . . 72.42 109.704 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.597 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 60.5 mt -111.51 -45.81 3.34 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 113.338 0.866 . . . . 73.32 113.338 -171.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.68 -1.31 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 113.146 0.795 . . . . 70.44 113.146 -172.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -112.41 12.18 25.95 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 111.616 -0.594 . . . . 63.13 111.616 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.413 ' NZ ' ' HB3' ' A' ' 522' ' ' LYS . 0.2 OUTLIER -146.53 -177.59 5.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 117.172 0.486 . . . . 53.52 111.505 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . 0.466 ' O ' HG23 ' A' ' 527' ' ' VAL . 76.3 p -96.17 163.3 13.16 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.214 0.53 . . . . 74.22 111.998 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.522 ' O ' HG13 ' A' ' 528' ' ' VAL . 37.9 mm-40 -55.24 -41.91 72.74 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.987 -1.006 . . . . 75.25 111.962 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.44 ' HA ' HG22 ' A' ' 528' ' ' VAL . 43.2 mt-10 -63.08 -31.81 73.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.105 0.479 . . . . 73.34 112.178 -175.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.88 -36.03 67.28 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.737 -0.665 . . . . 75.01 110.529 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.567 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 17.5 t -75.39 -41.5 42.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.393 -0.595 . . . . 73.31 109.393 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.709 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 16.3 m -62.18 -43.46 97.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 120.356 -0.538 . . . . 64.25 110.942 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.9 t -64.5 -37.06 86.22 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.451 -0.341 . . . . 73.31 111.325 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.597 HD11 HG13 ' A' ' 514' ' ' VAL . 1.2 pp -68.07 -37.54 81.39 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.011 -1.107 . . . . 73.53 108.011 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 471' ' ' LEU . 3.6 tt -62.98 -46.49 87.47 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.894 -1.048 . . . . 55.44 111.175 176.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.709 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 27.1 mmm180 -61.68 -33.63 74.32 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.127 -0.488 . . . . 73.13 110.409 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.0 m -82.96 -30.71 28.09 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.073 0.464 . . . . 74.12 110.685 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . 0.476 HG21 ' HE2' ' A' ' 466' ' ' LYS . 30.5 m 71.98 -83.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.606 1.162 . . . . 64.15 112.115 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.543 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 17.3 tppt? 167.27 157.64 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 106.405 -1.702 . . . . 75.53 106.405 -176.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.94 6.45 18.55 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.77 0.795 . . . . 72.03 110.212 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . 0.543 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 13.3 tp10 -96.88 -54.3 3.24 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.039 -1.096 . . . . 75.2 108.039 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 116.39 -20.21 12.54 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.322 -0.942 . . . . 72.51 112.587 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 3.4 m -104.7 136.23 44.6 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.987 -0.745 . . . . 72.3 108.987 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 87.2 t -123.43 136.69 59.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 123.139 0.575 . . . . 73.33 110.743 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.8 t -92.15 114.61 27.2 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.364 -0.606 . . . . 60.24 109.364 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.467 HD13 HD22 ' A' ' 505' ' ' LEU . 43.6 mt -99.51 119.72 38.48 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.498 -0.927 . . . . 61.44 108.498 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.595 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 45.5 tp -104.61 116.93 32.91 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.747 -1.575 . . . . 73.14 106.747 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 31.1 m -122.67 157.96 27.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.924 -0.58 . . . . 64.33 111.886 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -114.4 116.69 29.31 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.863 -0.608 . . . . 73.41 109.703 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -119.84 135.58 54.82 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.699 -0.682 . . . . 71.01 109.463 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -93.37 133.22 36.86 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.599 0.562 . . . . 73.12 111.583 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -102.21 133.02 47.75 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.475 -0.935 . . . . 74.15 108.475 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 C--N 1.292 -1.928 0 N-CA-C 108.992 -0.744 . . . . 73.3 108.992 -177.917 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.439 0 N-CA-C 110.88 -0.888 . . . . 34.04 110.88 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 51.5 m 64.36 86.49 0.12 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.778 0.831 . . . . 64.35 112.519 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -84.06 -52.95 5.89 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.94 -1.133 . . . . 72.23 107.94 175.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 16.2 m120 63.76 22.13 12.95 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.736 -1.12 . . . . 41.2 110.931 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 18.7 p -66.57 -39.02 88.27 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.893 -0.594 . . . . 70.53 110.323 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.92 95.77 10.24 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 109.118 -0.697 . . . . 74.25 109.118 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -132.22 158.2 42.37 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.247 -0.433 . . . . 73.33 110.127 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 11.8 tt -77.56 81.03 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 122.343 1.068 . . . . 74.45 110.767 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . 99.62 131.5 7.36 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 114.364 -1.289 . . . . 42.31 111.976 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 26.7 mtpp -103.5 157.51 16.99 Favored 'General case' 0 CA--C 1.478 -1.791 0 CA-C-O 121.363 0.601 . . . . 74.54 111.185 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 62.2 mtm180 -112.04 129.6 56.15 Favored 'General case' 0 N--CA 1.406 -2.663 0 N-CA-C 107.579 -1.267 . . . . 65.13 107.579 170.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -116.21 131.73 56.86 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.636 -0.875 . . . . 71.23 108.636 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -95.86 115.34 27.29 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.787 -0.82 . . . . 73.24 108.787 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . 0.437 HG22 ' CD2' ' A' ' 464' ' ' LEU . 60.8 mt -119.38 123.91 72.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 115.357 -0.838 . . . . 74.43 109.853 -175.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 47.6 mt-30 -102.37 130.55 49.15 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 121.824 -0.547 . . . . 53.31 112.282 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 542' ' ' LEU . 4.3 mm? -115.06 139.48 49.84 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.848 -0.614 . . . . 73.2 111.958 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -91.04 132.67 35.87 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 123.849 0.859 . . . . 72.21 110.481 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -72.87 105.21 4.3 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 114.593 -1.185 . . . . 63.35 109.402 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -144.53 137.33 7.2 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.82 -0.627 . . . . 63.22 111.741 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 35.5 m 64.54 -79.11 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.468 1.107 . . . . 73.55 112.048 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.412 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 5.7 mm-40 -102.28 -11.34 18.79 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.127 -0.694 . . . . 74.21 109.127 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 66.8 -144.51 45.37 Favored Glycine 0 CA--C 1.473 -2.582 0 CA-C-O 117.528 -1.707 . . . . 55.42 108.924 -172.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 531' ' ' LEU . 43.4 mt -52.25 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.316 1.558 . . . . 45.05 112.275 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . -102.43 59.64 0.55 Allowed Glycine 0 CA--C 1.464 -3.122 0 CA-C-N 114.256 -1.338 . . . . 54.11 111.237 -173.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.467 ' HB3' HD13 ' A' ' 493' ' ' ILE . 18.7 p90 -148.01 142.52 26.45 Favored 'General case' 0 C--N 1.258 -3.387 0 N-CA-C 108.117 -1.068 . . . . 72.21 108.117 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 20.0 m -115.0 143.81 44.6 Favored 'General case' 0 C--N 1.271 -2.843 0 N-CA-C 108.157 -1.053 . . . . 71.31 108.157 -176.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 10.2 pt -109.81 156.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-O 121.209 0.528 . . . . 54.4 111.502 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.486 HG21 ' HE2' ' A' ' 491' ' ' LYS . 9.1 t -136.63 141.21 43.21 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.908 -0.775 . . . . 72.14 108.908 176.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 59.3 p -114.44 130.7 56.73 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.749 -1.575 . . . . 43.03 106.749 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -155.91 -18.4 0.1 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 113.939 1.088 . . . . 74.25 113.939 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . 0.473 ' HB3' ' HD2' ' A' ' 487' ' ' PRO . 29.8 t70 -81.5 -5.04 57.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.279 1.038 . . . . 74.41 109.846 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 4.4 p -74.91 108.1 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-N 114.7 -1.137 . . . . 74.41 109.631 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.8 t -111.41 3.05 17.88 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.716 -0.674 . . . . 70.51 111.054 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 12.5 tt -153.42 -46.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 116.228 -0.442 . . . . 74.4 110.909 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 137.78 159.31 8.13 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 111.03 -0.828 . . . . 74.41 111.03 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 85.22 -61.74 4.6 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.676 -0.97 . . . . 74.42 110.676 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 26.6 m -87.18 84.02 7.32 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 108.442 -0.947 . . . . 74.11 108.442 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -122.57 98.8 43.02 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.835 -0.62 . . . . 74.43 111.372 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 479' ' ' ASP . 9.6 Cg_exo -74.92 134.93 18.56 Favored 'Trans proline' 0 C--O 1.255 1.347 0 C-N-CA 121.815 1.676 . . . . 74.14 109.464 172.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.534 HD12 ' OE1' ' A' ' 524' ' ' GLN . 41.1 mm -101.32 145.02 12.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.559 -1.275 . . . . 75.54 107.559 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -130.26 149.67 51.85 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 122.214 -0.304 . . . . 64.12 110.357 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 47.3 t -81.52 119.55 31.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.187 -1.042 . . . . 52.4 108.187 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.486 ' HE2' HG21 ' A' ' 476' ' ' THR . 17.8 tppt? -90.44 -52.51 4.88 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.237 0.615 . . . . 63.53 111.272 -177.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 64.4 t30 -130.18 150.25 51.52 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.076 -0.649 . . . . 75.22 111.327 -173.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 507' ' ' ALA . 28.7 mm -121.22 104.97 15.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.624 -1.25 . . . . 51.1 107.624 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.49 133.97 95.85 Favored Pre-proline 0 C--N 1.311 -1.101 0 CA-C-N 115.437 -0.801 . . . . 64.31 111.283 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.82 14.09 0.55 Allowed 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 124.624 3.549 . . . . 74.31 114.952 -172.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.441 ' HA ' HG21 ' A' ' 500' ' ' ILE . 18.8 ptt180 -156.63 6.09 0.17 Allowed 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 120.016 -0.673 . . . . 71.42 112.606 -176.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.612 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -91.23 -163.01 38.43 Favored Glycine 0 C--N 1.291 -1.936 0 C-N-CA 120.096 -1.049 . . . . 64.41 111.984 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.452 ' C ' HD12 ' A' ' 464' ' ' LEU . . . -55.92 -40.9 73.76 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 125.016 1.326 . . . . 70.35 110.374 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.0 76.21 Favored 'General case' 0 C--O 1.194 -1.861 0 CA-C-N 114.5 -1.227 . . . . 74.23 112.515 -174.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.441 HG21 ' HA ' ' A' ' 496' ' ' ARG . 11.5 tt -80.47 -29.57 12.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 112.216 0.45 . . . . 61.24 112.216 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 73.5 mm-40 -58.53 -45.75 88.22 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.333 -0.617 . . . . 62.24 109.333 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.504 ' HB2' HD13 ' A' ' 464' ' ' LEU . 3.3 m-20 -93.49 -38.28 11.49 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.486 -0.779 . . . . 71.03 110.561 175.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 71.8 17.11 76.54 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.847 -0.692 . . . . 73.21 113.304 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.429 ' CG ' HG23 ' A' ' 462' ' ' ILE . 27.5 tpt180 -91.32 -18.93 23.53 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.172 0.51 . . . . 75.33 110.822 -175.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 46.9 tp -108.52 150.49 27.38 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 110.159 -0.311 . . . . 74.11 110.159 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.41 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -143.98 170.25 16.28 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.38 -0.6 . . . . 74.3 109.38 178.048 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.564 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -89.33 150.2 22.68 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.982 0.42 . . . . 64.43 110.765 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 113.36 -30.56 7.21 Favored Glycine 0 C--N 1.303 -1.303 0 N-CA-C 111.088 -0.805 . . . . 70.15 111.088 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -68.37 146.99 52.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.112 0.482 . . . . 72.01 111.375 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 25.0 ttm180 -85.52 128.68 34.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.165 -0.679 . . . . 53.04 109.165 177.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.471 ' HG ' HD11 ' A' ' 519' ' ' LEU . 22.4 tp -90.03 127.72 36.12 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 108.494 -0.928 . . . . 73.12 108.494 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.454 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.2 mm -98.15 -41.54 10.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.079 0.466 . . . . 74.02 110.247 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -158.65 159.12 35.01 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.602 -0.726 . . . . 61.21 109.778 176.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.29 130.52 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 109.149 -0.685 . . . . 74.13 109.149 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 70.05 -48.1 0.62 Allowed 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 127.919 2.488 . . . . 71.13 111.867 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 169.49 8.3 0.03 OUTLIER Glycine 0 C--N 1.293 -1.81 0 CA-C-N 116.101 -0.5 . . . . 45.15 112.159 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 29.2 t -115.08 138.8 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.89 -0.781 . . . . 73.53 108.89 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -83.48 155.83 23.18 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 123.755 0.659 . . . . 75.42 110.28 -174.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.471 HD11 ' HG ' ' A' ' 511' ' ' LEU . 21.7 mt -104.79 -42.24 5.43 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.621 -0.718 . . . . 72.34 111.648 -174.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.7 t -72.37 91.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 115.571 -0.74 . . . . 55.14 109.747 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 144.63 -7.23 1.72 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 110.07 -1.212 . . . . 72.42 110.07 -174.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.442 ' HD3' ' HB2' ' A' ' 526' ' ' GLU . 17.5 ptpt -130.65 -178.46 4.8 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 110.021 -0.363 . . . . 74.13 110.021 175.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . 0.431 ' O ' HG23 ' A' ' 527' ' ' VAL . 46.2 t -95.56 162.61 13.56 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.113 0.482 . . . . 63.11 111.014 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.534 ' OE1' HD12 ' A' ' 488' ' ' ILE . 7.3 tp60 -58.37 -38.88 78.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.946 -1.024 . . . . 75.32 110.328 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.99 -31.62 72.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.489 -0.778 . . . . 74.25 111.428 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.442 ' HB2' ' HD3' ' A' ' 522' ' ' LYS . 15.1 mm-40 -71.31 -39.89 71.14 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.893 -0.78 . . . . 75.22 108.893 177.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 523' ' ' SER . 18.4 t -69.34 -40.5 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.365 -0.834 . . . . 52.23 110.012 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.609 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.0 m -62.46 -42.56 96.16 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.111 0 C-N-CA 120.16 -0.616 . . . . 74.21 110.383 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.2 t -62.68 -43.31 99.12 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 116.203 -0.453 . . . . 65.21 110.133 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 46.8 tp -58.27 -45.99 86.86 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.522 1.129 . . . . 65.43 109.566 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 471' ' ' LEU . 2.4 tt -62.94 -45.45 92.43 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.391 -0.822 . . . . 72.42 112.362 175.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 0.7 OUTLIER -58.17 -39.58 79.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.243 0.544 . . . . 71.42 110.416 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.2 t -63.9 -43.57 95.61 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.211 -0.904 . . . . 55.31 110.672 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 63.0 m 67.51 -88.41 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.249 0.62 . . . . 60.42 110.811 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 40.5 tttm 172.74 153.74 0.08 Allowed 'General case' 0 C--O 1.251 1.164 0 N-CA-C 106.685 -1.598 . . . . 64.23 106.685 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 16.0 tpt -75.03 -35.71 61.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.418 -0.513 . . . . 72.42 109.946 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.11 -48.67 56.63 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.977 -0.556 . . . . 71.44 110.56 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 133.12 -28.54 3.31 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 118.564 -1.779 . . . . 61.12 115.984 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 4.5 m -94.93 135.18 36.75 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 118.625 -1.23 . . . . 74.32 109.805 -177.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 63.5 t -118.35 137.29 52.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.851 -0.613 . . . . 72.41 110.267 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 68.9 m -91.86 113.29 25.52 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.426 0.632 . . . . 54.41 111.039 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 464' ' ' LEU . 3.6 mm? -101.36 122.41 43.68 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.657 -0.868 . . . . 73.53 108.657 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 36.9 tp -105.09 118.17 35.85 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.035 -1.469 . . . . 74.13 107.035 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 30.0 m -115.99 154.84 17.45 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 CA-C-O 121.042 0.449 . . . . 74.03 110.786 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.515 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 69.3 t80 -111.77 118.35 35.35 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.522 -0.918 . . . . 71.22 108.522 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -131.15 139.38 49.78 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.504 -1.295 . . . . 63.03 107.504 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -129.4 120.42 25.51 Favored 'General case' 0 C--N 1.269 -2.902 0 C-N-CA 120.298 -0.561 . . . . 64.21 109.823 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.67 99.03 4.91 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.256 -1.387 . . . . 62.24 107.256 173.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 108.958 -0.756 . . . . 71.44 108.958 -176.113 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.482 0 N-CA-C 111.566 -0.613 . . . . 20.33 111.566 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 35.2 p -76.21 146.46 39.07 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 122.229 0.212 . . . . 73.51 110.448 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -79.87 -67.39 0.77 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.938 -0.393 . . . . 71.23 109.938 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -148.96 103.37 3.35 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.791 -0.448 . . . . 41.54 109.791 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 29.3 p -119.74 155.98 31.44 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.328 -0.396 . . . . 73.52 111.898 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt 62.34 34.87 15.43 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.181 0.992 . . . . 72.13 111.81 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -75.48 144.49 42.03 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.463 -0.569 . . . . 61.34 109.463 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 29.6 pt -80.73 -17.2 12.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 112.208 0.447 . . . . 60.14 112.208 -174.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -133.57 109.26 0.8 Allowed Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 120.26 -0.971 . . . . 51.25 112.144 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -113.62 153.23 29.21 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 109.596 -0.52 . . . . 74.3 109.596 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.464 ' HB3' HD11 ' A' ' 543' ' ' LEU . 41.7 mtm180 -111.18 150.89 28.88 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.89 -0.595 . . . . 73.45 109.745 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.9 mm? -131.62 137.33 48.34 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.339 -0.615 . . . . 55.45 109.339 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -103.3 123.56 47.0 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.273 -0.64 . . . . 72.52 109.273 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 76.0 mt -119.26 120.8 64.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.197 -0.668 . . . . 75.31 109.197 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 96.0 mt-30 -100.75 127.27 47.24 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.39 0.614 . . . . 74.53 111.723 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 502' ' ' ASP . 5.9 tp -114.96 140.33 49.11 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-N 114.655 -1.157 . . . . 72.12 108.281 -173.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.518 ' HA ' ' HE3' ' A' ' 465' ' ' LYS . 1.3 tpmt? -101.98 121.98 43.19 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.303 -0.999 . . . . 62.25 108.303 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -63.49 92.02 0.06 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.786 -0.643 . . . . 73.13 110.103 175.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -116.47 142.87 17.81 Favored Glycine 0 N--CA 1.428 -1.845 0 CA-C-N 115.667 -0.697 . . . . 50.54 111.766 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . 0.5 HG23 ' H ' ' A' ' 469' ' ' GLU 0.354 10.0 t 52.03 -82.86 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.11 1.764 . . . . 72.21 114.885 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.5 ' H ' HG23 ' A' ' 468' ' ' THR . 32.9 tt0 -97.04 -15.02 21.23 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.847 0.832 . . . . 71.43 109.081 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.42 -155.85 51.67 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 114.981 -1.009 . . . . 75.33 113.419 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 540' ' ' VAL . 5.8 mp -48.12 104.5 0.06 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 113.517 0.932 . . . . 63.21 113.517 -170.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -118.56 54.58 0.62 Allowed Glycine 0 N--CA 1.422 -2.261 0 CA-C-N 114.567 -1.197 . . . . 72.15 111.174 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.525 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 16.2 p90 -136.64 142.24 43.24 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 109.292 -0.633 . . . . 75.55 109.292 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 37.1 p -115.26 153.41 30.94 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.948 -0.569 . . . . 74.02 109.963 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.41 151.3 21.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 121.076 0.465 . . . . 65.3 110.698 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.1 t -144.23 157.4 44.31 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.881 -0.599 . . . . 64.24 109.691 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 61.4 p -141.47 131.87 25.19 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.713 -1.217 . . . . 73.41 107.713 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -118.8 -60.2 1.79 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.94 0.4 . . . . 64.03 110.955 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -157.4 162.62 39.01 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.574 -0.898 . . . . 72.54 108.574 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.613 ' HA ' ' HD2' ' A' ' 487' ' ' PRO . 46.1 t -76.2 96.75 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-O 121.815 0.817 . . . . 64.12 109.889 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.6 p -85.32 -11.19 55.24 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.263 -1.335 . . . . 74.43 112.015 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.424 HG21 ' CZ ' ' A' ' 510' ' ' ARG . 6.4 tp -150.75 -59.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.547 -0.751 . . . . 63.13 112.075 -176.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . 0.408 ' H ' HG23 ' A' ' 482' ' ' ILE . . . 177.46 148.62 7.38 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.398 -1.081 . . . . 74.02 110.398 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.34 174.85 15.37 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.792 -0.923 . . . . 70.22 110.792 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 14.8 m -83.25 77.1 9.83 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.355 -0.98 . . . . 71.31 108.355 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.408 ' HA ' ' HD2' ' A' ' 487' ' ' PRO . . . 59.33 80.16 0.28 Allowed Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 114.414 -1.266 . . . . 75.31 109.691 -174.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.613 ' HD2' ' HA ' ' A' ' 480' ' ' VAL . 6.1 Cg_exo -36.43 134.96 0.3 Allowed 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 124.43 3.42 . . . . 44.04 114.601 -177.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.452 HG13 ' HB3' ' A' ' 519' ' ' LEU . 34.6 mm -87.55 130.28 37.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.163 -0.926 . . . . 74.02 108.956 -176.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -128.6 151.15 49.8 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 110.422 -0.214 . . . . 71.04 110.422 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 48.8 t -80.06 119.48 29.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.126 -1.064 . . . . 63.5 108.126 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -73.92 -60.74 2.12 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.102 -0.499 . . . . 74.25 110.536 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -145.51 158.04 43.9 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.369 0.604 . . . . 72.51 110.43 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 506' ' ' LYS . 30.2 mm -116.49 104.92 17.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 106.597 -1.631 . . . . 70.52 106.597 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.33 137.42 94.48 Favored Pre-proline 0 C--N 1.304 -1.37 0 CA-C-N 115.242 -0.89 . . . . 72.43 111.035 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -73.34 17.16 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 124.789 3.659 . . . . 70.11 117.0 -167.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -159.87 3.94 0.08 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 115.132 1.53 . . . . 74.14 115.132 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.499 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -98.69 -154.81 29.01 Favored Glycine 0 C--N 1.297 -1.623 0 C-N-CA 119.672 -1.251 . . . . 74.04 113.834 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.72 86.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.096 0.958 . . . . 44.04 111.616 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.451 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -58.11 -38.85 77.25 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.246 -0.888 . . . . 65.23 112.77 -176.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.5 tt -80.81 -32.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 112.286 0.476 . . . . 62.13 112.286 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 83.4 mm-40 -58.76 -41.92 87.72 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.998 0.428 . . . . 63.44 110.914 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.534 ' HB2' HD12 ' A' ' 464' ' ' LEU . 10.0 m-20 -89.35 -39.76 13.22 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.017 -0.538 . . . . 73.51 110.204 172.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 77.87 -19.18 4.39 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 115.639 1.016 . . . . 74.3 115.639 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -64.84 -23.38 67.22 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.234 0.54 . . . . 74.43 111.214 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.3 tp -92.72 135.64 33.93 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.143 -0.688 . . . . 64.24 109.143 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.51 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.0 OUTLIER -138.4 170.44 16.02 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.199 -0.297 . . . . 74.31 110.199 176.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.489 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -86.9 160.03 18.85 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.211 -0.449 . . . . 61.15 110.646 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 103.7 -29.21 12.66 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 121.054 -0.593 . . . . 74.41 113.014 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.56 162.31 24.36 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-O 121.28 0.562 . . . . 74.31 111.929 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.524 ' HD2' HD11 ' A' ' 512' ' ' ILE . 20.0 ttm180 -90.13 126.98 35.99 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.023 -0.99 . . . . 64.03 109.23 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.59 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -88.28 123.7 33.14 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.012 -1.477 . . . . 71.25 107.012 178.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.543 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 35.5 mm -98.46 -47.63 12.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 120.956 0.408 . . . . 62.44 111.248 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -158.16 145.52 18.09 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.703 -0.68 . . . . 60.03 110.201 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 541' ' ' SER . 4.5 p -124.72 127.84 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 CA-C-O 121.276 0.56 . . . . 74.13 109.692 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 17.4 m120 59.46 15.6 4.6 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.873 1.269 . . . . 71.14 113.142 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.7 -7.77 33.99 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.682 -0.77 . . . . 63.33 113.854 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.471 ' HB ' HD21 ' A' ' 530' ' ' LEU . 67.3 t -97.77 127.09 50.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 117.563 0.681 . . . . 71.54 110.554 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.24 136.5 40.95 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 123.837 0.855 . . . . 73.14 111.423 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.59 HD11 HD12 ' A' ' 511' ' ' LEU . 13.4 mt -101.64 -23.81 14.2 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.649 0.738 . . . . 55.12 109.935 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.46 -24.56 35.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.498 -1.228 . . . . 52.15 111.47 -171.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -106.9 21.34 32.06 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.988 -0.625 . . . . 54.11 112.742 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.4 178.67 7.43 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.669 0.618 . . . . 75.1 112.669 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 527' ' ' VAL . 33.7 m -95.73 161.25 14.1 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.169 -0.469 . . . . 74.34 111.856 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.4 ' O ' HG13 ' A' ' 528' ' ' VAL . 42.3 mm-40 -51.33 -46.72 62.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.997 1.319 . . . . 74.12 113.679 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.497 ' HA ' HG22 ' A' ' 528' ' ' VAL . 37.1 mt-10 -60.35 -35.05 74.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.199 0.444 . . . . 74.23 112.199 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -67.22 -40.32 86.4 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.135 -0.691 . . . . 53.15 109.135 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.586 HG13 HD22 ' A' ' 519' ' ' LEU . 30.0 t -70.38 -39.5 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 115.422 -0.808 . . . . 74.21 110.293 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.635 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 15.6 m -66.37 -39.95 85.43 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 C-N-CA 119.67 -0.812 . . . . 65.2 110.401 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.9 t -62.14 -38.86 90.57 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.489 0.661 . . . . 74.32 109.899 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.471 HD21 ' HB ' ' A' ' 517' ' ' VAL . 59.1 tp -64.13 -39.64 94.47 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 123.861 0.865 . . . . 73.41 109.244 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 2.8 tt -66.61 -45.1 80.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.443 0.697 . . . . 75.33 111.241 173.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 29.3 mmm180 -62.58 -32.98 74.06 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.062 -0.517 . . . . 64.3 110.949 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.0 m -68.32 -30.5 69.5 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 116.111 -0.495 . . . . 72.32 110.572 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 535' ' ' LYS . 90.7 m 66.81 -86.93 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.301 -0.863 . . . . 74.35 111.462 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 534' ' ' THR . 25.6 tptp 162.92 154.37 0.02 OUTLIER 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.158 -2.164 . . . . 74.05 105.158 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 85.9 mtp -70.41 -20.99 62.88 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.44 0.564 . . . . 61.24 111.655 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.71 -13.98 43.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.355 0.598 . . . . 74.15 109.783 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 75.12 6.08 78.29 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.398 -0.819 . . . . 65.42 112.746 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 6.2 m -104.34 125.1 50.29 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.721 -1.215 . . . . 61.43 107.721 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.526 HG21 HD21 ' A' ' 471' ' ' LEU . 60.2 t -108.65 127.06 65.43 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 CA-C-N 115.673 -0.694 . . . . 72.15 109.329 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 14.9 m -102.12 111.95 24.42 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 119.907 -0.717 . . . . 75.41 109.114 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.525 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 2.5 mm? -99.43 119.27 37.71 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.8 -1.185 . . . . 71.31 107.8 177.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.536 HD12 ' HB ' ' A' ' 512' ' ' ILE . 2.6 tm? -104.6 117.96 35.41 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 105.963 -1.866 . . . . 74.41 105.963 177.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.69 160.51 14.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.287 -0.869 . . . . 43.32 110.196 -174.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.543 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 25.5 t80 -122.53 130.49 53.1 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.418 -1.327 . . . . 73.44 107.418 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -129.87 118.27 21.46 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.266 0.555 . . . . 74.34 109.718 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -101.59 142.89 32.26 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.017 -0.992 . . . . 70.13 112.858 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -71.77 139.29 48.97 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 107.938 -1.134 . . . . 73.32 107.938 175.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 27.7 t70 . . . . . 0 C--N 1.304 -1.398 0 N-CA-C 109.273 -0.639 . . . . 71.43 109.273 -177.379 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.083 0 N-CA-C 110.314 -1.114 . . . . 61.31 110.314 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 39.6 m -125.51 85.99 2.48 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 121.034 0.445 . . . . 75.54 110.559 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -140.08 77.66 1.62 Allowed 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.398 -0.819 . . . . 74.31 110.544 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -137.92 104.18 5.19 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.112 -1.07 . . . . 74.15 108.112 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 86.9 m 75.47 -18.42 0.45 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.505 0.722 . . . . 73.43 111.762 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp 71.56 155.25 0.15 Allowed 'General case' 0 C--O 1.245 0.854 0 C-N-CA 124.567 1.147 . . . . 74.51 112.045 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -102.86 115.71 31.14 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 105.804 -1.924 . . . . 72.52 105.804 169.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 456' ' ' ILE . 2.1 mp -78.15 105.34 7.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.403 -0.591 . . . . 74.13 109.403 -174.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 126.37 135.6 4.26 Favored Glycine 0 N--CA 1.419 -2.49 0 CA-C-N 115.74 -0.664 . . . . 71.55 112.47 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -100.79 133.83 44.67 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 123.552 0.741 . . . . 72.11 110.356 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 70.4 mtm180 -100.85 138.69 37.57 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 107.628 -1.249 . . . . 75.11 107.628 172.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 459' ' ' ARG . 6.1 mp -130.29 134.07 46.95 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 123.236 0.335 . . . . 72.4 110.221 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -94.38 115.71 27.96 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.66 -0.7 . . . . 71.53 109.189 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . 0.482 HG23 ' CG ' ' A' ' 504' ' ' ARG . 66.0 mt -120.92 141.92 39.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.659 -0.701 . . . . 74.5 110.356 -174.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 76.2 mt-30 -123.93 130.34 52.44 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.517 0.562 . . . . 75.54 112.517 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.615 HD23 HD23 ' A' ' 542' ' ' LEU . 4.2 mm? -115.6 133.48 55.99 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 124.122 0.969 . . . . 61.35 109.466 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 539' ' ' THR . 22.5 ttpp -102.82 134.96 45.36 Favored 'General case' 0 N--CA 1.397 -3.096 0 CA-C-O 121.437 0.637 . . . . 75.43 109.839 -177.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -58.88 126.7 28.78 Favored 'General case' 0 C--N 1.268 -2.952 0 CA-C-N 114.699 -1.137 . . . . 62.33 109.561 175.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . 0.588 ' H ' ' HA2' ' A' ' 470' ' ' GLY . . . -140.22 -138.18 3.57 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 115.722 -0.672 . . . . 74.31 111.494 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . 0.499 HG23 ' H ' ' A' ' 469' ' ' GLU . 10.0 t -50.08 -70.72 0.08 Allowed 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 123.7 0.8 . . . . 72.31 113.057 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.499 ' H ' HG23 ' A' ' 468' ' ' THR . 0.6 OUTLIER -92.65 -2.62 55.94 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.451 -0.781 . . . . 73.54 110.351 175.038 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.588 ' HA2' ' H ' ' A' ' 467' ' ' GLY . . . 54.52 -149.23 19.65 Favored Glycine 0 C--O 1.2 -1.988 0 CA-C-N 114.603 -1.18 . . . . 23.04 113.264 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.544 HD11 HG21 ' A' ' 540' ' ' VAL . 66.2 mt -53.54 99.39 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 117.955 0.877 . . . . 54.25 111.324 -173.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -118.19 54.5 0.61 Allowed Glycine 0 N--CA 1.416 -2.673 0 CA-C-N 114.467 -1.242 . . . . 43.32 111.15 -174.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.462 ' HB3' HD13 ' A' ' 493' ' ' ILE . 20.4 p90 -137.56 141.28 41.36 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 114.984 -0.608 . . . . 74.53 109.441 173.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 36.7 m -118.41 148.92 42.05 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.489 -0.778 . . . . 63.54 109.508 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 21.3 pt -111.05 153.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.179 0.514 . . . . 74.12 111.822 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 491' ' ' LYS . 9.7 t -134.05 159.9 39.39 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.455 -1.313 . . . . 75.32 107.455 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 31.0 p -130.29 154.62 47.44 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.845 -0.428 . . . . 73.01 109.845 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.442 ' O ' ' HD2' ' A' ' 487' ' ' PRO . 26.5 mtm180 -132.56 167.18 20.48 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 106.071 -1.826 . . . . 75.51 106.071 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -72.63 136.72 45.75 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.104 -1.073 . . . . 72.45 108.104 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 484' ' ' GLY . 14.6 p -65.79 129.88 30.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 114.433 1.272 . . . . 64.42 114.433 -171.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 26.8 m -124.06 86.29 2.55 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 106.444 -1.687 . . . . 75.33 106.444 171.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 mp 68.28 103.07 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 124.135 0.974 . . . . 72.12 111.218 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 167.19 -30.34 0.18 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 119.962 -1.113 . . . . 74.34 113.732 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . 0.406 ' O ' HG21 ' A' ' 480' ' ' VAL . . . 132.59 -144.7 16.59 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.605 -0.998 . . . . 75.11 110.605 -177.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 30.2 m -89.59 87.5 7.06 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.949 -0.7 . . . . 71.45 111.663 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.472 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . . . 67.57 120.55 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 124.872 1.269 . . . . 73.21 113.577 176.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.533 ' HA ' HG12 ' A' ' 520' ' ' VAL . 14.9 Cg_endo -88.68 135.86 3.05 Favored 'Trans proline' 0 N--CA 1.439 -1.677 0 C-N-CA 122.199 1.933 . . . . 62.53 112.311 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.501 ' O ' ' HG3' ' A' ' 510' ' ' ARG . 49.9 mm -97.19 136.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.515 -0.766 . . . . 73.13 109.5 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.605 ' CE1' ' HD3' ' A' ' 510' ' ' ARG . 95.1 m-85 -129.46 153.99 47.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 122.223 0.209 . . . . 71.44 111.003 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 44.6 t -80.15 119.47 29.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 107.733 -1.21 . . . . 72.44 107.733 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.425 ' HD2' ' HB ' ' A' ' 476' ' ' THR . 76.0 tttt -95.14 -46.6 6.71 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.52 0.676 . . . . 62.12 110.387 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -137.13 142.33 42.26 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.466 -0.788 . . . . 65.25 109.871 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.471 HG12 ' HB2' ' A' ' 507' ' ' ALA . 28.3 mm -123.93 101.9 10.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 N-CA-C 106.312 -1.736 . . . . 73.3 106.312 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.89 126.85 92.54 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 115.934 -0.575 . . . . 70.31 110.972 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.07 34.38 0.33 Allowed 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 125.011 3.807 . . . . 70.22 112.73 -175.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.432 ' HB2' ' OE2' ' A' ' 469' ' ' GLU . 3.3 ptp180 -164.42 -4.63 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.867 0.691 . . . . 72.22 112.867 -176.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.45 ' O ' HG22 ' A' ' 500' ' ' ILE . . . -92.8 -158.7 34.53 Favored Glycine 0 C--N 1.302 -1.336 0 C-N-CA 119.115 -1.517 . . . . 75.02 112.596 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.71 85.77 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 124.119 0.968 . . . . 70.34 109.591 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.47 ' HA ' ' CD1' ' A' ' 464' ' ' LEU . . . -57.49 -37.79 73.53 Favored 'General case' 0 C--O 1.204 -1.31 0 CA-C-N 114.506 -1.224 . . . . 73.23 112.913 -176.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 497' ' ' GLY . 10.8 tt -81.47 -35.8 14.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.764 0.316 . . . . 35.33 111.83 176.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -58.64 -46.08 87.89 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.984 -0.553 . . . . 75.34 110.185 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.555 ' HB2' HD13 ' A' ' 464' ' ' LEU . 16.4 m-20 -89.47 -36.1 15.6 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.43 -0.581 . . . . 74.35 109.43 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.77 24.88 70.14 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.894 -0.594 . . . . 72.53 113.551 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.482 ' CG ' HG23 ' A' ' 462' ' ' ILE . 8.9 tpt180 -96.26 -11.84 25.4 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.434 -0.507 . . . . 72.41 110.625 -176.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 47.6 tp -120.29 154.19 35.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.687 -0.233 . . . . 74.3 110.654 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.444 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.1 OUTLIER -144.84 159.02 43.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.284 0.634 . . . . 72.42 111.517 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -83.46 155.55 23.35 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 120.798 0.332 . . . . 75.53 111.103 -176.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.82 18.06 57.0 Favored Glycine 0 C--N 1.312 -0.784 0 N-CA-C 110.713 -0.955 . . . . 63.43 110.713 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.645 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 16.3 t0 -108.74 165.54 11.47 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.99 -1.485 . . . . 72.22 106.99 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.605 ' HD3' ' CE1' ' A' ' 489' ' ' TYR . 44.9 ttp180 -107.64 122.29 46.4 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 118.572 0.624 . . . . 74.41 111.537 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.541 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.32 120.63 27.88 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 107.307 -1.368 . . . . 75.53 107.307 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.608 ' HB ' HD12 ' A' ' 543' ' ' LEU . 47.9 mm -98.39 -43.86 11.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 120.594 0.235 . . . . 74.41 111.579 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 9.3 pt-20 -156.99 148.05 21.89 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.833 -0.432 . . . . 72.04 109.833 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.494 HG12 HD21 ' A' ' 519' ' ' LEU . 5.7 p -129.57 128.44 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 109.77 -0.456 . . . . 75.42 109.77 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 58.61 21.24 8.49 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.137 0.975 . . . . 74.22 112.811 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.45 -5.97 60.89 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.192 -0.528 . . . . 70.45 113.25 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.88 132.37 39.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.608 -0.515 . . . . 63.15 109.608 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -77.3 144.37 38.15 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 123.862 0.726 . . . . 73.14 109.596 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.541 HD11 HD12 ' A' ' 511' ' ' LEU . 22.7 mt -101.36 -52.51 3.23 Favored 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 120.51 -0.476 . . . . 61.21 111.116 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 487' ' ' PRO . 27.8 m -69.46 97.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.696 0 CA-C-O 122.605 1.193 . . . . 32.45 111.011 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.29 -31.74 1.15 Allowed Glycine 0 N--CA 1.419 -2.498 0 CA-C-N 113.477 -1.692 . . . . 73.53 108.989 -173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.73 174.52 5.83 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.249 -0.476 . . . . 75.44 110.771 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 54.2 m -91.0 159.15 16.3 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.156 0.428 . . . . 75.55 112.156 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -56.95 -46.47 82.1 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.119 0.567 . . . . 72.13 111.752 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.511 ' HA ' HG22 ' A' ' 528' ' ' VAL . 45.0 mt-10 -58.86 -31.95 69.01 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.966 -0.561 . . . . 73.01 111.852 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.96 -41.73 90.87 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.709 -0.478 . . . . 73.25 109.709 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.71 -38.12 71.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.355 -0.839 . . . . 61.13 110.75 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.725 ' O ' ' HG3' ' A' ' 532' ' ' ARG . 19.7 m -65.26 -42.12 93.17 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.136 0 C-N-CA 119.443 -0.903 . . . . 64.45 110.135 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.0 m -62.31 -35.85 80.32 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.734 0.778 . . . . 65.42 109.813 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 22.8 tp -67.47 -36.28 80.84 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 124.941 1.296 . . . . 63.42 110.382 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.426 ' CD1' HD13 ' A' ' 471' ' ' LEU . 54.2 tp -76.36 -48.58 19.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.188 -0.46 . . . . 72.12 111.084 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.725 ' HG3' ' O ' ' A' ' 528' ' ' VAL . 20.4 mtm180 -54.7 -36.04 64.26 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.898 0.479 . . . . 65.22 111.013 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 34.1 t -66.45 -41.3 89.3 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.535 -0.757 . . . . 61.13 111.889 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 15.5 m 64.51 174.12 0.19 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 108.336 -0.987 . . . . 54.35 108.336 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.736 ' HE2' ' O ' ' A' ' 539' ' ' THR . 37.0 mtmt -91.83 168.72 11.25 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 120.651 -1.28 . . . . 71.03 108.023 175.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 83.6 mtp -74.83 -23.01 58.38 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.058 0.456 . . . . 75.4 109.851 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.63 -64.19 0.95 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.724 -1.584 . . . . 73.03 106.724 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 138.08 -19.77 3.25 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 119.971 -1.109 . . . . 75.04 114.393 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.736 ' O ' ' HE2' ' A' ' 535' ' ' LYS . 4.8 m -94.23 136.22 34.76 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.364 -0.976 . . . . 75.44 108.364 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.544 HG21 HD11 ' A' ' 471' ' ' LEU . 91.7 t -111.59 136.31 48.09 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 C-N-CA 123.103 0.561 . . . . 74.22 110.583 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 36.2 t -98.73 119.54 37.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.142 0.496 . . . . 73.42 110.983 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.615 HD23 HD23 ' A' ' 464' ' ' LEU . 2.6 mm? -113.56 123.16 49.31 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.019 -1.104 . . . . 72.23 108.019 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.608 HD12 ' HB ' ' A' ' 512' ' ' ILE . 3.0 tm? -104.84 120.07 40.52 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 105.979 -1.859 . . . . 64.0 105.979 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.645 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 33.6 m -115.03 161.6 13.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.601 -0.727 . . . . 64.12 111.124 -173.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -129.72 116.41 18.74 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.829 -0.623 . . . . 75.05 110.468 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' A' ' 509' ' ' ASP . 36.0 mtm-85 -129.2 137.45 51.14 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 116.139 -0.482 . . . . 61.15 111.238 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -132.56 143.44 49.72 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.868 -0.605 . . . . 72.25 109.857 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.43 92.45 4.61 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.265 -0.643 . . . . 64.05 109.265 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 C--O 1.251 1.182 0 CA-C-N 114.634 -1.166 . . . . 74.05 108.746 -176.21 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.086 0 N-CA-C 110.564 -1.014 . . . . 72.35 110.564 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 23.2 p -135.52 129.84 33.69 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.286 0.565 . . . . 73.13 111.495 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -101.04 -36.23 9.07 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.628 -0.714 . . . . 72.03 110.738 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -75.55 -19.42 59.32 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.737 -0.665 . . . . 74.22 112.427 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 21.9 p -72.34 -70.82 0.32 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.265 0.555 . . . . 73.31 112.437 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -125.53 139.92 53.19 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.868 -0.606 . . . . 75.13 109.82 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -115.67 122.77 46.56 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.063 -0.718 . . . . 75.24 109.063 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 15.6 tt -142.42 25.44 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-O 123.528 1.632 . . . . 63.53 106.775 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 154.2 144.3 3.88 Favored Glycine 0 N--CA 1.426 -2.008 0 CA-C-N 112.839 -1.982 . . . . 73.24 109.552 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -137.27 168.57 19.37 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 117.812 0.806 . . . . 74.35 110.937 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 92.5 mtt180 -104.69 139.64 39.22 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.023 -0.535 . . . . 74.5 110.404 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -127.82 135.4 50.01 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.147 0.579 . . . . 72.22 110.08 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -96.46 124.8 40.57 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.199 0.523 . . . . 74.32 109.788 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 66.4 mt -125.19 139.06 52.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 123.787 0.835 . . . . 72.24 109.467 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 94.9 mt-30 -120.78 126.97 51.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.663 0.986 . . . . 70.32 113.663 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 499' ' ' ALA . 7.3 mp -118.15 150.29 39.62 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 124.833 1.253 . . . . 75.42 111.328 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -115.3 131.95 56.77 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.096 -1.075 . . . . 74.23 108.096 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.602 ' HE2' HG21 ' A' ' 534' ' ' THR . 24.0 ttmm -52.62 96.9 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 124.536 1.134 . . . . 71.11 112.086 177.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.14 -136.75 9.34 Favored Glycine 0 CA--C 1.519 0.32 0 CA-C-N 116.194 -0.457 . . . . 74.14 113.002 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 496' ' ' ARG . 87.9 m -46.29 -65.42 0.56 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.641 1.176 . . . . 73.02 113.081 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.4 -2.18 52.43 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.226 -1.027 . . . . 75.2 108.226 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 60.56 -143.29 48.01 Favored Glycine 0 CA--C 1.473 -2.54 0 N-CA-C 108.885 -1.686 . . . . 32.14 108.885 -168.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.528 HD11 HG21 ' A' ' 540' ' ' VAL . 50.2 mt -53.0 99.27 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.824 1.312 . . . . 53.12 111.809 -174.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . -104.73 56.78 0.54 Allowed Glycine 0 CA--C 1.466 -2.971 0 CA-C-N 114.292 -1.322 . . . . 75.21 111.956 -172.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 492' ' ' ASN . 14.9 p90 -149.87 142.13 24.16 Favored 'General case' 0 C--N 1.267 -3.017 0 N-CA-C 108.392 -0.966 . . . . 75.52 108.392 177.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 40.0 m -115.8 160.7 19.78 Favored 'General case' 0 C--N 1.271 -2.81 0 N-CA-C 107.977 -1.12 . . . . 75.2 107.977 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 20.7 pt -117.45 151.09 19.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.2 0.524 . . . . 70.1 111.472 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.1 t -138.21 159.1 42.93 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.551 -1.277 . . . . 74.32 107.551 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 53.9 p -141.13 137.48 32.79 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.536 -0.542 . . . . 65.52 109.536 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.508 ' O ' ' HB2' ' A' ' 479' ' ' ASP . 4.2 tmm_? -71.43 -70.59 0.31 Allowed 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 106.772 -1.566 . . . . 63.41 106.772 176.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 478' ' ' ARG . 5.3 t70 165.72 -176.45 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 106.096 -1.816 . . . . 73.31 106.096 171.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.414 ' C ' ' H ' ' A' ' 482' ' ' ILE . 8.7 p -140.69 -17.7 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 109.697 -0.483 . . . . 61.13 109.697 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . 0.26 75.6 p 65.09 -17.1 0.09 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.385 1.874 . . . . 61.32 115.247 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 480' ' ' VAL . 32.8 pt -126.29 131.21 71.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 115.846 -0.615 . . . . 73.22 110.309 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 88.67 -81.35 1.55 Allowed Glycine 0 C--N 1.306 -1.117 0 C-N-CA 120.532 -0.842 . . . . 71.42 111.938 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 134.25 12.1 1.48 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.196 -1.002 . . . . 62.12 113.925 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 40.0 t -75.26 -61.51 1.88 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.32 0.56 . . . . 73.31 109.688 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 72.55 126.28 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.736 0 C-N-CA 124.694 1.198 . . . . 71.21 110.852 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.69 134.14 58.72 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.973 1.782 . . . . 71.24 111.506 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 42.9 mm -95.4 129.51 45.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.528 -0.76 . . . . 72.31 109.603 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -128.24 153.66 46.7 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.559 -0.534 . . . . 74.02 109.559 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.78 118.97 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 107.671 -1.233 . . . . 74.5 107.671 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -81.29 -56.96 3.72 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.293 -0.867 . . . . 73.44 110.377 -175.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 473' ' ' PHE . 64.7 t30 -147.3 157.77 43.71 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.824 -0.626 . . . . 61.34 109.427 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.511 HG12 ' HB2' ' A' ' 507' ' ' ALA . 29.8 mm -121.49 105.81 17.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.491 -1.299 . . . . 34.41 107.491 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.9 mp -55.93 133.92 73.51 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.49 -0.777 . . . . 60.43 111.987 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -66.55 6.92 0.45 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 124.896 3.731 . . . . 75.44 115.051 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.505 ' O ' ' HB ' ' A' ' 468' ' ' THR . 31.5 ptt180 -162.74 10.95 0.06 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.919 0.866 . . . . 61.12 111.752 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.526 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . -85.84 -174.29 49.74 Favored Glycine 0 C--N 1.294 -1.758 0 CA-C-N 115.42 -0.809 . . . . 61.42 112.512 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -51.52 -38.27 53.3 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.453 1.101 . . . . 74.34 110.538 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.728 ' HA ' HD21 ' A' ' 464' ' ' LEU . . . -61.68 -42.95 99.63 Favored 'General case' 0 C--O 1.197 -1.71 0 CA-C-N 114.185 -1.371 . . . . 72.15 113.248 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.454 HG23 HE21 ' A' ' 501' ' ' GLN . 12.0 tt -80.05 -29.44 12.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 120.925 0.393 . . . . 65.43 111.166 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 28.9 mm-40 -62.04 -46.31 89.72 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.89 -0.595 . . . . 74.34 109.633 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -84.65 -42.04 15.73 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 120.579 -0.448 . . . . 52.23 109.82 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 81.24 -14.66 27.0 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 116.753 1.461 . . . . 74.24 116.753 174.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -74.21 -16.69 60.96 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 117.77 0.785 . . . . 74.51 111.38 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.62 147.5 26.35 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.675 -0.491 . . . . 75.32 109.675 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.59 171.25 15.38 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.706 -0.479 . . . . 72.24 109.706 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -89.34 149.72 22.9 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 123.238 0.336 . . . . 72.01 110.529 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 107.0 5.27 35.49 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.55 -0.833 . . . . 21.1 113.504 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -113.74 156.18 24.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.942 0.371 . . . . 75.03 111.159 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -85.56 130.86 34.47 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.261 -0.427 . . . . 70.02 110.417 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.526 HD12 HD11 ' A' ' 519' ' ' LEU . 0.1 OUTLIER -86.67 128.95 35.03 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.832 -1.544 . . . . 71.32 106.832 -179.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 48.5 mm -100.04 -49.59 11.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.05 0.452 . . . . 73.55 111.252 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.24 150.51 21.96 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.898 -0.592 . . . . 73.41 109.858 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 541' ' ' SER . 4.2 p -125.05 123.82 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 CA-C-O 121.38 0.61 . . . . 72.44 109.98 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 19.4 m120 56.09 18.16 3.04 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.23 1.412 . . . . 61.54 114.475 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.76 -7.83 29.76 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.257 -0.973 . . . . 54.31 112.999 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.51 123.12 45.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 108.561 -0.903 . . . . 72.05 108.561 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -90.91 133.38 35.3 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.225 -1.028 . . . . 72.32 108.225 -172.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.526 HD11 HD12 ' A' ' 511' ' ' LEU . 23.2 mt -86.33 -46.31 10.4 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 112.427 0.529 . . . . 70.14 112.427 -170.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.38 100.59 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.854 0.835 . . . . 72.04 110.503 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 141.59 -33.55 1.96 Allowed Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 109.629 -1.388 . . . . 52.41 109.629 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.94 166.52 10.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.614 -0.293 . . . . 71.01 110.722 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 58.3 m -88.65 162.55 16.26 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.719 0.295 . . . . 53.44 111.763 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -54.92 -46.47 74.92 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 123.897 0.879 . . . . 73.43 112.205 -175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.552 ' HA ' HG22 ' A' ' 528' ' ' VAL . 40.9 mm-40 -60.39 -31.05 69.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.888 0.699 . . . . 74.52 112.888 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.63 -37.48 86.69 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.491 0.662 . . . . 63.4 109.258 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.42 ' O ' ' HB3' ' A' ' 530' ' ' LEU . 39.0 t -75.69 -34.94 29.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.69 -0.686 . . . . 73.33 110.04 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.616 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 13.5 m -66.5 -41.32 88.34 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 C-N-CA 119.953 -0.699 . . . . 63.34 110.687 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 40.5 t -59.67 -44.1 93.74 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.782 0.801 . . . . 70.2 109.327 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 527' ' ' VAL . 25.3 tp -58.35 -41.97 85.85 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 125.487 1.515 . . . . 55.01 110.163 176.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.474 HD12 HD13 ' A' ' 471' ' ' LEU . 35.4 tp -69.27 -48.07 62.78 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.724 0.81 . . . . 74.24 110.383 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 4.2 mmp_? -55.1 -45.39 75.46 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.761 0.825 . . . . 43.13 112.355 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 32.1 m -71.53 -37.12 71.18 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 111.553 0.205 . . . . 74.14 111.553 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . 0.602 HG21 ' HE2' ' A' ' 466' ' ' LYS . 26.3 m 70.42 152.45 0.11 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.057 0.943 . . . . 73.44 111.009 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.99 125.68 25.66 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.98 -1.489 . . . . 74.25 106.98 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.7 mtt -71.8 -6.3 40.49 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.269 0.841 . . . . 61.03 113.269 -173.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.55 -27.69 61.47 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.12 -1.067 . . . . 73.41 108.12 171.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 109.97 -25.16 17.22 Favored Glycine 0 N--CA 1.427 -1.965 0 CA-C-N 115.207 -0.906 . . . . 62.1 112.43 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 2.5 m -101.59 127.0 48.5 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 109.369 -0.604 . . . . 62.11 109.369 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.528 HG21 HD11 ' A' ' 471' ' ' LEU . 76.6 t -106.46 128.23 61.18 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.681 0 CA-C-N 115.744 -0.662 . . . . 64.35 110.363 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 20.2 m -100.9 114.02 27.51 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.575 -0.739 . . . . 44.55 109.519 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -104.77 128.23 52.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.802 -0.814 . . . . 51.0 108.802 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 37.3 tp -104.85 118.28 36.16 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 105.935 -1.876 . . . . 71.31 105.935 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 27.6 m -115.48 160.17 14.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 CA-C-O 120.966 0.412 . . . . 75.44 110.042 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -111.96 115.39 28.87 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-N 115.546 -0.752 . . . . 74.01 109.08 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.51 118.16 26.8 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 106.047 -1.834 . . . . 64.32 106.047 177.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -99.88 122.78 43.33 Favored 'General case' 0 C--N 1.26 -3.284 0 CA-C-N 115.306 -0.861 . . . . 75.33 109.863 -174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -93.54 86.92 5.36 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 122.052 0.929 . . . . 74.41 109.284 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--N 1.292 -1.903 0 CA-C-N 114.638 -1.164 . . . . 73.41 109.881 -178.148 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.958 0 N-CA-C 110.971 -0.852 . . . . 74.54 110.971 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 37.3 p -160.39 110.13 1.77 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.21 -0.663 . . . . 72.53 109.21 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -146.76 133.08 19.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.769 -0.456 . . . . 72.2 109.769 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -90.19 98.62 11.88 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.364 -0.606 . . . . 55.42 109.364 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 72.2 p -67.3 129.5 40.11 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.533 -0.758 . . . . 72.43 110.99 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -86.38 118.53 25.87 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.022 -0.733 . . . . 75.42 109.022 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -107.39 168.62 9.11 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.519 -0.919 . . . . 54.55 108.519 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 11.3 tt -121.84 90.19 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 122.284 1.04 . . . . 63.43 111.131 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 547' ' ' GLN . . . 139.06 142.55 4.29 Favored Glycine 0 N--CA 1.42 -2.417 0 CA-C-N 114.892 -1.049 . . . . 62.44 111.635 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 458' ' ' LYS . 0.5 OUTLIER -126.24 133.0 51.6 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.319 -0.623 . . . . 74.25 109.319 -179.014 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.415 ' HB3' HD21 ' A' ' 543' ' ' LEU . 84.5 mtm180 -102.03 149.4 24.29 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.166 -0.679 . . . . 75.54 109.166 174.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.4 mm? -133.98 150.53 51.27 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.358 -0.608 . . . . 71.55 109.358 -173.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.51 117.27 28.55 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.904 0.859 . . . . 75.11 110.935 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 54.7 mt -121.78 139.2 49.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 106.853 -1.536 . . . . 70.14 106.853 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 42.4 tt0 -125.66 126.58 44.92 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.895 -1.122 . . . . 72.11 108.512 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.552 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 6.4 mp -114.66 153.05 30.9 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.081 -0.647 . . . . 75.2 112.433 -177.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.716 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.2 OUTLIER -100.56 128.37 46.64 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.558 -0.904 . . . . 71.2 108.558 -177.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.631 ' HE3' HG21 ' A' ' 534' ' ' THR . 39.9 ttmt -60.1 113.28 2.26 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.952 -0.567 . . . . 53.24 110.182 172.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -104.58 -131.71 7.22 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 120.796 -0.716 . . . . 64.03 111.799 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 26.4 m -62.53 -64.97 0.76 Allowed 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.198 0.599 . . . . 75.5 111.947 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.558 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 11.8 mm-40 -85.24 -32.45 22.59 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.82 -0.752 . . . . 63.22 109.545 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.467 ' N ' ' HA2' ' A' ' 497' ' ' GLY . . . 70.77 141.63 0.21 Allowed Glycine 0 C--O 1.21 -1.352 0 CA-C-N 114.878 -1.055 . . . . 54.53 112.894 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.486 ' N ' ' H ' ' A' ' 498' ' ' ALA 0.25 4.9 mp 39.56 84.38 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.551 1.54 . . . . 72.45 114.118 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -94.04 54.14 2.2 Favored Glycine 0 CA--C 1.493 -1.297 0 CA-C-N 115.078 -0.965 . . . . 63.33 112.433 -173.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.539 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 3.7 p90 -146.67 142.05 27.48 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.177 0.513 . . . . 63.31 110.763 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 29.6 m -120.57 143.9 48.38 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.089 -1.448 . . . . 72.44 107.089 177.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 23.9 pt -109.59 158.85 9.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 121.441 0.638 . . . . 61.11 111.929 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.6 t -132.5 159.23 39.99 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.703 -1.591 . . . . 75.14 106.703 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 55.4 p -129.32 144.74 51.35 Favored 'General case' 0 C--N 1.269 -2.911 0 N-CA-C 108.953 -0.758 . . . . 73.23 108.953 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -83.37 -6.06 59.34 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.069 -1.086 . . . . 70.44 108.069 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 17.6 t70 69.08 156.26 0.13 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 112.894 -1.957 . . . . 65.54 111.932 172.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.509 HG22 ' H ' ' A' ' 482' ' ' ILE . 8.0 p -83.64 136.07 23.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 115.709 -0.678 . . . . 61.13 109.741 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.6 t -88.03 -8.09 56.09 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.892 -0.723 . . . . 73.14 111.715 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.509 ' H ' HG22 ' A' ' 480' ' ' VAL . 63.1 mt -116.15 -75.01 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 115.85 -0.614 . . . . 64.51 109.492 175.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 166.43 118.46 0.44 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.069 -0.813 . . . . 64.13 111.069 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . 0.445 ' H ' HG11 ' A' ' 480' ' ' VAL . . . 127.9 -88.89 0.33 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.324 -0.941 . . . . 60.44 112.705 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 32.6 t -79.88 89.27 5.27 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.476 0.655 . . . . 45.33 112.077 -174.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -92.57 128.94 42.34 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 115.487 -0.778 . . . . 42.33 110.136 175.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.85 134.97 20.7 Favored 'Trans proline' 0 C--O 1.249 1.068 0 C-N-CA 121.976 1.784 . . . . 64.35 111.702 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.46 ' O ' ' HG3' ' A' ' 510' ' ' ARG . 44.3 mm -109.56 136.59 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.966 -0.561 . . . . 74.23 109.976 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 91.9 m-85 -137.99 157.79 45.65 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.138 0.575 . . . . 70.22 110.468 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.462 ' CG1' ' HA ' ' A' ' 507' ' ' ALA . 13.0 t -74.68 121.41 26.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.108 -1.071 . . . . 70.14 108.108 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 24.2 ttmm -85.44 -58.9 2.48 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.728 -0.471 . . . . 74.15 109.728 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -146.61 147.83 31.47 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.042 -1.096 . . . . 63.22 108.042 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.538 HG13 ' HA ' ' A' ' 506' ' ' LYS . 26.1 mm -109.4 109.46 28.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.635 -0.876 . . . . 61.04 108.635 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 86.5 mt -53.69 154.69 6.52 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 114.838 -1.073 . . . . 74.33 111.168 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.17 -1.67 11.26 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 123.902 3.068 . . . . 51.13 111.657 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.568 ' HA ' HG21 ' A' ' 500' ' ' ILE . 99.5 mtt180 -150.39 -157.65 0.84 Allowed 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 115.12 -0.946 . . . . 65.32 108.559 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.558 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 82.98 -162.9 41.21 Favored Glycine 0 C--N 1.277 -2.735 0 N-CA-C 111.398 -0.681 . . . . 71.35 111.398 -176.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.489 ' O ' HD23 ' A' ' 464' ' ' LEU . . . -70.49 -27.78 64.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.885 0.342 . . . . 74.51 110.843 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.552 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -58.9 -41.37 87.05 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-N 115.182 -0.917 . . . . 71.22 112.057 -173.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.568 HG21 ' HA ' ' A' ' 496' ' ' ARG . 16.9 tt -79.48 -29.29 13.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.984 -0.553 . . . . 52.31 111.547 -179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 12.6 mm100 -62.37 -45.91 91.03 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.263 -0.643 . . . . 73.42 109.263 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.413 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 8.8 t70 -93.74 -34.88 13.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.291 -0.868 . . . . 51.43 110.048 -177.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 83.8 -27.65 4.27 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.622 1.409 . . . . 44.3 116.622 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -67.93 -13.59 62.29 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.191 1.182 . . . . 75.44 114.191 -174.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 46.7 tp -97.89 124.78 42.47 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 120.595 -0.442 . . . . 64.54 111.158 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.538 ' HA ' HG13 ' A' ' 493' ' ' ILE . 0.1 OUTLIER -135.27 164.07 28.55 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 111.809 0.3 . . . . 75.5 111.809 178.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.52 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -82.64 160.36 22.47 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 113.835 1.05 . . . . 64.34 113.835 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 78.93 46.77 8.14 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.234 -0.894 . . . . 32.41 112.247 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.502 ' OD1' ' HB ' ' A' ' 544' ' ' VAL . 7.5 t70 -144.08 178.63 7.74 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.579 -1.637 . . . . 62.54 106.579 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.494 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 48.6 ttp85 -109.28 136.83 48.09 Favored 'General case' 0 C--O 1.212 -0.875 0 C-N-CA 119.176 -1.01 . . . . 71.24 113.217 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.734 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.5 mm? -88.02 121.31 30.28 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.196 -0.911 . . . . 70.02 110.781 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.458 HD11 ' CB ' ' A' ' 545' ' ' PHE . 1.9 mp -106.83 -48.47 8.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 109.447 -0.575 . . . . 55.31 109.447 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.42 143.0 31.43 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.302 -0.863 . . . . 62.2 109.543 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 541' ' ' SER . 7.5 p -145.03 122.41 4.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 CA-C-N 114.632 -1.167 . . . . 75.25 109.506 175.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . 0.613 ' ND2' HG13 ' A' ' 540' ' ' VAL . 49.0 m-80 66.65 21.94 10.54 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.113 0.965 . . . . 63.4 112.176 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 83.41 25.96 45.26 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 121.147 -0.549 . . . . 73.03 112.158 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 62.0 t -121.8 138.04 53.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 109.752 -0.462 . . . . 75.32 109.752 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.99 128.31 34.57 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.038 -0.727 . . . . 74.24 109.038 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.734 ' CD1' ' HB3' ' A' ' 511' ' ' LEU . 24.6 mt -96.55 -44.05 7.33 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 113.057 0.762 . . . . 74.14 113.057 -170.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 56.4 t -72.47 92.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.752 0.787 . . . . 74.05 110.448 -174.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.29 -25.77 1.24 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 109.889 -1.284 . . . . 63.23 109.889 -175.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.09 179.09 4.36 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.793 -0.203 . . . . 63.14 110.671 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 52.5 m -94.2 157.97 15.81 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-O 121.065 0.46 . . . . 61.43 111.75 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -52.8 -47.18 67.78 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.42 1.088 . . . . 73.21 112.156 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.54 ' HA ' HG22 ' A' ' 528' ' ' VAL . 42.9 mt-10 -60.87 -34.29 74.39 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.564 0.579 . . . . 35.35 112.564 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.99 -42.18 97.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.48 0.657 . . . . 73.32 109.536 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.52 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 44.5 t -71.06 -40.36 75.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.715 -1.129 . . . . 75.42 110.374 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 525' ' ' GLU . 12.7 m -68.62 -38.91 79.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 C-N-CA 119.041 -1.064 . . . . 63.3 110.371 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 25.8 t -62.04 -43.14 99.48 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.874 -0.603 . . . . 74.25 110.54 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.695 HD11 HG13 ' A' ' 514' ' ' VAL . 3.5 pp -67.19 -32.29 73.26 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.24 0.543 . . . . 75.43 109.656 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 530' ' ' LEU . 2.6 tt -65.15 -47.97 75.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.918 -1.037 . . . . 71.15 111.073 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.606 ' HA ' ' HE ' ' A' ' 532' ' ' ARG . 0.2 OUTLIER -63.28 -37.04 85.68 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.906 -0.588 . . . . 55.32 110.447 -177.632 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.4 m -73.61 -40.95 63.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.492 -0.322 . . . . 73.31 110.502 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . 0.631 HG21 ' HE3' ' A' ' 466' ' ' LYS . 24.0 m 68.92 158.32 0.16 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.095 0.958 . . . . 61.32 111.261 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.493 ' HG3' ' H ' ' A' ' 537' ' ' GLU . 16.5 tppt? -67.67 127.25 32.07 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.075 -1.454 . . . . 70.33 107.075 172.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.6 ptp -61.38 -18.0 56.71 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.279 0.562 . . . . 73.04 111.493 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . 0.493 ' H ' ' HG3' ' A' ' 535' ' ' LYS . 39.6 tt0 -69.4 -24.17 63.82 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.888 0.875 . . . . 62.44 110.413 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 103.05 -29.09 13.19 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 116.053 -0.521 . . . . 54.43 112.684 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 0.6 OUTLIER -94.83 124.08 38.66 Favored 'General case' 0 N--CA 1.424 -1.733 0 C-N-CA 123.117 0.567 . . . . 54.53 112.372 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.613 HG13 ' ND2' ' A' ' 515' ' ' ASN . 72.1 t -104.3 129.74 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 108.565 -0.902 . . . . 74.13 108.565 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.706 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 47.2 t -91.1 134.0 34.88 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.506 -0.924 . . . . 45.5 108.506 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.539 HD11 ' CZ ' ' A' ' 473' ' ' PHE . 3.4 mm? -122.93 118.21 27.32 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.952 -1.129 . . . . 73.23 107.952 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 4.2 tt -110.31 117.65 34.21 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 104.35 -2.463 . . . . 73.31 104.35 173.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.502 ' HB ' ' OD1' ' A' ' 509' ' ' ASP . 30.6 m -121.25 160.39 22.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-N 115.888 -0.596 . . . . 72.13 111.336 -175.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.458 ' CB ' HD11 ' A' ' 512' ' ' ILE . 76.4 t80 -125.56 119.38 28.0 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 120.966 0.412 . . . . 71.05 110.601 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -119.62 123.3 43.54 Favored 'General case' 0 N--CA 1.401 -2.878 0 N-CA-C 108.191 -1.04 . . . . 71.22 108.191 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . 0.606 ' HA ' ' HA2' ' A' ' 457' ' ' GLY . 53.6 tt0 -79.78 119.98 23.43 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.426 -0.806 . . . . 70.34 109.861 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -76.03 102.1 5.52 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 106.575 -1.639 . . . . 64.23 106.575 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--N 1.289 -2.023 0 N-CA-C 107.181 -1.414 . . . . 37.36 107.181 -174.224 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.176 0 N-CA-C 111.961 -0.456 . . . . 65.32 111.961 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 34.1 p -87.0 124.1 32.82 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 112.2 0.444 . . . . 63.3 112.2 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -127.34 115.19 18.6 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 122.852 0.461 . . . . 65.42 110.362 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -122.37 103.23 8.6 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.315 -0.624 . . . . 73.23 109.315 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 9.9 t -87.49 98.95 11.67 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.982 0.896 . . . . 71.55 110.338 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -88.57 104.59 16.98 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.053 -0.721 . . . . 62.23 109.053 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -84.39 125.89 32.73 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.062 -0.718 . . . . 73.12 109.062 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 2.0 mp -77.74 106.33 7.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.714 -1.217 . . . . 65.23 107.714 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 547' ' ' GLN . . . 108.57 107.76 3.17 Favored Glycine 0 N--CA 1.421 -2.358 0 N-CA-C 109.636 -1.386 . . . . 63.52 109.636 -173.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -91.72 133.31 35.71 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 120.146 -0.622 . . . . 74.02 110.181 -178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 62.8 mtm180 -101.37 137.14 40.09 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 106.252 -1.758 . . . . 75.43 106.252 172.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 16.4 tp -129.18 129.05 44.58 Favored 'General case' 0 C--N 1.265 -3.099 0 CA-C-N 116.019 -0.537 . . . . 75.0 109.822 -172.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -98.53 115.65 29.05 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 108.859 -0.793 . . . . 71.34 108.859 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . 0.54 HG23 ' HD3' ' A' ' 504' ' ' ARG . 67.4 mt -116.43 142.56 29.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.384 -0.969 . . . . 74.41 108.384 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 78.5 mt-30 -122.36 128.63 51.23 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 118.564 0.62 . . . . 73.32 112.152 176.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.593 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 9.3 mp -115.75 146.69 41.69 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 123.834 0.854 . . . . 64.41 111.634 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.768 ' N ' ' HE3' ' A' ' 465' ' ' LYS . 0.2 OUTLIER -100.35 125.67 46.61 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 108.16 -1.052 . . . . 74.2 108.16 -178.219 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.88 114.97 2.32 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.249 -0.887 . . . . 63.12 110.358 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -87.08 -140.68 6.4 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.158 -1.177 . . . . 52.52 110.158 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . 0.472 HG23 ' OE2' ' A' ' 469' ' ' GLU . 9.9 t -81.8 -31.61 31.7 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.834 -0.747 . . . . 64.24 111.359 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.601 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 12.0 mp0 -91.77 -42.8 9.91 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 107.79 -1.189 . . . . 72.44 107.79 173.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 84.57 -148.09 23.57 Favored Glycine 0 C--O 1.202 -1.866 0 CA-C-O 118.365 -1.242 . . . . 50.32 111.312 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.566 ' H ' HD22 ' A' ' 471' ' ' LEU . 1.7 mm? -45.95 108.07 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.478 1.139 . . . . 70.0 113.294 -169.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.87 45.62 1.28 Allowed Glycine 0 N--CA 1.426 -1.977 0 CA-C-N 114.744 -1.117 . . . . 74.05 111.679 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.445 ' CZ ' HD11 ' A' ' 542' ' ' LEU . 23.1 p90 -134.69 143.11 47.04 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.036 -0.727 . . . . 71.43 109.036 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 39.5 m -115.46 157.47 23.93 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.469 -1.308 . . . . 73.24 107.469 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 15.2 pt -126.03 160.08 33.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.364 0.602 . . . . 70.21 112.366 -176.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.413 ' HB ' ' CE ' ' A' ' 491' ' ' LYS . 10.1 t -152.26 158.26 42.57 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.218 -1.03 . . . . 62.41 108.218 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 35.3 p -106.98 129.24 54.81 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 106.446 -1.687 . . . . 51.5 106.446 174.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -146.76 88.93 1.78 Allowed 'General case' 0 N--CA 1.41 -2.474 0 C-N-CA 119.713 -0.795 . . . . 71.41 111.941 -174.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 66.0 140.51 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.209 1.404 . . . . 73.54 114.656 177.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 485' ' ' SER . 7.6 p -85.82 107.53 16.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.552 -0.749 . . . . 70.4 112.13 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 32.7 m -124.37 96.55 4.95 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.064 -1.458 . . . . 52.3 107.064 173.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 1.9 mp 65.55 96.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.526 0.679 . . . . 64.33 109.358 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 160.34 -155.92 27.13 Favored Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 111.25 -0.74 . . . . 64.41 111.25 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -100.93 -92.66 2.14 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.372 -0.918 . . . . 61.3 112.55 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . 0.482 ' O ' ' HB ' ' A' ' 480' ' ' VAL . 19.8 m -89.39 -52.25 5.13 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.129 0.49 . . . . 71.14 110.282 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -168.34 114.98 0.59 Allowed Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.195 -0.669 . . . . 74.53 109.195 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 480' ' ' VAL . 38.0 Cg_exo -62.47 149.79 89.72 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.433 2.089 . . . . 55.54 112.039 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' A' ' 519' ' ' LEU . 39.2 mm -85.64 128.63 39.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 108.145 -1.057 . . . . 61.34 108.145 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -124.61 155.66 38.75 Favored 'General case' 0 CA--C 1.487 -1.455 0 O-C-N 122.117 -0.365 . . . . 73.42 110.962 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 49.4 t -74.04 125.91 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 108.592 -0.892 . . . . 72.12 108.592 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.413 ' CE ' ' HB ' ' A' ' 476' ' ' THR . 41.4 ttmt -82.54 -53.24 6.12 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.89 -0.781 . . . . 63.02 108.89 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -149.41 151.79 34.63 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.145 -0.934 . . . . 73.42 109.332 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.441 HG13 ' HA ' ' A' ' 506' ' ' LYS . 27.4 mm -114.39 106.83 21.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.175 -1.417 . . . . 71.25 107.175 175.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 495' ' ' PRO . 8.3 mp -50.55 157.79 1.2 Allowed Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 124.903 1.281 . . . . 55.24 113.124 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 494' ' ' LEU . 68.6 Cg_endo -72.21 -6.46 19.13 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 123.961 3.107 . . . . 41.33 111.979 -175.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.596 ' HA ' HG21 ' A' ' 500' ' ' ILE . 77.2 mtt180 -151.19 -161.05 1.25 Allowed 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.199 -0.91 . . . . 70.13 109.149 -174.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.601 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 81.48 -167.27 48.57 Favored Glycine 0 C--N 1.282 -2.461 0 CA-C-N 115.254 -0.885 . . . . 62.24 113.722 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.5 ' O ' HD23 ' A' ' 464' ' ' LEU . . . -65.76 -35.83 81.83 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 124.318 1.047 . . . . 63.53 110.377 -174.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.593 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -59.63 -39.62 84.91 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 115.089 -0.959 . . . . 53.41 112.331 -174.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.596 HG21 ' HA ' ' A' ' 496' ' ' ARG . 15.0 tt -80.09 -30.1 12.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 121.111 -0.235 . . . . 75.42 111.371 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 31.6 mm-40 -60.89 -45.57 94.06 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.879 -0.6 . . . . 74.5 110.307 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.472 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 7.5 t70 -92.67 -35.75 13.33 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.779 -0.823 . . . . 52.15 108.779 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 56.54 25.39 50.01 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 115.551 0.98 . . . . 72.21 115.551 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.54 ' HD3' HG23 ' A' ' 462' ' ' ILE . 63.9 ttt180 -99.95 -6.69 26.21 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.92 0.867 . . . . 73.23 109.331 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 44.4 tp -109.5 138.91 45.17 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.738 -1.208 . . . . 72.23 107.738 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.525 ' HD2' ' OD2' ' A' ' 509' ' ' ASP . 0.0 OUTLIER -138.27 177.5 7.84 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.597 -0.841 . . . . 75.11 109.149 175.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -82.99 29.12 0.48 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.513 0.673 . . . . 72.21 112.037 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . -126.23 13.7 7.03 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.021 -0.832 . . . . 72.14 111.021 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.525 ' OD2' ' HD2' ' A' ' 506' ' ' LYS . 42.6 m-20 -102.6 148.21 25.83 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 120.773 0.32 . . . . 74.45 110.694 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 544' ' ' VAL . 19.0 ttm180 -101.16 129.76 47.13 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 116.27 -0.423 . . . . 72.44 109.938 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.627 ' HB3' ' CD1' ' A' ' 519' ' ' LEU . 4.6 mm? -83.41 117.01 22.76 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 112.451 0.537 . . . . 61.24 112.451 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.4 HG13 ' HB2' ' A' ' 545' ' ' PHE . 45.9 mm -104.98 -39.63 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.69 0.757 . . . . 65.33 109.516 174.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 543' ' ' LEU . 30.8 tt0 -148.57 145.8 27.99 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 114.929 -1.032 . . . . 61.42 108.867 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.775 HG13 HD11 ' A' ' 530' ' ' LEU . 2.4 p -139.15 129.17 31.51 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.446 0 CA-C-N 115.051 -0.977 . . . . 72.34 108.375 174.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . 0.569 HD21 ' HB2' ' A' ' 535' ' ' LYS . 6.3 t-20 68.65 -58.92 0.47 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 127.712 2.405 . . . . 71.44 111.673 -176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 178.08 27.26 0.04 OUTLIER Glycine 0 C--N 1.296 -1.642 0 N-CA-C 110.081 -1.208 . . . . 54.12 110.081 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.88 136.76 57.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 109.829 -0.434 . . . . 63.31 109.829 -174.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.75 125.56 31.4 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.937 -0.764 . . . . 62.34 108.937 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 514' ' ' VAL . 32.5 mt -94.52 -35.2 12.38 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.01 -0.541 . . . . 74.3 112.061 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . . . . . . . . . 41.5 t -75.98 87.95 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 122.072 0.939 . . . . 74.43 110.374 -173.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.66 -26.51 1.19 Allowed Glycine 0 N--CA 1.425 -2.042 0 CA-C-N 114.132 -1.395 . . . . 32.45 110.142 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.31 176.95 4.99 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.808 0.337 . . . . 71.44 111.78 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 22.2 m -90.23 160.54 16.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.293 0.568 . . . . 51.12 112.394 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -53.0 -47.48 68.22 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.67 1.188 . . . . 74.31 113.834 177.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.49 ' HA ' HG22 ' A' ' 528' ' ' VAL . 46.6 mt-10 -62.65 -32.24 73.25 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 120.781 -0.368 . . . . 62.24 111.844 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.71 -38.81 92.5 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.075 0.464 . . . . 71.35 110.406 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 21.6 t -73.74 -41.42 54.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.738 -0.665 . . . . 74.04 109.61 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.601 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 11.4 m -65.65 -40.29 87.51 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 C-N-CA 119.462 -0.895 . . . . 75.24 110.456 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 27.6 m -63.06 -38.3 90.65 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.791 -0.641 . . . . 73.34 111.705 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.775 HD11 HG13 ' A' ' 514' ' ' VAL . 2.1 pp -69.56 -33.06 72.2 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.613 -0.884 . . . . 63.14 108.613 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.2 tt -65.22 -48.18 74.26 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 115.329 -0.85 . . . . 64.1 110.071 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 528' ' ' VAL . 30.5 mmm180 -61.2 -31.43 71.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.377 -0.828 . . . . 65.05 110.184 -177.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.0 t -76.39 -43.74 39.21 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.426 -0.806 . . . . 61.33 110.391 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 535' ' ' LYS . 12.6 m 64.49 177.41 0.18 Allowed 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 109.064 -0.717 . . . . 75.11 109.064 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.569 ' HB2' HD21 ' A' ' 515' ' ' ASN . 38.1 ttpt -102.33 139.5 37.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.833 -0.803 . . . . 51.33 108.833 175.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 88.1 mtp -65.36 -20.68 66.5 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.234 0.827 . . . . 53.21 113.234 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 33.4 tt0 -58.54 -39.07 79.17 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.431 -0.951 . . . . 71.14 108.431 172.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 115.96 -24.35 10.17 Favored Glycine 0 N--CA 1.431 -1.64 0 CA-C-N 114.878 -1.056 . . . . 75.55 112.443 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.485 ' O ' ' HE2' ' A' ' 535' ' ' LYS . 0.6 OUTLIER -96.17 140.69 30.51 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.707 -0.397 . . . . 70.33 109.944 -177.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 53.6 t -119.15 133.32 66.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 122.849 0.46 . . . . 64.2 111.544 174.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 462' ' ' ILE . 50.1 m -91.6 138.33 31.65 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.531 -0.759 . . . . 62.55 110.097 177.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.549 HD23 HD13 ' A' ' 464' ' ' LEU . 2.7 mm? -124.14 120.35 32.06 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 106.82 -1.548 . . . . 65.14 106.82 176.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 54.2 tp -104.88 117.07 33.12 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.027 -1.472 . . . . 64.3 107.027 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 510' ' ' ARG . 33.0 m -117.82 140.14 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.121 0 C-N-CA 119.907 -0.717 . . . . 74.01 111.701 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.429 ' HB3' ' HD2' ' A' ' 510' ' ' ARG . 62.2 t80 -111.3 116.79 31.6 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.138 -0.69 . . . . 70.32 109.138 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . 0.468 ' HD3' ' OD1' ' A' ' 509' ' ' ASP . 23.9 mtm180 -127.89 122.1 31.68 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.292 -1.003 . . . . 73.22 108.292 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . 0.51 ' HA ' ' HA2' ' A' ' 457' ' ' GLY . 9.9 tt0 -97.19 119.17 35.2 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.722 -1.214 . . . . 74.2 107.722 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . 0.502 ' HG2' ' H ' ' A' ' 549' ' ' ASP . 32.5 tt0 60.38 179.38 0.1 Allowed 'General case' 0 CA--C 1.564 1.509 0 O-C-N 124.408 1.067 . . . . 73.12 109.051 -174.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . 0.502 ' H ' ' HG2' ' A' ' 548' ' ' GLU . 31.2 t70 . . . . . 0 C--N 1.292 -1.932 0 O-C-N 121.29 -0.881 . . . . 54.42 108.797 175.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.293 0 N-CA-C 110.255 -1.138 . . . . 53.14 110.255 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 25.5 p -80.88 100.56 8.93 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 121.153 0.501 . . . . 73.43 110.949 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -162.42 109.53 1.3 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.788 -0.642 . . . . 72.24 110.315 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -102.18 136.6 41.74 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.501 -1.296 . . . . 73.14 107.501 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 40.2 p -80.18 95.02 6.15 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.994 0.902 . . . . 52.12 110.03 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -110.17 9.04 23.96 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.806 -1.088 . . . . 74.01 109.643 -173.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -120.77 165.52 15.02 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.53 -0.759 . . . . 73.31 110.372 -176.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 49.4 mm 54.01 97.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.242 1.417 . . . . 64.5 112.905 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 60.62 91.23 0.02 OUTLIER Glycine 0 CA--C 1.519 0.344 0 CA-C-N 116.182 -0.463 . . . . 44.35 112.537 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 545' ' ' PHE . 51.1 mtpt -96.13 151.96 18.99 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 113.159 0.8 . . . . 74.15 113.159 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 98.8 mtt180 -107.69 126.79 53.03 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 113.883 -1.508 . . . . 75.35 107.227 169.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 2.2 mm? -115.9 132.57 56.61 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 109.116 -0.698 . . . . 74.23 109.116 -176.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -98.14 120.18 38.1 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.393 -0.965 . . . . 73.01 108.393 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . 0.45 ' HA ' ' NH1' ' A' ' 504' ' ' ARG . 45.7 mt -122.16 142.64 37.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.898 -1.149 . . . . 61.01 107.898 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.55 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 93.1 mt-30 -123.03 125.97 46.23 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.606 0.717 . . . . 73.12 112.701 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 499' ' ' ALA . 7.9 mp -121.56 141.55 50.96 Favored 'General case' 0 CA--C 1.478 -1.802 0 CA-C-N 115.225 -0.898 . . . . 72.41 112.308 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 465' ' ' LYS . 39.7 ttmt -112.71 136.06 52.74 Favored 'General case' 0 N--CA 1.398 -3.031 0 CA-C-N 115.456 -0.793 . . . . 75.11 110.005 -176.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.543 ' HB2' HG21 ' A' ' 534' ' ' THR . 39.4 ttmt -65.93 113.74 4.62 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.724 -1.125 . . . . 73.42 111.865 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -93.1 -104.2 1.63 Allowed Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.142 -1.183 . . . . 62.01 110.142 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 41.5 m -90.73 -57.0 2.97 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 122.554 -0.38 . . . . 74.34 111.113 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -94.43 -33.51 13.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.933 -1.506 . . . . 62.33 106.933 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 79.51 -145.27 27.62 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 114.407 -1.27 . . . . 44.53 110.995 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.448 HD21 HG11 ' A' ' 540' ' ' VAL . 6.6 mp -43.43 97.64 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.205 1.187 . . . . 73.41 114.205 -172.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -103.79 50.08 0.9 Allowed Glycine 0 N--CA 1.433 -1.555 0 CA-C-N 114.432 -1.258 . . . . 63.0 112.417 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -133.39 146.67 51.45 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.537 -0.912 . . . . 71.33 108.537 175.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 47.1 m -116.03 156.97 25.39 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 108.465 -0.939 . . . . 54.11 108.465 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 12.2 pt -124.18 154.66 31.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.26 0.552 . . . . 72.22 111.799 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.8 t -142.07 159.03 43.04 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.05 -1.092 . . . . 70.22 108.05 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 64.4 p -107.97 134.42 50.91 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 107.65 -1.241 . . . . 73.22 107.65 174.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -88.11 -69.12 0.72 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.912 0.386 . . . . 60.33 110.398 -176.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -173.88 139.36 0.67 Allowed 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 106.412 -1.699 . . . . 74.23 106.412 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.487 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . 8.5 p -68.58 83.89 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 122.653 1.215 . . . . 71.43 112.855 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 38.2 p -93.32 -33.07 14.06 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.445 -1.252 . . . . 70.05 109.72 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 8.6 tp -141.42 140.57 31.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 CA-C-N 113.63 -1.623 . . . . 72.14 108.268 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 88.65 -164.16 32.77 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.716 -0.754 . . . . 45.45 111.273 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -119.12 146.3 18.28 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.805 -0.712 . . . . 75.13 111.703 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 57.1 m 70.31 -70.58 0.15 Allowed 'General case' 0 C--O 1.246 0.916 0 C-N-CA 124.461 1.104 . . . . 74.42 113.229 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . . . -163.29 129.62 2.34 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 110.393 -0.225 . . . . 42.31 110.393 -176.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 480' ' ' VAL . 2.4 Cg_endo -82.44 136.09 8.52 Favored 'Trans proline' 0 N--CA 1.438 -1.743 0 C-N-CA 122.151 1.901 . . . . 24.43 109.498 173.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.531 HG13 ' HB3' ' A' ' 519' ' ' LEU . 32.4 mm -89.95 131.37 37.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 116.135 -0.484 . . . . 74.24 109.971 -174.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 90.1 m-85 -129.97 161.63 30.48 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.091 0.556 . . . . 74.11 109.828 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 23.4 t -74.58 127.03 36.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.612 -0.884 . . . . 73.02 108.612 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -87.39 -51.18 6.08 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.741 -0.837 . . . . 73.33 108.741 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -159.0 157.84 32.04 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.282 -0.872 . . . . 73.34 109.307 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 507' ' ' ALA . 32.5 mm -121.07 109.33 24.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 106.523 -1.658 . . . . 73.21 106.523 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.411 ' HB3' ' HD2' ' A' ' 495' ' ' PRO . 3.7 mm? -56.12 158.95 6.47 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-N 115.575 -0.739 . . . . 74.31 111.761 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.422 ' HG2' ' HG2' ' A' ' 496' ' ' ARG . 26.5 Cg_endo -79.18 7.36 4.44 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 123.475 2.783 . . . . 72.43 111.453 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.665 ' HA ' HG21 ' A' ' 500' ' ' ILE . 17.3 ptp180 -159.41 -158.3 0.65 Allowed 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 115.728 -0.669 . . . . 75.15 110.371 -174.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 72.61 -157.46 52.66 Favored Glycine 0 C--N 1.287 -2.143 0 CA-C-N 114.954 -1.021 . . . . 74.55 111.013 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -69.85 -35.47 74.74 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 122.742 0.417 . . . . 74.21 111.242 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.515 ' HA ' ' CD2' ' A' ' 464' ' ' LEU . . . -58.07 -37.4 74.39 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 113.428 0.899 . . . . 70.14 113.428 -172.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.665 HG21 ' HA ' ' A' ' 496' ' ' ARG . 15.7 tt -79.71 -36.17 17.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 112.134 0.42 . . . . 65.41 112.134 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.51 HE21 HG23 ' A' ' 500' ' ' ILE . 28.9 mm-40 -63.75 -33.66 76.16 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.303 0.573 . . . . 74.24 110.789 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.407 ' CB ' ' HG ' ' A' ' 464' ' ' LEU . 16.5 t70 -89.75 -48.06 7.51 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.88 -0.6 . . . . 70.5 109.951 173.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 72.79 -3.49 27.04 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 117.559 1.784 . . . . 51.13 117.559 175.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.45 ' NH1' ' HA ' ' A' ' 462' ' ' ILE . 70.5 mtp180 -80.46 -15.06 57.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.882 1.341 . . . . 73.23 110.109 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 39.3 tp -96.49 134.47 39.64 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.282 -0.872 . . . . 61.24 108.949 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 506' ' ' LYS . 0.0 OUTLIER -142.76 175.41 9.83 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.765 -0.457 . . . . 65.01 109.765 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.531 ' HB2' HG12 ' A' ' 493' ' ' ILE . . . -102.4 82.74 2.21 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 120.351 -0.54 . . . . 42.33 110.676 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . -175.01 35.48 0.1 Allowed Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.306 -1.118 . . . . 61.24 110.306 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -153.76 177.19 11.26 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 122.96 0.504 . . . . 74.41 111.541 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.555 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 0.2 OUTLIER -115.19 142.31 46.83 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.358 0.503 . . . . 72.42 112.358 -174.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.628 ' HB3' HD12 ' A' ' 519' ' ' LEU . 4.6 mm? -85.3 128.06 34.56 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.889 -0.596 . . . . 70.23 112.599 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 36.6 mm -102.53 -58.77 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.062 0 CA-C-N 116.189 -0.46 . . . . 63.22 109.775 176.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.553 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.5 pt-20 -156.29 144.55 19.82 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 121.438 0.637 . . . . 51.55 111.056 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.738 HG12 HD21 ' A' ' 519' ' ' LEU . 2.6 p -130.61 135.2 60.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 N-CA-C 107.829 -1.174 . . . . 72.41 107.829 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 17.4 m120 66.47 9.91 6.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.52 0.728 . . . . 75.23 111.727 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 84.07 13.11 75.24 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 111.455 -0.658 . . . . 51.03 111.455 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.83 135.67 39.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.792 -0.818 . . . . 74.53 108.792 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.64 132.15 36.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.68 -0.489 . . . . 75.42 109.68 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.738 HD21 HG12 ' A' ' 514' ' ' VAL . 15.9 mt -97.76 -45.29 6.4 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 112.425 0.528 . . . . 71.45 112.425 -170.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' VAL . . . . . 0.531 HG21 HH21 ' A' ' 510' ' ' ARG . 59.8 t -78.41 99.9 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-O 121.787 0.803 . . . . 64.24 109.126 -175.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 143.68 -26.19 2.1 Favored Glycine 0 N--CA 1.414 -2.815 0 N-CA-C 109.249 -1.541 . . . . 74.11 109.249 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.01 179.71 4.25 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 110.163 -0.31 . . . . 73.33 110.163 175.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 46.5 t -87.3 155.02 20.24 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.268 0.556 . . . . 74.33 110.68 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 528' ' ' VAL . 28.8 mm-40 -54.55 -39.99 68.27 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.719 1.207 . . . . 74.02 111.41 174.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.443 ' HA ' HG22 ' A' ' 528' ' ' VAL . 42.9 mt-10 -66.81 -32.11 73.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.191 -0.459 . . . . 71.31 111.572 -176.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.18 -44.58 83.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.05 -0.523 . . . . 73.03 109.835 176.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 19.0 t -67.68 -43.56 86.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.665 -0.698 . . . . 61.34 109.634 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.524 ' O ' ' HG2' ' A' ' 532' ' ' ARG . 10.2 m -64.91 -38.73 83.52 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.044 0 C-N-CA 119.774 -0.77 . . . . 73.51 110.265 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.1 t -63.05 -45.43 92.24 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.857 -0.61 . . . . 62.43 110.763 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.625 HD11 HG13 ' A' ' 514' ' ' VAL . 2.6 pp -66.27 -35.52 80.61 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.441 0.639 . . . . 71.04 109.434 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.525 HD23 ' HE ' ' A' ' 532' ' ' ARG . 2.5 tt -62.11 -47.97 82.22 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.054 -0.976 . . . . 70.33 111.607 175.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.525 ' HE ' HD23 ' A' ' 531' ' ' LEU . 1.4 mmp_? -63.95 -37.08 86.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.105 -0.498 . . . . 73.03 109.705 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.2 m -67.4 -39.86 85.57 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.575 -0.739 . . . . 71.04 109.238 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 466' ' ' LYS . 95.3 m 72.78 -85.7 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.804 0.842 . . . . 71.24 111.599 177.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.539 ' HG2' ' H ' ' A' ' 537' ' ' GLU . 39.9 ttmt 170.8 133.67 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.71 1.204 . . . . 71.34 107.864 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 66.2 mtt -65.97 -29.26 69.62 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.666 0.269 . . . . 62.41 111.141 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . 0.539 ' H ' ' HG2' ' A' ' 535' ' ' LYS . 38.8 tt0 -74.07 -37.05 64.34 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.361 -0.381 . . . . 73.24 110.995 177.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 135.79 -45.48 1.09 Allowed Glycine 0 CA--C 1.539 1.584 0 N-CA-C 117.322 1.689 . . . . 75.31 117.322 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.411 ' CG2' ' HB3' ' A' ' 463' ' ' GLN . 5.5 m -101.95 140.19 36.58 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.442 1.121 . . . . 71.4 112.366 -172.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 69.2 t -113.52 140.28 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 124.037 0.935 . . . . 74.22 110.808 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 46.6 t -95.65 124.78 39.83 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.23 -0.656 . . . . 63.31 109.23 176.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.507 HD23 HD13 ' A' ' 464' ' ' LEU . 2.6 mm? -115.37 119.21 35.5 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.298 -1.371 . . . . 72.11 107.298 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 33.9 tp -108.54 117.37 34.0 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.074 -1.454 . . . . 71.53 107.074 174.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 35.6 m -116.17 150.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.803 -0.635 . . . . 71.32 110.837 -177.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 458' ' ' LYS . 69.6 t80 -112.14 116.52 30.62 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.207 -1.035 . . . . 72.51 108.207 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -116.57 130.74 56.92 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.817 -0.628 . . . . 73.21 110.474 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -82.9 128.07 34.1 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.01 -1.107 . . . . 73.55 108.01 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 64.61 -173.84 0.17 Allowed 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.126 0.97 . . . . 75.14 111.506 -175.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--N 1.302 -1.463 0 N-CA-C 109.018 -0.734 . . . . 74.52 109.018 -178.42 . . . . . . . . 0 0 . 1 stop_ save_